TransporterID	Gene_name	Protein_Name_generally	Synonyms	DrugID	Drug_Name	synonyms
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00015	Adefovir	((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00039	Glutathione	5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00044	Topotecan	(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin]
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00112	Irinotecan	(+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin]
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00135	Colchicine	(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide; 7-alpha-H-Colchicine; 7.alpha.H-Colchicine; 7alphaH-Colchicine; Benzo(a)heptalen-9(5H)-one; Binds to tubulin; C 9754; Colchicin; Colchicin [German]; Colchicina; Colchicina [Italian]; Colchicine (JP15/USP); Colchicine (TN); Colchicine [JAN]; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer; Colchicine, Colchicum autumnale; Colchicinum; Colchineos; Colchisol; Colchysat; Colcin; Colcrys; Colsaloid; Colstat; Condylon; Goutnil; Inhibits microtubular assembly; Kolkicin; LOC; MPC-004; N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide; N-Acetyl trimethylcolchicinic acid methylether; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; Spindle poison
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00143	Vincristine	22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00147	Ivermectin	IVERMECTIN; Ivermectin B1a; Dihydroavermectin B1a; 22,23-Dihydroavermectin B1a; 71827-03-7; avermectin H2B1a; UNII-91Y2202OUW
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00161	SN-38	(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00170	Epirubicin	(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00226	Saxagliptin	(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00264	Verapamil	(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00269	Mitoxantrone	1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00284	Daunorubicin	(+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00287	Resveratrol	(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; (E)-5-(p-Hydroxystyryl)resorcinol; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; (E)-resveratrol; 3,4',5-Stilbenetriol; 3,4',5-Trihydroxy-trans-stilbene; 3,4',5-Trihydroxystilbene; 3,4',5-trihydroxy-stilbene; 3,5,4'-Trihydroxy-trans-stilbene; 3,5,4'-Trihydroxystilbene; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CU-01000001503-3; Cis-resveratrol; KSC-10-164; KUC104385N; PREVENTION 8 (RESVERATROL); R 5010; RM-1812; Resveratrol-3-sulfate; Resvida; SRT 501; SRT-501; SRT501; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; Trans-3,4′,5-Trihydroxystilbene; Trans-3,4',5-trihydroxystilbene; Trans-resveratrol
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00290	Lopinavir	A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00299	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; Crixivan; Crixivan (TM); Crixivan (TN); IDV; Indinavir (*1:1 Sulfate salt*); Indinavir [USAN]; Indinavir, Sulfate (1:1); L 735524; L-735 524; L-735,524; L-735524; MK-639; N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; Propolis+Indinavir; RS-253
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00308	Vinblastine	(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00309	Saquinavir	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00312	Arsenite	13768-07-5; AC1L2NJ5; Arsenenous acid; Arsenite (ion)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00313	Cefadroxil	(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00319	Citalopram	1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; 1,3-dihydro[3,4]benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; AE-641/00603021; Akarin; Akarin (TN); Celapram; Celapram (TN); Celexa; Celexa (TN); Celius; Celius (TN); Ciazil; Ciazil (TN); Cilift; Cilift (TN); Cipram; Cipram (TN); Cipramil (TN); Ciprapine; Ciprapine (TN); Citabax; Citabax (TN); Citadur; Citadur (TN); Citalec; Citalec (TN); Citalopram (USP/INN); Citalopram [Celexa]; Citalopram [INN:BAN]; Citalopramum; Citalopramum [INN-Latin]; Citaxin (TN); Citol (TN); Citopam; Citopam (TN); Citox (TN); Citrol (TN); Cytalopram; Dalsan; Dalsan (TN); Humorup; Lu 10-171; Lu-10-171; Nitalapram; Oropram; Pramcit; Recital; Recital (TN); Seropram; Seropram (TN); Talam; Talam (TN); Talohexal; Temperax; Vodelax; Zentius; Zentius (TN); Zetalo; Zetalo (TN); [3H]Citalopram
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00344	Fluo-3	121714-13-4; 123632-39-3; 23D4W0B50Y; AC1L2XTQ; AKOS015894386; C11369; CHEBI:5107; CHEMBL509919; CTK8F0793; Fluo 3; Fluo-3; Fluo-3, suitable for fluorescence, ~70%; Fluo-3-AM; Glycine,N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-; OZLGRUXZXMRXGP-UHFFFAOYSA-N; SCHEMBL28109; UNII-23D4W0B50Y; ZINC8295051
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00386	Idarubicin	(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; DM5; DMDR; I 1656; IMI 30; IMI-30; Idamycin; Idamycin (TN); Idarubicin (INN); Idarubicin Hcl; Idarubicin Hcl Pfs; Idarubicin [INN:BAN]; Idarubicin hydrochloride; Idarubicina; Idarubicina [INN-Spanish]; Idarubicine; Idarubicine [INN-French]; Idarubicinum; Idarubicinum [INN-Latin]; Zavedos; Zavedos (TN)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00431	Phenytoin	2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00547	Fluorescein	fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00548	Ethacrynic acid	(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid; (2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid; (2,3-Dichloro-4-[2-methylenebutyryl]phenoxy)acetic acid; (4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid; 2,3-Dichloro-4(2-methylene-butyryl)phenoxy] acetic acid; 2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid; 2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid; 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; Acide etacrynique; Acide etacrynique [INN-French]; Acido etacrinico; Acido etacrinico [INN-Spanish]; Acidum etacrynicum; Acidum etacrynicum [INN-Latin]; Crinuryl; E0526; Edecril; Edecrin; Edecrin (TN); Edecrina; Endecril; Etacrinic acid; Etacrynic Acid; Etacrynic acid (JP15/INN); Etakrinic acid; Ethacrinic acid; Ethacrinique (acide); Ethacryinic Acid; Ethacrynate; Ethacrynic Acid, Sodium Salt; Ethacrynic acid (USP); Ethacrynic acid [USAN:BAN]; Hidromedin; Hydromedin; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova; Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech]; Kyselina ethakrynova; Kyselina ethakrynova [Czech]; MK 595; MK-595; Methylenebutyryl phenoxyacetic acid; Methylenebutyrylphenoxyacetic acid; Mingit; Otacril; Reomax; Taladren; Uregit; [2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid; [2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid;[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid; [2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid; [4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00595	Chlorpheniramine	1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine; 1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine; 3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; 3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; 3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; 4-Chloropheniramine; Aller-Chlor; Allergican; Allergisan; Antagonate; CHLORPHENIRAMINE (SEE ALSO: CHLORPHENIRAMINE MALEATE (CAS113-92-8)); Chlo-amine; Chlor-Pro; Chlor-Trimeton (TN); Chlor-Trimeton Repetabs; Chlor-Tripolon (TN); Chlor-trimeton; Chloropheniramine; Chlorophenylpyridamin; Chlorophenylpyridamine; Chloropiril; Chloroprophenpyridamine; Chlorphenamine; Chlorphenamine (INN); Chlorphenamine [INN]; Chlorphenaminum; Chlorphenaminum [INN-Latin]; Chlorpheniraminum; Chlorprophenpyridamine; Clofeniramina; Clofeniramina (TN); Clorfenamina; Clorfenamina [INN-Spanish]; Clorfeniramina; Clorfeniramina [Italian]; Cloropiril; Comakin (TN); Gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine; Gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine; Gen-Allerate; Haynon; Hayon; Histadur; ISOCLOR; Kloromin; Novo-Pheniram; Pediacare Allergy Formula; Phenetron; PiriIton; Piriton; Piriton (TN); Polaronil; Telachlor; Teldrin; [3H]Chlorpheniramine
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00638	Grepafloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN)
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR00846	Flutamide	1A Brand of Flutamide; 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide; 4'-Nitro-3'-(trifluoromethyl)isobutyranilide; 4'-Nitro-3'-trifluoromethylisobutyramilide; 4'-Nitro-3'-trifluoromethylisobutyranilide; 4-Nitro-3-(trifluoromethyl)isobutyranilide; Alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide; Alphapharm Brand of Flutamide; Apimid; Apo Flutamide; Apo-Flutamide; ApoFlutamide; Apogepha Brand of Flutamide; Apotex Brand of Flutamide; Azupharma Brand of Flutamide; Cebatrol; Cebatrol, veterinary; Cell pharm Brand of Flutamide; Chephasaar Brand of Flutamide; Chimax; Chiron Brand of Flutamide; Ciclum Brand of Flutamide; Cytamid; Drogenil; Esparma Brand of Flutamide; Essex Brand of Flutamide; Eulexin; Eulexin (TN); Eulexin, Flutamin, Drogenil,Flutamide; Eulexine; F 9397; F0663; Fluken; Flulem; Flumid; Fluta 1A Pharma; Fluta GRY; Fluta cell; Fluta-GRY; Fluta-cell; FlutaGRY; Flutacell; Flutamida; Flutamida [INN-Spanish]; Flutamide (AR inhibitor); Flutamide (JAN/USP/INN); Flutamide USP25; Flutamide [USAN:BAN:INN]; Flutamide(pubertal study); Flutamidum; Flutamidum [INN-Latin]; Flutamin; Flutandrona; Flutaplex; Flutexin; Fugerel; Gry Brand of Flutamide; Ham's F-12 medium; Hexal Brand of Flutamide; InibsaBrand of Flutamide; Ipsen Brand of Flutamide; Juta Brand of Flutamide; Kendrick Brand of Flutamide; Lemery Brand of Flutamide; M-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-(8CI); M-propionotoluidide,alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro; METHOXYCHLOR; NFBA; NK-601; Niftholide; Niftolid; Niftolide; Novo Flutamide; Novo-Flutamide; NovoFlutamide; Novopharm Brand of Flutamide; Odyne; Oncosal; PMS Flutamide; PMS-Flutamide; PUBERTAL FLUTAMIDE STUDY (PUBERTAL STUDIES OF VINCLOZOLIN; Pharmascience Brand of Flutamide; Prasfarma Brand of Flutamide; Prostacur; Prostandril; Prostica; Prostogenat; Q Pharm Brand of Flutamide; Q-Pharm Brand of Flutamide; SCH13521; Sch 13521; Sch-13521; Schering Brand of Flutamide; Schering Plough Brand of Flutamide; Schering-Plough Brand of Flutamide; TAD Brand of Flutamide; Tedec Meiji Brand of Flutamide; Testotard
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01203	Dactinomycin	1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; ACT D; ACTINOMYCIN D AMP; AD (VAN); Actactinomycin A IV; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin A IV; Actinomycin Aiv; Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin C1; Actinomycin D (JP15); Actinomycin D deriv. of 3H-phenoxaocardazine; Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin I1; Actinomycin IV; Actinomycin X 1; Actinomycin X1; Actinomycin cl; Actinomycin x i; Actinomycin-(threo-val-pro-sar-meval); Actinomycin-IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycindioic D acid, dilactone; Actinomyein-theo-val-pro-sar-meval; Acto-D; Antibiotic from Streptomyces parvullus; COSMEGEN (TN); Chounghwamycin B; Cosmegen; D Actinomycin; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; Dactinomicina; Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin D; Dactinomycin [USAN:BAN]; Dactinomycine; Dactinomycine [INN-French]; Dactinomycinum; Dactinomycinum [INN-Latin]; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; GNF-PF-1977; HBF 386; HBF 386 meractinomycin; Lyovac cosmegen; Meractinomycin; NP-005932; O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; Oncostatin K; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; X 97
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01215	Chlorcyclizine	1-(4-Chlorobenzhydryl)-4-methylpiperazine; Alergicide; Chlorcycline; Chlorcyclizine [INN:BAN]; Chlorcyclizinum; Chlorcyclizinum [INN-Latin]; Chlorocycline; Chlorocyclizine; Clorciclizina; Clorciclizina [DCIT]; Clorciclizinio [INN-Spanish]; Compound 47-282; Di-Paralene; Di-paralen; Diparalene; HSDB 3217; Histachlorazene; Histantin; Histantine; N-Methyl-N'-(4-chlorobenzhydryl)piperazine; NSC 25246; Perazyl; Piparalene; Trihistan; chlorcyclizine
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01378	99mTc-sestamibi	Sestamibi; RP-30; Tc-MIBI; Technetium-99m sestamibi
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01460	Phenethyl isothiocyanate	Phenethyl-isothiocyanate
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01473	Zoledronic acid	Aclasta; Reclast; ZOL; Zometa; Novartis brand of zoledronic acid; Zoledronic acid; Zometa Concentrate; Bisphosphonate 3; CGP 42446; CGP 42446A; Aclasta (TN); CGP 42'446; CGP-42446; KS-1132; Reclast (TN); Zoledronic acid (INN); Zoledronic acid [USAN:INN]; Zomera (TN); Zometa (Novartis); Zometa (TN); CGP-42'446; Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid; [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid); (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid; (1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate; 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid; 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01485	Leukotriene E4	Leukotriene E4; leukotriene E4; Leukotriene E; UNII-8EYT8ATL7G; 75715-89-8; 8EYT8ATL7G; CHEMBL509456; CHEBI:15650; OTZRAYGBFWZKMX-FRFVZSDQSA-N; 5S-hydroxy,6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C23H37NO5S; (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid; (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid; [3H]LTE4; AC1NQXPM; LEUKOTRIEN E4; BSPBio_001370; leukotriene E
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0001	ABCC1	Multidrug resistance-associated protein 1	ABC29; ABCC; ABCC1; ATP-binding cassette sub-family C member 1; GS-X; LTC4 transporter; Leukotriene C(4) transporter; MRP; MRP1	DR01698	Glutathione-S-S-glutathione	oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00010	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00013	Nilotinib	Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00015	Adefovir	((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00039	Glutathione	5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00050	Erythromycin	A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00066	Cidofovir	(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate; CDV; Cidofovir (Vistide); Cidofovir (anhydrous); Cidofovir anhydrous; Cidofovirum; Forvade; GS 0504; GS 504; GS-0504; GS-504; GS504; HPMPC; Vistide; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00071	Valsartan	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00112	Irinotecan	(+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin]
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00119	Arsenic trioxide	Acide arsenieux [French]; Anhydride arsenieux [French]; Arseni trioxydum; Arsenic blanc [French]; Arsenic oxide (As2O3); Arsenic trioxide (JP15/USAN); Arsenic trioxide [JAN]; Arsenic trioxide [UN1561] [Poison]; Arsenic(3+); Arsenic(III) trioxide; Arsenigen saure [German]; Arsenious Acid Anhydride; Arsenious trioxide; Arsenous oxide [ISO]; Arsenox; Arsentrioxide; Naonobin; Oxyde Arsenieux; Oxyde Arsenieux [ISO-French]; Oxygen(2-); Trisenox; Trisenox (TN); Trixenox
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00136	Regorafenib	24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00140	Ezetimibe	(-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00143	Vincristine	22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00161	SN-38	(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00170	Epirubicin	(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00195	Rhodamine 123	RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00196	Rifampicin	1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00201	Sulfasalazine	13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00213	Sincalide	CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00232	Probenecid	4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(Dipropylsulfamoyl)benzoic acid; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; 4-[(dipropylamino)sulfonyl]benzoic acid; Apurina; Bencid; Benecid; Benemid; Benemid (TN); Benemide; Benuryl; Benuryl (TN); Biokanol Brand of Probenecid; Col-BENEMID; ColBenemid (co mponent of); ColBenemid (component of); ICN Brand of Probenecid; IDIS Brand of Probenecid; Major Brand of Probenecid; Martec Brand of Probenecid; Merck Brand of Probenecid; Ophthalmic Brand of Probenecid; P-(Dipropylsulfamoyl)benzoic acid; P-(Dipropylsulfamyl)benzoic acid; P-[Dipropylsulfamoyl]benzoic acid; Panuric; Parabenem; Parmed Brand of Probenecid; Polycillin-BRB; Polycillin-PRB (component of); Pro-Cid; Probalan; Probampacin; Probecid; Proben; Probenecid (JP15/USP/INN); Probenecid Major Brand; Probenecid Martec Brand; Probenecid Parmed Brand; Probenecid Weimer; Probenecid Zenith Brand; Probenecid [INN:BAN:JAN]; Probenecid acid; Probenecida; Probenecida [INN-Spanish]; Probenecide; Probenecide [INN-French]; Probenecidum; Probenecidum [INN-Latin]; Probenemid; Probenicid; Probenid; Probexin; Prolongine; Robenecid; Sulprin; Synergid R; Tubophan; Uricosid; Urocid; Valdecasas Brand of Probenecid; Zenith Brand of Probenecid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00238	Leucovorin	5-formyltetrahydrofolate; Citrovorum factor; Folinic acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00243	Mycophenolate mofetil	2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00247	Vasopressin	ADH (hormone); American Pharmaceutical Brand of Vasopressin; American Regent Brand of Vasopressin; Antidiuretic Hormones; Antidiuretic hormone; Beta Hypophamine; Beta-Hypophamine; Inyectable de vasopresina; Inyectable de vasopresina [INN-Spanish]; Leiormone; Monarch Brand of Vasopressin; Parke-Davis Brand of Vasopressin (USP); Pitressin; Pitressin (TN); Pituitrin; Solute injectable de vasopressine; Solute injectable de vasopressine [INN-French]; Tonephin; Vasopressin (JP15/USP); Vasopressin (USP); Vasopressin Monarch Brand; Vasopressin injection; Vasopressina; Vasopressina [DCIT]; Vasopressine; Vasopressini injectio; Vasopressini injectio [INN-Latin]; Vasopressins; Vasopressinum
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00252	Bilirubin	21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00269	Mitoxantrone	1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00290	Lopinavir	A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00299	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; Crixivan; Crixivan (TM); Crixivan (TN); IDV; Indinavir (*1:1 Sulfate salt*); Indinavir [USAN]; Indinavir, Sulfate (1:1); L 735524; L-735 524; L-735,524; L-735524; MK-639; N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; Propolis+Indinavir; RS-253
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00308	Vinblastine	(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00309	Saquinavir	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00313	Cefadroxil	(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00316	Oxaliplatin	ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00318	Pemetrexed	(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN]
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00332	Ritonavir	1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 538, ABT; A-84538; ABBOTT-84538; ABT 538; ABT 84538; ABT-538; ABT538; Abbott 84538; DRG-0244; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; Norvir; Norvir (TM); Norvir (TN); Norvir Sec; RIT; RTV; Ritonavir (JAN/USAN/INN); Ritonavir [USAN]
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00367	Azithromycin	Azasite (TN); Azibiot; Azifine; Azithramycine; Azithromycin (INN); Azithromycin (TN); Zitrocin
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00391	Cerivastatin	.
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00395	Carbamazepine	Carbamazepine (iv, epilepsy); Carbamazepine (iv, epilepsy), Lundbeck; Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00399	Valproic Acid	2 PP (base); 2-Propylpentanoic acid; 2-Propylvaleric acid; 2-n-Propyl-n-valeric acid; 4-Heptanecarboxylic acid; Abbott 44090; Acide valproique; Acide valproique [INN-French]; Acido valproico; Acido valproico [INN-Spanish]; Acidum valproicum; Acidum valproicum [INN-Latin]; Alti-Valproic; Avugane; Baceca; Convulex; Convulex (TN); Convulsofin; Depacon (TN); Depakene; Depakene (TN); Depakin; Depakin chrono; Depakine; Depakine chrono; Depakote (TM); Depakote (TN); Depakote ER (TN); Deproic; Di-n-propylacetic acid; Di-n-propylessigsaeure; Di-n-propylessigsaure; Di-n-propylessigsaure [German]; Dipropyl Acetate; Dipropylacetate; Dipropylacetic acid; Dom-Valproic; Encorate (TN); Epilim (TN); Epival (TN); Ergenyl; G2M-777; Kyselina 2-propylvalerova; Kyselina 2-propylvalerova [Czech]; Med Valproic; Mylproin; Myproic Acid; N-DPA; N-Dipropylacetic acid; Novo-Valproic; Nu-Valproic; PMS-Valproic Acid; Penta-Valproic; Propylvaleric acid; Savicol; Semisodium Valproate; Stavzor; Stavzor (TN); VPA; Valproate; Valproic Acid, Sodium Salt (2:1); Valproic acid (USP); Valproic acid USP; Valproic acid USP24; Valproic acid [USAN:INN:BAN]; Valproinsaeure; Vupral; Winthrop (TN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00401	Talinolol	(+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin]
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00420	Nelfinavir	ARV-SR0121; NFV; Nelfinavir (SARS infection); Nelfinavir (SARS infection), aRigen; SARS therapy, aRigen; Viracept (SARS infection), aRigen
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00431	Phenytoin	2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00448	Cyclosporine	cyclosporin A; cyclosporine; Ciclosporin; Cyclosporine A; Ciclosporine; Neoral; Cyclosporin; Ciclosporinum; Ciclosporina; Sandimmune; Equoral; Neoplanta; Sandimmun; Sang-35; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; MFCD00274558; 83HN0GTJ6D; MLS001333756; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00471	Phenobarbital	5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione; 5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione; 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione; 5-Ethyl-5-phenylbarbituric acid; 5-Phenyl-5-ethylbarbituric acid;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione; 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; Acido 5-fenil-5-etilbarbiturico; Acido 5-fenil-5-etilbarbiturico [Italian]; Adonal; Aephe nal; Aephenal; Agrypnal; Amylofene; Antrocol; Aphenylbarbit; Aphenyletten; Arco-Lase Plus; Austrominal; Barbapil; Barbellen; Barbellon; Barbenyl; Barbilehae; Barbilehae (barbilettae); Barbinal; Barbipenyl; Barbiphen; Barbiphenyl; Barbipil; Barbita; Barbivis; Barbonal; Barbophen; Bardorm; Bartol; Bialminal; Blu-phen; Cabronal; Calmetten; Calminal; Cardenal; Chardonna-2; Chinoin; Codibarbita; Component of Antrocol; Component of Bronkotabs; Component of Hecadrol; Component of Primatene P; Component of Slowten; Component of Tedral; Component of Valpin 50-PB; Coronaletta; Cratecil; Damoral; Dezibarbitur; Donphen; Dormina; Dormiral; Dormital; Doscalun; Duneryl; Elixir of phenobarbital; Ensobarb; Ensodorm; Epanal; Epidorm; Epilol; Episedal; Epsylone; Eskabarb; Etilfen; Euneryl; Ezibarbitur; Fen osed; Fenbital; Fenemal; Fenobarbital; Fenobarbital [INN-Spanish]; Fenobarbitale; Fenobarbitale [DCIT]; Fenosed; Fenylettae; Gardenal; Gardepanyl; Glysoletten; Gustase-Plus; Haplopan; Haplos; Helional; Hennoletten; Henotal; Hypnaletten; Hypnette; Hypno-Tablinetten; Hypnogen; Hypnolone; Hypnoltol; Hysteps; Le phebar; Lefebar; Leonal; Lephebar; Lepinal; Lepinaletten; Levsin PB Drops and Tablets; Linasen; Liquital; Lixophen; Lubergal; Lubrokal; Lumen; Lumesettes; Lumesyn; Luminal; Luminal (TN); Lumofridetten; Luphenil; Luramin; Molinal; Neurobarb; Nirvonal; Noptil; Nova-Pheno; Nunol; PHOB; PUBERTAL PHENOBARBITAL STUDY; Pamine PB; Parkotal; Pharmetten; Phazyme-PB; Phen-Bar; Phenaemal; Phenemal; Phenemalum; Phenobal; Phenobarb; Phenobarbital (JP15/USP/INN); Phenobarbital (PB); Phenobarbital [USAN:INN:JAN]; Phenobarbital, Monosodium Salt; Phenobarbitalum; Phenobarbitalum [INN-Latin]; Phenobarbitalum [INN]; Phenobarbitol; Phenobarbitone; Phenobarbitonum; Phenobarbituric acid; Phenobarbyl; Phenoluric; Phenolurio; Phenomet; Phenonyl; Phenoturic; Phenyl-ethyl-barbituric acid; Phenylaethylbarbitursaeure; Phenylethyl barbituric acid; Phenylethylbarbiturate; Phenylethylbarbituric acid; Phenylethylbarbitursaeure; Phenylethylmalonylurea; Phenyletten; Phenylral; Phenyral; Polcominal; Promptonal; SK-Phenobarbital; Seda-Tablinen; Seda-tabl inen; Sedabar; Sedicat; Sedizorin; Sedlyn; Sedofen; Sedonal; Sedonal (sedative); Sedonettes; Sedophen; Sevenal; Solfoton; Solfoton talpheno; Solu-Barb; Sombutol; Somnolens; Somnoletten; Somnosan; Somonal; Spasepilin; Starifen; Starilettae; Stental; Stental Extentabs; Stental exte ntabs; Talpheno; Teolaxin; Teoloxin; Thenobarbital; Theoloxin; Theominal; Triabarb; Tridezibarbitur; Triphenatol; Valprin 50-PB; Versomnal; Zadoletten; Zadonal
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00513	Sulfinpyrazone	(+/-)-SULFINPYRAZONE; 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin; 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin [German]; 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl) pyrazolidine; 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione; 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl-3,5-pyrazolidinedione; 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione; 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione; Anturan; Anturane; Anturane (TN); Anturanil; Anturano; Anturen; Anturidin; Apo Sulfinpyrazone; Apo-Sulfinpyrazone; Apotex Brand of Sulfinpyrazone; Diphenylpyrazone; Enturan; Enturen; G 28,315; G 28315; Novartis Brand of Sulfinpyrazone; Novopyrazone; Nu Pharm Brand of Sulfinpyrazone; Nu Sulfinpyrazone; Nu-Pharm Brand of Sulfinpyrazone; Nu-Sulfinpyrazone; Sulfinpirazona; Sulfinpirazona [INN-Spanish]; Sulfinpyrazine; Sulfinpyrazon; Sulfinpyrazone (JP15/USP/INN); Sulfinpyrazone (SPZ); Sulfinpyrazone [USAN:INN:JAN]; Sulfinpyrazonum; Sulfinpyrazonum [INN-Latin]; Sulfoxyphenylpyrazolidin; Sulfoxyphenylpyrazolidine; Sulphinpyrazone; USAF GE-13
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00519	Tauroursodeoxycholate	TUDCA; Tauroursodeoxycholic acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00547	Fluorescein	fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D & C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00553	Ceftriaxone	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00576	Telithromycin	(1R,2R,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6R,7R,8R,10S,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2S,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; 11,12-Dideoxy-3-des(2,6-dideoxy-3-C,3-O-dimethyl-alpha-L-altropyranosyloxy)-6-O-methyl-3-oxo-12,11-(oxycarbonylimino)-N11-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]erythromycin A; HMR 3647; HMR-3647; HMR3647; Ketek; Ketek (TN); Levviax; RU 66647; RU-66647; RU66647; TEL; Telithromycin (JAN/USAN/INN); Telithromycin [USAN:BAN:INN]
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00638	Grepafloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00657	Cholic acid	(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00688	Gemifloxacin	7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid; 7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; Factiv; Factiv (TN); Factive; Factive (TN); Gemifloxacin (INN); Gemifloxacin [INN]; Gemifloxacin mesilate; LB 20304; LB 20304a; LB-20304; SB 265805; SB-265805
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00712	Ampicillin	6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00856	Mesalazine	2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00914	Glycyrrhizin	Uralsaponin A; glycyrrhizin; Glycyrrhizic acid; AC1L2TF0; Glycyrrhizin (JAN); Glycyrrhizinate; ZINC96319491; AKOS037514680; AKOS016036159; 3-Hydroxy-11 oxoolean-12-en-30-oic acid-3-O-glucuronopyranosyl-(1-2)glucuronopyranoside; D00157; C02284; beta-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-; (3beta,20beta)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucuronosyl-beta-D-glucosiduronic acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00950	Phlorizin	1-Propanone, 1-(2-(b; 1-[2-(beta-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone; 2'-(beta-D-Glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone; 60-81-1; AI3-19835; CHEBI:8113; CHEMBL245067; CU9S17279X; EINECS 200-487-1; Floridzin; IOUVKUPGCMBWBT-QNDFHXLGSA-N; NSC 2833; Phloretin 2'-glucoside; Phloretin-2'-O-beta-glucoside; Phloretin-2'-beta-glucoside; Phlorhizin; Phloridzin; Phloridzin dihydrate; Phloridzosid; Phlorizin; Phlorizine; Phlorizoside; Phlorrhizen; Phlorrhizin; UNII-CU9S17279X
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00958	Raltitrexed	(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; 112887-68-0; C21H22N4O6S; CHEBI:5847; CHEMBL225071; D 1694; D-1694; D1694; DSSTox_CID_26482; DSSTox_GSID_46482; DSSTox_RID_81653; FCB9EGG971; ICI D1694; ICI-D-1694; ICI-D1694; N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid; NCGC00229704-01; NSC-639186; Raltitrexed (Tomudex); Tomudex; UNII-FCB9EGG971; ZD 1694; ZD-16; ZD-1694; ZD1694
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR00988	Chelerythrine	broussonpapyrine; cheleritrine; chelerythrine hydroxide; toddalin
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01006	Acetaminophen	103-90-2; 4'-Hydroxyacetanilide; 4-Acetamidophenol; A-Per; APAP; Abenol; Abensanil; Abrol; Abrolet; Acamol; Accu-Tap; Acenol; Acephen; Acertol; Aceta Elixir; Acetaco; Acetagesic; Acetalgin; Acetaminofen; Acetamol; Acetavance; Acetofen; Actamin; Actifed Plus; Actimol; Afebrin; Afebryl; Aferadol; Algesidal; Algina; Algomol; Algotropyl; Alpiny; Alpinyl; Alvedon; Amadil; Aminofen; Anacin 3; Anaflon; Analter; Anapap; Andox; Anelix; Anhiba; Antidol; Anuphen; Apacet; Apadon; Apamide; Apitrelal; Arfen; Arthralgen; Asetam; Asomal; Aspac; Aspirin free anacin; Asplin; Atasol; Atralidon; Babikan; Bacetamol; Banesin; Bayer Select; Benmyo; Biocetamol; Cadafen; Calapol; Calmanticold; Calonal; Calpol; Capital; Captin; Causalon; Cefalex; Cetadol; Clixodyne; Codabrol; Codalgin; Codapane; Codicet; Codisal; Codoliprane; Cofamol; Conacetol; Cosutone; Cuponol; Curadon; Curpol; Custodial; D oliprane; Dafalgan; Darocet; Darvocet; Datril; Daygrip; Deminofen; Democyl; Demogripal; Desfebre; Dhamol; Dimindol; Dirox; Disprol; Dolcor; Dolefin; Dolegrippin; Dolgesic; Doliprane; Dolko; Dolofugin; Doloreduct; Dolorfug; Dolorstop; Dolotec; Dolprone; Dorocoff; Dresan; Dristancito; Duaneo; Dularin; Duorol; Duracetamol; Durapan; Dymadon; Dymadon Co; Dypap; Ecosetol; Elixodyne; Empracet; Enelfa; Eneril; Excipain; Exdol; Fanalgic; Farmadol; Febranine; Febrectal; Febrectol; Febrex; Febricet; Febridol; Febrilix; Febrin; Febrinol; Febrolin; Fendon; Fensum; Fepanil; Fevor; Finimal; Finiweh; Fluparmol; Fortalidon P; Gattaphen T; Gelocatil; Geluprane; Genapap; Genebs; Gripin Bebe; Grippostad; Gynospasmine; Hedex; Helon N; Homoolan; Ildamol; Inalgex; Infadrops; Influbene N; Injectapap; Janupap; Jin Gang; Kataprin; Korum; Labamol; Lekadol; Lemgrip; Lemsip; Lestemp; Liqiprine; Liquagesic; Lonarid; Lonarid Mono; Lupocet; Lyteca; Lyteca Syrup; Magnidol; Malex N; Malgis; Malidens; Maxadol; Medocodene; Mexalen; Minafen; Minoset; Miralgin; Momentum; Multin; N-(4-Hydroxyphenyl)acetamide; N-Acetyl-p-aminophenol; NEBS; Napafen; Naprinol; Nealgyl; NeoCitran; Neodol; Neodolito; Neopap; Neotrend; Neuridon; NilnOcen; Nina; Nobedon; Nodolex; Noral; Ofirmev; Oltyl; Oralgan; Ortensan; Oxycocet; Paceco; Pacemo; Pacemol; Pacet; Pacimol; Paedialgon; Paedol; Painex; Paldesic; Pamol; Panacete; Panadeine; Panadeine Co; Panadiene; Panadol; Panale ve; Panaleve; Panamax; Panasorb; Panasorbe; Panets; Panex; Panodil; Panofen; Pantalgin; Paracemol; Paracenol; Paracet; Paracetamol; Paracetamole; Paracetamolo; Paracetanol; Paracetol; Paracin; Paracod; Paracodol; Parador; Paradrops; Parakapton; Parake; Paralen; Paralief; Paralink; Paralyoc; Paramol; Paramolan; Paranox; Parapan; Parasedol; Parasin; Paraspen; Parcetol; Parelan; Parmol; Parogal; Paroma; Pasolind; Pasolind N; Pediapirin; Pediatrix; Pedric; Perfalgan; Phendon; Phenipirin; Phogoglandin; Pinex; Piramin; Pirinasol; Plicet; Polmofen; Predimol; Predualito; Prodol; Prompt; Prontina; Puernol; Pulmofen; Pyrigesic; Pyrinazine; Pyromed; Redutemp; Reliv; Remedol; Rivalgyl; Robigesic; Rounox; RubieMol; Rubophen; Rupemol; Salzone; Sanicet; Sanicopyrine; Scanol; Scentalgyl; Schmerzex; Sedalito; Semolacin; Servigesic; Seskamol; Setakop; Setamol; Setol; Sifenol; Sinaspril; Sinedol; Sinmol; Spalt N; Stanback; Stopain; Sunetheton; Supadol mono; Supofen; Suppap; TYL; Tabalgin; Tachiprina; Tapanol; Tapar; Tazamol; Temlo; Tempanal; Tempra; Termacet; Termalgin; Termalgine; Termofren; Tiffy; Titralgan; Toximer P; Tralgon; Treupel N; Treupel mon; Treuphadol; Tricoton; Tussapap; Ty lenol; Tylenol; Tylex; Tylex CD; Tylol; Tymol; Ultracet; Upsanol; Utragin; Valadol; Valgesic; Valorin; Veralgina; Vermidon; Verpol; Vips; Viruflu; Vivimed; Volpan; Zatinol; Zolben; acetaminophen; p-Acetamidophenol; p-Acetaminophenol; p-Hydroxyacetanilide
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01163	Octreotide	Octreotide; Octreotide acetate; Octreotidum; Octreotida; 79517-01-4; Sandostatin; UNII-RWM8CCW8GP; SMS 201-995; Longastatin; RWM8CCW8GP; SMS-201-995; CHEMBL1680; Octreotidum [Latin]; MFCD00871400; Octreotida [Spanish]; Octrotide; Octreotide [USAN:INN:BAN]; Octreotide-LAR; AC1L9M4X; Octreotide, >=98% (HPLC); SCHEMBL10044649; DEQANNDTNATYII-OULOTJBUSA-N; HMS2090C09; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01165	Gatifloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; AM 1155; AM-1155; AM-1155 (*Sesquihydrate*); BMS 206584-01; BMS-206584; BMS-206584-01; Bonoq; CG 5501;PD 135432; CG-5501; GTFX; Gaity; Gatiflo; Gatiflo (TN); Gatiflo,Tequin and Zymar, Gatifloxacin; Gatifloxacin & Gamma Interferon; Gatifloxacin (INN); Gatifloxacin (TN); Gatifloxacin [USAN:INN]; Gatilox; Gatiquin; Gatispan; PD-135432; PD135432; Tequin; Tequin (TN); Tequin in dextrose 5% in plastic container; Zymar; Zymar (TN); Zymaxid; Zymer; Zymer (TN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01166	Phenolphthalein	1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-; 1977/9/8; 3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone; 3,3-Bis(4-hydroxyphenyl)phthalide; Alophen; Chocolax; Colax; Correctol; Dihydroxyphthalophenone; Doxidan; Espotabs; Euchessina; Evac-Q-Kit; Evac-Q-Kwik; Evac-Q-Tabs; Evac-U-Gen; Ex-Lax; Feen-A-Mint Gum; FemiLax; Fenolftalein; Fenolftaleina; Koprol; Lax-Pills; Laxin; Laxogen; Lilo; Medilax; Phenolax; Phenolphtaleine; Phenophthalein; Phillips Gelcaps; Phthalimetten; Phthalin; Purga; Purgen; Purgophen; Spulmako-lax; Trilax; phenolphthalein
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01218	Mycophenolic acid	(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acide mycophenolique; Acido micofenolico; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum; CCRIS 5565; Lilly-68618; Ly 68618; Melbex; Micofenolico acido; Micofenolico acido [Spanish]; Mycophenoic acid; Mycophenolate; Mycophenolsaeure; Myfortic; NSC 129185; NSC-129185; UNII-HU9DX48N0T; mycophenolic acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01237	Technetium (99MTC) mebrofenin	F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01256	Succimer	(2R,3S)-rel-2,3-Dimercaptosuccinic acid; (R*,S*)-2,3-Dimercaptobutanedioic acid; 304-55-2; BRN 1725150; Butanedioic acid, 2,3-dimercapto-, (2R,3S)-rel-; Butanedioic acid, 2,3-dimercapto-, (R*,S*)-; CHEBI:63623; Chemet; DMSA; DX1U2629QE; Dim-sa; Dimercaptosuccinic acid; EINECS 206-155-2; HSDB 6783; Ro 1-7977; Succimer; Succimer [USAN:INN:BAN]; Succimero; Succimero [INN-Spanish]; Succimerum; Succimerum [INN-Latin]; UNII-DX1U2629QE; meso-2,3-Dimercaptobernsteinsaeure; meso-2,3-Dimercaptosuccinic acid; meso-Dimercaptosuccinic acid
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01257	Gadobenate dimeglumine	Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01316	Cefodizime	AC1NSFIB; CDZM; CHEBI:63214; CHEMBL2303613; Cefodizima; Cefodizima [INN-Spanish]; Cefodizime; Cefodizime (INN); Cefodizime Acid; Cefodizime [INN:BAN]; Cefodizimum; Cefodizimum [INN-Latin]; Cefodizme; DTXSID2022757; Diezime; EC 700-301-3; EX-A1379; HR 221 [AS SODIUM]; HR-221; HR-221 [As Sodium]; J-700161; Modivid; Neucef; S-771221B [As Sodium]; SCHEMBL151101; THR 221 [AS SODIUM]; THR-221; THR-221 [As Sodium]; Timecef; UNII-Z31298J4HQ; Z31298J4HQ
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01318	Genistein-7-glucoside	1POG3SCN5T; 4',5,7-trihydroxyisoflavone 7-D-glucoside; BRN 0064479; C21H20O10; CHEBI:27514; Genistein 7-O-beta-D-glucoside; Genistein 7-glucoside; Genistein glucoside; Genistein, 7-O-beta-D-glucoside; Genistein, 7-beta-D-glucopyranoside; Genistein-7-glucoside; Genisteol 7-monoglucoside; Genistin; Genistine; Genistoside; Glucopyranoside, genistein-7, beta-D-; Glucosyl-7-genistein; Isoflavone, 4',5,7-trihydroxy-, 7-D-glucoside; MFCD00016883; NSC 5112; UNII-1POG3SCN5T; ZCOLJUOHXJRHDI-CMWLGVBASA-N; genistein 7-O-glucoside
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01319	Temocaprilate	(+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; 2-(4-Carboxymethyl-5-oxo-2-thiophen-2-yl-[1,4]thiazepan-6-ylamino)-4-phenyl-butyric acid; 2D6A12Q12R; AC1L9E45; AJ-48035; AK116088; AKOS016010295; API0000849; AX8152551; BDBM50024710; O437; RNH 5139; RNH-5139; RS 5139; RS-5139; RT-015901; SCHEMBL498916; TL8000320; Temocapril Diacid; Temocaprilat; Temocaprilat [INN:BAN]; ZINC4099102; temocaprilate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01319	Temocaprilate	(+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; 2-(4-Carboxymethyl-5-oxo-2-thiophen-2-yl-[1,4]thiazepan-6-ylamino)-4-phenyl-butyric acid; 2D6A12Q12R; AC1L9E45; AJ-48035; AK116088; AKOS016010295; API0000849; AX8152551; BDBM50024710; O437; RNH 5139; RNH-5139; RS 5139; RS-5139; RT-015901; SCHEMBL498916; TL8000320; Temocapril Diacid; Temocaprilat; Temocaprilat [INN:BAN]; ZINC4099102; temocaprilate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01381	BQ-123	BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01383	Camptothecin	camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; (S)-Camptothecin; Camptothecine (8CI); 20(S)-Camptothecin; Camptothecine (S,+); CHEMBL65; UNII-XT3Z54Z28A; MLS000766223; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; XT3Z54Z28A; CHEBI:27656; VSJKWCGYPAHWDS-FQEVSTJZSA-N; Camptothecin, Camptotheca acuminata; NSC-94600; Camptothecin derivat
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01407	Pemirolast	Pemirolastum; Pemirox; Pemirolast [INN]; Pemiroplast Potassium; Alamast (TN); Alegysal (TN); Pemirolast (INN); Pemirolastum [INN-Latin]; Pemirox (TN); 9-TBX; 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one; 9-methyl-3-(2H-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01439	Belotecan	Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01440	5-methyltetrahydrofolate	5-methyl-THF; 5-methyl-tetrahydrofolate; 5-methyltetrahydrofolate; N5-methylfolate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01460	Phenethyl isothiocyanate	Phenethyl-isothiocyanate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01463	(-)-Epicatechin	(-)-Epicatechin; Epicatechin; 490-46-0; L-Epicatechin; (-)-Epicatechol; l-Acacatechin; (2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol; Epicatechol; l-Epicatechol; (-)epicatechin; (2R,3R)-(-)-Epicatechin; UNII-34PHS7TU43; epi-Catechin; epi-Catechol; CCRIS 7097; EINECS 207-710-1; NSC 81161; Epicatechol, (-)-; CHEBI:90; 34PHS7TU43; PFTAWBLQPZVEMU-UKRRQHHQSA-N; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; (-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol; AK105372; C15H14O6
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01545	Pitavastatin	Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN)
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01604	Alpha-Zearalenol	alpha-Zearalenol; trans-Zearalenol; cis-Zearalenol; alpha zearalenol; UNII-59D4EVJ5KC; Zearalenol; 59D4EVJ5KC; CHEMBL371463; CHEBI:35065; A-ZEARALENOL; (3S,7R,11E)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecin-1-one; .alpha.-Zearalenol; (-)-; A-Zearalenol; (2E,7R,11S)-7,15,17-trihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,14,16-tetraen-13-one; 36J; AC1NR4TQ; SCHEMBL343610; SCHEMBL109175; BIDD:ER0100; SGCUT00105; DTXSID8022402; FPQFYIAXQDXNOR-QDKLYSGJSA-N
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01605	Taxifolin	TAXIFOLIN; (+)-Taxifolin; dihydroquercetin; Distylin; Taxifoliol; (2R,3R)-Dihydroquercetin; (+)-Dihydroquercetin; TAXIFOLIN-(+); Lavitol; Lariksin; taxifolin (dihydroquercetin); 3,5,7,3',4'-Pentahydroxyflavanone; UNII-9SOB9E3987; trans-Dihydroquercetin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; (+)-trans-Taxifolin; (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE; (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01640	Scutellarin	Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01698	Glutathione-S-S-glutathione	oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H
DTD0002	ABCC2	Multidrug resistance-associated protein 2	ABC30; ABCC2; ATP-binding cassette sub-family C member 2; CMOAT; CMOAT1; CMRP; Canalicular multidrug resistance protein; Canalicular multispecific organic anion transporter 1; DJS; MRP2	DR01725	Olamufloxacin	Olamufloxacin; HSR-903; UNII-LJG8KL1435; HSR 903; LJG8KL1435; J-502473; (S)-5-Amino-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; (S)-(-)-5-Amino-7-(7-amino-5-azaspiro[2,4]hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid; 5-amino-7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-quinoline-3-carboxylic acid; Olamufloxacin [INN]; AC1Q5RCW; AC1L9XAZ; SCHEMBL1851976
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00001	Fesoterodine fumarate	Toviaz (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00002	Paraquat	1,1'-dimethyl-4,4' bipyridinium dichloride
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00008	Venetoclax	Venclexta
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00013	Nilotinib	Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00014	Simeprevir	TMC436
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00016	Meperidine	1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]; 1-Methyl-4-phenylisonipecotic acid, ethyl ester;1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester; 4-Carbethoxy-1-methyl-4-phenylpiperidine; 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester; Demarol; Demerol; Demerol (TN); Dolcontral; Dolosal; Dolsin; Ethyl 1-methyl-4-phenylisonipecotate; Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate; Isonipecain; Isonipecaine; Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester; Lidol; Lydol; Meperidine solution; Meperidol; Methyl phenylpiperidine carbonic acid ethyl ester; N-Methyl-4-phenyl-4-carbethoxypiperidine; Nemerol; Operidine EPJ I; Operidine EPJ-I; Pethanol; Pethidin; Pethidine; Pethidine (INN); Pethidine DBL; Pethidine DBL (TN); Pethidineter; Pethidinum; Pethidinum [INN-Latin]; Petidina; Petidina [INN-Spanish]; Petydyna; Petydyna [Polish]; Phetidine; Piperosal; Pipersal; YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00021	Teniposide	4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin thenylidene glucoside; 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside; 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside; Demethyl Epipodophyllotoxin Thenylidine Glucoside; Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); PTG; Teniposide (USAN/INN); Teniposide [USAN:BAN:INN]; Teniposido; Teniposido [INN-Spanish]; Teniposidum; Teniposidum [INN-Latin]; VM 26; VM-26; VM-26 (TN); Vee M-26; Veham-Sandoz; Vehem; Vumon; Vumon (TN); Vumon, VM-26, Vehem, NSC 122819, Teniposide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00026	Fexofenadine	2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00029	Moxidectin	C37H53NO8; Cydectin; Moxidectin [USAN:INN:BAN]; Moxidectina; Moxidectina [INN-Spanish]; Moxidectine; Moxidectine [INN-French]; Moxidectinum; Moxidectinum [INN-Latin]; NGU5H31YO9; ProHeart 6; UNII-NGU5H31YO9
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00032	Imatinib	112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00033	Atenolol	(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00035	Axitinib	AG 013736; AG-013736; AG-013736, Axitinib; AG-13736; AG013736; Axitinib (VEGFR inhibitor); N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00039	Glutathione	5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00044	Topotecan	(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00046	Levofloxacin	(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-Ofloxacin; (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; (R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (R)-isomer; (S)-(-)-Ofloxacin; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-Ofloxacin; Aeroquin; Cravit; Cravit (TN); Cravit Ophthalmic; D-Levofloxacin; DR 3354; DR-3355; DR-3355: L-isomer of ofloxacin; DR3355; Elequine; Floxacin; Floxel; HR 355; HR-355; Iquix; Iquix (TN); L-Ofloxacin; LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER; LFX; LVX; Leroxacin; Lesacin; Levaquin; Levaquin (TN); Levofloxacin (INN); Levofloxacin [USAN:INN:JAN]; Levofloxacin tablet, suspension or intravenous; Levofloxacine; Levofloxacine [INN-French];Levofloxacino [INN-Spanish]; Levofloxacino; Levofloxacinum; Levofloxacinum [INN-Latin]; Levokacin; Levox; Levoxacin; MP-376; Mosardal; Nofaxin; Ofloxacin; Ofloxacin S-(-)-form; Oftaquix; Oftaquix (TN); Quixin; Quixin (TN); R-Ofloxacin; RWJ 25213-097; RWJ-25213; Reskuin; S-(-)-Ofloxacin; Tavanic; Tavanic (TN); Volequin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00049	Levomilnacipran	(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide; (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide; 96847-54-0; AC1OCEN8; CHEMBL99946; F 2695; F-2695; Fetzima; Levomilnacipran (USAN/INN); Levomilnacipran HCl; Levomilnacipran [USAN:INN]; Milnacipram; UGM0326TXX; UNII-UGM0326TXX
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00050	Erythromycin	A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00054	Quinine	(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00056	Lamotrigine	3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine; BW 430C; BW-430C; Crisomet; Desitin Brand of Lamotrigine; EUR-1048; Faes Brand of Lamotrigine; GI 267119X; GW 273293; Glaxo Wellcome Brand of Lamotrigine; GlaxoSmithKline Brand of Lamotrigine; Juste Brand of Lamotrigine; L 3791; Labileno; Lamictal; Lamictal (TN); Lamictal Cd; Lamictal ODT; Lamictal XR; Lamictin; Lamictin (TN); Lamiktal; Lamitor; Lamotrigina; Lamotrigina [Spanish]; Lamotrigine (JAN/USAN/INN); Lamotrigine [USAN:INN:BAN]; Lamotriginum; Lamotriginum [Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00059	Tolvaptan	(-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide; 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine; Benzazepine derivative, 32; N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; OPC 41061; OPC-41061; Samsca; Samsca (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00061	Aliskiren fumarate	(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide; (2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]octanamide; Aliskiren (USAN/INN); Octanamide, .delta.-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-.gamma.-hydroxy-4-methoxy-3-(3-methoxypropoxy)-.alpha.,.zeta.-bis(1-methylethyl)-, [.alpha.S-(alpha.R*,.gamma.R*,.delta.R*,.zeta.R*)]; Rasilez; Rasilez (TN); SPP 100; Tekturna (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00063	Gemcitabine	2',2'-DiF-dC; 2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabina [INN-Spanish]; Gemcitabine (USAN/INN); Gemcitabine HCl; Gemcitabine stereoisomer; Gemcitabinum; Gemcitabinum [INN-Latin]; Gemtro; Gemzar; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY 188011; LY-188011; LY188011; Zefei
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00064	Indacaterol	5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one; 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one; Indacaterol (USAN/INN); QAB-149
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00069	Cabergoline	(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate; 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea; CG-101; Cabaser; Cabaser (TN); Cabaseril; Cabergolina; Cabergolina [Spanish]; Cabergoline (JAN/USAN/INN); Cabergoline [USAN:BAN:INN]; Cabergolinum; Cabergolinum [Latin]; Dostinex; Dostinex (TN); FCE-21336; Galastop; Sogilen
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00073	Rifaximin	Rifaximin; Rifaxidin; Rifacol; Xifaxan; Rifaximine; Rifamycin L 105; Rifamycin L 105SV; Rifaximina; Fatroximin; Normix; Rifaximinum; Rifamixin; Ritacol; Rifaximine [French]; Rifaximinum [Latin]; Rifaximina [Spanish]; Rifaximin [USAN:INN]; UNII-L36O5T016N; L 105SV; L 105 (Ansamacrolide antibiotic); L 105; C43H51N3O11; BRN 3584528; L36O5T016N; Rifaximin, 98%; Rifaximin (Xifaxan); MFCD00864973
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00075	Asunaprevir	BMS 650032; BMS-650032; Sunvepra
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00077	Brilinta	AR-C126532; AZD-6140; Brilique; Ticagrelor; Ticagrelor (USAN/INN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00080	Riociguat	625115-55-1; Adempas; BAY 63-2521; CHEBI:76018; Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate; Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester; RU3FE2Y4XI; Riociguat; Riociguat (BAY 63-2521); UNII-RU3FE2Y4XI; riociguatum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00086	L-tryptophan	(-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00088	Tramadol	Conzip; Rybix Odt; Ryzolt; Tramadol Hydrochloride; Ultram; Ultram Er
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00103	Ethinyl estradiol	17 alpha-Ethinylestradiol; 17 alpha-Ethynylestradiol; 17 alpha-Ethynyloestradiol; 17 alpha-ethinyestradiol; 17-Ethinyl-3,17-estradiol; 17-Ethinyl-3,17-oestradiol; 17-Ethinylestradiol; 17-Ethynylestradiol; 17-Ethynyloestradiol; 17-alpha-Ethinyl-17-beta-estradiol; 17-alpha-Ethynyl-17-beta-oestradiol; 17-alpha-Ethynylestradiol; 17-alpha-Ethynylestradiol-17-beta; 17-alpha-Ethynylestradiol-l7-beta; 17-alpha-Ethynyloestradiol-17-beta; 17-alpha-ethynyl estradiol; 17.alpha.-Ethinyl-17.beta.-estradiol; 17.alpha.-Ethinylestradiol; 17.alpha.-Ethynyl-17.beta.-oestradiol; 17.alpha.-Ethynylestradiol; 17.alpha.-Ethynyloestradiol; 17a-Ethynylestradiol; 17alpha-Ethinyl estradiol; 17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol-17beta; 17alpha-Ethynylestradiol; 17alpha-Ethynyloestradiol; 17alpha-Ethynyloestradiol-17beta; Aethinyloestradiolum; Aethinyoestradiol; Aethinyoestradiol [German]; Amenoron; Amenorone; Anovlar; Certostat; Chee-O-Gen; Chee-O-Genf; Component of Demulen; Component of Oracon; Component of Ortrel; Cyclosa; Dicromil; Diognat-E; Diogyn E; Diogyn-E; Diprol; Dyloform; EE(sub 2); EE2; ETHINYLESTRADIOL; Effik Brand of Ethinyl Estradiol; Ertonyl; Esteed; Estigyn; Estinyl; Estinyl (TN); Eston-E; Estopherol; Estoral; Estoral (Orion); Estoral (VAN);Estradiol, Ethinyl; Estoral [Orion]; Estorals; Estradiol, Ethynyl; Ethidol; Ethinoral; Ethinyl E2; Ethinyl Estradiol Hemihydrate; Ethinyl Estradiol [USP]; Ethinyl Estradiol, (8 alpha)-Isomer; Ethinyl Oestradiol Effik; Ethinyl estradiol (USP); Ethinyl-Oestradiol Effik; Ethinyl-oestranol; Ethinylestradiol (JP15/INN); Ethinylestradiol Jenapharm; Ethinylestradiol [INN:BAN:JAN]; Ethinylestradiolum; Ethinylestradiolum [INN-Latin]; Ethinylestriol; Ethinyloestradiol; Ethinyloestradiol [Steroidal oestrogens]; Ethy 11; Ethynyl estradiol; Ethynylestradiol; Ethynylestradiol, Ethinyl Estradiol; Ethynyloestradiol; Eticyclin; Eticyclol; Eticylol; Etinestrol; Etinestryl; Etinilestradiol; Etinilestradiol [INN-Spanish]; Etinilestradiolo; Etinilestradiolo [DCIT]; Etinoestryl; Etistradiol; Etivex; Feminone; Follicoral; Ginestrene; Hemihydrate, Ethinyl Estradiol; Inestra; Jenapharm Brand of Ethinyl Estradiol; Jenapharm, Ethinylestradiol; Kolpolyn; Linoral; Lynoral;Menolyn; Microfollin; Microfollin Forte; Neo-Estrone; Nogest-S; Novestrol; OVULEN-21; OVULEN-28; Oradiol; Orestralyn; Orestrayln; Organon Brand of Ethinyl Estradiol; Ortho-Cyclen; PUBERTAL ETHINYL ESTRADIOL STUDY; Palonyl; Perovex; Primogyn; Primogyn C; Primogyn M; Progynon C; Progynon M; Prosexol; Schering Brand of Ethinyl Estradiol; Spanestrin; Ylestrol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00108	Testosterone	(17beta)-17-Hydroxyandrost-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17-Hydroxy-4-androsten-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; 17b-hydroxy-4-androsten-3-one; 17beta-Hydroxy-3-oxo-4-androstene; 17beta-Hydroxy-4-androsten-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; 17beta-Hydroxyandrost-4-en-3-one; 17beta-Hydroxyandrost-4-ene-3-one; 4-Androsten-17-ol-3-one; 4-Androsten-17beta-ol-3-one; 4-androstene-17beta-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; AA 2500; Andro 100; AndroGel; Androderm; Androderm (TN); Androgel (TN); Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Androsorb; Androst-4-en-17beta-ol-3-one; Andrusol; Andryl 200; Beta testosterone; CDB 111C; CMC_13449; COL 1621; CP 601B; Cristerona T; Cristerone T; Delta(sup 4)-Androsten-17(beta)-ol-3-one; Delta4-Androsten-17beta-ol-3-one; Delta4-androsten-17b-ol-3-one; Depotest; Everone 200; Geno-cristaux gremy; Halotensin; Homosteron; Homosterone; Intrinsa; LibiGel; Malerone; Malestrone (amps); Malogen in Oil; Malogen, aquaspension injection; Mertestate; Neo-Hombreol F; Neo-testis; Neotestis; Oreton; Oreton F; Oreton-F; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Striant (TN); Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; Teslen; Testamone 100; Testandrone; Testaqua; Testiculosterone; Testim; Testim (TN); Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testosterona [INN-Spanish]; Testosterone (JAN/USP); Testosterone [Androgenic steroids, anabolic]; Testosterone [INN:BAN]; Testosterone and its esters; Testosterone hydrate; Testosterone solution; Testosteronum; Testosteronum [INN-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred Cypionate 200; Testrin-P.A; Testro AQ; Testrone; Testryl; Trans-Testosterone; Virilon IM; Virormone; Virosterone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00111	Posaconazole	Posaconazole; Noxafil; Sch 56592; Posaconazole SP; SCH56592; SCH-56592; UNII-6TK1G07BHZ; Schering 56592; CHEMBL1397; 6TK1G07BHZ; 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-5-(2,4-DIFLUOROPHENYL)TETRAHYDROFURAN-3-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)PHENYL)-1-((2S,3S)-2-HYDROXYPENTAN-3-YL)-1H-1,2,4-TRIAZOL-5(4H)-ONE
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00112	Irinotecan	(+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00113	Azathioprine	6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine; 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]; 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine; 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine; 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine; 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine; 6-(Methyl-p-nitro-5-imidazolyl)thiopurine; 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine; 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine; 6-[(1-Methyl-4-nitroimidazol-5-yl)-thio] purine; 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine; A 4638; AI-981/34845012; Azamun; Azamun (TN); Azamun [Czech]; Azanin; Azasan; Azasan (TN); Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine; Azathioprin; Azathioprine (JP15/USP/INN); Azathioprine [USAN:INN:BAN:JAN]; Azathioprine sodium; Azathioprinum; Azathioprinum [INN-Latin]; Azathiopurine; Azatiopr in; Azatioprin; Azatioprina; Azatioprina [INN-Spanish]; Azothioprine; B. W. 57-322; BW 57-322; BW 57322; BW-57-322; Ccucol; Cytostatics; Immuran; Imuran; Imuran (TN); Imurek; Imurel; Imurel (TN); Methylnitroimidazolylmercaptopurine; Muran; Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl); [Methyl(nitroimidazolyl)mercaptopurine]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00118	Sphingosine-1-phosphate	(2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00119	Arsenic trioxide	Acide arsenieux [French]; Anhydride arsenieux [French]; Arseni trioxydum; Arsenic blanc [French]; Arsenic oxide (As2O3); Arsenic trioxide (JP15/USAN); Arsenic trioxide [JAN]; Arsenic trioxide [UN1561] [Poison]; Arsenic(3+); Arsenic(III) trioxide; Arsenigen saure [German]; Arsenious Acid Anhydride; Arsenious trioxide; Arsenous oxide [ISO]; Arsenox; Arsentrioxide; Naonobin; Oxyde Arsenieux; Oxyde Arsenieux [ISO-French]; Oxygen(2-); Trisenox; Trisenox (TN); Trixenox
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00120	Lapatinib	4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline; FMM; GSK 572016; GSK572016; GW 572016; GW 572016X; GW572016; Lapatinib (ERBB2 inhibitor); Lapatinib (INN); Lapatinib Ditosylate; Lapatinib [INN]; Lapatinib tosilate hydrate; Lapatinib, Tykerb, GW572016; N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine; N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine; N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine; N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE; Tycerb; Tykerb (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00124	Fluvastatin	(+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00125	Levodopa	Levodopa (optimized formulation, Parkinson's disease); Levodopa (optimized formulation, Parkinson's disease), Orion; More effective levodopa (Parkinson's disease), Orion
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00127	Tetracycline	(-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00128	Methylprednisolone	Depo-medrol; M-predrol; Medrol; Medrol Acetate; Methylprednisolone Acetate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00129	Estradiol	17 beta-Estradiol; 17-.BETA.-Estradiol; 17-beta-OH-estradiol; 17-beta-estradiol; 17.beta.-Estradiol; 17.beta.-Oestradiol; 17b-Oestradiol; 17beta oestradiol; 17beta-Estradiol; 17beta-Oestradiol; 3,17-beta-Estradiol; 3,17-beta-Oestradiol; 3,17.beta.-Estradiol; 3,17beta-Estradiol; Activella (TN); Aerodiol; Alora; Alora (TN); Alpha-Estradiol; Alpha-Oestradiol; Altrad; AngeliQ (TN); Aquadiol; B-Estradiol; Bardiol; Beta-Oestradiol; Beta-estradiol; CMC_11154; Cis-Estradiol; Cis-Oestradiol; Climaderm; Climara; Climara (TN); Climara Forte; Component of Menrium; Compudose; Compudose 200; Compudose 365; Corpagen; D-3,17beta-Estradiol; D-Estradiol; D-Oestradiol; Dermestril; Destradiol; Dihydrofolliculin; Dihydromenformon; Dihydrotheelin; Dihydroxyesterin; Dihydroxyestrin; Dihydroxyoestrin; Dimenformon; Diogyn; Diogynets; Divigel; Divigel (TN); E 2; E 8875; E(sub 2); E0025; Elestrin; Elestrin (TN); Encore; Epiestriol 50; Esclim; Estrace; Estrace (TN); Estraderm; Estraderm (TN); Estraderm MX; Estraderm TTS; Estraderm TTS (TN); Estraderm TTS 100; Estraderm TTS 50; Estradiol [USAN:INN]; Estradiol acetate (TN); Estradiol cypionate (TN); Estradiol valerate (TN); Estradiol-17 beta; Estradiol-17-beta; Estradiol-17beta; Estradiol-3,17beta; Estradiolo; Estradiolo [DCIT]; Estradiolum; Estradiolum [INN]; Estradot; Estraldine; Estrapak 50; Estrasorb; Estrasorb (TN); Estrasorb Topical (TN); Estreva; Estrifam; Estring; Estring (TN); Estring vaginal ring; Estroclim; Estroclim 50; Estrodiolum; Estrofem (TN); Estrofem 2; Estrofem Forte; Estrogel; Estrogel (TN); Estrovite; EvaMist (TN); Evamist; Evorel; Extrasorb; Femanest; Femestral; Femestrol; Femogen; Fempatch; Femring (TN); Femtrace; Femtran; Follicyclin; Gelestra; Ginedisc; Ginosedol; GynPolar; Gynergon; Gynestrel; Gynodiol; Gynoestryl; Innofem; Innofem (TN); Lamdiol; Macrodiol; Macrol; Menest; Menorest; Menostar (TN); Microdiol; Nordicol; Oesclim; Oestergon; Oestradiol; Oestradiol Berco; Oestradiol R; Oestradiol-17-beta; Oestradiol-17beta; Oestradiolum; Oestrogel; Oestroglandol; Oestrogynal; Ovahormon; Ovasterol; Ovastevol; Ovociclina; Ovocyclin; Ovocycline; Ovocylin; Perlatanol; Polyestradiol; Primofol; Profoliol; Profoliol B; Progynon DH; Progynon-DH; Progynon;Syndiol; Progynova (TN); S-21400; SK-Estrogens; SL-1100; Sandrena 1; Sandrena Gel; Sisare Gel; Systen; Tradelia; Trial SAT; Trocosone; VIVELLE-DOT; Vagifem; Vagifem (TN); Vivelle; Vivelle (TN); Vivelle-Dot (TN); Zerella; Zesteem; Zesteen; Zumenon; [2,4,6,7-3H]-E2; [3H]-estradiol; [3H]]estradiol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00135	Colchicine	(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide; 7-alpha-H-Colchicine; 7.alpha.H-Colchicine; 7alphaH-Colchicine; Benzo(a)heptalen-9(5H)-one; Binds to tubulin; C 9754; Colchicin; Colchicin [German]; Colchicina; Colchicina [Italian]; Colchicine (JP15/USP); Colchicine (TN); Colchicine [JAN]; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer; Colchicine, Colchicum autumnale; Colchicinum; Colchineos; Colchisol; Colchysat; Colcin; Colcrys; Colsaloid; Colstat; Condylon; Goutnil; Inhibits microtubular assembly; Kolkicin; LOC; MPC-004; N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide; N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide; N-Acetyl trimethylcolchicinic acid methylether; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide; N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; Spindle poison
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00136	Regorafenib	24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00137	Nintedanib	(Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; 1160294-26-7; 656247-17-5; 928326-83-4; BIBF 1120; BIBF-1120; BIBF1120; CHEBI:85164; G6HRD2P839; Intedanib; Methyl (3z)-3-{[(4-{methyl[(4-Methylpiperazin-1-Yl)acetyl]amino}phenyl)amino](Phenyl)methylidene}-2-Oxo-2,3-Dihydro-1h-Indole-6-Carboxylate; Nintedanib (BIBF 1120); OFEV; UNII-G6HRD2P839; Vargatef
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00140	Ezetimibe	(-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00141	Methadone	(+)-Methadone; (+-)-Methadone; (+/-)-Methadone; (+/-)-Tussal; (-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; (-)-Methadone; (6R)-Methadone; (R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; (R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone; (S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; 3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)-(9CI); 6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture; 6-(dimethylamino)-4,4-diphenylheptan-3-one; 6-Dimethylamino-4,4-diphenyl-3-heptanone; 6-dimethylamino-4,4-di(phenyl)heptan-3-one; 6S-Methadone; A 4624; AN 148; AN-148 (*Hydrochloride*); Adanon; Algovetin; Althose; Amidon; Amidone; Amidone (TN); Biscuits; D-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; D-Methadone; Dextromethadone; Diaminon; Dl-Methadone; Dollies; Dolly; Dolophin; Dolophine; Dolophine (*Hydrochloride*); Dolophine (TN); Fenadone (*Hydrochloride*); Heptadon (TN); Heptadone; Heptadone (*Hydrochloride*); Heptanon; Heptanon (*Hydrochloride*); Heptanon (pharmaceutical); Hoechst 10820; Hoescht 10820 (*Hydrochloride*); K 174; Ketalgin; L-(+)-Methadone; L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone; L-Methadone; L-Polamidon; L-Polamivet; Levometadona; Levometadona [INN-Spanish]; Levomethadone [INN]; Levomethadonum; Levomethadonum [INN-Latin]; Levothyl; Metadona; Metadona [INN-Spanish]; Metadona [Spanish]; Metadone; Metadone [DCIT]; Metasedin; Methadon; Methadona; Methadona [Spanish]; Methadone (BAN); Methadone HCL Intensol; Methadone M; Methadone [INN:BAN]; Methadonum; Methadonum [INN-Latin]; Methadonum [Latin]; Methadose (TN); Methaquaione; Phenadone; Phenadone (*Hydrochloride*); Physeptone (TN); Polamidone; Polamivet; Racemic methadone; S-(+)-Methadone; Sedo-Rapide; Symoron (TN); Tussol; Westadone;Dolophine HCL
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00143	Vincristine	22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00144	Daclatasvir	1009119-64-5; 1214735-16-6; C40H50N8O6; CHEBI:82977; CHEMBL2023898; Daclatasvir (BMS-790052); Daclatasvir (USAN); Daclatasvir BMS 790052; EX-A410; KS-00000XPC; MLS006011140; SCHEMBL17897804; SCHEMBL2756027; cc-39; methyl N-[(1S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00146	Deflazacort	Deflan (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00147	Ivermectin	IVERMECTIN; Ivermectin B1a; Dihydroavermectin B1a; 22,23-Dihydroavermectin B1a; 71827-03-7; avermectin H2B1a; UNII-91Y2202OUW
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00151	Pomalidomide	Actimid (TN); Pomalidomide (Immunomodulator)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00154	Tretinoin	302-79-4; ATRA; Aberel; Airol; Aknefug; Aknoten; All-trans Retinoic Acid; Alltrans-retinoic acid; Atralin; Avitoin; Cordes vas; Dermairol; Effederm; Epi-aberel; Eudyna; Renova; Retin-A; Retin-A Micro; Retinoic acid; Retinoic acid, all-trans-; Retionic acid; TRETINON; Tretin M; Tretinoin; Vesanoid; Vitamin A acid; Vitamin A acid, all-trans-; Vitamin A1 acid, all-trans-; all-(E)-Retinoic acid; all-trans-Retinoic acid; all-trans-Tretinoin; all-trans-Vitamin A acid; all-trans-Vitamin A1 acid; beta-Ra; beta-Retinoic acid; trans-Retinoic acid; tretinoin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00159	Paliperidone	Invega Sustenna; JNS-010; Paliperidone (depot injection, NanoCrystal); Paliperidone (depot injection, NanoCrystal), Johnson & Johnson; Paliperidone (injectable, NanoCrystal), Elan; Paliperidone palmitate; Xeplion
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00163	Ranitidine	(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00164	Dabrafenib	1195765-45-7; CHEBI:75045; Dabrafenib (GSK2118436); Dabrafenib [USAN:INN]; GSK 2118436; GSK-2118436A; GSK2118436; GSK2118436A; N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide; N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide; QGP4HA4G1B; Tafinlar; UNII-QGP4HA4G1B
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00166	Edoxaban	Edoxaban
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00170	Epirubicin	(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00171	Loperamide	2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide; 4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide; 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide; Apo-Loperamide; Diamide (TN); Diarr-Eze; Dimor (TN); Imodium (TN); Imodium A-D Caplets; Ioperamide; Kaopectate II; Loperacap; Loperamida; Loperamida [INN-Spanish]; Loperamide (INN); Loperamide Monohydrochloride; Loperamide [INN:BAN]; Loperamidum; Loperamidum [INN-Latin]; Lopex (TN); Maalox Anti-Diarrheal; Nu-Loperamide; PMS-Loperamide; Pepto (TN); Pepto Diarrhea Control; R-18553; Rho-Loperamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00177	Cetirizine	(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid; (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid; Cetiderm; Cetiderm (TN); Cetirizin; Cetirizina; Cetirizina [Spanish]; Cetirizine (INN); Cetirizine [INN:BAN]; Cetirizinum; Cetirizinum [Latin]; Cetrizine Hcl; Cetryn; Hitrizin Film Tablet; P-071; Reactine (TN); Setir; Virlix; Ziptek; Zirtek; Zyrlex; Zyrtec (TN); [(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00180	Levetiracetam	(-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (2S)-2-(2-oxopyrrolidin-1-yl)butanamide; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; Etiracetam levo-isomer; Etiracetam, S-isomer; Keppra; Keppra (TN); Keppra XR; Keppra, Keppra XR),Levetiracetam; L-059; Levetiracetam [INN]; Levetiracetamum [INN-Latin]; Levetiractam; Leviteracetam; SIB-S1; Torleva; UCB-22059; UCB-L 059; UCB-L059; Ucb L060
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00181	Panobinostat	(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE; (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide; Faridak; LBH 589; LBH-589; LBH-589B; LBH589; NVP-LBH-589; NVP-LBH589; Panobinostat, NVP-LBH589, LBH589
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00182	Dasatinib	(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00183	Tacrine	1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE; 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE (SEE ALSO 1684-40-8); 1,2,3,4-Tetrahydro-9-acridineamine; 1,2,3,4-Tetrahydro-acridin-9-ylamine; 1,2,3,4-Tetrahydroaminoacridine; 1,2,3,4-tetrahydroacridin-9-amine; 5-Amino-6,7,8,9-tetrahydroacridine (European); 9-AMINOTETRAHYDROACRIDINE; 9-Acridinamine, 1,2,3,4-tetrahydro-(9CI); 9-Amino-1,2,3,4-Tetrahydroacridine Hydrate Hydrochloride Hydrate; 9-amino-1,2,3,4-tetrahydroacridine; BBL001044; CS 12602; Cognex; Cognex (TN); Romotal; Tacrina; Tacrina [INN-Spanish]; Tacrinal; Tacrinal (TN); Tacrine (INN); Tacrine [INN:BAN]; Tacrine hydrochloride; Tacrinum; Tacrinum [INN-Latin]; Tenakrin; Tetrahydroaminacrine; Tetrahydroaminoacridine; Tetrahydroaminocrin; Tetrahydroaminocrine; Tha
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00185	Pazopanib hydrochloride	5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide; 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide; 790713-33-6; 7RN5DR86CK; DSSTox_CID_28659; DSSTox_GSID_48733; DSSTox_RID_82929; GW 78603; GW 786034; GW-786034; GW786034; MFCD11616589; NCGC00188865-01; Pazopanib; Pazopanib (GW-786034); UNII-7RN5DR86CK; Votrient (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00186	Relugolix	Relumina; TAK-385
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00187	Prucalopride	0A09IUW5TP; 179474-81-8; 4-Amino-5-chloro-2,3-dihydro-N-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide; 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide; 4-Amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide; 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide; C18H26ClN3O3; CHEMBL117287; Motegrity; Prucalopride [USAN:INN:BAN]; R 093877; R-093877; R0-93877; R093877; UNII-0A09IUW5TP
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00190	Amoxicillin	(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00193	Tamoxifen	(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; Istubal (TN); Istubol; Nolvadex (TN); Nolvadex-D; Nourytam; Novaldex; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); TRANS FORM OF TAMOXIFEN; Tamizam; Tamone; Tamoplex (TN); Tamoxen; Tamoxifen (Hormonal therapy); Tamoxifen (INN); Tamoxifen (TN); Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; Tamoxifene; Tamoxifene [INN-French]; Tamoxifeno [INN-Spanish]; Tamoxifeno;Tamoxifenum; Tamoxifenum [INN-Latin]; Tomaxithen; Trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; Trans-Tamoxifen; Valodex; Valodex (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00195	Rhodamine 123	RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00196	Rifampicin	1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00203	Aspirin	2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00204	Ponatinib	Iclusig (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00211	Apixaban	1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd; Apixaban (JAN/USAN/INN); BMS 562247-01; BMS-562247; BMS-562247-01; BMS-562247-01, Apixaban; Eliquis (TN); GG2; Ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00212	Clomiphene citrate	Clomid; Clomiphene Citrate; Milophene; Serophene
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00215	Dexamethasone	(3H)-Dexamethasone; 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone; 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol; 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoroprednisolone; 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol; 16.alpha.-Methyl-9.alpha.-fluoroprednisolone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone; 16alpha-Methyl-9alpha-fluoroprednisolone; 9-alpha-Fluoro-16-alpha-methylprednisolone; 9.alpha.-Fluoro-16.alpha.-methylprednisolone; 9A-FLUORO-16BETA-METHYLPREDNISOLONE; 9alpha-Fluoro-16alpha-methylprednisolone; Adexone; Aeroseb-D; Aeroseb-Dex; Alcon Brand of Dexamethasone; Anaflogistico; Aphtasolon; Aphthasolone; Auxiron; Azium; Azium (Veterinary); Bisu DS; Calonat; Corson; Corsone; Cortisumman; DXM; Decacort; Decacortin; Decaderm; Decadron; Decadron (TN); Decadron Tablets, Elixir; Decadron, Dexamethasone; Decadron-LA; Decagel; Decaject; Decaject L.A.; Decaject-L.A.; Decalix; Decameth; Decasone; Decaspray; Dectancyl; Dekacort; Delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol; Delta1-9alpha-Fluoro-16alpha-methylcortisol; Deltafluorene; Dergramin; Deronil; Desadrene; Desametasone; Desametasone [DCIT]; Desamethasone; Desameton; Deseronil; Dex-ide; Dexa Mamallet; Dexa-Cortidelt;Dexa-Cortisyl; Dexa-Mamallet; Dexa-Scheroson; Dexa-sine; Dexacen-4; Dexacort; Dexacortal; Dexacortin; Dexadeltone; Dexafarma; Dexair; Dexalona; Dexaltin; Dexametasona; Dexametasona [INN-Spanish]; Dexameth; Dexamethansone; Dexamethasone (JP15/USP/INN); Dexamethasone Base; Dexamethasone Intensol; Dexamethasone [INN:BAN:JAN]; Dexamethasone alcohol; Dexamethasonum; Dexamethasonum [INN-Latin]; Dexamethazone; Dexamonozon; Dexapolcort; Dexaprol; Dexason; Dexasone; Dexinolon; Dexinoral; Dexone; Dexone 0.5; Dexone 0.75; Dexone 1.5; Dexone 4; Dexonium; Dexpak; Dextelan; Dezone; Dinormon; Dxms; ECR Brand of Dexamethasone; Fluormethylprednisolone; Fluormone; Fluorocort; Fortecortin; Foy Brand of Dexamethasone; Gammacorten; Hexadecadrol; Hexadrol; Hexadrol Elixir; Hexadrol Tablets; Hl-dex; ICN Brand of Dexamethasone; IontoDex; Isopto-Dex; Lokalison F; Loverine; Luxazone; MK 125; Maxidex; Mediamethasone; Merck Brand of Dexamethasone; Merz Brand 1 of Dexamethasone; Merz Brand 2 of Dexamethasone; Methylfluorprednisolone; Mexidex; Millicorten; Mymethasone; OTO-104; Ocu-trol;Pet-Derm Iii; Oradexon; Pet Derm III; Policort; Posurdex; Prednisolon F; Prednisolone F; Prodex; SK-Dexamethasone; Spoloven; Sunia Sol D; Superprednol; Turbinaire; Visumetazone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00216	Betrixaban	74RWP7W0J9; Betrixaban (USAN); Betrixaban [USAN:INN]; Bevyxxa; D0J0BU; EX-A358; GTPL9602; MolPort-009-682-948; PRT 054021; PRT054021; QCR-99; SCHEMBL158591; UNII-74RWP7W0J9; ZINC3; betrixaban maleate; betrixaban/
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00220	Eliglustat tartrate	Fabrazyme (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00221	Olaparib	4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one; 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one; AZD 2281; AZD-2281; AZD2281; Acylpiperazine analogue, 47; KU-0059436; KU-59436; Olaparib, KU-0059436, AZD2281,KU0059436, AZD2281
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00224	Everolimus	(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy; 40-O-(2-hydroxyethyl)-rapamycin; 42-O-(2-Hydroxyethyl)rapamycin; Afinitor; Afinitor (TN); CERTICAN(R); Certican; Certican (TN); Everolimus (JAN/USAN/INN); Everolimus [USAN]; MTOR kinase inhibitors; NVP-RAD-001; RAD 001; RAD-001; RAD-001C; RAD001; RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus; SDZ-RAD; Zortress
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00226	Saxagliptin	(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00227	Rivaroxaban	XARELTO (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00228	Ceritinib	1032900-25-6; 5-Chloro-N2-(5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl)-N4-(2-(propane-2-sulfonyl)phenyl)pyrim; 5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine; 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine; AK174337; C28H36ClN5O3S; CHEBI:78432; CHEMBL2403108; Eritinib (LDK378); K418KG2GET; LDK 378; LDK-378; LDK378; LDK378(Ceritinib); NVP-LDK378-NX; UNII-K418KG2GET; ZYKADIA; ceritinib
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00230	Hydrocortisone	11-beta-Hydrocortisone; 11-beta-Hydroxycortisone; 11beta,17,21-Trihydroxyprogesterone; 11beta-Hydrocortisone; 11beta-Hydroxycortisone; 17-Hydroxycorticosterone; 17alpha-Hydroxycorticosterone; ACETASOL HC; ACETIC ACID W/ HYDROCORTISONE; Acticort; Acticort (TN); Aeroseb HC; Aeroseb-HC; Ala-Cort; Ala-Scalp; Alacort; Algicirtis; Alphaderm; Amberin; Anflam; Anti-inflammatory hormone; Anucort; Anucort-HC; Anusol HC (TN); AnusolHC; Aquacort; Aquanil HC; Balneol-hc; Barseb HC; Basan-Corti; Beta-hc; COR-OTICIN; CaldeCORT Spray; Cetacort; Chronocort; Clear aid; Cleiton; Cobadex; Colocort; Colocort (TN); Component of Lubricort; Component of Neo-Cort-Dome; Component of Otalgine; Corhydron; Cort-Dome; Cortanal; Cortef; Cortef (TN); Cortenema; Cortesal; Corticreme; Cortifair; Cortifan; Cortiment; Cortisol; Cortisol alcohol; Cortisol, Hydrocortisone; Cortisolonum; Cortisporin; Cortisporin Otico; Cortispray; Cortolotion; Cortonema; Cortoxide; Cortril; Cremesone; Cremicort-H; Cutisol; Cyclodextrin-encapsulated hydrocortisone; Delacort; Derm-Aid; Dermacort; Dermaspray; Dermil; Dermocortal; Dermolate; Dihydrocostisone; Dioderm; Dome-cort; Domolene-HC; Drotic; DuoCort; Ef corlin; Efcorbin; Efcortelan; Efcortelin; Eldecort; Eldercort; Epicort; Epicortisol; Epiderm H; Esiderm H; Evacort; Ficortril; Fiocortril; Flexicort; Foille Insetti; Genacort; Genacort (lotion); Glycort; Gyno-Cortisone; H 4001; H-Cort; HC #1; HC #4; HC (HYDROCORTISONE); HYDROCORTISONE AND ACETIC ACID; HYDROCORTISONE IN ABSORBASE; Heb Cort; Heb-Cort; Hi-cor; Hidalone; Hidro-Colisona; Hidrocortisona [INN-Spanish]; Hycort; Hycortol; Hycortole; Hydracort; Hydrasson; Hydro-Adreson; Hydro-Colisona; Hydro-RX; Hydrocortal; Hydrocorticosterone; Hydrocortisone (JP15/USP/INN); Hydrocortisone [INN:BAN:JAN]; Hydrocortisone alcohol; Hydrocortisone base; Hydrocortisone free alcohol; Hydrocortisone solution; Hydrocortisone-Water Soluble; Hydrocortisonum [INN-Latin]; Hydrocortisyl; Hydrocortone; Hydroskin; Hydroxycortisone; Hytisone; Hytone; Hytone (TN); Hytone lotion; Idrocortisone; Idrocortisone [DCIT]; Incortin-H; Incortin-hydrogen; Kendall's compound F; Komed HC; Kyypakkaus; Lacticare HC; Lacticare-HC; Lactisona; Lubricort; Maintasone; Medicort; Meusicort; Mildison; Milliderm; Neo-Cortef; Neosporin-H Ear; Nogenic HC; Nutracort; Nystaform-HC; ORLEX HC; Optef; Otocort; Otosone-F; Pediotic Suspension; Penecort; Permicort; Polcort H; Preparation H Hydrocortisone Cream; Prepcort; Prevex HC; Proctocort; Proctozone HC; Protocort; Rectasol-HC; Rectoid; Reichstein's substance M; Remederm HC; Sanatison; Scalp-Cort; Scalpicin Capilar; Schericur; Scheroson F; Sigmacort; Signef; Stie-cort; Stiefcorcil; Synacort; Systral Hydrocort; Tarcortin; Texacort; Texacort lotion 25; Timocort; Transderma H; Traumaide; Uniderm; VoSol HC; Vytone; Zenoxone; [3H]cortisol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00233	Romidepsin	(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; Antibiotic FR 901228; Chromadax; Chromadax (TN); Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (35)-disulfide; FK 228; FK-228; FK-901228; FK228; FR 901228; FR-901228; FR901228; HDInhib_000006; Istodax; Istodax (TN); L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide; Romidepsin (USAN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00239	Digitoxin	5.beta.-Card-20(22)-enolide, 3.beta.,14-dihydroxy-, 3-[tris-(digitoxoside)]; Acedoxin; Asthenthilo; Cardidigin; Cardigin; Cardiolanata; Carditalin; Carditoxin; Coramedan; Cristapurat; Crystalline digitalin; Crystodigin; Crystodigin (TN); De-Tone; Digicor; Digilanid; Digilong; Digimed; Digimerck; Digipural; Digisidin; Digitalin, crystalline; Digitaline (TN); Digitaline cristallisee; Digitaline nativelle; Digitalinum verum; Digitoksim; Digitoksin; Digitophyllin; Digitossina; Digitossina [DCIT]; Digitoxigenin tridigitoxoside; Digitoxigenin-tridigitoxosid; Digitoxigenin-tridigitoxosid [German]; Digitoxin (JP15/USP/INN); Digitoxin [INN:BAN:JAN]; Digitoxina; Digitoxina [INN-Spanish]; Digitoxine; Digitoxine [INN-French]; Digitoxinum; Digitoxinum [INN-Latin]; Digitoxoside; Digitoxosidum; Digitrin; Ditaven; Glucodigin; Inhibits Na+/K+ ATPase; LT00244784; Lanatoxin; Lanostabil; Mono-digitoxid; Mono-digitoxid [German]; Mono-glycocard; Monodigitoxoside; Myodigin; Natigal; Pandigal; Panlanat; Purodigin; Purodigin, crystalline; Purpurid; Tardigal; Tri-digitoxoside; Tri-digitoxoside [German]; Unidigin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00241	Dabigatran	Pradaxa (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00243	Mycophenolate mofetil	2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00245	Clopidogrel	Clopidogrel (captisol-enabled); Clopidogrel (captisol-enabled), The Medicines Co; Clopidogrel (captisol-enabled, cardiovascular disease), Cydex; Clopidogrel (captisol-enabled, cardiovascular disease), Prism Pharmaceuticals; PM-103
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00246	Ranolazine	(-)-Ranolazine; CVT-303; KEG-1295; Latixa; N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide; RAN D; RS-43285; RS-43285-003; Ran4; Ranexa; Ranexa (TN); Ranexa, Ranolazine; Ranolazine (USAN/INN); Ranolazine 2HCl; Ranolazine dihydrochloride
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00249	Cannabidiol	(-)-CBD; (-)-Cannabidiol; (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; (-)-trans-Cannabidiol; 19GBJ60SN5; CBD; Epidiolex; GWP42003-P; QHMBSVQNZZTUGM-ZWKOTPCHSA-N; UNII-19GBJ60SN5; delta1(2)-trans-Cannabidiol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00250	Oseltamivir	(-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00253	Bosutinib	4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile; 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propo; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; Bosutinib (BCR-ABL inhibitor 3rd gen); Bosutinib (USAN); PF-5208763; SKI 606; SKI-606; SKI606; Xy]-3-quinolinecarbonitrile
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00254	Sitagliptin	(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00257	Biotin	Biodermatin; Bioepiderm; Bios II; Biotin Forte; Factor S; Lutavit H2; Meribin; Rovimix H2
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00261	Lenalidomide	3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; ALBB-015321; CC 5013; CC-5013; CC-5013, Revlimid, Lenalidomide; CC5013; CDC 501; CDC-501; CDC-5013; Celgene brand of lenalidomide; ENMD-0997; IMID-5013; IMiD3; IMiD3cpd; Lenalidomide (Immunomodulator); Lenalidomide (USAN/INN); Lenalidomide [USAN]; Revamid; Revimid; Revlimid; Revlimid (Celgene); Revlimid (TN); Thalidomide analog CC-5013
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00262	Sirolimus	(-)-Rapamycin; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29; 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; AY 22989; AY-22989; Antibiotic AY 22989; DE-109; Heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy; LCP-Siro; MS-R001; Perceiva; RAP; RAPA; RPM; Rapammune; Rapamune; Rapamune (TN); Rapamycin; Rapamycin (TN); Rapamycin C-7, analog 4; Rapamycin Immunosuppressant Drug; Rapamycin from Streptomyces hygroscopicus; SIIA 9268A; SILA 9268A; Sirolimus (MTOR inhibitor); Sirolimus (RAPAMUNE); Sirolimus (USAN/INN); Sirolimus [USAN:BAN:INN]; Sirolimus, Rapamune,Rapamycin; WY-090217; Wy 090217
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00263	Nizatidine	(E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Acinon; Acinon (TN); Antizid; Axid; Axid (TN); Axid Ar; Calmaxid; Cronizat; Distaxid; Galitidin; Gastrax; LY 139037; LY-139037; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin; Naxidine; Niatidine; Nizatidina; Nizatidina [Spanish]; Nizatidine (JAN/USP/INN); Nizatidine [USAN:BAN:INN:JAN]; Nizatidinum; Nizatidinum [Latin]; Nizax; Nizaxid; Panaxid; Splendil ER; Tazac; Tazac (TN); Ulcosol; Ulxid; ZE-101; ZL-101; Zanizal; Zinga
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00264	Verapamil	(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00265	Lenvatinib	4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide; E-7080, E7080; E7080
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00267	Indomethacin	Aconip; Aconip (TN); Amuno; Apo-Indomethacin; Arthrexin; Artracin; Artrinovo; Artrivia; Bonidin; Bonidon; Bonidon Gel; Catlep; Chibro-amuno; Chrono-indicid; Chrono-indocid; Confortid; DESMETHYL INDOMETHACIN; Dolcidium; Dolcidium PL;Flexin continus; Dolovin; Durametacin; Elmetacin; Hicin; I 7378; IMN; IN1454; Idomethine; Imbrilon; Inacid; Indacin; Indameth; Indmethacine; Indo-Lemmon; Indo-Spray; Indo-phlogont; Indo-rectolmin; Indo-tablinen; Indochron E-R (TN); Indocid; Indocid (TN); Indocid (pharmaceutical); Indocid Pda; Indocid Sr; Indocin; Indocin (TN); Indocin I.V; Indocin I.V.; Indocin Sr; Indocin-SR (TN); Indolar SR; Indomecol; Indomed; Indomee; Indomet 140; Indometacin; Indometacin (JP15/INN); Indometacina; Indometacina [INN-Spanish]; Indometacine; Indometacine [INN-French]; Indometacinum; Indometacinum [INN-Latin]; Indometacyna; Indometacyna [Polish]; Indomethacin & MAP-30; Indomethacin (USP); Indomethacin [USAN:BAN]; Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin; Indomethacine; Indomethacinum; Indomethancin; Indomethazine; Indomethegan; Indomethine; Indometicina; Indometicina [Spanish]; Indomo; Indomod; Indoptic; Indoptol; Indorektal; Indoxen; Inflazon; Infrocin; Inteban sp; Lausit; Liometacen; Metacen; Metartril; Methazine; Metindol; Mezolin; Miametan; Mikametan; Mobilan; Novo-Methacin; Novomethacin; Reumacide; Rhemacin LA; Rheumacin LA; Sadoreum; Tannex; Vonum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00269	Mitoxantrone	1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00271	Empagliflozin	(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; 864070-44-0; AK160980; BI 10773; BI-10773; BI10773; CHEBI:82720; Empagliflozin (BI 10773); HDC1R2M35U; JARDIANCE; UNII-HDC1R2M35U
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00279	Canagliflozin	(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene; 6S49DGR869; 842133-18-0; 928672-86-0; CHEBI:73274; Canagliflozin anhydrous; Canagliflozin hydrate; Invokana; JNJ 24831754ZAE; JNJ-28431754; TA 7284; TA-7284; UNII-6S49DGR869; canagliflozin hemihydrate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00280	Nicardipine	2-(Benzylmethylamino)ethylmethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester; 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cardene (TN); Cardene IV; Methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nicardipine (INN); Nicardipine LA; Nicardipine [INN:BAN]; Nicardipino; Nicardipino [INN-Spanish]; Nicardipinum; Nicardipinum [INN-Latin]; Y-93
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00281	Progesterone	LPCN-1107; Progesterone (oral, preterm labor); Progesterone (oral, preterm labor), Lipocine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00284	Daunorubicin	(+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00285	Silodosin	(R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide; 160970-64-9; CHEMBL24778; CUZ39LUY82; KAD 3213; KAD-3213; KMD 3213; KMD-3213; Q-102517; Rapaflo; Rapflo; Silodosin-d6; Silodyx; UNII-CUZ39LUY82; Urief; Urorec
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00290	Lopinavir	A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00299	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide; (2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; Crixivan; Crixivan (TM); Crixivan (TN); IDV; Indinavir (*1:1 Sulfate salt*); Indinavir [USAN]; Indinavir, Sulfate (1:1); L 735524; L-735 524; L-735,524; L-735524; MK-639; N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE; Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide; Propolis+Indinavir; RS-253
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00307	Berberine	0I8Y3P32UF; 2086-83-1; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLE; BRN 3570374; Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-; Berbamine sulphate acid; Berberal; Berberin; CHEBI:16118; CHEMBL12089; EINECS 218-229-1; ST055798; UNII-0I8Y3P32UF; Umbellatine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00308	Vinblastine	(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00309	Saquinavir	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00311	Ambrisentan	(+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid; 2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid; 2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; Ambrisentan [INN]; BSF 208075; BSF-208075; BSF208075; Benzenepropanoic acid, .alpha.-[(4,6-dimethyl-2-pyrimidinyl)oxy]-.beta.-methoxy-.beta.-phe; Gilead brand of ambrisentan; LU 208075; LU-208075; LU208075; Letairis
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00319	Citalopram	1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; 1,3-dihydro[3,4]benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; AE-641/00603021; Akarin; Akarin (TN); Celapram; Celapram (TN); Celexa; Celexa (TN); Celius; Celius (TN); Ciazil; Ciazil (TN); Cilift; Cilift (TN); Cipram; Cipram (TN); Cipramil (TN); Ciprapine; Ciprapine (TN); Citabax; Citabax (TN); Citadur; Citadur (TN); Citalec; Citalec (TN); Citalopram (USP/INN); Citalopram [Celexa]; Citalopram [INN:BAN]; Citalopramum; Citalopramum [INN-Latin]; Citaxin (TN); Citol (TN); Citopam; Citopam (TN); Citox (TN); Citrol (TN); Cytalopram; Dalsan; Dalsan (TN); Humorup; Lu 10-171; Lu-10-171; Nitalapram; Oropram; Pramcit; Recital; Recital (TN); Seropram; Seropram (TN); Talam; Talam (TN); Talohexal; Temperax; Vodelax; Zentius; Zentius (TN); Zetalo; Zetalo (TN); [3H]Citalopram
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00322	Baricitinib	1187594-09-7; Baricitinib (LY3009104, INCB028050); Baricitinib [USAN:INN]; C16H17N7O2S; INCB 028050; INCB-028050; INCB028050; ISP4442I3Y; J-503551; LY-3009104; LY3009104; Olumiant (TN); UNII-ISP4442I3Y; olumiant
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00331	Sumatriptan	(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide; 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide; 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide; GR 43175; GR 43175X; GR-43175; Imigran; Imigran (TN); Imitrex; Imitrex (TN); KS-1116; NP101; Sumatran; Sumatriptan (JAN/USP/INN); Sumatriptanum; Sumatriptanum [INN-Latin]; Sumax
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00332	Ritonavir	1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 538, ABT; A-84538; ABBOTT-84538; ABT 538; ABT 84538; ABT-538; ABT538; Abbott 84538; DRG-0244; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; Norvir; Norvir (TM); Norvir (TN); Norvir Sec; RIT; RTV; Ritonavir (JAN/USAN/INN); Ritonavir [USAN]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00334	Valinomycin	Antibiotic N-329 B; Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); Potassium ionophore I; UNII-N561YS75MN; Valinomicin; cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3; valino; valinomycin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00348	Metildigoxin	4'''-Methyldigoxin; 4'''-O-Methyldigoxin; Betamethyl digoxin; Digoxin, 4'''-O-methyl-; Lanirapid; Lanitop; MEDIGOXIN; Medigossina; Medigossina [DCIT]; Medigoxina; Medigoxina [Spanish]; Methyldigoxin; Metildigoxin; Metildigoxin [INN:BAN:JAN]; Metildigoxina; Metildigoxina [INN-Spanish]; Metildigoxine; Metildigoxine [INN-French]; Metildigoxinum; Metildigoxinum [INN-Latin]; beta-Methyl Digoxin; beta-Methyldigoxin; beta-Metildigoxina; beta-Metildigoxina [Spanish]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00354	Afatinib	(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide; BIBW 2992; BIBW-2992; EGFR inhibitor 2nd gens; Tomtovok; Tovok; Tovok (TN); Tovok, BIBW2992
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00357	Vibegron	Beova; Beova (TN); VIBEGRON; Vibegron (JAN/USAN); Vibegron [USAN:INN]; compound 7 [PMID: 26709102]; vibegronum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00358	Gilteritinib	6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide; ASP 2215; Gilteritinib; Gilteritinib (ASP-2215); Gilteritinib (ASP2215); Gilteritinib (USAN/INN); Gilteritinib [USAN:INN]; Gilteritinib(ASP2215); Xospata
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00360	Omadacycline	Amadacycline; Amadacycline (intravenous), Merck & Co; Amadacycline (intravenous), Paratek/Novartis; Amadacycline (oral), Merck & Co; Amadacycline (oral), Paratek/ Novartis; Antibacterial aminomethycyclines, Paratek/Bayer; MK-2764; Omadacycline; Omadacycline (intravenous), Merck & Co; Omadacycline (intravenous), Paratek; Omadacycline (intravenous), Paratek/ Novartis; Omadacycline (oral), Merck & Co; Omadacycline (oral), Paratek; Omadacycline (oral), Paratek/ Novartis; Omadacycline tosylate; P-000538; P-000642; P-001075; P-001207; P-001221; P-00136; P-002352; PTK-0796; PTK-796; Sancycline derivatives, Paratek; Tetracycline analogs, GlaxoSmithKline/Paratek; Tetracycline analogs, Paratek/Merck & Co;Tetracycline analogs (multi-drug-resistant infections), Paratek/Bayer
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00362	Ivosidenib	(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; Ivosidenib; Ivosidenib (USAN/INN); Ivosidenib [INN]; Ivosidenib [USAN]; Ivosidenib [WHO-DD]; Tibsovo
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00363	Baloxavir marboxil	(((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate; Baloxavir marboxil; Baloxavir marboxil (JAN/INN); Baloxavir marboxil [INN]; Xofluza (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00366	Talazoparib	(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one; (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one; (8s,9r)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1h-1,2,4-Triazol-5-Yl)-2,7,8,9-Tetrahydro-3h-Pyrido[4,3,2-De]phthalazin-3-One; LT-673; Talazoparib; Talazoparib (BMN 673); Talazoparib [USAN:INN]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00367	Azithromycin	Azasite (TN); Azibiot; Azifine; Azithramycine; Azithromycin (INN); Azithromycin (TN); Zitrocin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00372	Sofosbuvir	HSDB 8226; Hepcinat; Hepcvir; Resof; SOFOSBUVIR; Sofosbuvir (PSI-7977, GS-7977); Sofosbuvir [USAN:INN]; Sovaldi (TN); SoviHep
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00379	Melphalan	(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid; (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid; 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine; 4-(Bis(2-chloroethyl)amino)-L-phenylalanine; 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine; AY3360000; Alanine Nitrogen Mustard; Alkeran; Alkeran (TN); At-290; CB 3025; CB-3025; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine; L-PAM; L-Phenylalanine mustard; L-Sarcolysin; L-Sarcolysine; L-Sarkolysin; Levofalan; Levofolan; Levopholan; MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)); Melfalan; Melfalano; Melfalano [INN-Spanish]; Melphalan (JP15/USP/INN); Melphalan [USAN:INN:BAN:JAN]; Melphalanum; Melphalanum [INN-Latin]; P-Bis(beta-chloroethyl)aminophenylalanine; P-Di-(2-chloroethyl)amino-L-phenylalanine; P-L-Sarcolysin; P-L-sarcolysine; P-N,N-bis(2-chloroethyl)amino-L-phenylalanine; P-N-Bis(2-chloroethyl)amino-L-phenylalanine; P-N-Di(chloroethyl)aminophenylalanine; P-N-di(chloroethyl)aminophenylala nine; Phenylalanine mustard; Phenylalanine nitrogen mu stard; Phenylalanine nitrogen mustard; SK-15673; TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN); TRANSGENIC MODEL EVALUATION (MELPHALAN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00383	Dolutegravir	DTG; S/GSK1349572
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00384	Risperidone	3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one; 3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; Belivon; Consta, Risperdal; KS-1106; R 62 766; R 64 766, Risperdal, Risperidone; R 64,766; R 64766; R-118; R-64,766; R-64-766; R-64766; R64,766; R64766; Risperdal; Risperdal (TN); Risperdal Consta; Risperdal M-Tab; Risperdone; Risperidal; Risperidal M-Tab; Risperidona; Risperidona [Spanish]; Risperidone (JAN/USAN/INN); Risperidone (RIS); Risperidone [USAN:BAN:INN]; Risperidone, placebo; Risperidonum; Risperidonum [Latin]; Risperin; Rispolept; Rispolin; Sequinan
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00386	Idarubicin	(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; DM5; DMDR; I 1656; IMI 30; IMI-30; Idamycin; Idamycin (TN); Idarubicin (INN); Idarubicin Hcl; Idarubicin Hcl Pfs; Idarubicin [INN:BAN]; Idarubicin hydrochloride; Idarubicina; Idarubicina [INN-Spanish]; Idarubicine; Idarubicine [INN-French]; Idarubicinum; Idarubicinum [INN-Latin]; Zavedos; Zavedos (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00387	Omeprazole	(-)-Omeprazole; 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole; 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole; 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole; AGI-010; AULCER; Antra; Antra MUPS; Audazol; Axagon; Belmazol; Ceprandal; DM-3458; Danlox; Demeprazol; Desec; Dizprazol; Dudencer; Elgam; Emeproton; Emilok; Epirazole; Erbolin; Esomeprazol; Esomeprazole; Esomperazole; Esopral; Exter; Gasec; Gastrimut; Gastroloc; Gibancer; H 168-68; H 168/68; H-168/68; Indurgan; Inhibitron; Inhipump; Lensor; Logastric; Lomac; Losec; Losec (TN); Losec, Omesec, Prilosec, Zegerid, Omeprazole; Lucen; Mepral; Miol; Miracid; Mopral; Morecon; Nexium; Nexium IV; Nilsec; Nopramin; Nuclosina; O0359; OMEP; OMZ; Ocid; Olexin; Olit; Omapren; Omebeta; Omebeta 20; Omed; Omegast; Omepradex; Omepral; Omeprazol; Omeprazol [INN-Spanish]; Omeprazole (JAN/USP/INN); Omeprazole [USAN:INN:BAN:JAN]; Omeprazole delayed-release; Omeprazole magnesium; Omeprazolum; Omeprazolum [INN-Latin]; Omeprazon; Omeprazone; Omeprol; Omesek; Omez; Omezol; Omezolan; Omid; Omisec; Omizac; Ompanyt; Ortanol; Osiren; Ozoken; Paprazol; Parizac; Pepticum; Pepticus; Peptilcer; Prazentol; Prazidec; Prazolit; Prilosec; Prilosec (TN); Prilosec OTC; Procelac; Proclor; Prysma; Ramezol; Regulacid; Result; SAN-15; Sanamidol; Secrepina; Tedec Ulceral; Ulceral; Ulcesep; Ulcometion; Ulcozol; Ulcsep; Ulsen; Ultop; Ulzol; Victrix; Zefxon; Zegerid; Zepral; Zimor; Zoltum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00390	Fluvoxamine	(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine; 2-[({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine; Dumirox; Dumyrox; Faverin; Floxyfral; Fluvoxamina; Fluvoxamina [INN-Spanish]; Fluvoxamine (INN); Fluvoxamine [INN:BAN]; Fluvoxamine-CR; Fluvoxaminum; Fluvoxaminum [INN-Latin]; Luvox (TN); Maveral
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00391	Cerivastatin	.
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00393	Atomoxetine	(-)-Tomoxetine; (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine; Atomoxetine (INN); Attentin (TN); Strattera (TN); Tomoxetin (TN); Tomoxetina; Tomoxetina [Spanish]; Tomoxetine; Tomoxetine [INN]; Tomoxetinum; Tomoxetinum [Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00396	Nifedipine	AWD Pharma Brand of Nifedipine; Adalat; Adalat (TN); Adalat 10; Adalat 20; Adalat 5; Adalat CC; Adalat CR; Adalat Crono; Adalat FT; Adalat GITS; Adalat GITS 30; Adalat LA; Adalat LP; Adalat Oros; Adalat PA; Adalat Retard; Adalat XL; Adalate; Adalate LP; Adapine; Adapress; Adcock Ingram Brand of Nifedipine; Adipine XL; Afeditab; Afeditab CR; Afeditab CR (TN); Alat; Aldipin; Alfadal; Alonix; Alonix S; Alpha-Nifedipine Retard;Apo-Nifed; Angipec; Anifed; Anpine; Aprical; Aprical long; Bay-1040; Bay-a-1040; Bay1040; Bayer Brand of Nifedipine; Bonacid; Calcibloc; Calcigard; Calcilat; Camont; Cardifen; Cardilat; Cardionorm; Chronadalate; Chronadalate LP; Citilat; Coracten; Coracten XL; Coral; Cordafen; Cordaflex; Cordalat; Cordicant; Cordilan; Cordipin; Cordipine; Corinfar; Corotrend; Corynphar; Depin; Dignokonstant; Dilafed; Dipinkor; Duranifin; Ecodipi; Ecodipin; Ecodipin E; Emaberin; Fedcor; Fedcor Retard; Fenamon; Fenamon SR; Fenigidin; Fenihidin; Fenihidine; Fortipine LA; Glopir; Hadipin; Hexadilat; Infedipin; Introcar; KB-1712P; KRKA Brand of Nifedipine; Kordafen; Korinfar; Macorel; Megalat; Monohydrochloride, Nifedipine; Myogard; N 7634; N1fedilat; Nedipin; Nicardia; Nifangin; Nifar; Nifdemin; Nifebene; Nifecard; Nifecor; Nifedepat; Nifediac; Nifedical; Nifedical (TN); Nifedical XL; Nifedicor; Nifedin; Nifedine; Nifedipine (JP15/USP/INN); Nifedipine Bayer Brand; Nifedipine GTIS; Nifedipine KRKA Brand; Nifedipine Monohydrochloride; Nifedipine Orion Brand; Nifedipine Pfizer Brand; Nifedipine Retard; Nifedipine [USAN:BAN:INN:JAN]; Nifedipine-GTIS; Nifedipino; Nifedipino [INN-Spanish]; Nifedipinum; Nifedipinum [INN-Latin]; Nifedipres; Nifedirex LP; Nifelan; Nifelat; Nifelat Q; Nifelate; Nifensar XL; Nificard; Nifidine; Nifipen; Niphedipine; Orion Brand of Nifedipine; Orix; Oxcord; Pfizer Brand of Nifedipine; Pidilat; Procardia; Procardia (TN); Procardia XL; Sepamit; Slofedipine XL; Tensipine MR; Tibricol; Vascard; Zenusin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00397	Vindesine	3-(Aminocarbonyl)-O(sup 4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-(aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; 3-carbamoyl-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine; DAVA; Desacetylvinblastine amide; Lilly 112531; Methyl (5S,7S,9S)-9-[(2b,3b,4b,5a,12b,19a)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate; Methyl (5S,7S,9S)-9-[(2beta,3beta,4beta,5alpha,12beta,19alpha)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate; Vindesin; Vindesina; Vindesina [INN-Spanish]; Vindesine (USAN/INN); Vindesine [USAN:BAN:INN]; Vindesine [USAN:INN:BAN]; Vindesinum; Vindesinum [INN-Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00401	Talinolol	(+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00403	Paroxetine	(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine; (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine; (-)-Paroxetine; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine; (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine; (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; (3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine; 3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride; Aropax; BRL 29060; BRL-29060; Casbol; FG 7051; FG-7051; Frosinor; Motivan; NNC-20-7051; Paroxetina; Paroxetina [INN-Spanish]; Paroxetine (TN); Paroxetine (USP/INN); Paroxetine Hcl; Paroxetine [USAN:INN:BAN]; Paroxetinum; Paroxetinum [INN-Latin]; PaxPar; Paxetil; Paxil; Paxil (TN); Paxil CR;Seroxat CR; Pexeva; Seroxat; Seroxat (TN); [3H]Paroxetine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00406	Tacrolimus	(-)-FK 506; 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone; 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN; Advagraf; Advagraf (TN); FK 506; FK5; FK506; FR 900506; FR-900506; FR900506; Fk-506; Fujimycin; Graceptor; K506; L 679934; L-679934; LCP-Tacro; Modigraf; Prograf; Prograf (TN); Protopic; Protopic (TN); Protopy; Tacarolimus; Tacrolimus (INN); Tacrolimus (Prograf); Tacrolimus (anhydrous); Tacrolimus anhydrous; Tsukubaenolide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00410	Lovastatin	2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone; 6 Methylcompactin; 6 alpha-Methylcompactin; 6-Methylcompactin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin; Advicor (TN); Altocor; Altocor (TN); Altoprev; Altoprev (TN); Artein; Belvas; Cholestra; Closterol; Colevix; Hipolip; Hipovastin; L-154803; Lestatin; Lipdip; Lipivas; Lipofren; Liposcler; Lovalip; Lovalord; Lovastatin & Primycin; Lovastatin (USP/INN); Lovastatin [USAN:BAN:INN]; Lovastatin, (1 alpha(S*))-Isomer; Lovastatin, 1 alpha-Isomer (without R*/S* notation); Lovastatina; Lovastatina [Spanish]; Lovastatine; Lovastatine [French]; Lovastatinum; Lovastatinum [Latin]; Lovasterol; Lovastin; Lozutin; MK 803; MK-803; MK803; ML-530B; MSD 803; Mevacor; Mevacor (TN); Mevinacor; Mevinolin; Mevinolin from Aspergillus sp.; Mevlor; Monacolin K; Monakolin K; Nergadan; Paschol; Rextat; Rodatin; Rovacor; Sivlor;Taucor; Statosan (TN); Tecnolip; Teroltrat
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00412	Efavirenz	(-)-Efavirenz; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; DMP 266; DMP-266; EFV; EFZ; Efavirenz (JAN/INN); Efavirenz, (S)-isomer; Eravirenz; L 743726; L-741211; L-743,726; L-743725; L-743726; Met-SDF-1.beta. & Efavirenz; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; Stocrin; Stocrin (TN); Strocin (TM); Sustiva; Sustiva (TM); Sustiva (TN); Zoxazin-2-one
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00416	Cytarabine	(beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00420	Nelfinavir	ARV-SR0121; NFV; Nelfinavir (SARS infection); Nelfinavir (SARS infection), aRigen; SARS therapy, aRigen; Viracept (SARS infection), aRigen
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00423	Gefitinib	4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00426	Haloperidol	Aldo; Aloperidin; Aloperidin (TN); Aloperidol; Aloperidolo; Aloperidolo [DCIT]; Aloperidolo [Italian]; Aloperidon; Apo-Haloperidol; Bioperidolo; Bioperidolo (TN); Brotopon; Brotopon (TN); Dozic; Dozic (TN); Dozix; Duraperidol (TN); Einalon S; Einalon S (TN); Eukystol; Eukystol (TN); Fortunan; Galoperidol; H 1512; Haldol; Haldol (TN); Haldol La; Haldol Solutab; Halidol; Halojust; Halol; Halopal; Haloperido; Haloperidol (JP15/USP); Haloperidol (JP15/USP/INN); Haloperidol [USAN:INN:BAN:JAN]; Haloperidolum; Haloperidolum [INN-Latin]; Halopidol; Halopoidol; Halosten; Halosten (TN); Keselan; Keselan (TN); Lealgin compositum; Linton; Linton (TN);Novo-Peridol; McN-JR-1625; Mixidol; Pekuces; Peluces; Peluces (TN); Peridol; Pernox; Pms Haloperidol; R 1625; R-1625; Serenace; Serenace (TN); Serenase; Serenase (TN); Serenelfi; Sernas; Sernel; Sigaperidol; Sigaperidol (TN); Ulcolind; Uliolind; Vesalium
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00428	Prednisolone	Nanocort; Prednisolone (injectable liposome formulation, rheumatoid arthritis); Prednisolone (injectable liposome formulation, rheumatoid arthritis), Enceladus; Prednisolone (injectable liposome formulation, rheumatoid arthritis), Galapagos
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00429	Losartan	(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol; (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol; 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole; CL23623; Cozaar; Cozaar (TN); DUP 89; DuP-753; Hyzaar; LOSARTAN POTASSIUM; Lortaan; Losartan (INN); Losartan [INN:BAN]; Losartan monopotassium salt; Losartic; Losartic (TN); MK-954; MK954; [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00430	Fentanyl	Abstral; Actiq; Duragesic-100; Duragesic-12; Duragesic-25; Duragesic-50; Duragesic-75; Fentanyl; Fentanyl Citrate; Fentanyl Citrate Preservative Free; Fentanyl-100; Fentanyl-12; Fentanyl-25; Fentanyl-37; Fentanyl-50; Fentanyl-62; Fentanyl-75; Fentanyl-87; Fentora; Lazanda; Onsolis; Sublimaze Preservative Free; Subsys
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00431	Phenytoin	2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00432	Temsirolimus	Torisel
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00435	Simvastatin	(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; Cholestat; Coledis; Colemin; Corolin; DRG-0320; Denan; KS-1113; L 644128-000U; Labistatin; Lipex; Lipovas; Lodales; MK 0733; MK 733; MK-0733; MK-733; MK733; Medipo; Nivelipol; Pantok; Rendapid; Simcard (TN); Simlup (TN); Simovil; Simvacor (TN); Simvast CR; Simvastatin & Primycin; Simvastatin (JAN/USP/INN); Simvastatin [USAN:INN:BAN]; Simvastatin, Compactin; Simvastatina; Simvastatina [Spanish]; Simvastatine; Simvastatine [French]; Simvastatinum; Simvastatinum [Latin]; Sinvacor; Sivastin; Synvinolin; TNP00259; Vasotenal; Zocor; Zocor (TN); Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin; Zocord; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00438	Prednisone	(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione; (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione; (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione; 1,2-Dehydrocortisone; 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione; 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione; 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione; 1-Cortisone; 1-Dehydrocortisone; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione; 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione; Adasone; Ancortone; Apo-Prednisone; Bicortone; Cartancyl; Colisone; Cortan; Cortidelt; Cotone; Dacorten; Dacortin; Decortancyl; Decortin; Decortisyl; Dehydrocortisone; Dekortin; Dellacort; Dellacort A; Delta E; Delta E.; Delta cortelan; Delta(sup 1)-Cortisone; Delta(sup 1)-Dehydrocortisone; Delta(sup1)-Cortisone; Delta-1-Cortisone; Delta-1-Dehydrocortisone; Delta-Cortelan; Delta-Cortisone; Delta-Cortone; Delta-Dome; Delta-E; Delta1-Cortisone; Delta1-Dehydrocortisone; Deltacortene; Deltacortisone; Deltacortone; Deltasone; Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone; Deltison; Deltisona; Deltisone; Deltra; Di-Adreson; Diadreson; Econosone; Encorton; Encortone; Enkortolon; Enkorton; Fiasone; Hostacortin; In-Sone; Incocortyl; Juvason; Kortancyl; Liquid Pred; Lisacort; Lodotra; Me-Korti; Metacortandracin; Meticortelone (TN); Meticorten; Meticorten (TN); Meticorten (Veterinary); Metrevet (Veterinary); Nisona; Nizon; Novoprednisone; Nurison; Orasone; Origen Prednisone; P1276; Panafcort; Panasol; Paracort; Parmenison; Pehacort; Precort; Predeltin; Prednicen-M; Prednicorm; Prednicort; Prednicot; Prednidib; Prednilonga; Prednison; Prednisona; Prednisona [INN-Spanish]; Prednisone Intensol; Prednisone [INN:BAN]; Prednisonum; Prednisonum [INN-Latin]; Prednitone; Prednizon; Prednovister; Presone; Pronison; Pronisone; Rectodelt; Retrocortine; SK-Prednisone; Servisone; Sone; Sterapred; Supercortil; U 6020; Ultracorten; Ultracortene; Winpred; Wojtab; Zenadrid; Zenadrid (veterinary); Zenadrid [veterinary]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00440	Sertraline	(+)-Sertraline; (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine; (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; Apo-Sertraline; CP 51974; Lustral; Lustral (TN); SRE; Sertralina; Sertralina [Spanish]; Sertraline (INN); Sertraline (Zoloft); Sertraline [INN:BAN]; Sertraline [Zoloft]; Sertralinum; Sertralinum [Latin]; Zoloft (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00447	Nevirapine	11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE; 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one; 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody); 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one; BI RG 587; BI-RG-587; BI-RG-587 & CD4-IgG; BIRG 0587; BIRG 587; BIRG-0587; BIRG-587; BIRG587; Cahill May Roberts Brand of Nevirapine; N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin; NEV; NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE; NVP; Nevirapine & CD4-IgG; Nevirapine & PRO 140; Nevirapine (JAN/USP/INN); Nevirapine [USAN:INN]; Promeco Brand of Nevirapine; Viramune; Viramune (TN); Viramune(TM); Viramune, BI-RG 587, Nevirapine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00448	Cyclosporine	cyclosporin A; cyclosporine; Ciclosporin; Cyclosporine A; Ciclosporine; Neoral; Cyclosporin; Ciclosporinum; Ciclosporina; Sandimmune; Equoral; Neoplanta; Sandimmun; Sang-35; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; MFCD00274558; 83HN0GTJ6D; MLS001333756; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00453	Oxcarbazepine	10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide; 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide; Desitin brand of oxcarbazepine; Epilexter; Epliga; GP 47680; GP-47680; KIN-493; Novartis brand of oxcarbazepine; O0363; Oxacarbazepine; Oxaleptal (TN); Oxcarbamazepine; Oxcarbazepime; Oxcarbazepina; Oxcarbazepina [INN-Spanish]; Oxcarbazepine (USAN/INN); Oxcarbazepine [INN]; Oxcarbazepinum; Oxcarbazepinum [INN-Latin]; SPN-804; Timox; Trileptal; Trileptal (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00454	Sunitinib	5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00455	Dicloxacillin	(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 1702; Dichloroxacillin; Diclocil (TN); Diclossacillina; Diclossacillina [DCIT]; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilina [INN-Spanish]; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin sodium; Dicloxacillin, Monosodium Salt, Mono-Hydrate; Dicloxacilline; Dicloxacilline [INN-French]; Dicloxacillinum; Dicloxacillinum [INN-Latin]; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; R-13423
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00458	Pantoprazole	5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole; Astropan; Astropan (TN); BY 1023; BY-1023; Controloc (TN); Inipomp (TN); Pantecta (TN); Pantoloc (TN); Pantopan (TN); Pantoprazol; Pantoprazol [INN-Spanish]; Pantoprazole (USAN/INN); Pantoprazole Na; Pantoprazole Sodium; Pantoprazole [USAN:BAN:INN]; Pantoprazolum; Pantoprazolum [INN-Latin]; Pantoprozole; Pantor; Pantor (TN); Pantotab (TN); Pantozol; Pantozol (TN); Protium; Protium (TN); Protonix; Protonix (TN); Protonix IV; SK&F 96022; SK&F-96022; SK-96022; SKF-96022; Somac; Somac (TN); Ulcepraz (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00459	Fluoxetine	(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine; (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine;(+/-)-Fluoxetine; (+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; (+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine; (+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine; (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]; (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine; 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine; Animex-On; Dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine; Eufor; Floxetine; Fluoxetin; Fluoxetina; Fluoxetina [INN-Spanish]; Fluoxetina [Spanish]; Fluoxetine (Prozac); Fluoxetine (TN); Fluoxetine (USAN/INN); Fluoxetine Hcl; Fluoxetine [USAN:INN:BAN]; Fluoxetinum; Fluoxetinum [INN-Latin]; Fluval; Fontex; Lilly-110140; Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine; Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine; N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine; N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine; N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine; Portal; Prozac (TN); Prozac Weekly; Pulvules; Reconcile; Reneuron
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00462	Olanzapine	2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methyl-1-piperazinyl)-10 H-thieno[2,3-b ] [1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine; 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine; ALKS-7921; Eli Lilly brand of olanzapine; KS-1090; LY 170053; LY-170052; LY-170053; Lanzac; Lilly brand of olanzapine; Midax; Olansek; Olanzapina; Olanzapine (JAN/USAN/INN); Olanzapine (OLA); Olanzapine [USAN:INN]; Olanzapinum; Olzapin (TN); Rexapin (TN); Symbyax; Zalasta; Zalasta (TN); Zolafren (TN); Zydis; Zydis (TN); Zyprexa; Zyprexa (TN); Zyprexa Intramuscular; Zyprexa Velotab; Zyprexa Zydis
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00466	Ivacaftor	Kalydeco (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00467	Morphine	Astramorph Pf; Avinza; Depodur; Duramorph Pf; Infumorph; Kadian; Morphine Sulfate; Ms Contin; Oramorph Sr
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00470	Amitriptyline	10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene; 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(5),gamma-propylamine; 10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene; 3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)-N,N-dimethylpropylamin; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine; 5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene; 5-(3'-Dimethylaminopropylidene)-dibenzo-[a,d][1,4]-cycloheptadiene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(3-Dimethylaminopropylidene)-5H-dibenzo[a,d]-10,11-dihydrocycloheptene; 5-(3-dimethylaminopropylidene)dibenzo[a,d][1,4]-cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,d]10,11-dihydrocycloheptene; 5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene; Adepress; Adepril; Amitril; Amitriprolidine; Amitriptilina; Amitriptilina [INN-Spanish]; Amitriptilina [Italian]; Amitriptylin; Amitriptylin [German]; Amitriptyline (INN); Amitriptyline [INN:BAN]; Amitriptylinum; Amitriptylinum [INN-Latin]; Amitryptiline; Amitryptyline; Amytriptiline; Amytriptylin; Damilan; Damilen; Damitriptyline; Elanil; Elavil; Elavil (TN); Flavyl; Lantron; Laroxil; Laroxyl; Laroxyl (TN); MK 230; N 750; Proheptadiene; Redomex; Ro 4-1575; Sarotex; Seroten; Sylvemid; TP0; Triptanol; Triptilin; Triptisol; Tryptanol; [3-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-dimethyl-amine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00471	Phenobarbital	5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione; 5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione; 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione; 5-Ethyl-5-phenylbarbituric acid; 5-Phenyl-5-ethylbarbituric acid;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione; 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; Acido 5-fenil-5-etilbarbiturico; Acido 5-fenil-5-etilbarbiturico [Italian]; Adonal; Aephe nal; Aephenal; Agrypnal; Amylofene; Antrocol; Aphenylbarbit; Aphenyletten; Arco-Lase Plus; Austrominal; Barbapil; Barbellen; Barbellon; Barbenyl; Barbilehae; Barbilehae (barbilettae); Barbinal; Barbipenyl; Barbiphen; Barbiphenyl; Barbipil; Barbita; Barbivis; Barbonal; Barbophen; Bardorm; Bartol; Bialminal; Blu-phen; Cabronal; Calmetten; Calminal; Cardenal; Chardonna-2; Chinoin; Codibarbita; Component of Antrocol; Component of Bronkotabs; Component of Hecadrol; Component of Primatene P; Component of Slowten; Component of Tedral; Component of Valpin 50-PB; Coronaletta; Cratecil; Damoral; Dezibarbitur; Donphen; Dormina; Dormiral; Dormital; Doscalun; Duneryl; Elixir of phenobarbital; Ensobarb; Ensodorm; Epanal; Epidorm; Epilol; Episedal; Epsylone; Eskabarb; Etilfen; Euneryl; Ezibarbitur; Fen osed; Fenbital; Fenemal; Fenobarbital; Fenobarbital [INN-Spanish]; Fenobarbitale; Fenobarbitale [DCIT]; Fenosed; Fenylettae; Gardenal; Gardepanyl; Glysoletten; Gustase-Plus; Haplopan; Haplos; Helional; Hennoletten; Henotal; Hypnaletten; Hypnette; Hypno-Tablinetten; Hypnogen; Hypnolone; Hypnoltol; Hysteps; Le phebar; Lefebar; Leonal; Lephebar; Lepinal; Lepinaletten; Levsin PB Drops and Tablets; Linasen; Liquital; Lixophen; Lubergal; Lubrokal; Lumen; Lumesettes; Lumesyn; Luminal; Luminal (TN); Lumofridetten; Luphenil; Luramin; Molinal; Neurobarb; Nirvonal; Noptil; Nova-Pheno; Nunol; PHOB; PUBERTAL PHENOBARBITAL STUDY; Pamine PB; Parkotal; Pharmetten; Phazyme-PB; Phen-Bar; Phenaemal; Phenemal; Phenemalum; Phenobal; Phenobarb; Phenobarbital (JP15/USP/INN); Phenobarbital (PB); Phenobarbital [USAN:INN:JAN]; Phenobarbital, Monosodium Salt; Phenobarbitalum; Phenobarbitalum [INN-Latin]; Phenobarbitalum [INN]; Phenobarbitol; Phenobarbitone; Phenobarbitonum; Phenobarbituric acid; Phenobarbyl; Phenoluric; Phenolurio; Phenomet; Phenonyl; Phenoturic; Phenyl-ethyl-barbituric acid; Phenylaethylbarbitursaeure; Phenylethyl barbituric acid; Phenylethylbarbiturate; Phenylethylbarbituric acid; Phenylethylbarbitursaeure; Phenylethylmalonylurea; Phenyletten; Phenylral; Phenyral; Polcominal; Promptonal; SK-Phenobarbital; Seda-Tablinen; Seda-tabl inen; Sedabar; Sedicat; Sedizorin; Sedlyn; Sedofen; Sedonal; Sedonal (sedative); Sedonettes; Sedophen; Sevenal; Solfoton; Solfoton talpheno; Solu-Barb; Sombutol; Somnolens; Somnoletten; Somnosan; Somonal; Spasepilin; Starifen; Starilettae; Stental; Stental Extentabs; Stental exte ntabs; Talpheno; Teolaxin; Teoloxin; Thenobarbital; Theoloxin; Theominal; Triabarb; Tridezibarbitur; Triphenatol; Valprin 50-PB; Versomnal; Zadoletten; Zadonal
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00474	Clozapine	3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine; 8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine; 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; Asaleptin; C 6305; CLOZARIL; Clopine (TN); Clorazil; Clozapin; Clozapina; Clozapina [INN-Spanish]; Clozapine (JAN/USP/INN); Clozapine [USAN:INN:BAN]; Clozapine(tautomer); Clozapinum; Clozapinum [INN-Latin]; Clozaril (TN); Denzapine (TN); Fazaclo; Fazaclo (TN); Fazaclo ODT; Froidir (TN); HF-1854; HF1854; Iprox; KS-1166; Klozapol (TN); LEX-123; LX 100-129; Leponex; Leponex (TN); Lepotex; W-801; Zaponex (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00476	Clomipramine	10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5H-dibenz(b,f)azepine; 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; 3-Chloroimipramine; 3-chloro-10,11-dihydro-N,N-dimethyl-5H-Dibenz(b,f)azepine-5-propanamine; 5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-(8CI); Anafranil (TN); Anafranil (free base); Anafranil base; Chlomipramine; Chlorimipramine; Clomicalm; Clomipramina; Clomipramina [INN-Spanish]; Clomipramine (INN); Clomipramine [INN:BAN]; Clomipraminum; Clomipraminum [INN-Latin]; G 34586; Hydiphen; Monochlorimipramine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00484	Pimozide	1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone; 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine; 1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone; 1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one; 1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine; 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one; 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one; ASTA Medica Brand of Pimozide; Antalon; Janssen Brand of Pimozide;Orap forte; McN-JR 6238; McN-JR-6238; Neoperidole; Opiran; Orap; Orap (TN); P 1793; Pharmascience Brand of Pimozide; Pimozida; Pimozida [INN-Spanish]; Pimozide (JAN/USP/INN); Pimozide [USAN:INN:BAN:JAN]; Pimozidum; Pimozidum [INN-Latin]; Primozida; Primozida [INN-Spanish]; R 6238; R-6238
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00486	Protriptyline	3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine; 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine; 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene; 5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene; 5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride; 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; Amimetilina; Apo-Imipramine; Apo-Trimip; Impril; Maximed; N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine; N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine; Normethyl EX4442; Novo-Doxepin; Novo-Tripramine; Novopramine; Protriptilina; Protriptilina [INN-Spanish]; Protriptyline (INN); Protriptyline [INN:BAN]; Protriptylinum; Protriptylinum [INN-Latin]; Protryptyline; Rhotrimine; Triadapin 5; Triptil; Triptil hydrochloride; Triptyl; Vivactil; Vivactil (TN); Vivactyl
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00494	Estrone	(13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one; (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one;1,3,5(10)-Estratrien-3-ol-17-one; 1,3,5(10)-Oestratrien-3-ol-17-one; 3-Hydroxy-1,3,5(10)-estratrien-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene; 3-Hydroxy-17-keto-oestra-1,3,5-triene; 3-Hydroxy-oestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-triene-17-one; 3-hydroxy-estra-1,3,5(10)-trien-17-one; Aquacrine; Crinovaryl; Cristallovar; Crystogen; Delta-1,3,5-Estratrien-3beta-ol-17-one; Delta-1,3,5-Oestratrien-3beta-ol-17-one; Delta-1,3,5-estratrien-3-beta-ol-17-one; Delta-1,3,5-oestratrien-3-beta-ol-17-one; Destrone; Disynformon; E 9750; E(sub 1); E0026; Endofolliculina; Esterone; Estrin; Estrogenic Substance; Estrol; Estron; Estrona; Estrona [INN-Spanish]; Estrona [Spanish]; Estrone (E1); Estrone (JAN/USP/INN); Estrone (TN); Estrone [USAN:INN]; Estrone, (+-)-Isomer; Estrone, (8 alpha)-Isomer; Estrone, (9 beta)-Isomer; Estrone-A; Estronum; Estronum [INN-Latin]; Estrovarin; Estrugenone; Estrusol; Fem-O-Gen; Femestrone inj.; Femestrone injection; Femidyn; Fermidyn; Folikrin; Folipex; Folisan; Follestrine; Follestrol; Follicular hormone; Folliculin; Folliculine; Folliculine benzoate; Follicunodis; Glandubolin; Hauck Brand of Estrone; Hiestrone; Hormestrin; Hormofollin; Hormovarine; Hyrex Brand of Estrone; Kestrone; Ketodestrin; Ketohydroxy-Estratriene; Ketohydroxyestrin; Ketohydroxyoestrin; Ketophydroxyestrin; Kolpon; Menagen; Menformon; Menformon A; Mestronaq; NATURAL ESTROGENIC SUBSTANCE-ESTRONE; OESTRONE; Oestrin; Oestroform;Oestronum; Oestrone [Steroidal oestrogens]; Oestrone, Estrone; Oestroperos; Ovex (tablets); Ovifollin; Penncap M; Perlatan; Solliculin; Theelin; Thelestrin; Thelykinin; Thynestron; Tokokin; Unden; Unden (pharmaceutical); Unden (pharmaceutical) (VAN); Unigen; Vortech Brand of Estrone; Wehgen; Wynestron; WynestronPencap M;CMC_13458; [2,4,6,7-3H]-E1
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00497	Desloratadine	8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine; 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; Aerius; Aerius (TN); Allex; Azomyr; Claramax; Claramax (TN); Clarinex; Clarinex (TN); Clarinex RediTabs; Denosin; Desalex; Descarboethoxyloratadine; Descarboethoxyoratidine; Desloratadine (USAN/INN); Desloratadine [USAN]; Desloratidine; Essex brand of desloratadine; NeoClarityn (TN); Neoclarityn; Opulis; Sch 34117; Sch-34117; Schering brand of desloratadine; Schering-Plough brand of desloratadine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00499	Corticosterone	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE; (11beta)-11,21-Dihydroxypregn-4-ene-3,20-dione; 11,12-Dihydroxyprogesterone; 11,21-Dihydroxyprogesterone; 11-Hydroxycorticoaldosterone; 11-beta,21-Dihydroxypregn-3,20-dione; 11Beta,21-dihydroxypregn-4-ene-3,20-dione; 11beta,21-Dihydroxy-4-pregnene-3,20-dione; 11beta,21-Dihydroxyprogesterone; 17-Deoxycortisol; 4-Pregnene-11beta,21-diol-3,20-dione; 50-22-6; CCRIS 6753; CHEBI:16827; Compound B; Corticosteron; Corticosterone; Kendall's compound B; NSC9705; Reichstein's B; Reichstein's substance H; UNII-W980KJ009P
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00500	Ergotamine	(5'A)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate(2:1); 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione; Avetol; Cornutamin; Cornutamine; ERGOTAMINE (SEE ALSO: ERGOTAMINE TARTRATE (CAS 379-79-3)); ETIN; Ergam; Ergate; Ergomar; Ergomar (TN); Ergonsvine; Ergostat; Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-(9CI); Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt); Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1); Ergotamin; Ergotamina [INN-Spanish]; Ergotamine (INN); Ergotamine [INN:BAN]; Ergotamine bitartrate; Ergotamine hemitartrate; Ergotamine tartrate; Ergotamine tartrate (VAN); Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate; Ergotamine, tartrate (2:1); Ergotamine, tartrate (2:1) (salt) (8CI); Ergotaminum [INN-Latin]; Ergotartrate; Ergoton-A; Exmigra; Femergin;Gynergen; Gotamine tartrate; Lingraine; Lingran; Medihaler ergotamine; Migretamine; Neo-ergotin; Rigetamin; Secagyn; Secupan; Temigran; Wigrettes
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00501	Desipramine	(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine; 10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine; 10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine; 5-(gamma-Methylaminopropyl)iminodibenzyl; DMI (pharmaceutical); DMI 50475; Demethylimipramine; Desimipramine; Desimpramine; Desipramin; Desipramina; Desipramina [INN-Spanish]; Desipramine (D4); Desipramine (INN); Desipramine Hcl; Desipramine [INN:BAN]; Desipraminum; Desipraminum [INN-Latin]; Desmethylimipramine; Dezipramine; Dimethylimipramine; Methylaminopropyliminodibenzyl; Monodemethylimipramine; N-(3-Methylaminopropyl)iminobibenzyl; Norimipramine; Norpramin (TN); Norpramine; Pentofran; Pertofrane (TN); Pertrofane; Sertofran; ZERO/006017
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00502	Chlorpromazine	10-(3-Dimethylaminopropyl)-2-chlorophenothiazine; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+); 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine; 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine; 2-Chloropromazine; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]; 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine; 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine; Aminasine; Aminazin; Aminazine; Ampliactil; Amplicitil; Amplictil; BC 135; Chlor-PZ; Chlor-Promanyl; Chlordelazine; Chlorderazin; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]; Chloropromazine; Chlorpromados; Chlorpromanyl (discontinued); Chlorpromazin; Chlorpromazine (USP/INN); Chlorpromazine Tannate; Chlorpromazine [USAN:INN:BAN]; Chlorpromazinum; Chlorpromazinum [INN-Latin]; Clorpromazina; Clorpromazina [INN-Spanish]; Clorpromazina [Italian]; Contomin; Cromedazine; Elmarin; Esmind; Fenactil; Fenaktyl; Fraction AB; HL 5746; JHICC02042; Largactil; Largactil (TN); Largactil Liquid; Largactil Oral Drops; Largactilothiazine; Largactyl; Megaphen; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; Novo-Chlorpromazine; Novomazina; Phenactyl; Phenathyl; Phenothiazine hydrochloride; Plegomasine; Plegomazin; Prazilpromactil; Proma; Promactil; Promazil; Propaphen; Propaphenin; Prozil; Psychozine; SKF 2601-A; SKF 2601A; SKF-2601; Sanopron; Thorazine; Thorazine (TN); Thorazine Spansule; Thorazine Suppositories; Thorazine hydrochloride; Torazina; Wintermin; Z80; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00514	Darunavir	(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; AIDS073035; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; Darunavir (USAN/INN); Darunavir [USAN]; Darunavirum; Darunavirum [INN-Latin]; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; Prezista; Prezista(TM); TMC 114; TMC-114; TMC114; UIC 94017; UIC-94017; UIC-96017; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00521	Clonidine	1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00523	Crizotinib	Xalkori (TN); novel ALK inhibitors
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00528	Propranolol	(+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00541	Loratadine	1-Piperidenecarboxylic acid, 4-(8-chloro-5,6-duhydro-11H-benzo [5,6]cyclohepta[1,2-b]-pyridin-11-ylidene)-, ethyl ester; 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester; 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester; 1-piperidinecarboxylic acid,4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-,ethyl ester; 4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester; 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acidethyl ester; 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester; Aerotina; Alarin; Alavert; Alavert (TN); Alavert, Claritin, Loratadine; Alerpriv; AllergyX (TN); Allertidin; Anhissen; Bedix Loratadina; Biloina; Bonalerg; Children's Claritin; Civeran; Claratyne; Claratyne Cold; Claratyne Decongestant; Clarinase; Clarinase Reperabs; Claritin; Claritin (TN); Claritin D; Claritin Hives Relief; Claritin Hives Relief Reditab; Claritin Reditabs; Claritin reditab; Claritin-D (TN); Claritine (TN); Claritine;Clarityn; Clarityn (TN); Clarityne; Clarityne (TN); Clarityne Dy Repetabs; Clarityne-D; Clarium; Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate;Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylate; Flonidan (TN); Fristamin; Fristamin (TN); Histaloran; L 9664; Lergy; Lertamine; Lesidas; Lisino; Lomilan (TN); Loracert; Loradex; Loradif; Loranox; Lorantis; Lorastine; Loratadina; Loratadina [Spanish]; Loratadine (JAN/USAN/INN); Loratadine Redidose; Loratadine Wyeth Brand; Loratadine [USAN:BAN:INN]; Loratadinum; Loratadinum [Latin]; Loratidine; Loratyne; Loraver; Lorfast; Lorfast (TN); Loritine; Lowadina; Nularef; Optimin; Polaratyne; Pylor; Restamine; Rhinase; Rinolan (TN); Rinomex; Roletra; Roletra (TN); Sanelor; Sch 29851; Sch-29851; Sch29851; Sensibit; Sinhistan Dy; Sohotin; Symphoral (TN); Tadine; Talorat Dy; Tidilor (TN); Velodan; Versal; Wyeth Brand of Loratadine; Zeos
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00550	Bromocriptine	(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman; (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide; 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione; 2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptin; 2-Bromo-alpha-ergokryptine; 2-Bromoergocryptine Methanesulfonate; 2-Bromoergokryptine; Alti-Bromocriptine; Apo-Bromocriptine; Bagren; Bromergocryptine; Bromocriptin; Bromocriptina; Bromocriptina [INN-Spanish]; Bromocriptine (USAN/INN); Bromocriptine [BAN]; Bromocriptine [USAN:BAN:INN]; Bromocriptine methanesulfonate; Bromocriptinum; Bromocriptinum [INN-Latin]; Bromocryptin; Bromocryptine; Bromoergocriptine; Bromoergocryptine; CB-154; Ergocryptine, 2-bromo-(8CI); Ergoset; Parlodel; Parlodel (TN); Parlodel Snaptabs
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00552	Imipramine	1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine; 10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine; 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 2,2'-(3-Dimethylaminopropylimino)bibenzyl; 2,2'-(3-Dimethylaminopropylimino)dibenzyl; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine; 5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine; 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; 5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-(9CI); Antideprin; Antideprin (TN); Berkomine; Censtim; Censtin; Declomipramine; Deprimin (TN); Deprinol (TN); Depsonil (TN); Dimipressin; Dpid; Dyna-zina; Dynaprin; Dynaprin (TN); Eupramin; Eupramin (TN); G-22355; Imavate; Imidobenzyle; Imipramil (TN); Imipramin; Imipramina; Imipramina [INN-Spanish]; Imipramina [Italian]; Imipramine (INN); Imipramine [INN:BAN]; Imipraminum; Imipraminum [INN-Latin]; Imiprin; Imizin; Imizinum; Impramine; Intalpram; Iramil; Irmin; Irmin (TN); Janimine; Janimine (TN); Janimine (hydrochloride); Melipramin; Melipramin (TN); Melipramine; N-(3-Dimethylaminopropyl)-o-iminodibenzyl; N-(gamma-Dimethylaminopropyl)iminodibenzyl; N-(gamma.-Dimethylaminopropyl)iminodibenzyl; Nelipramin; Norchlorimipramine; Norfranil; Pramine; Prazepine; Promiben;Psychoforin; SK-Pramine; Surplix; Surplix (TN); Timolet; Tofranil; Tofranil (free base); Tofranil (hydrochloride); Tofranil(TN); Tofranil, base; Tofraniln A
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00553	Ceftriaxone	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00554	Emetine	EMETINE; Emetin; Cephaeline methyl ether; Methyl cephaeline; 6',7',10,11-Tetramethoxyemetan; Emetine hydrochloride; Emetine [BAN]; Cephaline-O-methyl ether; UNII-X8D5EPO80M; Emetan, 6',7',10,11-tetramethoxy-; HSDB 2150; TCMDC-125531; EINECS 207-592-1; BRN 0100829; X8D5EPO80M; CHEMBL50588; GNF-PF-196; Emetine dihydrochloride hydrate; Ipecine; Methylcephaeline; DSSTox_CID_2980; DSSTox_RID_76816; DSSTox_GSID_22980
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00558	Erlotinib	4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; AQ4; CP 358,774; CP-358,774; CP-358774; Erlotinib Base; Erlotinib(Tarceva); Erlotinib, OS-774; Erlotinin; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; N-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; OSI 744; R 1415; Tarceva; Tarceva (TN); [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00559	Curcumin	(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; CI Natural Yellow 3; Curcuma; Curcuma oil; Curcumin I; Curcumine; Diferaloylmethane; Diferuloylmethane; Gelbwurz; Golden seal; Haidr; Halad; Haldar; Halud; Hydrastis; Indian saffron; Indian turmeric; Kacha haldi; Kurkumin [Czech]; Merita earth; Natural yellow 3; Oils, curcuma; Orange Root; Safran d'Inde; Souchet; Terra Merita; Tumeric yellow; Turmeric; Turmeric extract; Turmeric oil; Turmeric yellow; Yellow Ginger; Yellow Root; Yellow puccoon; Yo-Kin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00572	Chloroquine	(+)-Chloroquine; (-)-Chloroquine; (R)-(-)-Chloroquine; 3377 RP opalate; 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline; 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline; Amokin; Aralen; Aralen HCl; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; CU-01000012392-2; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquine (USP/INN); Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquine [USAN:INN:BAN]; Chloroquine phosphate; Chloroquinium; Chloroquinum; Chloroquinum [INN-Latin]; Chlorquin; Cidanchin; Clorochina; Clorochina [DCIT]; Cloroquina; Cloroquina [INN-Spanish]; Cocartrit; Dawaquin (TN); Delagil; Dichinalex; Elestol; Gontochin; Gontochin phosphate; Heliopar; Imagon; Ipsen 225; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaquin (*Diphosphate*); Malaren; Malarex; Mesylith; Miniquine; N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine; N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine; Neochin; Nivachine; Nivaquine B; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; RP 3377; RP-3377; Resochen; Resochin; Resochin (TN); Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ro 01-6014/N2; Ronaquine; Roquine; SN 6718; SN-7618; ST 21; ST 21 (pharmaceutical); Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; W 7618;WIN 244; {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00576	Telithromycin	(1R,2R,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6R,7R,8R,10S,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; (1R,2S,4R,6R,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone; 11,12-Dideoxy-3-des(2,6-dideoxy-3-C,3-O-dimethyl-alpha-L-altropyranosyloxy)-6-O-methyl-3-oxo-12,11-(oxycarbonylimino)-N11-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]erythromycin A; HMR 3647; HMR-3647; HMR3647; Ketek; Ketek (TN); Levviax; RU 66647; RU-66647; RU66647; TEL; Telithromycin (JAN/USAN/INN); Telithromycin [USAN:BAN:INN]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00579	Dihydroergocristine	Nehydrin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00580	Valspodar	3'-Keto-bmt(1)-val(2)-cyclosporin A; Amdray; Amdray (TN); PSC-833; PSC833; Psc 833; SDZ-PSC 833; Sdz psc 833; Sdz-psc-833; Valspodar (USAN/INN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00584	Amprenavir	(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate; (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate; (3S)-tetrahydro-3-furyl N-[(1S,2R)-3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxy-propyl]carbamate; (3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate; 4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide; AMV; Agenerase; Agenerase (TM); Agenerase (TN); Amprenavir (JAN/USAN/INN); Amprenavir [USAN]; Amprenavir[usan]; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA); Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin(HHA); DRG-0258; GNA & Amprenavir; HHA & Amprenavir; KVX-478; Prozei; Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate; VX 478; VX-478; VX478; Vertex; Vertex VX478; [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00586	Nitrendipine	1A Pharma, Nitren; AL, Nitrendipin; AbZ, Nitre; Acis, Nitren; Atid, Nitrendipin; Basics, Nitrendipin; Bay-e-5009; Baylotensin; Bayotensin; Baypress; Baypress (TN); Bayvit, Nitrendipino; Beta, Nitrendipin; Biochemie, Nitrendi; Bylotensin; Ct, nitrendipin von; Deiten; Gericin; Heumann, Nitrendipin; Jutapress; KSK, Nitrend; Lich, Nitren; Lindo, Nitrendipin; N-144; Nidrel; Niprina; Nitre AbZ; Nitre Puren; Nitre-Puren; NitrePuren; Nitregamma; Nitren 1A Pharma; Nitren Lich;Nitren acis; Nitrend KSK; Nitrendepat; Nitrendi Biochemie; Nitrendidoc; Nitrendimerck; Nitrendipin; Nitrendipin AL; Nitrendipin Apogepha; Nitrendipin Atid; Nitrendipin Basics; Nitrendipin Heumann; Nitrendipin Lindo; Nitrendipin Stada; Nitrendipin beta; Nitrendipin corax; Nitrendipin von ct; Nitrendipin-corax; Nitrendipincorax; Nitrendipino; Nitrendipino Bayvit; Nitrendipinum; Nitrensal; Nitrepin; Nitrepress; Pharma, Nitren 1A; Stada, Nitrendipin; Tensogradal; Trendinol; Vastensium; Von ct, nitrendipin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00588	Abacavir	(+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC; Abacavir (INN); Abacavir [INN]; Trizivir; Ziagen; Ziagen (TM)(*Succinate salt*); Ziagen (TN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00590	Trimethoprim	AZT + TMP/SMX (mixture) combination; Abaprim; Alcorim-F; Alprim; Anitrim; Antrima; Antrimox; Apo-Sulfatrim; BW 56-72; BW 5672; BW-56-72; Bacdan; Bacidal; Bacide; Bacin; Bacta; Bacterial; Bacterial [Antibiotic]; Bacticel; Bactin; Bactoprim; Bactramin; Bencole; Bethaprim; Biosulten; Briscotrim; Chemotrin; Cidal; Co-Trimoxizole; Colizole; Colizole DS; Component of Bactrim; Component of Septra; Conprim; Cotrimel; Deprim; Duocide; Esbesul; Espectrin; Euctrim; Exbesul; Fermagex; Fortrim; Futin; Idotrim; Ikaprim; Instalac; KSC-4-158; KUC103659N; Kombinax; Lagatrim; Lagatrim Forte; Lastrim; Methoprim; Metoprim; Monoprim; Monotrim; Monotrim (TN); Monotrimin; NIH 204; NIH 204 (VAN); Novotrimel; Omstat; Oraprim; Pancidim; Polytrim; Priloprim; Primosept; Primsol; Proloprim; Proloprim (TN); Protrin; Purbal; Resprim; ResprimForte; Roubac; Roubal; Salvatrim; Septrin DS; Septrin Forte; Septrin S; Setprin; Sinotrim; Smz-Tmp; Stopan; Streptoplus; Sugaprim; Sulfamar; Sulfamethoprim; Sulfamethoxazole & Trimethoprim; Sulfoxaprim; Sulmeprim; Sulthrim; Sultrex; Syraprim; T 7883; TCMDC-125538; TMP; TMP/SMX (MIXTURE)); Tiempe; Tmp-Ratiopharm; Toprim; Trimanyl; Trimeth/Sulfa; Trimethioprim; Trimethopim(TMP); Trimethoprim & VRC3375; Trimethoprim (JAN/USP/INN); Trimethoprim [USAN:BAN:INN:JAN]; Trimethoprime; Trimethoprime [INN-French]; Trimethoprimum; Trimethoprimum [INN-Latin]; Trimethopriom; Trimetoprim; Trimetoprim [DCIT]; Trimetoprim [Polish]; Trimetoprima; Trimetoprima [INN-Spanish]; Trimexazole; Trimexol; Trimez-IFSA; Trimezol; Trimogal; Trimono; Trimopan; Trimpex; Trimpex (TN); Trimpex 200; Triprim; Triprim (TN); Trisul; Trisulcom; Trisulfam; Trisural; U-Prin; Uretrim; Uro-D S; Urobactrim; Utetrin; Velaten; WR 5949; Wellcoprim; Wellcoprin; Xeroprim; Zamboprim
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00594	Ketoconazole	(+)-Ketoconazole; (+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine; (+/-)-cis-1-Acetyl-4-(4-[(2-[2,4-dichlorophenyl]-2-[1H-imidazol-1-ylmethyl]-1,3-dioxolan-4-yl)-methoxy]phenyl)piperazine; (+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone; 1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine; CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE; Cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine; Fungarest; Fungoral; K 1003; KCZ; KS-1205; KTZ; KW-1414; Ketoconazol; Ketoconazole [USAN:INN:BAN:JAN]; Ketoderm; Nizoral (TN); Nizoral, Extina, Xolegel, Kuric, Ketoconazole; Perkhotal (TN); R 41,400; R 41400; R-41400; R41,400; R41400
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00600	Cefoperazone	(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6S,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid; CP 52640; Cefazone (TN); Cefobid; Cefobid (TN); Cefoperazon; Cefoperazone (INN); Cefoperazone [INN:BAN]; Cefoperazone sodium salt; Cefoperazono; Cefoperazono [INN-Spanish]; Cefoperazonum; Cefoperazonum [INN-Latin]; Peracef [veterinary]; Peracef [veterinary] (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00613	Dipyridamole	2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; Agilease; Anginal; Antistenocardin; Apo-Dipyridamole; Apo-Dipyridamole Fc; Apo-Dipyridamole Sc; Apotex Brand of Dipyridamole; Apricor; Ashbourne Brand of Dipyridamole; Belmac Brand of Dipyridamole; Berlin Chemie Brand of Dipyridamole; Berlin-Chemie Brand of Dipyridamole; Boehringer Ingelheim Brand of Dipyridamole; Cardioflux; Cardoxil; Cardoxin; Cerebrovase; Chilcolan; Cleridium; Cleridium 150; Coribon; Coridil; Coronarine; Corosan; Coroxin; Curantil; Curantyl; D 9766; Dipiridamol; Dipiridamol [INN-Spanish]; Dipyramidole; Dipyridamine; Dipyridamol; Dipyridamole (JP15/USP/INN); Dipyridamole [USAN:INN:BAN:JAN]; Dipyridamolum; Dipyridamolum [INN-Latin]; Dipyridan; Dipyudamine; Dypyridamol; Gulliostin; IPRAD Brand of Dipyridamole; Iv Persantine; Justpertin; Kurantil; Miosen; Natyl; Novo-Dipiradol; Novopharm Brand of Dipyridamole; Peridamol; Permiltin; Permole, Persantine, Dipyridan, Dipyridamole; Persantin; Persantine; Persantine (TN); Piroan; Prandiol; Prandiol 75; Protangix; RA-8; Stenocardil; Stenocardiol; Stimolcardio; Usaf Ge-12
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00619	Delavirdine	(1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4-[METHYLAMINO)PYRIDINYL]PIPERAZINE; (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide); 1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine; 1-(5-Methanesulphonamido)-1H-indol-2-yl-carbonyl)-4-[3-(isopropylamino)-2-pyridinyl]piperaz; 2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine; BHAP-U 90152; DELAVIRDINE MESYLATE; DLV; Delavirdine (*Mesylate salt*); Delavirdine (INN); Delavirdine [INN]; Delavirdine(U-90152) & .a.IFN; N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide; N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide; N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide; N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide; N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide; PNU-90152-T; Piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]-& alpha-Interferon; Rescriptor; Rescriptor (TM);Rescriptor (TN); SPP; U 90152; U-90152; U-90152S; U90152S (*Mesylate salt*)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00623	Mefloquine	(+)-(11R,2'S)-erythro-Mefloquine; (+)-Mefloquine; (+)-Threo-Mefloquine; (-)-(11S,2'R)-erythro-Mefloquine; (-)-Mefloquine; (-)-Threo-Mefloquine; (DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol; (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol; Alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol; Alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol; Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol; Lariam; Lariam (Hydrochloride); Lariam (TN); Mefaquin (TN); Mefloquin; Mefloquina; Mefloquina [INN-Spanish]; Mefloquine (USAN/INN); Mefloquine [USAN:INN:BAN]; Mefloquinone; Mefloquinum; Mefloquinum [INN-Latin]; Mephloquine; RO 13-7224; RO 13-7225; RTI1169-1-1; RTI1172-1-1; RTI1173-1-1; RTI1174-1-1; RTI1188-1-1; RTI1189-1-1; Racemic mefloquine; Ro 21-5998; Ro 21-5998 (Hydrochloride); Ro 215998; Ro-21-5998-001; SPB-80406; WR 142490; WR-142,490; WR-142490; WR-177,602; [2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00627	Acebutolol	(+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00629	Aldosterone	(+)-Aldosterone; (11BETA)-11,21-DIHYDROXY-3,20-DIOXOPREGN-4-EN-18-AL; (8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde; 11.beta.,21-Dihydroxypregn-4-ene-3,18,20-trione; 11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al; 11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al, 18,11-halbacetal; 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione; 11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al; 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al; 18-Aldocorticosterone; 18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione; 18-Oxocorticosterone; Aldocorten; Aldocortene; Aldocortin; Aldosterona; Aldosterona [INN-Spanish]; Aldosterone [INN:BAN:DCF]; Aldosterone, (+-)-Isomer; Aldosterone, (11 beta,17 alpha)-Isomer; Aldosteronum; Aldosteronum [INN-Latin]; D-Aldosterone; Electrocortin; Elektrocortin; Reichstein X
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00634	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; 1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one; 1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride; 1-[2-(2-Hydroxy-3-[propylamino]-propoxy)phenyl]-3-phenyl-1-propanone; 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one; Propafenon Hexal; Propafenon hexal (TN); Propafenona; Propafenona [INN-Spanish]; Propafenone (INN); Propafenone [INN:BAN]; Propafenone-HCl; Propafenonum; Propafenonum [INN-Latin]; Rythmol; Rythmol SR (TN); Rytmonorm (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00636	Reserpine	3P Reserp; Abesta; Abicol; Adelfan; Adelphin; Alkarau; Alkaserp; Alserin; Apoplon; Apoplon (TN); Apsical; Ascoserp; Ascoserpina; Austrapine; Banasil; Banisil; Benazyl; Bioserpine; Brinderdin; Briserine; Broserpine; Cam-Ap-Es; Cardioserpin; Carditivo; Carpacil; Carrserp; Darebon; Deserpine; Diupres 250; Diupres 500; Diupres-250; Diupres-500; Diurese-R; Diutensen-R; Dralserp; ENT 50146; Eberpine; Eberspine; Ebserpine; Elfanex; Elserpine; Enipresser; Esc aspere; Escaspere; Eserpine; Eskaserp; Eskaserpine; Gammaserpine; Gilucard; H 520; HYDRO-RESERP; Helfoserpin; Hexaplin; Hiposerpil; Hiserpia; Hydrap-ES; Hydromox R; Hydromox-R; Hydropine; Hydropres 25; Hydropres 50; Hydroserp; Hydrosine 25; Hypercal B; Hypersil; Hypersine; Hypertensan; Idoserp; Idsoserp; Interpina; Key-serpine; Kitine; Klimanosid; L"-Carpserp; L-Carpserp; Lemiserp; Loweser p; Loweserp; Mallopress; Maviserpin; Mayserpine; Mephaserpin; Modenol; Naquival; Nembuserpin; Neo-serp; Neose rfin; Neoserfin; Neoserp; Neoslowten; Orthoserpina; Perskleran; Pressimedin; Purserpine; Quiescin; R 0875; R-e-s; Rau sedyl; Rau-Sed; Raucap; Raudiford; Raudixin; Raudixoid; Raugal; Raulen; Rauloydin; Raumorine; Raunervil; Raunorine; Raunova; Raupasil; Raupoid; Raurine; Rausan; Rausedan; Rausedil; Rausedyl; Rauserpin; Rauserpine; Rauserpol; Rausingle; Rautrin; Rauvlid; Rauwasedin; Rauwilid; Rauwiloid; Rauwipur; Rauwita; Rauwoleaf; Rawilid; Recipin; Regroton; Renese R; Renese-R; Resaltex; Rese rpamed; Rese-lar; Resedrex; Resedril; Reser-ar; Reserbal; Resercaps; Resercen; Reserfia; Reserjen; Reserlor; Reserp; Reserpal; Reserpamed; Reserpanca; Reserpene; Reserpex; Reserpidefe; Reserpil; Reserpin; Reserpina; Reserpinum; Reserpka; Reserpoid; Reserpur; Reserutin; Resiatric; Residin; Residine; Resine; Resocalm; Resperin; Resperine; Respital; Restran; Rezerpin; Riserpa; Rivased; Rivasin; Rolserp; Roxel; Roxinoid; Roxynoid; Ryser; SK-Reserpine; Salupres; Sandril; Sandron; Se rpate; Sedaraupin; Sedaraupina; Sederaupin; Sedserp; Seominal; Ser-A-Gen; Serfin; Serfolia; Serolfia; Serpalan; Serpaloid; Serpaneurona; Serpanray; Serpasil; Serpasol; Serpate; Serpazil; Serpazol; Serpedin; Serpen; Serpena; Serpentil; Serpentin; Serpentina; Serpicon; Serpil; Serpiloid; Serpilum; Serpine; Serpipur; Serpivate; Serpivite; Serpogen; Serpoid; Serpone; Serpyrit; Sertabs; Sertens; Sertensin; Sertina; Supergan; T-Serp; Tefaserpina; Temposerpine; Tensanyl; Tenserpinie; Tensional; Tensionorme; Tepserpine; Terbolan; Transerpin; Triserpin; Tylandril; Unilord; Unipres; Usaf cb-27; V Serp; V-Serp; VI XO; VIXO; Veriloid; Vio-Serpine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00638	Grepafloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00642	Amiodarone	(2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone; (2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone; (2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone; (2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone; (2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone; (2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine; 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran; 2-Butyl-3-[3,5-diiodo-4-(2-di; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; 2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone; 2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone; 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran; ASTA Medica Brand of Amiodarone Hydrochloride; Alphapharm Brand of Amiodarone Hydrochloride; Amidorone; Aminodarone; Amio-Aqueous IV; Amiobeta; Amiodarex; Amiodarona; Amiodarona [INN-Spanish]; Amiodarone (USAN/INN); Amiodarone Base; Amiodarone [USAN:BAN:INN]; Amiodarons; Amiodaronum; Amiodaronum [INN-Latin]; Amiohexal; Amjodaronum; Ancar; Aratac (TN); Aratac;Arycor; Armstrong Brand of Amiodarone Hydrochloride; Arycor (TN); Atlansil (TN); Berenguer Infale Brand of Amiodarone Hydrochloride; Betapharm Brand of Amiodarone Hydrochloride; Braxan; Corbionax; Cordarex; Cordarone; Cordarone (TN); Cordarone Intravenous; Ethylaminoethoxy)benzoyl]benzofuran; G Gam Brand of Amiodarone Hydrochloride; Hexal Brand of Amiodarone Hydrochloride; Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl; Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI); Kordaron; L 3428; L-3428; L3428; Labaz; Leurquin Brand of Amiodarone Hydrochloride; Ortacrone; Pacerone; Pacerone (TN); Pharma Investi Brand of Amiodarone Hydrochloride; Pms-Amiodarone; Rytmarone; SKF 33134-A; SKF 33134A; Sanofi Winthrop Brand of Amiodarone Hydrochloride; Sedacoron; Sedacorone; Tachydaron; Wyeth Brand of Amiodarone Hydrochloride
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00643	Lansoprazole	lansoprazole; Prevacid; Monolitum; Bamalite; Lansoprazol; Limpidex; Agopton; Ogastro; Opiren; Lanzor; Prevacid SoluTab; Takepron; Lanzopral; Zoton; Lansoprazolum; Lasoprol; Mesactol; Lansopep; Lanproton; Lancid; Ketian; Prezal; Lanston; Aprazol; Blason; Ulpax; Lanz; Pro Ulco; AG-1749; Compraz; Suprecid; Prosogan; Ilsatec; Promp; Zoprol; Dakar; Prevacid Iv; Ogast; Lanzol-30; AG 1749; Lansoprazol [INN-Spanish]; Lansoprazolum [INN-Latin]; Lansox; Lanzo; A-65006; Prevacid NapraPAC; Prevacid 24HR; Lansoprazole [USAN:BAN:INN]; HSDB 7204
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00656	Diltiazem	(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate; (2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate; (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; Acalix; Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; Adizem; Adizem (TN); Aldizem; Altiazem (TN); Angiozem (TN); Angizem (TN); Angizem CD (TN); Anoheal; Apo-Diltiaz; Cardil; Cardizem; Cardizem (Hydrochloride); Cardizem (TN); Cardizen LA; Cartia XT (TN); Citizem; D-cis-Diltiazem; Dilacor; Dilacor-XR; Dilatam (TN); Dilatem (TN); Dilcardia (TN); Dilcontin; Dilcontin SR (TN); Dilren; Dilt-cd; Dilta-Hexal; Diltelan (TN); Diltia; Diltiazem (INN); Diltiazem [INN:BAN]; Diltiazemum; Diltiazemum [INN-Latin]; Dilticard; Diltime (TN); Diltzac; Dilzem (TN); Dilzen; Dyalec (TN); Endrydil; Filazem (TN); Herben (TN); Incoril AP; MK-793 (Malate); Nu-Diltiaz; Progor (TN); RG 83606 (Hydrochloride); Surazem (TN); Tiamate (TN); Tiazac (TN); Tiazac Tildiem; Tiazac XC; Tiazac XC (TN); Tildiem (TN); Vasmulax (TN); Viazem; Viazem (TN); Zandil (TN); Zemtrial (TN); [(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00658	Fluphenazine	1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine; 1-(2-Hydroxyethyl)-4-[3-(trifluoromethyl-10-phenothiazinyl)propyl]piperazine; 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI); 10-(3'-(4"-(beta-Hydroxyethyl)-1"-piperazinyl)-propyl)-3-trifluoromethylphenothiazine; 10-(3'-(4''-(beta-Hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine; 10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; 2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol; 2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethanol; 2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-pipe razinyl)propyl)phenothiazine; 2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol; 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol dihydrochloride; 4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; 4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol; 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-Piperazineethanol; 4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol; 4-[3-(2-Trifluoromethyl-10-phenothiazyl)-propyl]-1-piperazineethanol; Anatensol (TN); Apo-Fluphenazine; Dapotum; Dapotum (TN); Dapotum D (TN); Dapotum Injektion (TN); Decanoate (TN); Deconoate (TN); Elinol; Enanthate (TN); Fludecate (TN); Flufenazin; Flufenazina; Flufenazina [DCIT]; Flunanthate (TN); Fluorfenazine; Fluorophenazine; Fluorphenazine; Fluphenazine (INN); Fluphenazine [INN:BAN]; Fluphenazine hydrochloride; Fluphenazinum; Fluphenazinum [INN-Latin]; Ftorphenazine; Hydrochloride, Fluphenazine; Lyogen (TN); Modecate (TN); Moditen (TN); Moditen (Tabl or elixir); Moditen Enanthate Injection (TN); Moditen Hcl; Omca (TN); Pacinol; Permitil (TN); Permitil Concentrate; Phthorphenazine; Prolixin (TN); Prolixin Concentrate; Prolixine; S94; SQ 4918; Sediten (TN); Selecten (TN); Sevinol; Sevinol (TN); Sinqualone (TN); Siqualine; Siqualon; Trancin (TN); Triflumethazine; Vespazine; Yespazine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00664	Trifluoperazine	10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine; 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine; 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine; 10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine; 10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE; 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride; 2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; Apo-Trifluoperazine; Apo-trifluoperazine (TN); Calmazine; Eskazine; Eskazine (TN); Eskazinyl (TN); Fluoperazine; Flurazine; Jatroneural (TN); Modalina; Modalina (TN); NCI17474; Novo-Trifluzine; PMS Trifluoperazine; RP 7623; SKF 5019; Stelazine; Stelazine (*Dihydrochloride*); Stelazine (TN); Stelazine Concentrate; Stellazine; TFP; Terfluzine (TN); Trifluoperaz (TN); Trifluoperazin; Trifluoperazina; Trifluoperazina [INN-Spanish]; Trifluoperazina [Italian]; Trifluoperazine (INN); Trifluoperazine HCl; Trifluoperazine [INN:BAN]; Trifluoperazine dihydrochloride; Trifluoperazinum; Trifluoperazinum [INN-Latin]; Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; Trifluoromethylperazine; Trifluoroperazine; Trifluoroperazine dihydrochloride; Trifluperazine; Triflurin; Trifluroperizine; Triftazin; Triftazine; Triperazine; Tripfluoperazine Hydrochloride; Triphtazin; Triphtazine; Triphthasine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00666	Doxycycline	(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS); 5-Hydroxy-alpha-6-deoxytetracycline; 6-Deoxyoxytetracycline; 6-Deoxytetracycline; 6-alpha-Deoxy-5-oxytetracycline; 6alpha-Deoxy-5-oxytetracycline; Alpha-6-Deoxy-5-hydroxytetracycline; Alpha-6-Deoxyoxytetracycline; Alpha-Doxycycline; Alti-Doxycycline; Apo-Doxy; Atridox; Azudoxat; BMY-28689; BU-3839T; DMSC (*Fosfatex); DOXCYCLINE ANHYDROUS; DOXY; DOXYCYCLINE CALCIUM; DOXYCYCLINE MONOHYDRATE; Deoxymykoin; Dossiciclina; Dossiciclina [DCIT]; Doxiciclina; Doxiciclina [INN-Spanish]; Doxiciclina [Italian]; Doxitard; Doxivetin; Doxy-Caps; Doxy-Puren; Doxy-Tabs; Doxycen; Doxychel; Doxychel (TN); Doxycin; Doxycyclin; Doxycycline (200mg/day) or Placebo; Doxycycline (INN); Doxycycline (TN); Doxycycline (anhydrous); Doxycycline (internal use); Doxycycline anhydrous; Doxycycline hyclate; Doxycycline-Chinoin; Doxycyclinum; Doxycyclinum [INN-Latin]; Doxysol; Doxytec; Doxytetracycline; GS-3065 (*monohydrate); Hydramycin; Investin; Jenacyclin; Liviatin; Monodox; Monodox (*monohydrate); Novo-Doxylin; Nu-Doxycycline; Oracea; Periostat (TN); Ronaxan; Spanor; Supracyclin; Vibra-tabs; Vibramycin; Vibramycin (*monohydrate); Vibramycin Novum; Vibramycine; Vibravenos; Vivox (*Hyclate)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00668	Nisoldipine	(+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester; 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Bay k 5552; Bay-k-5552; Baymycard; Isobutyl 1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridincarboxylat;Methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nisocor; Nisoldipin; Nisoldipine (JAN/USAN/INN); Nisoldipine [USAN:BAN:INN:JAN]; Nisoldipino; Nisoldipino [INN-Spanish]; Nisoldipinum; Nisoldipinum [INN-Latin]; Sular; Sular (TN); Syscor; Zadipina
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00669	Clofazimine	(3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; B 663; B 663 (Pharmaceutical); B 663 (VAN); B 663, pharmaceutical; B-663; B. 663; CFZ; Chlofazimine; Clofazimina; Clofazimina [INN-Spanish]; Clofazimine (JAN/USP/INN); Clofazimine [USAN:INN:BAN]; Clofaziminum; Clofaziminum [INN-Latin]; G 30320; G-30,320; G-30320; Lampren; Lamprene; Lamprene (TN); Liposome-encapsulated clofazimine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine; N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine; N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine; SMP2_000339
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00684	Midazolam	4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate; 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride; 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine; 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine; Dazolam; Dormicum; Dormicum (TN); Hypnovel (TN); Midacum (TN); Midanium; Midazolam (JAN/INN); Midazolam Base; Midazolam [INN:BAN:JAN]; Midazolamum; Midazolamum [INN-Latin]; Midosed; Ro 21-3981; Versed; Versed (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00687	Itraconazole	(+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one; (1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one; 2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl); 4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; Canadiol; Cis-Itraconazole; Hyphanox; ITCZ; ITZ; Intraconazole; Itraconazol; Itraconazol [Spanish]; Itraconazole & Bovine Lactoferrin; Itraconazole & Nyotran; Itraconazole & Nyotran(Liposomal Nystatin); Itraconazole (JAN/USAN); Itraconazole [USAN:BAN:INN:JAN]; Itraconazole oral solution; Itraconazolum; Itraconazolum [Latin]; Itrizole; Itrizole (TN); Oriconazole; Oriconazole, R51211, Sporanox; Orungal; Prokanazol; R 51211; R-51211; Sempera; Spherazole; Sporal; Sporanos; Sporanox; Sporanox (TN); Sporonox; Triasporn
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00689	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; (+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; (+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol; 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol; Artist; Artist (TN); Atlana Pharma brand of carvedilol; BM 14190; BM-14-190; BM-14.190; BM-14190; Carloc (TN); Carvedilol (JAN/USAN/INN); Carvedilol [USAN:INN:BAN:JAN]; Carvedilol, (+-)-isomer; Carvedilol, (R)-isomer; Carvedilol, (S)-isomer; Carvedilol, 14C-labeled; Carvedilolum; Carvedilolum [Latin]; Coreg; Coreg (TN); Coreg CR; Coropres; Coropress; DQ 2466; DQ-2466; Dibloc; Dilatrend; Dilatrend (TN); EG-P042; Eucardic; Eucardic (TN); GlaxoSmithKline brand of carvedilol; Kredex; Lakeside brand of carvedilol; Querto; Roche brand of carvedilol; SK&F-105517; SKF 105517
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00691	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; (+/-)-ethylmethyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; 1A Brand of Felodipine; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-, ethyl methylester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2,3-dichlorophenyl)-2,6-dimethyl-,ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester; 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate; 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid ethyl methyl ester; 4-(2,3-dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester; 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester; 5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; AE-641/11429675; AGON SR; AbZ Brand of Felodipine; Agon; Aliud Brand of Felodipine; Alphapharm Brand of Felodipine; Alpharma Brand of Felodipine; Astra Brand of Felodipine; AstraZeneca Brand of Felodipine; Aventis Brand of Felodipine; Azupharma Brand of Felodipine; BC Brand of Felodipine; Betapharm Brand of Felodipine; CGH-869; Ct Arzneimittel Brand of Felodipine; Ct-Arzneimittel Brand of Felodipine; Dl-Felodipine; Ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; F 9677; Felo Biochemie; Felo Puren; Felo-Puren; Felobeta; Felocor; Feloday; Felodipin 1A Pharma; Felodipin AL; Felodipin AZU; Felodipin AbZ; Felodipin Heumann; Felodipin Stada; Felodipin dura; Felodipin ratiopharm; Felodipin von ct; Felodipin-ratiopharm; Felodipina; Felodipina [INN-Spanish]; Felodipine (JAN/USP/INN); Felodipine [USAN:BAN:INN]; Felodipine [USAN:INN:BAN]; Felodipinum; Felodipinum [INN-Latin]; Felodur; FelodurER; Felogamma; Felogard; Fensel; Flodil; H 154 82; H 154-82; H 154/82; H 15482; H-154/82; Heumann Brand of Felodipine; Heumann, Felodipin; Hexal Brand of Felodipine; Hoechst Brand of Felodipine; Hydac; Lexxel; Logimax; Merck dura Brand of Felodipine; Modip; Munobal; Munobal Retard; Penedil; Perfudal; Pharmaceutica Astra Brand of Felodipine; Pharmacia Spain Brandof Felodipine; Plandil; Plendil; Plendil (TN); Plendil Depottab; Plendil ER; Plendil Retard; Plendil, Renedil, Feloday, Felodipine; Preslow; Prevex; Promed Brand of Felodipine; Ratiopharm Brand of Felodipine; Renedil; Splendil; Stadapharm Brand of Felodipine; TheraPharm Brand of Felodipine; Worwag Brand of Felodipine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00693	Prazosin	1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; CP-12299; Furazosin; Hypovase (TN); Justac; Lentopres; Minipress (TN); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Prazocin; Prazosin (INN); Prazosin HCl; Prazosin [INN:BAN]; Prazosina; Prazosina [INN-Spanish]; Prazosine; Prazosine [INN-French]; Prazosinum; Prazosinum [INN-Latin]; TNP00312; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00702	Telaprevir	(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-6-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide; 402957-28-2; 655M5O3W0U; CHEBI:68595; CHEMBL231813; Incivek; Incivo; LY-570310; MP-424; S-Telaprevir; Telaprevir (VX-950); Telavic; UNII-655M5O3W0U; VRT-111950; VX 950; VX-950; VX-950(Telaprevir)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00705	Astemizole	1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; AlacanBrand of Astemizole; Alermizol; Alonga Brand of Astemizole; Alonga, Astemizol; Astemina; Astemisan; Astemisol; Astemison; Astemizol; Astemizol Alonga; Astemizol [German]; Astemizol [INN-Spanish]; Astemizol ratiopharm; Astemizole (JAN/USP/INN); Astemizole Alacan Brand; Astemizole Alonga Brand; Astemizole Byk Brand; Astemizole Diba Brand; Astemizole Elfar Brand; Astemizole Esteve Brand; Astemizole Fustery Brand; Astemizole ICN Brand; Astemizole Janssen Brand; Astemizole Lesvi Brand; Astemizole McNeil Brand; Astemizole Medinsa Brand; Astemizole Merck Brand; Astemizole Senosiain Brand; Astemizole Septa Brand; Astemizole Smaller Brand; Astemizole Urbion Brand; Astemizole Vita Brand; Astemizole [USAN:BAN:INN]; Astemizole ratiopharm Brand; Astemizolum; Astemizolum [INN-Latin]; Astesen; Byk Brand of Astemizole; Diba Brand of Astemizole; Elfar Brand of Astemizole; Emdar; Esmacen;Fustermizol; Esteve Brand of Astemizole; Fustery Brand of Astemizole; GNF-PF-2461; HISMANAL (TN); Hestazol; Hestazol, Kelp, Laridal, Retolen, Wareezol, HSBD 6799, BRN 4830190; Hismanal; Histamen; Histaminos; Histazol; Hubermizol; ICN Brand of Astemizole; Janssen Brand of Astemizole; Kelp; Laridal; Lesvi Brand of Astemizole; MJD-30; McNeil Brand of Astemizole; Medinsa Brand of Astemizole; Merck Brand of Astemizole; Metodih; Metodik; Nono-Nastizol A; Novo-mastizol A; Paralergin; R 42512; R 43 512; R-43-512; R-43512; R43512; Ratiopharm Brand of Astemizole; Ratiopharm, Astemizol; Reig Jofre Brand of Astemizole; Retolen; Rifedot; Rimbol; Romadin; Senosiain Brand of Astemizole; Septa Brand of Astemizole; Simprox; Smaller Brand of Astemizole; Urbion Brand of Astemizole; Urdrim; Vita Brand of Astemizole; Wareezol; Waruzol; [3H]Astemizole
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00708	Roxithromycin	9-(O-((2-Methoxyethoxy)methyl)oxime)erythromycin; 9-[O-(2-methoxyethoxymethyl)-oxime] of erythromycin; Assoral; Biaxsig (TN); Coroxin (TN); Erythromycin 9-(-O-[2-methoxyethoxy]methyloxime);Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime); Overall; RC2952; RU 28965; RU 965; RU-28965; RU-965; RXM; Rossitrol; Roxar (TN); Roximycin (TN); Roxithromycin & Tumor Necrosis Factor; Roxithromycin (JP15/USAN/INN); Roxithromycin [USAN:INN:JAN]; Roxithromycine; Roxithromycine [French]; Roxithromycinum; Roxithromycinum [Latin]; Roxitromicina; Roxitromicina [Spanish]; Roxl-150 (TN); Roxo (TN); Rulid; Rulide; Rulide (TN); Surlid; Surlid (TN); Tirabicin (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00709	Bepridil	Bepadin; Bepadin (TN); Bepridil (INN); Beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine; CERM 1978; N-Benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-yl-propyl]aniline hydrochloride; N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline; N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline; N-{3-[(2-methylpropyl)oxy]-2-pyrrolidin-1-ylpropyl}-N-(phenylmethyl)aniline; Vascor; Vascor (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00711	Vemurafenib	PLX4032; RG7204; RO5185426; Vemurafenib (BRAF inhibitor); Zelboraf (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00713	Clarithromycin	clarithromycin; 81103-11-9; Biaxin; Clarithromycine; Klaricid; 6-O-Methylerythromycin; Clathromycin; 6-O-Methylerythromycin a; Abbott-56268; Macladin; Veclam; Kofron; Klacid; Clarith; Clarithromycinum; Naxy; A-56268; Erythromycin, 6-O-methyl-; TE-031; Claritromicina; Fromilid; Claridar; Bicrolid; Astromen; Claricide; Clacine; Abbotic; Mabicrol; Clambiotic; Klaciped; Heliclar; Claripen; Claribid; Clarem; Clacid; Clacee; Zeclar; Maclar; Klarid; Crixan; Klarin; Klabax; Cyllid; Mavid; Helas; Biaxin filmtab; Adel; Klax; Biaxin xl filmtab; Biaxin HP; Klaricid Pe
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00716	Vecuronium	(2A,3A,5A,16A,17A)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane; (2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane; Norcuron (TN); [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00730	Maraviroc	376348-65-1; 4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(321)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide; 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[321]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide; CHEBI:63608; CHEMBL1201187; CHEMBL256907; Celsentri; Celsentri (TN); Celsentri(TM); Exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[321]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide; Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(321)octan-8-yl}-1-phenylpropyl)cyclohexanecarboxamide; MD6P741W8A; MVC; Maraviroc [USAN]; PRO 140 & Maraviroc; PRO 140 (Anti-CCR5 monoclonal antibody) & exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[321]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide; Selzentry; Selzentry (TN); Selzentry(TM); UK 427857; UK-427,857; UK-427,857 maraviroc (MVC); UK-427857; UNII-MD6P741W8A; [3H]maraviroc
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00733	Dihydrotestosterone	17beta-Hydroxy-3-androstanone; 17beta-Hydroxy-5alpha-androstan-3-one; 17beta-Hydroxyandrostan-3-one; 4,5alpha-Dihydrotestosterone; 4-Dihydrotestosterone; 5-alpha-Dihydrotestosterone; 521-18-6; 5alpha-Androstan-17beta-ol-3-one; 5alpha-DHT; 5alpha-Dihydrotestosterone; Anaboleen; Anabolex; Andractim; Androlone; Androstanolona; Androstanolone; Androstanolonum; Cristerona MB; DHT; Dihydrotestosteron; LG 152; Neodrol; Proteina; Protona; STANOLONE; Stanaprol; Stanolon; Stanorone; Testosterone, dihydro-; [3H]dihydrotestosterone; dihydrotestosterone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00745	Linagliptin	(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione; BI 1356; BI-1356; BI-1356-BS; Ondero; Ondero (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00755	Terfenadine	1-(4-tert-Butylphenyl)-4-(4-(alpha-hydroxybenzhydryl)piperidino)-butan-1-ol; 1-(4-tert-butylphenyl)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan-1-ol; 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol; 1-(p-tert-Butylphenyl)-4-(4'-(alpha-hydroxydiphenylmethyl)-1'-piperidyl)butanol; 1-[4-(1,1-dimethylethyl)phenyl]-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butan-1-ol; Aldaban; Aliud Brand of Terfenadine; Allerplus; Alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol; Alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; Alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenyl-methyl)-1-piperidine butanol; Alpha-(4-[1,1-Dimethylethyl]phenyl)-4-[hydroxydiphenylmethyl]-1-piperidinebutanol; Alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; Alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol; Balkis Saft Spezial; Bial Brand of Terfenadine; Cantabria Brand of Terfenadine; Ct Arzneimittel Brand of Terfenadine; Ct-Arzneimittel Brand of Terfenadine; Cyater; Dolorgiet Brand of Terfenadine; Heumann Brand of Terfenadine; Hisfedin; Hoechst Brand of Terfenadine; MDL 9918; MDL-9918; Merck dura Brand of Terfenadine; Mundipharma Brand of Terfenadine; RMI 9918; RMI-9918; RMI9918; Rapidal; Ratiopharm Brand of Terfenadine; Seldane; Seldane (TN); Sigma Tau Brand of Terfenadine; Sigma-Tau Brand of Terfenadine; Stadapharm Brand of Terfenadine; T 9652; Teldane; Teldane (TN); Teldanex; Terdin; Terfedura; Terfemundin; Terfen; Terfenadin AL; Terfenadin Heumann; Terfenadin Stada; Terfenadin von ct; Terfenadin-ratiopharm; Terfenadina; Terfenadina [INN-Spanish]; Terfenadine (JAN/USAN/INN); Terfenadine [USAN:BAN:INN:JAN]; Terfenadinum; Terfenadinum [INN-Latin]; Terfenidine; Terfex; Ternadin; Triludan; Triludan (TN); Wolff Brand of Terfenadine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00759	Perphenazine	1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina; 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]; 1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine; 1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine; 1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride; 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol; 2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine; 2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine; 2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine; 2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine; 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol;2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol; 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol; 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol; 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol; 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; Apo-Perphenazine; Chlorperphenazine; Chlorpiprazine; Decentan; Emesinal; Etaperazin; Etaperazine; Ethaperazine; F-mon; Fentazin;PZC; Gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine; Gamma-[4-(beta-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine; P 6402; Perfenazina; Perfenazina [INN-Spanish]; Perfenazina [Italian]; Perfenazine; Perphenan; Perphenazin; Perphenazine (JP15/USP/INN); Perphenazine [INN:BAN:JAN]; Perphenazine [Trilafon]; Perphenazine maleate; Perphenazinum; Perphenazinum [INN-Latin]; SCH-3940; Sch 3940; Siquil (TN); Thilatazin; Tranquisan; Triavil (TN); Trifaron; Trilafon; Trilifan; Triphenot
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00781	Mibefradil	Calcium T-channel inhibitor (Cytostatic Checkpoint Therapy, ovarian cancer), Tau Therapeutics; Mibefradil (Cytostatic Checkpoint Therapy, ovarian cancer); Mibefradil (Cytostatic Checkpoint Therapy, ovarian cancer), Tau Therapeutics
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00785	Thioridazine	(+-)-Thioridazine; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine; 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; Aldazine; Dl-Thioridazine; Mallorol; Malloryl; Meleril; Mellaril; Mellaril (*Hydrochloride*); Mellaril (TN); Mellaril-S; Mellaril-S (TN); Mellarit; Mellerets; Mellerette; Melleretten; Melleril; Melleril (liquid); Melleryl; Metlaril; Novoridazine; Novoridazine (TN); Orsanil; Ridazine; Sonapax; Stalleril; TP-21; Thioridazin; Thioridazine (USP/INN); Thioridazine Hcl; Thioridazine Hcl Intensol; Thioridazine [USAN:INN:BAN]; Thioridazine prolongatum; Thioridazine, prolongatum; Thioridazinum; Thioridazinum [INN-Latin]; Thioril (TN); Thioxidazine; Thoridazine hydrochloride; Tioridazin; Tioridazina; Tioridazina [INN-Spanish]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00790	Staurosporine	(+)-Staurosporine; 62996-74-1; 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-; AM-2282; Alkaloid AM-2282 from Streptomyces; Antibiotic 230; Antibiotic AM 2282; CCRIS 3272; CGP 39360; CHEBI:15738; CHEMBL388978; H88EPA0A3N; Staurosporin; UNII-H88EPA0A3N; staurosporine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00791	Sparfloxacin	(cis)-5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-Amino-1-cyclohexyl-7-(cis-3,5-dimethylpiperazino)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid & RU 40555; 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid; AT 4140; AT-4140; CP 103826; CP-103826; Cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; DRG-0143; Esparfloxacino; Esparfloxacino [INN-Spanish]; Liposome-encapsulated sparfloxacin; PD 1315-1; PD 131501; PD-131501; PD131501; RP-64206; Respipac (TN); SPFX; Spara; Sparfloxacin & RU 40555; Sparfloxacin (JAN/USAN/INN); Sparfloxacin [USAN:BAN:INN:JAN]; Sparfloxacin, cis-isomer; Sparfloxacine; Sparfloxacine [INN-French]; Sparfloxacinum; Sparfloxacinum [INN-Latin]; Zagam; Zagam (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00795	Bicalutamide	(+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide; 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide; Astra brand of bicalutamide; AstraZeneca brand of bicalutamide; Bicalutamide (JAN/USP/INN); Bicalutamide [USAN:INN:BAN]; Calutide (TN); Casodex; Casodex (TN); Casodex, Cosudex, Calutide, Kalumid, Bicalutamide; Cosudex; Cosudex (TN); KS-1161; Kalumid (TN); N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide; Propanamide; Raffolutil; Zeneca brand of bicalutamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00810	Ziprasidone	Geodon; 146939-27-7; 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one; 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 6-chloro-5-[2-[4-(7-thia-8-azabicyclo[430]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one; 6UKA5VEJ6X; C21H21ClN4OS; CHEBI:10119; CHEMBL708; CP 88059; CP 88059-01; CP-88,059; CP-88,059-01; CP-88,059-1; CP-88059-1; DSSTox_CID_3753; DSSTox_GSID_23753; DSSTox_RID_77186; Geodon; Geodon (TN); TC-5280; UNII-6UKA5VEJ6X; Zeldox; Zeldox (TN); Zipradon; Zipradon (TN); Ziprasidona; Ziprasidone (INN); Ziprasidone [INN:BAN]; Ziprasidone hydrochloride; Ziprasidone mesylate trihydrate; Ziprasidonum; Ziprazidone; ziprasidona; ziprasidonum; ziprazidone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00811	Alprenolol	1-(2-Allylphenoxy)-3-isopropylamino-2-propanol; 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol; 1-(o-Allylphenoxy)-3-isopropylamino)-2-propanol; 1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol; 1-[2-(propen-2-ylphenoxy)]-3-(isopropylamino)propan-2-ol; Alfeprol; Alfeprol [Russian]; Alpheprol; Alprenolol (INN); Alprenolol [INN:BAN]; Alprenololum; Alprenololum [INN-Latin]; Apllobal (TN); Aptine (TN); Aptol (TN); Duriles (TN); Gubernal (TN); H-56-28; Regletin (TN); Yobir; Yobir (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00833	Naringenin	( inverted exclamation markA)-Naringenin; (+/-)-Naringenin; (-)-Naringenin; (S)-Naringenin; 4',5,7-Trihydroxyflavanone; 4',7-Trihydroxyflavanone; 480-41-1; 5,7,4'-Trihydroxyflavanone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; 67604-48-2; 93602-28-9; AK122638; BE-14348A; CHEBI:50202; CHEMBL32571; FTVWIRXFELQLPI-UHFFFAOYSA-N; Flavanone, 4',5,7-trihydroxy-; MFCD00006844; MLS000028739; MLS000738094; NARIGENIN; NSC 11855; NSC 34875; NSC11855; NSC34875; Naringenine; SMR000059039; Salipurol; naringenin; naringetol; salipurpol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00836	Bupropion	Amfebutamon; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; (+-)-Bupropion; (-)-2-(tert-Butylamino)-3'-chloropropiophenone; (-)-2-(tert-Butylamino)-3'-chlorpropiophenon; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one; 1-Propanone; 2-(Tert-Butylamino)-3'-chloropropiophenone; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; 34841-39-9; 34911-55-2; AMFEBUTAMONE HCl; Alpha-(tert-Butylamino)-m-chloropropiophenone; Alpha-(tert-butylamino)-m-chloropropiophenone; Amfebutamon; Amfebutamona; Amfebutamona [INN-Spanish]; Amfebutamone; Amfebutamonum; Amfebutamonum [INN-Latin]; BRN 2101062; Bupropion (INN); Bupropion (Old RN); Bupropion (USAN); Bupropion Hcl; Bupropion SR; Bupropion [INN:BAN]; Bupropion hydrocloride; CHEBI:3219; CHEMBL894; Elont; Elontril; SNPPWIUOZRMYNY-UHFFFAOYSA-N; Wellbatrin; Zyban; alpha-(tert-butylamino)-m-chloropropiophenone; amfebutamonum; bupropion
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00849	Lidocaine	2-(Diethylamino)-2',6'-acetoxylidide; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide; 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide; After Burn Double Strength Gel; After Burn Double Strength Spray; After Burn Gel; After Burn Spray; Alfa-Dietilamino-2,6-dimetilacetanilide; Alfa-Dietilamino-2,6-dimetilacetanilide [Italian]; Alpha-(Diethylamino)-2,6-acetoxylidide; Alpha-Diethylamino-2,6-dimethylacetanilide; Alpha-Diethylaminoaceto-2,6-xylidide; Alphacaine; Anestacon; Anestacon Jelly; CDS1_000283; Cappicaine; Cito optadren; Cuivasil; Dalcaine; Dentipatch; Dentipatch (TN); DermaFlex; Diethylaminoaceto-2,6-xylidide; Dilocaine; Duncaine; ELA-Max; EMBOLEX; Emla Cream; Esracaine; Gravocain; Isicaina; Isicaine; Jetocaine; L-Caine; L1026_SIGMA; LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE); LIDOPEN; LQZ; Lanabiotic; Leostesin; Lida-Mantle; Lidocaina; Lidocaina [INN-Spanish]; Lidocaine (JP15/USP/INN); Lidocaine (VAN); Lidocaine Carbonate; Lidocaine Hydrocarbonate; Lidocaine Monohydrochloride; Lidocaine [USAN:INN:JAN]; Lidocainum; Lidocainum [INN-Latin]; Lidocaton; Lidoderm; Lidoject-1; Lidoject-2; Lignocaine; Lignocainum; Lingocaine; Maricaine; N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide; N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide; Norwood Sunburn Spray; Octocaine; Octocaine-100; Octocaine-50; Omega-Diethylamino-2,6-dimethylacetanilide; Remicaine; Rocephin Kit; Rucaina; Solarcaine aloe extraburn relief cream; Solcain; Xilina; Xilocaina; Xilocaina [Italian]; Xllina; Xycaine; Xylestesin; Xylesthesin; Xylocain; Xylocaine; Xylocaine (TN); Xylocaine 5% Spinal; Xylocaine CO2; Xylocaine Dental Ointment; Xylocaine Endotracheal; Xylocaine Test Dose; Xylocaine Viscous; Xylocaine-Mpf; Xylocaine-Mpf with Glucose; Xylocard; Xylocitin; Xyloneural (free base); Xylotox; Zilactin-L; Zingo
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00855	Quetiapine	111974-69-7; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol; 2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol; BGL0JSY5SI; C21H25N3O2S; CHEBI:8707; CHEMBL716; Co-Quetiapine; Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-; Ketipinor (TN); NCGC00095911-03; Norsic; Norsic (TN); PD-172760; Quetiapina; Quetiapine (INN); Quetiapine [INN:BAN]; Quetiapine hemifumarate; Quetiapinum; Seroquel (Fumarate); Seroquel (TN); UNII-BGL0JSY5SI; URKOMYMAXPYINW-UHFFFAOYSA-N; quetiapine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00892	Gallopamil	(+/-)-Methoxyverapamil hydrochloride; 16662-47-8; 5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-; C28H40N2O5; CHEBI:34772; D 600; D600; GSK 796406; Gallopamil [INN:BAN]; Gallopamillum [INN-Latin]; Galopamilo; Galopamilo [INN-Spanish]; Methoxyverapamil; methoxyverapamil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00895	Chlorambucil	Ambochlorin; Amboclorin; C0253; CB 1348; CB-1348; CB1348; Cb l348; Chlocambucil; Chloorambucol; Chlorambucil (USP/INN); Chlorambucil [INN:BAN]; Chlorambucilum; Chlorambucilum [INN-Latin]; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chlorbutinum; Chloroambucil; Chlorobutin; Chlorobutine; Clorambucile; Clorambucile [DCIT]; Clorambucilo; Clorambucilo [INN-Spanish]; Ecloril; Elcoril; Elcorin; Glaxo Wellcome Brand of Chlorambucil; GlaxoSmithKline Brand of Chlorambucil; LEUKERAN (TN); Leuk ersan; Leukeran; Leukeran (TN); Leukeran tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Lympholysin; Phenylbuttersaeure-lost; Phenylbuttersaeure-lost[German]; Phenylbutyric acid nitrogen mustard; Wellcome Brand of Chlorambucil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00900	Timolol	(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole; (2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; (S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol; (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol; (S)-timolol; Apo-Timol; Apo-Timol (TN); Apo-Timop; Apo-Timop (TN); Aquanil; Betim; Betimol; Betimol (TN); Blocadren; Blocadren (TN); Gen-Timolol (TN); Istalol; Istalol (TN); L-714,465; MK-950; Novo-Timol; Nu-Timolol; Nu-Timolol (TN); Optimol; PMS-Timolol (TN); Phoxal-timolol; Phoxal-timolol (TN); Proflax; S(-)-Timolol maleate; S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole; TIM; Temserin; Tenopt; Tim-AK; Tim-AK (TN); Timacar; Timolol (INN); Timolol (TN); Timolol GFS; Timolol Maleate, (1:1) Salt; Timolol [USAN]; Timololum; Timololum [INN-Latin]; Timopic; Timoptic (TN); Timoptic OcuDose; Timoptic OcuDose. (TN); Timoptic-XE; Timoptic-XE (TN); Timoptol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00909	Ondansetron	(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one; 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one; 9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one; 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one; Apo-ondansetron; DESMETHYLONDANSETRON; GR 38032; GR 38032X; GR-38032F; GR38032F; Novo-ondansetron; Ondansetron (JAN/USP/INN); Ondansetron (Zofran); Ondansetron [USAN:INN:BAN]; Ondansetron, (+,-)-Isomer; PHL-ondansetron; PMS-ondansetron; Ratio-ondansetron; SN-307; Sandoz ondansetron; ZOFRAN IN PLASTIC CONTAINER; Zofran; Zofran (TN); Zofran ODT; Zofran ODT (TN); Zophren; Zudan
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00922	Diethylstilbestrol	(E)-3,4-Bis(4-hydroxyphenyl)-3-hexene; (E)-4,4'-(hex-3-ene-3,4-diyl)diphenol; (E)-Diethylstilbestrol; 3,4'(4,4'-Dihydroxyphenyl)hex-3-ene; 3,4-Bis(p-hydroxyphenyl)-3-hexene; 3,4-bis(4-hydroxyphenyl)hex-3-ene; 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol; 4,4'-Dihydroxydiethylstilbene; 4,4'-hex-3-ene-3,4-diyldiphenol; APS Brand of Diethylstilbestrol; Acnestrol; Agostilben; Alpha,alpha'-Diethyl-4,4'-stilbenediol; Alpha,alpha'-Diethylstilbenediol; Anti gestil; Antigestil; Apstil; Bufon; Cis-Des; Cis-Diethylstilbesterol; Cis-Diethylstilbestrol; Climaterine; Co Pharma Brand of Diethylstilbestrol; Co-Pharma Brand of Diethylstilbestrol; Comestrol; Comestrol estrobene; Cyren; Cyren A; DES; DES (synthetic estrogen); Dawe's destrol; Desma; Destrol; Di-Estryl; DiBestrol "2" Premix; DiBestrol 2 Premix; Diaethylstilboestrolum; Diastyl; Dibestrol; Dibestrol '2' premix; Dicorvin; Diethylstilbesterol; Diethylstilbestrol (DES); Diethylstilbestrol (USP/INN); Diethylstilbestrol BP; Diethylstilbestrol [USAN:INN]; Diethylstilbestrol, (Z)-Isomer; Diethylstilbestrol, Disodium Salt; Diethylstilbestrolum; Diethylstilbestrolum [INN-Latin]; Diethylstilboesterol; Dietilestilbestrol; Dietilestilbestrol [INN-Spanish]; Dietilestilbestrol [Spanish]; Dietilstilbestrolo; Dietilstilbestrolo [DCIT]; Distilbene; Domestrol; Dyestrol; E-Diethylstilbestrol; Estilbin (MCO); Estilbin MCO; Estril; Estrobene; Estrogen, Stilbene; Estrogenine; Estromenin; Estrosyn; Fonatol; Gerda Brand of Diethylstilbestrol; Grafestrol; Gynopharm; Hi-Bestrol; Hibestrol; Idroestril; Iscovesco; MG 137; Makarol; Menostilbeen; Micrest; Microest; Milestrol; Neo-Oestranol 1; Neo-Oestranol I; Neo-oe stranol 1; New-Estranol 1; OeKolp; Oestrogenine; Oestrol vetag; Oestrolmensil; Oestromenin; Oestromensil; Oestromensyl; Oestromienin; Oestromon; Pabestrol; Palestrol; Percutatrine oestrogenique iscovesco; Protectona; Rumestrol 1; Rumestrol 2; ST IL; Sedestran; Serral; Sexocretin; Sibol; Sintestrol; Stibilium; Stil-Rol; Stilbene Estrogen; Stilbestroform; Stilbestrol; Stilbestrol (TN); Stilbestrone; Stilbetin; Stilboefral; Stilboestroform; Stilboestrol; Stilbofolin; Stilbofollin; Stilbol; Stilkap; Strobene; Synestrin; Synthestrin; Synthoestrin; Synthofolin; Syntofolin; TRANS-DIETHYSTILBESTEROL; TRANSGENIC MODEL EVALUATION (DES); Tampovagan; Tampovagan stilboestrol; Trans-Diethylstilbesterol; Trans-Diethylstilbestrol; Trans-Diethylstilboesterol; Tylosterone; Vagestrol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00946	Melagatran	159776-70-2; 2A9QP32MD4; C22H31N5O4; CHEBI:43966; H-319/68; MEL; MELAGATRAN (ASTRA-ZENECA); Melagatran; Melagatran (INN); Melagatran [INN]; N-((R)-(((2S)-2-((-p-Amidobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine; N-((R)-(((2S)-2-((p-Amidinobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine; UNII-2A9QP32MD4; [((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00963	Domperidone	4-(5-Chloro-2-oxo-1-benzimidazolinyl)-1-[3-(2-oxobenzimidazolinyl)propyl]piperidine; 5-Chloro-1-(1-(3-(2-oxo-1-benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone; 5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one; 5-Chloro-1-[1-[3-(2-oxo-1-benzimidazolinyl)propyl]-4-piperidyl]-2-benzimidazolinone; 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one; 5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one; Costi (TN); D-122; Domperidon; Domperidona; Domperidona [INN-Spanish]; Domperidone (JAN/USAN/INN); Domperidone [USAN:BAN:INN:JAN]; Domperidonum; Domperidonum [INN-Latin]; HS-0067; KW 5338; KW-5338; Motilium; Motilium (TN); Motillium (TN); Motinorm (TN); NCI299589; Nauzelin; R 33,812; R-33,812; R-33812
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00981	Eletriptan	(R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole; (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole; 3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole; 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole; 5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole; Eletriptan (INN); Eletriptan [INN:BAN]; Eletriptanum; Relpax; Relpax (TN); UK 116044; UK-116044; UK-116044-04; UK116044
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00989	Chloramphenicol	Ak-chlor; Alficetyn; Alficetyn (TN); Alficetyn, Chlornitromycin, Chloromycetin, Chloramphenicol; Ambofen; Amphenicol; Amphicol; Amphicol (TN); Amseclor; Anacetin; Aquamycetin; Austracil; Austracol; Biocetin; Biomicin (TN); Biophenicol; Brochlor (TN); C.A.F; CAF; CAF (pharmaceutical); CHLOROPTIC S.O.P; CLM; Catilan; Cedoctine (TN); Ch loramex; Chemiceticol; Chemicetin; Chemicetina; Chlomin; Chlomycol; Chlora-tabs; Chloramex; Chloramex (TN); Chloramfenikol; Chloramfenikol [Czech]; Chloramficin; Chloramfilin; Chloramphenicol & VRC3375; Chloramphenicol (JP15/USP/INN); Chloramphenicol [INN:BAN:JAN]; Chloramphenicol crystalline; Chloramphenicolum; Chloramphenicolum [INN-Latin]; Chloramsaar; Chlorasol; Chlorbiotic (Veterinary); Chloricol; Chlormycetin R; Chlornitromycin; Chlornitromycin (TN); Chloro-25 vetag; Chloroamphenicol; Chlorocaps; Chlorocid; Chlorocid S; Chlorocide; Chlorocidin C; Chlorocidin C tetran; Chlorocol; Chlorofair; Chloroject L; Chloromax; Chloromycetin; Chloromycetin (TN); Chloromycetin® Chloromycetny; Chloromycetny [Polish]; Chloromyxin; Chloronitrin; Chloroptic; Chloroptic S.O.P.; Chlorovules; Chlorsig; Chlorsig (TN); Cidocetine; Ciplamycetin; Cloramfen; Cloramfenicol; Cloramfenicol [INN-Spanish]; Cloramfenicolo; Cloramfenicolo [DCIT]; Cloramficin; Cloramical; Cloramicol; Cloramidina; Cloranfenicol; Cloroamfenicolo; Cloroamfenicolo [Italian]; Clorocyn; Cloromisan; Cloromissan; Clorosintex; Comycetin; Cylphenicol; D(-)-threo-2-dichloroacetamido-1-p-nitrophen yl-propanediol; D(-)-threo-2-dichloroacetamido-1-p-nitrophenyl-propanediol; D(-)-threo-Chloramphenicol; D-(-)-Chloramphenicol; D-(-)-threo-Chloramphenicol; D-Chloramphenicol; D-threo-Chloramphenicol; Desphen; Detreomycin; Detreomycine; Dextromycetin; Dispersadron C (TN); Doctamicina; Duphenicol; Econochlor; Econochlor (TN); Elase-Chloromycetin; Embacetin; Emetren; Enicol; Enteromycetin; Erbaplast; Ertilen; F armicetina; Farmicetina; Fenicol; Fenicol (TN); Globenicol; Glorous; Golden Eye (TN); Halomycetin; Hortfenicol; I 337A; Interomycetine; Intramycetin; Intramyctin; Isicetin; Ismicetina; Isophenicol; Isopto fenicol; Isoptophenicol (TN); Juvamycetin; Kamaver; Kemicetina; Kemicetine; Kemicetine (TN); Kloramfenikol; Klorita; Klorocid S; Laevomycetin (TN); Laevomycetinum; Leukamycin; Leukomyan; Leukomycin; Levomicetina; Levomitsetin; Levomycetin; Loromicetina; Loromisan; Loromisin; Mastiphen; Mediamycetine; Medichol; Medicom (TN); Micloretin; Micochlorine; Micoclorina; Microcetina; Mychel; Mychel-Vet; Mycinol; Myscel; Nevimycin (TN); Normimycin V; Novochlorocap; Novomycetin; Novophenicol; Oftalent; Oftan Chlora (TN); Oleomycetin; Opclor; Opelor; Ophthochlor; Ophtochlor; Optomycin; Optrex Infected Eyes (TN); Orchadexoline (TN); Otachron; Otophen; Pantovernil; Paraxin; Pentamycetin; Phenicol (TN); Quemicetina; Renicol (TN); Rivomycin; Romphenil; Ronfenil; Ronphenil; Septicol; Sificetina; Silmycetin (TN); Sintomicetina; Sintomicetine R; Sno Phenicol; Sno-Phenicol; Stanomycetin; Synthomycetin; Synthomycetine; Synthomycine; Synthomycine (TN); Syntomycin; Tea-Cetin; Tega-Cetin; Tevcocin; Tevcosin; Tifomycin; Tifomycine (TN); Tifomycine;Tiromycetin; Treomicetina; U-6062; Unimycetin; Vernacetin (TN); Veticol; Veticol (TN); Vice ton; Viceton
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR00999	Diazepam	Diazepam (intranasal, epilepsy); 439-14-5; Amiprol; Ansiolin; Ansiolisina; Apaurin; Apozepam; Assival; Atensine; Atilen; Bensedin; Bialzepam; Calmocitene; Calmpose; Ceregulart; Condition; Diacepan; Diapam; Diazemuls; Diazepan; Diazetard; Dipezona; Domalium; Faustan; Kiatrium; Levium; Liberetas; Methyldiazepinone; Neurolytril; Paranten; Quetinil; Quiatril; Quievita; Relaminal; Relanium; Renborin; Ruhsitus; Sedipam; Seduksen; Seduxen; Serenack; Serenamin; Serenzin; Sibazon; Sonacon; Stesolid; Stesolin; Tensopam; Tranimul; Tranqdyn; Tranquirit; Umbrium; Unisedil; Valitran; Valium; diazepam
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01007	Cortisone	11-dehydro-17-hydroxycorticosterone; 17-hydroxy-11-dehydrocorticosterone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01010	Epinastine	(+-)-Epinastine; 3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine; 3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine; 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine; Elestat (TN); Epinastina; Epinastina [Spanish]; Epinastine (INN); Epinastine [INN]; Epinastinum; Epinastinum [Latin]; Purivist; Purivist (TN); Relestat (TN); WAL 80; WAL 801; WAL 801CL; WAL-80 Cl
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01161	Ajmaline	Ajmaline; Cardiorythmine; Ajmalin; Raugalline; Tachmalin; Gilurytmal; (+)-Ajmaline; Aritmina; Rauwolfine; Rhytmaton; Rauwolfin; Merabitol; Takycor; Siddiqui; Rytmalin; Ignazin; Ritmos; 4360-12-7; UNII-1PON08459R; 1PON08459R; Takhmalin; Cartagine; Tajmalin; NSC 15627; Ajmaline [JAN]; Ajmalan-17,21-diol; EINECS 224-439-4; NSC 628054; (17R,21alpha)-Ajmalan-17,21-diol; (17R,21-alpha)-Ajmalan-17,21-diol; AI3-62668; Ajmalan-17,21-diol, (17R,21alpha)-, compound with methanol (1:1); ZINC898188
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01165	Gatifloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; AM 1155; AM-1155; AM-1155 (*Sesquihydrate*); BMS 206584-01; BMS-206584; BMS-206584-01; Bonoq; CG 5501;PD 135432; CG-5501; GTFX; Gaity; Gatiflo; Gatiflo (TN); Gatiflo,Tequin and Zymar, Gatifloxacin; Gatifloxacin & Gamma Interferon; Gatifloxacin (INN); Gatifloxacin (TN); Gatifloxacin [USAN:INN]; Gatilox; Gatiquin; Gatispan; PD-135432; PD135432; Tequin; Tequin (TN); Tequin in dextrose 5% in plastic container; Zymar; Zymar (TN); Zymaxid; Zymer; Zymer (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01170	Toremifene	(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1); 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC); 2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine; 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Acapodene; Acapodene (TN); Estrimex; FC-1157a; Fareston (TN); Farestone; GTX-006 (Acapodene); GTx 006; GTx-006; Toremifene (INN); Toremifene Base; Toremifene Citrate (1:1); Toremifene [INN:BAN]; Toremifeno; Toremifeno [Spanish]; Toremifenum; Toremifenum [Latin]; Z-Toremifene; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01177	Hydroxyurea	1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01203	Dactinomycin	1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; ACT D; ACTINOMYCIN D AMP; AD (VAN); Actactinomycin A IV; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin A IV; Actinomycin Aiv; Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin C1; Actinomycin D (JP15); Actinomycin D deriv. of 3H-phenoxaocardazine; Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin I1; Actinomycin IV; Actinomycin X 1; Actinomycin X1; Actinomycin cl; Actinomycin x i; Actinomycin-(threo-val-pro-sar-meval); Actinomycin-IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycindioic D acid, dilactone; Actinomyein-theo-val-pro-sar-meval; Acto-D; Antibiotic from Streptomyces parvullus; COSMEGEN (TN); Chounghwamycin B; Cosmegen; D Actinomycin; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; Dactinomicina; Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin D; Dactinomycin [USAN:BAN]; Dactinomycine; Dactinomycine [INN-French]; Dactinomycinum; Dactinomycinum [INN-Latin]; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; GNF-PF-1977; HBF 386; HBF 386 meractinomycin; Lyovac cosmegen; Meractinomycin; NP-005932; O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; Oncostatin K; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; X 97
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01204	Norfloxacin	1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; AM 0715; AM 715; AM-0715; AM-715; AM0715; Apo-Norflox (TN); Baccidal; Barazan; Chibroxin; Chibroxin (TN); Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; Fulgram; Insensye (TN); Lexinor; MK 0366; MK 366; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; NFLX; Norflo; Norflohexal (TN); Norfloxacin (JP15/USP/INN); Norfloxacin Merck Brand; Norfloxacin [USAN:BAN:INN:JAN]; Norfloxacine; Norfloxacine [INN-French]; Norfloxacino; Norfloxacino [INN-Spanish]; Norfloxacinum; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin; Noroxin (TN); Nufloxib (TN); Roxin (TN); Sebercim; Utin (TN); Utinor (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01211	Nimodipine	1,4-Dihydro-2,6-dimethyl-4-(3′-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester;1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 2-Methoxyethyl-1-methylethyl ester; 2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester; 3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester; 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester; 3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide; Admon; Almirall Brand of Nimodipine; Alpharma Brand of Nimodipine; Andromaco Brand of Nimodipine; Bay-E 9736; Bay-e-9736; Bayer Brand of Nimodipine; Bayvit Brand of Nimodipine; Brainal; Calnit; Cantabria Brand of Nimodipine; DRG-0139; EG-1961; Elan Brand of Nimodipine; Esteve Brand of Nimodipine; Hexal Brand of Nimodipine; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Kenesil; Modus; N-149; NIMOTOP (TN); NimoGel; Nimodipin Hexal; Nimodipin ISIS; Nimodipin-ISIS; NimodipinISIS; Nimodipine (USAN/INN); Nimodipine [USAN:BAN:INN]; Nimodipino; Nimodipino Bayvit; Nimodipino [INN-Spanish]; Nimodipinum; Nimodipinum [INN-Latin]; Nimotop; Nimotop (TN); Nimotop(TM); Nimotop, Nimodipine; Periplum; Periplum, Nimotop, BRN 0459792, DRG-0139; Remontal; Vita Brand of Nimodipine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01212	Mitomycin	Ametycin; 1950/7/7; 7-Amino-9alpha-methoxymitosane; Ametycin; Ametycine; C15H18N4O5; CCRIS 414; EINECS 200-008-6; HSDB 3239; MMC; Mit-C; Mitamycin; Mito-C; Mitocin C; Mitocin-C; Mitomicina; Mitomicina [INN-Spanish]; Mitomycin (TN); Mitomycin (USP/INN); Mitomycin C; Mitomycin C (JP15); Mitomycin C from Streptomyces caespitosus; Mitomycin C,; Mitomycin C, Streptomyces caespitosus; Mitomycin C, Streptomyces caespitosus, Carrier-Free; Mitomycin [USAN:INN:BAN]; Mitomycin-C; Mitomycine; Mitomycine [INN-French]; Mitomycins; Mitomycinum; Mitomycinum C; Mitomycinum [INN-Latin]; Mitomycyna C; Mitomycyna C [Polish]; Mitosol; Mitozytrex; Muamycin; Muamycin (TN); Mutamycin; Mytomycin; Mytozytrex; NCI-C04706; NSC 26980; NSC-26980; NSC26980; RCRA waste number U010; UNII-50SG953SK6; mitomycin C
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01235	Celiprolol	3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea; BRN 2776298; CCRIS 3400; Celectol; Celiprolol [INN:BAN]; Celiprololum; Celiprololum [INN-Latin]; EINECS 260-497-7; N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea; RHC 5320 A; RHC-5320A; ST-1396; Selectol; UL/1677; Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-; celiprolol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01259	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-anisamid; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide; 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide; Aminosultopride; Amisulpiride; Amisulprida; Amisulprida [INN-Spanish]; Amisulpride (INN); Amisulpride [INN]; Amisulpridum; Amisulpridum [INN-Latin]; DAN 2163; DAN-2163; Deniban; Deniban (TN); SL-91.1077; Socian; Solian; Solian (TN); Solian, Amisulpride
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01260	Tadalafil	(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; ADCIRCA; Acdirca; Cialis; Cialis (TN); Cialis, GF 196960, IC 351, ICOS 351, Tadalafil; GF 196960; GF-196960; IC 351; IC-351; ICOS 351; Ic351; KS-1117; Lilly brand of tadalafil; Tadalafil (JAN/USAN/INN); Tadalafil [USAN]; Tadanafil
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01261	Nadolol	(2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol; 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol; Alti-Nadolol (TN); Anabet; Anabet (TN); Apo-Nadol (TN); Corgard; Corgard (TN); Corgaretic; Corzide (TN); Nadic; Nadolol (JP15/USP/INN); Nadolol [USAN:BAN:INN:JAN]; Nadololum; Nadololum [INN-Latin]; Novo-Nadolol (TN); SQ 11725; SQ-11725; SQ11725; Solgol; Solgol (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01262	Actinomycin D	AC1O8OFK; CCG-35952; CCG-36086; NCIMech_000599
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01264	Apremilast	Apremilast (USAN); CC-10004; N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01265	Perazine	PERAZINE; Pernazine; Taxilan; Psytomin; N-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine; P 725; 10-(3-(4-Methyl-1-piperazinyl)propyl)-10H-phenothiazine; N-Methyl-piperazinyl-N'-propyl-phenothiazin; UNII-8915147A2B; EINECS 201-578-9; Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-; 10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-; NSC638694; N-Methyl-piperazinyl-N'-propyl-phenothiazin [German]; N-Methyl-piperazinylpropyl-phenothiazine; NCGC00159492-02; 10H-Phenothiazine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01266	Naloxegol	NKTR-118
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01267	Asimadoline	Asimadoline [INN]; EMD 61753; N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01268	Leupeptin	(2S)-2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide; 2-(2-Acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methylvaleramide; 24365-55-7; AC1L97IT; Valeramide, 2-(2-acetamido-4-methylvaleramido)-N-(1-formyl-4-guanidinobutyl)-4-methyl-
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01269	Flavonoids	FAIMs, Novogen; Flavonoids (inflammatory disease/pain); Flavonoids (inflammatory disease/pain), Novogen
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01270	Ibrutinib	Ibrutinib (BTK inhibitor); PCI-32765
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01271	Levomepromazine	2-Methoxytrimeprazine; 60-99-1; 9G0LAW7ATQ; Arc-VI-C-5; Bayer 1213; CL 36467; CL 39743; Dedoran; EINECS 200-495-5; F-5116; Hirnamine; Levomepromazin; Levomepromazina; Levomepromazina [INN-Spanish]; Levomepromazinum; Levomepromazinum [INN-Latin]; Levopromazioni; Levoprome; Levotomin; METHOTRIMEPRAZINE; Methotrimeprazine; Methotrimeprazine (USP); Methotrimeprazine [USP]; Methoxytrimeprazine; Milezin; Minozinan; Neozine; Nirnamine; Nocinan; Nomizan; Nosinan; Nozinan; RP-7044; UNII-9G0LAW7ATQ; Veractil; XP03
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01273	Azidopine	3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-(trifluoromethyl)phenyl)-, 2-((4-azidobenzoyl)amino)ethyl ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]-2-[(4-azidobenzoyl)amino]ethyl ethyl ester (9CI); 90523-31-2; AC1LCUW1; Azidopine; C11282; CHEBI:2952; CHEMBL1993397; GTPL6980; NCI60_005410; NSC-617999; NSC617999; O5-[2-[(4-azidobenzoyl)amino]ethyl] O3-ethyl 2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3,5-dicarboxylate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01274	Fosamprenavir	((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-(phosphonooxy)propyl)carboxamide; (3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester; Amprenavir phosphate; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester; Fosamprenavir (INN); Fosamprenavir [INN]; GW 433908; GW433908; GW433908A (*Sodium Salt*); GW433908G (*Calcium Salt*); Lexiva (TM); Lexiva (TN); Telzir; Telzir (TN); Telzir(TM); VX 175; VX-175; [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01276	Gramicidin D	1,10-anhydro(L-leucyl-D-phenylalanyl-L-prolyl-L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl-L-valyl-L-ornithine); Cyclo(L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl-L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl); Gramacidine S; Gramacidine S [INN-French]; Gramicidin A(1); Gramicidin C; Gramicidin Dubos; Gramicidin J; Gramicidin K; Gramicidin P; Gramicidin S; Gramicidin S [INN]; Gramicidin [INN:BAN]; Gramicidina D; Gramicidina S; Gramicidina S [INN-Spanish]; Gramicidina [INN-Spanish]; Gramicidine [INN-French]; Gramicidins; Gramicidinum S; Gramicidinum S [INN-Latin]; Gramicidinum [INN-Latin]; Gramicin S 1; Gramicin S-A; Gramoderm; Neosporin Ophthalmic Solution
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01278	Zolmitriptan	(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one; AscoTop; AscoTop (TN); BW-311C90; Flezol; KS-5072; Zolmitriptan RapidFilm; Zolmitriptan [USAN]; Zolmitriptane; Zolmitriptanum; Zomig; Zomig (TN); Zomig Nasal Spray; Zomig ZMT; Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan; Zomig-ZMT; Zomigon; Zomigon (TN); Zomigoro (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01279	Phenprocoumon	2-hydroxy-3-(1-phenylpropyl)chromen-4-one; 3-(1'-Phenyl-propyl)-4-oxycoumarin; 3-(1'-Phenyl-propyl)-4-oxycoumarin [German]; 3-(1-Phenylpropyl)-4-hydroxycoumarin; 3-(alpha-Ethylbenzyl)-4-hydroxycoumarin; 3-(alpha-Phenylpropyl)-4-hydroxycoumarin; 4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one; 4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one; Falithiom; Falithrom; Falithrom (TN); Fencumar; Fenprocoumona; Fenprocoumona [INN-Spanish]; Fenprocumon; Fenprocumone; Fenprocumone [DCIT]; Hexal Brand of Phenprocoumon; Liquamar; Liquamar (TN); Marcoumar; Marcoumar (TN); Marcumar; Marcumar (TN); Marcuphen; Phenprocoumalol; Phenprocoumarol; Phenprocoumarole; Phenprocoumon (USAN/INN); Phenprocoumon [USAN:INN:BAN]; Phenprocoumone; Phenprocoumone [INN-French]; Phenprocoumonum; Phenprocoumonum [INN-Latin]; Phenprocumone; Phenprocumonum; Phenprogramma; Phenylpropylhydroxycumarinum; Ro 1-4849; Roche Brand of Phenprocoumon; U29342; Worwag Brand of Phenprocoumon
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01283	Tiapamil	ORE-5002; Tiapamil (CNS disease); Tiapamil (CNS disease), Ore Pharmaceuticals
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01284	Trospium chloride	trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01285	Ixabepilone	Azaepothilone B; BMS-247550; Ixempra (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01286	Pentazocine	(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol; (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol; 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan; 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan; 2-(3,3-Dimethylallyl)cyclazocine; 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan; 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol; Algopent (free base); Fortal (TN); Fortalgesic; Fortalin; Fortral; Fortral (TN); Fortwin (TN); II-C-2; KF-1820; L-pentazocine; Lexir; Liticon; NIH 7958; Pentagin; Pentazocaine; Pentazocin; Pentazocina; Pentazocina [DCIT]; Pentazocine (JP15/USP/INN); Pentazocine [USAN:INN:BAN:JAN]; Pentazocine, Pentazocin, Sosegon, WIN 20228; Pentazocinum; Pentazocinum [INN-Latin]; Sosegon; Soseton; Sosigon; Talacen; Talacen (TN); Talwan; Talwin (TN); Talwin NX (TN); Talwin PX (TN); WIN 20228
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01288	Palbociclib	LQQ; 571190-30-2; 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE; 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one; 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one; G9ZF61LE7G; HMR-2934; Ibrance; PD 0332991; PD 332991; PD 332991, PD 0332991, PD0332991; PD-0332991; PD-332991; PD0332991; Palbociclib(PD0332991); UNII-G9ZF61LE7G
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01289	Dasabuvir	1132935-63-7; ABT 333; ABT-333; ABT333; C26H27N3O5S; CHEBI:85182; DE54EQW8T1; Dasabuvir (ABT-333); Dasabuvir (USA; Dasabuvir [INN]; Dasabuvir [USAN:INN]; N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide; N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide; N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamide; UNII-DE54EQW8T1
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01290	Ledipasvir	013TE6E4WV; 1256388-51-8; CHEBI:85089; CHEMBL2374220; DTXSID90154829; EX-A411; GS 5885; GS-5885; GS5885; Ledipasvir (GS5885); Ledipasvir (USAN); Ledipasvir [USAN:INN]; MolPort-039-138-665; SCHEMBL15116943; SCHEMBL2706494; UNII-013TE6E4WV; WHO 9796; methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01291	Pibrentasvir	2WU922TK3L; A-1325912.0; ABT 530; ABT-530; ABT-530;Pibrentasvir; CHEMBL3545123; CS-8135; D10816; DB13878; Dimethyl N,N'-(((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)pyrrolidine-2,5-diyl)bis((6-fluoro-1H-benzimidazole-5,2-diyl)((2S)-pyrrolidine-2,1-diyl)((2S,3R)-3-methoxy-1-oxobutane-1,2-diyl)))biscarbamate; EX-A865; J-690144; J3.646.121G; Pibrentasvir; Pibrentasvir (JAN/USAN/INN); Pibrentasvir [USAN]; SCHEMBL17639956; SCHEMBL2756579; UNII-2WU922TK3L
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01292	Hoechst 33342	2'-(4'-Ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bis-1H-benzimidazole trihydrochloride trihydrate; 2'-(4-Ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-1H,1'H-2,5'-bibenzo[d]imidazole; 2'-(4-ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-1H-benzimidazole; 2'-(4-ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-benzimidazole; 99KZS6CNZX; Bisbenzimide; Bisbenzimide (Hoechst 33258); CHEBI:51232; CHEMBL343002; EINECS 245-691-1; Ho 342; UNII-99KZS6CNZX; hoechst33342
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01293	Pepstatin A	26305-03-3; 39324-30-6; Ahpatinin C; C34H63N5O9; CCRIS 3603; CHEMBL296588; DSSTox_CID_26095; DSSTox_GSID_46095; DSSTox_RID_81334; FAXGPCHRFPCXOO-LXTPJMTPSA-N; Ia Quinidine; Iboctadekin + rituximab; Iva-Val-Val-Sta-Ala-Sta-OH; MLS002222329; NCGC00161670-06; Pepstatin (VAN); Pepstatin (nonspecific); Pepstatina; Pepstatine; Pepstatinum; UNII-V6Y2T27Q1U; V6Y2T27Q1U
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01294	Trans-flupentixol	(E)-4-(3-(2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol; (E)-Flupenthixol; 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-9H-thioxanthen-9-ylidene)propyl)-, (E)-; 2-[4-[(3E)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol; 2709-56-0; 53772-85-3; 895OJP78MJ; EINECS 258-759-0; FLUPENTHIXOL, Alpha; FLUPENTIXOLE; Flupenthixol, Beta; Flupentiol; UNII-895OJP78MJ; beta-Flupenthixol; trans-(E)-Flupentixol; trans-Flupentixol; trans-flupenthixol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01295	Clobazam	Onfi; 1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine; 1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl-; 22316-47-8; 7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione; 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione; BRN 0758410; CCRIS 7506; Chlorepin; Clobazam - Lundbeck; Clobazamum; Clobazamum [INN-Latin]; Clorepin; EINECS 244-908-7; Frisium; H 4723; H-4723; HR 376; LM 2717; LM-2717; NSC 336279; Onfi; RU-4723; UNII-2MRO291B4U; Urbadan; Urbanyl
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01298	Flupentixol	2-[4-[(3Z)-3-[2-(Trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol; 4-(3-(2-(Trifluoromethyl)thioxanthen-9-ylidene)propyl)-1-piperazineethanol; 53772-82-0; ALPHA-FLUPENTHIXOL; EINECS 220-304-9; EINECS 258-756-4; Emergil; FA0UYH6QUO; FLUPENTHIXOL; Fluanxol; Flupenthixole; Flupentixol; Flupentixolum [INN-Latin]; Fluphenthixol; Fluxanxol; LC 44; N 7009; Siplaril; Siplarol; UNII-FA0UYH6QUO; cis-(Z)-Flupenthixol; cis-(Z)-Flupenthixol dihydrochloride; cis-Flupenthixol; cis-Flupentixol; flupentixolum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01299	Sunitinib malate	(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate; LVX8N1UT73; MFCD08282795; N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate; PHA-290940AD; SU 011248; SU010398; SU011248; SU011248 L-malate salt; SUNITINIB MALEATE; Sunitinib malate; Sunitinib malate [USAN]; UNII-LVX8N1UT73
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01304	Bcecf-Am	117464-70-7; 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester; 2',7'-bis(2-Carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester Mixed isomers; AKOS015916474; BCECF-AM solution; BCECF-AM solution (5 mM in DMSO), 1 mg in 0.25 ml DMSO; BCECF-acetoxymethyl; FT-0622598; I14-51975; J-100048; MFCD00036969; SCHEMBL15570087; Spiro(isobenzofuran-1(3H),9'-(9H)xanthene)-2',7'-dipropanoic acid; ZINC169730836
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01305	Bisantrene	39C34M111K; 78186-34-2; 9,10-Anthracendicarbaldehyde bis(2-imidazolin-2-ylhydrazon); 9,10-Anthracenedicarboxaldehyde, bis((4,5-dihydro-1H-imidazol-2-yl)hydrazone)-; BISANTRENE HYDROCHLORIDE; BRN 0966309; Bisantrene; Bisantrene [INN]; Bisantreno; Bisantreno [INN-Spanish]; Bisantrenum; Bisantrenum [INN-Latin]; CHEMBL25336; CL 216942; N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazono)methyl]-9-anthryl]methyleneamino]-4,5-dihydro-1H-imidazol-2-amine; NSC 337766; UNII-39C34M111K
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01308	Glecaprevir	A-1282576.0; ABT 493; ABT-493; ABT-493(Glecaprevir); CS-8098; D10814; DB13879; EX-A1940; Glecaprevir; Glecaprevir (USAN/INN); Glecaprevir [USAN]; HY-17634; J3.646.120I; K6BUU8J72P; SB19760; SCHEMBL883097; UNII-K6BUU8J72P; glecaprevirum
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01311	Ombitasvir	2302768XJ8; ABT 267; ABT-267; ABT-267;ABT267;ABT 267; ABT267; CHEBI:85183; CHEMBL3127326; CS-5330; DB09296; Ombitasvir; Ombitasvir (USAN); Ombitasvir [USAN:INN]; Ombitasvir pound>>ABT-267; Ombitasvir(ABT-267); SB16895; SCHEMBL8542284; UNII-2302768XJ8; ZINC150601177; dimethyl ([(2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis{(4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl[(2S)-3-methyl-1-oxobutane-1,2-diyl]})biscarbamate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01312	Paritaprevir	(2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide; ABT 450; ABT-450; ABT450; CHEMBL3391662; EX-A2278; OU2YM37K86; Paritaprevir; Paritaprevir [USAN:INN]; Paritaprevir(ABT-450); Paritaprevir(Veruprevir ABT-450); SCHEMBL3069964; UNII-OU2YM37K86; Veruprevir; Veruprevir [INN]; Veruprevir anhydrous
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01314	Velpatasvir	GS 5816; GS-5816; GS5816; KCU0C7RS7Z; UNII-KCU0C7RS7Z; Velpatasvir; Velpatasvir [USAN:INN]; Verpatasvir; methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01315	Voxilaprevir	0570F37359; DB12026; GS-9857; J3.665.048F; SCHEMBL15412621; UNII-0570F37359; Voxilaprevir; Voxilaprevir (USAN/INN); Voxilaprevir [USAN:INN]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01323	Albendazole	((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle; ((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]; (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; (5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester; 5-(Propylthio)-2-carbomethoxyaminobenzimidazole; Albendazol; Albendazol [INN-Spanish]; Albendazole (JAN/USP/INN); Albendazole Armstrong Brand; Albendazole Diba Brand; Albendazole Fustery Brand; Albendazole Hormona Brand; Albendazole Liferpal Brand; Albendazole Monohydrochloride; Albendazole Noe-Socopharm Brand; Albendazole Pfizer Brand; Albendazole Sanicoopa Brand; Albendazole Valdecasas Brand; Albendazole [USAN:INN:BAN:JAN]; Albendazolum; Albendazolum [INN-Latin]; Albendoral; Albenza; Albenza (TN); Albenza, Eskazole, Zentel, Andazol, Albendazole; Armstrong Brand of Albendazole; Bendapar; Bilutac; CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER; Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester; Diba Brand of Albendazole; Digezanol; Disthelm; Disthelm, Mediamix V; Endoplus; Eskazole; Eskazole (TN); Fustery Brand of Albendazole; Gascop; Hormona Brand of Albendazole; Liferpal Brand of Albendazole; Lurdex; Mediamix V Disthelm; Methyl 5-(propyl-thio)-2-benzimidazolecarbamate; Methyl 5-(propylthio)-2-benzimidazolecarbamate; Methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate; Methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate; Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate; Methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate; Methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate; Methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate; Methyl-5-[propylthio]-2-benzimidazole carbamate; MethylN-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate; Metiazol; Monohydrochloride, Albendazole; Noe Socopharm Brand of Albendazole; Noe-Socopharm Brand of Albendazole; O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate; Pfizer Brand of Albendazole; Proftril; SK&F 62979; SK&F-62979; SK&F62979; SKF 62979; SKF-62979; SKF62979; Sanicoopa Brand of Albendazole; Smith Kline & French Brand of Albendazole; SmithKline Beecham Brand of Albendazole; V Disthelm, Mediamix; Valbazen; Valdecasas Brand of Albendazole; Zental; Zentel; Zentel (TN); [5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester; [5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01324	Carfilzomib	(S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; 72X6E3J5AR; 868540-17-4; CHEBI:65347; CHEMBL451887; Carfilzomib; Carfilzomib (PR-171); DSSTox_CID_28616; DSSTox_GSID_48690; DSSTox_RID_82886; Kyprolis; N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide; NCGC00249613-01; PR-171; UNII-72X6E3J5AR
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01326	Thiamphenicol	(+)-Thiamphenicol; 15318-45-3; Armai (TN); C12H15Cl2NO5S; D-Thiocymetin; D-Thiophenicol; Descocin; Dexawin; Dextrosulphenidol; EINECS 239-355-3; Efnicol; Hyrazin; Igralin; Macphenicol; Masatirin; Neomyson; RACEPHENICOL; Raceophenidol; Rincrol; SW 5063; Thiamcol; Thiamphenicol (Thiophenicol); Thiamphenicol [USAN:INN:BAN:JAN]; Thiamphenicolum; Thiamphenicolum [INN-Latin]; Thiocymetin; Thiocymetin (TN); Thiophenicol; Tiamfenicol [INN-Spanish]; Tiamfenicolo [DCIT]; UNII-FLQ7571NPM; Unaseran-D; Urfamicina; Urfamycine; WIN-5063-2; thiamphenicol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01331	Bortezomib	179324-69-7; 69G8BD63PP; Boronic acid,; Bortezomib (PS-341); Bortezomib (Proteasome inhibitor); Bortezomib(JAN/USAN/INN); CHEMBL325041; DPBA; LPD 341; LPD-341; MLN-341; N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide; PROSCRIPT BORONIC ACID; Peptide boronate; Pyz-Phe-boroLeu; UNII-69G8BD63PP; VELCADE (TN); Velcade; Velcade (TN); Velcade, MG-341, PS-341, Bortezomib; [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid; [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01333	Boceprevir	(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; 3-{[(1R,2S,5S)-3-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide; 394730-60-0; 89BT58KELH; Boceprevir; CHEBI:68621; EBP 520; SCH 503034; SCH-503034; UNII-89BT58KELH; Victrelis
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01336	Binimetinib	181R97MR71; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; 606143-89-9; ARRY 162; ARRY 438162; ARRY-162; ARRY-438162; Binimetinib (JAN/USAN); Binimetinib (MEK162, ARRY-162, ARRY-438162); Binimetinib [USAN:INN]; D0C4LF; MEK 162; MEK-162; MEK162; MEK162 (ARRY-162, ARRY-438162); MEK162(Binimetinib); NVP-ME; UNII-181R97MR71
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01337	Tenofovir alafenamide	(S)-Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate; AK109983; EL9943AG5J; GS 7340; GS-7339; GS-7340; GS7340; J4414G3BUK; L-Alanine, N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester; TENOFOVIR ALAFENAMIDE; Tenofovir Alafenamide (GS-7340); Tenofovir Alafenamide [USAN:INN]; UNII-EL9943AG5J; UNII-J4414G3BUK; Vemlidy
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01340	Nafoxidine	Nafoxidine; 1845-11-0; Nafoxidine [INN]; Nafoxidinum [INN-Latin]; Nafoxidina [INN-Spanish]; UNII-4RIY10WM82; U-11000A; BRN 1440873; CHEMBL28211; 4RIY10WM82; CHEBI:34881; NSC 70735; C29H31NO2; JEYWNNAZDLFBFF-UHFFFAOYSA-N; 1-(2-(p-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)pyrrolidine; Pyrrolidine, 1-(2-(4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy)ethyl)-; 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine; Pyrrolidine, 1-(2-(p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01343	Vinorelbine	Eunades; Exelbine; NVB; Navelbine; Vinorelbin; Vinorelbina; Vinorelbinum; Navelbine base; Vinorelbina [Spanish]; Vinorelbine Ditartarate; Vinorelbine ditartrate; Vinorelbine tartrate; Vinorelbinum [Latin]; KW 2307; KW 2307 base; ANX-530; KW-2307; Navelbine (TN); SDP-012; Vinorelbine (INN); Vinorelbine [INN:BAN]; Aspidospermidine-3-carboxylic acid; Nor-5'-anhydrovinblastine; Methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; Methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01344	Nalbuphine	Intapan; Nalbufina; Nalbuphinum; Intapan (TN); Nalbuphine (INN); Nubain (TN); (5alpha,6alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol; 17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alpha,14-triol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01345	Okadaic acid	78111-17-8; CHEMBL280487; CHEBI:44658; C44H68O13; 9,10-Deepithio-9,10-didehydroacanthifolicin; Ocadaic Acid; OKA; (2R)-3-[(2S,5R,6R,8S)-8-[(2R,3E)-4-[(2R,4'aR,5R,6'S,8'R,8'aS)-8'-hydroxy-6'-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-7'-methylidene-hexahydro-3'H-spiro[oxolane-2,2'-pyrano[3,2-b]pyran]-5-yl]but-3-en-2-yl]-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl]-2-hydroxy-2-methylpropanoic acid; UNII-1W21G5Q4N2; CCRIS 3329; HSDB 7243; 1W21G5Q4N2; 1jk7
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01346	Morphine-6-glucuronide	Morphine-6-glucuronide; Morphine 6-glucuronide; 20290-10-2; UNII-64Y9KYM60R; Morphine 6-beta-D-glucopyranosiduronide; 64Y9KYM60R; CHEBI:80581; MORPHINE GLUCURONIDE; MORPHINE 6-GLUCURONIDE(MINOR); beta-D-Glucopyranosiduronic acid, (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl; Morphine 6-beta-D-Glucuronide; Glucopyranosiduronic acid, 7,8-didehydro-4,5-alpha-epoxy-3-hydroxy-17-methylmorphinan-6-alpha-yl-, beta-D-; Morphine glucuronide [INN]; morphine-glucuronide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01347	Raloxifene	Raloxifene (extended-release, CDT)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01350	Flesinoxan	Flesinoxan hydrochloride; DU-29373
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01352	Pafenolol	H-138/03; Pafenolol; Rac-N-[2-[4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl]ethyl]-N'-isopropylurea
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01353	Isoxicam	isoxicam; 34552-84-6; Maxicam; Isoxicamo; Isoxicamum; UNII-8XU734C4NG; Pacyl (antiinflammatory); Isoxicamum [INN-Latin]; Isoxicamo [INN-Spanish]; EINECS 252-084-5; W 8495; BRN 0577221; 8XU734C4NG; CHEBI:76163; C14H13N3O5S; NCGC00016829-05; CAS-34552-84-6; 4-Hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide; 4-Hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; DSSTox_CID_25462; DSSTox_RID_80893; DSSTox_GSID_45462
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01354	Nogalamycin	AC1MBPR2
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01357	Olopatadine	Allelock; Opatanol; Pataday; Patanase; Patanol; OLOPATADINE HCl; OLOPATADINE HYDROCHLORIDE; ALO4943A; HCl of KW 4679; KW 4679; O0361; AL-4943A; ALO-4943A; Allelock (TN); KW-4679; KW-4943A; Olopatadine [INN:BAN]; Pataday (TN); Patanase (TN); Patanol S (TN); {(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride; 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01358	Niguldipine	NIGULDIPINE; S(+)-niguldipine; UNII-Z81N45O25Z; S(+)-Niguldipine hydrochloride; 113165-32-5; Z81N45O25Z; (+)-NIGULDIPINE; Niguldipine [INN]; niguldipine[inn]; (S)-Niguldipine; Tocris-1123; Tocris-1124; AC1Q1ZUF; AC1L1TKT; S(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(4,4-diphenyl-1-piperidinyl)-propyl methyl ester hydrochloride; GTPL487; SCHEMBL245992; CHEMBL41929; CHEMBL405355; DTXSID60274008; CHEBI:103931; MFCD00873564; BDBM50034683; BDBM50453799; ZINC100001967; DB09239; NCGC00025015-01
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01359	Triflupromazine	Adazine; Fluopromazine; Fluorofen; Neoprin; Nivoman; Psyquil; Siquil; Trifluopromazine; Triflupromazina; Triflupromazinum;Vesprin; Vetame; Fluopromazine monohydrochloride; Trifluopromazine hydrochloride; Triflupromazine [INN]; Triflupromazina [INN-Spanish]; Triflupromazinum [INN-Latin]; Vesprin (TN); Triflupromazine (USP/INN); N,N-Dimethyl-2-(trifluoromethyl)-10H-phenothiazine-10-propanamine; N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine; N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine hydrochloride; N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-amine; N,N-dimethyl-3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)-1-propanamine; 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine; 10-3-(Dimethylamino)propyl-2-(trifluoromethyl)phenothiazine; 2-(Trifluoromethyl)promazine; 2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01363	Tolafentrine	BY-4070
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01365	ABT-263	Navitoclax; ABT 263; S1001_Selleck; ABT263, Navitoclax; 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({4-({(1R)-3-morpholin-4-yl-1-[(phenylsulfanyl)methyl]propyl}amino)-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)benzamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01367	Cycloheximide	naramycin A; NSC 185; FT 3422-2; NM-MCD 80
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01368	Beclomethasone	Anceron; Beclocort; Beclometason; Beclometasona; Beclometasonum; Becloval; Becodisks; Beconasol; Becotide; Inalone; Viarex; Beclometasondipropionat Mikron; Beclometasone [INN]; Vancenase AQ; B 0385; BMJ 5800; Beclometason (TN); Beclometasona [INN-Spanish]; Beclometasone (INN); Beclometasonum [INN-Latin]; Beconase (TN); Clipper (TN); Propaderm (TN); Vancenase (TN); (11beta,16beta)-9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; (8R,9S,10S,11S,13R,14R,16R,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9alpha-Chloro-11beta,17alpha,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9alpha-Chloro-16beta-methyl-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione; 9alpha-Chloro-16beta-methylprednisolone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01369	Prostaglandin A2	medullin; PGA2
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01370	Midostaurin	PKC412; 120685-11-2; Cgp 41251; 4'-N-Benzoylstaurosporine; CGP-41251; Benzoylstaurosporine; PKC-412; RYDAPT; PKC 412; UNII-ID912S5VON; N-Benzoylstaurosporine; ID912S5VON; CHEMBL608533; CHEBI:63452; Cgp 41 251; N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide; PKC-412(Midostaurin); Midostaurin (PKC412); Midostaurin (USAN/INN); Midostaurin [USAN:INN]; CGP 41231; Rydapt (TN); CPG 41251
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01372	Topiramate	Epitoma; Epitomax; TOR; Tipiramate; Tipiramato; Topamac; Topamax; Topimax; Topina; Topiramato; Topiramatum; Topomax; Cilag brandof topiramate; Janssen brand of topiramate; Ortho brand of topiramate; Tipiramate [French]; Tipiramato [Spanish]; Topamax Sprinkle; Topiramate tablet; Topiramatum [Latin]; Topiramic acid; McN 4853; RWJ 17021; KS-1122; KW-6485; McN-4853; RWJ-17021; Topamax (TN); Topamax, Topiramate; Topiramate (TPM); Topiramate / Placebo; Topiramato [INN-Spanish]; Topiramatum [INN-Latin]; USL-255; RWJ-17021-000; Topiramate [USAN:BAN:INN]; Topiramate (JAN/USAN/INN); Beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate; Beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI);Beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate; [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate; 2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate; 2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate; 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-(beta)-D-fructopyranose sulfamate; 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate; 5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, beta
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01375	Neostigmine	Eustigmin; Eustigmine; Intrastigmina; Juvastigmin; Neostigmin; Neostigminum; Prostigmin; Prostigmine; Prozerin; Sulfonatooxymethane; Synstigmin; Syntostigmine; Vagostigmin; Vagostigmine; Neostigmine [BAN]; Neostigmine omega; M-Trimethylammoniumphenyldimethylcarbamate; Neostigmine (BAN); Prostigmin (TN); Vagostigmin (TN); [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide; Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester); Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-(9CI); (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate; (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester); 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium; 3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01379	Mequitazine	Butix; Instotal; Kitazemin; Mequitazina; Mequitazinum; Metaplexan; Mircol; Primalan; Quitadrill; Vigigan; Virginan; Zesulan; Italfarmaco brand of mequitazine; Mequitazina [Spanish]; Mequitazine hydrochloride; Pierre Fabre brand of mequitazine; LM 209; Kitazemin (TN); LM-209; Mequitazina [INN-Spanish]; Mequitazinum [INN-Latin]; Mequitazine (JP15/INN); Mequitazine [INN:BAN:DCF:JAN]; Mequitazine tartrate, (R-(R*,R*))-isomer; 10-(1-Azabicyclo[2.2.2]oct-3-ylmethyl)-10H-phenothiazine; 10-(1-azabicyclo(2.2.2)oct-8-ylmethyl)phenothiazine; 10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine; 10-(3-Quinuclidinylmethyl)phenothiazine; 10H-Phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)-(9CI); 3-Methylquinuclidinyl-10-phenothiazine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01385	Labetalol	Albetol; Ibidomide; Labetalolum; Labetolol; NORMOZIDE; AH 5158; AH-5158; Labetalol (INN); Labetalol [INN:BAN]; Labetalolum [INN-Latin]; Normodyne (TN); Sch-19927; Trandate (TN); 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01386	Cefotetan	Cefotetanum; Apatef (TN); Cefotan (TN); Cefotetan (JP15/USP/INN); (6R,7S)-7-(4-(carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01387	Dexniguldipine	Dexniguldipine hydrochloride; BY-935; B-8509-035; B-859-35
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01388	Silvestrol	Naturally derived compounds (cancer); Naturally derived compounds (cancer), Bristol-Myers Squibb/National Cancer Institute
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01391	Clomifene	Androxal; Chlomaphene; Chloramifene; Cisclomifenum; Cisclomiphene; Clomifen; Clomifeno; Clomifenum; Clomifert; Clomiphene; Clostilbegit; Enclomifene; Enclomifeno; Enclomifenum; Enclomiphen; Enclomiphene; Klostilbegit; Transclomifenum; Transclomiphene; Zuclomifene; Zuclomifeno; Zuclomifenum; Zuclomiphene; Clomiphene B;Enclomiphene [USAN]; ISOMER B; Zuclomiphene [USAN]; Cis-Clomifene; Cis-Clomiphene; Clomid (TN); Clomifene (INN); Clomifene (TN); Clomifene [INN:BAN]; Clomifeno [INN-Spanish]; Clomifenum [INN-Latin]; En-Clomiphene; Enclomifeno [INN-Spanish]; Enclomifenum [INN-Latin]; Enclomiphene (USAN); Milophene (TN); RMI 16,289; RMI-16289; RMI-16312; Serophene (TN); Trans-Clomifene; Trans-Clomiphene; Zuclomifeno [INN-Spanish]; Zuclomifenum [INN-Latin]; Zuclomiphene (USAN); Cis-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; Trans-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; Cis-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; Trans-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; (E)-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; (Z)-2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; (Z)-isomer; 1-(p-(beta-Diethylaminoethoxy)-phenyl)-1,2-diphenylchloroethylene; 2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; 2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine; 2-(p-(beta-Chloro-alpha-phenylstyryl)phenoxy)-triethylamine; 2-(p-(beta-chloro-alpha-phenylstyryl)phenoxy)triethylamine; 2-({4-[(Z)-2-chloro-1,2-diphenylethenyl]phenyl}oxy)-N,N-diethylethanamine; 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine; 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine; 2-[4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine; 2-{4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy}-N,N-diethylethanamine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01392	Betamethasone	betamethasone; 378-44-9; Betadexamethasone; Flubenisolone; Betamethazone; Rinderon; Visubeta; Celestene; Betnelan; Betapredol; Betacortril; Betacorlan; Methazon; Betsolan; Betamamallet; Hormezon; Betasolon; Betametasone; Cidoten; Bebate; Bedifos; Becort; beta-Methasone; Desacort-Beta; Rinderon A; beta-Methasone alcohol; Betametasona; Betafluorene; Betamethasonum; Celestone; Betamethasone cream; Betamethasone alcohol; Betametasone [DCIT]; 9alpha-Fluoro-16beta-methylprednisolone; Celestone Syrup and Tablets; Celeston; Celestona; Cellestoderm; Luxiqo; Betamethasone Base; Betamethasone Valearate; Betamethasonvalerat Mikron; LT00441022; SCH 4831; Beta-Methasone; Beta-Methasone alcohol; Betametasona [INN-Spanish]; Betamethasonum [INN-Latin]; Betnovate (TN); Celestone (TN); Diprolene (TN); Diprosone (TN); Lotrisone (TN); Rinderon (TN); SCH-4831; Betamethasone (JP15/USP/INN); Betamethasone [USAN:BAN:INN:JAN]; Betamethasone [USAN:INN:BAN:JAN]; Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone; 1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol; 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione; 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-16beta-methylprednisolone; 9-alpha-Fluoro-16-beta-methylprednisolone; 9alpha-Fluoro-16 beta-methyl-prednisolone; Betamethasone sodium phosphate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01395	Triprolidine	Actidil; Actidilat; Entra; Histafed; Myidyl; Tripolidina; Triprolidin; Triprolidinum; Venen; Triprolidine HCL; Triprolidine Monohydrochloride; Triprolidine hydrochloride; Triprolidine hydrochloride anhydrous; T 6764; Actidil (TN); Myidil (TN); Pro-Actidil; Pro-Entra; Tripolidina [INN-Spanish]; Triprolidine (INN); Triprolidine Hydrochloride (anhydrous); Triprolidine Monohydrochloride, Monohydrate; Triprolidine [INN:BAN]; Triprolidinum [INN-Latin]; Venen (TN); Trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine; Trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride; Trans-1-(2-Pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene; Trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene; Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, monohydrate, stereoisomer; Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride; Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1); (E)-2-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)pyridine; (E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ium-1-ylprop-1-enyl]pyridine chloride; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01398	Aprepitant	Aprepitant [USAN]; L 754030; MK 0869; Emend (TN); L-754030; MK-0869; ONO-7436; Aprepitant (JAN/USAN/INN); MK-869, L-754030, Emend, Aprepitant; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one; 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01399	Mithramycin	NCGC00181319-05; NCGC00181319-01; DSSTox_CID_3492; DSSTox_RID_77052; Plicatomycin; DSSTox_GSID_23492; CAS-18378-89-7; AC1NR4RB; SCHEMBL4516; DTXSID6023492; Tox21_112787; Tox21_112751; NCGC00181319-08; NCGC00181319-06; NCGC00181319-03; NCGC00181319-04; NCGC00181319-02; NCGC00181319-07
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01401	Tenoxicam	Artriunic; Liman; Mobiflex; Reutenox; Tenoxicamum; Tilcotil; Apotex brand of tenoxicam; Novag brand of tenoxicam; Novopharm brand of tenoxicam; Roche brand of tenoxicam; Solvay brand of tenoxicam; Apo-Tenoxicam; Mobiflex (TN); Novo-Tenoxicam; Ro 12-0068; Ro-120068; Tenoxicamum [INN-Latin]; Tilcotil (TN); Ro 12-0068/000; Ro-12-0068; Tenoxicam (JAN/USAN/INN); Tenoxicam [USAN:BAN:INN:JAN]; (3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; (3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; 2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide; 3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one; 4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-THIENO[2,3-E]-1,2-THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE; 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide1,1-dioxide; 4-Hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide; 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01403	Substance P	Substance P; 33507-63-0; Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2; CCRIS 7229; UNII-675VGV5J1D; EINECS 251-545-8; CHEMBL235363; 675VGV5J1D; 12769-48-1; P substance; Neurokinin P; Substanz-P; C63H98N18O13S; Substance P analogue; AC1Q5IQE; AC1L1VX3; tachykinin substance P (SP); SCHEMBL1116347; GTPL2098; ArgProLysProGlnGlnPhePheGlyLeuMet; MolPort-023-276-010; ADNPLDHMAVUMIW-CUZNLEPHSA-N; 2053AH; BDBM50001450; AKOS024456424; NCGC00167123-01; 11035-08-8; LS-147256; Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-amine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01404	Ximelagatran	Exanta; Exarta; H 376/95; Ximelagatran [USAN:INN]; 192939-46-1; H 376-95; H 37695; Glycine, N-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-, ethyl ester; NCGC00183598-01; Ethyl (((1R)-1-cyclohexyl-2-((2S)-2-((4-(hydroxycarbamimidoyl)benzyl)carbamoyl)azetidin-1-yl-2-oxoethyl)amino)acetate; Glycine, N-((1R)-1-cyclohexyl-2-((2S)-2-((((4-(hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ethyl ester; H 376 95; Exanta (TN); Exarta (TN); Xi-melagatran; H-376/95; Ximelagatran (JAN/USAN/INN); Glycine, N-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester; Glycine, N-((1R)1-cyclohexyl-2-((2S)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester; Glycine, N-((1R)-1-cyclohexyl-2-((2S)-2-((((4-((hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ester ester; H376/95
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01407	Pemirolast	Pemirolastum; Pemirox; Pemirolast [INN]; Pemiroplast Potassium; Alamast (TN); Alegysal (TN); Pemirolast (INN); Pemirolastum [INN-Latin]; Pemirox (TN); 9-TBX; 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one; 9-methyl-3-(2H-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01408	Ciclesonide	Alvesco; Omnair; Omnaris; Osonase; Osonide; Alvesco HFA; Ciclesonide [INN]; Omnaris HFA; RPR 251526; Alvesco (TN); BTR-15; BTR-15K; BY-9010; BYK-20426; KS-1165; Omnaris (TN); Omniair (TN); TBN-15; B-9207-015; Ciclesonide (JAN/USAN/INN); (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01409	Vildagliptin	Equa; Galvu; Galvus; Jalra; Xiliarx; Galvus (TN); Vidagliptin (see Vildagliptin); Vildagliptin (JAN/USAN/INN); (2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile; (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile; 1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile; 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-(9CI)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01410	Guanabenz	GBZ; Guanabenzo; Guanabenzum; Wytensin; Guanabenz acetate; Guanabenz monoacetate; Wy 8678; Wy 8678 base; BR-750; Guanabenz [USAN:INN]; Guanabenz(USAN); Guanabenzo [INN-Spanish]; Guanabenzum [INN-Latin]; Wy-8678; Wytensin (TN); Guanabenz (USAN/INN); [(2,6-Dichlorobenzylidene)amino]guanidine; N-((2,6-Dichlorobenzylidene)amino)guanidine; Guanidine, ((2,6-dichlorobenzylidene)amino)-(8CI); N-(2,6-Dichlorobenzylidene)-N'-amidinohydrazine; ((2,6-Dichlorobenzylidene)amino)guanidine; 2,6-Dichlorobenzylideneaminoguanidine;2-((2,6-Dichlorophenyl)methylene)-hydrazinecarboximidamide; 2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01411	ABT-737	ABT-737; 852808-04-9; ABT 737; ABT737; UNII-Z5NFR173NV; Z5NFR173NV; 4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide; CHEMBL376408; C42H45ClN6O5S2; 4-{4-[(4'-Chlorobiphenyl-2-Yl)methyl]piperazin-1-Yl}-N-{[4-({(1r)-3-(Dimethylamino)-1-[(Phenylthio)methyl]propyl}amino)-3-Nitrophenyl]sulfonyl}benzamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01413	Beta-Acetyldigoxin	Novodigal (TN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01414	Beta-Carotene	beta-carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Betacarotene; Provitamin A; Solatene; Carotaben; Provatene; all-trans-beta-Carotene; Serlabo; Natural Yellow 26; Karotin; KPMK; C.I. Food Orange 5; Solatene (caps); Karotin [Czech]; Food orange 5; Zlut prirodni 26; Betacarotenum [Latin]; Betacaroteno [Spanish]; Lucaratin; BetaVit; beta-Karotin; beta-Carotin; beta;-Carotene; beta-Carotene, all-trans-; .beta. Carotene; .beta.-Carotene; Betacarotenum [INN-Latin]; C.I. 75130; Betacaroteno [INN-Spanish]; Zlut prirodni 26 [Czech]
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01418	Acrivastine	Acrivastin; Acrivastina; Acrivastinum; Semprex; Acrivastina [Spanish]; Acrivastinum [Latin]; Benadryl allergy relief; BW 0270C; BW 825C; BW A825C; BW-825C; Acrivastine (USAN/INN); Acrivastine [USAN:INN:BAN]; E-(9CI); (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; (E,E)-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid; 3-{6-[1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01419	Methysergide	Deseril; Desernil; Desernyl; Deseryl; Desril; Dimethylergometrin; Methylmethylergonovine; Methysergid; Methysergidum; Metisergide; Metisergido; Sansert; Methyllysergic acid butanolamide; Metisergide [DCIT]; UML 491; Deseril (TN); Methysergidum [INN-Latin]; Metisergido [INN-Spanish]; Sansert (TN); UML-491; Methysergide (USAN/INN); Methysergide [USAN:INN:BAN]; N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide; N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide; (+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide; (+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide; (8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide; 1-Methyl-D-lysergic acid butanolamide; 1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide; 1-Methylmethylergonovine; 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01424	Droloxifene	E-droloxifene; FK-435; K-060; K-060E; RP-60850; K-21.060E; 3-hydroxytamoxifen
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01425	Ramosetron	132036-88-5; UNII-7ZRO0SC54Y; Ramosetron [INN]; 7ZRO0SC54Y; CHEMBL1643895; Ramosetron (INN); (1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone; Nor-YM 060; SCHEMBL16701; GTPL2301; DTXSID0043842; NTHPAPBPFQJABD-LLVKDONJSA-N; MolPort-019-991-383; CHEBI:135156; ZINC5116719; AC1L3355; BDBM50334454; 8235AH; AKOS015896003; SB19072; DB09290; SC-92398; AJ-53160; LS-187182; TL8000762; R-146; FT-0651831; D08466; A806353; (-)-(R)-1-Methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl ketone; Nasea (TN); YM060
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01427	Calphostin C	calphostin C; CHEMBL460433; UNII-I271P23G24; I271P23G24; CHEMBL1256495; Ucn 1028 C; UCN 1028C; BSPBio_001520; GTPL5156; SCHEMBL15185703; HSDB 7592; SRJYZPCBWDVSGO-NHCUHLMSSA-N; HMS1989L22; HMS3402L22; HMS1791L22; BDBM213748; Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester; Carbonic acid, (1R)-2-(12-((2R)-2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxy
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01428	Pirenzepine	Gasteril; Gastrotsepin; Gastrozepin; Pirenzepin; Pirenzepina; Pirenzepinum; Pyrenzepine; Ulcosan; Pirenzepine Gastrozepin; Gastrozepin (TN); L-S 519; Pirenzepina [INN-Spanish]; Pirenzepine (INN); Pirenzepine [INN:BAN]; Pirenzepinum [INN-Latin]; 11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one; 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one; 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one; 5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01429	CP-122721	CP-122721; UNII-R7OYP6N58F; R7OYP6N58F; CHEMBL319118; CHEMBL1917847; DSSTox_CID_27251; DSSTox_RID_82210; DSSTox_GSID_47251; SCHEMBL156646; DTXSID9047251; Tox21_300205; BDBM50067935; ZINC22441997; AKOS030542331; DB05421; NCGC00254228-01; NCGC00247927-01; CAS-145742-28-5; (2S,3S)-N-(2-methoxy-5-(trifluoromethoxy)benzyl)-2-phenylpiperidin-3-amine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01430	Pirarubicin	pirarubicin; Theprubicin; MFCD00869742; THP-doxorubicin; C32H37NO12; NCGC00167982-01; AC1LCS5T; Pirarubicin (JP17/INN); SCHEMBL15472856; CHEMBL1398373; EX-A494; AOB5649; KMSKQZKKOZQFFG-HSUXVGOQSA-N; ZINC3913909; AKOS015895621; NCGC00167982-02; BC225325; K234; D01885; 15207-EP2316833A1; 15207-EP2311829A1; 15207-EP2298765A1; 15207-EP2298748A2; 15207-EP2295427A1; 15207-EP2295416A2; 15207-EP2272827A1; 15207-EP2316832A1; 15207-EP2298778A1; 15207-EP2298768A1; 15207-EP2295426A1; 15207-EP2295055A2; 15207-EP2311808A1
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01431	Famciclovir	FCV; Famciclovirum; Famvir; Oravir; BRL 42810; IN1338; Anti-Farnesyl Rabbit pAb; BRL-42810; Famciclovirum [INN-Latin]; Famvir (TN); Famciclovir [USAN:BAN:INN]; Famciclovir (JAN/USAN/INN); [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate; Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine; 1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester); 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester); 2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate; 2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate; 2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate; 2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate; 9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine; 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01435	Estriol	Aacifemine; Destriol; Estratriol; Estriel; Estriolo; Gynaesan; Hemostyptanon; Holin; Hormomed; Hormonin; Klimoral; Oestratriol; Oestriol; Oestriolum; Orestin; Orgastyptin; Overstin; Ovestin; Ovestrion; Stiptanon; Synapause; Theelol; Thulol; Tridestrin; Trihydroxyestrin; Trihydroxyoestrin; Triodurin; Triovex; Deuslon A; Estriolo [Italian]; Folicular hormone; Follicular hormone hydrate; Oestriol [Steroidal oestrogens]; A 13610; E0218; OE3; Deuslon-A; Estriel (TN); Estriol [USAN:JAN]; Estriol, unconjugated; Ortho-Gynest; Estriol (JP15/USP); Estra-1,3,5(10)-trien-3,16alpha,17beta-triol; Estra-1,3,5(10)-triene-3,16,17-triol; Estra-1,3,5(10)-triene-3,16alpha,17beta-triol; Oestra-1,3,5(10)-triene-3,16alpha,17beta-triol; Oestra-1,3,5(10)-triene-3,16-alpha,17-beta-triol; Estra-1,3,5(10)-trien-3,16.alpha., 17.beta.-triol; Estra-1,3,5(10)-trien-3,16.alpha.,17.beta.-triol; Estra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol; Estra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol; Oestra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol; Oestra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol; (16.alpha.,17.beta.)-Estra-1,3,5(10)-triene-3,16,17-triol; (16.alpha.,17.beta.)-Oestra-1,3,5(10)-triene-3,16,17-triol; (16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol; (16alpha,17beta)-Oestra-1,3,5(10)-triene-3,16,17-triol; 1,3,5(10)-ESTRATRIENE-3,16,17-TRIOL; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol; 1,3,5(10)-Estratriene-3,16.alpha., 17.beta.-triol; 1,3,5(10)-Estratriene-3,16.alpha.,17.beta.-triol; 1,3,5(10)-Estratriene-3,16alpha,17beta-Triol; 1,3,5-Estratriene-3.beta.,16-.alpha.,17-.beta.-triol; 1,3,5-Estratriene-3beta,16alpha,17beta-triol; 1,3,5-Oestratriene-3-.beta.,16.alpha.,17.beta.-triol; 1,3,5-Oestratriene-3beta,16alpha,17beta-triol; 16,17-Epiestriol; 16-Epiestriol; 16-Hydroxyestradiol; 16-alpha,17-beta-Estriol; 16-alpha,17-beta-Oestriol; 16-alpha-Hydroxyestradiol; 16-alpha-Hydroxyoestradiol; 16.alpha.,17.beta.-Estriol; 16.alpha.,17.beta.-Oestriol; 16.alpha.-Estriol; 16.alpha.-Hydroxy-17.beta.-estradiol; 16.alpha.-Hydroxyestradiol; 16.alpha.-Hydroxyoestradiol; 16alpha,17beta-Estriol; 16alpha,17beta-Oestriol; 16alpha-Hydroxy-17beta-estradiol; 16alpha-Hydroxyestradiol; 16alpha-Hydroxyoestradiol; 3,16-alpha,17-beta-Estriol; 3,16-alpha,17-beta-Oestriol; 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-estratriene; 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-oestratriene; 3,16-alpha,17-beta-Trihydroxyestra-1,3,5(10)-triene; 3,16-alpha,17-beta-Trihydroxyoestra-1,3,5(10)-triene; 3,16.alpha.,17.beta.-Estriol; 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-estratriene; 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-oestratriene; 3,16.alpha.,17.beta.-Trihydroxy-1,3,5(10)-estratriene; 3,16.alpha.,17.beta.-Trihydroxyestra-1,3,5(10)-triene; 3,16alpha,17beta-Estriol; 3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene; 3,16alpha,17beta-Trihydroxy-delta-1,3,5-oestratriene; 3,16alpha,17beta-trihydroxy-Delta(1,3,5)-estratriene
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01439	Belotecan	Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01443	Norverapamil	Arverapamil; (R)-norverapamil; Agi-003; UNII-3J8P56R04P; (R)-(+)-Nor Verapamil Hydrochloride; 123932-43-4; 3J8P56R04P; Rezular; (+)-norverapamil; (R)-desmethylverapamil; (+)-desmethylverapamil; CHEBI:134082; ZINC13492624; AKOS030532539; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, (alphaR)-; UNII-957Z3K3R56 component UPKQNCPKPOLASS-AREMUKBSSA-N
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01444	NSC325663	21-Cyanosaframycin-B; NSC 325663; 66082-27-7; C29H30N4O8; 21-cyanosaframycin B; AC1L2P2O; SCHEMBL637953; CHEMBL452709
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01452	S9788	S-9788; S9788; S 9788; CHEMBL85156; 140945-01-3; 6-(4-(2,2-di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N'-di-2-propenyl-1,3,5-triazine-2,4-diamine; 1,3,5-Triazine-2,4-diamine, 6-(4-((2,2-bis(4-fluorophenyl)ethyl)amino)-1-piperidinyl)-N,N'-di-2-propenyl-; AC1L32YH; SCHEMBL1527824; DTXSID80161502; GERNFWKTMKWULM-UHFFFAOYSA-N; BDBM50053888; LS-187603; LS-186957; N,N''-Diallyl-6-{4-[2,2-bis-(4-fluoro-phenyl)-ethylamino]-piperidin-1-yl}-[1,3,5]triazine-2,4-diamine; H2O
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01455	Hydroxybupropion	Hydroxybupropion
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01464	Cinchonidine	CINCHONIDINE; Cinchonan-9-ol; cinchonine; alpha-Quinidine; 485-71-2; GNF-PF-5411; 118-10-5; MLS002637808; NSC5364; .alpha.-Quinidine; NSC 5364; Cinchonan-9-ol, (8.alpha.,9R)-; Cinchonan-9-ol, (9S)-; (8alpha,9R)Cinchonan-9-ol; a-quinidine; (8-alpha,9R)-Cinchonan-9-ol; EINECS 207-622-3; {5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}(quinolin-4-yl)methanol; SMR001488502; AI3-15317; 4-quinolyl-(5-vinylquinuclidin-2-yl)methanol; 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl-; (+)-Quinolin-4-yl(5-vinylquinuclidin-2-yl)methanol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01467	Geneticin	Geneticin; geneticin; antibiotic G 418; antibiotic G-418; UNII-A08F5XTI6G; 49863-47-0; BRN 1669188; A08F5XTI6G; O-2-Amino-2,7-dideoxy-D-glycero-alpha-D-gluco-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-D-streptamine; G 418 sulfate; G 418; G-418; C20H40N4O10; GET; D-Streptamine, O-2-amino-2,7-dideoxy-D-glycero-alpha-D-gluco-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-; AC1L3XFV; SCHEMBL5006573; CHEMBL215226; DTXSID10198129
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01468	Amphotericin B	amphotericin b; Amphotericine B; Amphotericin; Amfotericina B; Amphotericinum B; Fungizone; Halizon; Amphocin; AMPH-B; Liposomal Amphotericin B; Fungilin; Amphozone; Ambisome; Abelcet; Ampho-Moronal; Amphotericin-B; Amphortericin B; UNII-7XU7A7DROE; Amphotec; Abelecet; Mysteclin-F; MFCD00877763; 7XU7A7DROE; NCGC00090808-01; DSSTox_CID_2601; NSC 527017; DSSTox_RID_76653; DSSTox_GSID_22601; Amphomoronal; Fungisome; Fungisone; Amphotericinum B [INN-Latin]; Amfotericina B [INN-Spanish]; Amphotericine B [INN-French]; CCRIS 5963
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01471	AG1478	AG-1478; 153436-53-4; Tyrphostin AG 1478; N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine; 175178-82-2; Tyrphostin AG-1478; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline; AG 1478; AG1478; TYRPHOSTIN; 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-; UNII-SUH0SEZ9HY; SUH0SEZ9HY; AG-1478 hydrochloride; AG-1478 (Tyrphostin AG-1478); CHEMBL7917; CHEBI:75404; N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine; NSC-693255; AK-63142; N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine; BRD6408; BRD-6408; SR-01000076156; NSC693255
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01479	Debrisoquine	Debrisochinum; Debrisoquina; Debrisoquine; Debrisoquinum; Declinax; Equitonil; Isocaramidine; Tendor; DEBRISOQUIN SULFATE; Debrisoquin hemisulfate; Debrisoquine sulfate; Isocaramidine sulfate; Debrisoquina [INN-Spanish]; Debrisoquine [INN:BAN]; Debrisoquinum [INN-Latin]; Ro 5-3307/1; Sulfuric acid compound with 3,4-dihydro-2(1H)-isoquinolinecarboximidamide (1:1); 1,2,3, 4-Tetrahydro-isoquinoline-2-carboxamidine sulfate; 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-(7CI,8CI); 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-, sulfate (2:1); 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1); 2-Amidino-1,2,3,4-tetrahydroisoquinoline; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine sulfate (2:1); 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide; 3,4-Dihydro-2(1H;)-isoquinoline carboxamidine sulfate; 3,4-dihydro-1H-isoquinoline-2-carboximidamide; 3,4-dihydroisoquinoline-2(1H)-carboximidamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01481	E-guggulsterone	Guggulsterone E; (E)-Guggulsterone; E-Guggulsterone; Guggulsterones E; trans-Guggulsterone; 39025-24-6; Pregna-4,17-diene-3,16-dione; UNII-9B259YE66O; (17E)-Pregna-4,17(20)-diene-3,16-dione; Z-Guggulsterone; CHEMBL402063; 95975-55-6; 9B259YE66O; (8R,9S,10R,13S,14S,17E)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione; E-Guggulsteron; Pregna-4,17(20)-diene-3,16-dione; Guggulsterone, (E)-; Guglip; Z/E-Guggulsterone; Pregna-4,17(20)-diene-3,16-dione, (17E)-; Guggulsterone E; Guggulsterones Z; Cis-Guggulsterone; Trans-Guggulsterone; (17E)-pregna-4,17-diene-3,16-dione; (17Z)-Pregna-4,17(20)-diene-3,16-dione; (17Z)-pregna-4,17-diene-3,16-dione; (8R,9S,10R,13S,14S,17Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione; (Z)-Guggulsterone; 4,17(20)-cis-Pregnadiene-3,16-dione; E-GUGGULSTERONE
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01483	Ingenol-3-angelate	Picato; Ingenol 3-angelate; 75567-37-2; PEP-005; PEP005; 3-Angeloylingenol; UNII-7686S50JAH; PEP 005; 3-Ingenyl angelate; Ingenol-3-angelate; 7686S50JAH; Picato (TN); Euphorbia factor H1; Euphorbia factor An1; Ingenol mebutate [USAN:INN]; [dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[?]yl] (Z)-2-methylbut-2-enoate; I3A; Ingenol-3- angelate; Ingenol mebutate (USAN); (Z)-2-methylbut-2-enoate; SCHEMBL2526605; GTPL7443; CHEMBL1863513; HSDB 8308; VDJHFHXMUKFKET-WDUFCVPESA-N; MolPort-003-941-761; AN-262; POL-103A
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01484	Apafant	Apafant; 105219-56-5; WEB-2086; Web 2086; Apafant [USAN:INN]; Apafantum [INN-Latin]; Apafanto [INN-Spanish]; WEB 2086BS; WEB2086; UNII-J613NI05SV; WEB 2086 BS; BRN 4302553; C22H22ClN5O2S; J613NI05SV; CHEMBL280164; NCGC00092377-03; NCGC00092377-02; Apafantum; Apafanto; DSSTox_CID_28900; DSSTox_RID_83168; DSSTox_GSID_48974; 4-(3-(4-(o-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepin-2-yl)propionyl)morpholine; [3H]apafant; Morpholine; Apafant (ophthalmic formulation), Santen
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01487	4-Hydroxytamoxifen	4-Hydroxytamoxifen; Afimoxifene; (Z)-4-Hydroxytamoxifen; Hydroxytamoxifen; 4-Monohydroxytamoxifen; Tamogel; 68047-06-3; trans-4-Hydroxytamoxifen; Ici 79280; 68392-35-8; 65213-48-1; 4-OH-TAM; (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol; Z-4-hydroxytamoxifen; UNII-95K54647BZ; CHEMBL489; ICI 79,280; TAMOXIFEN, 4-HYDROXY-, (Z)-; BRN 4910749; (E/Z)-4-Hydroxy Tamoxifen; MLS000069742; C26H29NO2; CHEBI:44616; 95K54647BZ; SMR000058939; 4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01493	Spiperone	Spiperone; spiperone; Spiroperidol; Spiropitan; 749-02-0; Espiperona; Spiperonum; [3H]-spiperone; R 5147; Spiperonum [INN-Latin]; Espiperona [INN-Spanish]; E 525; UNII-4X6E73CJ0Q; NSC 170983; MLS000028615; Spiperone [USAN:INN:BAN:JAN]; 8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(45)decan-4-one; 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[45]decan-4-one; 8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane; EINECS 212-024-0; BRN 0632204; SMR000058674; [3H]-spiperone; SPIPERONE
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01494	Roscovitine	Seliciclib; roscovitine; 186692-46-6; R-Roscovitine; (R)-roscovitine; CYC202; CYC-202; CYC 202; 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine; UNII-0ES1C2KQ94; Roscovitine (Seliciclib,CYC202); NSC 701554; AL-39256; Roscovitine; CHEMBL14762; 0ES1C2KQ94; CHEBI:45307; NSC701554; NSC-701554; (2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol; (R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol; (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol; RRC; Rosco; M02443; BMK1-E12; CYC202, Seliciclib, R-roscovitine, Roscovitine; (2r)-2-{[6-(benzylamino)-9-isopropyl-9h-purin-2-yl]amino}-1-butanol; 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol; 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-(R)-1-butanol; 6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01499	Azasetron	Azasetron; Nazasetron; Azasetron [INN]; C17H20ClN3O3; 123039-99-6; WUKZPHOXUVCQOR-UHFFFAOYSA-N; Azasetron (INN); 6-Chloro-4-methyl-3-oxo-N-(quinuclidin-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide; NCGC00024563-02; DSSTox_RID_81029; DSSTox_CID_25651; DSSTox_GSID_45651; (- )-6-Chloro-3,4-dihydro-4-methyl-3-oxo-N-3-quinuclidinyl-2H-1,4-benzoxazine-8-carboxamide; N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01503	Cepharanthine	CEPHARANTHINE; Cepharanthin; (+)-Cepharanthine; O-Methylcepharanoline; Cepharantin; Cepharanthine [JAN]; UNII-7592YJ0J6T; CCRIS 6539; NSC 623442; BRN 0075231; 6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan; CHEBI:3546; 7592YJ0J6T; NSC623442; Cepharanthine (JAN); NSC-623442; ecaene (non-preferred name); DSSTox_RID_81253; DSSTox_CID_25957; DSSTox_GSID_45957; Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-; CAS-481-49-2; SR-01000779734; Cepharanthin,(S)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01505	Dolastatin 10	Dolastatin 10; Dolastatin-10; Dolostatin 10; UNII-EI946JT51X; CCRIS 7310; CHEBI:67357; NSC 376128; EI946JT51X; L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01514	Bunitrolol	Bunitrolol; 2-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitrile; Bunitrolol [INN]; Stresson; Bunitrololum [INN-Latin]; KO-1366; Bunitrolol HCl; BRN 2374567; 2-Nitrilo-N-tert-butylphenoxypropanolamine; Koe 1366; o-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitrile; 2-Propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)-; (RS)-2-(3-(tert-Butylamino)-2-hydroxypropoxy)benzonitril; 2-[3-(tert-butylamino)-2-hydroxypropoxy]benzonitrile; Bunitrololum; BENZONITRILE, o-(3-(tert-BUTYLAMINO)-2-HYDROXYPROPOXY)-
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01525	Puromycin	puromycin; Stylomycin; Puromycinum; Puromycine; Puromicina; UNII-4A6ZS6Q2CL; P-638; Stillomycin; CL 13900; 3123L; 4A6ZS6Q2CL; 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine; (S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine; GNF-PF-2016; Puromycinum [INN-Latin]; Puromycine [INN-French]; Puromicina [INN-Spanish]; 9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine; Bacterenomycin
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01537	Coelenterazine	coelenterazine; Coelenteramine; Oplophorus luciferin; UNII-3O1CB88RRD; CLZN; 8-benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one; coelenterate luciferin; Coelenterazine, native; 3O1CB88RRD; MFCD00467176; C-7001; C-7002; 8-benzyl-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-7H-imidazo[1,2-a]pyrazin-3-one; 8-Benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo-[1,2a]pyrazin-3(7H)-one; 2-(p-Hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo[1,2-a]pyrazin-3-(7H)-one
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01542	Simvastatin acid	Simvastatin acid; Tenivastatin; UNII-9L6M5TH46B; DIMETHYL-COMPACTIN; 9L6M5TH46B; (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; Tenivastatin [INN]; (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}-3,5-dihydroxyheptanoic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01543	Pazufloxacin	Pazufloxacin; T-3761; Pazufloxacin [INN]; UNII-4CZ1R38NDI; CCRIS 7312; T 3761; 4CZ1R38NDI; C16H15FN2O4; NCGC00167534-01; DSSTox_CID_26697; DSSTox_RID_81831; DSSTox_GSID_46697; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)-; SMR000466380; (-)-(3S)-10-(1-Aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01558	Nonactin	nonactin; Werramycin-A; Antibiotic from Actinomycete; Upjohn 170t (high melting); UPJOHN 170T, high melting; UNII-TTP24WX8P7; 5342 PFW 19; TA-25-M-I; EINECS 229-911-3; A 4426; NSC 56409; E-79-C; NSC 52141; N-329-A; BRN 0076434; TTP24WX8P7; CHEBI:7614; GNF-PF-1094; 3584-A; NSC52141; 4,13,22,31,37,38,39,40-Octaoxapentacyclo(32.2.1.1(sup 7,10).1(sup 16,19).1(sup 25,28))tetracontane-3,12,21,30-tetrone, 2,5,11,14,20,23,29,32-octamethyl-, (1R-(1R*,2R*,5R*,7R*,10S*,11S*,14S*,16S*,19R*,20R*,23R*,25R*,28S*,29S*,32S*,34S*))-
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01583	Abamectin B1A	AVERMECTIN B1A; abamectin component B1a; Avermectin B(1)a; Abamectine [French]; Abamectinum [Latin]; Abamectina [Spanish]; Caswell No. 063AB; Antibiotic C 076B1a; Abamectin komponente B1a; 5-O-Demethylavermectin A1a; UNII-K54ZMM929K; Avermectin; Avermectin A1a, 5-O-demethyl-; EINECS 265-610-3; Antibiotic C 076A1a, 5-O-demethyl-; K54ZMM929K; CHEBI:29534; Avermectin A(sub 1a), 5-O-demethyl-; DSSTox_CID_3892; DSSTox_RID_77221; DSSTox_GSID_23892; Abamectina; Abamectine; C48H72O14; Abamectin B1a
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01584	Selamectin	selamectin; UNII-A2669OWX9N; A2669OWX9N; UK-124,114; 25-cyclohexyl-25-de(1-methylpropyl)-5-deoxy-22 23-dihydro-5-(hydroxyimino)-avermectin B1 monosaccharide; Stronghold; Revolution; 220119-17-5; 25-Cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-avermectin A1a
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01592	Desmethylsertraline	Desmethylsertraline; Norsertraline; (1s,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine; UNII-CJJ71O9BE8; CJJ71O9BE8; CHEMBL40733; (1S,4S)-4-(3,4-Dichloro-phenyl)-1,2,3,4-tetrahydronaphthalen-1-amine; CHEMBL1743864; N-Demethylsertraline; N-Desmethylsertraline; Demethylsertraline; CP 62508; CP-53261; AC1L3FVW; AC1Q3O5M; SCHEMBL145234; NAP005; CTK8E0157; DTXSID60236666; SRPXSILJHWNFMK-ZBEGNZNMSA-N; ZINC6117444; PDSP2_001789; BDBM50367182; MFCD00871799; BDBM50028066; AKOS027382323
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01613	MG-132	MG-132; Z-Leu-leu-leu-al; MG132; Zlllal; MG 132; Z-LLL-CHO; Zlll-cho; Z-Leu-leu-leucinal; Z-Leu-Leu-Leu-H; Z-Leu-Leu-Leu-CHO; Carbobenzoxy-leucyl-leucyl-leucinal; UNII-RF1P63GW3K; Benzyloxycarbonyl-leu-leu-leu-aldehyde; Benzyloxycarbonyl-leucyl-leucyl-leucinal; Lll cpd; Carbobenzoxyl-leucinyl-leucinyl-leucinal-H; Cbz-Leu-Leu-Leu-H; Benzyloxycarbonylleucyl-leucyl-leucine aldehyde; benzyl (S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate; RF1P63GW3K
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01615	Norbuprenorphine	Norbuprenorphine; N-Desalkylbuprenorphine; Des(cyclopropylmethyl)buprenorphine; UNII-7E53B4O073; 7E53B4O073; 6,14-Ethenomorphinan-7-methanol, alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)-; AC1L3GBB; SCHEMBL14408877; CHEMBL1743323; YOYLLRBMGQRFTN-IOMBULRVSA-N; ZINC6031944; LS-67705; 6,14-ethenomorphinan-3-ol, 4,5-epoxy-18,19-dihydro-18-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-methoxy-, (5alpha,6beta,14beta,18R)-
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01623	Eslicarbazepine acetate	Eslicarbazepine acetate; BIA 2-093; Aptiom; Zebinix; Stedesa; Exalief; Eslicarbazepine (acetate); UNII-BEA68ZVB2K; BIA-2-093; (S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate; Sep 0002093; BIA 2093; BEA68ZVB2K; SEP-0002093; CHEMBL87992; Eslicarbazepine acetate [USAN]; CHEBI:87016; exelief; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate; Eslicarbazepine acetate (USAN)
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01626	Genz 644282	GENZ-644282; Genz 644282; genz644282; UNII-717I541I2R; 717I541I2R; 2,3-dimethoxy-12-(2-(methylamino)ethyl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one; SCHEMBL241696; CHEMBL191958; EX-A481; AOB87160; BCP20983; ZINC6718458; SAR402674; AKOS030526835; CS-1525; SAR 402674; SAR-402674; HY-16228; Benzo(C)(1,3)benzodioxolo(5,6-H)(1,6)naphthyridin-13(12H)-one, 2,3-dimethoxy-12-(2-(methylamino)ethyl)-; BC600645; DA-42192; GENZ-644282/GENZ644282; FT-0700324; A3434; W-6112; A13206
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01627	(Z)-endoxifen	Endoxifen; Z-Endoxifen; 4-Hydroxy-N-desmethyltamoxifen; (E/Z)-Endoxifen; Endoxifen Z-Isomer; UNII-46AF8680RC; N-Desmethyl-4-hydroxytamoxifen; 110025-28-0; 4-Hydroxy-N-desmethyl-tamoxifen; CHEBI:80555; 46AF8680RC; 4OHNDtam; W-200834; N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture); (Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer); 4-hydroxy-N-desmethyltamoxifen, (Z)-isomer; (Z)-Endoxifen; Endoxifen(E/Z=1:1); 4-hydroxy-N-desmethyl tamoxifen; SCHEMBL10107920; CHEMBL1093458; GTPL10203; EX-A645
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01628	Guanfacine	GUANFACINE; Tenex; Guanfacinum [INN-Latin]; Guanfacina [INN-Spanish]; Estulic; Intuniv; N-amidino-2-(2,6-dichlorophenyl)acetamide; CHEBI:5558; INJOMKTZOLKMBF-UHFFFAOYSA-N; SPD 503; C9H9Cl2N3O; N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide; N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide; Guanfacine Monohydrochloride; NCGC00015469-05; Lon798; Guanfacine (INN); Estulic (TN); Tenex (Salt/Mix); Estulic (Salt/Mix); Tocris-1030; Prestwick1_000339; Prestwick3_000339; Prestwick2_000339; Prestwick0_000339; Lopac-G-1043
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01638	N-desethyl sunitinib	N-Desethyl Sunitinib; N-DesethylSunitinib; UNII-42LJ35612R; 42LJ35612R; C20H23FN4O2; N-[2-(ethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; SCHEMBL2115189; CHEMBL3542344; DTXSID10437828
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01643	Fluticasone propionate	FLUTICASONE PROPIONATE; Flovent; Cutivate; Flixotide; Flonase; Flixonase; Flovent HFA; Flunase; Flutide; Fluspiral; Flusonal; atemur; Flutivate; Fluinol; Axotide; Asmatil; Brethal; Flovent Diskus 50; Flixotide Disks; Flixotide Disk; Flovent Diskus; Flovent Diskus 100; Flovent Diskus 250; Flixotide Inhaler; Trialona; Rinosone; Inalacor; Cultivate; Ubizol; Zoflut; Flixonase Nasal Spray; Flonase Aq; Fluticasonpropionat Allen; Fluticasone (propionate); UNII-O2GMZ0LF5W; CCI-18781; CCI 18781; MFCD00866007; O2GMZ0LF5W
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01644	Bouvardin	Bouvardin; MLS002703036; NSC259968; NSC 259968; NSC-259968; AC1L8NRS; Neuro_000123; SCHEMBL8739404; SMR001566844; From fraction F049 of Bouvardia ternifolia; Cyclic(D-alanyl-L-alanyl-N, cyclic(54.fwdarw.63)-ether, (S)-; 17,24-dihydroxy-10-(4-methoxybenzyl)-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2~18,21~.1~23,27~]tritriaconta-18,20,23(31),24,26,32-hexaene-2,5,8,11,14,30-hexone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01645	Cephaeline	Cephaeline; Cephaelin; 483-17-0; 7',10,11-Trimethoxyemetan-6'-ol; UNII-QA971541A1; Desmethylemetine; QA971541A1; Dihydropsychotrine; Cepheline; GNF-Pf-307; (1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol; NSC32944; Cephaelinel; (-)-Cephaeline; EINECS 207-591-6; Prestwick2_000428; Prestwick3_000428; Prestwick1_000428; Prestwick0_000428; AC1L9CF2; BSPBio_000416; SCHEMBL181711; SPBio_002355; CHEMBL255708
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01649	Metkephamid	METKEFAMIDE; UNII-MNL20FXH9Y; MNL20FXH9Y; Metkephamid; Metkephamide; Metkefamida; Metkefamidum; L-Methioninamide, L-tyrosyl-D-alanylglycyl-L-phenylalanyl-N2-methyl-; Metkefamidum [INN-Latin]; Metkefamida [INN-Spanish]; L-Tyrosyl-D-alanylglycyl-L-phenylalanyl-N2-methyl-L-methioninamide; Metkefamide [INN]; AC1NUZ1B; SCHEMBL329997; CHEMBL2220405; CTK2F4766
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01663	Fucoxanthin	Fucoxanthin; UNII-06O0TC0VSM; CCRIS 4055; all-trans-Fucoxanthin; BRN 0073179; 06O0TC0VSM; beta,beta-Carotene, 3'-(acetyloxy)-6',7'-didehydro-5,6-epoxy-5,5',6,6',7,8-hexahydro-3,5'-dihydroxy-8-oxo-, (3S,3'S,5R,5'R,6S,6'R)-; (3S,5R,6S,3'S,5'R,6'R)-3,5'-dihydroxy-8-oxo-6',7'-didehydro-5,6-epoxy-5,6,7,8,5',6'-hexahydro-beta,beta-caroten-3'-yl acetate; (3'S,5'R,6'R)-3'-acetoxy-5,6-epoxy-3,5'-dihydroxy-6',7'-didehydro-5,6,7,8,5',6'-hexahydro-beta,beta-caroten-8-one
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01664	Crocin	.
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01665	Beclomethasone dipropionate	BECLOMETHASONE DIPROPIONATE; Beclometasone dipropionate; Beconase; Beclovent; Vancenase; Beclorhinol; Becloforte; Sanasthmyl; Beclazone; Sanasthmax; Propaderm; Beclomet; Vanceril; Aerobec; Becloturmant; Beclacin; Respocort; Entyderma; Korbutone; Viarox; Rino-clenil; Clenil-A; Beclometasone 17,21-dipropionate; Becotide; Aldecin; Turbinal; Aldecina; Rhinosol; Beclate; Atomase; Alanase; Benconase; Aldecine; Clenil; Spir; Beclocort Nasel; Beclomet Nasal; Propaderm Forte; Rhino Clenil; Inalone O; Inalone R; Qvar; QNASL; Beconase AQ; Qvar 80
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01676	Epothilone A	Epothilone A; (-)-Epothilone A; Epo A; epothile; Epothilone-A; UNII-51E07YBX96; Epoa; 51E07YBX96; EP; Epothilones; Epothilon A; (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12-tetramethyl-3-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione; 4,17-Dioxabicyclo[14.1.0]heptadecane-5,9-dione,7,11-dihydroxy-8,8,10,12-tetramethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-,(1S,3S,7S,10R,11S,12S,16R)-
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01679	Lovastatin acid	Lovastatin acid; Mevinolinic acid; Monacolinic K acid; MSD 803 acid; MSD 803 free acid; UNII-5CLV35Y90C; MK 819; L-154819; L 154819; 5CLV35Y90C; CHEBI:82985; (3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID; (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01687	Sitafloxacin	Sitafloxacin; Gracevit; Sitafloxacin Sesquihydrate; UNII-3GJC60U4Q8; Sitafloxacin isomer II; DU-6859a; C19H18ClF2N3O3; 3GJC60U4Q8; 7-((S)-7-AMINO-5-AZASPIRO[2.4]HEPTAN-5-YL)-8-CHLORO-6-FLUORO-1-((1R,2S)-2-FLUOROCYCLOPROPYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; STFX; 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxo-quinoline-3-carboxylic acid
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01688	Ebastine	ebastine; Kestine; Ebastel; Ebastin; Evastel; Kestin; Bactil; Ebastinum [Latin]; LAS W-090; Ebastina [Spanish]; Estivan; UNII-TQD7Q784P1; RP 64305; 1-(4-tert-butylphenyl)-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one; TQD7Q784P1; CHEMBL305660; 4-Diphenylmethoxy-1-(3-(4-tert-butylbenzoyl)propyl)piperidine; C32H39NO2; MFCD00865661; 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone; NCGC00164603-01; RP-64305; 4'-tert-Butyl-4-(4-(diphenylmethoxy)piperidino)butyrophenone
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01689	Tenofovir disoproxil	Tenofovir disoproxil; PMPA prodrug; Bis(POC)PMPA; Tenofovir (Disoproxil); UNII-F4YU4LON7I; 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine; F4YU4LON7I; CHEBI:63717; tenofovir bis(isopropyloxycarbonyloxymethyl) ester; Tenofovir Disoproxil Fumarate; [[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphoryl]oxymethyl isopropyl carbonate
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01713	S-licarbazepine	Eslicarbazepine; (S)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; S-licarbazepine; UNII-S5VXA428R4; BIA 2-194; S-10-Monohydroxy-dihydro-carbamazepin; S5VXA428R4; S-(+)-10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide; (5S)-5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide; (10S)-10,11-Dihydro-10-hydroxy-5H-Dibenz[b,f]azepine-5-carboxamide; (S)-Licarbazepine; S(+)-Liscarbazepine; (10S)-10,11-Dihydro-10-hydroxy-5H-dibenz(b,f)azepine-5-carboxamide
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01717	Saphris	Asenapine maleate; Saphris; Asenapine (maleate); Org 5222; Sycrest; Org-5222; Asenapine maleate [USAN]; C17H16ClNO.C4H4O4; Asenapine/; Saphris (TN); EINECS 288-064-8; Org 5222 maleate; trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole maleate; (S,S)-Asenapine Maleate; SCHEMBL175228; Asenapine maleate (JAN/USAN); CHEBI:71248; GMDCDXMAFMEDAG-CHHFXETESA-N; ABP000604; s1283; MFCD00900588; Asenapine maleate, >=98% (HPLC); AKOS015951084; SCH-900274; MK-8274; CS-0859; HY-11100; AC-24116
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01721	BMS-3870032	SNS-032; BMS-387032; SNS 032; BMS 387032; N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; SNS-032 (BMS-387032); N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide; N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide; UNII-9979I93686; N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide; CHEMBL296468; SNS032; C17H24N4O2S2; BMS387032
DTD0003	ABCB1	P-glycoprotein 1	ABC20; ABCB1; ATP-binding cassette sub-family B member 1; CD243; CLCS; GP170; MDR1; P-GP; PGY1; hMDR1	DR01722	Gepirone	Gepirone; 4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione; Gepirone ER; Gepironum [Latin]; Gepirone [INN]; Gepirona [Spanish]; UNII-JW5Y7B8Z18; BMY-13805; JW5Y7B8Z18; CHEMBL284092; MJ-13805; Variza; Ariza; Gepironum; AK115965; Gepirona; 4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione; Travivo; 2,6-Piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-; BMY 13805; MJ 13805; gepiron ER; MJ 13805-1; ORG-13011(Gepirone); AC1L1IK6; AC1Q6F8Q
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00013	Nilotinib	Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00015	Adefovir	((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00021	Teniposide	4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin thenylidene glucoside; 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside; 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside; Demethyl Epipodophyllotoxin Thenylidine Glucoside; Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); PTG; Teniposide (USAN/INN); Teniposide [USAN:BAN:INN]; Teniposido; Teniposido [INN-Spanish]; Teniposidum; Teniposidum [INN-Latin]; VM 26; VM-26; VM-26 (TN); Vee M-26; Veham-Sandoz; Vehem; Vumon; Vumon (TN); Vumon, VM-26, Vehem, NSC 122819, Teniposide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00029	Moxidectin	C37H53NO8; Cydectin; Moxidectin [USAN:INN:BAN]; Moxidectina; Moxidectina [INN-Spanish]; Moxidectine; Moxidectine [INN-French]; Moxidectinum; Moxidectinum [INN-Latin]; NGU5H31YO9; ProHeart 6; UNII-NGU5H31YO9
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00032	Imatinib	112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00039	Glutathione	5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00044	Topotecan	(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00050	Erythromycin	A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00079	Riboflavin	(-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00080	Riociguat	625115-55-1; Adempas; BAY 63-2521; CHEBI:76018; Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate; Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester; RU3FE2Y4XI; Riociguat; Riociguat (BAY 63-2521); UNII-RU3FE2Y4XI; riociguatum
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00087	Cladribine	(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00092	Teriflunomide	(2Z)-2-[hydroxy-[4-(trifluoromethyl)anilino]methylidene]-3-oxobutanenitrile; (Z)-2-Cyano-alpha'alpha'alpha-trifluoro-3-hydroxy-p-crotonotoluidide; 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide; 2-hydroxyethylidene-cyanoacetic acid-4-trifluoromethyl anilide; A 771726; A-771726; Active metabolite of leflunomide; Flucyamide; HMR 1726; HMR-1726; N-(4-Trifluoromethylphenyl)-2-cyano-2-hydroxycrotonamide; RS 61980; RS-61980; SU 20; SU-0020; Teriflunomide [INN]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00094	Glibenclamide	1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Abbenclamide; Adiab; Apo-Glibenclamide; Azuglucon; Bastiverit; Benclamin; Betanase; Betanese 5; Calabren; Cytagon; Daonil; Daonil (TN); Debtan; Dia-basan; Diabeta; Diabeta (TN); Diabiphage; Dibelet; Duraglucon; Euclamin; Euglucan; Euglucon; Euglucon (TN); Euglucon 5; Euglucon N; Euglykon; G 0639; GBN 5; Gen-Glybe; Gewaglucon; Gilemal; Glamide; Glibadone; Gliban; Gliben; Gliben-Puren N; Glibenbeta; Glibenclamid AL; Glibenclamid Basics; Glibenclamid Fabra; Glibenclamid Genericon; Glibenclamid Heumann; Glibenclamid Riker M; Glibenclamid Riker M.; Glibenclamid-Cophar; Glibenclamid-Ratiopharm; Glibenclamida; Glibenclamida [INN-Spanish]; Glibenclamide (JP15/INN); Glibenclamidum; Glibenclamidum [INN-Latin]; Glibenil; Glibens; Glibesyn; Glibet; Glibetic; Glibil; Gliboral; Glicem; Glidiabet; Glimel; Glimide; Glimidstata; Glisulin; Glitisol; Glubate; Gluben; Gluco-Tablimen; Glucobene; Glucohexal; Glucolon; Glucomid; Glucoremed; Glucoven; Glyben; Glybenclamide; Glybenzcyclamide; Glyburide; Glyburide (USP); Glyburide (micronized); Glyburide [USAN]; Glycolande; Glycomin; Glynase; Glynase (TN); HB 419; HB 420; HB-419; HB-420; HB419; HB420; Hemi-Daonil; Hexaglucon; Humedia; Lederglib; Libanil; Lisaglucon; Maninil; Med-Glionil; Melix; Micronase; Micronase (TN); Micronized glyburide; Miglucan; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Nadib; Neogluconin; Norglicem 5; Normoglucon; Novo-Glyburide; Orabetic; Pira; Praeciglucon; PresTab; Prodiabet; Renabetic; Semi-Daonil (TN); Semi-Euglucon; Semi-Gliben-Puren N; Semi-daonil; Sugril; Suraben; Tiabet; U 26452; U-26452; UR 606; Yuglucon
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00108	Testosterone	(17beta)-17-Hydroxyandrost-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17-Hydroxy-4-androsten-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; 17b-hydroxy-4-androsten-3-one; 17beta-Hydroxy-3-oxo-4-androstene; 17beta-Hydroxy-4-androsten-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; 17beta-Hydroxyandrost-4-en-3-one; 17beta-Hydroxyandrost-4-ene-3-one; 4-Androsten-17-ol-3-one; 4-Androsten-17beta-ol-3-one; 4-androstene-17beta-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; AA 2500; Andro 100; AndroGel; Androderm; Androderm (TN); Androgel (TN); Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Androsorb; Androst-4-en-17beta-ol-3-one; Andrusol; Andryl 200; Beta testosterone; CDB 111C; CMC_13449; COL 1621; CP 601B; Cristerona T; Cristerone T; Delta(sup 4)-Androsten-17(beta)-ol-3-one; Delta4-Androsten-17beta-ol-3-one; Delta4-androsten-17b-ol-3-one; Depotest; Everone 200; Geno-cristaux gremy; Halotensin; Homosteron; Homosterone; Intrinsa; LibiGel; Malerone; Malestrone (amps); Malogen in Oil; Malogen, aquaspension injection; Mertestate; Neo-Hombreol F; Neo-testis; Neotestis; Oreton; Oreton F; Oreton-F; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Striant (TN); Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; Teslen; Testamone 100; Testandrone; Testaqua; Testiculosterone; Testim; Testim (TN); Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testosterona [INN-Spanish]; Testosterone (JAN/USP); Testosterone [Androgenic steroids, anabolic]; Testosterone [INN:BAN]; Testosterone and its esters; Testosterone hydrate; Testosterone solution; Testosteronum; Testosteronum [INN-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred Cypionate 200; Testrin-P.A; Testro AQ; Testrone; Testryl; Trans-Testosterone; Virilon IM; Virormone; Virosterone
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00112	Irinotecan	(+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00116	Lamivudine	(+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (+/-)-3TC; (+/-)-BCH-189; (+/-)-SddC; (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)-NGPB-21; (-)-SddC; (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2',3' Dideoxy 3' thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA); 3'-Thia-2',3'-dideoxycytidine; 3TC; 3TC & GNA; 3TC & SST; 3TC (AIDS INITIATIVE) (AIDS INITIATIVE); 3TC and NV-01; 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine; 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; BCH 189; BCH-189; BCH-790; BCH189; Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To; Beta-L-2',3'-Dideoxy-3'-thiacytidine; Beta-L-3'-Thia-2',3'-dideoxycytidine; DRG-0126; DTHC; Epivir; Epivir (TN); Epivir(TM); Epivir-HBV; Epivir-HBV (TN); GG-714; GR-109714X; GR109714X; HHA & 3TC; HHA & Lamivudine; Hepitec; Heptivir; Heptodin; Heptovir; Heptovir (TN); LMV; Lamivir; Lamivudine & GNA; Lamivudine (JAN/USP/INN); Lamivudine [USAN:BAN:INN]; Lamivudine [USAN:INN:BAN]; Lamivudine, (2S-cis)-Isomer; Zeffix; Zeffix (TN); Zefix
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00118	Sphingosine-1-phosphate	(2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00120	Lapatinib	4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline; FMM; GSK 572016; GSK572016; GW 572016; GW 572016X; GW572016; Lapatinib (ERBB2 inhibitor); Lapatinib (INN); Lapatinib Ditosylate; Lapatinib [INN]; Lapatinib tosilate hydrate; Lapatinib, Tykerb, GW572016; N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine; N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine; N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine; N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE; Tycerb; Tykerb (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00124	Fluvastatin	(+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00127	Tetracycline	(-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00129	Estradiol	17 beta-Estradiol; 17-.BETA.-Estradiol; 17-beta-OH-estradiol; 17-beta-estradiol; 17.beta.-Estradiol; 17.beta.-Oestradiol; 17b-Oestradiol; 17beta oestradiol; 17beta-Estradiol; 17beta-Oestradiol; 3,17-beta-Estradiol; 3,17-beta-Oestradiol; 3,17.beta.-Estradiol; 3,17beta-Estradiol; Activella (TN); Aerodiol; Alora; Alora (TN); Alpha-Estradiol; Alpha-Oestradiol; Altrad; AngeliQ (TN); Aquadiol; B-Estradiol; Bardiol; Beta-Oestradiol; Beta-estradiol; CMC_11154; Cis-Estradiol; Cis-Oestradiol; Climaderm; Climara; Climara (TN); Climara Forte; Component of Menrium; Compudose; Compudose 200; Compudose 365; Corpagen; D-3,17beta-Estradiol; D-Estradiol; D-Oestradiol; Dermestril; Destradiol; Dihydrofolliculin; Dihydromenformon; Dihydrotheelin; Dihydroxyesterin; Dihydroxyestrin; Dihydroxyoestrin; Dimenformon; Diogyn; Diogynets; Divigel; Divigel (TN); E 2; E 8875; E(sub 2); E0025; Elestrin; Elestrin (TN); Encore; Epiestriol 50; Esclim; Estrace; Estrace (TN); Estraderm; Estraderm (TN); Estraderm MX; Estraderm TTS; Estraderm TTS (TN); Estraderm TTS 100; Estraderm TTS 50; Estradiol [USAN:INN]; Estradiol acetate (TN); Estradiol cypionate (TN); Estradiol valerate (TN); Estradiol-17 beta; Estradiol-17-beta; Estradiol-17beta; Estradiol-3,17beta; Estradiolo; Estradiolo [DCIT]; Estradiolum; Estradiolum [INN]; Estradot; Estraldine; Estrapak 50; Estrasorb; Estrasorb (TN); Estrasorb Topical (TN); Estreva; Estrifam; Estring; Estring (TN); Estring vaginal ring; Estroclim; Estroclim 50; Estrodiolum; Estrofem (TN); Estrofem 2; Estrofem Forte; Estrogel; Estrogel (TN); Estrovite; EvaMist (TN); Evamist; Evorel; Extrasorb; Femanest; Femestral; Femestrol; Femogen; Fempatch; Femring (TN); Femtrace; Femtran; Follicyclin; Gelestra; Ginedisc; Ginosedol; GynPolar; Gynergon; Gynestrel; Gynodiol; Gynoestryl; Innofem; Innofem (TN); Lamdiol; Macrodiol; Macrol; Menest; Menorest; Menostar (TN); Microdiol; Nordicol; Oesclim; Oestergon; Oestradiol; Oestradiol Berco; Oestradiol R; Oestradiol-17-beta; Oestradiol-17beta; Oestradiolum; Oestrogel; Oestroglandol; Oestrogynal; Ovahormon; Ovasterol; Ovastevol; Ovociclina; Ovocyclin; Ovocycline; Ovocylin; Perlatanol; Polyestradiol; Primofol; Profoliol; Profoliol B; Progynon DH; Progynon-DH; Progynon;Syndiol; Progynova (TN); S-21400; SK-Estrogens; SL-1100; Sandrena 1; Sandrena Gel; Sisare Gel; Systen; Tradelia; Trial SAT; Trocosone; VIVELLE-DOT; Vagifem; Vagifem (TN); Vivelle; Vivelle (TN); Vivelle-Dot (TN); Zerella; Zesteem; Zesteen; Zumenon; [2,4,6,7-3H]-E2; [3H]-estradiol; [3H]]estradiol
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00130	Leflunomide	4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl; 4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl); 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide; 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide; 5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide); 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide; 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide; 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide; 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide; AP-501/42475599; Alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide; Arava; Arava (TN); Arava, Leflunomide; Aventis Behring Brand of Leflunomide; Aventis Brand of Leflunomide; Aventis Pharma Brand of Leflunomide; HWA 486; HWA-486; Hoechst Brand of Leflunomide; L 5025; Leflunomid; Leflunomida; Leflunomida [INN-Spanish]; Leflunomide (JAN/USAN/INN); Leflunomide [USAN:INN]; Leflunomidum; Leflunomidum [INN-Latin]; Lefunamide; Lefunomide [Inn-Spanish]; N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide; N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide; RS-34821; SU 101; SU 101 (pharmaceutical); SU-101; SU101
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00136	Regorafenib	24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00140	Ezetimibe	(-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00143	Vincristine	22-Oxovincaleukoblastine; Indole alkaloid; LCR; Leurocristine; Lilly37231 (1:1 sulfate salt); Liposomal Vincristine; Marqibo; Onco TCS; Oncovin (1:1 sulfate salt); Oncovin (TN); Oncovine; Tecnocris; Tecnocris (TN); VCR; VIN; Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Vincasar; Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincristina; Vincristina [DCIT]; Vincristine (INN); Vincristine [INN:BAN]; Vincristinum; Vincristinum [INN-Latin]; Vincrstine; Vincrystine; Vinkristin; Z-D-Val-Lys(Z)-OH
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00161	SN-38	(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00164	Dabrafenib	1195765-45-7; CHEBI:75045; Dabrafenib (GSK2118436); Dabrafenib [USAN:INN]; GSK 2118436; GSK-2118436A; GSK2118436; GSK2118436A; N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide; N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide; QGP4HA4G1B; Tafinlar; UNII-QGP4HA4G1B
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00170	Epirubicin	(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside; (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione; 4'-Epi-DXR; 4'-Epiadriamycin; 4'-epi-DX; 4'-epi-Doxorubicin; 4'-epidoxorubicin; 4-Epidoxorubicin; Ebewe (TN); Ellence; Ellence (TN); Epi-DX; Epiadriamycin; Epidoxorubicin; Epirubicin (INN); Epirubicin (TN); Epirubicin [INN:BAN]; Epirubicina; Epirubicina [INN-Spanish]; Epirubicina [Spanish]; Epirubicine; Epirubicine [French]; Epirubicine [INN-French]; Epirubicinum; Epirubicinum [INN-Latin]; Epirubicinum [Latin]; Farmorubicin (TN); IMI 28; Pharmorubicin (TN); Pharmorubicin Pfs; Pidorubicin; Pidorubicina; Pidorubicina [INN-Spanish]; Pidorubicine; Pidorubicine [INN-French]; Pidorubicinum; Pidorubicinum [INN-Latin]; Ridorubicin; WP 697
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00172	Uric acid	urate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00182	Dasatinib	(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00185	Pazopanib hydrochloride	5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide; 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide; 790713-33-6; 7RN5DR86CK; DSSTox_CID_28659; DSSTox_GSID_48733; DSSTox_RID_82929; GW 78603; GW 786034; GW-786034; GW786034; MFCD11616589; NCGC00188865-01; Pazopanib; Pazopanib (GW-786034); UNII-7RN5DR86CK; Votrient (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00193	Tamoxifen	(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; Istubal (TN); Istubol; Nolvadex (TN); Nolvadex-D; Nourytam; Novaldex; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); TRANS FORM OF TAMOXIFEN; Tamizam; Tamone; Tamoplex (TN); Tamoxen; Tamoxifen (Hormonal therapy); Tamoxifen (INN); Tamoxifen (TN); Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; Tamoxifene; Tamoxifene [INN-French]; Tamoxifeno [INN-Spanish]; Tamoxifeno;Tamoxifenum; Tamoxifenum [INN-Latin]; Tomaxithen; Trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; Trans-Tamoxifen; Valodex; Valodex (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00195	Rhodamine 123	RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00196	Rifampicin	1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00201	Sulfasalazine	13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00204	Ponatinib	Iclusig (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00205	Riluzole	2-Amino-6-(trifluoromethoxy)-benzothiazole; 2-Amino-6-(trifluoromethoxy)benzothiazole; 2-Amino-6-trifluoro-methoxybenzothiazole; 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole; 2-amino-6-(trifluoromethoxy)benzo[d]thiazole; 2-amino-6-(trifluoromethoxyl)benzothiazole; 2-amino-6-trifluoromethoxybenzothiazole; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine; 6-(trifluoromethoxy)benzo[d]thiazol-2-amine; 6-Trifluoromethoxy-benzothiazol-2-ylamine; 6-trifluoromethoxybenzothiazole-2-yl-amine; ALBB-006046; Amino-2 trifluoromethoxy-6 benzothiazole; Amino-2 trifluoromethoxy-6 benzothiazole [French]; BF-37; PK-26124; PK-26124, RP-54274, Rilutek, Riluzole; R-116; RP 54274; RP-54274; Rilutek; Rilutek (TN); Riluzol; Riluzol [INN-Spanish]; Riluzole (JAN/USAN/INN); Riluzole HCl; Riluzole [USAN:INN]; Riluzolum; Riluzolum [INN-Latin]; ZERO/001785
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00209	Verteporfin	Visudyne (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00211	Apixaban	1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd; Apixaban (JAN/USAN/INN); BMS 562247-01; BMS-562247; BMS-562247-01; BMS-562247-01, Apixaban; Eliquis (TN); GG2; Ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00219	Idelalisib	(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one; (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one; 1146702-54-6; 5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]-4(3H)-QUINAZOLINONE; 5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one; AK145603; CAL 101; CAL-101; CAL-101 (Idelalisib, GS-1101); CAL101; CHEBI:82701; CHEMBL2216870; GS-1101; Idelalisib; UNII-YG57I8T5M0; YG57I8T5M0; Zydelig
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00227	Rivaroxaban	XARELTO (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00235	Flavopiridol	(-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one; 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE; 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one; Alvocidib [INN]; FLAVO; Flavopiridol; Flavopiridol hydrochloride; HMR-1275; HMR-1275, Alvocidib, L868275, Flavopiridol; L 868275; L-868275; L86-8275
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00243	Mycophenolate mofetil	2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00269	Mitoxantrone	1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00271	Empagliflozin	(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; 864070-44-0; AK160980; BI 10773; BI-10773; BI10773; CHEBI:82720; Empagliflozin (BI 10773); HDC1R2M35U; JARDIANCE; UNII-HDC1R2M35U
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00279	Canagliflozin	(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene; 6S49DGR869; 842133-18-0; 928672-86-0; CHEBI:73274; Canagliflozin anhydrous; Canagliflozin hydrate; Invokana; JNJ 24831754ZAE; JNJ-28431754; TA 7284; TA-7284; UNII-6S49DGR869; canagliflozin hemihydrate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00280	Nicardipine	2-(Benzylmethylamino)ethylmethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester; 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cardene (TN); Cardene IV; Methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nicardipine (INN); Nicardipine LA; Nicardipine [INN:BAN]; Nicardipino; Nicardipino [INN-Spanish]; Nicardipinum; Nicardipinum [INN-Latin]; Y-93
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00281	Progesterone	LPCN-1107; Progesterone (oral, preterm labor); Progesterone (oral, preterm labor), Lipocine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00284	Daunorubicin	(+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00287	Resveratrol	(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; (E)-5-(p-Hydroxystyryl)resorcinol; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; (E)-resveratrol; 3,4',5-Stilbenetriol; 3,4',5-Trihydroxy-trans-stilbene; 3,4',5-Trihydroxystilbene; 3,4',5-trihydroxy-stilbene; 3,5,4'-Trihydroxy-trans-stilbene; 3,5,4'-Trihydroxystilbene; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CU-01000001503-3; Cis-resveratrol; KSC-10-164; KUC104385N; PREVENTION 8 (RESVERATROL); R 5010; RM-1812; Resveratrol-3-sulfate; Resvida; SRT 501; SRT-501; SRT501; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; Trans-3,4′,5-Trihydroxystilbene; Trans-3,4',5-trihydroxystilbene; Trans-resveratrol
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00290	Lopinavir	A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00308	Vinblastine	(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00309	Saquinavir	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00316	Oxaliplatin	ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00318	Pemetrexed	(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00322	Baricitinib	1187594-09-7; Baricitinib (LY3009104, INCB028050); Baricitinib [USAN:INN]; C16H17N7O2S; INCB 028050; INCB-028050; INCB028050; ISP4442I3Y; J-503551; LY-3009104; LY3009104; Olumiant (TN); UNII-ISP4442I3Y; olumiant
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00336	Hematoporphyrin	1,3,5,8-Tetramethyl-2,4-bis(alpha-hydroxyethyl)prophine-6,7-dipropionic acid; 2,18-Porphinedipropionic acid, 7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-; 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis(1-hydroxyethyl); 7,12-Bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid; HEMATOPORPHYRIN; HP; HP (VAN); Haematoporphyrin; Hematoporphyrin I; Hematoporphyrin IX; ISOHEMATOPORPHYRIN IX; NSC 267084; NSC 59265; NSC59265; Photodyn
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00354	Afatinib	(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide; BIBW 2992; BIBW-2992; EGFR inhibitor 2nd gens; Tomtovok; Tovok; Tovok (TN); Tovok, BIBW2992
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00366	Talazoparib	(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one; (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one; (8s,9r)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1h-1,2,4-Triazol-5-Yl)-2,7,8,9-Tetrahydro-3h-Pyrido[4,3,2-De]phthalazin-3-One; LT-673; Talazoparib; Talazoparib (BMN 673); Talazoparib [USAN:INN]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00368	Brigatinib	Alunbrig
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00372	Sofosbuvir	HSDB 8226; Hepcinat; Hepcvir; Resof; SOFOSBUVIR; Sofosbuvir (PSI-7977, GS-7977); Sofosbuvir [USAN:INN]; Sovaldi (TN); SoviHep
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00386	Idarubicin	(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-DMD; 4-Demethoxydaunomycin; 4-Demethoxydaunorubicin; 4-Desmethoxydaunorubicin; DM5; DMDR; I 1656; IMI 30; IMI-30; Idamycin; Idamycin (TN); Idarubicin (INN); Idarubicin Hcl; Idarubicin Hcl Pfs; Idarubicin [INN:BAN]; Idarubicin hydrochloride; Idarubicina; Idarubicina [INN-Spanish]; Idarubicine; Idarubicine [INN-French]; Idarubicinum; Idarubicinum [INN-Latin]; Zavedos; Zavedos (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00391	Cerivastatin	.
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00420	Nelfinavir	ARV-SR0121; NFV; Nelfinavir (SARS infection); Nelfinavir (SARS infection), aRigen; SARS therapy, aRigen; Viracept (SARS infection), aRigen
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00423	Gefitinib	4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00435	Simvastatin	(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; Cholestat; Coledis; Colemin; Corolin; DRG-0320; Denan; KS-1113; L 644128-000U; Labistatin; Lipex; Lipovas; Lodales; MK 0733; MK 733; MK-0733; MK-733; MK733; Medipo; Nivelipol; Pantok; Rendapid; Simcard (TN); Simlup (TN); Simovil; Simvacor (TN); Simvast CR; Simvastatin & Primycin; Simvastatin (JAN/USP/INN); Simvastatin [USAN:INN:BAN]; Simvastatin, Compactin; Simvastatina; Simvastatina [Spanish]; Simvastatine; Simvastatine [French]; Simvastatinum; Simvastatinum [Latin]; Sinvacor; Sivastin; Synvinolin; TNP00259; Vasotenal; Zocor; Zocor (TN); Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin; Zocord; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00448	Cyclosporine	cyclosporin A; cyclosporine; Ciclosporin; Cyclosporine A; Ciclosporine; Neoral; Cyclosporin; Ciclosporinum; Ciclosporina; Sandimmune; Equoral; Neoplanta; Sandimmun; Sang-35; Gengraf; Sandimmun Neoral; UNII-83HN0GTJ6D; Antibiotic S 7481F1; Consupren; Restasis; Ramihyphin A; SangCyA; MFCD00274558; 83HN0GTJ6D; MLS001333756; CSA; S-Neoral; Cipol N; Sigmasporin Microoral; Sang 35; DSSTox_CID_365; Ciclosporinum [INN-Latin]; Ciclosporine [INN-French]; Ciclosporina [INN-Spanish]; DSSTox_RID_75541; Ciclosporin (Ciclosporin A)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00449	Hydroxychloroquine	2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol; 2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol; 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol; 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol; 7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline; 7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline; 7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline; Gen-Hydroxychloroquine 200mg Tablets; HCQ; Hidroxicloroquina; Hidroxicloroquina [INN-Spanish]; Hydroxychlorochin; Hydroxychloroguine; Hydroxychloroquine (INN);Hydroxychloroquine [INN:BAN]; Hydroxychloroquine Sulfate (1:1) Salt; Hydroxychloroquinum; Hydroxychloroquinum [INN-Latin]; Idrossiclorochina; Idrossiclorochina [DCIT]; Oxichlorochinum; Oxichloroquine; Oxychlorochin; Oxychloroquine; Plaquenil (TN); Polirreumin; Polirreumin (TN); Quensyl; WIN 1258
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00454	Sunitinib	5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00458	Pantoprazole	5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole; Astropan; Astropan (TN); BY 1023; BY-1023; Controloc (TN); Inipomp (TN); Pantecta (TN); Pantoloc (TN); Pantopan (TN); Pantoprazol; Pantoprazol [INN-Spanish]; Pantoprazole (USAN/INN); Pantoprazole Na; Pantoprazole Sodium; Pantoprazole [USAN:BAN:INN]; Pantoprazolum; Pantoprazolum [INN-Latin]; Pantoprozole; Pantor; Pantor (TN); Pantotab (TN); Pantozol; Pantozol (TN); Protium; Protium (TN); Protonix; Protonix (TN); Protonix IV; SK&F 96022; SK&F-96022; SK-96022; SKF-96022; Somac; Somac (TN); Ulcepraz (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00510	Thioguanine	2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; BW 5071; DX4; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Guanine, thio-(VAN); LT00455187; Lanvis; Lanvis (TN); Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; THG; Tabloid; Thioguanin GSK; Thioguanin-GSK; ThioguaninGSK; Thioguanine (Guanine analog); Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Thioguanine [USAN:BAN]; Tioguanin; Tioguanina; Tioguanina Wellcome; Tioguanina[INN-Spanish]; Tioguanine; Tioguanine (INN); Tioguanine GlaxoSmithKline Brand; Tioguaninum; Tioguaninum [INN-Latin]; Wellcome Brand of Thioguanine; Wellcome U3B
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00517	Ofloxacin	(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (+/-)-Floxin; (-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; Bactocin; DEXTROFLOXACINE; DL 8280; DL-8280; DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin; Danoflox; Effexin; Exocin; Exocine; FLOXIN IN DEXTROSE 5%; FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER; Flobacin; Flodemex; Flotavid; Flovid; Floxal; Floxil; Floxin; Floxin (TN); Floxin Otic (TN); Floxin otic; Floxstat; Fugacin; HOE 280; HOE-280;Hoe-280; Inoflox; Kinflocin; Kinoxacin; Liflox; Loxinter; Marfloxacin; Marfloxacin (TN); Medofloxine; Mergexin; Novecin; Nufafloqo; O 8757; O-Flox; OFLX; OFX; ORF 18489; ORF-28489; Obide; Occidal; Ocuflox; Ocuflox (TN); Ofcin; Oflin; Oflocee; Oflocet; Oflocin; Oflodal; Oflodex; Oflodura; Oflox; Ofloxacin (JP15/USP/INN); Ofloxacin Otic; Ofloxacin [USAN:BAN:INN:JAN]; Ofloxacin, (S)-Isomer; Ofloxacina; Ofloxacina [DCIT]; Ofloxacine; Ofloxacine [French]; Ofloxacino; Ofloxacino [Spanish]; Ofloxacinum; Ofloxacinum [Latin]; Ofloxin; Ofus; Onexacin; Operan; Orocin; Otonil; Oxaldin; PT 01; Pharflox; Praxin; Puiritol; Qinolon; Qipro; Quinolon; Quotavil; Rilox; Ru-43280; Sinflo; Tabrin; Taravid; Tariflox; Tarivid; Telbit; Tructum; Uro Tarivid; Viotisone; Visiren; WP-0405; XED; Zanocin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00557	Hesperetin	(-)-hesperetin; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-chromen-4-one; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one; (S)-2,3-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone; (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',5,7-Trihydroxy-4'-methoxyflavanone; 3',5,7-Trihydroxy-4-methoxyflavanone; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-(9CI); 5,7,3'-Trihydroxy-4'-methoxyflavanone; Cyanidanon 4'-methyl ether 1626; Flavanone, 3',5,7-trihydroxy-4'-methoxy-(VAN); Flavanone, 3',5,7-trihydroxy-4'-methoxy-(VAN) (8CI); Hesperin; Hesperitin; TNP00238; YSO2
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00558	Erlotinib	4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; AQ4; CP 358,774; CP-358,774; CP-358774; Erlotinib Base; Erlotinib(Tarceva); Erlotinib, OS-774; Erlotinin; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; N-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; OSI 744; R 1415; Tarceva; Tarceva (TN); [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00588	Abacavir	(+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC; Abacavir (INN); Abacavir [INN]; Trizivir; Ziagen; Ziagen (TM)(*Succinate salt*); Ziagen (TN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00604	Cephalothin	Cephalothin; Cephalothin Sodium; Cephalothin Sodium W/ Dextrose In Plastic Container; Cephalothin Sodium W/ Sodium Chloride In Plastic Container; Keflin; Keflin In Plastic Container; Seffin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00613	Dipyridamole	2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine; 2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine; Agilease; Anginal; Antistenocardin; Apo-Dipyridamole; Apo-Dipyridamole Fc; Apo-Dipyridamole Sc; Apotex Brand of Dipyridamole; Apricor; Ashbourne Brand of Dipyridamole; Belmac Brand of Dipyridamole; Berlin Chemie Brand of Dipyridamole; Berlin-Chemie Brand of Dipyridamole; Boehringer Ingelheim Brand of Dipyridamole; Cardioflux; Cardoxil; Cardoxin; Cerebrovase; Chilcolan; Cleridium; Cleridium 150; Coribon; Coridil; Coronarine; Corosan; Coroxin; Curantil; Curantyl; D 9766; Dipiridamol; Dipiridamol [INN-Spanish]; Dipyramidole; Dipyridamine; Dipyridamol; Dipyridamole (JP15/USP/INN); Dipyridamole [USAN:INN:BAN:JAN]; Dipyridamolum; Dipyridamolum [INN-Latin]; Dipyridan; Dipyudamine; Dypyridamol; Gulliostin; IPRAD Brand of Dipyridamole; Iv Persantine; Justpertin; Kurantil; Miosen; Natyl; Novo-Dipiradol; Novopharm Brand of Dipyridamole; Peridamol; Permiltin; Permole, Persantine, Dipyridan, Dipyridamole; Persantin; Persantine; Persantine (TN); Piroan; Prandiol; Prandiol 75; Protangix; RA-8; Stenocardil; Stenocardiol; Stimolcardio; Usaf Ge-12
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00618	Vandetanib	4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; AZD-6474; CH 331; CH-331; F9995-0087; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib (JAN/INN); Vandetanib (Pan-TK inhibitor); Vandetanib [INN]; Vandetanib, Zactima, ZD6474; ZD 6474; ZD-6474; ZD6474; Zactima; Zactima, ZD6474
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00619	Delavirdine	(1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4-[METHYLAMINO)PYRIDINYL]PIPERAZINE; (N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide); 1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine; 1-(5-Methanesulphonamido)-1H-indol-2-yl-carbonyl)-4-[3-(isopropylamino)-2-pyridinyl]piperaz; 2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine; BHAP-U 90152; DELAVIRDINE MESYLATE; DLV; Delavirdine (*Mesylate salt*); Delavirdine (INN); Delavirdine [INN]; Delavirdine(U-90152) & .a.IFN; N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide; N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide; N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide; N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide; N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide; PNU-90152-T; Piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]-& alpha-Interferon; Rescriptor; Rescriptor (TM);Rescriptor (TN); SPP; U 90152; U-90152; U-90152S; U90152S (*Mesylate salt*)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00636	Reserpine	3P Reserp; Abesta; Abicol; Adelfan; Adelphin; Alkarau; Alkaserp; Alserin; Apoplon; Apoplon (TN); Apsical; Ascoserp; Ascoserpina; Austrapine; Banasil; Banisil; Benazyl; Bioserpine; Brinderdin; Briserine; Broserpine; Cam-Ap-Es; Cardioserpin; Carditivo; Carpacil; Carrserp; Darebon; Deserpine; Diupres 250; Diupres 500; Diupres-250; Diupres-500; Diurese-R; Diutensen-R; Dralserp; ENT 50146; Eberpine; Eberspine; Ebserpine; Elfanex; Elserpine; Enipresser; Esc aspere; Escaspere; Eserpine; Eskaserp; Eskaserpine; Gammaserpine; Gilucard; H 520; HYDRO-RESERP; Helfoserpin; Hexaplin; Hiposerpil; Hiserpia; Hydrap-ES; Hydromox R; Hydromox-R; Hydropine; Hydropres 25; Hydropres 50; Hydroserp; Hydrosine 25; Hypercal B; Hypersil; Hypersine; Hypertensan; Idoserp; Idsoserp; Interpina; Key-serpine; Kitine; Klimanosid; L"-Carpserp; L-Carpserp; Lemiserp; Loweser p; Loweserp; Mallopress; Maviserpin; Mayserpine; Mephaserpin; Modenol; Naquival; Nembuserpin; Neo-serp; Neose rfin; Neoserfin; Neoserp; Neoslowten; Orthoserpina; Perskleran; Pressimedin; Purserpine; Quiescin; R 0875; R-e-s; Rau sedyl; Rau-Sed; Raucap; Raudiford; Raudixin; Raudixoid; Raugal; Raulen; Rauloydin; Raumorine; Raunervil; Raunorine; Raunova; Raupasil; Raupoid; Raurine; Rausan; Rausedan; Rausedil; Rausedyl; Rauserpin; Rauserpine; Rauserpol; Rausingle; Rautrin; Rauvlid; Rauwasedin; Rauwilid; Rauwiloid; Rauwipur; Rauwita; Rauwoleaf; Rawilid; Recipin; Regroton; Renese R; Renese-R; Resaltex; Rese rpamed; Rese-lar; Resedrex; Resedril; Reser-ar; Reserbal; Resercaps; Resercen; Reserfia; Reserjen; Reserlor; Reserp; Reserpal; Reserpamed; Reserpanca; Reserpene; Reserpex; Reserpidefe; Reserpil; Reserpin; Reserpina; Reserpinum; Reserpka; Reserpoid; Reserpur; Reserutin; Resiatric; Residin; Residine; Resine; Resocalm; Resperin; Resperine; Respital; Restran; Rezerpin; Riserpa; Rivased; Rivasin; Rolserp; Roxel; Roxinoid; Roxynoid; Ryser; SK-Reserpine; Salupres; Sandril; Sandron; Se rpate; Sedaraupin; Sedaraupina; Sederaupin; Sedserp; Seominal; Ser-A-Gen; Serfin; Serfolia; Serolfia; Serpalan; Serpaloid; Serpaneurona; Serpanray; Serpasil; Serpasol; Serpate; Serpazil; Serpazol; Serpedin; Serpen; Serpena; Serpentil; Serpentin; Serpentina; Serpicon; Serpil; Serpiloid; Serpilum; Serpine; Serpipur; Serpivate; Serpivite; Serpogen; Serpoid; Serpone; Serpyrit; Sertabs; Sertens; Sertensin; Sertina; Supergan; T-Serp; Tefaserpina; Temposerpine; Tensanyl; Tenserpinie; Tensional; Tensionorme; Tepserpine; Terbolan; Transerpin; Triserpin; Tylandril; Unilord; Unipres; Usaf cb-27; V Serp; V-Serp; VI XO; VIXO; Veriloid; Vio-Serpine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00638	Grepafloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00641	Genistein	4 inverted exclamation marka,5,7-Trihydroxyisoflavone; 4′,5,7-Trihydroxyisoflavone; 4',5, 7-Trihydroxyisoflavone; 4',5,7-Trihydroxy isoflavone; 4',5,7-Trihydroxyisoflavone; 4,5,7-Trihydroxyiso-flavone; 4,6,7-Trihydroxyisoflavone; 5,7,4'-Trihydroxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one; Bonistein; C.I. 75610; Differenol A; ENDOCRINE DISRUPTOR (GENISTEIN) (SEE ALSO GENISTEIN (446-72-0)); G 6649; G10000; GEN; GENISTEIN (ENDOCRINE DISRUPTER); Genestein; Genisteol; Genisterin; IN1327; Lactoferrin-genistein; NPI 031L; PTI G4660 (Genistein); PTI-G4660; Prunetol; SIPI 807-1; SIPI-9764-I; STO514; Sophoricol; TNP00151
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00646	Chlorothiazide	2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Aldoclor; Alurene; C 4911; Chloriazid; Chlorosal; Chlorothiazid; Chlorothiazide (JAN/USP/INN); Chlorothiazide [USAN:INN:BAN]; Chlorothiazidum; Chlorothiazidum [INN-Latin]; Chlorotiazida; Chlorthiazid; Chlorthiazide; Chlorthiazidum; Chlortiazid; Chlorurit; Chlotride; Chlrosal; Clorotiazida; Clorotiazida [INN-Spanish]; Clorotiazide; Clorotiazide [DCIT]; Clotride; Component of Aldoclor; Diupres; Diuresal; Diuril; Diuril (TN); Diuril Boluses; Diuril Boluses, Veterinary; Diuril, Chlotride, Chlorothiazide; Diurilix; Diurite; Diutrid; Flumen; Minzil; Neo-Dema; Salisan; Salunil; Saluretil; Saluric; Sk-chlorothiazide; Thiazide; Urinex; Warduzide; Yadalan
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00657	Cholic acid	(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00681	Diclofenac	Diclofenac (sodium matrix patch, pain)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00693	Prazosin	1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; CP-12299; Furazosin; Hypovase (TN); Justac; Lentopres; Minipress (TN); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Prazocin; Prazosin (INN); Prazosin HCl; Prazosin [INN:BAN]; Prazosina; Prazosina [INN-Spanish]; Prazosine; Prazosine [INN-French]; Prazosinum; Prazosinum [INN-Latin]; TNP00312; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00783	Ciprofloxacin	85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00795	Bicalutamide	(+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide; 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide; Astra brand of bicalutamide; AstraZeneca brand of bicalutamide; Bicalutamide (JAN/USP/INN); Bicalutamide [USAN:INN:BAN]; Calutide (TN); Casodex; Casodex (TN); Casodex, Cosudex, Calutide, Kalumid, Bicalutamide; Cosudex; Cosudex (TN); KS-1161; Kalumid (TN); N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide; Propanamide; Raffolutil; Zeneca brand of bicalutamide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00819	Apatinib	Apatinib; Apatinib Mesylate; YN968D1; YN-968D1; UNII-TK02X14ASJ; YN 968D1; TK02X14ASJ; 3-Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-pyridinylmethyl)amino)-, methanesulfonate (1:1); Rivoceranib mesylate; 3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-, methanesulfonate (1:1); Apatinib-YN968D1; Apatinib - YN968D1; Apatinib (YN968D1); MLS006011286; CHEMBL3545414; KS-00000TST; DTXSID80153427; HMS3655H12; BCP15234; AOB87128; BDBM50152828; s2221; AKOS026750547
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00836	Bupropion	Amfebutamon; (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone; (+-)-Bupropion; (-)-2-(tert-Butylamino)-3'-chloropropiophenone; (-)-2-(tert-Butylamino)-3'-chlorpropiophenon; 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one; 1-Propanone; 2-(Tert-Butylamino)-3'-chloropropiophenone; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; 34841-39-9; 34911-55-2; AMFEBUTAMONE HCl; Alpha-(tert-Butylamino)-m-chloropropiophenone; Alpha-(tert-butylamino)-m-chloropropiophenone; Amfebutamon; Amfebutamona; Amfebutamona [INN-Spanish]; Amfebutamone; Amfebutamonum; Amfebutamonum [INN-Latin]; BRN 2101062; Bupropion (INN); Bupropion (Old RN); Bupropion (USAN); Bupropion Hcl; Bupropion SR; Bupropion [INN:BAN]; Bupropion hydrocloride; CHEBI:3219; CHEMBL894; Elont; Elontril; SNPPWIUOZRMYNY-UHFFFAOYSA-N; Wellbatrin; Zyban; alpha-(tert-butylamino)-m-chloropropiophenone; amfebutamonum; bupropion
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00845	Daidzein	7-Dihydroxyisoflavone; 4',7-Dihydroxy-iso-flavone; 4',7-Dihydroxyisoflavone; 4,7-Dihydroxyisoflavone; 486-66-8; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; 7,4'-Dihydroxyisoflavone; 7,4'-dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; BRN 0231523; CCRIS 7600; CHEMBL8145; DIADZEIN; Daidzein; Daidzeol; EINECS 207-635-4; K 251b; UNII-6287WC5J2L; d-(+)-alpha-methylbenzylamine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00886	Nitrofurantoin	1-(((5-nitro-2-furanyl)methylene)amino)-2,4-imidazolidinedione; 1-((5-Nitrofurfurylidene)amino)hydantoin; 1-(5-Nitro-2-furfurylidenamino)hydantoin; 1-(5-Nitro-2-furfurylideneamino)hydantoin; 1-[(5-:nitrofurfurylidene)amino]hydantoin; 1-[(5-Nitrofurfurylidene)amino]hydantoin; 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione; 1-[[(5-Nitro-2-furanyl)methylene]amino]-2,4-imidazolidinedione; 1-{[(1E)-(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione; 1-{[(1E)-(5-nitrofuran-2-yl)methylidene]amino}imidazolidine-2,4-dione; 5-Nitrofurantoin; Alfuran; Benkfuran; Berkfuran; Berkfurin; Ceduran; Chemiofuran; Cistofuran; Cyantin; Cystit; Dantafur; Fua Med; Fua-med; Fur-ren; Furabid; Furachel; Furadantin; Furadantin (TN); Furadantin Retard; Furadantina MC; Furadantine; Furadantine mc; Furadantine-MC; Furadantoin; Furadoine; Furadonin; Furadonine; Furadoninum; Furadontin; Furalan; Furaloid; Furantoin; Furatoin; Furedan; Furina; Furobactina; Furodantin; Furophen; Furophen T; Gerofuran; Ituran; Macpac; Macrobid; Macrobid (TN); Macrodantin; Macrodantin (TN); Macrodantina; Macrofuran; Macrofurin; N-(5-Nitro-2-furfurylidene)-1-aminohydantoin; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina; N-(5-Nitro-2-furfurylideno)-1-aminohydantoina [Polish]; N-(5-Nitrofurfurylidene)-1-aminohydantoin; N-(5-nitro-2-furfurylidene)-1-aminohyda ntoin; N-Toin; ND-3320; ND-7248; NITROFURANTION; NITROFURANTOIN MACROCRYSTALLINE; NITROFURANTOIN, MACROCRYSTALLINE; Nierofu; Nifurantin; Nifuretten; Nitoin; Nitrex; Nitro Macro (TN); Nitrofur-C; Nitrofuradantin; Nitrofurantoin (JAN/USP/INN); Nitrofurantoin [USAN:INN:BAN:JAN]; Nitrofurantoina; Nitrofurantoina [DCIT]; Nitrofurantoine; Nitrofurantoine [INN-French]; Nitrofurantoinum; Nitrofurantoinum [INN-Latin]; Novofuran; Orafuran; Parfuran; Phenurin; PiyEloseptyl; Ro-Antoin; Siraliden; Trantoin; Uerineks; Urantoin; Urantoin (TN); Urizept; Uro-Selz; Uro-Tablinen; Uro-tablineu; Urodil; Urodin; Urofuran; Urofurin; Urolisa; Urolong; Usaf ea-2; Welfurin; Zoofurin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00908	Eltrombopag	Eltrombopag; Revolade; Promacta; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; UNII-S56D65XJ9G; SB497115; Eltrombopag-Isomer; SB-497115; SB 497115; S56D65XJ9G; CHEMBL461101; 1807882-48-9; SB-497115-GR; Eltrombopag (SB-497115-GR); 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; NCGC00274067-01
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00932	Coumestrol	3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one; 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one; 3,9-Dihydroxycoumestan; 479-13-0; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-; 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-; 7,12-Dihydroxycoumestan; BRN 0266702; CCRIS 7311; CHEBI:3908; CHEMBL30707; COUMESTROL; Coumesterol; Cumoesterol; Cumoestrol; Cumostrol; EINECS 207-525-6; MLS000738006; NSC 22842; NSC22842; UNII-V7NW98OB34; V7NW98OB34; ZZIALNLLNHEQPJ-UHFFFAOYSA-N
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR00958	Raltitrexed	(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; 112887-68-0; C21H22N4O6S; CHEBI:5847; CHEMBL225071; D 1694; D-1694; D1694; DSSTox_CID_26482; DSSTox_GSID_46482; DSSTox_RID_81653; FCB9EGG971; ICI D1694; ICI-D-1694; ICI-D1694; N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid; NCGC00229704-01; NSC-639186; Raltitrexed (Tomudex); Tomudex; UNII-FCB9EGG971; ZD 1694; ZD-16; ZD-1694; ZD1694
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01167	Menadione	Aquakay; 1,4-Naphthalenedione, 2-methyl-,radical ion(1-); 2-Methyl-1,4-naftochinon; 2-Methyl-1,4-naftochinon [Czech]; 2-Methyl-1,4-naphthalenedione; 2-Methyl-1,4-naphthochinon; 2-Methyl-1,4-naphthochinon [German]; 2-Methyl-1,4-naphthoquinone; 2-Methylnaphthoquinone; 2-methyl-1,4-naphthoquinone, 5; 2-methylnaphthalene-1,4-dione; 3-Methyl-1,4-naphthoquinone; 58-27-5; Aquakay; Aquinone; Ascorbic acid/menadione; Hemodal; Juva-K; K-Thrombyl; K-Vitan; Kaergona; Kanone; Kappaxan (VAN); Kappaxin; Kappaxin (TN); Karcon; Kareon; Kativ-G; Kayklot; Kaykot; Kayquinone; Kipca; Kipca, oil soluble; Kipca-Oil Soluble; Klottone; Klottone;Koaxin; Koaxin; Kolklot; M0373; Memodol; Menadion; Menadione (K3); Menadione (USP); Menadione [USAN:BAN]; Menadione semiquinone; Menadionum; Menaphthon; Menaphthone; Menaphtone; Menaquinone 0; Methyl-1,4-naphthalenedione; Methyl-1,4-naphthoquinone; Methylnaphthoquinone; Mitenon; Mitenone; Panosine; Prokayvit; Synkay; Thyloquinone; Triglycyl-lysine-vasopressin; Usaf; Usaf ek-5185; VK3; Vicasol; Vitamin K 3; Vitamin K0; Vitamin K2(0); Vitamin K3; Vitamin K3 : 2-Methyl-1,4-naphthoquinone; Vitamin-K3; menadione
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01193	Prasterone	17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01195	Rabeprazole	2-(((4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole; 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole; Aciphex (TN); CL23619; Dexrabeprazole; Eraloc; Eraloc (TN); LY307640; Pariet (TN); Rabeprazole (INN); Rabeprazole [BAN:INN]; Rabeprazole [INN:BAN]; Rablet (TN); Rebeprazole sodium
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01203	Dactinomycin	1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide; ACT D; ACTINOMYCIN D AMP; AD (VAN); Actactinomycin A IV; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin A IV; Actinomycin Aiv; Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin C1; Actinomycin D (JP15); Actinomycin D deriv. of 3H-phenoxaocardazine; Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin I1; Actinomycin IV; Actinomycin X 1; Actinomycin X1; Actinomycin cl; Actinomycin x i; Actinomycin-(threo-val-pro-sar-meval); Actinomycin-IV; Actinomycin-[threo-val-pro-sar-meval]; Actinomycindioic D acid, dilactone; Actinomyein-theo-val-pro-sar-meval; Acto-D; Antibiotic from Streptomyces parvullus; COSMEGEN (TN); Chounghwamycin B; Cosmegen; D Actinomycin; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; Dactinomicina; Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin D; Dactinomycin [USAN:BAN]; Dactinomycine; Dactinomycine [INN-French]; Dactinomycinum; Dactinomycinum [INN-Latin]; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; GNF-PF-1977; HBF 386; HBF 386 meractinomycin; Lyovac cosmegen; Meractinomycin; NP-005932; O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; Oncostatin K; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; X 97
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01204	Norfloxacin	1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; AM 0715; AM 715; AM-0715; AM-715; AM0715; Apo-Norflox (TN); Baccidal; Barazan; Chibroxin; Chibroxin (TN); Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; Fulgram; Insensye (TN); Lexinor; MK 0366; MK 366; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; NFLX; Norflo; Norflohexal (TN); Norfloxacin (JP15/USP/INN); Norfloxacin Merck Brand; Norfloxacin [USAN:BAN:INN:JAN]; Norfloxacine; Norfloxacine [INN-French]; Norfloxacino; Norfloxacino [INN-Spanish]; Norfloxacinum; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin; Noroxin (TN); Nufloxib (TN); Roxin (TN); Sebercim; Utin (TN); Utinor (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01221	Rosiglitazone	.
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01258	Chrysin	3CN01F5ZJ5; 480-40-0; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-; 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one; 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one; 5,7-Dihydroxy-2-phenyl-4H-chromen-4-one; 5,7-Dihydroxy-2-phenyl-chromen-4-one; 5,7-Dihydroxyflavone; 5,7-dihydroxy-2-phenylchromen-4-one; BRN 0233276; CAS-480-40-0; CHEBI:75095; CHEMBL117; Chrysin, 99+%; Chrysine; Crysin; EINECS 207-549-7; FLAVONE, 5,7-DIHYDROXY-; MFCD00006834; NSC 407436; NSC-407436; NSC407436; RTIXKCRFFJGDFG-UHFFFAOYSA-N; UNII-3CN01F5ZJ5; chrysin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01272	Pyrimethamine	2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine; 5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; 5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine; AZT + Pyrimethamine combination; Aventis Brand of Pyrimethamine; BW 50-63; BW 5063; CRL-8131 & Pyrimethamine; CRL-8142 & Pyrimethamine; Chloridin; Chloridine; Chloridyn; Darachlor; Daraclor; Darapram; Daraprim; Daraprim (TN); Daraprime; Daraprin; Diaminopyritamin; EXR-101; Erbaprelina; Ethylpyrimidine; Fansidar (Pyrimethamine/Sulfadoxine); Glaxo Wellcome Brand of Pyrimethamine; GlaxoSmithKline Brand of Pyrimethamine; Khloridin; Lactoferrin B & Pyrimethamine; Lactoferrin H & Pyrimethamine; M alocid; Malacid; Malocid; Malocide; Maloprim; Pirimecidan; Pirimetamin; Pirimetamina; Pirimetamina [INN-Spanish]; Pirimetamina [Spanish]; Primethamine; Pyremethamine; Pyrimethamin; Pyrimethamine (JAN/USP/INN); Pyrimethamine (Pyr); Pyrimethamine Hcl; Pyrimethamine [USAN:INN:BAN:JAN]; Pyrimethaminum; Pyrimethaminum [INN-Latin]; RP 4753; TCMDC-123831; TCMDC-125860; Tindurin; Tindurine; Tinduring; WR 2978; Wellcome Brand of Pyrimethamine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01275	Entacapone	(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; COM-998; Comtan; Comtan (TN); Comtess; Entacapona; Entacapona [INN-Spanish]; Entacapone (JAN/USAN/INN); Entacapone [USAN:INN]; Entacaponum; Entacaponum [INN-Latin]; KB475572; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; Novartis brand of entacapone; OR 611; OR-611; Orion brand of entacapone; Stalevo (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01287	Ortataxel	Hexanoic acid; 13-(N-tert-butoxycarbonyl-beta-isobutyisoserinyl)-14-hydroxy-baccatin-1,14-carbonate; 13-(N-tert-butoxycarbonyl-beta-isobutyisoserinyl)-14-hydroxybaccatin-1,14-carbonate; 186348-23-2; 8H61Y4E29N; BAY-59; Bay-59-8862; CHEMBL382300; DB11669; Genz29155; Hexanoic acid, 3-(((1,1-dimethylethoxy)carbonyl)amino)-2-hydroxy-5-methyl-,; IDN 5109; IDN-5109; IND-5109; IND5109; Ortataxel [INN]; SB-T 101131; SB-T-101131; SCHEMBL9932772; UNII-8H61Y4E29N; Z-3102; idn5109
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01288	Palbociclib	LQQ; 571190-30-2; 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE; 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one; 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one; G9ZF61LE7G; HMR-2934; Ibrance; PD 0332991; PD 332991; PD 332991, PD 0332991, PD0332991; PD-0332991; PD-332991; PD0332991; Palbociclib(PD0332991); UNII-G9ZF61LE7G
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01301	Deoxycholic acid	(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-oic acid; 3,12-Dihydroxycholanic acid; 3alpha,12alpha-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,12alpha-Dihydroxy-5beta-cholanic acid; 5-beta-Deoxycholic acid; 7-Deoxycholic acid; 7alpha-Deoxycholic acid; ATX-101; Choleic acid; Cholerebic; Cholic acid, deoxy-; Cholorebic; DEOXYCHOLIC ACID; Degalol; Deoxy cholic acid; Deoxycholatic acid; Desoxycholic acid; Desoxycholsaeure; Dihydroxycholanoic acid; Droxolan; Pyrochol; Septochol; Sodium deoxycholate; deoxycholate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01305	Bisantrene	39C34M111K; 78186-34-2; 9,10-Anthracendicarbaldehyde bis(2-imidazolin-2-ylhydrazon); 9,10-Anthracenedicarboxaldehyde, bis((4,5-dihydro-1H-imidazol-2-yl)hydrazone)-; BISANTRENE HYDROCHLORIDE; BRN 0966309; Bisantrene; Bisantrene [INN]; Bisantreno; Bisantreno [INN-Spanish]; Bisantrenum; Bisantrenum [INN-Latin]; CHEMBL25336; CL 216942; N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazono)methyl]-9-anthryl]methyleneamino]-4,5-dihydro-1H-imidazol-2-amine; NSC 337766; UNII-39C34M111K
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01330	Clofarabine	(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01336	Binimetinib	181R97MR71; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; 606143-89-9; ARRY 162; ARRY 438162; ARRY-162; ARRY-438162; Binimetinib (JAN/USAN); Binimetinib (MEK162, ARRY-162, ARRY-438162); Binimetinib [USAN:INN]; D0C4LF; MEK 162; MEK-162; MEK162; MEK162 (ARRY-162, ARRY-438162); MEK162(Binimetinib); NVP-ME; UNII-181R97MR71
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01337	Tenofovir alafenamide	(S)-Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate; AK109983; EL9943AG5J; GS 7340; GS-7339; GS-7340; GS7340; J4414G3BUK; L-Alanine, N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester; TENOFOVIR ALAFENAMIDE; Tenofovir Alafenamide (GS-7340); Tenofovir Alafenamide [USAN:INN]; UNII-EL9943AG5J; UNII-J4414G3BUK; Vemlidy
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01339	Gimatecan	LBQ-707; ST-1480; ST-1481; Camptothecin analogs, Sigma-Tau; 7-cyano-camptothecin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01349	Karenitecin	Karenitecin (TN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01362	Befloxatone	MD-370503
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01366	Dirithromycin	Dirithromycine; Dirithromycinum; Diritromicina; Divitross; Dynabac; Noriclan; Valodin; Dirithromycine [French]; Dirithromycinum [Latin]; Diritromicina [Spanish]; LY 237216; AS-E 136; ASE-136; Dynabac (TN); LY-237216; Dirithromycin (USP/INN); Dirithromycin [USAN:BAN:INN]; (9S)-9-deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)ethylidene]erythromycin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01371	9-Aminocamptothecin	IDEC-132; (S)-10-Amino-4-ethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione; 9-Amino-20(S)-camptothecin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01377	Piritrexim	Piritrexim; 72732-56-0; Piritrexim [INN]; Piritreximum [Latin]; Piritrexime [French]; 6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine; Piritrexima [Spanish]; BW 301U; UNII-MK2A783ZUT; BW-301U; TCMDC-137235; BRN 5768301; MK2A783ZUT; CHEMBL7492; 2,4-Diamino-5-methyl-6-(2,5-dimethoxybenzyl)pyrido(2,3-d)pyrimidine; 6-(2,5-DIMETHOXY-BENZYL)-5-METHYL-PYRIDO[2,3-D]PYRIMIDINE-2,4-DIAMINE; 6-((2,5-Dimethoxyphenyl)methyl)-5-methylpyrido(2,3-d)pyrimidine-2,4-diamine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01382	Alfuzosin	Alfusosine; Alfuzosina; Alfuzosine; Alfuzosinum; Alphuzosine; Alfuzosina [Spanish]; Alfuzosine [French]; Alfuzosinum [Latin]; Alfuzosin (INN); Alfuzosin [INN:BAN]; Xatral (TN); N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide; N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01383	Camptothecin	camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; (S)-Camptothecin; Camptothecine (8CI); 20(S)-Camptothecin; Camptothecine (S,+); CHEMBL65; UNII-XT3Z54Z28A; MLS000766223; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; XT3Z54Z28A; CHEBI:27656; VSJKWCGYPAHWDS-FQEVSTJZSA-N; Camptothecin, Camptotheca acuminata; NSC-94600; Camptothecin derivat
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01390	CP-724714	CP 724714; CP-724,714; CP724,714, CP-724,714; 2-Methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide; 2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01396	Nifurtimox	NIFURTIMOX; Lampit; Bayer 2502; 23256-30-6; BAY 2502; Nifurtimox [INN:BAN]; Nifurtimoxum [INN-Latin]; CCRIS 2201; EINECS 245-531-0; CHEBI:7566; C10H13N3O5S; 4-Thiomorpholinamine, 3-methyl-N-((5-nitro-2-furanyl)methylene)-, 1,1-dioxide; 4-((5-Nitrofurfurylidene)amino)-3-methylthiomorpholine-1,1-dioxide; 3-Methyl-N-[(5-nitro-2-furanyl)methylene]-4-thiomorpholinamine 1,1-dioxide; 3-Methyl-4-(5'-nitrofurylidene-amino)-tetrahydro-4H-1,4-thiazine-1,1-dioxide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01400	NB-506	J-107185; L-753000; N-[12-(beta-D-Glucopyranosyl)-1,11-dihydroxy-5,7-dioxo-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-6-yl]formamide; 6-(Formamido)-12-(beta-D-glucopyranosyl)-1,11-dihydroxy-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01405	Phosphatidylserine	distearoylphosphatidylserine; LifeExtension PS Caps
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01415	Becatecarin	BMS-181176; Becatecarin < USAN; DEAE-Rebeccamycin; XL-119; BMY-27557-01 (HCl); BMY-27557-14 (tartrate); 1,11-Dichloro-6-[2-(diethylamino)ethyl]-12-(4-O-methyl-beta-D-glucopyranosyl)-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01423	Lurtotecan	OSI-211; Lurtotecan [INN]; 149882-10-0; UNII-4J1L80T08I; OSI 211; NX 211; GG 211; Gi 147211; 4J1L80T08I; C28H30N4O6; CHEMBL341028; 11H-1,4-Dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8H,14H)-dione, 8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-, (8S)-; GI-147211C; lurtotecan liposome; AC1L1U8C; SCHEMBL19208; CHEMBL305666; DTXSID30164422; GG-211; ZINC22010625; NX-211; GW-211; BDBM50036130; DB12222; LS-173358; Lurtotecan dihydrochloride; GI 147211C; GG-147211C; GI-147211; GI-147211A; GL-147211C; Liposomal lurtotecan
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01430	Pirarubicin	pirarubicin; Theprubicin; MFCD00869742; THP-doxorubicin; C32H37NO12; NCGC00167982-01; AC1LCS5T; Pirarubicin (JP17/INN); SCHEMBL15472856; CHEMBL1398373; EX-A494; AOB5649; KMSKQZKKOZQFFG-HSUXVGOQSA-N; ZINC3913909; AKOS015895621; NCGC00167982-02; BC225325; K234; D01885; 15207-EP2316833A1; 15207-EP2311829A1; 15207-EP2298765A1; 15207-EP2298748A2; 15207-EP2295427A1; 15207-EP2295416A2; 15207-EP2272827A1; 15207-EP2316832A1; 15207-EP2298778A1; 15207-EP2298768A1; 15207-EP2295426A1; 15207-EP2295055A2; 15207-EP2311808A1
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01434	Trimetrexate	TMQ; Trimetrexato; Trimetrexatum; JB 11; Jb-11; Trimetrexato [INN-Spanish]; Trimetrexatum [INN-Latin]; Trimetrexate (USAN/INN); Trimetrexate [USAN:BAN:INN]; 2,4-Diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline; 5-Methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-2,4-quinazolinediamine; 5-methyl-6-({[3,4,5-tris(methyloxy)phenyl]amino}methyl)quinazoline-2,4-diamine; 5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine; 6-[((3,4,5-Trimethoxyphenyl)amino)methyl]-5-methyl-2,4-quinazolinediamine
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01437	UCN-01	UCN; UCN01; Ucn 01; KRX-0601; KW-2401; UCN-02; (5s,6r,7r,9r,16r)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one; 7-Hydroxystaurosporine; 7-hydroxystaurosporine (UCN-01)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01439	Belotecan	Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01445	Hypericin	Hypericin; VIMRxyn; Synthetic hypericin, Nexell
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01447	E3040	E-3040; E 3040; CHEMBL105139; 145096-30-6; E3040; AC1L9EDQ; CHEBI:4732; 6-Hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole; SCHEMBL6009376; DTXSID80162877; CHEBI:271098; 5,7-Dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-6-benzothiazolol; BDBM50037037; 6-Benzothiazolol, 5,7-dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-; C11593; L001447; 5,7-Dimethyl-2-methylamino-4-pyridin-3-ylmethyl-benzothiazol-6-ol; 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01450	J-107088	Edotecarin; Edotecarinum; UNII-1V8X590XDP; J-107088; PF-804950; CHEMBL435191; 1V8X590XDP; Edotecarina; E'dotecarine; Edotecarin [USAN:INN]; Edotecarinum [INN-Latin]; E'dotecarine [INN-French]; C29H28N4O11; Edotecarin (USAN/INN); J 107088; SCHEMBL5177060; ZINC3946372; BDBM50086570; DB04882; CS-6688; HY-13618; Z1880; D03954
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01453	SJG-136	SG-2000; SJG-136; SP-2001
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01454	Protoporphyrin	protoporphyrin IX; protoporphyrin; 553-12-8; Ooporphyrin; Protoporpyrin IX; Porphyrinogen IX; Protoporphyrin IX disodium; Kammerer's prophyrin; ppIX; Protoporphyrin IX (VAN); H2ppIX; Kammerer's porphyrin; MLS001074731; UNII-C2K325S808; NSC2632; NSC 2632; EINECS 209-033-7; 3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid; SMR000127405; 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-diethenyl-3,8,13,17-tetramethyl-; CHEMBL267548; CHEBI:15430; C34H34N4O4
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01459	C-1311	XF-02; NSC-645809; C-1311; Imidacrine; Symadex; CHEMBL3545337; XJYNBZQTAZDMHZ-UHFFFAOYSA-N; Imidazoacridone dihydrocheloride hydrate; 138154-55-9; 5-((2-(diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one dihydrochloride hydrate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01460	Phenethyl isothiocyanate	Phenethyl-isothiocyanate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01461	AG 337	Thymitaq; AG-337; ZX-337; Nolatrexed (intravenous), EXIMIAS
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01469	Exatecan mesylate	Exatecan mesylate; DX-8951; DX-8951a; DX-8951f; UM-1; UM-2
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01471	AG1478	AG-1478; 153436-53-4; Tyrphostin AG 1478; N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine; 175178-82-2; Tyrphostin AG-1478; 4-(3-Chloroanilino)-6,7-dimethoxyquinazoline; AG 1478; AG1478; TYRPHOSTIN; 4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-; UNII-SUH0SEZ9HY; SUH0SEZ9HY; AG-1478 hydrochloride; AG-1478 (Tyrphostin AG-1478); CHEMBL7917; CHEBI:75404; N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine; NSC-693255; AK-63142; N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine; BRD6408; BRD-6408; SR-01000076156; NSC693255
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01475	Butyrate	butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; 1-propanecarboxylic acid; Butanic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; CCRIS 6552; HSDB 940; butoic acid; Ethyacetic Acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01478	Quinacrine	quinacrine; mepacrine; atabrine; Acrinamine; Acriquine; 83-89-6; Quinactine; Antimalarina; Haffkinine; Akrichin; Italchine; acrichine; Erion; Mepacrinum; Quinacrine hydrochloride; Mepacrine [INN:BAN]; St 439; Mepacrinum [INN-Latin]; Mepacrina [INN-Spanish]; atebrin; Malaricida; Methoquine; Palacrin; Italchin; Pentilen; Palusan; Atebrine; Metochin; Mecryl; Quinacrine, Mepacrine; 3-Chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine; 2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine; HSDB 3253
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01495	JNJ 7706621	JNJ-7706621; 443797-96-4; JNJ7706621; 4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide; UNII-74GK72DON8; RWJ-387252; 4-[[5-amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide; CHEMBL191003; 74GK72DON8; 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide; JNJ 7706621; 4-(5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01498	BN-80915	BN-80915; R-1536; Diflomotecan; (+)-5(R)-Ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01525	Puromycin	puromycin; Stylomycin; Puromycinum; Puromycine; Puromicina; UNII-4A6ZS6Q2CL; P-638; Stillomycin; CL 13900; 3123L; 4A6ZS6Q2CL; 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine; (S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine; GNF-PF-2016; Puromycinum [INN-Latin]; Puromycine [INN-French]; Puromicina [INN-Spanish]; 9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine; Bacterenomycin
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01545	Pitavastatin	Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01557	Oxfendazole	Oxfendazole; Fenbendazole sulfoxide; Synanthic; Systamex; OFDZ; Systemax; Repidose; Oxfendazolum; Oxfendazol; Synanthic (Veterinary); RS-8858; fenbendazole S-oxide; RS 8858; 5-Phenylsulfinyl-2-carbomethoxyaminobenzimidazole; Oxfendazol [INN-Spanish]; Oxfendazolum [INN-Latin]; UNII-OMP2H17F9E; HOE 8105; methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate; Oxfendazole [USAN:BAN:INN]; Methyl 5-(phenylsulfinyl)-2-benzimidazolecarbamate; Oxfendazole (USP/INN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01565	Enrofloxacin	Enrofloxacin; 93106-60-6; Baytril; Enrofloxacine; CFPQ; Enrofloxacinum; Enrofloxacino; endrofloxicin; BAY VP 2674; Bay-Vp-2674; Enrofloxacine [French]; Enrofloxacinum [Latin]; Enrofloxacino [Spanish]; UNII-3DX3XEK1BN; N-Ethylciprofloxacin; Baytril (TN); ERFX; Enrofloxacin [USAN:BAN:INN]; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; HSDB 6952; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 3DX3XEK1BN; Enrofloxacin (USAN/INN)
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01570	Homocamptothecin	homocamptothecin; UNII-5B3LFU8GLM; 5B3LFU8GLM; E-Homocamptothecin; E-Homocamptothecine; (20R)-Homocamptothecin; E-Homocamptothecin, (R)-; CHEMBL74190; SCHEMBL5860320; PAEZRCINULFAGO-OAQYLSRUSA-N; ZINC840834; 3H,15H-Oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy-, (5R)-; 3H,15H-Oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione, 5-ethyl-1,4,5,13-tetrahydro-5-hydroxy-, (R)-
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01581	HPPH	CHEMBL500853; SCHEMBL12722713; EX-A2655; 14-Ethyl-9-(1-(hexyloxy)ethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid; HY-13722; 3-Phorbinepropanoic acid, 14-ethyl-9-[1-(hexyloxy)ethyl]-4,8,13,18-tetramethyl-20-oxo-, (3S,4S)-; CS-0007752
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01591	Mycophenolic acid glucuronide	MPAG; Mycophenolic acid glucosiduronate; mycophenolic acid glucuronide; UNII-54TS5J9T0K; 54TS5J9T0K; AC1O5XMV; BYFGTSAYQQIUCN-HGIHDBQLSA-N; Mycophenolic Acid ; A-D-Glucuronide; ZINC13550000; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[5-[(E)-6-hydroxy-3-methyl-6-oxohex-2-enyl]-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-4-yl]oxy]oxane-2-carboxylic acid; 5-[(2E)-5-Carboxy-3-methyl-2-penten-1-yl]-1,3-dihydro-6-methoxy-7-methyl-3-oxo-4-isobenzofuranyl
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01601	Pancratistatin	Pancratistatin; (+)-Pancratistatin; NSC349156; MLS002701837; AC1L9BE4; SCHEMBL93612; CHEMBL419335; VREZDOWOLGNDPW-ALTGWBOUSA-N; ZINC4097654; (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one; NSC-349156; SMP1_000217; NCI60_003105; B844009K070; C08535
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01618	Benzo(a)pyrene	benzo[a]pyrene; 3,4-Benzopyrene; benzo[pqr]tetraphene; BENZO(A)PYRENE; 3,4-Benzpyrene; Benzpyrene; benzo[def]chrysene; 6,7-Benzopyrene; Benz[a]pyrene; 3,4-BP; 3,4-Benz[a]pyrene; 3,4-Benzopirene; 3,4-Benzpyren; Benzo[d,e,f]chrysene; Benz(a)pyrene; (B(a)P); B(a)P; BP; 3,4 Benzpyrene; RCRA waste number U022; Benzo(d,e,f)chrysene; 3,4-Benz(a)pyrene; NSC 21914; 3,4-Benzo(a)pyrene; B[a]p; 3,4-Benzpyren [German]; CCRIS 76; Benzo[A]-Pyrene; Benzo(def)chrysene; 3,4-benzylpyrene; 3,4-Benzopirene [Italian]
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01619	BMS 536924	BMS-536924; BMS 536924; BMS536924; UNII-40E3AZG1MX; 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone; 40E3AZG1MX; CHEMBL401930; CS-0117; HY-10262; MLS006011171; SCHEMBL4132577; SCHEMBL15974144; BDBM27879; BCP02116; ZINC6718468; 2278AH; s1012; ABP000159; ZINC140935730; AKOS024458339; AKOS025149514; SB19378; RL03740; KIN0000061; NCGC00346460-05; NCGC00346460-02; SMR004702940; BMS-536924/BMS536924; A2238; X5078; SW218124-2; S-7752
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01638	N-desethyl sunitinib	N-Desethyl Sunitinib; N-DesethylSunitinib; UNII-42LJ35612R; 42LJ35612R; C20H23FN4O2; N-[2-(ethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-ethylamino-ethyl)-amide; SCHEMBL2115189; CHEMBL3542344; DTXSID10437828
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01640	Scutellarin	Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01696	Benzoylphenylurea	benzoylphenylurea; SCHEMBL83109
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01700	Azidothymidine monophosphate	azidothymidine monophosphate; SCHEMBL17515060
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01712	Barasertib-hQPA	AZD1152-HQPA; Barasertib (AZD1152-HQPA); AZD-1152HQPA; barasertib-hQPA; UNII-29P8LWS24N; INH 34; AZD1152 HPQA; 29P8LWS24N; CHEMBL215152; 2-[5-(7-{3-[Ethyl-(2-hydroxy-ethyl)-amino]-propoxy}-quinazolin-4-ylamino)-2H-pyrazol-3-yl]-N-(3-fluoro-phenyl)-acetamide; 2-(3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-5-yl)-N-(3-fluorophenyl)acetamide; 5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide; AZD 1152
DTD0004	ABCG2	Breast cancer resistance protein	ABC15; ABCG2; ABCP; ATP-binding cassette sub-family G member 2; BCRP; BCRP1; BMDP; CD338; CDw338; EST157481; GOUT1; MRX; MXR; MXR-1; MXR1; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; UAQTL1; Urate exporter; hABCG2	DR01715	Parabis	Dichlorophen; dichlorophene; Dichlorofen; Dichlorphen; 2,2'-Methylenebis(4-chlorophenol); Didroxane; Didroxan; Trivex; Difentan; Dicestal; Antiphen; Vermithana; Teniatol; Prevental; Teniotol; Embephen; Anthiphen; Teniathane; Taeniatol; Panacide; Cordocel; Palacel; Halenol; Parabis; Korium; Hyosan; Antifen; Dichlorophen B; Dichlorophene 10; Dichloorfeen; Gingivit; Wespuril; Gefir; Fungicide M; Plath-Lyse; DDDM; Bis(5-chloro-2-hydroxyphenyl)methane; Preventol GD; Fungicide GM; Preventol GDC; Diphenthane 70; Sandocide; Super mosstox
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00050	Erythromycin	A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00074	Allopurinol	4-HPP; A 8003; AL-100; Adenock; Ailural; Ailurial; Allo-Puren; Allohexal; Allohexal (TN); Allohexan; Alloprin; Allopur; Allopurin; Allopurinol(I); Allopurinolum; Allorin; Allosig (TN); Allozym; Allpargin; Allural; Aloprim; Alopurinol; Aloral; Alositol; Aluline; Anoprolin; Anzief; Apo-Allopurinol; Apulonga; Apurin; Apurol; Atisuril; B. W. 56-158; BW 56-158; BW 56158; BW-56-158; Bleminol; Bloxanth; Caplenal; Capurate; Cellidrin; Cosuric; Dabrosin; Dabroson; Dura Al; Embarin; Epidropal; Epuric; Foligan; Geapur; Gichtex; Gotax; Hamarin; Hexanuret; Jenapurinol; Ketanrift; Ketobun-A; Ledopur; Lopurin; Lysuron; Milurit; Milurite; Miniplanor; Monarch; Nektrohan; Novopurol; Pan Quimica; Progout; Progout (TN); Pureduct; Puricos (TN); Purinol; Quimica, Pan; Remid; Riball; Rimapurinol; Roucol; Sigapurol; Suspendol; Takanarumin; Tipuric; Urbol; Uribenz; Uricemil; Uridocid; Uriprim; Uripurinol; Uritas; Urobenyl; Urolit; Urosin; Urtias; Urtias 100; Xanthomax; Xanturat; Xanturic; Zygout; Zyloprim; Zyloprim (TN); Zyloric; Zyloric (TN)
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00127	Tetracycline	(-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base)
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00163	Ranitidine	(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00191	Theophylline	1,3 Dimethylxanthine; 1,3-Dimethylxanthine; 1H-purine-2,6-dione; Accurbron; Acet-theocin; Aerobin; Aerolate; Aerolate III; Aerolate SR; Afonilm; Afonilum; Afonilum Retard; Aminophylline; Aquaphyllin; Armophylline; Asmalix; Asmax; Austyn; Bilordyl; Bronchodid Duracap; Bronchoparat; Bronchoretard; Bronkodyl; Bronkodyl SR; Bronkotabs; Cetraphylline; Choledyl SA; Chronophyllin; Constant T; Constant-T; ConstantT; Ct, theo von; Diffumal; Dimethylxanthine; Doraphyllin; Duraphyl; Duraphyllin; Egifilin; Elixex; Elixicon; Elixomin; Elixophyllin; Elixophyllin (TN); Elixophyllin SR; Elixophyllin(e); Elixophylline; Etheophyl; Euphylong; GS 2591A; Hylate; LASMA; LaBID; Labophylline; Lanophyllin; Liquophylline; Maphylline; Medaphyllin; Mudrane; Nuelin; Nuelin S.A; Nuelin S.A.; Nuelin SA; Optiphyllin; Parkophyllin; Physpan; Pro-vent; Pseudotheophylline; Pulmidur; Pulmo-Timelets; Quibron; Quibron T; Quibron T SR; Quibron T-SR; Quibron T/SR; Quibron TSR; Quibron-T; Quibron-T/SR; Quibron-t (TN); Respbid; Respicur; Respid; Slo Phyllin; Slo-bid; Slo-phyllin; SloPhyllin; Solosin; Somophyllin CRT; Somophyllin T; Somophyllin-CRT; Somophyllin-DF; Somophyllin-t; SomophyllinT; Spophyllin retard; Sustaire; Synophylate; T-Phyl; THEOBID JR; Talotren; Tefamin; Telb-DS; Telbans DrySyrup; Teocen 200; Teofilina; Teofilina [Polish]; Teofyllamin; Teolair; Teonova;Teosona; Tesona; Theacitin; Theal tablets; Theo 24; Theo Dur; Theo von ct; Theo-11; Theo-24; Theo-24 (TN); Theo-DS; Theo-Dur-Sprinkle; Theo-Nite; Theo-Organidin; Theo-Sav; Theo-dur; Theo24; Theobid; Theobid Duracap; Theobid Jr.; Theochron; Theocin; Theoclair-SR; Theoclear; Theoclear 80; Theoclear L.A.-130; Theoclear LA; Theoclear-200; Theoclear-80;Theodur G (TN); Theocontin; Theodel; Theodrip; Theodur; Theodur Dry Syrup; Theodur G; Theofol; Theograd; Theokin; Theolair; Theolair (TN); Theolair-SR; Theolix; Theolixir; Theona P; Theonite; Theopek; Theophyl; Theophyl-225; Theophyl-SR; Theophyline; Theophyllin; Theophylline (JP15); Theophylline-SR; Theophylline-[8-3H; Theoplus; Theospan; Theostat; Theostat 80; Theotard; Theovent; Uni-Dur; Unifyl; Unilong; Uniphyl; Uniphyl (TN); Uniphyllin; Uniphyllin continus; Uniphylline; Von ct, theo; X 115; Xanthium; Xantivent
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00203	Aspirin	2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00272	Bumetanide	3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3&prime;-Azido-3&prime;-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR01263	Penciclovir	2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one; 39809-25-1; 9-(4-HYDROXY-3-(HYDROXYMETHYL)BUT-1-YL)GUANINE; 9-(4-Hydroxy-3-(Hydroxymethyl)but-1-Yl)Guanine; 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine; 9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine; 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine; BRL 39123; BRL-39123; CCRIS 9213; Denavir; Denavir (TN); PE2; Penciceovir; Penciclovir [USAN:INN:BAN]; Penciclovirum; Penciclovirum [INN-Latin]; Pencyclovir; UNII-359HUE8FJC; Vectavir; penciclovir
DTD0005	SLC22A7	Organic anion transporter 2	NLT; Novel liver transporter; OAT2; SLC22A7; Solute carrier family 22 member 7; hOAT11; hOAT2	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00023	Memantine	Memantine (extended release); Memantine (extended release), Forest; Memantine ER; Namenda XR
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00040	Amantadine	1-Adamantamine; 1-Adamantanamine; 1-Adamantanamine (8CI); 1-Adamantylamine; 1-Aminoadamantane; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; ADAMANTANE,1-AMINO; Adamantamine; Adamantan-1-amine; Adamantan-1-ylamine; Adamantanamine; Adamantylamine; Amant; Amantadina; Amantadina [INN-Spanish]; Amantadine (INN); Amantadine Base; Amantadine [INN:BAN]; Amantadinum; Amantadinum [INN-Latin]; Amantidine; Aminoadamantane; BIA4304; Endantadine; Gen-Amantadine; Mantadine; OR14310; Pk-merz; Symadine; Symmetrel; Symmetrel (TN); TCMDC-125869; Tricyclo(3.3.1.1(3,7))-decan-1-amine; Tricyclo(3.3.1.1(sup 3,7))decan-1-amine; Tricyclo(3.3.1.1(sup 3.7))decan-1-amine; Tricyclo(3.3.1.13,7)decan-1-amine; Tricyclo[3.3.1.1(3,7)]decan-1-amine;Tricyclo[3.3.1.1(3,7)]decan-1-ylamine; Tricyclo[3.3.1.1(3,7)]decane-1-amine; Tricyclo[3.3.1.1(sup3,7)]decan-1-amine; Tricyclo[3.3.1.1^3,7]decan-1-amine; Tricyclo[3.3.1.1~3,7~]decan-1-amine; Wiregyt
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00054	Quinine	(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00081	Ergotidine	1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00097	Abemaciclib	1231929-97-7; Abemaciclib,LY2835219; LY-2835219; LY2835219; LY2835219 free base; UNII-60UAB198HK; Verzenio
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00106	Tetraethylammonium	4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00110	YM155	Sepantronium
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00116	Lamivudine	(+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (+/-)-3TC; (+/-)-BCH-189; (+/-)-SddC; (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)-NGPB-21; (-)-SddC; (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2',3' Dideoxy 3' thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA); 3'-Thia-2',3'-dideoxycytidine; 3TC; 3TC & GNA; 3TC & SST; 3TC (AIDS INITIATIVE) (AIDS INITIATIVE); 3TC and NV-01; 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine; 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; BCH 189; BCH-189; BCH-790; BCH189; Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To; Beta-L-2',3'-Dideoxy-3'-thiacytidine; Beta-L-3'-Thia-2',3'-dideoxycytidine; DRG-0126; DTHC; Epivir; Epivir (TN); Epivir(TM); Epivir-HBV; Epivir-HBV (TN); GG-714; GR-109714X; GR109714X; HHA & 3TC; HHA & Lamivudine; Hepitec; Heptivir; Heptodin; Heptovir; Heptovir (TN); LMV; Lamivir; Lamivudine & GNA; Lamivudine (JAN/USP/INN); Lamivudine [USAN:BAN:INN]; Lamivudine [USAN:INN:BAN]; Lamivudine, (2S-cis)-Isomer; Zeffix; Zeffix (TN); Zefix
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00163	Ranitidine	(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00189	Serotonin	1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00207	Amiloride	3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide; 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide; 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide; 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8)); Amiclaran; Amiclaran (TN); Amikal (Hydrochloride dihydrate); Amilorida; Amilorida [INN-Spanish]; Amiloride (INN); Amiloride (Na-Ca chanel blocker); Amiloride HCL; Amiloride [INN:BAN]; Amiloride hydrochloride hydrate; Amiloridum; Amiloridum [INN-Latin]; Amipramidin; Amipramizid; Amipramizide; Amiprazidine; Amyloride; Biduret (TN); Guanamprazin; Guanamprazine; MK-870 (Hydrochloride dihydrate); Midamor; Midamor (Hydrochloride dihydrate); N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide; N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid; Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00217	Gabapentin	1-(Aminomethyl)-cyclohexaneacetic acid; 1-(Aminomethyl)cyclohexaneacetic acid; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Aclonium; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; DDS-2003; DM-1796; DM-5689; G-154; GBN; GOE 2450; Gabapen; Gabapentin (JAN/USAN/INN); Gabapentin (Neurontin); Gabapentin GR; Gabapentin Hexal; Gabapentin Stada; Gabapentin [USAN:INN:BAN]; Gabapentin-ratiopharm; Gabapentina; Gabapentine; Gabapentine [INN-French]; Gabapentinium; Gabapentino; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum; Gabapentinum [INN-Latin]; Gabapetin; Go 3450; Goe-3450; Hexal brand of gabapentin; Neurontin; Neurontin (TN); Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Ratiopharm brand of gabapentin; Serada; Stadapharm brand of gabapentin; Vultin; Warner-Lambert brand of gabapentin; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00237	Varenicline	7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine; 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline; CP 526555; Champix (TN); Chantix (TN); Varenicline (INN)
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00278	Famotidine	(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide; Amfamox; Antodine; Apo-Famotidine; Apogastine; Bestidine; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Dibrit 40; Digervin; Dinul; Dipsin; Dispromil; Dispronil; Duovel; Durater; Evatin; F 6889; F0530; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Fadin; Fadine; Fadyn; Fagastine; Famo; Famocid; Famodar; Famodil; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotidina [Spanish]; Famotidine [USAN:BAN:INN:JAN]; Famotidinum [Latin]; Famotin; Famovane; Famowal; Famox; Famoxal; Famtac; Famulcer; Fanobel; Fanosin; Fanox; Farmotex; Ferotine; Fibonel; Fluxid; Fudone; Ganor; Gaster; Gastridan; Gastridin; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; HS-0054; Hacip; Huberdina; Ingastri; Invigan; L 643341; Lecedil; Logos; MK 208; MK-208; Mensoma; Midefam; Mosul; Motiax; Muclox; Mylanta AR; N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; Neocidine; Nevofam; Notidin; Novo-Famotidine; Nu-Famotidine; Nulceran; Nulcerin; PEPCID; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Panalba; Pepcid (TN); Pepcid AC; Pepcid AC Gelcaps; PepcidRPD; Pepcidac; Pepcidin; Pepcidin Rapitab; Pepcidina; Pepcidine; Pepcidine (TN); Pepdif; Pepdine; Pepdul; Pepfamin; Peptan; Peptidin; Peptifam; Pepzan; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); Purifam; Quamatel; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Sedanium-R; Sigafam; Supertidine; Tairal; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; Weimok; Whitidin; YM 11170; YM-11170; YM-1170; Yamarin
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00283	Dopamine	(3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00316	Oxaliplatin	ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00337	N-methylpyridinium	1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl-
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00521	Clonidine	1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00528	Propranolol	(+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN)
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00620	Pramipexole	(-)-Pramipexole; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; 111GE001; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; 2-amino-6-propylaminotetrahydrobenzothiazole; Mirapex; Mirapex (TN); Mirapexin (TN); Pramipexol; Pramipexole (USAN/INN); Pramipexole [USAN:INN]; Pramipexolum; SND-919; SUD919CL2Y; Sifrol(TN); U-98528E
DTD0006	SLC22A2	Organic cation transporter 2	OCT2; SLC22A2; Solute carrier family 22 member 2; hOCT2	DR00724	Dofetilide	1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00002	Paraquat	1,1'-dimethyl-4,4' bipyridinium dichloride
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00044	Topotecan	(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin]
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00097	Abemaciclib	1231929-97-7; Abemaciclib,LY2835219; LY-2835219; LY2835219; LY2835219 free base; UNII-60UAB198HK; Verzenio
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00106	Tetraethylammonium	4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00292	Procainamide	2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00330	Cephalexin	7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00337	N-methylpyridinium	1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl-
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00572	Chloroquine	(+)-Chloroquine; (-)-Chloroquine; (R)-(-)-Chloroquine; 3377 RP opalate; 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline; 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline; Amokin; Aralen; Aralen HCl; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; CU-01000012392-2; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquine (USP/INN); Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquine [USAN:INN:BAN]; Chloroquine phosphate; Chloroquinium; Chloroquinum; Chloroquinum [INN-Latin]; Chlorquin; Cidanchin; Clorochina; Clorochina [DCIT]; Cloroquina; Cloroquina [INN-Spanish]; Cocartrit; Dawaquin (TN); Delagil; Dichinalex; Elestol; Gontochin; Gontochin phosphate; Heliopar; Imagon; Ipsen 225; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaquin (*Diphosphate*); Malaren; Malarex; Mesylith; Miniquine; N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine; N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine; Neochin; Nivachine; Nivaquine B; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; RP 3377; RP-3377; Resochen; Resochin; Resochin (TN); Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ro 01-6014/N2; Ronaquine; Roquine; SN 6718; SN-7618; ST 21; ST 21 (pharmaceutical); Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; W 7618;WIN 244; {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00672	Emtricitabine	(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-.beta.-L-FTC; (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine; (-)-2'-Deoxy-5-fluoro-3'-thiacytidine; (-)-FTC; (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine; (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine; 2',3',5-FTC; 2',3'-Dideoxy-5-fluoro-3'-thiacytidine; 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine; 2'-Deoxy-5-fluoro-3'-thiacytidine; 2-FTC; 3'-Thia-2'.3'-dideoxy-5-fluorocytidine; 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine; 524W91; BW 1592; BW 524W91; BW-524W91; BW524W91; Beta-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine; Coviracil; Coviracil (TN); Coviracil(TM); DOTFC; DRG-0208; Emtricitabine (JAN/USAN/INN); Emtriva; Emtriva(TM); FTC; RCV; Racivir
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR00724	Dofetilide	1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR01223	Mephenoxalone	5-((2-Methoxyphenoxy)methyl)oxazolidin-2-one; 5-(o-Methoxyphenoxymethyl)-2-oxazolidinone; 5-(o-Methoxyphenoxymethyl)-2-oxazolidone; AHR 233; Alkapol peg-400; CL 27,319; Control-OM; Dorsiflex; Dorsilon; EINECS 200-723-3; Ekilan; Lenetran; Lenetran TAB; Lenetranat; MEPHENOXALONE; Mefenoxalona; Mefenoxalona [INN-Spanish]; Mefenoxalone; Mephenoxalone [INN:DCF]; Mephenoxalonum [INN-Latin]; Methoxadone; Methoxydon; Methoxydon(E); Methoxydone; Metoxadone; Moderamin; Placidex; Riself; Transpoise; Trepidone; Valanas; Xerene
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR01272	Pyrimethamine	2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine; 5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; 5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine; AZT + Pyrimethamine combination; Aventis Brand of Pyrimethamine; BW 50-63; BW 5063; CRL-8131 & Pyrimethamine; CRL-8142 & Pyrimethamine; Chloridin; Chloridine; Chloridyn; Darachlor; Daraclor; Darapram; Daraprim; Daraprim (TN); Daraprime; Daraprin; Diaminopyritamin; EXR-101; Erbaprelina; Ethylpyrimidine; Fansidar (Pyrimethamine/Sulfadoxine); Glaxo Wellcome Brand of Pyrimethamine; GlaxoSmithKline Brand of Pyrimethamine; Khloridin; Lactoferrin B & Pyrimethamine; Lactoferrin H & Pyrimethamine; M alocid; Malacid; Malocid; Malocide; Maloprim; Pirimecidan; Pirimetamin; Pirimetamina; Pirimetamina [INN-Spanish]; Pirimetamina [Spanish]; Primethamine; Pyremethamine; Pyrimethamin; Pyrimethamine (JAN/USP/INN); Pyrimethamine (Pyr); Pyrimethamine Hcl; Pyrimethamine [USAN:INN:BAN:JAN]; Pyrimethaminum; Pyrimethaminum [INN-Latin]; RP 4753; TCMDC-123831; TCMDC-125860; Tindurin; Tindurine; Tinduring; WR 2978; Wellcome Brand of Pyrimethamine
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR01280	Enoxacin	1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid; AT 2266; AT-2266; AT2266; Almitil; Almitil (TN); Bactidan; Bactidan (TN); Bactidron (TN); CI919; CL23362; Comprecin; Comprecin (TN); E0762; Enoksetin (TN); Enoram; Enoxacin (USAN/INN); Enoxacin Sesquihydrate; Enoxacin [USAN:BAN:INN:JAN]; Enoxacine; Enoxacine [French]; Enoxacino; Enoxacino [Spanish]; Enoxacinum; Enoxacinum [Latin]; Enoxen (TN); Enoxin; Enoxin (TN); Enoxor; Enoxor (TN); Enroxil (TN); Faulding Brand of Enoxacin; Flumark; Flumark (TN); Gyramid (TN); PD 107779; PD-107779; PD107779; Penetrex; Penetrex (TN); Pierre Fabre Brand of Enoxacin Sesquihydrate; Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate; Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate; Sesquihydrate, Enoxacin; Vinone (TN)
DTD0007	SLC47A1	Multidrug and toxin extrusion protein 1	MATE-1; MATE1; SLC47A1; Solute carrier family 47 member 1; hMATE-1	DR01329	Auranofin	AURANOFIN; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate; CTK8F7877; KS-00001FB9; MMV688978; AKOS026750078; FT-0662343
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00010	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00013	Nilotinib	Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00014	Simeprevir	TMC436
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00032	Imatinib	112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00035	Axitinib	AG 013736; AG-013736; AG-013736, Axitinib; AG-13736; AG013736; Axitinib (VEGFR inhibitor); N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00071	Valsartan	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00107	Levothyroxine	(-)-Thyroxine; (125I)T4; (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid; 3,3',5,5"-Tetraiodo-L-thyronine; 3,3',5,5''-Tetraiodo-L-thyronine; 3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodothyronine; 3,5,3'5'-Tetraiodo-L-thyronine; 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; Beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine;O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; DL-Thyroxin; Eltroxin; Eltroxin (TN); Euthyrox; Euthyrox (TN); Eutirox (TN); Forthyron; Forthyron (TN); L-3,5,3',5'-Tetraiodothyronine; L-T4; L-Thryoxin; L-Thyroxin; L-thyroxine; L-thyroxine (TN); LT00440967; Laevothyroxinum; Laevothyroxinum (acid); Laevoxin; Levaxin (TN); Levo-T; Levolet; Levothroid; Levothroid (*Sodiumsalt*); Levothyrox; Levothyroxin; Levothyroxine (BAN); Levothyroxine Sodium (L-thyroxine); Levothyroxine sodium; Levothyroxinum (acid); Levoxyl; Levoxyl (TN); O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Oroxine; Synthroid; Synthroid (*Sodium salt*); Synthroid (TN); Synthroid sodium; T-3850; T4 (Hormone); T4 levothyroxine; THX; Tetraiodothyronine; Thyratabs; Thyrax; Thyrax (TN); Thyreoideum; Thyrox (TN); Thyroxevan; Thyroxin; Thyroxinal; Thyroxine (VAN); Thyroxine (l); Thyroxine [BAN]; Thyroxine iodine; Thyroxine, L-(8CI)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00124	Fluvastatin	(+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00136	Regorafenib	24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00140	Ezetimibe	(-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00149	Eluxadoline	MuDelta
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00155	Ouabain	3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00161	SN-38	(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00182	Dasatinib	(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00185	Pazopanib hydrochloride	5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide; 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide; 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide; 790713-33-6; 7RN5DR86CK; DSSTox_CID_28659; DSSTox_GSID_48733; DSSTox_RID_82929; GW 78603; GW 786034; GW-786034; GW786034; MFCD11616589; NCGC00188865-01; Pazopanib; Pazopanib (GW-786034); UNII-7RN5DR86CK; Votrient (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00196	Rifampicin	1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00213	Sincalide	CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00222	Torsemide	1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea; 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea; 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea; 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulfonyl]urea; AC 4464; BM 02015; BM-02015; Demadex; Demadex (TN); Demadex, Torsemide; Dilutol; GJ-1090; JDL 464; JDL-464; KS-1123; Luprac; Luprac (TN); N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide; N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide; N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide; PW-2132; Presoril; Sutril; TORSEMIDE; Toradiur; Torasemida; Torasemida [INN-Spanish]; Torasemide (JAN/INN); Torasemide N; Torasemidum; Torasemidum [INN-Latin]; Torem; Torocard; Torrem; Torsemide (USP); Torsemide [USAN]; Unat
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00235	Flavopiridol	(-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one; 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE; 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one; Alvocidib [INN]; FLAVO; Flavopiridol; Flavopiridol hydrochloride; HMR-1275; HMR-1275, Alvocidib, L868275, Flavopiridol; L 868275; L-868275; L86-8275
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00243	Mycophenolate mofetil	2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00252	Bilirubin	21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00262	Sirolimus	(-)-Rapamycin; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29; 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; AY 22989; AY-22989; Antibiotic AY 22989; DE-109; Heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy; LCP-Siro; MS-R001; Perceiva; RAP; RAPA; RPM; Rapammune; Rapamune; Rapamune (TN); Rapamycin; Rapamycin (TN); Rapamycin C-7, analog 4; Rapamycin Immunosuppressant Drug; Rapamycin from Streptomyces hygroscopicus; SIIA 9268A; SILA 9268A; Sirolimus (MTOR inhibitor); Sirolimus (RAPAMUNE); Sirolimus (USAN/INN); Sirolimus [USAN:BAN:INN]; Sirolimus, Rapamune,Rapamycin; WY-090217; Wy 090217
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00273	Danoprevir	DANOPREVIR; ITMN-191; Danoprevir (ITMN-191); Danoprevir (RG7227); UNII-911Z9PCQ5F; ITMN 191; RO5190591; 911Z9PCQ5F; R 7227; RG7227; R7227; Intermune ITMN-191; ITMN B; Danoprevir [USAN:INN]; R-7227; (2R,6S,13aS,14aR,16aS,Z)-6-((tert-butoxycarbonyl)amino)-14a-((cyclopropylsulfonyl)carbamoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1; Danoprevir (ITMN191); MLS006011139; R 05190591; CHEMBL258734; C35H46FN5O9S; SCHEMBL2289034; AOB87156; ZINC29058869; s1183; RL05263
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00288	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; Actelion; Bosentan (INN); Bosentan [USAN:INN:BAN]; Bosentanum; KS-5062; P-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; P-tert-Butyl-N-[6-(2-hydroxyethoxy); Ro 47-0203; Ro 47-0203/039; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039; Tracleer; Tracleer (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00290	Lopinavir	A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00305	Bromsulphthalein	BSP; bromosulfophthalein; sulfobromophthalein
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00309	Saquinavir	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00344	Fluo-3	121714-13-4; 123632-39-3; 23D4W0B50Y; AC1L2XTQ; AKOS015894386; C11369; CHEBI:5107; CHEMBL509919; CTK8F0793; Fluo 3; Fluo-3; Fluo-3, suitable for fluorescence, ~70%; Fluo-3-AM; Glycine,N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-; OZLGRUXZXMRXGP-UHFFFAOYSA-N; SCHEMBL28109; UNII-23D4W0B50Y; ZINC8295051
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00391	Cerivastatin	.
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00407	Nateglinide	(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; A-4166; AY-4166; DJN 608; DJN-608; Fastic; IPCCPA; N-((4-isopropylcyclohexyl)carbonyl)phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; Nate-glinide; Nateglinide [INN]; Nateglinide, (D-Phe)-isomer; Nateglinide, (cis,D-Phe)-isomer; Novartis brand of nateglinide; SDZ-DJN-608; Senaglinide; Starlix; Starlix (TN); Starsis; Trazec; YM-026
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00410	Lovastatin	2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone; 6 Methylcompactin; 6 alpha-Methylcompactin; 6-Methylcompactin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin; Advicor (TN); Altocor; Altocor (TN); Altoprev; Altoprev (TN); Artein; Belvas; Cholestra; Closterol; Colevix; Hipolip; Hipovastin; L-154803; Lestatin; Lipdip; Lipivas; Lipofren; Liposcler; Lovalip; Lovalord; Lovastatin & Primycin; Lovastatin (USP/INN); Lovastatin [USAN:BAN:INN]; Lovastatin, (1 alpha(S*))-Isomer; Lovastatin, 1 alpha-Isomer (without R*/S* notation); Lovastatina; Lovastatina [Spanish]; Lovastatine; Lovastatine [French]; Lovastatinum; Lovastatinum [Latin]; Lovasterol; Lovastin; Lozutin; MK 803; MK-803; MK803; ML-530B; MSD 803; Mevacor; Mevacor (TN); Mevinacor; Mevinolin; Mevinolin from Aspergillus sp.; Mevlor; Monacolin K; Monakolin K; Nergadan; Paschol; Rextat; Rodatin; Rovacor; Sivlor;Taucor; Statosan (TN); Tecnolip; Teroltrat
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00423	Gefitinib	4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00435	Simvastatin	(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; Cholestat; Coledis; Colemin; Corolin; DRG-0320; Denan; KS-1113; L 644128-000U; Labistatin; Lipex; Lipovas; Lodales; MK 0733; MK 733; MK-0733; MK-733; MK733; Medipo; Nivelipol; Pantok; Rendapid; Simcard (TN); Simlup (TN); Simovil; Simvacor (TN); Simvast CR; Simvastatin & Primycin; Simvastatin (JAN/USP/INN); Simvastatin [USAN:INN:BAN]; Simvastatin, Compactin; Simvastatina; Simvastatina [Spanish]; Simvastatine; Simvastatine [French]; Simvastatinum; Simvastatinum [Latin]; Sinvacor; Sivastin; Synvinolin; TNP00259; Vasotenal; Zocor; Zocor (TN); Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin; Zocord; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00446	Repaglinide	(+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; (S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid; (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid; 111GE012; 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid; 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid; 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid; 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid; AG-EE 388; AG-EE 388 ZW; AG-EE 623 ZW; AG-EE-388; AG-EE-623 ZW; AGEE-623ZW; Actulin; Glaxo Wellcome brand of replaginide; GlucoNorm; GlucoNorm (TN); NN-623; Novo Nordisk brand 2 of repaglinide; Novo Nordisk brand of repaglinide; NovoNorm; NovoNorm (TN); Prandin; Prandin (TN); Prandin, GlucoNorm, NovoNorm, Repaglinide; Repa-glinide; Repaglinida; Repaglinida [INN-Spanish]; Repaglinide (JAN/USP/INN); Repaglinide [USAN]; Repaglinide, (+-)-isomer; Repaglinidum; Repaglinidum [INN-Latin]; SMP-508
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00454	Sunitinib	5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00493	Caspofungin	Caspofungin; Cancidas; Cancidas (TN); Capsofungin; Caspofungin (INN); MK 0991; L 743872; AC1MCVUN; MK-0991; CHEMBL499808; SCHEMBL6726364; L-743872; JYIKNQVWKBUSNH-OGZDCFRISA-N; L-743,872; N-[(2-aminoethylamino)-[(1R)-3-amino-1-hydroxy-propyl]-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-trihydroxy-[(1R)-1-hydroxyethyl]-hexaoxo-[?]yl]-10,12-dimethyl-tetradecanamide; LS-187303; FT-0696944; L 743; D07626
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00514	Darunavir	(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; AIDS073035; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; Darunavir (USAN/INN); Darunavir [USAN]; Darunavirum; Darunavirum [INN-Latin]; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; Prezista; Prezista(TM); TMC 114; TMC-114; TMC114; UIC 94017; UIC-94017; UIC-96017; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00523	Crizotinib	Xalkori (TN); novel ALK inhibitors
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00547	Fluorescein	fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&amp;C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D &amp; C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00577	Cefazolin	(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00600	Cefoperazone	(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6S,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid; CP 52640; Cefazone (TN); Cefobid; Cefobid (TN); Cefoperazon; Cefoperazone (INN); Cefoperazone [INN:BAN]; Cefoperazone sodium salt; Cefoperazono; Cefoperazono [INN-Spanish]; Cefoperazonum; Cefoperazonum [INN-Latin]; Peracef [veterinary]; Peracef [veterinary] (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00615	Chenodeoxycholic acid	(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid; (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; 17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol; 3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid; 3,7-Dihydroxycholan-24-oic acid; 3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid; 3-alpha,7-beta-Dihydroxycholanic acid; 3-alpha,7-beta-Dioxycholanic acid; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,7beta-Dihydroxy-5beta-cholanic acid; 5beta-Cholan-24-oic acid-3alpha,7beta-diol; 5beta-Cholanic Acid-3alpha,7beta-diol; 7-beta-Hydroxylithocholic acid; 7beta-Hydroxylithocholic acid; Acide ursodesoxycholique; Acide ursodesoxycholique [INN-French]; Acido ursodeossicolico; Acido ursodeossicolico [Italian]; Acido ursodeoxicolico; Acido ursodeoxicolico [INN-Spanish]; Acidum ursodeoxycholicum; Acidum ursodeoxycholicum [INN-Latin]; Actigall; Actigall (TN); Antigall; Arsacol; Chenodeoxycholic acid; Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-(9CI); Cholit-ursan; Delursan; Deoxyursocholic Acid; Destolit; Deursil; Deursil (TN); Dom-ursodiol c; ISO-URSODEOXYCHOLIC ACID; IU5; Litursol; Lyeton; PHL-ursodiol c; PMS-ursodiol c; Peptarom; Sodium Ursodeoxycholate; Solutrat; U-9000; U0030; UDCA;UDCS; UrSO; Urosiol; Ursacholic Acid; Ursacol; Urso (TN); Urso 250; Urso DS; Urso Forte; Urso Forte (TN); Ursobilin; Ursochol; Ursodamor; Ursodeoxy cholic acid; Ursodeoxycholate; Ursodeoxycholic acid (JP15/INN); Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol; Ursodesoxycholicacid; Ursodexycholic Acid; Ursodiol; Ursodiol (USP); Ursodiol [USAN]; Ursofalk; Ursolvan; Ursosan; Ursosan (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00618	Vandetanib	4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; AZD-6474; CH 331; CH-331; F9995-0087; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib (JAN/INN); Vandetanib (Pan-TK inhibitor); Vandetanib [INN]; Vandetanib, Zactima, ZD6474; ZD 6474; ZD-6474; ZD6474; Zactima; Zactima, ZD6474
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00657	Cholic acid	(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00711	Vemurafenib	PLX4032; RG7204; RO5185426; Vemurafenib (BRAF inhibitor); Zelboraf (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR00856	Mesalazine	2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01177	Hydroxyurea	1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01237	Technetium (99MTC) mebrofenin	F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01257	Gadobenate dimeglumine	Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01275	Entacapone	(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; COM-998; Comtan; Comtan (TN); Comtess; Entacapona; Entacapona [INN-Spanish]; Entacapone (JAN/USAN/INN); Entacapone [USAN:INN]; Entacaponum; Entacaponum [INN-Latin]; KB475572; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; Novartis brand of entacapone; OR 611; OR-611; Orion brand of entacapone; Stalevo (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01322	Cilostazol	Cilostazole; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 73963-72-1; BRN 3632107; C 0737; C20H27N5O2; CHEBI:31401; CL23867; Cilostazol (JP15/USAN/INN); Cilostazol [INN:JAN]; Cilostazole; Cilostazolum; Cilostazolum [INN-Latin]; MLS000028470; OPC 13013; OPC 21; OPC-13013; OPC-21; Otsuka brand of cilostazol; Pleta (TN); Pletaal; Pletal; Pletal (TN); Pletal, Cilostazol; UNII-N7Z035406B; cilostazol
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01332	Bromfenac	2-Amino-3-(4-bromobenzoyl)benzeneacetic acid; 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; AHR-10282; BROMFENAC SODIUM; Bromfenac (INN); Bromfenac [INN]; Bromfenaco; Bromfenaco [Spanish]; Bromfenacum; Bromfenacum [Latin]; Duract; Duract (TN); Sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate; Xibrom; Xibrom (TN); [2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid; [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; {2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01339	Gimatecan	LBQ-707; ST-1480; ST-1481; Camptothecin analogs, Sigma-Tau; 7-cyano-camptothecin
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01349	Karenitecin	Karenitecin (TN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01351	TR-14035	232271-19-1; TR-14035; (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid; CHEMBL91485; N-(2,6-DICHLOROBENZOYL)-4-(2,6-DIMETHOXYPHENYL)-L-PHENYLALANINE; C24H21Cl2NO5; DRSJLVGDSNWQBI-SFHVURJKSA-N; TR 14035; SCHEMBL1222491; BDBM16801; CTK8C1530; MolPort-023-334-229; ZINC1490484; ANW-66841; N-Acyl-4-arylphenylalanine analogue.; AKOS016008162; CS-1812; CS-W000631; MP-2027; NCGC00390619-01; SB683698; HY-15770; AK-95353; AJ-26339; KB-210922; TC-155586; AB0077984; AX8237663; ST24020804; Z4458
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01381	BQ-123	BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01384	Nafcillin	Nafcilina; Nafcilline; Nafcillinum; Nallpen; Naphcillin; Naphthamidopenicillin; Unipen; NAFCILLIN SODIUM; Nafcillin sodium for injection; Nallpen In Plastic Container; Nafcilin-1; Nafcilina [INN-Spanish]; Nafcillin & VRC3375; Nafcillin (INN); Nafcillin [INN:BAN]; Nafcilline [INN-French]; Nafcillinum [INN-Latin]; Nafcillin, Monosodium Salt, Anhydrous; (2-Ethoxy-1-naphthyl)penicillin; (2-ethoxy-1-naphthalenyl)penicillin; (2S,5R,6R)-6-({[2-(ethyloxy)naphthalen-1-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(2-ethoxy-1-naphthamido)penicillanic acid; 6-[(2-Ethoxy-naphthalene-1-carbonyl)-amino]-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion; 6beta-(2-ethoxynaphthalene-1-carboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01394	Cefditoren	Cefditoren [USAN:INN]; Meiact (TN); Spectracef (TN); (+)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-((Z)-2-(4-methyl-5-thiazolyl)vinyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime); (6R-(3(Z),6alpha,7beta(Z)))-7-((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01433	Atrasentan	Xinlay; Atrasentan [INN]; A 127722; A 147627; ABT 627; A-127722; A-147627; ABT-627; Xinlay (TN); A-127722.5; (+)-A 127722; (+)-A-127722; (11C)ABT-627; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid; 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid; 2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01466	YM758	YM 758 Phosphate; (R)-(-)-N-[2-[3-[(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)carbonyl]piperidino]ethyl]-4-fluorobenzamide monophosphate; YM 758; N-[2-[(3R)-3-[(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)carbonyl]-1-piperidinyl]ethyl]-4-fluorobenzamide Phosphate
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01485	Leukotriene E4	Leukotriene E4; leukotriene E4; Leukotriene E; UNII-8EYT8ATL7G; 75715-89-8; 8EYT8ATL7G; CHEMBL509456; CHEBI:15650; OTZRAYGBFWZKMX-FRFVZSDQSA-N; 5S-hydroxy,6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C23H37NO5S; (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid; (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid; [3H]LTE4; AC1NQXPM; LEUKOTRIEN E4; BSPBio_001370; leukotriene E
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01490	[D-Ala2, D-Leu5]-enkephalin	Dadle; 63631-40-3; H-TYR-D-ALA-GLY-PHE-D-LEU-OH; DADL; (D-Ala2,D-Leu5)-Enkephalin; [D-Ala2, D-Leu5]-enkephalin; CHEMBL340032; BW-180C; Tyr-D-Ala-Gly-Phe-D-Leu; (2R,5S,11R,14S)-14-Amino-5-benzyl-15-(4-hydroxyphenyl)-2-isobutyl-11-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecan-1-oic acid; (2R)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid; UNII-HB4QD9GL6F; HB4QD9GL6F; DADLE-OH; AC1OCEJN; ZINC14952092; H-Tyr-D-Ala-Gly-Phe-D-Leu
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01528	Temocapril	Temocapril; Temocaprilum; 2-((2S,6R)-6-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-4-yl)acetic acid; UNII-18IZ008EU6; 18IZ008EU6; Temocapril [INN:BAN]; Temocaprilum [INN-Latin]; C23H28N2O5S2; 2-((2S,6R)-6-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)-5-OXO-2-(THIOPHEN-2-YL)-1,4-THIAZEPAN-4-YL)ACETIC ACID; (2S-(2alpha,6beta(R*)))-6-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; Temocapril (INN); AC1L9FDI
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01545	Pitavastatin	Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN)
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01616	Cholyl lysyl fluorescein	.
DTD0008	SLCO1B1	Organic anion transporting polypeptide 1B1	LST-1; LST1; Liver-specific organic anion transporter 1; OATP-2; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6; SLCO1B1; Sodium-independent organic anion-transporting polypeptide 2; Solute carrier family 21 member 6; Solute carrier organic anion transporter family member 1B1	DR01617	Primovist	Eovist; Primovist; gadoxate disodium; AC1L9OPS; gadolinium ethoxybenzyl-DTPA; MOLI000482; 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; gadolinium(3+)
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00028	Etilefrine	2-Ethylamino-1-(3-hydroxyphenyl)ethanol Hydrochloride; 3-(2-(Ethylamino)-1-hydroxyethyl)phenol hydrochloride; 3-[2-(ethylamino)-1-hydroxyethyl]phenol hydrochloride; 534-87-2; 943-17-9; Apocretin; Circupon; Effontil; Effortilvet; Ethyl adrianol; Ethylephrine hydrochloride; Eti-Puren; Etilefrin Hydrochloride; Etilefrine HCl; Etilefrine hydrochloride; Etilefrine hydrochloride (TN); Funasol; Kertasin; Phetanol; Phetasin; Pulsamin; Tonus-Forte; Updormin; dl-Effortil hydrochloride; dl-Etilefrin hydrochloride; dl-N-Ethylnorphenylephrine h
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00070	Acetylcholine	Miochol; Miochol-e
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00076	Epinephrine	(-)-(R)-Epinephrine; (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; (-)-Adrenalin; (-)-Adrenaline; (-)-Epinephrine; (-)-R-Epinephrine; (R)-(-)-Adnephrine; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; (R)-Adrenaline; (R)-Epinephrine; 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; 1-Adrenalin; 1-Epinephrine; 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; ADR ADRENALINE; ADROP; Adnephrine; Adrenal; Adrenalin; Adrenalin (TN); Adrenalin in Oil; Adrenalin-Medihaler; Adrenalina; Adrenalina [DCIT]; Adrenaline; Adrenaline (JP15); Adrenaline/Epinephrine; Adrenalinum; Adrenamine; Adrenan; Adrenapax; Adrenasol; Adrenatrate; Adrenine; Adrenodis; Adrenohorma; Adrenosan; Adrenutol; Adrin; Adrine; Ana-Guard; Antiasthmatique; Asmatane Mist; Asthma meter mist; Asthma-nefrin; Asthmahaler Mist; Asthmanefrin; Astmahalin; Astminhal; Balmadren; Bernarenin; Biorenine; Bosmin; Brevirenin; Bronkaid; Bronkaid Mist; Bronkaid Suspension Mist; Bupivacaine Hcl and Epinephrine; Chelafrin; Citanest Forte; Corisol; D-Adrenaline; D-Epifrin; D-Epinephrine; Drenamist; Dylephrin; Dyspne-Inhal; EPI E Z PEN JR; EPIPEN E Z PEN; EPIPEN JR; Epi EZ Pen Jr; Epifrin; Epiglaufrin; Epinefrin; Epinefrin [Czech]; Epinefrina; Epinefrina [INN-Spanish]; Epinephran; Epinephrin; Epinephrine (USP); Epinephrine (USP/INN); Epinephrine [USAN:INN:JAN]; Epinephrine hydrochloride; Epinephrinum; Epinephrinum [INN-Latin]; Epipen; Epipen (TN); Epipen Auto-Injector; Epipen EZ Pen; Epipen Jr.; Epipen Jr. Auto-Injector; Epirenamine; Epirenan; Epirenin; Epitrate; Eppy; Esphygmogenina; Exadrin; Glaucon; Glaucosan; Glauposine; Glycirenan; Haemostasin; Haemostatin; Hektalin; Hemisine; Hemostasin; Hemostatin; Hypernephrin; Hyporenin; IOP; Intranefrin; Iontocaine; Isoptoepinal; Kidoline; L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; L-Adrenalin; L-Adrenaline; L-Adrenaline Base; L-Epinehphrine; L-Epinephine; L-Epinephrine (synthetic); L-Epirenamine; L-Methylaminoethanolcatechol; L-epinephrine; Levo-Methylaminoethanolcatechol; Levoadrenaline; Levoepinephrine; Levorenen; Levorenin; Levorenine; Lyophrin; Medihaler-Epi; Metanephrin; Methylaminoethanolcatechol; Methylarterenol; Micronefrin; Micronephrine; Mucidrina; Myosthenine; Mytrate; Nephridine; Nieraline; Paranephrin; Primatene; Primatene Mist; R-(-)-Epinephrine; R-Adrenaline; Racemic Epinephrine; Racepinephrine; Renagladin; Renaglandin; Renaglandulin; Renaleptine; Renalina; Renoform; Renostypricin; Renostypticin; Renostyptin; SUS-PHRINE SULFITE-FREE; Scurenaline; Septocaine; Simplene; Sindrenina; Soladren; Sphygmogenin; Stryptirenal; Styptirenal; Supracapsulin; Supradin; Supranefran; Supranephrane; Supranephrine; Supranol; Suprarenaline; Suprarenin; Suprel; Surenine; Surrenine; Sus-Phrine; Susphrine; Sympathin I; Takamina; Takamine; Tokamina; Tonogen; Twinject; Twinject 0.15; Twinject 0.3; Twinject 0.30; Vaponefrin; Vasoconstrictine; Vasoconstrictor; Vasodrine; Vasoton; Vasotonin
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00081	Ergotidine	1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00084	Amphetamine	Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00337	N-methylpyridinium	1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl-
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00521	Clonidine	1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR00528	Propranolol	(+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN)
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR01173	Sodium chloride	7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0009	SLC22A3	Organic cation transporter 3	OCT3; EMT; EMTH; Extraneuronal monoamine transporter; SLC22A3; Solute carrier family 22 member 3	DR01303	Guanidine	(NH2)2C=NH; 4-03-00-00148 (Beilstein Handbook Reference); AC1L1G4E; AC1Q50DT; AC1Q50DU; Aminoformamidine; Aminomethanamidine; Carbamamidine; Carbamidine; GAI; Gu; Guanidin; Guanidine, Hydrochloride; Guanidine, free base;BRN 0506044; H2N-C(=NH)-NH2; HSDB 7603; Imidourea; Iminourea; JU58VJ6Y3B; NCIOpen2_007946; UNII-JU58VJ6Y3B; ZRALSGWEFCBTJO-UHFFFAOYSA-N; guanidine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00017	Tiotropium	(1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide; (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide; 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; BA 679 BR; BA 679BR; BA-679 BR; BA-679-BR; Spiriva; Spiriva (TN); Spiriva Handihaler; Spiriva Respimat; TIOTROPIUM BROMIDE; Tiotropium bromide [USAN:INN]
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00026	Fexofenadine	2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00032	Imatinib	112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00033	Atenolol	(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00054	Quinine	(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00055	Codeine	(-)-Codeine; 76-57-3; CCRIS 7555; CHEBI:16714; CODEINE BASE; Codein; Codeine Anhydrate; Codeine anhydrous; Codeine polistirex; Codicept; Coducept; EINECS 200-969-1; HSDB 3043; Methylmorphine; Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-; Morphine 3-methyl ether; Morphine monomethyl ether; Morphine-3-methyl ester; Morphine-3-methyl ether; Norcodeine, N-methyl; Norcodine, N-methyl; O(3)-methylmorphine; O3-Methylmorphine; UNII-UX6OWY2V7J; UX6OWY2V7J; codeina; codeinum; l-Codeine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00056	Lamotrigine	3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine; BW 430C; BW-430C; Crisomet; Desitin Brand of Lamotrigine; EUR-1048; Faes Brand of Lamotrigine; GI 267119X; GW 273293; Glaxo Wellcome Brand of Lamotrigine; GlaxoSmithKline Brand of Lamotrigine; Juste Brand of Lamotrigine; L 3791; Labileno; Lamictal; Lamictal (TN); Lamictal Cd; Lamictal ODT; Lamictal XR; Lamictin; Lamictin (TN); Lamiktal; Lamitor; Lamotrigina; Lamotrigina [Spanish]; Lamotrigine (JAN/USAN/INN); Lamotrigine [USAN:INN:BAN]; Lamotriginum; Lamotriginum [Latin]
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00064	Indacaterol	5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one; 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one; Indacaterol (USAN/INN); QAB-149
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00070	Acetylcholine	Miochol; Miochol-e
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00076	Epinephrine	(-)-(R)-Epinephrine; (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; (-)-Adrenalin; (-)-Adrenaline; (-)-Epinephrine; (-)-R-Epinephrine; (R)-(-)-Adnephrine; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; (R)-Adrenaline; (R)-Epinephrine; 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; 1-Adrenalin; 1-Epinephrine; 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol; 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; ADR ADRENALINE; ADROP; Adnephrine; Adrenal; Adrenalin; Adrenalin (TN); Adrenalin in Oil; Adrenalin-Medihaler; Adrenalina; Adrenalina [DCIT]; Adrenaline; Adrenaline (JP15); Adrenaline/Epinephrine; Adrenalinum; Adrenamine; Adrenan; Adrenapax; Adrenasol; Adrenatrate; Adrenine; Adrenodis; Adrenohorma; Adrenosan; Adrenutol; Adrin; Adrine; Ana-Guard; Antiasthmatique; Asmatane Mist; Asthma meter mist; Asthma-nefrin; Asthmahaler Mist; Asthmanefrin; Astmahalin; Astminhal; Balmadren; Bernarenin; Biorenine; Bosmin; Brevirenin; Bronkaid; Bronkaid Mist; Bronkaid Suspension Mist; Bupivacaine Hcl and Epinephrine; Chelafrin; Citanest Forte; Corisol; D-Adrenaline; D-Epifrin; D-Epinephrine; Drenamist; Dylephrin; Dyspne-Inhal; EPI E Z PEN JR; EPIPEN E Z PEN; EPIPEN JR; Epi EZ Pen Jr; Epifrin; Epiglaufrin; Epinefrin; Epinefrin [Czech]; Epinefrina; Epinefrina [INN-Spanish]; Epinephran; Epinephrin; Epinephrine (USP); Epinephrine (USP/INN); Epinephrine [USAN:INN:JAN]; Epinephrine hydrochloride; Epinephrinum; Epinephrinum [INN-Latin]; Epipen; Epipen (TN); Epipen Auto-Injector; Epipen EZ Pen; Epipen Jr.; Epipen Jr. Auto-Injector; Epirenamine; Epirenan; Epirenin; Epitrate; Eppy; Esphygmogenina; Exadrin; Glaucon; Glaucosan; Glauposine; Glycirenan; Haemostasin; Haemostatin; Hektalin; Hemisine; Hemostasin; Hemostatin; Hypernephrin; Hyporenin; IOP; Intranefrin; Iontocaine; Isoptoepinal; Kidoline; L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol; L-Adrenalin; L-Adrenaline; L-Adrenaline Base; L-Epinehphrine; L-Epinephine; L-Epinephrine (synthetic); L-Epirenamine; L-Methylaminoethanolcatechol; L-epinephrine; Levo-Methylaminoethanolcatechol; Levoadrenaline; Levoepinephrine; Levorenen; Levorenin; Levorenine; Lyophrin; Medihaler-Epi; Metanephrin; Methylaminoethanolcatechol; Methylarterenol; Micronefrin; Micronephrine; Mucidrina; Myosthenine; Mytrate; Nephridine; Nieraline; Paranephrin; Primatene; Primatene Mist; R-(-)-Epinephrine; R-Adrenaline; Racemic Epinephrine; Racepinephrine; Renagladin; Renaglandin; Renaglandulin; Renaleptine; Renalina; Renoform; Renostypricin; Renostypticin; Renostyptin; SUS-PHRINE SULFITE-FREE; Scurenaline; Septocaine; Simplene; Sindrenina; Soladren; Sphygmogenin; Stryptirenal; Styptirenal; Supracapsulin; Supradin; Supranefran; Supranephrane; Supranephrine; Supranol; Suprarenaline; Suprarenin; Suprel; Surenine; Surrenine; Sus-Phrine; Susphrine; Sympathin I; Takamina; Takamine; Tokamina; Tonogen; Twinject; Twinject 0.15; Twinject 0.3; Twinject 0.30; Vaponefrin; Vasoconstrictine; Vasoconstrictor; Vasodrine; Vasoton; Vasotonin
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00085	Pentamidine	1,3-BIS(4-AMIDINOPHENOXY)PENTANE; 4, 4'-Diamidinodiphenoxypentane; 4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide; 4,4'-(Pentamethylenedioxy)dibenzamide; 4,4'-(Pentamethylenedioxy)dibenzamidine; 4,4'-Diamidino-.alpha.,.omega.-diphenoxypentane; 4,4'-Diamidinodiphenoxypentane; 4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide; 4-[5-(4-Carbamimidoylphenoxy)pentoxy]benzenecarboximidamide; Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-(9CI); Lomidine; Lomidine (TN); MB 800; MB-800; Nebupent; Nebupent (*Isethionate); Nebupent (as isethionate); P,p'-(Pentamethylene-dioxy)bis-benzamidine; P,p'-(Pentamethylenedioxy)bis[benzamidine]; P,p'-(Pentamethylenedioxy)dibenzamidine; PENTAM; PENTAMIDINE ISETHIONATE; PNT; Pentacarinat; Pentacarinat (as isethionate); Pentam 300; Pentam 300 (*Isethionate); Pentam 300 (as isethionate); Pentamide; Pentamidin; Pentamidina; Pentamidina [DCIT]; Pentamidine (INN); Pentamidine Isethionate 2-Hydroxy-Ethanesulfonic Acid;Pentamidine [INN:BAN:DCF]; Pentamidine isetionate; Pentamidine mesylate; Pentamidinum; Pentamidinum [INN-Latin]; Pneumopent; RP 2512 (*Isethionate); RP-2512
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00087	Cladribine	(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00106	Tetraethylammonium	4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00110	YM155	Sepantronium
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00116	Lamivudine	(+/-)-(Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (+/-)-3TC; (+/-)-BCH-189; (+/-)-SddC; (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine; (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-2'-Deoxy-3'-thiacytidine; (-)-BCH 189; (-)-BCH-189; (-)-NGPB-21; (-)-SddC; (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine; (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; 2',3' Dideoxy 3' thiacytidine; 2',3'-Dideoxy-3'-thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-)-(Cis); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Galanthus Nivalis Agglutinin (GNA); 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)-(2R,5S) & Hippeastrum hybrid agglutinin(HHA); 3'-Thia-2',3'-dideoxycytidine; 3TC; 3TC & GNA; 3TC & SST; 3TC (AIDS INITIATIVE) (AIDS INITIATIVE); 3TC and NV-01; 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine; 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; BCH 189; BCH-189; BCH-790; BCH189; Beta-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To; Beta-L-2',3'-Dideoxy-3'-thiacytidine; Beta-L-3'-Thia-2',3'-dideoxycytidine; DRG-0126; DTHC; Epivir; Epivir (TN); Epivir(TM); Epivir-HBV; Epivir-HBV (TN); GG-714; GR-109714X; GR109714X; HHA & 3TC; HHA & Lamivudine; Hepitec; Heptivir; Heptodin; Heptovir; Heptovir (TN); LMV; Lamivir; Lamivudine & GNA; Lamivudine (JAN/USP/INN); Lamivudine [USAN:BAN:INN]; Lamivudine [USAN:INN:BAN]; Lamivudine, (2S-cis)-Isomer; Zeffix; Zeffix (TN); Zefix
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00163	Ranitidine	(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00207	Amiloride	3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide; 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide; 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide; 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide; AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8)); Amiclaran; Amiclaran (TN); Amikal (Hydrochloride dihydrate); Amilorida; Amilorida [INN-Spanish]; Amiloride (INN); Amiloride (Na-Ca chanel blocker); Amiloride HCL; Amiloride [INN:BAN]; Amiloride hydrochloride hydrate; Amiloridum; Amiloridum [INN-Latin]; Amipramidin; Amipramizid; Amipramizide; Amiprazidine; Amyloride; Biduret (TN); Guanamprazin; Guanamprazine; MK-870 (Hydrochloride dihydrate); Midamor; Midamor (Hydrochloride dihydrate); N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide; N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid; Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00237	Varenicline	7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine; 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline; CP 526555; Champix (TN); Chantix (TN); Varenicline (INN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00254	Sitagliptin	(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00263	Nizatidine	(E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Acinon; Acinon (TN); Antizid; Axid; Axid (TN); Axid Ar; Calmaxid; Cronizat; Distaxid; Galitidin; Gastrax; LY 139037; LY-139037; N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin; Naxidine; Niatidine; Nizatidina; Nizatidina [Spanish]; Nizatidine (JAN/USP/INN); Nizatidine [USAN:BAN:INN:JAN]; Nizatidinum; Nizatidinum [Latin]; Nizax; Nizaxid; Panaxid; Splendil ER; Tazac; Tazac (TN); Ulcosol; Ulxid; ZE-101; ZL-101; Zanizal; Zinga
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00264	Verapamil	(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00277	Ipratropium	(+-)-Ipratropine; (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane; (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; 3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azoniabicyclo[3.2.1]octane; Aerodose; Aerovent; Apo-Ipravent; Apovent; Apovent (TN); Atronase; Atrovent; Atrovent (TN); Atrovent Aerosol; Atrovent Hfa; Atrovent Nasal; Bitrop; Disne-Asmol; Ipatropium Bromide; Ipratropium bromide; Ipravent; Ipvent; Kendral-Ipratropium; N-Isopropylatropine; Narilet; Rhinotrop; Rhinovent; Rinatec; Rinoberen; Rinovagos; Vagos; X8M; [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00283	Dopamine	(3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00292	Procainamide	2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3&prime;-Azido-3&prime;-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00307	Berberine	0I8Y3P32UF; 2086-83-1; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLE; BRN 3570374; Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-; Berbamine sulphate acid; Berberal; Berberin; CHEBI:16118; CHEMBL12089; EINECS 218-229-1; ST055798; UNII-0I8Y3P32UF; Umbellatine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00316	Oxaliplatin	ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00319	Citalopram	1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; 1,3-dihydro[3,4]benzofuran-5-carbonitrile; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; AE-641/00603021; Akarin; Akarin (TN); Celapram; Celapram (TN); Celexa; Celexa (TN); Celius; Celius (TN); Ciazil; Ciazil (TN); Cilift; Cilift (TN); Cipram; Cipram (TN); Cipramil (TN); Ciprapine; Ciprapine (TN); Citabax; Citabax (TN); Citadur; Citadur (TN); Citalec; Citalec (TN); Citalopram (USP/INN); Citalopram [Celexa]; Citalopram [INN:BAN]; Citalopramum; Citalopramum [INN-Latin]; Citaxin (TN); Citol (TN); Citopam; Citopam (TN); Citox (TN); Citrol (TN); Cytalopram; Dalsan; Dalsan (TN); Humorup; Lu 10-171; Lu-10-171; Nitalapram; Oropram; Pramcit; Recital; Recital (TN); Seropram; Seropram (TN); Talam; Talam (TN); Talohexal; Temperax; Vodelax; Zentius; Zentius (TN); Zetalo; Zetalo (TN); [3H]Citalopram
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00331	Sumatriptan	(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide; 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide; 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide; 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide; GR 43175; GR 43175X; GR-43175; Imigran; Imigran (TN); Imitrex; Imitrex (TN); KS-1116; NP101; Sumatran; Sumatriptan (JAN/USP/INN); Sumatriptanum; Sumatriptanum [INN-Latin]; Sumax
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00337	N-methylpyridinium	1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl-
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00370	Antiparasitics	Antiparasitics, Immtech; DAP-092; DB-075; DB-244; DB-75; Furamidine; WR-199385
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00416	Cytarabine	(beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00501	Desipramine	(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine; 10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine; 10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine; 5-(gamma-Methylaminopropyl)iminodibenzyl; DMI (pharmaceutical); DMI 50475; Demethylimipramine; Desimipramine; Desimpramine; Desipramin; Desipramina; Desipramina [INN-Spanish]; Desipramine (D4); Desipramine (INN); Desipramine Hcl; Desipramine [INN:BAN]; Desipraminum; Desipraminum [INN-Latin]; Desmethylimipramine; Dezipramine; Dimethylimipramine; Methylaminopropyliminodibenzyl; Monodemethylimipramine; N-(3-Methylaminopropyl)iminobibenzyl; Norimipramine; Norpramin (TN); Norpramine; Pentofran; Pertofrane (TN); Pertrofane; Sertofran; ZERO/006017
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00521	Clonidine	1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-(9CI); 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine; 2,6-dichloro-N-(2-imidazolidinylidene)aniline; 2,6-dichloro-N-2-imidazolidinylidenebenzenamide; 2,6-dichloro-N-imidazolidin-2-ylideneaniline; 2-((2,6-Dichlorophenyl)imino)imidazolidine; 2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2);2-(2,6-Dichloroanilino)-2-imidazoline; 2-(2,6-Dichlorophenylamino)-2-imidazoline; 2-(2,6-Dichlorophenylimino)imidazolidine; 2-Imidazoline, 2-(2,6-dichloroanilino)-(7CI,8CI); 2-[(2,6-Dichlorophenyl)imino]imidazoline; 2-[(2,6-dichlorophenyl)imino]-2-imidazoline; 734571A; Adesipress; CATAPRES-TTS-1; CATAPRES-TTS-2; CATAPRES-TTS-3; Catapres (TN); Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpres-TTS; Catarpres-TTS (TN); Catarpresan; Chlornidinum; Clofenil; Clonidin; Clonidina; Clonidina [INN-Spanish]; Clonidine (JAN/USAN/INN); Clonidine [USAN:BAN:INN]; Clonidinhydrochlorid; Clonidinum; Clonidinum [INN-Latin]; Clopheline; Dixarit; Duraclon; Duraclont; Gemiton; Hemiton; Isoglaucon; Klofelin; Klofenil; M 5041T; M-5041T; N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; SKF 34427; ST 155BS; ST-155-BS; ST-155BS; Tenso-Timelets
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00528	Propranolol	(+-)-Propranolol; (1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol; (R)-(+)-propranolol; (S)-(-)-PROPRANOLOL; 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol; 1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane; 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol; 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol; 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol; 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol; 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol; 1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol; 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol; 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-(9CI); 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-(9CI); 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol; AY 64043; AY-20694; Anaprilin; Anapriline; Anaprilinum (TN); Avlocardyl; Avlocardyl (TN); Bedranol; Berkolol; Beta Neg; Beta-Propranolol; Beta-Tablinen; Beta-Timelets; Betachron; Betadren; Betalong; Caridolol; Corpendol; D,L-Propranolol; DL-Propranolol hydrochloride; Deralin (TN); Dociton; Dociton (TN); Efektolol;Etalong; Euprovasin; Herzbase; INDERIDE-40/25; INDERIDE-80/25; Ikopal; Inderal; Inderal (TN); Inderal LA (TN); Inderal hydrochloride; Inderalici; Inderalici (TN); Inderex; Inderol; InnoPran XL (TN); Intermigran; Kemi; Kemi S; Migrastat; Naprilin; Obsidan; Obzidan; Pranolol; Pronovan; Propanalol; Propanix; Propanolol; Propanolol [INN-Spanish]; Propranalol; Propranolol (INN); Propranolol (TN); Propranolol Hcl Intensol; Propranolol [INN:BAN]; Propranololo; Propranololo [DCIT]; Propranololum; Propranololum [INN-Latin]; Proprasylyt; R,S-Propranolol Hydrochloride; Racemic propranolol; Reducor; Reducorline; Sawatal; Servanolol; Sumial; Sumial (TN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00536	Tubocurarine	(+)-Tubocurarine; (+)-Tubocurarine chloride; (+)-Tubocurarine chloride hydrochloride; 2,2',2'-trimethyl-6,6'-bis(methyloxy)tubocuraran-2,2'-diium-7',12'-diol dichloride; 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium; 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraran-2'-ium; Amelizol; Chlorure de tubocurarine; Chlorure de tubocurarine [INN-French]; Cloruro de tubocurarina; Cloruro de tubocurarina [INN-Spanish]; Curarin-haf; D-(+)-Tubocurarine chloride; D-7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium chloride; D-Paracurarine chloride; D-Tubocurarine; D-Tubocurarine chloride; D-Tubocurarine dichloride; D-Tubocurarine hydrochloride; Delacurarine; Delacurarine (TN); Dextrotubocurarine chloride; Intocostrine T; Isoquinoline alkaloid; Jex (TN); Jexin; Metubine (TN); Tubadil; Tubaine; Tubaine (TN); Tubarine; Tubarine (TN); Tubocuraranium, 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyl-, chloride, hydrochloride; Tubocurarin; Tubocurarina cloruro; Tubocurarina cloruro [DCIT]; Tubocurarine chloride; Tubocurarine chloride (INN); Tubocurarine chloride (TN); Tubocurarine chloride (anhydrous); Tubocurarine hydrochloride; Tubocurarine, chloride, hydrochloride, (+)-(8CI); Tubocurarini chloridum; Tubocurarini chloridum [INN-Latin]; Tubocurarinum; Tubocurarinum (TN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00561	Phenformin	1-(diaminomethylidene)-2-phenethylguanidine; 1-Phenethylbiguanide; Azucaps; Beta-PEBG; Beta-Phenethybiguanide; Beta-Phenethylbiguanide; Cronoformin; D Bretard; DB Comb; DBI; DBI monohydrochloride; Db-retard; Debeone; Debeone (TN); Debinyl; Diabis; Dibein; Dibiraf; Dibotin; Dipar; Feguanide; Fenfoduron; Fenformin; Fenformina; Fenformina [INN-Spanish]; Fenormin; Glukopostin; Glyphen; Insoral; Lentobetic; Meltrol; Meltrol-50; N'-beta-Fenetilformamidiniliminourea; N'-beta-Fenetilformamidiniliminourea [Italian]; N'-beta-Phenethylformamidinylliminourea; N-(2-Phenylethyl)imidodicarbonimidic diamide; N-Phenethylbiguanide hydrochloride; Normoglucina; PHENFORMIN (SEE ALSO PHENFORMIN HYDROCHLORIDE 834-28-6); Pedg; Phenethyldiguanide; Phenformin (BAN); Phenformin [INN:BAN]; Phenformine; Phenformine HCl; Phenformine [INN-French]; Phenforminum; Phenforminum [INN-Latin]; Phenformix; Phenoformine hydrochloride; Phenylethylbiguanide; Retardo; W 32
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00590	Trimethoprim	AZT + TMP/SMX (mixture) combination; Abaprim; Alcorim-F; Alprim; Anitrim; Antrima; Antrimox; Apo-Sulfatrim; BW 56-72; BW 5672; BW-56-72; Bacdan; Bacidal; Bacide; Bacin; Bacta; Bacterial; Bacterial [Antibiotic]; Bacticel; Bactin; Bactoprim; Bactramin; Bencole; Bethaprim; Biosulten; Briscotrim; Chemotrin; Cidal; Co-Trimoxizole; Colizole; Colizole DS; Component of Bactrim; Component of Septra; Conprim; Cotrimel; Deprim; Duocide; Esbesul; Espectrin; Euctrim; Exbesul; Fermagex; Fortrim; Futin; Idotrim; Ikaprim; Instalac; KSC-4-158; KUC103659N; Kombinax; Lagatrim; Lagatrim Forte; Lastrim; Methoprim; Metoprim; Monoprim; Monotrim; Monotrim (TN); Monotrimin; NIH 204; NIH 204 (VAN); Novotrimel; Omstat; Oraprim; Pancidim; Polytrim; Priloprim; Primosept; Primsol; Proloprim; Proloprim (TN); Protrin; Purbal; Resprim; ResprimForte; Roubac; Roubal; Salvatrim; Septrin DS; Septrin Forte; Septrin S; Setprin; Sinotrim; Smz-Tmp; Stopan; Streptoplus; Sugaprim; Sulfamar; Sulfamethoprim; Sulfamethoxazole & Trimethoprim; Sulfoxaprim; Sulmeprim; Sulthrim; Sultrex; Syraprim; T 7883; TCMDC-125538; TMP; TMP/SMX (MIXTURE)); Tiempe; Tmp-Ratiopharm; Toprim; Trimanyl; Trimeth/Sulfa; Trimethioprim; Trimethopim(TMP); Trimethoprim & VRC3375; Trimethoprim (JAN/USP/INN); Trimethoprim [USAN:BAN:INN:JAN]; Trimethoprime; Trimethoprime [INN-French]; Trimethoprimum; Trimethoprimum [INN-Latin]; Trimethopriom; Trimetoprim; Trimetoprim [DCIT]; Trimetoprim [Polish]; Trimetoprima; Trimetoprima [INN-Spanish]; Trimexazole; Trimexol; Trimez-IFSA; Trimezol; Trimogal; Trimono; Trimopan; Trimpex; Trimpex (TN); Trimpex 200; Triprim; Triprim (TN); Trisul; Trisulcom; Trisulfam; Trisural; U-Prin; Uretrim; Uro-D S; Urobactrim; Utetrin; Velaten; WR 5949; Wellcoprim; Wellcoprin; Xeroprim; Zamboprim
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00620	Pramipexole	(-)-Pramipexole; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; 111GE001; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; 2-amino-6-propylaminotetrahydrobenzothiazole; Mirapex; Mirapex (TN); Mirapexin (TN); Pramipexol; Pramipexole (USAN/INN); Pramipexole [USAN:INN]; Pramipexolum; SND-919; SUD919CL2Y; Sifrol(TN); U-98528E
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00627	Acebutolol	(+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00644	Disopyramide	4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide; 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide; Alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide; Alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide; Alpha-[2-[Bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridine acetamide; D 7644; Dicorantil; Disopiramida; Disopiramida [INN-Spanish]; Disopyramide (JP15/USAN/INN); Disopyramide Free Base; Disopyramide [USAN:BAN:INN:JAN]; Disopyramidum; Disopyramidum [INN-Latin]; Gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide; H 3292; Isorythm; Lispine; Norpace (TN); Ritmodan; Rythmodan; Rythmodan (TN); Rythmodan P; Rythmodan P (TN); Rythmodan-La; SC 7031; SC-7031; Searle 703; Xi-Disopyramide
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00661	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine; Angel dust; Aurora borealis; Busy bee; Cadillac; Cl-395; Crystal; Crystal joints; Cycline; Cyclones; Dust; Elephant tranquilizer; Embalming fluid; Fenciclidina; Goon; Horse tracks; Killer weed; Magic mist; Mist; Monkey dust; PCP (Anesthetic); Peace; Peace pill; Peace weed; Phencyclidinum; Piperidine, 1-(1-phenylcyclohexyl)-; Pits; Rocket fuel; Scuffle; Selma; Sheets; Sherman; Snorts; Supergrass; Superjoint; Superweed; Surfer; Tranks; Whack; Whacky weed; Wobble weed; Zombie dust
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00665	Atropine	(+,-)-Tropyl tropate; (+-)-atropine; (+-)-hyoscyamine; (+/-)-Atropine; (+/-)-Hyoscyamine; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane; (3-exo)-8-methyl-8-azabicyclo[3.2.1]octan-3-ol; 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester); 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI); 1alphaH,5alphaH-Tropan-3alpha-ol; 1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester); 1alphaH,5alphaH-Tropan-3beta-ol; 2-Phenylhydracrylic acid 3-alpha-tropanyl ester; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate; 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate; A-Tropine; Anaspaz; Atropair; Atropen; Atropen (TN); Atropin; Atropin [German]; Atropin-flexiolen; Atropina; Atropina [Italian]; Atropine (USP); Atropine Care; Atropine Sulfate S.O.P.; Atropine [BAN]; Atropinium cation; Atropinium(1+); Atropinol; Atropt; Atrosulf; B eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Belladenal; Bellergal-S; Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester; Beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]; Beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]; Cytospaz; D1-hyoscyamine; DL-Tropanyl 2-hydroxy-1-phenylpropionate; DL-Tropyl tropate; Dl-Hyoscyamine; Dl-Tropyltropate; Endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Endo-8-methyl-8-azabicyclo[3.2.1]octan-3-ol; Eyesules; Hyoscyamine; Hyoscyamine sulfate; I-Tropine; Isopto Atropine; Isopto-atropine; Lomotil (TN); Minims; Minims Atropine; NP-010662; Neo-Diophen; OR22908; Ocu-Tropine; Protamine & Atropine; Tropan-3alpha-ol; Tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate; Tropan-3beta-ol; Tropanol; Tropic acid, 3-alpha-tropanyl ester; Tropic acid, ester with tropine; Tropine (+/-)-tropate; Tropine tropate; Tropine, tropate (ester); Troyl tropate; Urised; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00693	Prazosin	1-(3-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; CP-12299; Furazosin; Hypovase (TN); Justac; Lentopres; Minipress (TN); Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-(8CI); Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-(9CI); Prazocin; Prazosin (INN); Prazosin HCl; Prazosin [INN:BAN]; Prazosina; Prazosina [INN-Spanish]; Prazosine; Prazosine [INN-French]; Prazosinum; Prazosinum [INN-Latin]; TNP00312; Vasoflex (TN); [3H]-Prazosin; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00696	Phenoxybenzamine	2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane; 688A; A 688; Bensylyt; Bensylyt NEN; Bensylyte; Benzyl(2-chloroethyl)-(1-methyl-2-phenoxyethyl)amine; Benzylyt; Dibenylene; Dibenylin; Dibenyline; Dibenziran; Dibenzylene; Dibenzylin; Dibenzyline (TN); Dibenzyran; Fenossibenzamina; Fenossibenzamina [DCIT]; Fenoxibenzamina; Fenoxibenzamina [INN-Spanish]; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine; N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine; N-(2-chloroethyl)-N-(phenylmethyl)-1-(phenyloxy)propan-2-amine; N-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine; N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine; POB HCl; Phenoxybenzamine (INN);Phenoxybenzamine [INN:BAN]; Phenoxybenzamine Hcl; Phenoxybenzaminum; Phenoxybenzaminum [INN-Latin]
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00759	Perphenazine	1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina; 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]; 1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine; 1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine; 1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride; 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol; 2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine; 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine; 2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine; 2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine; 2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine; 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol;2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol; 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol; 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol; 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol; 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol; Apo-Perphenazine; Chlorperphenazine; Chlorpiprazine; Decentan; Emesinal; Etaperazin; Etaperazine; Ethaperazine; F-mon; Fentazin;PZC; Gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine; Gamma-[4-(beta-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine; P 6402; Perfenazina; Perfenazina [INN-Spanish]; Perfenazina [Italian]; Perfenazine; Perphenan; Perphenazin; Perphenazine (JP15/USP/INN); Perphenazine [INN:BAN:JAN]; Perphenazine [Trilafon]; Perphenazine maleate; Perphenazinum; Perphenazinum [INN-Latin]; SCH-3940; Sch 3940; Siquil (TN); Thilatazin; Tranquisan; Triavil (TN); Trifaron; Trilafon; Trilifan; Triphenot
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00840	Metoclopramide	(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide; (metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide; 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one; 2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide; 2-Methoxy-5-chloroprocainamide; 2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide; 4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; 4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide; 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide; 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide; 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp); 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide); 4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide); 4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide; 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide; 5-Chloro-2-methoxyprocainamide; Apo-Metoclop; Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-(9CI); CLOPRA-YELLOW; Cerucal; Clopra; Clopra-Yellow; Clopromate; DEL 1267; Degan (TN); Duraclamid; Elieten; Elieten (TN); Emetid; Emitasol; Emperal; Eucil; Gastrese; Gastro-Timelets; Gastrobid; Gastromax; Gastronerton; Gastrosil; Gastrotablinen; Gastrotem; Imperan; Maxeran; Maxeran (TN); Maxolon; Maxolon (TN); Meclopran; Metaclopramide; Metaclopromide; Metamide; Methochlopramide; Methoclopramide; Metochlopramide; Metoclol; Metoclopramida; Metoclopramida [INN-Spanish]; Metoclopramide (JP15/INN); Metoclopramide Monohydrochloride, Monohydrate; Metoclopramide Omega; Metoclopramide [INN:BAN:JAN]; Metoclopramidum; Metoclopramidum [INN-Latin]; Metocobil; Metramid; Moriperan; Mygdalon; N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide; Neu-Sensamide; Nu-Metoclopramide; O-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-(8CI); Octamide; Parmid; Paspertin; Peraprin; Plasil; Plasil (pharmaceutical); Pms-Metoclopramide; Pramidin; Pramiel; Pramin; Primperan; Primperan (TN); Pylomid (TN); Reclomide; Reglan; Reglan (TN); Reliveran; Terperan; Terperan (TN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00883	Camostat	0FD207WKDU; 4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate; 59721-28-7; C20H22N4O5; CCRIS 7219; CHEMBL85164; Camostat; Camostat (INN); Camostat [INN]; Camostatum; Camostatum [INN-Latin]; Dimethylcarbamoylmethyl 4-(4-guqnidinobenzoyloxy)phenylacetat; FOY 305; FOY-305; Foipan; UNII-0FD207WKDU; [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate; camostate; camostate-mesilate; foypan; p-Guanidinobenzoic acid, ester with (p-hydroxyphenyl)acetic acid, ester with N
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR00971	Terbutaline	(+-)-5-(2-((1,1-Dimethylethyl)amino)-1-hydroxyethyl)-1,3-benzenediol; (+-)-Terbutaline; 1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-(9CI); 5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL; 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; 5-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}benzene-1,3-diol; Asthmasian; Asthmasian (TN); Brethaire; Brethaire (TN); Brethine; Brethine (TN); Brican; Bricanyl; Bricanyl (TN); Bricar; Bricaril; Bricyn; KWD 2019; KWD-2019; Terbutalin; Terbutalina; Terbutalina [DCIT]; Terbutaline (INN); Terbutaline [INN:BAN]; Terbutaline sulfate; Terbutalino; Terbutalino [INN-Spanish]; Terbutalinum; Terbutalinum [INN-Latin]
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01250	Spermidine	124S209; 1pot; 4-04-00-01300 (Beilstein Handbook Reference); =99% (GC); AC1L1AQB; ACMC-20ajn3; AI3-26636; AJ-26792; AKOS006222987; AN-22947; ATHGHQPFGPMSJY-UHFFFAOYSA-N; Aminopropylbutandiamine; BDBM50009353; BPBio1_001276; BRN 1698591; BSPBio_002613; Biomol-NT_000212; C00315; CCG-205124; CHEBI:16610; CHEMBL19612; CS-0013804; CTK3J1693; DB-026892; DB03566; DTXSID4036645; DivK1c_001007; EINECS 204-689-0; FT-0629162; GTPL2390; HY-B1776; IDI1_001007; KBio1_001007; KBio2_000345; KBio2_002913; KBio2_005481; KBio3_001833; KBioGR_001542; KBioSS_000345; LS-45643; Lopac-S-2501; Lopac0_001047; M923; MCULE-8096530192; MFCD00008229; MolPort-001-761-230; N-(3-Aminopropyl)-4-aminobutylamine; N-(4-Aminobutyl)-1,3-diaminopropane; NCGC00015937-01; NCGC00015937-02; NCGC00015937-03; NCGC00015937-04; NCGC00015937-05; NCGC00024903-01; NCGC00024903-02; NCGC00024903-03; NCI60_004294; NINDS_001007; NSC528399; PA(34); RTR-003757; SC-69371; SCHEMBL15618; SDCCGMLS-0066822.P001; SPBio_000947; SR0; ST24048721; ST45025991; Spectrum2_000874; Spectrum3_000977; Spectrum4_001101; Spectrum5_001561; Spectrum_000005; Spermidin; Spermidine 0.1 M solution; Spermidine hydrochloride; Spermidine, &gt; Spermidine, analytical standard; TR-003757; Tocris-0959; U87FK77H25; UNII-U87FK77H25; ZINC1532612; bmse000116; bmse000951; bmse000955
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01278	Zolmitriptan	(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one; (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one; (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone; (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one; (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone; 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one; AscoTop; AscoTop (TN); BW-311C90; Flezol; KS-5072; Zolmitriptan RapidFilm; Zolmitriptan [USAN]; Zolmitriptane; Zolmitriptanum; Zomig; Zomig (TN); Zomig Nasal Spray; Zomig ZMT; Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan; Zomig-ZMT; Zomigon; Zomigon (TN); Zomigoro (TN)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01281	Rizatriptan	MK 462 free base; Maxalt (TN); N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine; N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine; N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; Risatriptan; Rizaliv (TN); Rizalt (TN); Rizatriptan (INN); Rizatriptan [INN:BAN]; Rizatriptan benzoat; Rizatriptanum
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01282	Naratriptan	Amerge (TN); Amerge, Naramig,Naratriptan; Colatan; N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide; N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide; N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide; Naramig; Naramig (TN); Naratriptan (INN); Naratriptanum
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01284	Trospium chloride	trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01329	Auranofin	AURANOFIN; (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate; CTK8F7877; KS-00001FB9; MMV688978; AKOS026750078; FT-0662343
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01341	Triamterene	Ademin; Ademine; Amteren; Anjal; Dazid; Diarol; Dinazide; Diren; Ditak; Diucelpin; Diurene; Diutensat; Diuteren; Dyberzide; Dyren; Dyrenium; Dytac; Dytenzide; Esiteren; Hidiurese; Hydrene; Hypertorr; Isobar; Jatropur; Jenateren; Kalspare; Masuharmin; Nephral; Noridil; Noridyl; Pterofen; Pterophene; Renezide; Reviten; Taturil; Teriam; Teridin; Triamizide; Triampur; Triamteren; Triamterena; Triamterenum; Triamteril; Triamterine; Triamthiazid; Tricilone; Trispan; Triteren; Triurene; Trizid; Turfa; Uretren; Urocaudal; Goldshield Brand of Triamterene; Jorba Brand of Triamterene; Pter ophene; SmithKline Beecham Brand of Triamterene; TRIAMTERENE USP; Thiazid Wolff; Triamteril complex; Wellspring Brand of Triamterene; Fluss 40; SKF 8542; T 4143; Ademin(e); Apo-triazide; Dyrenium (TN); Pteridine deriv. 11; SALI-PUREN; SK&F 8542; SK-8542; Tri-Span; Triamterena [INN-Spanish]; Triamterenum [INN-Latin]; SK&F-8542; Triamterene (JP15/USP/INN); Triamterene [USAN:INN:BAN:JAN]; 2,4,7-Triamino-6-fenilpteridina; 2,4,7-Triamino-6-fenilpteridina [Italian]; 2,4,7-Triamino-6-phenylpteridine; 6-PHENYL-2,4,7-TRIAMINO PTERIDINE; 6-Phenyl-2,4,7-pteridinetriamine; 6-Phenyl-2,4,7-triaminopteridine; 6-phenylpteridine-2,4,7-triamine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01348	Benzamil	Benzamil; 2898-76-2; UNII-04659UUJ94; N-(N-Benzylamidino)-3,5-diamino-6-chloropyrazine carboxamide; GNF-Pf-192; CHEMBL212579; CHEBI:34558; 04659UUJ94; 3,5-Diamino-6-chloro-N-(imino((phenylmethyl)amino)methyl)pyrazinecarboxamide; 3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide; Pyrazinecarboxamide, 3,5-diamino-6-chloro-N-(imino((phenylmethyl)amino)methyl)-; Spectrum3_001823; Prestwick1_000657; Prestwick3_000657; Prestwick2_000657; Prestwick0_000657; Lopac-B-2417; AC1L33CQ; Lopac0_000211; KBioGR_000300
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01355	Formoterol	Foradile; Formoterol tartrate; Oxeze Turbuhaler Foradil; MOLI000351; Atimos (TN); Atock (TN); Foradil (TN); Foradile (TN); Formoterol (INN); Modulite (TN); Oxeze (TN); Oxis (TN); Perforomist (TN); Formoterol, ((R*,R*)-(+-)-)-isomer; N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide; N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide; N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide; (+-)-2'-Hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide; 3-formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01356	Fenoterol	Berotec; Berotek; Fenoterolum; Phenoterol; TH 1165A; Berotec (TN); Fenoterolum [INN-Latin]; P-Hydroxyphenylorciprenaline; Th-1165a; Fenoterol (USAN/INN); Fenoterol [USAN:BAN:INN]; P-Hydroxyphenyl-orciprenaline; 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane; 1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane; 3,5-Dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol; 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol; 5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)benzene-1,3-diol; 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol; 5-{1-Hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01389	Tyramine	Tyramine; 4-(2-Aminoethyl)phenol; 51-67-2; 4-Hydroxyphenethylamine; p-Tyramine; 2-(4-Hydroxyphenyl)ethylamine; Uteramine; Tyramin; Tyrosamine; Tocosine; 4-Hydroxyphenylethylamine; Systogene; Phenol, 4-(2-aminoethyl)-; p-Hydroxyphenethylamine; Tenosin-wirkstoff; p-Hydroxyphenylethylamine; p-(2-Aminoethyl)phenol; 2-(p-Hydroxyphenyl)ethylamine; Phenethylamine, p-hydroxy-; p-beta-Aminoethylphenol; Phenol, p-(2-aminoethyl)-; Benzeneethanamine, 4-hydroxy-; Tyramine base; beta-Hydroxyphenylethylamine; NSC 249188; p-tyramine; [3H]tyramine
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01393	Oxyphenonium	Argicillin; Atrenyl; Hydroxymethylgramicidin; Methacin; Methocidin; Methocidine; Methocidinum; Metocidina; Oxiphenonum; Spastrex;Oxyphenonium Chloride; Oxyphenonium Iodide; Methocidin [DCF:INN]; Methocidine [INN-French]; Methocidinum [INN-Latin]; Metocidina [INN-Spanish]; [2-(2-Cyclohexyl-2-hydroxy-2-phenyl-acetoxy)-ethyl]-diethyl-methyl-ammonium; 2-((Cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methylethanaminium; 2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium; 2-[2-cyclohexyl(hydroxy)phenylacetoxy]-n,n-diethyl-n-methylethanaminium
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01406	Salbutamol	Aerolin; Airomir; Almotex; Anebron; Asmadil; Asmanil; Asmasal; Asmatol; Asmaven; Asmidon; Asmol; Asthalin; Asthavent; Broncovaleas; Bronter; Bugonol; Bumol; Butamol; Butohaler; Butotal; Butovent; Buventol; Cetsim; Cobutolin; Dilatamol; Ecovent; Farcolin; Gerivent; Grafalin; Libretin; Medolin; Mozal; Novosalmol; Parasma; Pneumolat; Proventil; Respax; Respolin; Rotahaler; Sabutal; Sabutamol; Salamol; Salbetol; Salbron; Salbuhexal; Salbulin; Salbupur; Salbusian; Salbutalan; Salbutamolum; Salbutan; Salbutard; Salbutine; Salbutol; Salbuven; Salbuvent; Sallbupp; Salmaplon; Salomol; Salvent; Saventol; Servitamol; Solbutamol; Spreor; Sultanol; Suprasma; Suxar; Theosal; Tobybron; Vencronyl; Ventamol; Ventilan; Ventiloboi; Ventodisks; Ventoline; Volma; Volmax; Zaperin; Albuterol Sulphate; Albuterol [USAN]; Albuterol hemisulfate; Proventil HFA; Proventil Inhaler; Salbutamol Sulphate; Salbutamol sulfate; Sultanol N; Ventalin inhaler; Ventolin Inhaler; Ventolin Rotacaps; Volare albuterol HFA; AH 3365; S 8260; Aerolin (TN); Albuterol (USP); Alti-Salbutamol; Arubendol-Salbutamol; Asmol Uni-Dose; Asthalin (TN); Broncho-Spray; Buto-Asma; Dl-Albuterol; Dl-Salbutamol; ProAi (TN); Proventil (TN); Racemic-Salbutamol; Salbu-BASF; Salbu-Fatol; Salbutamolum [INN-Latin]; Ventolin (TN); Volare easi-breathe; R,S-Albuterol; Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha-diol; Alpha-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol; DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine; Alpha'-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; Alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; (alpha1-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha-diol); 1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol; 2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol; 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol; 4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol; 4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; 4-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01412	Glycopyrrolate	GLYCOPYRROLATE; 596-51-0; Glycopyrrolate bromide; Robinul; Gastrodyn; Tarodyl; Nodapton; Tarodyn; Asecryl; Copyrrolate; Cuvposa; Glycopyrronii bromidum; AHR-504; ROBINUL FORTE; Robinal; Robanul; Bromuro de glicopirronio; Bromure de glycopyrronium; NVA-237; AHR 504; Glycopyrronii bromidum [INN-Latin]; EINECS 209-887-0; Bromure de glycopyrronium [INN-French]; Bromuro de glicopirronio [INN-Spanish]; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01420	N1-methylnicotinamide	Trigonellinamide; 1-methylnicotinamide; N(1)-Methylnicotinamide; N1-Methylnicotinamide; 3-(Aminocarbonyl)-1-methylpyridinium; 1-Methyl nicotinamide; 3-carbamoyl-1-methylpyridinium; 3106-60-3; Pyridinium, 3-carbamoyl-1-methyl-; UNII-UM47085BXC; N(sup 1)-Methylnicotinamide; 3-carbamoyl-1-methylpyridin-1-ium; BRN 3540351; 1-methylpyridine-3-carboxamide; UM47085BXC; CHEBI:16797; 1-methylpyridin-1-ium-3-carboxamide; CHEMBL1209652; Trigonellamide; Pyridinium, 3-(aminocarbonyl)-1-methyl-; 1-methyl-3-carbamoylpyridinium; 8GC; I-methyl n
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01421	Clidinium	clidinium; N-Methyl quinuclidinyl benzilate; 7020-55-5; 3-hydroxy-1-methylquinuclidinium benzilate ester; 3-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[222]octane; Ro-23773; 3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[222]octane; 1-Azoniabicyclo(222)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-; [3H]clidinium; (-)MQNB; Clidinium bromid; (1-methyl-1-azoniabicyclo[222]octan-8-yl) 2-hydroxy-2,2-di(phenyl)acetate; 3-Hydroxy-1-methylquinuclidinium benzilate (ester); Quinuclidinium,; Librax (TN); Benzilic acid, ester with 3-hydroxy-1-methylquinuclidinium; Quinuclidinium, 3-hydroxy-1-methyl-, benzilate (ester); (1-methyl-1-azoniabicyclo[222]octan-3-yl) 2-hydroxy-2,2-diphenylacetate
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01436	Procaterol	Meptin; Procaterolo; Procaterolum; Procaterol Monohydrochloride; Procaterolo [DCIT]; Procaterolum [Latin]; Meptin (TN); OPC-2009; Procaterol (INN); Procaterol [INN:BAN]; Procaterolum [INN-Latin]; (R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone; 5-[1-hydroxy-2-(propan-2-ylamino)butyl]quinoline-2,8-diol; 8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone; 8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01474	Tetramethylammonium	Tetramethylammonium; TETRAMETHYLAMMONIUM ION; tetramethylazanium; 51-92-3; N,N,N-trimethylmethanaminium; UNII-H0W55235FC; Tetramethylammonium octahydrotriborate; EINECS 235-626-5; CHEMBL46486; Methanaminium, N,N,N-trimethyl-, octahydrotriborate(1-); CHEBI:46020; Methanaminium, N,N,N-trimethyl-; H0W55235FC; Tetramethylammonium pentaiodide; Tetramethyl-Ammonium; Ammonium, (pentaiodide); AC1L1MEF; 19269-48-8; bmse000780; 64-20-0 (bromide); 75-59-2 (hydroxide); 75-57-0 (chloride); 75-58-1 (iodide); 12386-10-6; 373-68-2 (fluoride)
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01479	Debrisoquine	Debrisochinum; Debrisoquina; Debrisoquine; Debrisoquinum; Declinax; Equitonil; Isocaramidine; Tendor; DEBRISOQUIN SULFATE; Debrisoquin hemisulfate; Debrisoquine sulfate; Isocaramidine sulfate; Debrisoquina [INN-Spanish]; Debrisoquine [INN:BAN]; Debrisoquinum [INN-Latin]; Ro 5-3307/1; Sulfuric acid compound with 3,4-dihydro-2(1H)-isoquinolinecarboximidamide (1:1); 1,2,3, 4-Tetrahydro-isoquinoline-2-carboxamidine sulfate; 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-(7CI,8CI); 2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-, sulfate (2:1); 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1); 2-Amidino-1,2,3,4-tetrahydroisoquinoline; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine; 3,4-Dihydro-2(1H)-isoquinolinecarboxamidine sulfate (2:1); 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide; 3,4-Dihydro-2(1H;)-isoquinoline carboxamidine sulfate; 3,4-dihydro-1H-isoquinoline-2-carboximidamide; 3,4-dihydroisoquinoline-2(1H)-carboximidamide
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01669	Buformin	Buformin; 1-Butylbiguanide; Buformine; Butyldiguanide; Butylbiguanide; Butformin; Butylbiguanidum; Glybigid; 1-Butyldiguanide; Glybigidum; N-Butylbiguanide; Buformina; Buforminum; Buformine [INN-French]; Buforminum [INN-Latin]; Buformina [INN-Spanish]; Silubin; Adebit; BIGUANIDE, 1-BUTYL-; Buformin [USAN:INN]; W 37; Buformin HCl; Imidodicarbonimidic diamide, N-butyl-; Sindiatil; Panformin; Diabrin; Biforon; Andere; UNII-W2115E9C7B; Buformine HCl; N-butylimidodicarbonimidic diamide; DBV hydrochloride; H 224
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01670	(R)-Xamoterol	.
DTD0010	SLC22A1	Organic cation transporter 1	OCT1; SLC22A1; Solute carrier family 22 member 1; hOCT1; oct1_cds	DR01671	(S)-Xamoterol	UNII-ZIB581LRDV; ZIB581LRDV; (S)-Xamoterol; Xamoterol, (S)-; 69630-22-4; SCHEMBL11533496; ZINC1532365; UNII-7HE0JQL703 component DXPOSRCHIDYWHW-AWEZNQCLSA-N; 4-Morpholinecarboxamide, N-(2-(((2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00021	Teniposide	4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin thenylidene glucoside; 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside; 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside; Demethyl Epipodophyllotoxin Thenylidine Glucoside; Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); PTG; Teniposide (USAN/INN); Teniposide [USAN:BAN:INN]; Teniposido; Teniposido [INN-Spanish]; Teniposidum; Teniposidum [INN-Latin]; VM 26; VM-26; VM-26 (TN); Vee M-26; Veham-Sandoz; Vehem; Vumon; Vumon (TN); Vumon, VM-26, Vehem, NSC 122819, Teniposide
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00026	Fexofenadine	2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN)
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00094	Glibenclamide	1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Abbenclamide; Adiab; Apo-Glibenclamide; Azuglucon; Bastiverit; Benclamin; Betanase; Betanese 5; Calabren; Cytagon; Daonil; Daonil (TN); Debtan; Dia-basan; Diabeta; Diabeta (TN); Diabiphage; Dibelet; Duraglucon; Euclamin; Euglucan; Euglucon; Euglucon (TN); Euglucon 5; Euglucon N; Euglykon; G 0639; GBN 5; Gen-Glybe; Gewaglucon; Gilemal; Glamide; Glibadone; Gliban; Gliben; Gliben-Puren N; Glibenbeta; Glibenclamid AL; Glibenclamid Basics; Glibenclamid Fabra; Glibenclamid Genericon; Glibenclamid Heumann; Glibenclamid Riker M; Glibenclamid Riker M.; Glibenclamid-Cophar; Glibenclamid-Ratiopharm; Glibenclamida; Glibenclamida [INN-Spanish]; Glibenclamide (JP15/INN); Glibenclamidum; Glibenclamidum [INN-Latin]; Glibenil; Glibens; Glibesyn; Glibet; Glibetic; Glibil; Gliboral; Glicem; Glidiabet; Glimel; Glimide; Glimidstata; Glisulin; Glitisol; Glubate; Gluben; Gluco-Tablimen; Glucobene; Glucohexal; Glucolon; Glucomid; Glucoremed; Glucoven; Glyben; Glybenclamide; Glybenzcyclamide; Glyburide; Glyburide (USP); Glyburide (micronized); Glyburide [USAN]; Glycolande; Glycomin; Glynase; Glynase (TN); HB 419; HB 420; HB-419; HB-420; HB419; HB420; Hemi-Daonil; Hexaglucon; Humedia; Lederglib; Libanil; Lisaglucon; Maninil; Med-Glionil; Melix; Micronase; Micronase (TN); Micronized glyburide; Miglucan; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Nadib; Neogluconin; Norglicem 5; Normoglucon; Novo-Glyburide; Orabetic; Pira; Praeciglucon; PresTab; Prodiabet; Renabetic; Semi-Daonil (TN); Semi-Euglucon; Semi-Gliben-Puren N; Semi-daonil; Sugril; Suraben; Tiabet; U 26452; U-26452; UR 606; Yuglucon
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00140	Ezetimibe	(-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00238	Leucovorin	5-formyltetrahydrofolate; Citrovorum factor; Folinic acid
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00313	Cefadroxil	(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN)
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00345	Epipodophyllotoxins	(-)-epipodophyllotoxin; 137513-EP2272827A1; 137513-EP2292088A1; AC1L2Y2E; AJ-42064; BRN 0099162; C22H22O8; CHEMBL282256; Epipodophyllotoxin; Etopside; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9S)-; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-beta,8a-alpha,9-beta))-; LS-70861; SCHEMBL5792464; VP16; ZINC2572657
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00412	Efavirenz	(-)-Efavirenz; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one; DMP 266; DMP-266; EFV; EFZ; Efavirenz (JAN/INN); Efavirenz, (S)-isomer; Eravirenz; L 743726; L-741211; L-743,726; L-743725; L-743726; Met-SDF-1.beta. & Efavirenz; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; Stocrin; Stocrin (TN); Strocin (TM); Sustiva; Sustiva (TM); Sustiva (TN); Zoxazin-2-one
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00467	Morphine	Astramorph Pf; Avinza; Depodur; Duramorph Pf; Infumorph; Kadian; Morphine Sulfate; Ms Contin; Oramorph Sr
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00597	Etravirine	4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile; 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE; 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile; 65B; DAPY deriv; Diaminopyrimidine deriv; ETR; Etravirine (JAN/USAN/INN); Intelence; Intelence (TN); Intelence(TM); R 165335; R-165335; R165335; R165335-TMC125; TMC 125; TMC-125; TMC-125/R-165335; TMC125
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR00914	Glycyrrhizin	Uralsaponin A; glycyrrhizin; Glycyrrhizic acid; AC1L2TF0; Glycyrrhizin (JAN); Glycyrrhizinate; ZINC96319491; AKOS037514680; AKOS016036159; 3-Hydroxy-11 oxoolean-12-en-30-oic acid-3-O-glucuronopyranosyl-(1-2)glucuronopyranoside; D00157; C02284; beta-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-; (3beta,20beta)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucuronosyl-beta-D-glucosiduronic acid
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01213	Trabectedin	Yondelis
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01237	Technetium (99MTC) mebrofenin	F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01616	Cholyl lysyl fluorescein	.
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01640	Scutellarin	Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01698	Glutathione-S-S-glutathione	oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H
DTD0012	ABCC3	Multidrug resistance-associated protein 3	ABC31; ABCC3; ATP-binding cassette sub-family C member 3; CMOAT2; Canalicular multispecific organic anion transporter 2; EST90757; MLP2; MOAT-D; MRP3; Multi-specific organic anion transporter D	DR01708	Monomethyl-auristatin-E	Monomethyl auristatin E; UNII-V7I58RC5EJ; MMAE; V7I58RC5EJ; N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide; Monomethyl auristatin E (MMAE); Monomethylauristatin E; 4Q5; monomethyl-auristatin-e-mmae; MMAE, monomethyl auristatin E; SCHEMBL5402144; CHEMBL2103835; AOB5196; DASWEROEPLKSEI-UIJRFTGLSA-N; C39H67N5O7; MFCD22124498; ZINC85537145; s7721; CS-0837
DTD0013	ABCB4	Multidrug resistance protein 3	ABC21; ABCB4; ATP-binding cassette sub-family B member 4; GBD1; ICP3; MDR2; MDR2/3; MDR3; P-glycoprotein 3; PFIC-3; PGY3; Phosphatidylcholine translocator ABCB4	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0013	ABCB4	Multidrug resistance protein 3	ABC21; ABCB4; ATP-binding cassette sub-family B member 4; GBD1; ICP3; MDR2; MDR2/3; MDR3; P-glycoprotein 3; PFIC-3; PGY3; Phosphatidylcholine translocator ABCB4	DR00264	Verapamil	(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
DTD0013	ABCB4	Multidrug resistance protein 3	ABC21; ABCB4; ATP-binding cassette sub-family B member 4; GBD1; ICP3; MDR2; MDR2/3; MDR3; P-glycoprotein 3; PFIC-3; PGY3; Phosphatidylcholine translocator ABCB4	DR00285	Silodosin	(R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide; 160970-64-9; CHEMBL24778; CUZ39LUY82; KAD 3213; KAD-3213; KMD 3213; KMD-3213; Q-102517; Rapaflo; Rapflo; Silodosin-d6; Silodyx; UNII-CUZ39LUY82; Urief; Urorec
DTD0013	ABCB4	Multidrug resistance protein 3	ABC21; ABCB4; ATP-binding cassette sub-family B member 4; GBD1; ICP3; MDR2; MDR2/3; MDR3; P-glycoprotein 3; PFIC-3; PGY3; Phosphatidylcholine translocator ABCB4	DR00308	Vinblastine	(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid; NDC 0002-1452-01; Nincaluicolflastine; Rozevin; VLB; VR-8; Vinblastin; Vinblastina; Vinblastina (TN); Vinblastina [DCIT]; Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum; Vinblastinum [INN-Latin]; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine
DTD0013	ABCB4	Multidrug resistance protein 3	ABC21; ABCB4; ATP-binding cassette sub-family B member 4; GBD1; ICP3; MDR2; MDR2/3; MDR3; P-glycoprotein 3; PFIC-3; PGY3; Phosphatidylcholine translocator ABCB4	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0014	ABCB11	Bile salt export pump	ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0014	ABCB11	Bile salt export pump	ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0014	ABCB11	Bile salt export pump	ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP	DR00140	Ezetimibe	(-)-Sch 58235; (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone); (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one; (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione; 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone; Essex brand of ezetimibe; Ezedoc; Ezetimib; Ezetimibe (JAN/USAN/INN); Ezetimibe [USAN:INN]; Ezetrol; Inegy (TN); MK-0653; MSD brand of ezetimibe; Merck brand of ezetimibe; SCH-58235; SCH58235; Sch 58235; Schering-Plough brand of ezetimibe; Vytorin (TN); Zetia; Zetia (TN); Zetia , Ezetrol, Ezetimibe; Zient
DTD0014	ABCB11	Bile salt export pump	ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP	DR00158	Glimepiride	1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea; 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea; 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide; 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro; 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide; 64598P; Amarel; Amaryl; Amaryl (TN); Amaryl, Glista OD, Glimepiride; Endial; Glimepirid; Glimepirida; Glimepirida [Spanish]; Glimepiride (JAN/USP/INN); Glimepiride [USAN:BAN:INN]; Glimepiridum; Glimepiridum [Latin]; Glimepride; Glimer; Glymepirid; HOE 490; Hoe-490; Novo-glimepiride; PMS-glimepiride; Ratio-glimepiride; Roname; Sandoz glimepiride; Solosa
DTD0014	ABCB11	Bile salt export pump	ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP	DR00329	Glipizide	1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea; 1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea; Aldiab; Alphapharm Brand of Glipizide; CP 28,720; CP 28720; CP-28720; Digrin; Dipazide; G-117; Glibenese; Glibenese Brand of Glipizide; Glibetin; Glican; Glide; Glidiab; Glidiazinamide; Glipid; Glipizida; Glipizida [INN-Spanish]; Glipizide (USP/INN); Glipizide Extended-Release Tablets; Glipizide Kenfarma Brand; Glipizide [USAN:BAN:INN]; Glipizidum; Glipizidum [INN-Latin]; Gluco-Rite; Glucolip; Glucotrol; Glucotrol (TN); Glucotrol XL; Glucotrol XL, Glucotrol, Glipizide; Glucozide; Glupitel; Glupizide; Glyde; Glydiazinamide; Glypidizine; K 4024; K-4024; K4024; KS-1068; Kenfarma Brand of Glipizide; Lacer Brand of Glipizide; Lilly Brand of Glipizide; Melizide; Metaglip; Mindiab; Minidab; Minidiab; Minodiab; N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide; N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea; N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide; N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide; Napizide; Ozidia; Pfizer Brand 2 of Glipizide; PfizerBrand 1 of Glipizide; Samarium(III) ionophore I; Semiglynase; Sucrazide; TK 1320
DTD0014	ABCB11	Bile salt export pump	ABC16; ABCB11; ATP-binding cassette sub-family B member 11; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00015	Adefovir	((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00039	Glutathione	5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00044	Topotecan	(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin]
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00087	Cladribine	(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00112	Irinotecan	(+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin]
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00161	SN-38	(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00210	Alprostadil	(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00238	Leucovorin	5-formyltetrahydrofolate; Citrovorum factor; Folinic acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00250	Oseltamivir	(-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00287	Resveratrol	(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; (E)-5-(p-Hydroxystyryl)resorcinol; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; (E)-resveratrol; 3,4',5-Stilbenetriol; 3,4',5-Trihydroxy-trans-stilbene; 3,4',5-Trihydroxystilbene; 3,4',5-trihydroxy-stilbene; 3,5,4'-Trihydroxy-trans-stilbene; 3,5,4'-Trihydroxystilbene; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CU-01000001503-3; Cis-resveratrol; KSC-10-164; KUC104385N; PREVENTION 8 (RESVERATROL); R 5010; RM-1812; Resveratrol-3-sulfate; Resvida; SRT 501; SRT-501; SRT501; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; Trans-3,4&prime;,5-Trihydroxystilbene; Trans-3,4',5-trihydroxystilbene; Trans-resveratrol
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00295	Cyclic adenosine monophosphate	3',5'-AMP; 3',5'-cyclic AMP; 60-92-4; Adenosine 3',5'-cyclic monophosphate; Adenosine 3',5'-cyclophosphate; Adenosine 3',5'-monophosphate; Adenosine 3',5'-phosphate; Adenosine cyclic 3',5'-monophosphate; Adenosine cyclic 3',5'-phosphate; Adenosine cyclic monophosphate; Adenosine cyclophosphate; Adenosine-3',5'-cyclophosphate; Cyclic AMP; Cyclic adenylic acid; [3H]cAMP; cAMP; cyclic 3',5'-AMP; cyclic 3',5'-Adenylic acid; cyclic Adenosine 3',5'-monophosphate; cyclic Adenosine 3',5'-phosphate
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3&prime;-Azido-3&prime;-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00313	Cefadroxil	(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN)
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00320	Ceftizoxime	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00425	Cyclophosphamide	(+-)-Cyclophosphamide; (-)-Cyclophosphamide; (RS)-Cyclophosphamide; 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin; 4-Hydroxy-cyclophosphan-mamophosphatide; ASTA; ASTA B518; Asta B 518; B 518; B-518; Bis(2-Chloroethyl)phosphami de cyclic propanolamide; Bis(2-Chloroethyl)phosphamide cyclic propanolamide ester; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; C 0768; CB 4564; CB-4564; Ciclofosfamida; Ciclofosfamida [INN-Spanish]; Ciclophosphamide; Ciclophosphamide [INN]; Clafen; Claphene; Cycloblastin; Cyclophosphamid; Cyclophosphamide (INN); Cyclophosphamide (TN); Cyclophosphamide (anhydrous form); Cyclophosphamide (anhydrous); Cyclophosphamide Sterile; Cyclophosphamide anhydrous; Cyclophosphamide, (+-)-Isomer; Cyclophosphamides; Cyclophosphamidum; Cyclophosphamidum [INN-Latin]; Cyclophosphan; Cyclophosphane; Cyclophosphanum; Cyclophosphoramide; Cyclostin; Cyklofosfamid; Cyklofosfamid [Czech]; Cytophosphan; Cytophosphane; Cytoxan; Cytoxan (TN); Cytoxan Lyoph; D,L-Cyclophosphamide; Endoxan; Endoxan (TN); Endoxan R; Endoxan-Asta; Endoxana; Endoxanal; Endoxane; Enduxan; Genoxal; Lyophilized Cytoxan; Mitoxan; N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; Neosar; Neosar (TN); Occupation, cyclophosphamide exposure; Procytox; Procytox (TN); Revimmune; Revimmune (TN); SK 20501; Semdoxan; Sendoxan; Senduxan; Zyklophosphamid; Zyklophosphamid [German]
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00510	Thioguanine	2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; BW 5071; DX4; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Guanine, thio-(VAN); LT00455187; Lanvis; Lanvis (TN); Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; THG; Tabloid; Thioguanin GSK; Thioguanin-GSK; ThioguaninGSK; Thioguanine (Guanine analog); Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Thioguanine [USAN:BAN]; Tioguanin; Tioguanina; Tioguanina Wellcome; Tioguanina[INN-Spanish]; Tioguanine; Tioguanine (INN); Tioguanine GlaxoSmithKline Brand; Tioguaninum; Tioguaninum [INN-Latin]; Wellcome Brand of Thioguanine; Wellcome U3B
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00577	Cefazolin	(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN)
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00588	Abacavir	(+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (+/-)-Abacavir; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; ABC; Abacavir (INN); Abacavir [INN]; Trizivir; Ziagen; Ziagen (TM)(*Succinate salt*); Ziagen (TN); [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol; {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00657	Cholic acid	(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00715	Sulindac	(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid; 2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; Aclin; Aflodac; Alphapharm Brand of Sulindac; Apo Sulin; Apo-Sulin; Apotex Brand of Sulindac; Arthrobid; Arthrocine; Cahill May Roberts Brand of Sulindac; Chemia Brand of Sulindac; Chibret; Cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; Cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; Clinoril; Clinoril (TN); Copal; Copal resin; Copal rosin varnish; Copals; Gum copal; Kenalin; KendrickBrand of Sulindac; Klinoril; MK 231; MK-231; MK231; Merck Brand of Sulindac; Merck Sharp & Dohme Brand of Sulindac; Mobilin; Novo Sundac; Novo-Sundac; Novopharm Brand of Sulindac; Nu Pharm Brand of Sulindac; Nu Sulindac; Nu-Pharm Brand of Sulindac; Nu-Sulindac; Resin copal; S 8139; Sulindac (JAN/USP/INN); Sulindac [USAN:BAN:INN:JAN]; Sulindac sulfoxide; Sulindaco; Sulindaco [INN-Spanish]; Sulindacum; Sulindacum [INN-Latin]; Sulindal; Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid; [(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid; {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00783	Ciprofloxacin	85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR00948	Glycodeoxycholic acid	glycodeoxycholate
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01193	Prasterone	17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01300	4-(2-Aminoethyl) benzenesulfonyl fluoride	4-(2-Aminoethyl)benzenesulfonyl fluoride; 4-(2-Aminoethyl)benzenesulfonylfluoride; 4-(2-aminoethyl)-benzenesulfonyl fluoride; 4-(2-aminoethyl)benzene-1-sulfonyl fluoride; 4-beta-Aminoethylbenzolsulfofluoride; AC1L1C1L; AC1Q4OX1; AEBSF; AEBSF.HCl; AES; Benzenesulfonyl fluoride, 4-(2-aminoethyl)-; C8H10FNO2S; CHEMBL1256178; Lopac-A-8456; Lopac0_000132; MGSKVZWGBWPBTF-UHFFFAOYSA-N; Pefabloc; SR-01000075690
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01383	Camptothecin	camptothecin; Camptothecine; 7689-03-4; (S)-(+)-Camptothecin; Campathecin; d-Camptothecin; (+)-Camptothecine; (+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; NSC94600; (S)-Camptothecin; Camptothecine (8CI); 20(S)-Camptothecin; Camptothecine (S,+); CHEMBL65; UNII-XT3Z54Z28A; MLS000766223; (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; XT3Z54Z28A; CHEBI:27656; VSJKWCGYPAHWDS-FQEVSTJZSA-N; Camptothecin, Camptotheca acuminata; NSC-94600; Camptothecin derivat
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01438	Rubitecan	9-Nitrocamptothecin; 91421-42-0; Orathecin; 9-nitro-20(S)-camptothecin; Camptogen; 9-NC; RFS 2000; RFS-2000; UNII-H19C446XXB; Nitrocamptothecin; H19C446XXB; CHEBI:90225; C20H15N3O6; (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; NCGC00167969-01; (s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione; 9NC; Q-100889; (4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione; Inhaled Orathecin; L9NC; Rubitecan (inhaled); Aerosolized liposomal 9 nitro-20 (S) camptothecin; Rubitecan (inhaled), SuperGen; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin (9-NC)
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01489	Hydroxycamptothecin	10-Hydroxycamptothecin; 19685-09-7; (S)-10-Hydroxycamptothecin; Hydroxycamptothecin; 10-hydroxycamptothecine; 10-Hydroxy camptothecin; Hydroxycamptothecine; Camptothecin, hydroxy-; 10-Hydroxy-Camptothecin; (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Camptothecin, 10-hydroxy-; Camptothecine, 10-hydroxy-; UNII-9Z01632KRV; NSC 107124; HCPT; (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-Hydroxycamptothecin hydrate; NSC107124
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0015	ABCC4	Multidrug resistance-associated protein 4	ABCC4; ATP-binding cassette sub-family C member 4; MOAT-B; MOATB; MRP/cMOAT-related ABC transporter; MRP4; Multi-specific organic anion transporter B	DR01700	Azidothymidine monophosphate	azidothymidine monophosphate; SCHEMBL17515060
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00063	Gemcitabine	2',2'-DiF-dC; 2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabina [INN-Spanish]; Gemcitabine (USAN/INN); Gemcitabine HCl; Gemcitabine stereoisomer; Gemcitabinum; Gemcitabinum [INN-Latin]; Gemtro; Gemzar; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY 188011; LY-188011; LY188011; Zefei
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00112	Irinotecan	(+)-Irinotecan; (4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE; (4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate; Biotecan; Biotecan (TN); CP0; Campto (TN); Camptosar; Camptosar (TN); Camptosar, Campto, CPT-11, Irinotecan; IRINOTECAN HYDROCHLORIDE Trihydrate; IRINOTECAN, CPT-11; Irinotecan (INN); Irinotecan (TOPO1 inhibitor); Irinotecan Hcl; Irinotecan [INN:BAN]; Irinotecan hydrochloride; Irinotecanum; Irinotecanum [INN-Latin]
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00295	Cyclic adenosine monophosphate	3',5'-AMP; 3',5'-cyclic AMP; 60-92-4; Adenosine 3',5'-cyclic monophosphate; Adenosine 3',5'-cyclophosphate; Adenosine 3',5'-monophosphate; Adenosine 3',5'-phosphate; Adenosine cyclic 3',5'-monophosphate; Adenosine cyclic 3',5'-phosphate; Adenosine cyclic monophosphate; Adenosine cyclophosphate; Adenosine-3',5'-cyclophosphate; Cyclic AMP; Cyclic adenylic acid; [3H]cAMP; cAMP; cyclic 3',5'-AMP; cyclic 3',5'-Adenylic acid; cyclic Adenosine 3',5'-monophosphate; cyclic Adenosine 3',5'-phosphate
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00318	Pemetrexed	(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN]
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00365	Carboxydichlorofluorescein	5,6-carboxydichlorofluorescein
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00547	Fluorescein	fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&amp;C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D &amp; C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow
DTD0016	ABCC5	Multidrug resistance-associated protein 5	ABC33; ABCC5; ATP-binding cassette sub-family C member 5; EST277145; MOAT-C; MOATC; MRP5; Multi-specific organic anion transporter C; SMRP; pABC11	DR00904	Adenosine	(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-D-ribofuranosyl-9H-purine; 9-(beta-D-Arabinofuranosyl)adenine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-beta-D-Ribofuranosyladenine; 9beta-D-Ribofuranosyladenine; Adenine 9-beta-D-arabinofuranoside; Adenine-9-beta-D-ribofuranoside; Adenosine, homopolymer; Beta-D-Ribofuranoside, adenine-9; EA6C60C2-6AFB-4264-A2F0-541373DB950E
DTD0017	ABCC6	Multidrug resistance-associated protein 6	ABC34; ABCC6; ARA; ATP-binding cassette sub-family C member 6; Anthracycline resistance-associated protein; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; Multi-specific organic anion transporter E; PXE; PXE1; URG7	DR00284	Daunorubicin	(+)-Daunomycin; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside; (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; Acetyladriamycin; Anthracyline; Antibiotics from Streptomyces coeruleorubidus; Cerubidin; Cerubidine; DAUNORUBICIN HCL; DM1; Daunamycin; Daunarubicinum; Dauno-Rubidomycine; DaunoXome; DaunoXome (TN); Daunoblastin; Daunoblastine; Daunomycin; Daunorrubicina; Daunorubicin (INN); Daunorubicin (liposomal); Daunorubicin [INN:BAN]; Daunorubicin, Hydrochloride; Daunorubicine; Daunorubicinum; Daunorubicinum [INN-Latin]; FI 6339; FI6339; Leukaemomycin C; RP 13057; Rubidomycin; Rubomycin; Rubomycin C; VS-103
DTD0017	ABCC6	Multidrug resistance-associated protein 6	ABC34; ABCC6; ARA; ATP-binding cassette sub-family C member 6; Anthracycline resistance-associated protein; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; Multi-specific organic anion transporter E; PXE; PXE1; URG7	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0017	ABCC6	Multidrug resistance-associated protein 6	ABC34; ABCC6; ARA; ATP-binding cassette sub-family C member 6; Anthracycline resistance-associated protein; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; Multi-specific organic anion transporter E; PXE; PXE1; URG7	DR00327	Benzbromarone	(2-Ethyl-3-benzofuranyl)-(3,5-dibrom-4-hydroxyphenyl)keton; (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone; (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone; 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran; 3, 5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran; 3-[3,5-DIBROMO-4-HYDROXYBENZOYL]-2-ETHYLBENZOFURAN; AL, Benzbromaron; Acifugan; Aliud Brand of Benzbromarone; Azubromaron; Benzbromaron; Benzbromaron AL; Benzbromaron ratiopharm; Benzbromaron-ratiopharm; Benzbromarone (JP15/USAN/INN); Benzbromarone Aliud Brand; Benzbromarone Heumann Brand; Benzbromarone Sanfer Brand; Benzbromarone [USAN:INN:BAN]; Benzbromarone ratiopharm Brand; Benzbromaronratiopharm; Benzbromaronum; Benzbromaronum [INN-Latin]; Benzobromarona; Benzobromarona [INN-Spanish]; Besuric; Desuric; Exurate; Harolan; Heumann Brand of Benzbromarone; Hipurik; KETONE, 3,5-DIBROMO-4-HYDROXYPHENYL 2-ETHYL-3-BENZOFURANYL; L 2214; L 2214-Labaz; L-2214; L2214; MJ 10061; Methanone, (3; Minuric; NCI85433; Narcaricin; Normurat; Ratiopharm Brand of Benzbromarone; Sanfer Brand of Benzbromarone; Sanofi Winthrop Brand of Benzbromarone; Uricovac; Urinorm; Uroleap; Uroleap (TN)
DTD0017	ABCC6	Multidrug resistance-associated protein 6	ABC34; ABCC6; ARA; ATP-binding cassette sub-family C member 6; Anthracycline resistance-associated protein; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; Multi-specific organic anion transporter E; PXE; PXE1; URG7	DR00345	Epipodophyllotoxins	(-)-epipodophyllotoxin; 137513-EP2272827A1; 137513-EP2292088A1; AC1L2Y2E; AJ-42064; BRN 0099162; C22H22O8; CHEMBL282256; Epipodophyllotoxin; Etopside; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9S)-; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-beta,8a-alpha,9-beta))-; LS-70861; SCHEMBL5792464; VP16; ZINC2572657
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR00391	Cerivastatin	.
DTD0019	SLC10A1	Sodium/taurocholate cotransporting polypeptide	Cell growth-inhibiting gene 29 protein; NTCP; Na(+)/bile acid cotransporter; Na(+)/taurocholate transport protein; SLC10A1; Sodium/bile acid cotransporter; Solute carrier family 10 member 1	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0020	SLC10A2	Apical sodium-dependent bile acid transporter	ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0020	SLC10A2	Apical sodium-dependent bile acid transporter	ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2	DR00657	Cholic acid	(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate
DTD0020	SLC10A2	Apical sodium-dependent bile acid transporter	ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2	DR00948	Glycodeoxycholic acid	glycodeoxycholate
DTD0020	SLC10A2	Apical sodium-dependent bile acid transporter	ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0020	SLC10A2	Apical sodium-dependent bile acid transporter	ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2	DR01301	Deoxycholic acid	(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-oic acid; 3,12-Dihydroxycholanic acid; 3alpha,12alpha-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,12alpha-Dihydroxy-5beta-cholanic acid; 5-beta-Deoxycholic acid; 7-Deoxycholic acid; 7alpha-Deoxycholic acid; ATX-101; Choleic acid; Cholerebic; Cholic acid, deoxy-; Cholorebic; DEOXYCHOLIC ACID; Degalol; Deoxy cholic acid; Deoxycholatic acid; Desoxycholic acid; Desoxycholsaeure; Dihydroxycholanoic acid; Droxolan; Pyrochol; Septochol; Sodium deoxycholate; deoxycholate
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00003	Lisdexamfetamine	Lisdexamfetamine (INN); NRP104; Vyvanse (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00006	Moexipril	(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid; Moexipril (INN); Moexipril [INN:BAN]; Moexiprilum; Moexiprilum [INN-Latin]; Perdix (TN); Uniretic; Univasc (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00010	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00031	Ramipril	(2 S ,3 aS,6 aS)-1[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure; (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name); (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid; (2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic; (2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p; (2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]; Acovil; Almirall Brand of Ramipril; Altace; Altace (TN); Astra Brand of Ramipril; AstraZeneca Brand of Ramipril; Aventis Brand of Ramipril; Aventis Pharma Brand of Ramipril; Carasel; Cardace; Delix; HOE 498; HOE498; Hoe-498; Hoechst Brand of Ramipril; Hypren; Hytren; Lostapres; Monarch Brand of Ramipril; N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid; Naprix; Pramace; Pramace (discontinued); Promed Brand of Ramipril; Quark; Ramace; Ramipril (USP/INN); Ramipril [USAN:INN:BAN]; Ramiprilum; Ramiprilum [Latin]; Ramipro, Tritace, Altace, Prilace, Ramipril; Triatec; Tritace; Tritace (TN); Vesdil; Zabien; [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; [2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00057	Aminolevulinic acid	5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00058	Perindopril	(2S)-2-[(1S)-1-Carbethoxybutylamino]-1-oxopropyl-(2S,3aS,7aS)-perhydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; ACEON; Aceon (TN); Acertil (TN); Armix (TN); Coverene (TN); Coverene Cor; Coverex; Coverex (TN); Coversum; Coversum (TN); Coversyl; Cpd with unspecified MF; DW-7950; Ethyl N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvalinate; McN-A-2833; Perindopril (USAN/INN); Prestarium; Prestarium (TN); Prexanil (TN); Prexum (TN); Procaptan (TN); S-9490; SED-9490
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00071	Valsartan	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00078	Valacyclovir	2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00095	Spirapril	(2S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,9-dithia-3-azaspiro[4.4]nonane-2-carboxylic acid; Espirapril [Spanish]; Not established; Renormax; Sandopril; Sch-33844; Setrilan; Spirapril (INN); Spirapril [INN:BAN]; Spiraprilum [Latin]; TI-211-950
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00176	Ribavirin	1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00190	Amoxicillin	(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00201	Sulfasalazine	13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00215	Dexamethasone	(3H)-Dexamethasone; 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone; 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol; 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone; 16-alpha-Methyl-9-alpha-fluoroprednisolone; 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol; 16.alpha.-Methyl-9.alpha.-fluoroprednisolone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone; 16alpha-Methyl-9alpha-fluoroprednisolone; 9-alpha-Fluoro-16-alpha-methylprednisolone; 9.alpha.-Fluoro-16.alpha.-methylprednisolone; 9A-FLUORO-16BETA-METHYLPREDNISOLONE; 9alpha-Fluoro-16alpha-methylprednisolone; Adexone; Aeroseb-D; Aeroseb-Dex; Alcon Brand of Dexamethasone; Anaflogistico; Aphtasolon; Aphthasolone; Auxiron; Azium; Azium (Veterinary); Bisu DS; Calonat; Corson; Corsone; Cortisumman; DXM; Decacort; Decacortin; Decaderm; Decadron; Decadron (TN); Decadron Tablets, Elixir; Decadron, Dexamethasone; Decadron-LA; Decagel; Decaject; Decaject L.A.; Decaject-L.A.; Decalix; Decameth; Decasone; Decaspray; Dectancyl; Dekacort; Delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol; Delta1-9alpha-Fluoro-16alpha-methylcortisol; Deltafluorene; Dergramin; Deronil; Desadrene; Desametasone; Desametasone [DCIT]; Desamethasone; Desameton; Deseronil; Dex-ide; Dexa Mamallet; Dexa-Cortidelt;Dexa-Cortisyl; Dexa-Mamallet; Dexa-Scheroson; Dexa-sine; Dexacen-4; Dexacort; Dexacortal; Dexacortin; Dexadeltone; Dexafarma; Dexair; Dexalona; Dexaltin; Dexametasona; Dexametasona [INN-Spanish]; Dexameth; Dexamethansone; Dexamethasone (JP15/USP/INN); Dexamethasone Base; Dexamethasone Intensol; Dexamethasone [INN:BAN:JAN]; Dexamethasone alcohol; Dexamethasonum; Dexamethasonum [INN-Latin]; Dexamethazone; Dexamonozon; Dexapolcort; Dexaprol; Dexason; Dexasone; Dexinolon; Dexinoral; Dexone; Dexone 0.5; Dexone 0.75; Dexone 1.5; Dexone 4; Dexonium; Dexpak; Dextelan; Dezone; Dinormon; Dxms; ECR Brand of Dexamethasone; Fluormethylprednisolone; Fluormone; Fluorocort; Fortecortin; Foy Brand of Dexamethasone; Gammacorten; Hexadecadrol; Hexadrol; Hexadrol Elixir; Hexadrol Tablets; Hl-dex; ICN Brand of Dexamethasone; IontoDex; Isopto-Dex; Lokalison F; Loverine; Luxazone; MK 125; Maxidex; Mediamethasone; Merck Brand of Dexamethasone; Merz Brand 1 of Dexamethasone; Merz Brand 2 of Dexamethasone; Methylfluorprednisolone; Mexidex; Millicorten; Mymethasone; OTO-104; Ocu-trol;Pet-Derm Iii; Oradexon; Pet Derm III; Policort; Posurdex; Prednisolon F; Prednisolone F; Prodex; SK-Dexamethasone; Spoloven; Sunia Sol D; Superprednol; Turbinaire; Visumetazone
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00240	Trandolapril	(2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; (2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid; 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid; Gopten; Mavik; Mavik (TN); Odric; Odrik; Preran; RU 44570; RU-44570; RU44570; Trandolapril (JAN/INN); Trandolapril [INN:BAN]; Trandolaprilum; Trandolaprilum [Latin]; Udrik
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00250	Oseltamivir	(-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00258	Furosemide	2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00259	Cefaclor	(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00275	Bestatin	((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-D-leucine; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid; AC1L972Z; AKOS026750073; BDBM50010142; Bestatin (TN); C00732; CHEBI:140702; CHEBI:3070; CHEMBL476869; D00087; DTXSID4048430; GTPL5151; NCGC00161660-01; SCHEMBL25971; SureCN25971; UPCMLD-DP116; UPCMLD-DP116:001; Ubenimex (JP16/INN); Ubenimex (JP17/INN); ZINC01532730; ZINC1532730
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00286	Benazepril	2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; Benazapril; Benazepril (INN); Benazepril Sandoz; Benazepril Sandoz (TN); Benazepril [INN:BAN]; Benazeprilum; Benazeprilum [Latin]; Benzazepril; CGS-14824-A; Forteekor [veterinary]; Forteekor [veterinary] (TN); Fortekor (TN); Lotensin (TN); [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00313	Cefadroxil	(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00330	Cephalexin	7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00404	Valganciclovir	5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one; Cymeval; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester; L-Valine, ester with ganciclovir; RO1079070/194; RS 79070; Valcyte (TN); Valganciclovir (INN); Valganciclovir (Oral); Valganciclovir [INN:BAN]; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00429	Losartan	(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol; (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol; 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole; 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole; CL23623; Cozaar; Cozaar (TN); DUP 89; DuP-753; Hyzaar; LOSARTAN POTASSIUM; Lortaan; Losartan (INN); Losartan [INN:BAN]; Losartan monopotassium salt; Losartic; Losartic (TN); MK-954; MK954; [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00436	Metoprolol	(RS)-Metoprolol; 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol; 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol; 3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol; AstraZeneca Brand of Metaoprolol Tartrate; AstraZeneca Brand of Seloken; Beatrolol; Beloc Duriles; Beloc-Duriles; BelocDuriles; Betaloc; Betaloc (TN); Betaloc Astra; Betaloc-Astra; BetalocAstra; Betalok; CGP 2175; CGP-2175; CGP2175; Corvitol (TN); Dl-Metoprolol; Dutoprol; H 93 26; H 93-26; H 9326; LOPRESSIDONE; Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate; Lopresor; Lopresoretic; Lopressor; Lopressor (TN); Meijoprolol; Metohexal; Metoprolol (USAN/INN); Metoprolol [USAN:INN:BAN]; Metoprolol succinate; Metoprololum; Metoprololum [INN-Latin]; Metrol (TN); Metroprolol; Minax (TN); Neobloc (TN); Novartis Brand of Metprolol Tartrate; Preblok; Presolol; Selo-Zok; Selokeen (TN); Seloken; Seloken AstraZeneca Brand; Seroken; Spesicor; Spesikor; TOPROL-XL; Tartrate, Metoprolol; Toprol; Toprol-XL (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00455	Dicloxacillin	(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 1702; Dichloroxacillin; Diclocil (TN); Diclossacillina; Diclossacillina [DCIT]; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilina [INN-Spanish]; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin sodium; Dicloxacillin, Monosodium Salt, Mono-Hydrate; Dicloxacilline; Dicloxacilline [INN-French]; Dicloxacillinum; Dicloxacillinum [INN-Latin]; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; R-13423
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00480	Cyclacillin	(1-Aminocyclohexyl)penicillin; (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI); 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)penicillanic acid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid; 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid; AC 98; Aminocyclohexyl penicillin; Aminocyclohexylpenicillin; Bastcillin; C-12104; Calthor; Ciclacilina; Ciclacilina [INN-Spanish]; Ciclacillin; Ciclacillin (JP15/INN); Ciclacilline; Ciclacilline [INN-French]; Ciclacillinum; Ciclacillinum [INN-Latin]; Ciclacillum; Citosarin; Cyclacillin (USAN); Cyclacillin [USAN]; Cyclapen; Cyclapen (TN); Cyclapen-W; Cyclapen-W (TN); Noblicil; Orfilina; Peamezin; Syngacillin; Ultracillin; Vastcillin; Vastcillin (TN); Vipicil; WY 4508; WY4508; Wy-4508; Wyvital
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00482	Irbesartan	2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one; 2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one; 2-butyl-3-[ p-(o-1 H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4,4]non-1-en-4-one; 2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; 2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one; 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one; Aprovel; Aprovel (TN); Avalide (TN); Avapro; Avapro (TN); BMS 186295; BMS Brand of Irbesartan; BMS-186295; BMS-186295, SR-47436,Aprovel, Karvea, Irbesartan; Bristol Myers Brand of Irbesartan; Irbesarran; Irbesartan (JAN/USAN/INN); Irbesartan [USAN:INN]; Irbetan; Karvea; Karvea (TN); Lrbesartan; SR 47436; SR-47436; SanofiWinthrop Brand of Irbesartan
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00537	Ceftibuten	(+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7432-S; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid; Antibiotic 7432S; CETB; Cedax; Cedax (TN); Ceftem; Ceftibuten [USAN:INN:BAN]; Ceftibuten(USAN/INN); Ceftibutene; Ceftibutene [INN-French]; Ceftibuteno; Ceftibuteno [INN-Spanish]; Ceftibutenum; Ceftibutenum [INN-Latin]; Cephalosporin 7432-S; Cephem; Ceprifran; Cis-Ceftibutin; Cis-ceftibuten; Isocef; Keimax; S 7432; Sch 39720; Sch-39720; Trans-Ceftibuten
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00539	Cefmetazole	(6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 6beta-{[(cyanomethyl)sulfanyl]acetamido}-6alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; CMZ; CS 1170; CS-1170; Cefmetazole (USP/INN); Cefmetazole Monosodium Salt; Cefmetazole [USAN:INN]; Cefmetazolo; Cefmetazolo [INN-Spanish]; Cefmetazolum; Cefmetazolum [INN-Latin]; SKF 83088; U 72791; U-72791A
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00544	Cephradine	(6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid; Anspor; Anspor (TN); CEPHRADINE SODIUM; Cefradin; Cefradina; Cefradina [INN-Spanish]; Cefradine (JAN/INN); Cefradinum; Cefradinum [INN-Latin]; Cephradin; Cephradine; Cephradine (USP); Cephradine (anhydrous); Cephradine [USAN:BAN]; Eskacef; SK&F D-39304; SK-D-39304; SKF D 39304; SQ 11436; SQ-11436; SQ-22022; Sefril; VELOSEF 125; VELOSEF 250; VELOSEF 500; Velosef; Velosef (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00546	Cefixime	(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b; 7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; CFIX; CL-284635; Cefixima; Cefixime (JP15/USP/INN); Cefiximum; Denvar; FK-027; FR-17027; Necopen; Ofex (TN); Suprax (TN); Tricef
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00551	Cefamandole	(6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid; (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; Cefadole; Cefamandole (USAN/INN); Cefamandolum
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00553	Ceftriaxone	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00577	Cefazolin	(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00612	Cephaloridine	50-59-9; Ampligram; Betaine cephaloridine; CHEBI:3537; Cefaloridin; Cefaloridina; Cefaloridina [INN-Spanish]; Cefaloridine; Cefaloridinum; Cefaloridinum [INN-Latin]; Cefalorizin; Ceflorin; Cepaloridin; Cepalorin; Cephalomycine; Cephaloridin; Cephaloridinum; Ceporan; Ceporin; Ceporine; Cilifor; Deflorin; Faredina; Glaxoridin; Intrasporin; Keflodin; Keflordin; Kefloridin; Kefspor; Lloncefal; Loridine; N-(7-(2'-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SCH; Sasperin; Sefacin; UNII-LVZ1VC61HB; Verolgin; Vioviantine
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00628	Captopril	(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid; (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline; (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline; 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline; 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline; 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S); 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline; 3-Mercapto-2-methylpropionyl-proline; Acediur; Aceplus; Acepress; Acepril; Alopresin; Apopril; Apopril (TN); Asisten; C 4042; Capoten; Capoten (TN); Captolane; Captopril (JP15/USP/INN); Captopril [USAN:INN:BAN:JAN]; Captoprilum; Captoprilum [INN-Latin]; Captopryl; Captoril; Captril; Cesplon; D-2-Methyl-3-mercaptopropanoyl-L-proline; D-3-Mercapto-2-methylpropanoyl-L-proline; D-3-Mercapto-2-methylpropionylproline; Dilabar; Garranil; Garranil (discontinued); Hipertil; Hypertil; Isopresol; L-Captopril; Lopirin; Lopirin [Switzerland]; Lopril; MCO; N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline;(2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline; SA 333; SQ 14,225; SQ 14225; SQ-14,225; SQ-14,534; SQ-14225; SQ-14534; Tenosbon; Tensiomin; Tensobon; Tensoprel; X8Z; [2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00645	Carnosine	L-carnosine; beta-alanyl-L-histidine
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00692	Cefdinir	(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid; 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; BMY 28488; CFDN; Cefdinir (JP15/USAN/INN); Cefdinir [USAN:INN]; Cefdinirum; Cefdinirum [INN-Latin]; Cefdinyl; Cefdirnir; Cefzon; Cefzon (TN); FK 482; FK-482; FR-80482; KS-1038; Omnicef; Omnicef (TN); Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir; PD 134393; PD-134393
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00701	Fosinopril	fosinopril; (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid; 474519-28-3; C30H46NO7P; (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; SR-05000001490; SCHEMBL15626; AC1L1K09; CHEMBL3306578; DTXSID1023079; HMS3715N21; HMS2089P08
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00704	Cefsulodin	(6R,7R)-3-{[4-(aminocarbonyl)pyridinium-1-yl]methyl}-8-oxo-7-{[phenyl(sulfo)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; AC1NR4MP; Cefsulodin free acid (SCE-129), Antibiotic for Culture Media Use Only; DTXSID6022769; SCHEMBL65524
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00712	Ampicillin	6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00828	Cefoxitin	cefoxitin; Mefoxin; Cefoxitine; Cefoxitinum; Cefoxitina; CEPHOXITIN; Mefoxitin; Rephoxitin; UNII-6OEV9DX57Y; CHEMBL996; 6OEV9DX57Y; CFX; AK118716; DSSTox_CID_2764; DSSTox_RID_76721; DSSTox_GSID_22764; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7S)-; CAS-35607-66-0; NCGC00183034-01; ceftoxitin; Cefoxotin; 4kow
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00857	Piperacillin	(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S-(2alpha,5alpha,6beta(S*)))-6-(((((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 4-ethyl-2,3-dioxopiperazine carbonyl ampicillin; 6-(D-(-)-alpha-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanicacid; 6beta-{(2R)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid; Cl-227193; PIPC; PIPERACILLIN SODIUM; Peperacillin; Peracin; Peracin (TN); Piperacillin (INN); Piperacillin (anhydrous); Piperacillin Monosodium Salt; Piperacillin anhydrous; Pipercillin; Pipracil; Pipracil, Piper; Pipril; T-1220; Zobactin (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00961	Flucloxacillin	(2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S(2alpha,5alpha,6beta)); 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido]-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 2039; FLOXACILLIN; Flopen (TN); Floxacillin (USAN); Floxacillin [USAN]; Floxapen; Floxapen (TN); Fluclox; Flucloxacilina; Flucloxacilina [INN-Spanish]; Flucloxacillin (INN); Flucloxacillin sodium; Flucloxacillin-Sodium; Flucloxacilline; Flucloxacilline [INN-French]; Flucloxacillinum; Flucloxacillinum [INN-Latin]; Fluorochloroxacillin; MFIPC; Rel-(2R,6S)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylato
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00974	Cefpodoxime	(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CPDX; Cefpodoxim acid; Cefpodoxima; Cefpodoxima [Spanish]; Cefpodoxime (INN); Cefpodoxime [INN:BAN]; Cefpodoximum; Cefpodoximum [Latin]; Epoxim; Epoxim (TN); RU 51807; Vantin (TN)
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR00991	Lisinopril	(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid; (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline; (S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; 1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline; 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline; Acerbon; Acercomp; Alapril; Carace; Cipral; Cipril; Coric; Doneka; Hipril (TN); Inhibril; Inopril; LPR; Linopril; Linvas; Lipril; Lisinal; Lisinopril (INN); Lisinopril (anhydrous); Lisinopril anhydrous; Lisinoprilum; Lisinoprilum [Latin]; Lisipril; Lisoril; Lispril; Longes; Loril; Lysinopril; MK 521; MK 522; MK-521; N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline; N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline; N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; Noperten; Novatec; Presiten; Prinil; Prinivil; Prinivil (TN); Sinopril; Sinopryl; Tensopril; Tensopril (TN); Tensyn; Tersif; Vivatec; Zestril; Zestril (TN); [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01164	Midodrine	(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride; (+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride; (+-)-Midodrine hydrochloride; (+/-)-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol; (-)-Midodrin hydrochloride; (-)-Midodrine hydrochloride; (RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid; 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol; 1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride; 1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide; 2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide; 2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride; 2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride; 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide; 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride; A 4020 Linz; A-4020 Linz; Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride; Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride; Alphamine; Amatine; DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid; Gutron; Hipertan; MIDODRINE HYDROCHLORIDE; Metligene; Midamine; Midodrin; Midodrina; Midodrina [INN-Spanish]; Midodrine (INN); Midodrine HCL; Midodrine Monohydrochloride; Midodrine [BAN:INN]; Midodrine [INN:BAN]; Midodrine hydrochloride (JAN/USAN); Midodrine hydrochloride [USAN:JAN]; Midodrine hydrochloride [USAN]; Midodrinum; Midodrinum [INN-Latin]; N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide; N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide; Pro-Amatine; Pro-Amatine (TN); ProAmatine; Proamatine (TN); ST-1085; St 1085; St. Peter 224; TS 701; [+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01168	Sulpiride	(+/-)-Sulpiride; (RS)-(+/-)-sulpiride; (inverted question mark)-Sulpiride; Abilit; Aiglonyl; Alimoral; Allphar Brand of Sulpiride; Almirall Brand of Sulpiride; Areu Brand of Sulpiride; Arminol; Bosnyl (TN); Calmoflorine; Centrum Brand of Sulpiride; Championyl; Coolspan; Darleton; Deponerton; Desisulpid; Desitin Brand of Sulpiride; Desmenat; Digton; Dobren; Dogmatil; Dogmatil (TN); Dogmatyl; Dogmatyl (TN); Dolmatil; Dolorgiet Brand of Sulpiride; Dresent; Eglonil; Eglonyl; Eglonyl (TN); Ekilid; Enimon; Equilid; Erempharma Brand of Sulpiride; Eusulpid; Fardalan; Fidelan; Fumouzer Brand of Sulpiride; Guastil; Hennig Brand of Sulpiride; Hexal Brand of Sulpiride; Hoechst Brand of Sulpiride; Hormosan Brand of Sulpiride; Isnamide; Krewel Brand of Sulpiride; Kylistro; Lebopride; Levobren; Levopraid; Levosulpirida; Levosulpirida [INN-Spanish]; Levosulpiride [INN]; Levosulpiridum; Levosulpiridum [INN-Latin]; Lisopiride; Magnetic resonance imaging sulpiride; Mariastel; Meresa; Meresa (TN); Miradol; Mirbanil; Misulvan; N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide; Neogama; Neuraxpharm (TN); Norestran; Normum; Nufarol; Omiryl; Omperan; Ozoderpin; Pharmacia Brand of Sulpiride; Pontiride; Psicocen; Psicofarma Brand of Sulpiride; Pyrikappl; Pyrkappl; R. D. 1403; R.D. 1403; RD 1403; RV-12309; Ratiopharm (TN); Restful; Rosemont Brand of Sulpiride; S 8010; Sanofi Synthelabo Brand of Sulpiride; Sanofi-Synthelabo Brand of Sulpiride; Sernevin; Splotin; Spyfarma Brand of Sulpiride; Stamonevrol; Sulp; Sulperide; Sulpirid; Sulpirid (TN); Sulpirida; Sulpirida [INN-Spanish]; Sulpiride (JP15/USAN/INN); Sulpiride [USAN:INN:BAN:JAN]; Sulpiridum; Sulpiridum [INN-Latin]; Sulpiryd (TN); Sulpitil; Sulpivert; Sulpor; Sulpride; Sulpyrid; Suprium; Sursumid; Synedil; Tepavil; Uriach Brand of Sulpiride; Valirem; Vertigo Meresa; Vertigo neogama; Vertigo-Meresa; Vertigo-neogama; Zemorcon
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01208	Eprosartan	(4-carboxybenzyl)imidazole-5-acrylic acid; (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid; (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid; (E)-4-((2-Butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid; (E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid; 133040-01-4; 2KH13Z0S0Y; 4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid; CHEBI:4814; CHEMBL813; Eprosartan (USAN/INN); Eprosartan [USAN:BAN:INN]; F 108566; F-108566; SK&F 108566; SK&F-108566; SK-108566; SKF-108566; Teveten; Teveten (TN); UNII-2KH13Z0S0Y; [3H]eprosartan
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01243	N-acetylaspartylglutamate	NAAG; isospaglumic acid; spaglumic acid
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01319	Temocaprilate	(+)-(2S,6R)-6-(((1S)-1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; 2-(4-Carboxymethyl-5-oxo-2-thiophen-2-yl-[1,4]thiazepan-6-ylamino)-4-phenyl-butyric acid; 2D6A12Q12R; AC1L9E45; AJ-48035; AK116088; AKOS016010295; API0000849; AX8152551; BDBM50024710; O437; RNH 5139; RNH-5139; RS 5139; RS-5139; RT-015901; SCHEMBL498916; TL8000320; Temocapril Diacid; Temocaprilat; Temocaprilat [INN:BAN]; ZINC4099102; temocaprilate
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01338	Metampicillin	(2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-(methylideneamino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-[(2R)-2-(methylideneamino)-2-phenylacetamido]penicillanic acid; Blomopen; Bonopen; CHEBI:52060; Celinmicina; Elatocilline; G0H6U7VSTK; METHAMPICILLIN; Magnipen; Metampicilina; Metampicillina; Metampicilline; Metampicillinum; Micinovo; Pangocilin; Probiotic; Relyothenate; Ruticina; Rutizina; Sedomycin; Suvipen; UNII-G0H6U7VSTK; Viderpen; Viderpin; Vioplex; metampicillin; metampilene
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01360	Ceronapril	Ceranapril; SQ-29852
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01373	Cephaloglycin	CEG; Cefaloglicina; Cefaloglycin; Cefaloglycine; Cefaloglycinum; Cephaloglycine; Kafocin; Kefglycin; Cephaloglycinanhdyous; Cephaloglycin anhydrous; Cephaoglycin acid; Lilly 39435; Cefaloglicina [INN-Spanish]; Cefaloglycin (JAN); Cefaloglycine [INN-French]; Cefaloglycinum [INN-Latin]; Cephaloglycin (anhydrous); D-Cephaloglycine; D-(-)-Cephaloglycin; (6R,7R)-3-(acetoxymethyl)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-((Acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-acetoxymethyl-7beta-[(2R)-2-amino-2-phenylacetamido]-3,4-didehydrocepham-4-carboxylic acid; 7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate (ester); 7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)octane-2-carboxylic acid, acetate inner salt; 7-(2-D-alpha-Aminophenylacetamido)cephalosporanic acid; 7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup3)-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenyl-acetamido)cephalosporanic acid
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01416	Enalaprilat	EAL; Enalaprilate; Enalaprilatum; ENALAPRILAT INHIBITOR; Enalapril acid; Enalapril diacid; Enalaprilat anhydrous; Enalaprilic acid; Enalprilat hydrate; Enalprilate hydrate; Enalaprilat (USP); MK-422; Vasotec I.V.; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2); (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate; 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01519	Cefuroxime axetil	cefuroxime axetil; Ceftin; Zinnat; Elobact; Zinat; Cefuroxime 1-acetoxyethyl ester; Bioracef; CXM-AX; Coliofossim; Furoxime; Cetoxil; Celocid; Cethixim; Nivador; Medoxm; Kalcef; Zoref; Sharox-500; UNII-Z49QDT0J8Z; DRG-0157; SN 407; CCI 15641; CCI-15641; Cepazine; CCI 1564; BRN 6854419; Z49QDT0J8Z; CHEBI:3516; (RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate; C20H22N4O10S; Cefazine; Altacef
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01528	Temocapril	Temocapril; Temocaprilum; 2-((2S,6R)-6-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-4-yl)acetic acid; UNII-18IZ008EU6; 18IZ008EU6; Temocapril [INN:BAN]; Temocaprilum [INN-Latin]; C23H28N2O5S2; 2-((2S,6R)-6-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)-5-OXO-2-(THIOPHEN-2-YL)-1,4-THIAZEPAN-4-YL)ACETIC ACID; (2S-(2alpha,6beta(R*)))-6-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic acid; Temocapril (INN); AC1L9FDI
DTD0021	SLC15A1	Peptide transporter 1	HPECT1; HPEPT1; Intestinal H(+)/peptide cotransporter; Oligopeptide transporter, small intestine isoform; PEPT1; SLC15A1; Solute carrier family 15 member 1	DR01586	QSP	.
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00006	Moexipril	(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid; Moexipril (INN); Moexipril [INN:BAN]; Moexiprilum; Moexiprilum [INN-Latin]; Perdix (TN); Uniretic; Univasc (TN)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00010	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00031	Ramipril	(2 S ,3 aS,6 aS)-1[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester; (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure; (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name); (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid; (2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic; (2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p; (2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]; Acovil; Almirall Brand of Ramipril; Altace; Altace (TN); Astra Brand of Ramipril; AstraZeneca Brand of Ramipril; Aventis Brand of Ramipril; Aventis Pharma Brand of Ramipril; Carasel; Cardace; Delix; HOE 498; HOE498; Hoe-498; Hoechst Brand of Ramipril; Hypren; Hytren; Lostapres; Monarch Brand of Ramipril; N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid; Naprix; Pramace; Pramace (discontinued); Promed Brand of Ramipril; Quark; Ramace; Ramipril (USP/INN); Ramipril [USAN:INN:BAN]; Ramiprilum; Ramiprilum [Latin]; Ramipro, Tritace, Altace, Prilace, Ramipril; Triatec; Tritace; Tritace (TN); Vesdil; Zabien; [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid; [2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00057	Aminolevulinic acid	5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00058	Perindopril	(2S)-2-[(1S)-1-Carbethoxybutylamino]-1-oxopropyl-(2S,3aS,7aS)-perhydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; ACEON; Aceon (TN); Acertil (TN); Armix (TN); Coverene (TN); Coverene Cor; Coverex; Coverex (TN); Coversum; Coversum (TN); Coversyl; Cpd with unspecified MF; DW-7950; Ethyl N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvalinate; McN-A-2833; Perindopril (USAN/INN); Prestarium; Prestarium (TN); Prexanil (TN); Prexum (TN); Procaptan (TN); S-9490; SED-9490
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00078	Valacyclovir	2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00095	Spirapril	(2S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,9-dithia-3-azaspiro[4.4]nonane-2-carboxylic acid; Espirapril [Spanish]; Not established; Renormax; Sandopril; Sch-33844; Setrilan; Spirapril (INN); Spirapril [INN:BAN]; Spiraprilum [Latin]; TI-211-950
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00190	Amoxicillin	(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00240	Trandolapril	(2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; (2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid; 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid; Gopten; Mavik; Mavik (TN); Odric; Odrik; Preran; RU 44570; RU-44570; RU44570; Trandolapril (JAN/INN); Trandolapril [INN:BAN]; Trandolaprilum; Trandolaprilum [Latin]; Udrik
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00259	Cefaclor	(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00275	Bestatin	((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-D-leucine; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid; AC1L972Z; AKOS026750073; BDBM50010142; Bestatin (TN); C00732; CHEBI:140702; CHEBI:3070; CHEMBL476869; D00087; DTXSID4048430; GTPL5151; NCGC00161660-01; SCHEMBL25971; SureCN25971; UPCMLD-DP116; UPCMLD-DP116:001; Ubenimex (JP16/INN); Ubenimex (JP17/INN); ZINC01532730; ZINC1532730
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00286	Benazepril	2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid; Benazapril; Benazepril (INN); Benazepril Sandoz; Benazepril Sandoz (TN); Benazepril [INN:BAN]; Benazeprilum; Benazeprilum [Latin]; Benzazepril; CGS-14824-A; Forteekor [veterinary]; Forteekor [veterinary] (TN); Fortekor (TN); Lotensin (TN); [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid; [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00313	Cefadroxil	(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid; BL-S 578; BL-S578; CDX; Cefadroxil (JP15); Cefadroxil anhydrous; Cefadroxilo; Cefadroxilo [INN-Spanish]; Cefadroxilum; Cefadroxilum [INN-Latin]; Cephadroxil; Curisafe (TN); D-Cefadroxil; MJF-11567-3; S 578; S-578; Sumacef; Sumacef (TN)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00330	Cephalexin	7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00455	Dicloxacillin	(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid; BRL 1702; Dichloroxacillin; Diclocil (TN); Diclossacillina; Diclossacillina [DCIT]; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilina [INN-Spanish]; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin sodium; Dicloxacillin, Monosodium Salt, Mono-Hydrate; Dicloxacilline; Dicloxacilline [INN-French]; Dicloxacillinum; Dicloxacillinum [INN-Latin]; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; R-13423
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00480	Cyclacillin	(1-Aminocyclohexyl)penicillin; (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI); 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)penicillanic acid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid; 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid; AC 98; Aminocyclohexyl penicillin; Aminocyclohexylpenicillin; Bastcillin; C-12104; Calthor; Ciclacilina; Ciclacilina [INN-Spanish]; Ciclacillin; Ciclacillin (JP15/INN); Ciclacilline; Ciclacilline [INN-French]; Ciclacillinum; Ciclacillinum [INN-Latin]; Ciclacillum; Citosarin; Cyclacillin (USAN); Cyclacillin [USAN]; Cyclapen; Cyclapen (TN); Cyclapen-W; Cyclapen-W (TN); Noblicil; Orfilina; Peamezin; Syngacillin; Ultracillin; Vastcillin; Vastcillin (TN); Vipicil; WY 4508; WY4508; Wy-4508; Wyvital
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00537	Ceftibuten	(+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(E)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7432-S; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid; Antibiotic 7432S; CETB; Cedax; Cedax (TN); Ceftem; Ceftibuten [USAN:INN:BAN]; Ceftibuten(USAN/INN); Ceftibutene; Ceftibutene [INN-French]; Ceftibuteno; Ceftibuteno [INN-Spanish]; Ceftibutenum; Ceftibutenum [INN-Latin]; Cephalosporin 7432-S; Cephem; Ceprifran; Cis-Ceftibutin; Cis-ceftibuten; Isocef; Keimax; S 7432; Sch 39720; Sch-39720; Trans-Ceftibuten
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00544	Cephradine	(6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid; 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid; 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid; Anspor; Anspor (TN); CEPHRADINE SODIUM; Cefradin; Cefradina; Cefradina [INN-Spanish]; Cefradine (JAN/INN); Cefradinum; Cefradinum [INN-Latin]; Cephradin; Cephradine; Cephradine (USP); Cephradine (anhydrous); Cephradine [USAN:BAN]; Eskacef; SK&F D-39304; SK-D-39304; SKF D 39304; SQ 11436; SQ-11436; SQ-22022; Sefril; VELOSEF 125; VELOSEF 250; VELOSEF 500; Velosef; Velosef (TN)
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00546	Cefixime	(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b; 7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; CFIX; CL-284635; Cefixima; Cefixime (JP15/USP/INN); Cefiximum; Denvar; FK-027; FR-17027; Necopen; Ofex (TN); Suprax (TN); Tricef
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00546	Cefixime	(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b; 7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; CFIX; CL-284635; Cefixima; Cefixime (JP15/USP/INN); Cefiximum; Denvar; FK-027; FR-17027; Necopen; Ofex (TN); Suprax (TN); Tricef
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00654	Moxalactam	(6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-(6alpha,7alpha,7(S*)))-7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 1-Oxacephalosporin; 7b-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7a-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid; 7beta-(2-Carboxy-2-(4-hydroxyphenyl)acetamido)-7alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid; Disodium Moxalactam; Festamoxin; LMOX; Lamoxactam; Latamoxef (INN); Latamoxef [INN:BAN]; Latamoxefum; Latamoxefum [INN-Latin]; Lilly 127935; Ly127935; Moxalactam; Oxa-cephem; S-6059; Sid 734787
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00701	Fosinopril	fosinopril; (2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid; 474519-28-3; C30H46NO7P; (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; SR-05000001490; SCHEMBL15626; AC1L1K09; CHEMBL3306578; DTXSID1023079; HMS3715N21; HMS2089P08
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00712	Ampicillin	6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR00712	Ampicillin	6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0022	SLC15A2	Peptide transporter 2	Kidney H(+)/peptide cotransporter; Oligopeptide transporter, kidney isoform; PEPT2; SLC15A2; Solute carrier family 15 member 2	DR01338	Metampicillin	(2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-(methylideneamino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-[(2R)-2-(methylideneamino)-2-phenylacetamido]penicillanic acid; Blomopen; Bonopen; CHEBI:52060; Celinmicina; Elatocilline; G0H6U7VSTK; METHAMPICILLIN; Magnipen; Metampicilina; Metampicillina; Metampicilline; Metampicillinum; Micinovo; Pangocilin; Probiotic; Relyothenate; Ruticina; Rutizina; Sedomycin; Suvipen; UNII-G0H6U7VSTK; Viderpen; Viderpin; Vioplex; metampicillin; metampilene
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00017	Tiotropium	(1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide; (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide; 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide; BA 679 BR; BA 679BR; BA-679 BR; BA-679-BR; Spiriva; Spiriva (TN); Spiriva Handihaler; Spiriva Respimat; TIOTROPIUM BROMIDE; Tiotropium bromide [USAN:INN]
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00054	Quinine	(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00084	Amphetamine	Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00150	Acetyl-l-carnitine	(3S)-3-acetoxy-4-(trimethylammonio)butyrate; 1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, hydroxide, inner salt, (R)-; 1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, inner salt, (2S)-; 4398-79-2; 521T0J13MA; AC1L2BM0; Acetylcarnitine, (R)-Isomer; Acylcarnitine C2:0; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, acetate, L-; C9H18NO4; CAR(2:0); CHEBI:86045; DTXSID90196007; GTPL4520; O-acetyl-D-carnitine; SCHEMBL677128; UNII-521T0J13MA; acetyl-d-carnitine
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00184	Potassium chloride	11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00255	L-carnitine	(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00264	Verapamil	(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00277	Ipratropium	(+-)-Ipratropine; (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane; (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; 3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azoniabicyclo[3.2.1]octane; Aerodose; Aerovent; Apo-Ipravent; Apovent; Apovent (TN); Atronase; Atrovent; Atrovent (TN); Atrovent Aerosol; Atrovent Hfa; Atrovent Nasal; Bitrop; Disne-Asmol; Ipatropium Bromide; Ipratropium bromide; Ipravent; Ipvent; Kendral-Ipratropium; N-Isopropylatropine; Narilet; Rhinotrop; Rhinovent; Rinatec; Rinoberen; Rinovagos; Vagos; X8M; [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00350	D-carnitine	(+)-Carnitine; (3S)-3-hydroxy-4-(trimethylammonio)butanoate; (3S)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (S)-3-Hydroxy-4-(trimethylammonio)butanoate; CHEBI:11060; Carnitine D-form; D-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; D-carnitine; U9VY0ZOK7A; UNII-U9VY0ZOK7A
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00369	Beta-lactam antibiotics	Beta-lactam antibiotics (bacterial infections)
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR00564	Pyrilamide	2-((2-(Dimethylamino)ethyl)-(p-methoxybenzyl)amino)pyridine; 2-((p-Methoxybenzyl)(2-(dimethylamino)ethyl)amino)pyridine; 2-[(p-Methoxybenzyl)[2-(dimethylamino)ethyl]amino]pyridine; 2-[[2-(Dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine; 2-[[2-(Dimethylamino)ethyl]-(p-methoxybenzyl)amino]pyridine; 2-dimethylaminoethyl-p-anisyl-(2-pyridyl)amine; Afko-Hist; Anhistabs; Anhistol; Antalergan; Antallergan; Antamine; Anthisan; Copsamine; Coradon; Dipane; Dorantamin; Harvamine; Histacap; Histalon; Histapyran; Histasan; Isamin; Kriptin; Maranhist; Mepiramina; Mepiramina [INN-Spanish]; Mepiramine; Mepyramin; Mepyramin [German]; Mepyramine (INN); Mepyramine [INN:BAN]; Mepyraminum; Mepyraminum [INN-Latin]; Mepyren; N',N'-Dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)ethylenediamine; N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine; N,N-dimethyl-N'-{[4-(methyloxy)phenyl]methyl}-N'-pyridin-2-ylethane-1,2-diamine; N-((4-Methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N-(4-methoxybenzyl)-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha.-pyridyl)ethylenediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-(pyridylethylene)diamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridyl-1,2-ethanediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine; N-(para-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine; N-Dimethylamino-aethyl-N-p-methoxy-benzyl-.alpha.-amino-pyridin-maleat; N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyridin-2-amine; N-p-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine; N-para-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine; Neo-Bridal; Neoantergan; Neobridal; Nyscaps; P-Methoxy-benzyl-.alpha.-pyridyl-dimethyl-aethylendiamin; P-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin; P-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin [German]; PYRA; Paraminyl; Parmal; Pyramal; Pyranisamine; Pyrilamide; Pyrilamine; Pyrilamine salt with fine resin; R.d. 2786; RP 2786; Stamine; Stangen; Statomin; Thylogen; Wait's green mountain antihistamine; [3H]mepyramine; [3H]pyrilamine
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR01232	Acetylcarnitine	(-)-Acetylcarnitine; (3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate; (R)-Acetylcarnitine; 3040-38-8; 6DH1W9VH8Q; ALCAR; Acetyl-L-(-)-carnitine; Acetyl-L-carnitine; Acetylcarnitine, L-; CAR(2:0); CHEBI:57589; Carnitine, acetyl-, L-; HSDB 7587; L-ACETYLCARNITINE; L-Acetyl carnitine; L-Carnitine acetyl ester; L-O-Acetylcarnitine; Levocarnitine acetyl; Nicetile; O-Acetyl-L-carnitine; R-Acetylcarnitine; RDHQFKQIGNGIED-MRVPVSSYSA-N; UNII-6DH1W9VH8Q; acetyl l-carnitine; acetyl-carnitine; acetylcarnitine
DTD0023	SLC22A5	Organic cation/carnitine transporter 2	CDSP; High-affinity sodium-dependent carnitine cotransporter; OCTN2; SLC22A5; Solute carrier family 22 member 5	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00015	Adefovir	((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00066	Cidofovir	(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate; CDV; Cidofovir (Vistide); Cidofovir (anhydrous); Cidofovir anhydrous; Cidofovirum; Forvade; GS 0504; GS 504; GS-0504; GS-504; GS504; HPMPC; Vistide; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00083	Glutarate	(C4-C6) Dibasic acids; 1,3-Propanedicarboxylic acid; 1,5-Pentanedioic acid; 110-94-1; AI3-24247; BRN 1209725; CAS-110-94-1; CHEBI:17859; Carboxylic acids, C6-18 and C5-15-di-; Carboxylic acids, di-, C4-6; DSSTox_CID_1654; DSSTox_GSID_21654; DSSTox_RID_76266; EINECS 203-817-2; GLUTARIC ACID; Glutaric acid, 99%; Glutarsaeure; H849F7N00B; HSDB 5542; JFCQEDHGNNZCLN-UHFFFAOYSA-N; MFCD00004410; NSC 9238; NSC9238; Pentandioate; Pentandioic acid; Pentanedioic acid; UNII-H849F7N00B; glutarate; n-Pyrotartaric acid; propane-1,3-dicarboxylic acid
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00091	Dimesna	Tavocept (TN)
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00096	Trifluridine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN)
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00101	Edaravone	(MCI-186); 1-Fenyl-3-methyl-2-pyrazolin-5-on; 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]; 1-Phenyl-3-methyl-5-oxo-2-pyrazoline; 1-Phenyl-3-methyl-5-pyrazolone; 1-Phenyl-3-methylpyrazolone; 1-Phenyl-3-methylpyrazolone-5; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; 3-Methyl-1-phenyl-2-pyrazoline-5-one; 3-Methyl-1-phenyl-5-pyrazolone; 3-Methyl-1-phenylpyrazol-5-one; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one; 5-methyl-2-phenyl-4H-pyrazol-3-one; AE-641/00371017; C.I. Developer 1; CDS1_000986; CI Developer 1; Developer Z; Edarabone; Edaravone; Edaravone (JAN/INN); Edaravone [INN]; Edaravone(jan); IN1263; M0687; MCI 186; Methylphenylpyrazolone; Monopyrazolone; Norantipyrine; Norphenazone; Phenyl methyl pyrazolone; Phenylmethylpyrazolone; Radicut; Radicut (TN)
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00172	Uric acid	urate
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00175	Zalcitabine	1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; 2',3'-DIDEOXYCYTIDINE; 2',3'-Dideoxycytidine & Interferon-alpha; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); 2,3-dideoxycytidine; 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; Beta-D-2',3'-Dideoxycytidine; Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor; Beta-D-DDC; Cytidine, 2',3'-dideoxy & Interferon alpha; Cytidine, 2',3'-dideoxy-& Colony-stimulating factor; D 5782; DDC (DDC); DS-4152 & ddC; DdC; DdC & GM-CSF; DdC & IFN-alpha; DdC & Interferon alpha; DdC & NP (from PHCA or HSA); DdC & sCD4; DdC (Antiviral); DdCyd; Dideoxycytidine; HIVID; Hivid (TN); Hivid(TM); Hivid, Dideoxycytidine, NSC 606170, Zalcitabine; Interferon AD + ddC; KS-1130; Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine; PC-SOD & ddC; Ro 24-2027/000; Ro-24-2027/000; SRI-7707; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; Zalcitabine (JAN/USP/INN); Zalcitabine [USAN:INN:BAN]; Zalcitibine
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00190	Amoxicillin	(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AMK (TN); AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; AMPC; Actimoxi; Actimoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; Alphamox (TN); Amoclen; Amoksibos (TN); Amoksiklav (TN); Amolin; Amopen; Amopenixin; Amoxi; Amoxi-Mast; Amoxibiotic; Amoxibiotic (TN); Amoxicaps; Amoxicilina; Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillanyl; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicillin anhydrous; Amoxicilline; Amoxicilline [INN-French]; Amoxicilline [INN]; Amoxicillinum; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxiden; Amoxil; Amoxil (TN); Amoxin (TN); Amoxivet; Amoxycillin; Amoxycillin Trihydrate; Anemolin; Apo-Amoxi; Apo-Amoxi (TN); Aspenil; Augmentin (TN); BL-P 1410; BLP 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Biomox; Bristamox; Cemoxin; Cilamox (TN); Clamoxyl; Clamoxyl (TN); Curam (TN); D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-Amoxicillin; Dedoxil (TN); Delacillin; DisperMox; Dispermox (TN); Duomox (TN); Efpenix; Enhancin (TN); Flemoxin; Geramox (TN); Gimalxina (TN); Hiconcil; Hiconcil (TN); Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Isimoxin (TN); Klavox (TN); Lamoxy; Lamoxy (TN); Larotid; Metafarma capsules; Metifarma capsules; Moxacin; Moxal; Moxatag; Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox; Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Piramox; Polymox; Polymox (TN); Ro 10-8756; Robamox; Samthongcillin (TN); Sandoz (TN); Sawamox PM; Senox (TN); Sinacilin (TN); Sumox; Tolodina; Tolodina (TN); Trimox; Trimox (TN); Unicillin; Utimox; Vetramox; Wymox; Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN)
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00210	Alprostadil	(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00229	Ochratoxin A	(-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00250	Oseltamivir	(-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00258	Furosemide	2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00259	Cefaclor	(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00278	Famotidine	(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide; Amfamox; Antodine; Apo-Famotidine; Apogastine; Bestidine; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Dibrit 40; Digervin; Dinul; Dipsin; Dispromil; Dispronil; Duovel; Durater; Evatin; F 6889; F0530; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Fadin; Fadine; Fadyn; Fagastine; Famo; Famocid; Famodar; Famodil; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotidina [Spanish]; Famotidine [USAN:BAN:INN:JAN]; Famotidinum [Latin]; Famotin; Famovane; Famowal; Famox; Famoxal; Famtac; Famulcer; Fanobel; Fanosin; Fanox; Farmotex; Ferotine; Fibonel; Fluxid; Fudone; Ganor; Gaster; Gastridan; Gastridin; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; HS-0054; Hacip; Huberdina; Ingastri; Invigan; L 643341; Lecedil; Logos; MK 208; MK-208; Mensoma; Midefam; Mosul; Motiax; Muclox; Mylanta AR; N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; Neocidine; Nevofam; Notidin; Novo-Famotidine; Nu-Famotidine; Nulceran; Nulcerin; PEPCID; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Panalba; Pepcid (TN); Pepcid AC; Pepcid AC Gelcaps; PepcidRPD; Pepcidac; Pepcidin; Pepcidin Rapitab; Pepcidina; Pepcidine; Pepcidine (TN); Pepdif; Pepdine; Pepdul; Pepfamin; Peptan; Peptidin; Peptifam; Pepzan; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); Purifam; Quamatel; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Sedanium-R; Sigafam; Supertidine; Tairal; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; Weimok; Whitidin; YM 11170; YM-11170; YM-1170; Yamarin
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3&prime;-Azido-3&prime;-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00320	Ceftizoxime	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00343	6-Carboxyfluorescein	3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-6-carboxylic acid; 3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6-carboxylic acid; 5(6)-carboxy fluorescein; 6-Carboxyfluorescein; 6-Carboxyfluorescein, 96%; 6-FAM; FLUOS; J-100061; Spiro(isobenzofuran-1(3H),9'-(9H)xanthene)-6-carboxylic acid, 3',6'-dihydroxy-3-oxo-; Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 3',6'-dihydroxy-3-oxo-; carboxyfluorescein
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00547	Fluorescein	fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&amp;C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D &amp; C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR00577	Cefazolin	(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN)
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR01200	Meropenem	(1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid trihydrate; (2S,3R,4R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid; (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid; MEPM; MERONEM; Mepem (TN); Meronem; Meronem (TN); Meropen; Meropen (TN); Meropenem (INN); Meropenem anhydrous; Merrem; Merrem (TN); Merrem I.V. (TN); Neopenem (TN); SM-7338
DTD0024	SLC22A6	Organic anion transporter 1	OAT1; PAH transporter; PAHT; ROAT1; Renal organic anion transporter 1; SLC22A6; Solute carrier family 22 member 6; hOAT1; hPAHT; hROAT1	DR01218	Mycophenolic acid	(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acide mycophenolique; Acido micofenolico; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum; CCRIS 5565; Lilly-68618; Ly 68618; Melbex; Micofenolico acido; Micofenolico acido [Spanish]; Mycophenoic acid; Mycophenolate; Mycophenolsaeure; Myfortic; NSC 129185; NSC-129185; UNII-HU9DX48N0T; mycophenolic acid
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00015	Adefovir	((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid; 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid; 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; ADEFOVIR; GS 0393; GS 393; GS-0393; N-(2-Phophonomethoxyethyl-2,6-diaminopurine); N-(2-Phosphonylmethoxyethyl)adenine; PMEA; {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00066	Cidofovir	(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate; CDV; Cidofovir (Vistide); Cidofovir (anhydrous); Cidofovir anhydrous; Cidofovirum; Forvade; GS 0504; GS 504; GS-0504; GS-504; GS504; HPMPC; Vistide; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00071	Valsartan	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00074	Allopurinol	4-HPP; A 8003; AL-100; Adenock; Ailural; Ailurial; Allo-Puren; Allohexal; Allohexal (TN); Allohexan; Alloprin; Allopur; Allopurin; Allopurinol(I); Allopurinolum; Allorin; Allosig (TN); Allozym; Allpargin; Allural; Aloprim; Alopurinol; Aloral; Alositol; Aluline; Anoprolin; Anzief; Apo-Allopurinol; Apulonga; Apurin; Apurol; Atisuril; B. W. 56-158; BW 56-158; BW 56158; BW-56-158; Bleminol; Bloxanth; Caplenal; Capurate; Cellidrin; Cosuric; Dabrosin; Dabroson; Dura Al; Embarin; Epidropal; Epuric; Foligan; Geapur; Gichtex; Gotax; Hamarin; Hexanuret; Jenapurinol; Ketanrift; Ketobun-A; Ledopur; Lopurin; Lysuron; Milurit; Milurite; Miniplanor; Monarch; Nektrohan; Novopurol; Pan Quimica; Progout; Progout (TN); Pureduct; Puricos (TN); Purinol; Quimica, Pan; Remid; Riball; Rimapurinol; Roucol; Sigapurol; Suspendol; Takanarumin; Tipuric; Urbol; Uribenz; Uricemil; Uridocid; Uriprim; Uripurinol; Uritas; Urobenyl; Urolit; Urosin; Urtias; Urtias 100; Xanthomax; Xanturat; Xanturic; Zygout; Zyloprim; Zyloprim (TN); Zyloric; Zyloric (TN)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00078	Valacyclovir	2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00086	L-tryptophan	(-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin]
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00091	Dimesna	Tavocept (TN)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00101	Edaravone	(MCI-186); 1-Fenyl-3-methyl-2-pyrazolin-5-on; 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]; 1-Phenyl-3-methyl-5-oxo-2-pyrazoline; 1-Phenyl-3-methyl-5-pyrazolone; 1-Phenyl-3-methylpyrazolone; 1-Phenyl-3-methylpyrazolone-5; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; 3-Methyl-1-phenyl-2-pyrazoline-5-one; 3-Methyl-1-phenyl-5-pyrazolone; 3-Methyl-1-phenylpyrazol-5-one; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one; 5-methyl-2-phenyl-4H-pyrazol-3-one; AE-641/00371017; C.I. Developer 1; CDS1_000986; CI Developer 1; Developer Z; Edarabone; Edaravone; Edaravone (JAN/INN); Edaravone [INN]; Edaravone(jan); IN1263; M0687; MCI 186; Methylphenylpyrazolone; Monopyrazolone; Norantipyrine; Norphenazone; Phenyl methyl pyrazolone; Phenylmethylpyrazolone; Radicut; Radicut (TN)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00127	Tetracycline	(-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00163	Ranitidine	(E)-1-N'-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; Achedos; Acidex; Alquen; Atural; Axoban; Biotidin; Coralen; Curan; Duractin; Ezopta; Fendibina; Gastrial; Gastridina; Gastrolav; Gastrosedol; Istomar; Kuracid; Logast; Mauran; Melfax; Microtid; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; Noctone; Nu-Ranit; Ptinolin; Quantor; Quicran; RND; Radinat; Randin; Rani-Q; Rani-nerton; Raniben; Raniberl; Ranibloc; Ranidine; Ranifur; Ranin; Raniogas; Raniplex; Ranisen; Raniter; Ranitidin; Ranitidina; Ranitidina [INN-Spanish]; Ranitidine (TN); Ranitidine (USAN/INN); Ranitidine HCL; Ranitidine [USAN:BAN:INN]; Ranitidinum; Ranitidinum [INN-Latin]; Ranitiget; Ranitin; Rantacid; Rantidine; Rantidine HCL; Ratic; Raticina; Sampep; Sostril; Taural; Terposen; Ul-Pep; Ulceranin; Ulcex; Ultidine; Urantac; Verlost; Vesyca; Vizerul; Weichilin; Weidos; Xanidine; ZANTAC; Zantab; Zantac (TN); Zantadin; Zantic
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00172	Uric acid	urate
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00226	Saxagliptin	(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00229	Ochratoxin A	(-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00250	Oseltamivir	(-)-oseltamivir; (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid; 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid; Agucort; Agucort (TN); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate; GS 4104; GS-4104; GS4104; OTV; Oseltamivir (INN); Oseltamivir [INN:BAN]; Oseltamivirum; Ro-64-0796; Ro-640796; Tamiflu (*Phosphate salt 1:1*); Tamiflu (TN); Tamiflu-Free; Tamvir
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00254	Sitagliptin	(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Janumet; Januvia; Januvia (TN); Januvia (merck & Co.); MK-0431; Sitagliptan; Sitagliptin (Prop.INN); Sitagliptin phosphate; Xelevia
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00258	Furosemide	2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00259	Cefaclor	(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate; 7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; Alenfral; Alenfral (TN); Alfacet; Alfatil; Alfatil Kapseln; CCL; Ceclor; Ceclor (TN); Ceclor, Distaclor, Keflor, Raniclor, Cefaclor; Cefaclor (JP15); Cefaclor (USP); Cefaclor [USAN:INN:BAN:JAN]; Cefaclor anhydrous; Cefaclor hydrate; Cefaclor monohydrate; Cefaclor-1-wasser; Cefaclorum; Distaclor; Distaclor (TN); Dystaclor MR; Keflor (TN); Kefolor; Kefolor Suspension; L-Kefral; Lilly 99638 hydrate; Muco Panoral; Panacef; Panoral; Raniclor (TN); S-6472
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00272	Bumetanide	3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00278	Famotidine	(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide; Amfamox; Antodine; Apo-Famotidine; Apogastine; Bestidine; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Dibrit 40; Digervin; Dinul; Dipsin; Dispromil; Dispronil; Duovel; Durater; Evatin; F 6889; F0530; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Fadin; Fadine; Fadyn; Fagastine; Famo; Famocid; Famodar; Famodil; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotidina [Spanish]; Famotidine [USAN:BAN:INN:JAN]; Famotidinum [Latin]; Famotin; Famovane; Famowal; Famox; Famoxal; Famtac; Famulcer; Fanobel; Fanosin; Fanox; Farmotex; Ferotine; Fibonel; Fluxid; Fudone; Ganor; Gaster; Gastridan; Gastridin; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; HS-0054; Hacip; Huberdina; Ingastri; Invigan; L 643341; Lecedil; Logos; MK 208; MK-208; Mensoma; Midefam; Mosul; Motiax; Muclox; Mylanta AR; N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; Neocidine; Nevofam; Notidin; Novo-Famotidine; Nu-Famotidine; Nulceran; Nulcerin; PEPCID; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Panalba; Pepcid (TN); Pepcid AC; Pepcid AC Gelcaps; PepcidRPD; Pepcidac; Pepcidin; Pepcidin Rapitab; Pepcidina; Pepcidine; Pepcidine (TN); Pepdif; Pepdine; Pepdul; Pepfamin; Peptan; Peptidin; Peptifam; Pepzan; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); Purifam; Quamatel; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Sedanium-R; Sigafam; Supertidine; Tairal; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; Weimok; Whitidin; YM 11170; YM-11170; YM-1170; Yamarin
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3&prime;-Azido-3&prime;-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00320	Ceftizoxime	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)-2Z-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxyamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-carbonsaeure-7-(Z)-(O-methyloxim); (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2,3-didehydropenam-2-carboxylic acid; Cefizox (TN); Ceftix; Ceftizoxima; Ceftizoxima[INN-Spanish]; Ceftizoxime (INN); Ceftizoxime Monosodium Salt; Ceftizoxime [INN:BAN]; Ceftizoximum; Ceftizoximum [INN-Latin]; Eposerin; FK-749; FK749; FR 13749; FR-13479; FR-13749; SK&F 88373-2; SKF-88373; Syn-7-(2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00577	Cefazolin	(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN)
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00612	Cephaloridine	50-59-9; Ampligram; Betaine cephaloridine; CHEBI:3537; Cefaloridin; Cefaloridina; Cefaloridina [INN-Spanish]; Cefaloridine; Cefaloridinum; Cefaloridinum [INN-Latin]; Cefalorizin; Ceflorin; Cepaloridin; Cepalorin; Cephalomycine; Cephaloridin; Cephaloridinum; Ceporan; Ceporin; Ceporine; Cilifor; Deflorin; Faredina; Glaxoridin; Intrasporin; Keflodin; Keflordin; Kefloridin; Kefspor; Lloncefal; Loridine; N-(7-(2'-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SCH; Sasperin; Sefacin; UNII-LVZ1VC61HB; Verolgin; Vioviantine
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00646	Chlorothiazide	2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; 6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Aldoclor; Alurene; C 4911; Chloriazid; Chlorosal; Chlorothiazid; Chlorothiazide (JAN/USP/INN); Chlorothiazide [USAN:INN:BAN]; Chlorothiazidum; Chlorothiazidum [INN-Latin]; Chlorotiazida; Chlorthiazid; Chlorthiazide; Chlorthiazidum; Chlortiazid; Chlorurit; Chlotride; Chlrosal; Clorotiazida; Clorotiazida [INN-Spanish]; Clorotiazide; Clorotiazide [DCIT]; Clotride; Component of Aldoclor; Diupres; Diuresal; Diuril; Diuril (TN); Diuril Boluses; Diuril Boluses, Veterinary; Diuril, Chlotride, Chlorothiazide; Diurilix; Diurite; Diutrid; Flumen; Minzil; Neo-Dema; Salisan; Salunil; Saluretil; Saluric; Sk-chlorothiazide; Thiazide; Urinex; Warduzide; Yadalan
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00692	Cefdinir	(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid; 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; BMY 28488; CFDN; Cefdinir (JP15/USAN/INN); Cefdinir [USAN:INN]; Cefdinirum; Cefdinirum [INN-Latin]; Cefdinyl; Cefdirnir; Cefzon; Cefzon (TN); FK 482; FK-482; FR-80482; KS-1038; Omnicef; Omnicef (TN); Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir; PD 134393; PD-134393
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00707	Trichloromethiazide	(+-)-6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-,1,1-dioxide; 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide; 3-Dichloromethyl-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide; 3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; 3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide; 3-Dichloromethylhydrochlorothiazide; 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide; 6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide; 6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide; 6-Chloro-3-[dichloromethyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide; 6-Chloro-3-dichloromethyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide; 6-Chloro-3-dichloromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide; Achletin; Achletin (TN); Anistadin; Aponorin; Aquazide; Carvacron; Chlopolidine; Ciba 7057-Su; Cretonin; Diu-Hydrin; Diu-Hydrin (TN); Diurazida; Diurese; Diuroral;Esmarin; Eurinol; Fluitran; Flurese; Flurese (VAN); Flutra; Gangesol; Hydrotrichlorothiazide; Intromene; Isestran; Jones Brand of Trichloromethiazide; Kubacron; Metahydrin; Metatensin; Nakva; Naqua; Naqua (TN); Naquasone; Salurin (wadel); Schebitran; Schering Brand of Trichlormethiazide; Tachionin; Tolcasone; Trichlordiuride; Trichlorex; Trichlormas; Trichlormetazid; Trichlormethiazid; Trichlormethiazide (JP15/USP/INN); Trichlormethiazide W/ Reserpine; Trichlormethiazide [INN:JAN]; Trichlormethiazidum; Trichlormethiazidum [INN-Latin]; Trichloromethiadiazide; Trichloromethiazide; Trichloromethiazide, 6; Triclordiuride; Triclormetiazida; Triclormetiazida[INN-Spanish]; Triclormetiazide; Triclormetiazide [DCIT]; Triclormetiazide [Italian]; Triflumen (TN); Triflumen;American Urologicals Brand of Trichloromethiazide
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR00783	Ciprofloxacin	85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR01193	Prasterone	17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR01194	Cefotiam	(6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-(2-dimethylaminoethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}thio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7b-[2-(aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid; 7beta-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid; Abbott-48999; Aspil; Aspil (TN); CEFOTIAM HYDROCHLORIDE; CGP 14221E; CGP-14221-E; CTM; Cefotiam (INN); Cefotiam [INN:BAN]; Cefotiamum; Cefotiamum [INN-Latin]; Ceradolan; Haloapor; SCE-963
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR01234	Phenolsulfonphthalein	3,3-Bis(4-hydroxyphenyl)-3H-benzo[c][1,2]oxathiole 1,1-dioxide; 4,4'-(3H-2,1-Benzoxathiol-3-ylidene)diphenol S,S-dioxide; BRN 0326470; EINECS 205-609-7; Fenolipuna; I6G9Y0J1OJ; MFCD00003552; NSC 10459; NSC10459; PHENOL RED; PSP; PSP (indicator); Phenol Red, ACS reagent; Phenol red; Phenol, 4,4'-(1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis-; Phenolred; Phenolsulfonephthalein; Phenolsulphonphthalein; Phenosulfophthalein; Sulfonphthal; Sulphental; Sulphonthal; UNII-I6G9Y0J1OJ; phenolsulfonphthalein
DTD0025	SLC22A8	Organic anion transporter 3	OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3	DR01322	Cilostazol	Cilostazole; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 73963-72-1; BRN 3632107; C 0737; C20H27N5O2; CHEBI:31401; CL23867; Cilostazol (JP15/USAN/INN); Cilostazol [INN:JAN]; Cilostazole; Cilostazolum; Cilostazolum [INN-Latin]; MLS000028470; OPC 13013; OPC 21; OPC-13013; OPC-21; Otsuka brand of cilostazol; Pleta (TN); Pletaal; Pletal; Pletal (TN); Pletal, Cilostazol; UNII-N7Z035406B; cilostazol
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00127	Tetracycline	(-)-Tetracycline; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Abramycin; Abricycline; Achromycin; Achromycin (naphthacene derivative); Achromycin V; Achromycin, naphthacene derivative; Agromicina; Ambramicina; Ambramycin; Amycin; Biocycline; Bristaciclin; Bristaciclin alpha; Bristaciclina; Bristacycline; Cefracycline; Cefracycline suspension; Centet (base); Ciclibion; Component of Tetrastatin; Copharlan; Criseociclina; Cyclomycin; Cyclopar; Cytome; Democracin; Deschlorobiomycin; Dumocyclin; Enterocycline; Hostacyclin; Lemtrex (base); Lexacycline; Limecycline; Liquamycin (Veterinary); Liquamycin, veterinary; Medocycline; Mericycline; Methyl-1,11-dioxo-2-naphthacenecarboxamide; Micycline; Neocycline; Omegamycin; Orlycycline; Panmycin; Panmycin (TN); Piracaps (base); Polycycline; Polycycline (VAN); Polycycline (antibiotic); Polycycline, antibiotic; Polyotic; Purocyclina; Resteclin; Robitet; Roviciclina; SK-Tetracycline; Sanclomycine; Solvocin; Sumycin; Sumycin (TN); Sumycin syrup; T-125; Tetra-Co; Tetrabon; Tetrachel; Tetraciclina; Tetraciclina [INN-Spanish]; Tetracycl; Tetracyclin; Tetracycline & VRC3375; Tetracycline (JAN/USP/INN); Tetracycline (internal use); Tetracycline Free Base; Tetracycline I; Tetracycline II; Tetracycline Monohydrochloride; Tetracycline [USAN:INN:BAN:JAN]; Tetracyclinum; Tetracyclinum [INN-Latin]; Tetracyn; Tetracyn (TN); Tetradecin; Tetrafil; Tetraverine; Tetrazyklin; Topicycline; Tsiklomistsin; Tsiklomitsin; Veracin; Vetacyclinum; Vetquamycin-324 (free base)
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00172	Uric acid	urate
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00229	Ochratoxin A	(-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00272	Bumetanide	3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR00296	Zidovudine	1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3&prime;-Azido-3&prime;-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-2',3'-Dideoxythymidine; 3'-Azido-3'-deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'-deoxythymidine (AIDS); 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-Deoxy-3'-azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; AZT; AZT & CD4(178)-PE 40; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Li & EPO; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & Lymphoblastoid Interferon; AZT & NP (from PHCA or HSA); AZT & PM-19; AZT & SST; AZT & rIFN.alpha.2; AZT & rsCD4 & rIFN.alpha.A; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; AZT+PRO 140; AZT, Antiviral; Antiviral; Antiviral AZT; Apo-Zidovudine; Azidodeoxythymidine; Azidothymidine; Aztec; BW A509U; BW-A 509U; BW-A-509U; BW-A509U; BWA 509U; BWA-509U; BWA509U; Cpd S; DRG-0004; DS-4152 & AZT; Interferon AD + 3'-azido-3'-deoxythymidine; Intron A & AZT; K7 [P Ti2 W10 O40]; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Met-SDF-1.beta. & AZT; Met-SDF-1.beta. & Zidovudine; Novo-Azt; PC-SOD+AZT;RIFN-beta seron & AZT; Propolis+AZT; Racemic Liposomal AZT; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Retrovir; Retrovir (TN); Retrovir(TM); Retrovis (TN); SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); ZDV; ZIDOVUDINE [AZT]; ZVD; Zidovudin; Zidovudina; Zidovudina [Spanish]; Zidovudine (JAN/USP/INN); Zidovudine EP III; Zidovudine [USAN:INN:BAN:JAN]; Zidovudine+PRO 140; Zidovudinum; Zidovudinum [Latin]
DTD0026	SLC22A11	Organic anion transporter 4	OAT4; SLC22A11; Solute carrier family 22 member 11; hOAT4	DR01302	Levocetirizine	(-)-Cetirizine; (-)-Cetirizine Dihydrochloride; (2-(4-((R-p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; (R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid; (R)-Cetirizine dihydrochloride; 6U5EA9RT2O; Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-; Levocetirizine; Levocetirizine HCl; UNII-6U5EA9RT2O; Xarlin; Xyzal; cetirizine-d4; levocetrizine
DTD0027	SLC22A12	Urate anion exchanger 1	OAT4L; OATL4; Organic anion transporter 4-like protein; RST; Renal-specific transporter; SLC22A12; Solute carrier family 22 member 12; URAT1	DR00123	Oxypurinol	Oxypurinol (intravenous)
DTD0027	SLC22A12	Urate anion exchanger 1	OAT4L; OATL4; Organic anion transporter 4-like protein; RST; Renal-specific transporter; SLC22A12; Solute carrier family 22 member 12; URAT1	DR00157	Orotate	2,4-dioxo-1H-pyrimidine-6-carboxylate; 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate; 21317-EP2281559A1; 21317-EP2284172A1; 21317-EP2314295A1; 4-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-2,6-dioxo-, ion(1-); 73-97-2; AC1LSPNG; AG-G-93379; CHEBI:30839; CJ-15820; CTK5D9013; DTXSID80363448; Orotic acidanion; PXQPEWDEAKTCGB-UHFFFAOYSA-M
DTD0027	SLC22A12	Urate anion exchanger 1	OAT4L; OATL4; Organic anion transporter 4-like protein; RST; Renal-specific transporter; SLC22A12; Solute carrier family 22 member 12; URAT1	DR00172	Uric acid	urate
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00037	Cimetidine	1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; 2-Cyano-1-methyl-3-[2-(5-methyl-1H-imidazol-4-yl-methylthio)ethyl]guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Acibilin; Acinil; Altramet; Biomet400; Brumetidina; C 4522; CIMETIDINE A/AB; Ci metum; Cimal; Cimetadine; Cimetag; Cimetidina; Cimetidina [INN-Spanish]; Cimetidine (JP15/USP/INN); Cimetidine Hcl; Cimetidine [USAN:INN:BAN:JAN]; Cimetidinum; Cimetidinum [INN-Latin]; Cimetum; DRG-0150; Dyspamet; Edalene; Eureceptor; Evicer; FPF 1002; Gastrobitan; Gastromet; Histodil; Magicul; Metracin; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-Cyano-N'-Methyl-N''-(2-(((5-Methyl-1H-Imidazol-4-YL)Methyl)Thio)Ethyl) Guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; Peptol; SK&F-92334; SKF 92334; SKF-92334; Sigmetadine; Tagamet; Tagamet (TN); Tagamet HB (TN); Tagamet HB200 (TN); Tagamet Hb; Tagamet Hb 200; Tagamet, SKF-92334, Tratul, Tametin, Dyspamet, Acinil, Cimetidine; Tametin; Tratul; Ulcedin; Ulcedine; Ulcestop; Ulcimet; Ulcofalk; Ulcomedina; Ulcomet; Ulhys; Valmagen; Venopex
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00044	Topotecan	(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Dimethylaminomethyl-10-hydroxycamptothecin; Hycamptamine; Hycamptin; Hycamtamine; Hycamtin; Hycamtin (TN); SK&F-104864-A; SKF 104864; SKF-104864-A; SKF-S 104864; TOPOTECAN, HYCAMTIN; Topotecan (BAN); Topotecan Monohydrochloride, (S)-Isomer; Topotecan [INN:BAN]; Topotecan lactone; Topotecane; Topotecane [INN-French]; Topotecanum; Topotecanum [INN-Latin]
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00097	Abemaciclib	1231929-97-7; Abemaciclib,LY2835219; LY-2835219; LY2835219; LY2835219 free base; UNII-60UAB198HK; Verzenio
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00106	Tetraethylammonium	4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00292	Procainamide	2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00337	N-methylpyridinium	1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl-
DTD0028	SLC47A2	Multidrug and toxin extrusion protein 2	Kidney-specific H(+)/organic cation antiporter; MATE-2; MATE2; MATE2-B; MATE2-K; MATE2K; SLC47A2; Solute carrier family 47 member 2; hMATE-2	DR00724	Dofetilide	1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane; 1-MSPMPE; Beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide; Dofetilida; Dofetilida [INN-Spanish]; Dofetilide (JAN/USAN/INN); Dofetilide [USAN:BAN:INN]; Dofetilidum; Dofetilidum [INN-Latin];Tikosyn (TN); Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl); N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide; Tikosyn; Tikosyn, UK68798, Dofetilide; UK 68,798; UK 68798; UK-68,798; UK-68798; Xelide
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00010	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00026	Fexofenadine	2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00032	Imatinib	112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00033	Atenolol	(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; (+-)-Atenolol; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; (inverted question mark)-Atenolol; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide; A 7655; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Aircrit; Alinor; Altol; Anselol; Antipressan; Apo-Atenolol; Atcardil; Atecard; Atehexal; Atenblock; Atendol; Atenet; Ateni; Atenil; Atenol; Atenol 1A pharma; Atenol AL; Atenol Atid; Atenol Cophar; Atenol Fecofar; Atenol GNR; Atenol Gador; Atenol Genericon; Atenol Heumann; Atenol MSD; Atenol NM Pharma; Atenol Nordic; Atenol PB; Atenol Quesada; Atenol Stada; Atenol Tika; Atenol Trom; Atenol acis; Atenol ct; Atenol von ct; Atenol-Mepha; Atenol-Wolff; Atenol-ratiopharm; Atenolin; Atenolol (JP15/USP/INN); Atenolol [USAN:INN:BAN:JAN]; Atenololum; Atenololum [INN-Latin]; Atenomel; Atereal; Aterol; Betablok; Betacard; Betasyn; Betatop Ge; Blocotenol; Blokium; Cardaxen; Cardiopress; Corotenol; Cuxanorm; Duraatenolol; Duratenol; Evitocor; Farnormin; Felo-Bits; Hipres; Hypoten; Ibinolo; Internolol; Jenatenol; Juvental; Lo-ten; Loten; Lotenal; Myocord; Neatenol; Normalol; Normiten; Noten; Oraday; Ormidol; Panapres; Plenacor; Premorine; Prenolol; Prenormine; Prinorm; Scheinpharm Atenol; Seles beta; Selobloc; Serten; Servitenol; Stermin; Tenidon; Teno-basan; Tenobloc; Tenoblock; Tenolol; Tenoprin; Tenormin; Tenormin (TN); Tenormine; Tenormine [French]; Tensimin; Tensotin; Tredol; Unibloc; Uniloc; Vascoten; Vericordin; Wesipin; Xaten
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00046	Levofloxacin	(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-Ofloxacin; (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; (R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (R)-isomer; (S)-(-)-Ofloxacin; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-Ofloxacin; Aeroquin; Cravit; Cravit (TN); Cravit Ophthalmic; D-Levofloxacin; DR 3354; DR-3355; DR-3355: L-isomer of ofloxacin; DR3355; Elequine; Floxacin; Floxel; HR 355; HR-355; Iquix; Iquix (TN); L-Ofloxacin; LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER; LFX; LVX; Leroxacin; Lesacin; Levaquin; Levaquin (TN); Levofloxacin (INN); Levofloxacin [USAN:INN:JAN]; Levofloxacin tablet, suspension or intravenous; Levofloxacine; Levofloxacine [INN-French];Levofloxacino [INN-Spanish]; Levofloxacino; Levofloxacinum; Levofloxacinum [INN-Latin]; Levokacin; Levox; Levoxacin; MP-376; Mosardal; Nofaxin; Ofloxacin; Ofloxacin S-(-)-form; Oftaquix; Oftaquix (TN); Quixin; Quixin (TN); R-Ofloxacin; RWJ 25213-097; RWJ-25213; Reskuin; S-(-)-Ofloxacin; Tavanic; Tavanic (TN); Volequin
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00048	Urea	.
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00072	Lifitegrast	SAR-1118; SAR-1119; SHP606; SPD606; Xiidra
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00107	Levothyroxine	(-)-Thyroxine; (125I)T4; (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid; 3,3',5,5"-Tetraiodo-L-thyronine; 3,3',5,5''-Tetraiodo-L-thyronine; 3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodothyronine; 3,5,3'5'-Tetraiodo-L-thyronine; 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; Beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine;O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; DL-Thyroxin; Eltroxin; Eltroxin (TN); Euthyrox; Euthyrox (TN); Eutirox (TN); Forthyron; Forthyron (TN); L-3,5,3',5'-Tetraiodothyronine; L-T4; L-Thryoxin; L-Thyroxin; L-thyroxine; L-thyroxine (TN); LT00440967; Laevothyroxinum; Laevothyroxinum (acid); Laevoxin; Levaxin (TN); Levo-T; Levolet; Levothroid; Levothroid (*Sodiumsalt*); Levothyrox; Levothyroxin; Levothyroxine (BAN); Levothyroxine Sodium (L-thyroxine); Levothyroxine sodium; Levothyroxinum (acid); Levoxyl; Levoxyl (TN); O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Oroxine; Synthroid; Synthroid (*Sodium salt*); Synthroid (TN); Synthroid sodium; T-3850; T4 (Hormone); T4 levothyroxine; THX; Tetraiodothyronine; Thyratabs; Thyrax; Thyrax (TN); Thyreoideum; Thyrox (TN); Thyroxevan; Thyroxin; Thyroxinal; Thyroxine (VAN); Thyroxine (l); Thyroxine [BAN]; Thyroxine iodine; Thyroxine, L-(8CI)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00155	Ouabain	3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00195	Rhodamine 123	RH 123; Rh-123, Huntington; Rhodamine 123; Rhodamine-123 (intravenous infusion); Rhodamine-123 (intravenous infusion), Huntington Medical Research Institutes
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00232	Probenecid	4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(Dipropylsulfamoyl)benzoic acid; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; 4-[(dipropylamino)sulfonyl]benzoic acid; Apurina; Bencid; Benecid; Benemid; Benemid (TN); Benemide; Benuryl; Benuryl (TN); Biokanol Brand of Probenecid; Col-BENEMID; ColBenemid (co mponent of); ColBenemid (component of); ICN Brand of Probenecid; IDIS Brand of Probenecid; Major Brand of Probenecid; Martec Brand of Probenecid; Merck Brand of Probenecid; Ophthalmic Brand of Probenecid; P-(Dipropylsulfamoyl)benzoic acid; P-(Dipropylsulfamyl)benzoic acid; P-[Dipropylsulfamoyl]benzoic acid; Panuric; Parabenem; Parmed Brand of Probenecid; Polycillin-BRB; Polycillin-PRB (component of); Pro-Cid; Probalan; Probampacin; Probecid; Proben; Probenecid (JP15/USP/INN); Probenecid Major Brand; Probenecid Martec Brand; Probenecid Parmed Brand; Probenecid Weimer; Probenecid Zenith Brand; Probenecid [INN:BAN:JAN]; Probenecid acid; Probenecida; Probenecida [INN-Spanish]; Probenecide; Probenecide [INN-French]; Probenecidum; Probenecidum [INN-Latin]; Probenemid; Probenicid; Probenid; Probexin; Prolongine; Robenecid; Sulprin; Synergid R; Tubophan; Uricosid; Urocid; Valdecasas Brand of Probenecid; Zenith Brand of Probenecid
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00248	Telmisartan	2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00305	Bromsulphthalein	BSP; bromosulfophthalein; sulfobromophthalein
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00309	Saquinavir	(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide; CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE; Fortovase; Fortovase (TN); Fortovase(TM); Invirase; Invirase (TN); Invirase(TM)(monomesylate); QNC-ASN-HPH-DIQ-NTB; ROC; Ro 31-8959; Ro 318959; Ro-31-8959; SQV; Saguinavir; Saquinavir (JAN/USP/INN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00328	Quinolones	AC1MI0KP
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00382	Montelukast	(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid; Apxi toxin; Brondilat; Brondilat (TN); MK 0476; MK-0476; Montair; Montelukast (INN); Montelukast [INN:BAN]; Singulair (TN); Singular; Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate; {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00401	Talinolol	(+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin]
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00442	Rocuronium	(2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane; Esmeron (TN); Zemuron (TN); [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00507	Lomefloxacin	(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride; DM 10 (bactericide); DM-10; LFLX; Lomefloxacin (USAN); Lomefloxacin [USAN:BAN:INN]; Lomefloxacine; Lomefloxacine [French]; Lomefloxacino; Lomefloxacino [Spanish]; Lomefloxacinum; Lomefloxacinum[Latin]; Maxaquin (TN); Maxaquin (hydrochloride); NY-198 (hydrochloride); Okacyn (TN); SC 4711; SC 47111A; SC-4711; SC-47111 (hydrochloride); SC-47111A; SC-47111B (mesylate); Uniquin (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00514	Darunavir	(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester; (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE; (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate; AIDS073035; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester; Darunavir (USAN/INN); Darunavir [USAN]; Darunavirum; Darunavirum [INN-Latin]; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; Prezista; Prezista(TM); TMC 114; TMC-114; TMC114; UIC 94017; UIC-94017; UIC-96017; [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester; {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00519	Tauroursodeoxycholate	TUDCA; Tauroursodeoxycholic acid
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00627	Acebutolol	(+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00638	Grepafloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; Grepafloxacin (unspecified); Grepafloxacin [INN]; Raxar; Raxar (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00657	Cholic acid	(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3,7,12-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; BHQCQFFYRZLCQQ-OELDTZBJSA-N; CHEBI:16359; CHEMBL205596; Cholalic acid; Cholalin; Cholic acid [USAN]; Cholic acid, 5beta-; Cholsaeure; Colalin; G1JO7801AE; HSDB 982; NSC-6135; NSC6135; UNII-G1JO7801AE; cholate
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00783	Ciprofloxacin	85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00895	Chlorambucil	Ambochlorin; Amboclorin; C0253; CB 1348; CB-1348; CB1348; Cb l348; Chlocambucil; Chloorambucol; Chlorambucil (USP/INN); Chlorambucil [INN:BAN]; Chlorambucilum; Chlorambucilum [INN-Latin]; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chlorbutinum; Chloroambucil; Chlorobutin; Chlorobutine; Clorambucile; Clorambucile [DCIT]; Clorambucilo; Clorambucilo [INN-Spanish]; Ecloril; Elcoril; Elcorin; Glaxo Wellcome Brand of Chlorambucil; GlaxoSmithKline Brand of Chlorambucil; LEUKERAN (TN); Leuk ersan; Leukeran; Leukeran (TN); Leukeran tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Lympholysin; Phenylbuttersaeure-lost; Phenylbuttersaeure-lost[German]; Phenylbutyric acid nitrogen mustard; Wellcome Brand of Chlorambucil
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR00905	Sotalol	4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide; 4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid; Beta-Cardone; Betapace (TN); Betapace AF (TN); D,l-Sotalol; Darob mite; Darob mite (TN); MJ-1999; Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-(9CI); N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide; N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide; N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide; Sotacor (TN); Sotalex (TN); Sotalol (INN); Sotalol Monohydrochloride; Sotalol [INN:BAN]; Sotalolum; Sotalolum [INN-Latin]
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01165	Gatifloxacin	(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; AM 1155; AM-1155; AM-1155 (*Sesquihydrate*); BMS 206584-01; BMS-206584; BMS-206584-01; Bonoq; CG 5501;PD 135432; CG-5501; GTFX; Gaity; Gatiflo; Gatiflo (TN); Gatiflo,Tequin and Zymar, Gatifloxacin; Gatifloxacin & Gamma Interferon; Gatifloxacin (INN); Gatifloxacin (TN); Gatifloxacin [USAN:INN]; Gatilox; Gatiquin; Gatispan; PD-135432; PD135432; Tequin; Tequin (TN); Tequin in dextrose 5% in plastic container; Zymar; Zymar (TN); Zymaxid; Zymer; Zymer (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01177	Hydroxyurea	1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01204	Norfloxacin	1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; AM 0715; AM 715; AM-0715; AM-715; AM0715; Apo-Norflox (TN); Baccidal; Barazan; Chibroxin; Chibroxin (TN); Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; Fulgram; Insensye (TN); Lexinor; MK 0366; MK 366; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; NFLX; Norflo; Norflohexal (TN); Norfloxacin (JP15/USP/INN); Norfloxacin Merck Brand; Norfloxacin [USAN:BAN:INN:JAN]; Norfloxacine; Norfloxacine [INN-French]; Norfloxacino; Norfloxacino [INN-Spanish]; Norfloxacinum; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin; Noroxin (TN); Nufloxib (TN); Roxin (TN); Sebercim; Utin (TN); Utinor (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01235	Celiprolol	3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea; BRN 2776298; CCRIS 3400; Celectol; Celiprolol [INN:BAN]; Celiprololum; Celiprololum [INN-Latin]; EINECS 260-497-7; N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea; RHC 5320 A; RHC-5320A; ST-1396; Selectol; UL/1677; Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-; celiprolol
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01261	Nadolol	(2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol; (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol; 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol; 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol; Alti-Nadolol (TN); Anabet; Anabet (TN); Apo-Nadol (TN); Corgard; Corgard (TN); Corgaretic; Corzide (TN); Nadic; Nadolol (JP15/USP/INN); Nadolol [USAN:BAN:INN:JAN]; Nadololum; Nadololum [INN-Latin]; Novo-Nadolol (TN); SQ 11725; SQ-11725; SQ11725; Solgol; Solgol (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01280	Enoxacin	1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid; AT 2266; AT-2266; AT2266; Almitil; Almitil (TN); Bactidan; Bactidan (TN); Bactidron (TN); CI919; CL23362; Comprecin; Comprecin (TN); E0762; Enoksetin (TN); Enoram; Enoxacin (USAN/INN); Enoxacin Sesquihydrate; Enoxacin [USAN:BAN:INN:JAN]; Enoxacine; Enoxacine [French]; Enoxacino; Enoxacino [Spanish]; Enoxacinum; Enoxacinum [Latin]; Enoxen (TN); Enoxin; Enoxin (TN); Enoxor; Enoxor (TN); Enroxil (TN); Faulding Brand of Enoxacin; Flumark; Flumark (TN); Gyramid (TN); PD 107779; PD-107779; PD107779; Penetrex; Penetrex (TN); Pierre Fabre Brand of Enoxacin Sesquihydrate; Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate; Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate; Sesquihydrate, Enoxacin; Vinone (TN)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01284	Trospium chloride	trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01351	TR-14035	232271-19-1; TR-14035; (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid; CHEMBL91485; N-(2,6-DICHLOROBENZOYL)-4-(2,6-DIMETHOXYPHENYL)-L-PHENYLALANINE; C24H21Cl2NO5; DRSJLVGDSNWQBI-SFHVURJKSA-N; TR 14035; SCHEMBL1222491; BDBM16801; CTK8C1530; MolPort-023-334-229; ZINC1490484; ANW-66841; N-Acyl-4-arylphenylalanine analogue.; AKOS016008162; CS-1812; CS-W000631; MP-2027; NCGC00390619-01; SB683698; HY-15770; AK-95353; AJ-26339; KB-210922; TC-155586; AB0077984; AX8237663; ST24020804; Z4458
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01381	BQ-123	BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp)
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01385	Labetalol	Albetol; Ibidomide; Labetalolum; Labetolol; NORMOZIDE; AH 5158; AH-5158; Labetalol (INN); Labetalol [INN:BAN]; Labetalolum [INN-Latin]; Normodyne (TN); Sch-19927; Trandate (TN); 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide; 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide; 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol; 5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01433	Atrasentan	Xinlay; Atrasentan [INN]; A 127722; A 147627; ABT 627; A-127722; A-147627; ABT-627; Xinlay (TN); A-127722.5; (+)-A 127722; (+)-A-127722; (11C)ABT-627; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid; 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid; 2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0029	SLCO1A2	Organic anion transporting polypeptide 1A2	OATP-A; OATP1A2; Organic anion-transporting polypeptide 1; SLC21A3; SLCO1A2; Sodium-independent organic anion transporter; Solute carrier family 21 member 3; Solute carrier organic anion transporter family member 1A2	DR01545	Pitavastatin	Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00010	Enalapril	(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00013	Nilotinib	Nilotinib; Tasigna; AMN107; AMN 107; AMN-107; Nilotinib(AMN-107); Nilotinib (AMN-107); UNII-F41401512X; 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide; CHEMBL255863; C28H22F3N7O; HHZIURLSWUIHRB-UHFFFAOYSA-N; NSC747599; MFCD09833716
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00026	Fexofenadine	2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00032	Imatinib	112GI019; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; Alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide; Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-(9CI); CGP 57148B; Cgp 57148; Glamox; Glamox (TN); Gleevec (TN); Glivec (TN); Imatinib (INN); Imatinib Methansulfonate; Imatinib [INN:BAN]; Imatinib free base; N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; STI; STI 571; STI571; Sti-571
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00039	Glutathione	5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00050	Erythromycin	A/T/S; Abboticin; Abomacetin; Acneryne; Acnesol; Adecane-2,10-dione (non-preferred name); Ak-Mycin; Akne Cordes Losung; Akne-Mycin; Akne-mycin (TN); Aknederm Ery Gel; Aknemycin; Aknin; AustriaS; Benzamycin; Benzamycin Pak; C-Solve-2; Del-Mycin; Derimer; Deripil; Dotycin; Dumotrycin; E-Base; E-Base (base); E-Glades; E-Mycin; E-Mycin (base); E-Solve 2; E-mycin, Erycin, Robimysin; E0751; ERY; ERYC; ERYC (base); ERYTHROMYCIN STEARATE; Emgel; Emu-V; Emu-Ve; Emuvin; Emycin; Endoeritrin; Erecin; Erimycin-T; Erisone; Eritomicina; Eritrocina; Eritromicina; Eritromicina [INN-Spanish]; Ermycin; Eros; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-Tab (base); Ery-maxin; Eryacne; Eryacnen; Eryc (TN); Eryc 125; Eryc Sprinkles; Eryc-125; Eryc-250; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Erygel (TN); Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythra-Derm; Erythro; Erythro-Statin; Erythro-Teva; Erythroderm; Erythrogran; Erythroguent; Erythromast 36; Erythromid; Erythromycin & VRC3375; Erythromycin (JP15/USP/INN); Erythromycin A; Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Erythromycin Lactate; Erythromycin Ointment; Erythromycin [INN:BAN:JAN]; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Erythromycin, compd. with monododecyl sulfate, sodium salt; Erythromycine; Erythromycine [INN-French]; Erythromycinum; Erythromycinum [INN-Latin]; Erytop; Erytrociclin; Ilocaps; Ilosone (TN); Ilosone (estolate); Iloticina; Ilotycin; Ilotycin T.S; Ilotycin T.S.; Inderm; Inderm Gel; IndermRetcin; Kesso-Mycin; Latotryd; Lederpax; Mephamycin; Mercina; N-Methylerythromycin A; Oftalmolosa Cusi Eritromicina; Oftamolets; PCE Dispertab (base); Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pce (TN); Pharyngocin; Primacine; Propiocine; Proterytrin; R-P Mycin; Retcin; Robimycin; Romycin; Sans-acne; Sansac; Skid Gel E; Staticin; Staticin (TN); Stiemicyn; Stiemycin; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; T-Stat; T-stat (TN); Taimoxin-F; Theramycin Z; Tiloryth; Tiprocin; Torlamicina; Udima Ery Gel; Wemid
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00071	Valsartan	(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00108	Testosterone	(17beta)-17-Hydroxyandrost-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17-Hydroxy-4-androsten-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; 17-beta-Hydroxyandrost-4-en-3-one; 17b-hydroxy-4-androsten-3-one; 17beta-Hydroxy-3-oxo-4-androstene; 17beta-Hydroxy-4-androsten-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; 17beta-Hydroxyandrost-4-en-3-one; 17beta-Hydroxyandrost-4-ene-3-one; 4-Androsten-17-ol-3-one; 4-Androsten-17beta-ol-3-one; 4-androstene-17beta-ol-3-one; 7-beta-Hydroxyandrost-4-en-3-one; AA 2500; Andro 100; AndroGel; Androderm; Androderm (TN); Androgel (TN); Androlin; Andronaq; Andronate 100; Andronate 200; Andropatch; Andropository 200; Androsorb; Androst-4-en-17beta-ol-3-one; Andrusol; Andryl 200; Beta testosterone; CDB 111C; CMC_13449; COL 1621; CP 601B; Cristerona T; Cristerone T; Delta(sup 4)-Androsten-17(beta)-ol-3-one; Delta4-Androsten-17beta-ol-3-one; Delta4-androsten-17b-ol-3-one; Depotest; Everone 200; Geno-cristaux gremy; Halotensin; Homosteron; Homosterone; Intrinsa; LibiGel; Malerone; Malestrone (amps); Malogen in Oil; Malogen, aquaspension injection; Mertestate; Neo-Hombreol F; Neo-testis; Neotestis; Oreton; Oreton F; Oreton-F; Orquisteron; Perandren; Percutacrine androgenique; Primotest; Primoteston; Relibra; Scheinpharm Testone-Cyp; Striant; Striant (TN); Sustanon; Sustanone; Sustason 250; Synandrol F; T-Cypionate; Teslen; Testamone 100; Testandrone; Testaqua; Testiculosterone; Testim; Testim (TN); Testobase; Testoderm; Testoderm Tts; Testogel; Testoject-50; Testolin; Testopel Pellets; Testopropon; Testosteroid; Testosteron; Testosterona; Testosterona [INN-Spanish]; Testosterone (JAN/USP); Testosterone [Androgenic steroids, anabolic]; Testosterone [INN:BAN]; Testosterone and its esters; Testosterone hydrate; Testosterone solution; Testosteronum; Testosteronum [INN-Latin]; Testostosterone; Testoviron; Testoviron Schering; Testoviron T; Testred Cypionate 200; Testrin-P.A; Testro AQ; Testrone; Testryl; Trans-Testosterone; Virilon IM; Virormone; Virosterone
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00124	Fluvastatin	(+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00155	Ouabain	3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00161	SN-38	(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 0H43101T0J; 10-Hydroxy-7-ethylcamptothecin; 113015-38-6; 7-Ethyl-10-hydroxy camptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxy-camptothecin; 7-Ethyl-10-hydroxycamptothecin; 7-Ethyl-10-hydroxycamptothecine; 86639-52-3; Captothecin, 7-ethyl-10-hydroxy-; LE-SN38; NSC673596; SN 38; SN 38 lactone; SN38; UNII-0H43101T0J
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00182	Dasatinib	(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide; BMS 354825; BMS-354825; BMS-354825, Sprycel, BMS354825, Dasatinib; BMS354825; Dasatinib (USAN); Dasatinib [USAN]; Dasatinib anhydrous; Dasatinib, BMS 354825; Dasatinibum; N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; SPRYCEL (TN); Sprycel; Spyrcel
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00196	Rifampicin	1-b]furan-21-yl acetate; 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; 8CI); AZT + Rifampin; Abrifam; Archidyn; Arficin; Arzide; BA-41166E; Ba 41166; Ba 41166/E; Benemicin; Benemycin; DRG-0109; Dione 21-acetate; Dipicin; Doloresum; Eremfat; Famcin; Fenampicin; L-5103; L-5103 Lepetit; Piperine & Rifampicin; R-Cin; R/AMP; RFP; RMP; Ramp; Reserpine & Rifampicin; Rifa; Rifadin; Rifadin (TN); Rifadin I.V; Rifadin I.V.; Rifadin, Rimactane, Rifampicin, Rifampin; Rifadine; Rifagen; Rifaldazin; Rifaldazine; Rifaldin; Rifam; Rifamicin AMP; Rifamor; Rifampicin; Rifampicin & EEP; Rifampicin & Propolis; Rifampicin (JP15/INN); Rifampicin SV; Rifampicin[INN:BAN:JAN]; Rifampicina; Rifampicina [INN-Spanish]; Rifampicine; Rifampicine [French]; Rifampicinum; Rifampicinum [INN-Latin]; Rifampin (USP); Rifampin [USAN]; Rifamsolin; Rifamycin AMP; Rifaprodin; Rifcin; Rifinah; Rifobac; Rifoldin; Rifoldine; Riforal; Rimactan; Rimactan (TN); Rimactane; Rimactane (TN); Rimactazid; Rimactizid; Rimazid; Rimycin; Rimycin (TN); Sinerdol; Sinerdol (TN); Tubocin; Tubocin (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00213	Sincalide	CCK-8; CCK-8 (sulphated); cholecystokinin 8; cholecystokinin fragment 26-33 amide (sulphated)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00233	Romidepsin	(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone; Antibiotic FR 901228; Chromadax; Chromadax (TN); Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (35)-disulfide; FK 228; FK-228; FK-901228; FK228; FR 901228; FR-901228; FR901228; HDInhib_000006; Istodax; Istodax (TN); L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide; Romidepsin (USAN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00243	Mycophenolate mofetil	2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); CellCept; CellCept, RS 61443, TM-MMF, Mycophenolate mofetil; Cellcept (TN); ME-MPA; MMF; MMF CellCept(TM); Munoloc; Mycophenolate mofetil (JAN/USAN); Mycophenolic acid morpholinoethyl ester; Mycophenylate mofetil; R-99; RS 61443; RS-61443; RS-61443-190; TM-MMF
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00248	Telmisartan	2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00252	Bilirubin	21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00273	Danoprevir	DANOPREVIR; ITMN-191; Danoprevir (ITMN-191); Danoprevir (RG7227); UNII-911Z9PCQ5F; ITMN 191; RO5190591; 911Z9PCQ5F; R 7227; RG7227; R7227; Intermune ITMN-191; ITMN B; Danoprevir [USAN:INN]; R-7227; (2R,6S,13aS,14aR,16aS,Z)-6-((tert-butoxycarbonyl)amino)-14a-((cyclopropylsulfonyl)carbamoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1; Danoprevir (ITMN191); MLS006011139; R 05190591; CHEMBL258734; C35H46FN5O9S; SCHEMBL2289034; AOB87156; ZINC29058869; s1183; RL05263
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00288	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; Actelion; Bosentan (INN); Bosentan [USAN:INN:BAN]; Bosentanum; KS-5062; P-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; P-tert-Butyl-N-[6-(2-hydroxyethoxy); Ro 47-0203; Ro 47-0203/039; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039; Tracleer; Tracleer (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00305	Bromsulphthalein	BSP; bromosulfophthalein; sulfobromophthalein
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00344	Fluo-3	121714-13-4; 123632-39-3; 23D4W0B50Y; AC1L2XTQ; AKOS015894386; C11369; CHEBI:5107; CHEMBL509919; CTK8F0793; Fluo 3; Fluo-3; Fluo-3, suitable for fluorescence, ~70%; Fluo-3-AM; Glycine,N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-; OZLGRUXZXMRXGP-UHFFFAOYSA-N; SCHEMBL28109; UNII-23D4W0B50Y; ZINC8295051
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00347	Olmesartan medoxomil	Benevas; Benicar; Benicar (TN); Benicar, Olmetec,Olmesartan; Berlin-Chemie Brand of Olmesartan Medoxomil; Forest Brand of Olmesartan Medoxomil; Olmesartan medoximil; Olmesartan medoxomil (JAN/USAN); Olmetec; Olmetec (TN); Olvance; Sankyo Brand of Olmesartan Medoxomil
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00364	Amanitin	alpha-amanitin
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00391	Cerivastatin	.
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00407	Nateglinide	(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; A-4166; AY-4166; DJN 608; DJN-608; Fastic; IPCCPA; N-((4-isopropylcyclohexyl)carbonyl)phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; Nate-glinide; Nateglinide [INN]; Nateglinide, (D-Phe)-isomer; Nateglinide, (cis,D-Phe)-isomer; Novartis brand of nateglinide; SDZ-DJN-608; Senaglinide; Starlix; Starlix (TN); Starsis; Trazec; YM-026
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00423	Gefitinib	4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; CU-00000000396-1; Gefitini; Gefitinib (JAN/USAN/INN); Gefitinib [USAN]; Gefitinib,Iressa, ZD1839; IRE; Iressa; Iressa (TN); Iressa(TM); Irressat; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; ZD 1839; ZD-1839; ZD-1839, Iressa, Gefitinib; ZD1839
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00454	Sunitinib	5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00485	Indocyanine green	3599-32-4; AC1L2DMU; Cardiogreen; F9995-0163; GTPL4844; Indocyanine green; KS-00000YFZ; MOLI001001; sodium 4-(2-((1E,3E,5E,7E)-7-(1,1-dimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indol-2(3H)-ylidene)hepta-1,3,5-trienyl)-1,1-dimethyl-1H-benzo[e]indolium-3-yl)butane-1-sulfonate; sodium 4-[2-[(1E,3E,5E,7Z)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-2-ylidene]hepta-1,3,5-trienyl]-1,1-dimethylbenzo[e]indol-3-ium-3-yl]butane-1-sulfonate
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00523	Crizotinib	Xalkori (TN); novel ALK inhibitors
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00539	Cefmetazole	(6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 6beta-{[(cyanomethyl)sulfanyl]acetamido}-6alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; CMZ; CS 1170; CS-1170; Cefmetazole (USP/INN); Cefmetazole Monosodium Salt; Cefmetazole [USAN:INN]; Cefmetazolo; Cefmetazolo [INN-Spanish]; Cefmetazolum; Cefmetazolum [INN-Latin]; SKF 83088; U 72791; U-72791A
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00547	Fluorescein	fluorescein; Solvent Yellow 94; Resorcinolphthalein; Yellow fluorescein; 3',6'-Dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one; D and C Yellow No. 7; Fluoresceine; 3,6-Fluorandiol; D&amp;C Yellow No. 7; Japan Yellow 201; C.I. Solvent Yellow 94; 3',6'-Dihydroxyfluoran; Fluorescein acid; Fluoreszein; D &amp; C Yellow no. 7; Soap Yellow F; Hidacid fluorescein; Fluorescein sodium; D+C Yellow No. 7; 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone; Fluorescein Red; 11712 Yellow
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00553	Ceftriaxone	(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate; (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid; Biotrakson; CEFTRIAXONE SODIUM; CTRX; Cefatriaxone; Ceftriaxon; Ceftriaxona; Ceftriaxona [INN-Spanish]; Ceftriaxone (INN); Ceftriaxone (TN); Ceftriaxone [USAN:JAN]; Ceftriaxone intravenous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Ceftriaxonum; Ceftriaxonum [INN-Latin]; Ceftriazone; DRG-0071; Longacef; Longaceph; Ro 139904; Ro-13-9904; Ro13-9904; Rocefin; Rocephin; Rocephin (TN); Rocephine
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00569	Glycocholic acid	Glycocholate; cholylglycine
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00600	Cefoperazone	(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure; (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6S,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}(4-hydroxyphenyl)acetyl]amino}-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-3,4-didehydrocepham-4-carboxylic acid; CP 52640; Cefazone (TN); Cefobid; Cefobid (TN); Cefoperazon; Cefoperazone (INN); Cefoperazone [INN:BAN]; Cefoperazone sodium salt; Cefoperazono; Cefoperazono [INN-Spanish]; Cefoperazonum; Cefoperazonum [INN-Latin]; Peracef [veterinary]; Peracef [veterinary] (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00618	Vandetanib	4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; AZD-6474; CH 331; CH-331; F9995-0087; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib (JAN/INN); Vandetanib (Pan-TK inhibitor); Vandetanib [INN]; Vandetanib, Zactima, ZD6474; ZD 6474; ZD-6474; ZD6474; Zactima; Zactima, ZD6474
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00681	Diclofenac	Diclofenac (sodium matrix patch, pain)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00711	Vemurafenib	PLX4032; RG7204; RO5185426; Vemurafenib (BRAF inhibitor); Zelboraf (TN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00856	Mesalazine	2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR00984	Warfarin	(-)-Warfarin; (S)-Warfarin; 200 coumarin; Arab Rat Death; Arab rat deth; Athrombine-K; Brumolin; CBKinase1_000192; CBKinase1_012592; CO-Rax; Choice; Choice (TN); Coumadin; Coumadin (TN); Coumafen; Coumafene; Coumafene [French]; Coumaphen; Coumaphene; Coumarins; Coumefene; Cov-R-Tox; D-Con; Dethmor; Dethnel; Dicusat E; Eastern states duocide; Fasco fascrat powder; Frass-Ratron; Jantoven (TN); Kumader; Kumadu; Kumatox; Kypfarin; Latka 42; Latka 42 [Czech]; Liqua-tox; Maag Rattentod Cum; Mar-Frin; Marevan (TN); Martin's mar-frin; Maveran; Mouse pak; PS104_SUPELCO; Panwarfin; Place-pax; Prothromadin; RAX; Rac-Warfarin; Rat & mice bait; Rat-B-gon; Rat-Gard; Rat-Kill; Rat-Mix; Rat-Ola; Rat-Trol; Rat-a-way; Rat-o-cide #2; Ratorex; Ratoxin; Ratron; Ratron G; Rats-no-more; Ratten-Koederrohr; Rattenstreupulver Neu Schacht; Rattenstreupulver new schacht; Rattentraenke; Rattunal; Ro-Deth; Rodafarin; Rodafarin C; Rodex blox; Rosex; Rough & ready mouse mix; Sofarin; Solfarin; Sorexa plus; Spray-trol brand roden-trol; Temus W; Tox-hid; Twin light rat away; Vampirinip II; Vampirinip iii; W.A.R.F. 42; WARF compound 42; Waran (TN); Warf 10; Warf 42; Warfarat; Warfarin (INN); Warfarin (and salts of); Warfarin Q; Warfarin [BSI:ISO]; Warfarin [INN:BAN]; Warfarin plus; Warfarin plus [discontinued]; Warfarin titrated to an INR of 2.5-3.0; Warfarin(R); Warfarina; Warfarina [INN-Spanish]; Warfarine; Warfarine [INN-French]; Warfarine [ISO-French]; Warfarinum; Warfarinum [INN-Latin]; Warficide; Zoocoumarin; Zoocoumarin [Netherlands and USSR]; Zoocoumarin [Russian]
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01177	Hydroxyurea	1-HYDROXYUREA; Biosupressin; Carbamide oxide; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamohydroxyamic acid; Carbamoyl oxime; Carbamyl hydroxamate; Carrbamoyl Oxime; DRG-0253; Droxia; Droxia (TM); Droxia (TN); H 8627; HYDREA (TN); HYDROXY-UREA; Hidrix; Hidroxicarbamida; Hidroxicarbamida [INN-Spanish]; Hydrea; Hydrea (TM); Hydrea, Biosupressin, Cytodrox, Hydroxyurea; Hydreia; Hydroxicarbamidum; Hydroxyaminomethanamide; Hydroxycarbamid; Hydroxycarbamide; Hydroxycarbamide (JAN/INN); Hydroxycarbamidum; Hydroxycarbamidum [INN-Latin]; Hydroxycarbamine; Hydroxyharnstoff; Hydroxyharnstoff [German]; Hydroxylurea; Hydroxyurea (D4); Hydroxyurea (USP); Hydroxyurea [USAN:BAN]; Hydroxyurea(d4); Hydura; Hydurea; Idrossicarbamide; Idrossicarbamide [DCIT]; Litaler; Litalir; Mylocel; N-(Aminocarbonyl) Hydroxyamine; N-Carbamoylhydroxylamine; N-HYDROXY UREA; N-Hydroxymocovina; N-Hydroxymocovina [Czech]; N-Hydroxyurea; NHY; Onco-carbide; Oncocarbide; Oxyurea; S-phase/G-1 interface inhibitor; SK 22591; SQ 1089; SQ-1089; Siklos; Tetratogen: inhibits ribonucleoside diphosphate reductase
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01237	Technetium (99MTC) mebrofenin	F2NQ468L52; Glycine, N-(2-((3-bromo-2,4,6-trimethylphenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-, technetium-99Tc salt; Mebrofenin / 99Tc; Mebrofenin / technetium-99Tc; Mebrofenin mixture with technetium-99Tc; TECHNETIUM TC-99M MEBROFENIN KIT; Technetium (99Mtc) Mebrofenin; Technetium TC-99M mebrofenin kit; Technetium Tc 99m DISIDA; Technetium Tc 99m diisopropyl-iminodiacetic acid; Technetium Tc 99m mebrofenin; Technetium Tc-99m mebrofenin; UNII-F2NQ468L52
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01257	Gadobenate dimeglumine	Multihance Multipack; Multihance; Gd-Bopta/dimeg; Gadobenate dimeglumine; Gadobenic acid dimeglumine salt; Gadobenate Dimeglumine [USAN]; B 1903617; Gadobenic acid; 127000-20-8; Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01322	Cilostazol	Cilostazole; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 73963-72-1; BRN 3632107; C 0737; C20H27N5O2; CHEBI:31401; CL23867; Cilostazol (JP15/USAN/INN); Cilostazol [INN:JAN]; Cilostazole; Cilostazolum; Cilostazolum [INN-Latin]; MLS000028470; OPC 13013; OPC 21; OPC-13013; OPC-21; Otsuka brand of cilostazol; Pleta (TN); Pletaal; Pletal; Pletal (TN); Pletal, Cilostazol; UNII-N7Z035406B; cilostazol
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01381	BQ-123	BQ-123; 136553-81-6; BQ123; BQ 123; Cyclo(D-trp-D-asp-pro-D-val-leu); UNII-S2A8YZM151; CHEBI:2965; S2A8YZM151; CHEMBL314691; cyclo[D-Trp-D-Asp-Pro-D-Val-Leu]; cyclo(D-Asp-Pro-D-Val-Leu-D-Trp); cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu); cyclo-[D-Asp-Pro-d-Val-Leu-d-Trp]; cyclo-(D-Asp-Pro-D-Val-Leu-D-Trp); Cyclo(D-trp-D-asp-L-pro-D-val-L-leu); Cyclo[D-trp-D-asp-L-pro-D-val-L-leu]; cyclo[(D)Trp-(D)Asp-Pro-(D)Val-Leu]; cyclo[D-Asp-L-Pro-D-Val-L-Leu-D-Trp]; cyclo(D-Asp-L-Pro-D-Val-L-Leu-D-Trp)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01433	Atrasentan	Xinlay; Atrasentan [INN]; A 127722; A 147627; ABT 627; A-127722; A-147627; ABT-627; Xinlay (TN); A-127722.5; (+)-A 127722; (+)-A-127722; (11C)ABT-627; (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid; 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid; 2R-(4-methoxyphenyl)-4S(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonyl-methyl)-pyrrolidine-3R-carboxylic acid
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01545	Pitavastatin	Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN)
DTD0030	SLCO1B3	Organic anion transporting polypeptide 1B3	LST-2; LST-3TM13; LST2; LST3; Liver-specific organic anion transporter 2; OATP-8; OATP1B3; OATP8; Organic anion transporter 8; Organic anion-transporting polypeptide 8; SLC21A8; SLCO1B3; Solute carrier family 21 member 8; Solute carrier organic anion transporter family member 1B3	DR01617	Primovist	Eovist; Primovist; gadoxate disodium; AC1L9OPS; gadolinium ethoxybenzyl-DTPA; MOLI000482; 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; gadolinium(3+)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00026	Fexofenadine	2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; Allegra (TN); Carboxyterfenadine; F 9427; Fastofen (TN); Fexofenadine (INN); Fexofenadine [INN:BAN]; Fexofendine; MDL 16455; Telfast (TN); Terfenadine acid metabolite; Terfenadine carboxylate; Terfenadine-COOH; Terfenidine carboxylate, MDL 16455; Tilfur (TN)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00061	Aliskiren fumarate	(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide; (2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]octanamide; Aliskiren (USAN/INN); Octanamide, .delta.-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-.gamma.-hydroxy-4-methoxy-3-(3-methoxypropoxy)-.alpha.,.zeta.-bis(1-methylethyl)-, [.alpha.S-(alpha.R*,.gamma.R*,.delta.R*,.zeta.R*)]; Rasilez; Rasilez (TN); SPP 100; Tekturna (TN)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00072	Lifitegrast	SAR-1118; SAR-1119; SHP606; SPD606; Xiidra
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00093	Latanoprostene bunod	BOL-303259-X; BOL-303259-X1; NCX-116; NO donors (glaucoma), NicOx/Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), NicOx/ Bausch & Lomb; NO-donating prostaglandin F2-alpha analogs (glaucoma), NicOx/Pfizer; NO-donating prostaglandin F2-alpha analogs (glaucoma), Pfizer; Nitric oxide-donating prostaglandin F2-alpha analogs (eye disease), NicOx/Pfizer; PF-03187207; PF-3187207
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00094	Glibenclamide	1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Abbenclamide; Adiab; Apo-Glibenclamide; Azuglucon; Bastiverit; Benclamin; Betanase; Betanese 5; Calabren; Cytagon; Daonil; Daonil (TN); Debtan; Dia-basan; Diabeta; Diabeta (TN); Diabiphage; Dibelet; Duraglucon; Euclamin; Euglucan; Euglucon; Euglucon (TN); Euglucon 5; Euglucon N; Euglykon; G 0639; GBN 5; Gen-Glybe; Gewaglucon; Gilemal; Glamide; Glibadone; Gliban; Gliben; Gliben-Puren N; Glibenbeta; Glibenclamid AL; Glibenclamid Basics; Glibenclamid Fabra; Glibenclamid Genericon; Glibenclamid Heumann; Glibenclamid Riker M; Glibenclamid Riker M.; Glibenclamid-Cophar; Glibenclamid-Ratiopharm; Glibenclamida; Glibenclamida [INN-Spanish]; Glibenclamide (JP15/INN); Glibenclamidum; Glibenclamidum [INN-Latin]; Glibenil; Glibens; Glibesyn; Glibet; Glibetic; Glibil; Gliboral; Glicem; Glidiabet; Glimel; Glimide; Glimidstata; Glisulin; Glitisol; Glubate; Gluben; Gluco-Tablimen; Glucobene; Glucohexal; Glucolon; Glucomid; Glucoremed; Glucoven; Glyben; Glybenclamide; Glybenzcyclamide; Glyburide; Glyburide (USP); Glyburide (micronized); Glyburide [USAN]; Glycolande; Glycomin; Glynase; Glynase (TN); HB 419; HB 420; HB-419; HB-420; HB419; HB420; Hemi-Daonil; Hexaglucon; Humedia; Lederglib; Libanil; Lisaglucon; Maninil; Med-Glionil; Melix; Micronase; Micronase (TN); Micronized glyburide; Miglucan; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Nadib; Neogluconin; Norglicem 5; Normoglucon; Novo-Glyburide; Orabetic; Pira; Praeciglucon; PresTab; Prodiabet; Renabetic; Semi-Daonil (TN); Semi-Euglucon; Semi-Gliben-Puren N; Semi-daonil; Sugril; Suraben; Tiabet; U 26452; U-26452; UR 606; Yuglucon
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00124	Fluvastatin	(+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; Canef; Canef(TN); Cranoc; Fluindostatin; Fluvas; Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina; Fluvastatina [INN-Spanish]; Fluvastatine; Fluvastatine [INN-French]; Fluvastatinum; Fluvastatinum [INN-Latin]; Lescol; Lescol (TN); Lescol XL; Vastin (TN); XU 62320; XU-62320
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00162	Etoposide	(-)-Etoposide; 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside; DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; Demethyl EpipodophyllotoxinEthylidine Glucoside; Demethyl-epiodophyllotoxin ethylidene glucoside; Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; E0675; Epipodophyllotoxin VP-16213; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); Eposide; Eposin; Eposin (TN); Eposin, Vepesid, VP-16, Toposar, Etoposide; Etopol; Etopophos (TN); Etopophos (phosphate salt);Etoposide (VP16); Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Etoposido; Etoposido [INN-Spanish]; Etoposidum; Etoposidum [INN-Latin]; Etosid; Lastet; NK 171; Toposar; Trans-Etoposide; VP 16; VP 16 (pharmaceutical); VP 16-213; VP 16213; VP-16; VP-16 (TN); VP-16-213; VePESID (TN); VePesid; Vepesid J; Vepeside; Zuyeyidal
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00168	Latanoprost	AR-202; Catioprost; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; L1167_SIGMA; Latanoprost (JAN/USAN/INN); Latanoprost free acid; Nova-21027; PHXA-41; PhXA34 [as 15(R,S)-isomer]; PhXA41; Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate; Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; XA-41; XA41; Xalatan; Xalatan (TN)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00201	Sulfasalazine	13gs; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid; 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; Accucol; Alphapharm Brand of Sulfasalazine; Alti-Sulfasalazine; Ashbourne Brand of Sulfasalazine; Asulfidine; Azlufidine EN-Tabs; Azopyrin; Azopyrine; Azosulfidin; Azulfadine; Azulfidine; Azulfidine (TN); Azulfidine EN; Azulfidine EN-tabs; Benzosulfa; Colo Pleon; Colo-Pleon; EN, Azulfidine; FNA Brand of Sulfasalazine; Henning Berlin Brand of Sulfasalazine; Heyl Brand of Sulfasalazine; Medac Brand of Sulfasalazine; PMS-Sulfasalazine; Pfizer Brand of Sulfasalazine; Pleon; Pms-Sulfasalazine E.C.; Pyralin EN; Ratio Sulfasalazine; Ratio-Sulfasalazine; Ratiopharm Brandof Sulfasalazine; Reupirin; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; SASP; SI-88; SSZ; Salazo-sulfapyridinum; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin (TN); Salazopyrin EN-Tabs; Salazosulfapiridina; Salazosulfapiridina [INN-Spanish]; Salazosulfapyridin; Salazosulfapyridine; Salazosulfapyridine (JP15); Salazosulfapyridinum; Salazosulfapyridinum [INN-Latin]; Salicylazosulfapyridine; Salisulf; Sanofi Synthelabo Brand of Sulfasalazine; Sas-500; Sulcolon; Sulfasalazin; Sulfasalazin Heyl; Sulfasalazin medac; Sulfasalazin-Heyl; Sulfasalazina; Sulfasalazina [INN-Spanish]; Sulfasalazine (USP/INN); Sulfasalazine FNA; Sulfasalazine Pfizer Brand; Sulfasalazine [USAN:INN]; Sulfasalazinum; Sulfasalazinum [INN-Latin]; Sulfazalazine; Sulphasalazine; Ucine; Ulcol; W-t Sasp oral
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00206	Pitavastatin calcium	147526-32-7; 2C25H23FNO4Ca; AK-50694; Alipza; Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt; CHEBI:71258; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Flovas; IYD54XEG3W; Itavastatin calcium; Livalo; Livazo; NK 104 (acid); NK-104; Nisvastatin; Pitavastatin calcium; Pitavastatin calcium (JAN); Pitavastatin hemicalcium; UNII-IYD54XEG3W
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00223	Rosuvastatin	(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R*,S*-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R*,S*-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E); AZD-4522; Astende; Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; Cirantan; Cresadex; Creston; Creston (TN);Crestor (TN); Crestor; Provisacor; Pyrimidine Compound, 26; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosuvastatin (INN); Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium (JAN/USAN); Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; Rosvel; Rovartal; S 4522; S-4522; Simestat; Sinlip; Vivacor; ZD 4522; ZD 4522, calcium salt; ZD-4522; ZD4522
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00248	Telmisartan	2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid; 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid; 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid; 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid; 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid; Abbott brand of telmisartan; BIBR 277; BIBR 277SE; BIBR-277; BIBR-277-SE; BIBR-277SE; Bay 68-9291; Boehringer Ingelheim brand of telmisartan; Glaxo Wellcome brand of telmisartan; GlaxoSmithKline brand of telmisartan; Kinzal; Kinzalmono; Micardis; Micardis (TN); Micardis, Targit, Temax, BIBR277, Telmisartan; Pritor; Telmisartan (JAN/USAN/INN); Telmisartan [USAN:INN]; YM-086
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00288	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide; 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide; 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide; Actelion; Bosentan (INN); Bosentan [USAN:INN:BAN]; Bosentanum; KS-5062; P-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide; P-tert-Butyl-N-[6-(2-hydroxyethoxy); Ro 47-0203; Ro 47-0203/039; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039; Tracleer; Tracleer (TN)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00305	Bromsulphthalein	BSP; bromosulfophthalein; sulfobromophthalein
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00318	Pemetrexed	(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN]
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00332	Ritonavir	1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate; 538, ABT; A-84538; ABBOTT-84538; ABT 538; ABT 84538; ABT-538; ABT538; Abbott 84538; DRG-0244; N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide; Norvir; Norvir (TM); Norvir (TN); Norvir Sec; RIT; RTV; Ritonavir (JAN/USAN/INN); Ritonavir [USAN]
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00382	Montelukast	(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid; Apxi toxin; Brondilat; Brondilat (TN); MK 0476; MK-0476; Montair; Montelukast (INN); Montelukast [INN:BAN]; Singulair (TN); Singular; Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate; {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00391	Cerivastatin	.
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00401	Talinolol	(+-)-N-Cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea; (+-)-Talinolol; 1-(3-(3-Cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)PHENYL)-3-CYCLOHEXYLUREA; 1-(4-(cyclohexylureido)phenoxy)-3-(tert-butylamino)-2-propanol; 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; 38649-73-9; Cordanum; NCGC00164542-01; Racemic talinolol; Talinolol (INN); Talinolol [INN]; Talinololum [INN-Latin]
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00442	Rocuronium	(2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane; Esmeron (TN); Zemuron (TN); [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00856	Mesalazine	2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR00908	Eltrombopag	Eltrombopag; Revolade; Promacta; (Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; UNII-S56D65XJ9G; SB497115; Eltrombopag-Isomer; SB-497115; SB 497115; S56D65XJ9G; CHEMBL461101; 1807882-48-9; SB-497115-GR; Eltrombopag (SB-497115-GR); 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; NCGC00274067-01
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR01327	Abiraterone acetate	CB-7630; JNJ-212082; Zytiga
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR01462	M17055	M-12285; M-17000; M-17055; MD-31
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR01513	Dehydroepiandrosterone sulfate	Prasterone sulfate; DHEA sulfate; DEHYDROEPIANDROSTERONE SULFATE; Dehydroisoandrosterone sulfate; DHEAS; Dehydroepiandrosterone sulphate; Dehydroepiandrosterone monosulfate; 3-O-Sulfodehydroepiandrosterone; Dehydroepiandrosterone 3-sulfate; Dehydroandrosterone sulfate; Dehydroisoandrosterone-3-sulfate; 17-Ketoandrost-5-en-3beta-yl sulfate; DHEA-S; Androst-5-en-17-on-3beta-yl sulfuric acid; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; CCRIS 6746; (3-beta)-3-(Sulfooxy)androst-5-en-17-one; DHEA sulphate
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR01545	Pitavastatin	Pitavastatin; Itavastatin; Livalo; NK 104; Pitavastatin [INN]; Pitavastatin calcium; UNII-M5681Q5F9P; NK-104; C25H24FNO4; M5681Q5F9P; Zypitamag; Flovas; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; P 872441; P-872441; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid; NK 104 (acid); Pitavastatin calcium (JAN)
DTD0031	SLCO2B1	Organic anion transporting polypeptide 2B1	KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; Organic anion transporter B; Organic anion transporter polypeptide-related protein 2; SLC21A9; SLCO2B1; Solute carrier family 21 member 9; Solute carrier organic anion transporter family member 2B1	DR01640	Scutellarin	Scutellarin; Breviscapin; Scutellarein-7-glucuronide; Scutellarin B; Breviscapine; Scutellarein-7beta-D-glucuronide; Scutellarein 7-beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; UNII-16IGP0ML9A; Scutellarein 7-b-D-glucuronide; Scutellarein 7-O-beta-D-glucuronide; 16IGP0ML9A; SCUTELLAREIN 7-O-GLUCURONIDE; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl
DTD0034	SLC18A2	Vesicular amine transporter 2	Monoamine transporter; PKDYS2; SLC18A2; SVAT; SVMT; Solute carrier family 18 member 2; VAT2; VMAT2; Synaptic vesicular amine transporter	DR00081	Ergotidine	1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine
DTD0034	SLC18A2	Vesicular amine transporter 2	Monoamine transporter; PKDYS2; SLC18A2; SVAT; SVMT; Solute carrier family 18 member 2; VAT2; VMAT2; Synaptic vesicular amine transporter	DR00189	Serotonin	1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY
DTD0034	SLC18A2	Vesicular amine transporter 2	Monoamine transporter; PKDYS2; SLC18A2; SVAT; SVMT; Solute carrier family 18 member 2; VAT2; VMAT2; Synaptic vesicular amine transporter	DR00256	Methamphetamine	(+)-(S)-Deoxyephedrine; (+)-(S)-N-alpha-Dimethylphenethylamine; (+)-2-(N-Methylamino)-1-phenylpropane; (+)-Methylamphetamine; (+)-N,alpha-Dimethyl-beta-phenylethylamine; (+)-N,alpha-Dimethylphenethylamine; (+)-N-Methylamphetamine; (+)-methamphetamine; (2S)-N-methyl-1-phenylpropan-2-amine; (S)-(+)-Deoxyephedrine; (S)-(+)-Methamphetamine; (S)-(+)-N,alpha,dimethylphenethylamine; (S)-Methamphetamine; (S)-Methylamphetamine; (S)-N,alpha-Dimethylbenzeneethanamine; (S)-N,alpha-Dimethylbenzeneethanoamine; (alphaS)-N,alpha-dimethylbenzeneethanamine; 1-Phenyl-2-methylamino-propan; 1-Phenyl-2-methylamino-propan [German]; 1-Phenyl-2-methylaminopropane; 2S-(+)-Methamphetamine; Benzeneethanamine, N,alpha-dimethyl-, (S)-(9CI); Benzeneethanamine, N,alpha-dimethyl-, (alphaS)-(9CI); Crank; Crank [Street Name]; Crystal Meth; Crystal Meth [Street Name]; D-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropan; D-1-Phenyl-2-methylaminopropan [German]; D-1-Phenyl-2-methylaminopropane; D-Deoxyephedrine; D-Desoxyephedrine; D-Methamphetamine; D-Methylamphetamine; D-N,.alpha.-Dimethylphenethylamine; D-N,alpha-dimethylphenethylamine; D-N-Methylamphetamine; D-Phenylisopropylmethylamine;Desoxyn (TN); Desohyephedrine; Desyphed; Desyphed hydrochloride; ICE [Street Name]; L-Methamphetamine; Metamfetamina; Metamfetamina [INN-Spanish]; Metamfetamine; Metamfetamine (INN); Metamfetamine [INN];Metamfetaminum [Latin]; Metamfetamine-m; Metamfetaminum; Metamfetaminum [INN-Latin]; Metamphetamine; Metanfetamina [INN-Spanish]; Metanfetamina [Spanish]; Meth; Meth (Street Name); Methamphetamine, its salts, isomers, and salts of its isomers; Methamphetaminum; Methamphetaminum [INN-Latin]; Methamphetaminum [JP]; Methyl-.beta.-phenylisopropylamine; Methyl-beta-phenylisopropylamine; Methylamphetamine; N-Methyl-1-phenyl-2-propanamine; N-Methyl-beta-phenylisopropylamin; N-Methyl-beta-phenylisopropylamin [German]; N-Methyl-beta-phenylisopropylamine; N-Methylamphetamine; Norodin; Phenethylamine, N,alpha-dimethyl-, (S)-(+)-(8CI); S-(+)-Methamphetamine; Speed; Speed [Street Name]; Stimulex
DTD0034	SLC18A2	Vesicular amine transporter 2	Monoamine transporter; PKDYS2; SLC18A2; SVAT; SVMT; Solute carrier family 18 member 2; VAT2; VMAT2; Synaptic vesicular amine transporter	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0034	SLC18A2	Vesicular amine transporter 2	Monoamine transporter; PKDYS2; SLC18A2; SVAT; SVMT; Solute carrier family 18 member 2; VAT2; VMAT2; Synaptic vesicular amine transporter	DR00283	Dopamine	(3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine
DTD0035	SLC30A8	Zinc transporter 8	SLC30A8; Solute carrier family 30 member 8; ZNT8; ZnT-8	DR00068	Zinc salts	.
DTD0036	ABCA1	ATP-binding cassette sub-family A member 1	ABC-1; ABC1; ABCA1; ATP-binding cassette 1; ATP-binding cassette transporter 1; CERP; Cholesterol efflux regulatory protein; HDLDT1; TGD	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0036	ABCA1	ATP-binding cassette sub-family A member 1	ABC-1; ABC1; ABCA1; ATP-binding cassette 1; ATP-binding cassette transporter 1; CERP; Cholesterol efflux regulatory protein; HDLDT1; TGD	DR00651	Fenofibric acid	2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid; 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid; 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoic acid; AK117112; BGF9MN2HU1; BRN 2058973; C17H15ClO4; CCRIS 7302; CHEBI:83469; CHEMBL981; EINECS 255-626-9; FNF Acid; LF 153; LF 178 acid; NSC 281318; Procetofenic acid; Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-; Trilipix; UNII-BGF9MN2HU1; W-106287; alpha 1081
DTD0038	ABCA12	ATP-binding cassette sub-family A member 12	ABC12; ABCA12; ARCI4A; ARCI4B; ATP-binding cassette 12; ATP-binding cassette transporter 12; ICR2B; LI2	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0040	ABCA2	ATP-binding cassette sub-family A member 2	ABC2; ABCA2; ATP-binding cassette 2; ATP-binding cassette transporter 2; KIAA1062	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0041	ABCA3	ATP-binding cassette sub-family A member 3	ABC-C transporter; ATP-binding cassette transporter 3; ATP-binding cassette 3; ABC3	DR00269	Mitoxantrone	1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE; 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione; 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon; 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone; 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione; 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone; 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI); AN-584/42007670; DHAD; DHAQ; DHAQ (*Diacetate salt*); DHAQ HCl; Dihydroxyanthraquinone; Liposome Encapsulated Mitoxantrone (LEM); MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE; MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE; MIX; Misostol; Misostol (TN); Mitoxanthrone; Mitoxantron; Mitoxantrona; Mitoxantrona [INN-Spanish]; Mitoxantrone (INN); Mitoxantrone (free base); Mitoxantrone 2HCl; Mitoxantrone [INN]; Mitoxantronum; Mitoxantronum [INN-Latin]; Mitozantrone; Mitozantrone hydrochloride; Novantrone (TN); Novantrone(R) (mitoxantrone for injection concentrate)
DTD0042	ABCA4	ATP-binding cassette sub-family A member 4	ABC10; ABCA4; ABCR; ARMD2; CORD3; FFM; RIM ABC transporter; RIM protein; RP19; Retinal-specific ATP-binding cassette transporter; RmP; STGD; STGD1; Stargardt disease protein	DR00294	Phosphatidylethanolamine	Cephalin
DTD0043	ABCA5	ATP-binding cassette sub-family A member 5	ABC13; ABCA5; EST90625; HTC3; KIAA1888	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0046	ABCA8	ATP-binding cassette sub-family A member 8	ABCA8; KIAA0822; ATP-binding cassette A member 8	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0046	ABCA8	ATP-binding cassette sub-family A member 8	ABCA8; KIAA0822; ATP-binding cassette A member 8	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0046	ABCA8	ATP-binding cassette sub-family A member 8	ABCA8; KIAA0822; ATP-binding cassette A member 8	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0046	ABCA8	ATP-binding cassette sub-family A member 8	ABCA8; KIAA0822; ATP-binding cassette A member 8	DR00229	Ochratoxin A	(-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY
DTD0051	ABCB5	ATP-binding cassette sub-family B member 5	ABCB5; ABCB5 P-gp; ABCB5alpha; ABCB5beta; EST422562; P-glycoprotein ABCB5	DR00300	Fostamatinib	901119-35-5; Fostamatinib [USAN:INN]; R 788; R-788; R-788 Free acid; R-935788 Free acid; R788; R7935788; SQ8A3S5101; Tavalisse; UNII-SQ8A3S5101
DTD0051	ABCB5	ATP-binding cassette sub-family B member 5	ABCB5; ABCB5 P-gp; ABCB5alpha; ABCB5beta; EST422562; P-glycoprotein ABCB5	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0051	ABCB5	ATP-binding cassette sub-family B member 5	ABCB5; ABCB5 P-gp; ABCB5alpha; ABCB5beta; EST422562; P-glycoprotein ABCB5	DR00368	Brigatinib	Alunbrig
DTD0052	ABCB6	ATP-binding cassette sub-family B member 6	ABCB6; LAN; MTABC3; Mitochondrial ABC transporter 3; Mt-ABC transporter 3; P-glycoprotein-related protein; PRP; UMAT; Ubiquitously-expressed mammalian ABC half transporter	DR00209	Verteporfin	Visudyne (TN)
DTD0052	ABCB6	ATP-binding cassette sub-family B member 6	ABCB6; LAN; MTABC3; Mitochondrial ABC transporter 3; Mt-ABC transporter 3; P-glycoprotein-related protein; PRP; UMAT; Ubiquitously-expressed mammalian ABC half transporter	DR00341	Tomatine	(3beta,5alpha,22beta,25S)-Spirosolan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-xylopyranosyl)-(1-3))-O-(beta-D-glucopyranosyl-(1-4)-beta-D-Galactopyr; A''-Tomatidine; Lycopersicin; Tomatidine, glycoside; Tomatin; Tomatine; alpha-Tomatine; beta-D-Galactopyranoside, (3beta,5alpha,22beta,25S)-spirosolan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4)-
DTD0054	ABCB8	ATP-binding cassette sub-family B member 8	ABCB8; EST328128; M-ABC1; MABC1; Mitochondrial ATP-binding cassette 1	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0055	ABCB9	TAP-like protein	ABC transporter 9 protein; ABCB9; ATP-binding cassette sub-family B member 9; ATP-binding cassette transporter 9; EST122234; KIAA1520; TAPL; hABCB9	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0055	ABCB9	TAP-like protein	ABC transporter 9 protein; ABCB9; ATP-binding cassette sub-family B member 9; ATP-binding cassette transporter 9; EST122234; KIAA1520; TAPL; hABCB9	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0056	ABCC10	Multidrug resistance-associated protein 7	ATP-binding cassette sub-family C member 10; ABCC10; MRP7; SIMRP7	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0056	ABCC10	Multidrug resistance-associated protein 7	ATP-binding cassette sub-family C member 10; ABCC10; MRP7; SIMRP7	DR00193	Tamoxifen	(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; Istubal (TN); Istubol; Nolvadex (TN); Nolvadex-D; Nourytam; Novaldex; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); TRANS FORM OF TAMOXIFEN; Tamizam; Tamone; Tamoplex (TN); Tamoxen; Tamoxifen (Hormonal therapy); Tamoxifen (INN); Tamoxifen (TN); Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; Tamoxifene; Tamoxifene [INN-French]; Tamoxifeno [INN-Spanish]; Tamoxifeno;Tamoxifenum; Tamoxifenum [INN-Latin]; Tomaxithen; Trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; Trans-Tamoxifen; Valodex; Valodex (TN)
DTD0056	ABCC10	Multidrug resistance-associated protein 7	ATP-binding cassette sub-family C member 10; ABCC10; MRP7; SIMRP7	DR00251	Docetaxel	(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate; ANX-514; Docetaxel (INN); Docetaxel 114977-28-5; Docetaxel anhydrous; Docetaxel, Trihydrate; EmDOC; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; N-debenzoyl-N-Boc-10-deacetyl taxol; RP-56976; SDP-014; TXL; Taxotere; Taxotere (TN); Taxotere(R); XRP-6976L
DTD0056	ABCC10	Multidrug resistance-associated protein 7	ATP-binding cassette sub-family C member 10; ABCC10; MRP7; SIMRP7	DR00342	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-b; 7-epi-Paclitaxel; ABI-007; Abraxane; Capxol; Ebetaxel; EmPAC; Genaxol; Genetaxyl; Genexol; Intaxel; LipoPac; OncoGel; Onxol; Paclitaxel (Taxol); Paxceed; Paxene; Plaxicel; TAXOL; TaxAlbin; Taxol A; Xorane; Yewtaxan; Zisu; nab-paclitaxel; paclitaxel
DTD0057	ABCC11	Multidrug resistance-associated protein 8	ABCC11; ATP-binding cassette sub-family C member 11; EWWD; MRP8; WW	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0057	ABCC11	Multidrug resistance-associated protein 8	ABCC11; ATP-binding cassette sub-family C member 11; EWWD; MRP8; WW	DR00174	Tenofovir	(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
DTD0057	ABCC11	Multidrug resistance-associated protein 8	ABCC11; ATP-binding cassette sub-family C member 11; EWWD; MRP8; WW	DR00175	Zalcitabine	1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; 2',3'-DIDEOXYCYTIDINE; 2',3'-Dideoxycytidine & Interferon-alpha; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); 2,3-dideoxycytidine; 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; Beta-D-2',3'-Dideoxycytidine; Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor; Beta-D-DDC; Cytidine, 2',3'-dideoxy & Interferon alpha; Cytidine, 2',3'-dideoxy-& Colony-stimulating factor; D 5782; DDC (DDC); DS-4152 & ddC; DdC; DdC & GM-CSF; DdC & IFN-alpha; DdC & Interferon alpha; DdC & NP (from PHCA or HSA); DdC & sCD4; DdC (Antiviral); DdCyd; Dideoxycytidine; HIVID; Hivid (TN); Hivid(TM); Hivid, Dideoxycytidine, NSC 606170, Zalcitabine; Interferon AD + ddC; KS-1130; Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine; PC-SOD & ddC; Ro 24-2027/000; Ro-24-2027/000; SRI-7707; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; Zalcitabine (JAN/USP/INN); Zalcitabine [USAN:INN:BAN]; Zalcitibine
DTD0057	ABCC11	Multidrug resistance-associated protein 8	ABCC11; ATP-binding cassette sub-family C member 11; EWWD; MRP8; WW	DR01193	Prasterone	17-Chetovis; 17-Hormoforin; 3beta-hydroxyandrost-5-en-17-one; 5,6-Dehydroisoandrosterone; 5,6-Dehydroisoandrostorone; 5,6-Didehydroisoandrosterone; 5-Dehydroepiandrosterone; 53-43-0; Andrestenol; Androstenolone; Caswell No 051F; DHEA; Dehydro-epi-androsterone; Dehydroepiandrosterone; Dehydroisoandrosterone; Diandron; Diandrone; Epiandrosterone, 5-dehydro-; Intrarosa; PRASTERONE; Prasterona; Prasteronum; Prestara; Psicosterone; Siscelar plus; trans-Dehydroandrosterone
DTD0061	ABCC8	Sulfonylurea receptor 1	ATP-binding cassette sub-family C member 8; ABCC8; ABC36; HRINS; SUR; SUR1; HHF1; TNDM2; SUR1delta2	DR00104	Tolbutamide	1-Butyl-3-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-(para-tolylsulfonyl) urea; 1-Butyl-3-tosylurea; 1-butyl-3-(4-methylphenyl)sulfonylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; 3-(p-tolylsulfonyl)-1-butylurea; 3-[p-Tolyl-4-sulfonyl]-1-butylurea; Aglicid; Apo-Tolbutamide; Apotex Brand of Tolbutamide; Arcosal; Arkozal; Artosin; Artozin; Aventis Brand of Tolbutamide; Beglucin; Berlin-Chemie Brand of Tolbutamide; BerlinChemie Brand of Tolbutamide; Butamid; Butamide; Butamide Brand of Tolbutamide; Butamidum; D 860; Diaben; Diabesan; Diabetamid; Diabetol; Diabuton; Diasulfon; Diaval; Dirastan; Dolipol; Drabet; Glyconon; HLS 831; Hoechst Brand of Tolbutamide; Ipoglicone; Mobenol; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Tolylsulfonyl)-N'-butylcarbamide; N-(p-tolylsulfonyl)-N'-n-butylurea; N-4-(Methylbenzolsulfonyl)-n-butylurea; N-4-Methylbenzolsulfonyl-N-butylurea; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-p-toluenesulfonylurea; N-Butyl-N'-toluene-p-sulfonylurea; N-n-Butyl-N'-tosylurea; Novo-Butamide; Orabet; Oralin; Oramide; Orezan; Orinase; Orinase (TN); Orinaz; Oterben; Pfizer Brand of Tolbutamide; Pramidex; R.A.N. Brand of Tolbutamide; Rastinon; Restinon; Sk-tolbutamide; T 0891; TOLBUTAMIDE USP; Tarasina; Tol-Tab; Tolbet;Tolbusal; Tolbutamid; Tolbutamid R.A.N.; Tolbutamida; Tolbutamida [INN-Spanish]; Tolbutamide (JP15/USP/INN); Tolbutamide Aventis Brand; Tolbutamide Butamide Brand; Tolbutamide Hoechst Brand; Tolbutamide Pfizer Brand; Tolbutamide [INN:BAN:JAN]; Tolbutamidum; Tolbutamidum [INN-Latin]; Tolbutone; Toluina; Tolumid; Toluran; Toluvan; Tolylsulfonylbutylurea; U 2043; Valdecasas Brand of Tolbutamide; Willbutamide; Yamanouchi Brand of Tolbutamide
DTD0062	ABCC9	Sulfonylurea receptor 2	ATP-binding cassette sub-family C member 9; ABCC9; SUR2; ABC37; CANTU; CMD1O; ATFB12	DR00104	Tolbutamide	1-Butyl-3-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-(para-tolylsulfonyl) urea; 1-Butyl-3-tosylurea; 1-butyl-3-(4-methylphenyl)sulfonylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; 3-(p-tolylsulfonyl)-1-butylurea; 3-[p-Tolyl-4-sulfonyl]-1-butylurea; Aglicid; Apo-Tolbutamide; Apotex Brand of Tolbutamide; Arcosal; Arkozal; Artosin; Artozin; Aventis Brand of Tolbutamide; Beglucin; Berlin-Chemie Brand of Tolbutamide; BerlinChemie Brand of Tolbutamide; Butamid; Butamide; Butamide Brand of Tolbutamide; Butamidum; D 860; Diaben; Diabesan; Diabetamid; Diabetol; Diabuton; Diasulfon; Diaval; Dirastan; Dolipol; Drabet; Glyconon; HLS 831; Hoechst Brand of Tolbutamide; Ipoglicone; Mobenol; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Tolylsulfonyl)-N'-butylcarbamide; N-(p-tolylsulfonyl)-N'-n-butylurea; N-4-(Methylbenzolsulfonyl)-n-butylurea; N-4-Methylbenzolsulfonyl-N-butylurea; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-p-toluenesulfonylurea; N-Butyl-N'-toluene-p-sulfonylurea; N-n-Butyl-N'-tosylurea; Novo-Butamide; Orabet; Oralin; Oramide; Orezan; Orinase; Orinase (TN); Orinaz; Oterben; Pfizer Brand of Tolbutamide; Pramidex; R.A.N. Brand of Tolbutamide; Rastinon; Restinon; Sk-tolbutamide; T 0891; TOLBUTAMIDE USP; Tarasina; Tol-Tab; Tolbet;Tolbusal; Tolbutamid; Tolbutamid R.A.N.; Tolbutamida; Tolbutamida [INN-Spanish]; Tolbutamide (JP15/USP/INN); Tolbutamide Aventis Brand; Tolbutamide Butamide Brand; Tolbutamide Hoechst Brand; Tolbutamide Pfizer Brand; Tolbutamide [INN:BAN:JAN]; Tolbutamidum; Tolbutamidum [INN-Latin]; Tolbutone; Toluina; Tolumid; Toluran; Toluvan; Tolylsulfonylbutylurea; U 2043; Valdecasas Brand of Tolbutamide; Willbutamide; Yamanouchi Brand of Tolbutamide
DTD0071	ABCG1	ATP-binding cassette sub-family G member 1	ABC8; ABCG1; ATP-binding cassette transporter 8; WHITE1; WHT1; White protein homolog	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0079	SLC10A7	Sodium/bile acid cotransporter 7	Na(+)/bile acid cotransporter 7; Solute carrier family 10 member 7; SLC10A7; PSEC0051; C4orf13	DR00317	Iron monocation	3ZhP; ATW 230; ATW 432; Ancor B; Ancoren 80/150; Armco iron; Atomel 28; Atomel 300M200; Atomel 500M; Atomel 95; Atomiron 44MR; Atomiron 5M; Atomiron AFP 25; Atomiron AFP 5; Carbonyl iron; Copy Powder CS 105-175; DSP 1000; DSP 128B; DSP 135; DSP 135C; DSP 138; Diseases (animal), iron overload; Diseases, iron overload; EF 1000; EF 250; EFV 200/300; EFV 250; EFV 250/400; Ed-In-Sol; Eisen; F 60 (metal); FT 3 (element); Fe-40; Fe1+; Feronate; Ferretts; Ferro-Caps; Ferro-Time; Ferrous iron; Ferrousal; Ferrovac E; Ferrum; GS 6; HF 2 (element); HL (iron); HQ (metal); HS (iron); HS 4849; Hemocyte; Hierro; Hoeganaes ATW 230; Hoeganaes EH; Iron; Iron (Fe); Iron (Fe1+); Iron ion (Fe+); Iron ion(1+); Iron standard for AAS; Iron(1+); Iron(1+) ion; Iron(III) nitrate solution; Iron, elemental; Iron, ion (Fe1+); Iron, ion (Fe1+) (8CI,9CI); LOHA; NC 100; PZh-1M3; PZh-2; PZh1M1; PZh2M; PZh2M1; PZh2M2; PZh3; PZh3M; PZh4M; PZhO; Remko; SUY-B 2; Siderol; Vitedyn-Slo; Yieronia
DTD0081	SLC11A2	Natural resistance-associated macrophage protein 2	AHMIO1; DCT1; DMT-1; DMT1; Divalent cation transporter 1; Divalent metal transporter 1; NRAMP 2; NRAMP2; SLC11A2; Solute carrier family 11 member 2	DR00317	Iron monocation	3ZhP; ATW 230; ATW 432; Ancor B; Ancoren 80/150; Armco iron; Atomel 28; Atomel 300M200; Atomel 500M; Atomel 95; Atomiron 44MR; Atomiron 5M; Atomiron AFP 25; Atomiron AFP 5; Carbonyl iron; Copy Powder CS 105-175; DSP 1000; DSP 128B; DSP 135; DSP 135C; DSP 138; Diseases (animal), iron overload; Diseases, iron overload; EF 1000; EF 250; EFV 200/300; EFV 250; EFV 250/400; Ed-In-Sol; Eisen; F 60 (metal); FT 3 (element); Fe-40; Fe1+; Feronate; Ferretts; Ferro-Caps; Ferro-Time; Ferrous iron; Ferrousal; Ferrovac E; Ferrum; GS 6; HF 2 (element); HL (iron); HQ (metal); HS (iron); HS 4849; Hemocyte; Hierro; Hoeganaes ATW 230; Hoeganaes EH; Iron; Iron (Fe); Iron (Fe1+); Iron ion (Fe+); Iron ion(1+); Iron standard for AAS; Iron(1+); Iron(1+) ion; Iron(III) nitrate solution; Iron, elemental; Iron, ion (Fe1+); Iron, ion (Fe1+) (8CI,9CI); LOHA; NC 100; PZh-1M3; PZh-2; PZh1M1; PZh2M; PZh2M1; PZh2M2; PZh3; PZh3M; PZh4M; PZhO; Remko; SUY-B 2; Siderol; Vitedyn-Slo; Yieronia
DTD0081	SLC11A2	Natural resistance-associated macrophage protein 2	AHMIO1; DCT1; DMT-1; DMT1; Divalent cation transporter 1; Divalent metal transporter 1; NRAMP 2; NRAMP2; SLC11A2; Solute carrier family 11 member 2	DR00338	Manganese	Colloidal manganese; Cutaval; MANGANESE COMPOUNDS; Magnacat; Mangan; Mangan [Polish]; Mangan nitridovany; Mangan nitridovany [Czech]; Manganese; Manganese element; Manganese fume; Manganese ion(4 ); Manganese metal alloy; Manganese(1-); Manganese(4 ); Manganese(7+); Manganese, 99+%, powder, -40 mesh; Manganese, elemental; Manganese, ion (Mn1-); Manganese, ion (Mn4 ); Manganese-55; Teprosyn M; Tronamang; manganeso; manganide; manganum
DTD0082	SLC12A1	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2	BSC1; Kidney-specific Na-K-Cl symporter; NKCC2; SLC12A1; Solute carrier family 12 member 1	DR00184	Potassium chloride	11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
DTD0082	SLC12A1	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2	BSC1; Kidney-specific Na-K-Cl symporter; NKCC2; SLC12A1; Solute carrier family 12 member 1	DR01173	Sodium chloride	7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling
DTD0083	SLC12A2	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1	Basolateral Na-K-Cl symporter; Solute carrier family 12 member 2; SLC12A2; NKCC1	DR00184	Potassium chloride	11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
DTD0083	SLC12A2	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1	Basolateral Na-K-Cl symporter; Solute carrier family 12 member 2; SLC12A2; NKCC1	DR01173	Sodium chloride	7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling
DTD0084	SLC12A3	Thiazide-sensitive sodium-chloride cotransporter	NCC; NCCT; Na-Cl cotransporter; Na-Cl symporter; SLC12A3; Solute carrier family 12 member 3; TSC	DR00272	Bumetanide	3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex
DTD0084	SLC12A3	Thiazide-sensitive sodium-chloride cotransporter	NCC; NCCT; Na-Cl cotransporter; Na-Cl symporter; SLC12A3; Solute carrier family 12 member 3; TSC	DR01032	Metolazone	2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide; 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide; Diulo; Metalazone; Metalozone; Metenix; Metolazona; Metolazona [INN-Spanish]; Metolazone (JAN/USP/INN); Metolazone [USAN:BAN:INN:JAN]; Metolazonum; Metolazonum [INN-Latin]; Microx; Mykrox; Mykrox (TN); Mykrox, Zaroxolyn, Diulo, Metolazone; Oldren; SR 720-22; SR-720-22; Xuret; Zaroxolyn; Zaroxolyn (TN)
DTD0085	SLC12A4	Electroneutral potassium-chloride cotransporter 1	Erythroid K-Cl cotransporter 1; hKCC1; KCC1; SLC12A4; Solute carrier family 12 member 4	DR00184	Potassium chloride	11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
DTD0086	SLC12A5	Electroneutral potassium-chloride cotransporter 2	hKCC2; Neuronal K-Cl cotransporter; K-Cl cotransporter 2; KCC2; KIAA1176; Solute carrier family 12 member 5	DR00184	Potassium chloride	11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
DTD0087	SLC12A6	Electroneutral potassium-chloride cotransporter 3	ACCPN; K-Cl cotransporter 3; KCC3; KCC3A; KCC3B; SLC12A6; Solute carrier family 12 member 6	DR00184	Potassium chloride	11118_FLUKA; Acronitol; Addi-K; Apo-K; Celeka; Cena-K; Chlorid draselny; Chlorid draselny [Czech]; Chloride of potash; Chloride, Potassium; Chloropotassuril; Chloropotassuril diffu-K; Chlorvescent; Clor-K-Zaf; Conductance standard solution; Conductivity Standard Solution, 1413-S/cm; Conductivity Standard Solution, 500-S/cm; Diffu-K; Dipotassium dichloride; Duffi-K; Durekal; Durules; Durules-K; Emplets potassium chloride; Enpott; Enseal; Hydrochloric acid potassium salt (1:1); IN2900; ISA (ionic strength adjustment solution: 1 M KCl); Infalyte; K Tab; K+10; K+8; K-10; K-Care; K-Contin; K-Dur; K-Grad; K-Lease; K-Lor; K-Lyte Cl; K-Lyte/Cl; K-Norm; K-Predne-Dome; K-SR; K-Sol; K-Tab; K-dur (TN); K-lyte/C1; K. tab; KCL; KCL (TN); KCL Retard; KCl-retard Zyma; KM potassium chloride; KSR; Kadalex; Kalcorid; Kaleorid; Kaleorod; Kaliduron; Kaliglutol; Kalilente; Kalinor-Retard P; Kalinorm; Kalinorm Depottab; Kaliolite; Kalipor; Kalipoz; Kalitabs; Kalitrans Retard; Kalium Duriles; Kalium Durules; Kalium Retard; Kalium S.R; Kalium S.R.; Kalium SR; Kalium-Durettes; Kalium-R; Kalium-duriles; Kaliumchlorid; Kaochlor; Kaon Cl; Kaon Cl-10; Kaon Ultra; Kaon-Cl; Kaon-Cl (TN); Kaon-Cl 10; Kaon-Cl TABS; Kaon-ci; Kaskay; Kato; Kay Ciel; Kay-Cee-L; Kay-Ciel; Kay-EM; Kayback; Kayciel; Kaysiel; Kelp salt; Keylyte; Klor-Con; Klor-Con M10; Klor-Con M15; Klor-Con M20; Klor-Lyte; Klor-con (TN); Kloren; Klorvess; Klotrix; Klotrix (TN); Kolyum; Lento-K; Lento-Kalium; Leo K; Leo-K; Micro-K; Micro-K 10; Micro-K Extentcaps; Micro-K LS; Micro-Kalium Retard; Miopotasio; Monopotassium chloride; Muriate of potash; Natural sylvite; Neobakasal; Nu-K; POTASSIUM CHLORIDE, ACS; POTASSIUM CHLORIDE, U.S.P.; Peter-kal; Pfiklor; Plus Kalium Retard; Potasion; Potasol; Potassium Chloride 10meq in Plastic Container; Potassium Chloride BP; Potassium Chloride in Plastic Container; Potassium Cl; Potassium atomic spectroscopy standard concentrate 1.00 g K; Potassium chloride (JP15/USP); Potassium chloride (K3Cl3); Potassium chloride (KCl); Potassium chloride 20meq inplastic container; Potassium chloride 30meq in plastic container; Potassium chloride 40meq in plastic container; Potassium chloride [JAN]; Potassium chloride solution; Potassium chloride standard; Potassium monochloride; Potassium muriate; Potassium standard concentrate 10.00 g K; Potassium thallium chloride (KTlCl); Potavescent; Rekawan; Rekawan Retard; Repone K; Repone-K; Rum-K; Sal digestnum sylvii; Sando-K; Selora; Slow-K; Slow-K tablets; Span-K; Steropotassium; Super K; Super K (salt); Sylvite; Ten-K; Tripotassium trichloride; Trona muriate of potash; Trona potassium chloride; Ultra K Chlor; Ultra-K-Chlor; [KCl]
DTD0088	SLC12A7	Electroneutral potassium-chloride cotransporter 4	K-Cl cotransporter 4; KCC4; SLC12A7; Solute carrier family 12 member 7	DR01254	Cation chloride	.
DTD0089	SLC12A8	Cation-chloride cotransporter 9	Solute carrier family 12 member 8; SLC12A8; CCC9	DR00719	Nicotinamide mononucleotide	Beta-NMN; Beta-Nicotinamide mononucleotide; Beta-Nicotinamide ribonucleotide; Nicotinamide D-ribonucleotide; Nicotinamide mononucleotide; Nicotinamide nucleotide; Nicotinamide ribonucleotide; Nicotinamide ribotide
DTD0091	SLC13A1	Sodium/sulfate cotransporter 1	NAS1; NASI1; NaSi-1; SLC13A1; Solute carrier family 13 member 1; Na(+)/sulfate cotransporter; hNaSi-1; Renal sodium/sulfate cotransporter	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0092	SLC13A2	Sodium/dicarboxylate cotransporter 1	NADC1; Na(+)/dicarboxylate cotransporter 1; NaDC-1; SDCT1; SLC13A2; Solute carrier family 13 member 2; Renal sodium/dicarboxylate cotransporter	DR01245	Dicarboxylate	1,3-Propanedioic acid; 9KX7ZMG0MK; AI3-15375; BRN 1751370; CHEBI:30794; Carboxyacetic acid; DICARBOXYLIC ACID C3; Dicarboxylate; Dicarboxylic acid; Dicarboxymethane; EINECS 205-503-0; Kyselina malonova; Kyselina malonova [Czech]; METAHNEDICARBOXYLIC ACID; MFCD00002707; Malonic acid; Malonic acid, 99%; Methanedicarbonic acid; Methanedicarboxylic acid; NSC 8124; NSC8124; OFOBLEOULBTSOW-UHFFFAOYSA-N; PROPANEDIOLIC ACID; Thallium malonate; UNII-9KX7ZMG0MK; USAF EK-695; alpha,omega-Dicarboxylic acid; malonic acid; propanedioic acid
DTD0093	SLC13A3	Sodium/dicarboxylate cotransporter 3	ARLIAK; NADC3; Na(+)/dicarboxylate cotransporter 3; NaDC-3; SDCT2; SLC13A3; Solute carrier family 13 member 3; hNaDC3; Sodium-dependent high-affinity dicarboxylate transporter 2	DR00139	Alpha-ketoglutaric acid	2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate
DTD0093	SLC13A3	Sodium/dicarboxylate cotransporter 3	ARLIAK; NADC3; Na(+)/dicarboxylate cotransporter 3; NaDC-3; SDCT2; SLC13A3; Solute carrier family 13 member 3; hNaDC3; Sodium-dependent high-affinity dicarboxylate transporter 2	DR01245	Dicarboxylate	1,3-Propanedioic acid; 9KX7ZMG0MK; AI3-15375; BRN 1751370; CHEBI:30794; Carboxyacetic acid; DICARBOXYLIC ACID C3; Dicarboxylate; Dicarboxylic acid; Dicarboxymethane; EINECS 205-503-0; Kyselina malonova; Kyselina malonova [Czech]; METAHNEDICARBOXYLIC ACID; MFCD00002707; Malonic acid; Malonic acid, 99%; Methanedicarbonic acid; Methanedicarboxylic acid; NSC 8124; NSC8124; OFOBLEOULBTSOW-UHFFFAOYSA-N; PROPANEDIOLIC ACID; Thallium malonate; UNII-9KX7ZMG0MK; USAF EK-695; alpha,omega-Dicarboxylic acid; malonic acid; propanedioic acid
DTD0093	SLC13A3	Sodium/dicarboxylate cotransporter 3	ARLIAK; NADC3; Na(+)/dicarboxylate cotransporter 3; NaDC-3; SDCT2; SLC13A3; Solute carrier family 13 member 3; hNaDC3; Sodium-dependent high-affinity dicarboxylate transporter 2	DR01246	Succinate	.
DTD0094	SLC13A4	Na(+)/sulfate cotransporter SUT-1	NaS2; SLC13A4; SUT-1; SUT1; Solute carrier family 13 member 4	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0095	SLC13A5	Sodium-coupled citrate transporter	EIEE25; INDY; Na(+)/citrate cotransporter; SLC13A5; Sodium-dependent citrate; NaCT transporter; Solute carrier family 13 member 5; mIndy	DR00139	Alpha-ketoglutaric acid	2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate
DTD0095	SLC13A5	Sodium-coupled citrate transporter	EIEE25; INDY; Na(+)/citrate cotransporter; SLC13A5; Sodium-dependent citrate; NaCT transporter; Solute carrier family 13 member 5; mIndy	DR01246	Succinate	.
DTD0095	SLC13A5	Sodium-coupled citrate transporter	EIEE25; INDY; Na(+)/citrate cotransporter; SLC13A5; Sodium-dependent citrate; NaCT transporter; Solute carrier family 13 member 5; mIndy	DR01247	Citrate	.
DTD0096	SLC14A1	Urea transporter 1	HUT11; HsT1341; JK; RACH1; RACH2; SLC14A1; Solute carrier family 14 member 1; UT-B1; UT1; UTE; Urea transporter, erythrocyte; hUT1; UT1b	DR00349	Thiourea	2-Thiopseudourea; 2-Thiourea; Carbamimidothioic acid; Caswell No. 855; Isothiourea; Pseudothiourea; Pseudourea, 2-thio-; RCRA waste no. U219;.beta.-Thiopseudourea; RCRA waste number U219; Sulfourea; Sulfouren; Sulourea; THIOUREA; Thiocarbamid; Thiocarbamide; Thiocarbonic acid diamide; Thioharnstoff; Thiokarbamid; Thiomocovina; Thiomocovina [Czech]; Thiurea; Thiuronium; Tsizp 34; Urea, 2-thio-; Urea, thio-; beta-Thiopseudourea; carbonothioic diamide; sulfocarbamide; thio-urea
DTD0096	SLC14A1	Urea transporter 1	HUT11; HsT1341; JK; RACH1; RACH2; SLC14A1; Solute carrier family 14 member 1; UT-B1; UT1; UTE; Urea transporter, erythrocyte; hUT1; UT1b	DR00721	Methylurea	1-Methylurea; 1-Methylurea;1-Methylurea; 3-methyl-urea; 598-50-5; AC1L1XZ6; ACMC-1AKB9; AI3-15088; CCRIS 9137; CH3NHCONH2; CHEBI:44383; CTK1H1160; DTXSID5060510; EC 209-935-0; EINECS 209-935-0; GTPL4662; KSC271C6B; Methyl urea; Methylharnstoff; Methylharnstoff [German]; Methylmocovina; Methylmocovina [Czech]; Methylurea, 97%; Monomethylurea; N-Methylurea; N-Methylurea, 97%; N-methyl urea; UNII-VZ89YBW3P8; Urea, methyl-; VZ89YBW3P8; XGEGHDBEHXKFPX-UHFFFAOYSA-N; bmse000738; methyl-urea; methylisourea; urea, N-methyl-
DTD0097	SLC14A2	Urea transporter 2	HUT2; SLC14A2; Solute carrier family 14 member 2; UT-A2; UT2; UTA; UTR; Urea transporter, kidney; hUT-A6	DR00721	Methylurea	1-Methylurea; 1-Methylurea;1-Methylurea; 3-methyl-urea; 598-50-5; AC1L1XZ6; ACMC-1AKB9; AI3-15088; CCRIS 9137; CH3NHCONH2; CHEBI:44383; CTK1H1160; DTXSID5060510; EC 209-935-0; EINECS 209-935-0; GTPL4662; KSC271C6B; Methyl urea; Methylharnstoff; Methylharnstoff [German]; Methylmocovina; Methylmocovina [Czech]; Methylurea, 97%; Monomethylurea; N-Methylurea; N-Methylurea, 97%; N-methyl urea; UNII-VZ89YBW3P8; Urea, methyl-; VZ89YBW3P8; XGEGHDBEHXKFPX-UHFFFAOYSA-N; bmse000738; methyl-urea; methylisourea; urea, N-methyl-
DTD0098	SLC15A3	Peptide/histidine transporter 2	OCTP; Osteoclast transporter; PHT2; PTR3; Peptide transporter 3; Solute carrier family 15 member 3; SLC15A3	DR00282	L-histidine	Histidine
DTD0099	SLC15A4	Peptide transporter 4	FP12591; PHT1; PTR4; Peptide/histidine transporter 1; SLC15A4; Solute carrier family 15 member 4; hPHT1	DR00282	L-histidine	Histidine
DTD0099	SLC15A4	Peptide transporter 4	FP12591; PHT1; PTR4; Peptide/histidine transporter 1; SLC15A4; Solute carrier family 15 member 4; hPHT1	DR00375	Peptides	Peptides (drug-resistant bacterial infections); Peptides (drug-resistant bacterial infections), BioAMPS International; V13K
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00089	Gabapentin enacarbil	ASP8825; GSK 1838262; Gabapentin-XP; Horizant; Regnite; Solzira; XP13512
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00257	Biotin	Biodermatin; Bioepiderm; Bios II; Biotin Forte; Factor S; Lutavit H2; Meribin; Rovimix H2
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00293	Pyroglutamic acid	5-oxoproline; PCA; pidolic acid
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00556	Salicylic acid	2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR00987	Gamma-hydroxybutyric acid	3-carboxypropoxy acid; 4 HB; 4-Hydroxy; 4-Hydroxyacid; 4-Hydroxyalkanoic acid; 4-Hydroxybutanoic acid; 4-Hydroxybuttersaeure; 4-Hydroxybutyrate sodium; 4-Hydroxybutyric acid; 4-Hydroxybutyric acid monosodium salt; 4-Hydroxycarboxylic acid; 4-OHB; 4-hydroxy-butyric acid; AA3E2AF0-AB7A-4A1E-A391-199C049D7162; Anetamin; Butanoic acid, 4-hydroxy-, monosodium salt; Butanoic acid, 4-hydroxy-, sodium salt; Butyric acid, 4-hydroxy-, monosodium salt; Butyric acid, 4-hydroxy-, sodium salt; EB 27; GHB; Gam-OH; Gamma OH; Gamma-Hydroxy butyrate; Gamma-Hydroxy sodium butyrate; Gamma-Hydroxybutanoic acid; Gamma-Hydroxybutyrate sodium; Gamma-Hydroxybutyric acid; Gamma-Hydroxybutyric acid decomposition product; Gamma-Hydroxybutyric acid monosodium salt; Gamma-Hydroxybutyric acid, sodium salt; Gamma-OH; Hydroxyb; Oxy-n-butyric acid; Oxybate; Oxybate sodium; SHB; Sodium .gamma.-hydroxybutyrate; Sodium .gamma.-oxybutyrate; Sodium Oxybate (4-hydroxybutanoic acid); Somsanit; Utyric acid monosodium salt; WY 3478; Xyrem; Xyrem (TN)
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR01241	Milchsaure	(+/-)-Lactic acid; 1-Hydroxyethanecarboxylic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; 26100-51-6; Acidum lacticum; Aethylidenmilchsaeure; DL-Lactic acid; DL-Milchsaeure; Ethylidenelactic acid; Kyselina 2-hydroxypropanova; Kyselina mlecna; Lactic acid; Lactic acid (natural); Lactic acid USP; Lacticum acidum; Lactovagan; Milchsaeure; Milchsaure; Milchsaure [German]; Milk acid; Ordinary lactic acid; Polylactic acid; Propanoic acid, 2-hydroxy-; Racemic lactic acid; Tonsillosan; alpha-Hydroxypropionic acid; lactate; lactic acid
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR01397	Pyruvic acid	BTS; Brenztraubensaeure; Acetylformic acid; Acide pyruvique; Pyroracemic acid; CH3COCOOH; A-Ketopropionic acid; Alpha-Ketopropionic acid; Alpha-Oxopropionsaeure; Alpha-keto propionic acid; Alpha-ketopropionic acid; P-9250; Pyruvic acid (8CI); Pyruvic acid (natural); Propanoic acid, 2-oxo-(9CI); 2-Ketopropionic acid; 2-Oxopropanoate; 2-Oxopropanoic acid; 2-Oxopropansaeure; 2-Oxopropionic acid; 2-Oxopropionsaeure; 2-oxo(1-14c)propanoic acid; 2-oxo-propionic acid
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR01475	Butyrate	butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; 1-propanecarboxylic acid; Butanic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; CCRIS 6552; HSDB 940; butoic acid; Ethyacetic Acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H
DTD0100	SLC16A1	Monocarboxylate transporter 1	HHF7; MCT; MCT 1; MCT1; MCT1D; SLC16A1; Solute carrier family 16 member 1; hMCT1	DR01497	Glycolic acid	glycolic acid; 2-Hydroxyacetic acid; hydroxyacetic acid; 79-14-1; Glycollic acid; Hydroxyethanoic acid; Acetic acid, hydroxy-; glycolate; Caswell No. 470; alpha-Hydroxyacetic acid; Kyselina glykolova; Kyselina glykolova [Czech]; Kyselina hydroxyoctova; HOCH2COOH; 2-Hydroxyethanoic acid; Kyselina hydroxyoctova [Czech]; Glycocide; EPA Pesticide Chemical Code 000101; GlyPure; HSDB 5227; NSC 166; Acetic acid, 2-hydroxy-; AI3-15362; UNII-0WT12SX38S; GlyPure 70; BRN 1209322; GLYCOLLATE; C2H4O3; Acetic acid, hydroxy-, homopolymer; EINECS 201-
DTD0101	SLC16A10	Monocarboxylate transporter 10	Aromatic amino acid transporter 1; Solute carrier family 16 member 10; T-type amino acid transporter 1; SLC16A10; MCT10; TAT1	DR00086	L-tryptophan	(-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin]
DTD0103	SLC16A12	Monocarboxylate transporter 12	CJMG; CRT2; CTRCT47; Creatine transporter 2; MCT 12; MCT12; SLC16A12; Solute carrier family 16 member 12	DR00034	Creatine ALS-08	AL-02 (ALS), Avicena; AL-08 (ALS), Avicena; ALS-02; ALS-05; ALS-08; Creatine; Creatine (ALS), Avicena; Creatine (Huntington's disease), Avicena; Creatine (Parkinson's disease), Avicena; Creatine (amyotrophic lateral sclerosis), Avicena; HD-02; PD-01, Avicena; PD-02; PD-04; PD-06
DTD0107	SLC16A3	Monocarboxylate transporter 4	MCT 4; MCT4; SLC16A3; Solute carrier family 16 member 3	DR01241	Milchsaure	(+/-)-Lactic acid; 1-Hydroxyethanecarboxylic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; 26100-51-6; Acidum lacticum; Aethylidenmilchsaeure; DL-Lactic acid; DL-Milchsaeure; Ethylidenelactic acid; Kyselina 2-hydroxypropanova; Kyselina mlecna; Lactic acid; Lactic acid (natural); Lactic acid USP; Lacticum acidum; Lactovagan; Milchsaeure; Milchsaure; Milchsaure [German]; Milk acid; Ordinary lactic acid; Polylactic acid; Propanoic acid, 2-hydroxy-; Racemic lactic acid; Tonsillosan; alpha-Hydroxypropionic acid; lactate; lactic acid
DTD0109	SLC16A5	Monocarboxylate transporter 6	Monocarboxylate transporter 5; MCT 5; MCT 6; Solute carrier family 16 member 5; SLC16A5; MCT5; MCT6	DR00232	Probenecid	4-((Dipropylamino)sulfonyl)benzoic acid;4-(Di-n-propylsulfamoyl)benzoesaeure; 4-(Dipropylsulfamoyl)benzoic acid; 4-(N,N-Dipropylsulfamoyl)benzoesaeure; 4-[(dipropylamino)sulfonyl]benzoic acid; Apurina; Bencid; Benecid; Benemid; Benemid (TN); Benemide; Benuryl; Benuryl (TN); Biokanol Brand of Probenecid; Col-BENEMID; ColBenemid (co mponent of); ColBenemid (component of); ICN Brand of Probenecid; IDIS Brand of Probenecid; Major Brand of Probenecid; Martec Brand of Probenecid; Merck Brand of Probenecid; Ophthalmic Brand of Probenecid; P-(Dipropylsulfamoyl)benzoic acid; P-(Dipropylsulfamyl)benzoic acid; P-[Dipropylsulfamoyl]benzoic acid; Panuric; Parabenem; Parmed Brand of Probenecid; Polycillin-BRB; Polycillin-PRB (component of); Pro-Cid; Probalan; Probampacin; Probecid; Proben; Probenecid (JP15/USP/INN); Probenecid Major Brand; Probenecid Martec Brand; Probenecid Parmed Brand; Probenecid Weimer; Probenecid Zenith Brand; Probenecid [INN:BAN:JAN]; Probenecid acid; Probenecida; Probenecida [INN-Spanish]; Probenecide; Probenecide [INN-French]; Probenecidum; Probenecidum [INN-Latin]; Probenemid; Probenicid; Probenid; Probexin; Prolongine; Robenecid; Sulprin; Synergid R; Tubophan; Uricosid; Urocid; Valdecasas Brand of Probenecid; Zenith Brand of Probenecid
DTD0109	SLC16A5	Monocarboxylate transporter 6	Monocarboxylate transporter 5; MCT 5; MCT 6; Solute carrier family 16 member 5; SLC16A5; MCT5; MCT6	DR00272	Bumetanide	3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Aquazone; AstraZeneca Brand of Bumetanide; Atlantis Brand of Bumetanide; B 3023; Bumedyl; Bumetanida; Bumetanida [INN-Spanish]; Bumetanide (JP15/USP); Bumetanide (JP15/USP/INN); Bumetanide AstraZeneca Brand; Bumetanide Atlantis Brand; Bumetanide Farmacusi Brand; Bumetanide Grossmann Brand; Bumetanide Leo Brand; Bumetanide Roche Brand; Bumetanide Senosiain Brand; Bumetanide [USAN:BAN:INN:JAN]; Bumetanidum; Bumetanidum [INN-Latin]; Bumethanide; Bumex; Bumex (TN); Bumex, Bumetanide; Burine; Burinex; Butinat; Cambiex; Diurama; Drenural; Farmacusi Brand of Bumetanide; Fontego; Fordiuran; Grossmann Brand of Bumetanide; Leo Brand of Bumetanide; Lixil; Lixil-Leo; Lunetoron; Miccil; PF 1593; PF-1593; PF1593; Ro 10-6338; Ro-10-6338; Roche Brand of Bumetanide; Segurex; Senosiain Brand of Bumetanide; Yurinex
DTD0109	SLC16A5	Monocarboxylate transporter 6	Monocarboxylate transporter 5; MCT 5; MCT 6; Solute carrier family 16 member 5; SLC16A5; MCT5; MCT6	DR00407	Nateglinide	(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; 3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; A-4166; AY-4166; DJN 608; DJN-608; Fastic; IPCCPA; N-((4-isopropylcyclohexyl)carbonyl)phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; Nate-glinide; Nateglinide [INN]; Nateglinide, (D-Phe)-isomer; Nateglinide, (cis,D-Phe)-isomer; Novartis brand of nateglinide; SDZ-DJN-608; Senaglinide; Starlix; Starlix (TN); Starsis; Trazec; YM-026
DTD0110	SLC16A6	Monocarboxylate transporter 7	SLC16A6; MCT7; Solute carrier family 16 member 6	DR01252	Monocarboxylic acids	.
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR00030	Atorvastatin	(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; Atogal; Atorlip; Atorpic; Atorvastatin (INN); Atorvastatin [INN:BAN]; Atorvastatina; Atorvastatine; Atorvastatinium; Atrovastin; Cardyl; Faboxim; Lipitor (TN); Lipitor(TM); Lipotropic; Lipovastatinklonal; Liprimar; Lowden; Sincol; Sortis; Sortis (TN); Sotis; Torvacard; Torvast; Totalip; Tozalip; Tulip; Vastina; Xanator; Xarator; Xavator; Zurinel
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR00399	Valproic Acid	2 PP (base); 2-Propylpentanoic acid; 2-Propylvaleric acid; 2-n-Propyl-n-valeric acid; 4-Heptanecarboxylic acid; Abbott 44090; Acide valproique; Acide valproique [INN-French]; Acido valproico; Acido valproico [INN-Spanish]; Acidum valproicum; Acidum valproicum [INN-Latin]; Alti-Valproic; Avugane; Baceca; Convulex; Convulex (TN); Convulsofin; Depacon (TN); Depakene; Depakene (TN); Depakin; Depakin chrono; Depakine; Depakine chrono; Depakote (TM); Depakote (TN); Depakote ER (TN); Deproic; Di-n-propylacetic acid; Di-n-propylessigsaeure; Di-n-propylessigsaure; Di-n-propylessigsaure [German]; Dipropyl Acetate; Dipropylacetate; Dipropylacetic acid; Dom-Valproic; Encorate (TN); Epilim (TN); Epival (TN); Ergenyl; G2M-777; Kyselina 2-propylvalerova; Kyselina 2-propylvalerova [Czech]; Med Valproic; Mylproin; Myproic Acid; N-DPA; N-Dipropylacetic acid; Novo-Valproic; Nu-Valproic; PMS-Valproic Acid; Penta-Valproic; Propylvaleric acid; Savicol; Semisodium Valproate; Stavzor; Stavzor (TN); VPA; Valproate; Valproic Acid, Sodium Salt (2:1); Valproic acid (USP); Valproic acid USP; Valproic acid USP24; Valproic acid [USAN:INN:BAN]; Valproinsaeure; Vupral; Winthrop (TN)
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR00556	Salicylic acid	2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR00663	Ibuprofen	ACHES-N-PAIN; Act-3; Act-3 (TN); Actiprofen; Adex 200; Adran; Advil; Advil (TN); Ak+C2278tren; Aktre (TN); Alaxan; Alaxan (TN); Algofen; Algoflex (TN); Alivium (TN); Am-Fam 400; Amelior; Amersol; Amibufen; Anafen; Anco; Andran; Anflagen; Antagil; Antalfene; Antarene; Antiflam; Apsifen; Apsifen-F; Arthrofen (TN); Artofen; Artril; Artril 300; Balkaprofen; Betaprofen; Bloom; Bluton; Bonifen (TN); Brofen; Brufanic; Brufen; Brufen (TN); Brufen 400; Bruflam; Brufort; Buburone; Bufeno; Bufigen; Bugesic (TN); Bukrefen; Bupron; Buracaps; Burana; Burana (TN); Butylenin; Caldolor (TN); Calprofen (TN); Cap-Profen; Carol;Cesra; Citalgan; Cobo; Codral; Combiflam; Cunil; DOLO PUREN; Daiprophen; Dalsy; Dalsy (TN); Dansida; Deep Relief; Dentigoa; Dibufen; Dignoflex; Dismenol (TN); Diverin (TN); Dolgirid; Dolgit; Dolgit (TN); Dolibu; Dolmaral; Dolo-Dolgit; Dolo-Spedifen (TN); Dolocyl; Dolofen; Dolofen-F; Dolofin; Dolofort; Dolofort (TN); Dologel; Dolomax; Doloraz (TN); Doloren; Dolormin; Dolormin (TN); Doltibil; Dolven; Donjust B; Dorival; Dorival (TN); Drin; Duafen; Duobrus; Dura-Ibu; Dysdolen; Easifon; Ebufac; Ebufac (TN); Emflam; Emflam-200; EmuProfen (TN); Epobron; Eputex; Ergix; Espidifen (TN); Esprenit; Eve (TN); Exneural; Faspic; Femadon; Femafen; Femapirin; Femidol; Fenbid (TN); Fenbid;Fendol; Fenpaed (TN); Fenspan; Fibraflex; Finalflex (TN); Galprofen (TN); Gelufene; Gofen; Grefen; Gynofug; Haltran; Hedex (TN); Herron Blue (TN); I 4883; I-profen (TN); IB-100; IBU-Ratiopharm (TN); IBUFEN (TN); IP 82; IP-82; IP82; Ibalgin (TN); Ibol; Ibren; Ibu; Ibu-Attritin; Ibu-Tab; Ibu-Tab 200; Ibu-Vivimed (TN); Ibu-slo; Ibu-slow; IbuHEXAL (TN); Ibubest; Ibubeta; Ibucasen; Ibudol; Ibudolor; Ibufen; Ibuflamar; Ibufug; Ibugel; Ibugel (TN); Ibugen; Ibugesic; Ibuhexal; Ibulagic; Ibular; Ibulav; Ibuleve; Ibuleve (TN); Ibulgan; Ibum (TN); Ibumax (TN); Ibumed; Ibumerck; Ibumetin; Ibumetin (TN); Ibupirac; Ibuprin; Ibuprocin; Ibuprofene; Ibuprofeno; Ibuprofenum; Ibuprohm; Ibuprom (TN); Ibuprophen; Ibuprosyn (TN); Ibusal; Ibutid; Ibux (TN); Ibuxin (TN); Ifen; Inabrin; Inflam; Inoven; Ipren; Ipren (TN); Irfen; Isodol; Jenaprofen; Junifen; Kesan; Kratalgin; Kratalgin (TN); Lamidon; Lebrufen; Librofem; Lidifen; Liptan; Lopane; Malafene; Manypren; Medicol (TN); Medipren; Melfen; Mensoton; Midol; Midol 200; Moment; Moment (TN); Motrin; Motrin (TN); Motrin IB; Mynosedin; Nagifen-D; Napacetin; Narfen; Narfen (TN); Neo-Helvagit; Neo-Mindol; Neobrufen; Neobrufen (TN); Neofen (TN); Nerofen; Noalgil; Nobafon; Nobfelon; Nobfen; Nobgen; Noritis; Norton; Norvectan (TN); Novadol; Novo-Profen; Novogent; Novogent N; Novoprofen; Nuprilan; Nuprin; Nuprin (TN); Nureflex (TN); Nurofen; Nurofen (TN); Optifen; Opturem; Oralfene; Orbifen (TN); Ostarin; Ostofen; Ozonol; Paduden; Panafen; Panafen (TN); Pantrop; Paxofen; Pedia-Profen; PediaProfen; Perifar (TN); Perofen; Proartinal; Profen; Profin (TN); Proflex; Provon; Quadrax; R.D. 13621; RD 13621; Rafen; Ranofen; Ratiodolor (TN); Rebugen; Relcofen; Retard (TN); Rhinadvil; Rimafen (TN); Rofen; Roidenin; Rufen; Rufin; Rupan; Sadefen; Salivia; Salprofen; Salvarina (TN); Seclodin; Sednafen; Seklodin; Seskafen; Siyafen; Solpaflex; Solpaflex (TN); Solufen; Spedifen (TN); Speedpain NANO (TN); Spidifen (TN); Stelar; Sugafen; Suprafen; Suspren; Syntofene; Tab-Profen; Tabalon; Tabalon 400; Tatanal; Tempil; Tofen; Togal N; Tonal; Trendar; U 18573; U-18,573; U-18573; UCB 79171; Unipron; Upfen; Upfen (TN); Uprofen; Urem; VUFB 9649; Zafen; Zofen
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR00720	Propicillin	(1-Phenoxypropyl)penicillin; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxybutanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 551-27-9; 6beta-(2-phenoxybutanamido)-2,2-dimethylpenam-3alpha-carboxylic acid; 8X1R260V33; AC1L3P0Y; AC1Q5QWR; CHEBI:52429; EINECS 208-995-5; NCGC00160673-01; Propicilina; Propicilina [INN-Spanish]; Propicillin (BAN); Propicillin [INN:BAN:DCF]; Propicilline; Propicilline [INN-French]; Propicillinum; Propicillinum [INN-Latin]; UNII-8X1R260V33; phenoxypropylpenicillin
DTD0111	SLC16A7	Monocarboxylate transporter 2	Solute carrier family 16 member 7; MCT 2; SLC16A7; MCT2	DR01241	Milchsaure	(+/-)-Lactic acid; 1-Hydroxyethanecarboxylic acid; 2-hydroxypropanoic acid; 2-hydroxypropionic acid; 26100-51-6; Acidum lacticum; Aethylidenmilchsaeure; DL-Lactic acid; DL-Milchsaeure; Ethylidenelactic acid; Kyselina 2-hydroxypropanova; Kyselina mlecna; Lactic acid; Lactic acid (natural); Lactic acid USP; Lacticum acidum; Lactovagan; Milchsaeure; Milchsaure; Milchsaure [German]; Milk acid; Ordinary lactic acid; Polylactic acid; Propanoic acid, 2-hydroxy-; Racemic lactic acid; Tonsillosan; alpha-Hydroxypropionic acid; lactate; lactic acid
DTD0112	SLC16A8	Monocarboxylate transporter 3	MCT 3; MCT3; REMP; SLC16A8; Solute carrier family 16 member 8	DR00333	Phenylacetic acid	.alpha.-Toluic acid; .omega.-Phenylacetic acid; 2-Phenylacetic acid; Acetic acid, phenyl-; Benzenacetic acid; Benzeneacetic acid; Benzylcarboxylic acid; Benzylformic acid; Kyselina fenyloctova; Kyselina fenyloctova [Czech]; PHENYL ACETIC ACID; PHENYL-ACETIC ACID; PHENYLACETIC ACID; Phenylacetic acid (natural); Phenylethanoic acid; Phenyllacetic acid; alpha-Toluic acid; omega-Phenylacetic acid; phenylacetate
DTD0113	SLC16A9	Monocarboxylate transporter 9	C10orf36; MCT 9; MCT9; SLC16A9; Solute carrier family 16 member 9	DR00172	Uric acid	urate
DTD0113	SLC16A9	Monocarboxylate transporter 9	C10orf36; MCT 9; MCT9; SLC16A9; Solute carrier family 16 member 9	DR00255	L-carnitine	(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT
DTD0114	SLC17A1	Sodium-dependent phosphate transport protein 1	NAPI-1; NPT-1; NPT1; Na(+)/PI cotransporter 1; Na/Pi-4; Renal Na(+)-dependent phosphate cotransporter 1; Renal sodium-dependent phosphate transport protein 1; Renal sodium-phosphate transport protein 1; SLC17A1; Sodium/phosphate cotransporter 1; Solute carrier family 17 member 1	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0114	SLC17A1	Sodium-dependent phosphate transport protein 1	NAPI-1; NPT-1; NPT1; Na(+)/PI cotransporter 1; Na/Pi-4; Renal Na(+)-dependent phosphate cotransporter 1; Renal sodium-dependent phosphate transport protein 1; Renal sodium-phosphate transport protein 1; SLC17A1; Sodium/phosphate cotransporter 1; Solute carrier family 17 member 1	DR00203	Aspirin	2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate
DTD0115	SLC17A2	Sodium-dependent phosphate transport protein 3	NPT3; Na(+/PI cotransporter 3; SLC17A2; Sodium/phosphate cotransporter 3; Solute carrier family 17 member 2	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0116	SLC17A3	Sodium-dependent phosphate transport protein 4	GOUT4; NPT4; Na(+)/PI cotransporter 4; SLC17A3; Sodium/phosphate cotransporter 4; Solute carrier family 17 member 3; UAQTL4	DR00067	Aminohippuric acid	4-Aminohippuric acid; Aminohippurate; N-(4-Aminobenzoyl)glycine; PAH; PAHA; Para-aminohippurate
DTD0116	SLC17A3	Sodium-dependent phosphate transport protein 4	GOUT4; NPT4; Na(+)/PI cotransporter 4; SLC17A3; Sodium/phosphate cotransporter 4; Solute carrier family 17 member 3; UAQTL4	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0117	SLC17A4	Probable small intestine urate exporter	KAIA2138; SLC17A4; Solute carrier family 17 member 4	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0117	SLC17A4	Probable small intestine urate exporter	KAIA2138; SLC17A4; Solute carrier family 17 member 4	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0117	SLC17A4	Probable small intestine urate exporter	KAIA2138; SLC17A4; Solute carrier family 17 member 4	DR00203	Aspirin	2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate
DTD0117	SLC17A4	Probable small intestine urate exporter	KAIA2138; SLC17A4; Solute carrier family 17 member 4	DR00556	Salicylic acid	2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon
DTD0117	SLC17A4	Probable small intestine urate exporter	KAIA2138; SLC17A4; Solute carrier family 17 member 4	DR00663	Ibuprofen	ACHES-N-PAIN; Act-3; Act-3 (TN); Actiprofen; Adex 200; Adran; Advil; Advil (TN); Ak+C2278tren; Aktre (TN); Alaxan; Alaxan (TN); Algofen; Algoflex (TN); Alivium (TN); Am-Fam 400; Amelior; Amersol; Amibufen; Anafen; Anco; Andran; Anflagen; Antagil; Antalfene; Antarene; Antiflam; Apsifen; Apsifen-F; Arthrofen (TN); Artofen; Artril; Artril 300; Balkaprofen; Betaprofen; Bloom; Bluton; Bonifen (TN); Brofen; Brufanic; Brufen; Brufen (TN); Brufen 400; Bruflam; Brufort; Buburone; Bufeno; Bufigen; Bugesic (TN); Bukrefen; Bupron; Buracaps; Burana; Burana (TN); Butylenin; Caldolor (TN); Calprofen (TN); Cap-Profen; Carol;Cesra; Citalgan; Cobo; Codral; Combiflam; Cunil; DOLO PUREN; Daiprophen; Dalsy; Dalsy (TN); Dansida; Deep Relief; Dentigoa; Dibufen; Dignoflex; Dismenol (TN); Diverin (TN); Dolgirid; Dolgit; Dolgit (TN); Dolibu; Dolmaral; Dolo-Dolgit; Dolo-Spedifen (TN); Dolocyl; Dolofen; Dolofen-F; Dolofin; Dolofort; Dolofort (TN); Dologel; Dolomax; Doloraz (TN); Doloren; Dolormin; Dolormin (TN); Doltibil; Dolven; Donjust B; Dorival; Dorival (TN); Drin; Duafen; Duobrus; Dura-Ibu; Dysdolen; Easifon; Ebufac; Ebufac (TN); Emflam; Emflam-200; EmuProfen (TN); Epobron; Eputex; Ergix; Espidifen (TN); Esprenit; Eve (TN); Exneural; Faspic; Femadon; Femafen; Femapirin; Femidol; Fenbid (TN); Fenbid;Fendol; Fenpaed (TN); Fenspan; Fibraflex; Finalflex (TN); Galprofen (TN); Gelufene; Gofen; Grefen; Gynofug; Haltran; Hedex (TN); Herron Blue (TN); I 4883; I-profen (TN); IB-100; IBU-Ratiopharm (TN); IBUFEN (TN); IP 82; IP-82; IP82; Ibalgin (TN); Ibol; Ibren; Ibu; Ibu-Attritin; Ibu-Tab; Ibu-Tab 200; Ibu-Vivimed (TN); Ibu-slo; Ibu-slow; IbuHEXAL (TN); Ibubest; Ibubeta; Ibucasen; Ibudol; Ibudolor; Ibufen; Ibuflamar; Ibufug; Ibugel; Ibugel (TN); Ibugen; Ibugesic; Ibuhexal; Ibulagic; Ibular; Ibulav; Ibuleve; Ibuleve (TN); Ibulgan; Ibum (TN); Ibumax (TN); Ibumed; Ibumerck; Ibumetin; Ibumetin (TN); Ibupirac; Ibuprin; Ibuprocin; Ibuprofene; Ibuprofeno; Ibuprofenum; Ibuprohm; Ibuprom (TN); Ibuprophen; Ibuprosyn (TN); Ibusal; Ibutid; Ibux (TN); Ibuxin (TN); Ifen; Inabrin; Inflam; Inoven; Ipren; Ipren (TN); Irfen; Isodol; Jenaprofen; Junifen; Kesan; Kratalgin; Kratalgin (TN); Lamidon; Lebrufen; Librofem; Lidifen; Liptan; Lopane; Malafene; Manypren; Medicol (TN); Medipren; Melfen; Mensoton; Midol; Midol 200; Moment; Moment (TN); Motrin; Motrin (TN); Motrin IB; Mynosedin; Nagifen-D; Napacetin; Narfen; Narfen (TN); Neo-Helvagit; Neo-Mindol; Neobrufen; Neobrufen (TN); Neofen (TN); Nerofen; Noalgil; Nobafon; Nobfelon; Nobfen; Nobgen; Noritis; Norton; Norvectan (TN); Novadol; Novo-Profen; Novogent; Novogent N; Novoprofen; Nuprilan; Nuprin; Nuprin (TN); Nureflex (TN); Nurofen; Nurofen (TN); Optifen; Opturem; Oralfene; Orbifen (TN); Ostarin; Ostofen; Ozonol; Paduden; Panafen; Panafen (TN); Pantrop; Paxofen; Pedia-Profen; PediaProfen; Perifar (TN); Perofen; Proartinal; Profen; Profin (TN); Proflex; Provon; Quadrax; R.D. 13621; RD 13621; Rafen; Ranofen; Ratiodolor (TN); Rebugen; Relcofen; Retard (TN); Rhinadvil; Rimafen (TN); Rofen; Roidenin; Rufen; Rufin; Rupan; Sadefen; Salivia; Salprofen; Salvarina (TN); Seclodin; Sednafen; Seklodin; Seskafen; Siyafen; Solpaflex; Solpaflex (TN); Solufen; Spedifen (TN); Speedpain NANO (TN); Spidifen (TN); Stelar; Sugafen; Suprafen; Suspren; Syntofene; Tab-Profen; Tabalon; Tabalon 400; Tatanal; Tempil; Tofen; Togal N; Tonal; Trendar; U 18573; U-18,573; U-18573; UCB 79171; Unipron; Upfen; Upfen (TN); Uprofen; Urem; VUFB 9649; Zafen; Zofen
DTD0118	SLC17A5	Vesicular H(+)/Aspartate-glutamate cotransporter	AST; H(+)/nitrate cotransporter; ISSD; Membrane glycoprotein HP59; NSD; SD; SIASD; SLC17A5; SLD; Sialin; Solute carrier family 17 member 5; H(+)/sialic acid cotransporter	DR00009	Nitrate	14797-55-8; 84145-82-4 (Parent); AC1L1ADK; AKOS015904030; BDBM26988; CHEBI:17632; CHEMBL186200; CTK0H4660; I14-18318; MCULE-5142506228; NHNBFGGVMKEFGY-UHFFFAOYSA-N; NITRATE ION; NO3; NO3(-); NO3-; Nitrate(1-); Nitrate(6CI,7CI,8CI,9CI); Nitrates; Nitrates, in; Nitrates, inorganic, aqueous solution, n.o.s.; Nitrates, inorganic, n.o.s.; Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer]; T93E9Y2844; UN3218; UNII-T93E9Y2844; [NO3](-); nitrooxidane; trioxidonitrate; trioxidonitrate(1-); trioxonitrate; trioxonitrate(1-); trioxonitrate(V)
DTD0118	SLC17A5	Vesicular H(+)/Aspartate-glutamate cotransporter	AST; H(+)/nitrate cotransporter; ISSD; Membrane glycoprotein HP59; NSD; SD; SIASD; SLC17A5; SLD; Sialin; Solute carrier family 17 member 5; H(+)/sialic acid cotransporter	DR01243	N-acetylaspartylglutamate	NAAG; isospaglumic acid; spaglumic acid
DTD0119	SLC17A6	Vesicular glutamate transporter 2	DNPI; Differentiation-associated BNPI; Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; SLC17A6; Solute carrier family 17 member 6; VGluT2	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0119	SLC17A6	Vesicular glutamate transporter 2	DNPI; Differentiation-associated BNPI; Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; SLC17A6; Solute carrier family 17 member 6; VGluT2	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0120	SLC17A7	Vesicular glutamate transporter 1	BNPI; Brain-specific Na(+)-dependent inorganic phosphate cotransporter; SLC17A7; Solute carrier family 17 member 7; VGluT1	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0120	SLC17A7	Vesicular glutamate transporter 1	BNPI; Brain-specific Na(+)-dependent inorganic phosphate cotransporter; SLC17A7; Solute carrier family 17 member 7; VGluT1	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0121	SLC17A8	Vesicular glutamate transporter 3	DFNA25; SLC17A8; Solute carrier family 17 member 8; VGluT3	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0123	SLC18A1	Vesicular amine transporter 1	Chromaffin granule amine transporter; Solute carrier family 18 member 1; VAT1; VMAT1; SLC18A1	DR00081	Ergotidine	1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine
DTD0123	SLC18A1	Vesicular amine transporter 1	Chromaffin granule amine transporter; Solute carrier family 18 member 1; VAT1; VMAT1; SLC18A1	DR00189	Serotonin	1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY
DTD0123	SLC18A1	Vesicular amine transporter 1	Chromaffin granule amine transporter; Solute carrier family 18 member 1; VAT1; VMAT1; SLC18A1	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0123	SLC18A1	Vesicular amine transporter 1	Chromaffin granule amine transporter; Solute carrier family 18 member 1; VAT1; VMAT1; SLC18A1	DR00283	Dopamine	(3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine
DTD0124	SLC18A3	Vesicular acetylcholine transporter	CMS21; SLC18A3; Solute carrier family 18 member 3; VAChT	DR00070	Acetylcholine	Miochol; Miochol-e
DTD0125	SLC18B1	MFS-type transporter SLC18B1	C6orf192; SLC18B1; Solute carrier family 18 member B1; dJ55C23.6	DR01249	Spermine	1,4-Bis(aminopropyl) butanediamine; 1,4-Bis(aminopropyl)butanediamine; 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-; 1,4-Diaminobutane, N,N'-bis; 4,9-Diaza-1,12-dodecanediamine; 4,9-Diazadodecamethylenediamine; 4,9-Diazadodecane-1,12-diamine; 71-44-3; Diaminopropyltetramethylenediamine; N,N'-Bis(3-aminopropyl)-1,4-butanediamine; N,N'-Bis(3-aminopropyl)butane-1,4-diamine; N1,N1'-(Butane-1,4-diyl)bis(propane-1,3-diamine); Spermin; Spermine Derivative; Spermine, puriss; UNII-2FZ7Y3VOQX; gerontine; musculamine; neuridine; spermine
DTD0125	SLC18B1	MFS-type transporter SLC18B1	C6orf192; SLC18B1; Solute carrier family 18 member B1; dJ55C23.6	DR01250	Spermidine	124S209; 1pot; 4-04-00-01300 (Beilstein Handbook Reference); =99% (GC); AC1L1AQB; ACMC-20ajn3; AI3-26636; AJ-26792; AKOS006222987; AN-22947; ATHGHQPFGPMSJY-UHFFFAOYSA-N; Aminopropylbutandiamine; BDBM50009353; BPBio1_001276; BRN 1698591; BSPBio_002613; Biomol-NT_000212; C00315; CCG-205124; CHEBI:16610; CHEMBL19612; CS-0013804; CTK3J1693; DB-026892; DB03566; DTXSID4036645; DivK1c_001007; EINECS 204-689-0; FT-0629162; GTPL2390; HY-B1776; IDI1_001007; KBio1_001007; KBio2_000345; KBio2_002913; KBio2_005481; KBio3_001833; KBioGR_001542; KBioSS_000345; LS-45643; Lopac-S-2501; Lopac0_001047; M923; MCULE-8096530192; MFCD00008229; MolPort-001-761-230; N-(3-Aminopropyl)-4-aminobutylamine; N-(4-Aminobutyl)-1,3-diaminopropane; NCGC00015937-01; NCGC00015937-02; NCGC00015937-03; NCGC00015937-04; NCGC00015937-05; NCGC00024903-01; NCGC00024903-02; NCGC00024903-03; NCI60_004294; NINDS_001007; NSC528399; PA(34); RTR-003757; SC-69371; SCHEMBL15618; SDCCGMLS-0066822.P001; SPBio_000947; SR0; ST24048721; ST45025991; Spectrum2_000874; Spectrum3_000977; Spectrum4_001101; Spectrum5_001561; Spectrum_000005; Spermidin; Spermidine 0.1 M solution; Spermidine hydrochloride; Spermidine, &gt; Spermidine, analytical standard; TR-003757; Tocris-0959; U87FK77H25; UNII-U87FK77H25; ZINC1532612; bmse000116; bmse000951; bmse000955
DTD0126	SLC19A1	Folate transporter 1	CHMD; FLOT1; FOLT; IFC-1; IFC1; Intestinal folate carrier 1; Placental folate transporter; REFC; RFC; RFC1; Reduced folate carrier protein; SLC19A1; Solute carrier family 19 member 1	DR00041	Pralatrexate	Folotyn (TN)
DTD0126	SLC19A1	Folate transporter 1	CHMD; FLOT1; FOLT; IFC-1; IFC1; Intestinal folate carrier 1; Placental folate transporter; REFC; RFC; RFC1; Reduced folate carrier protein; SLC19A1; Solute carrier family 19 member 1	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0126	SLC19A1	Folate transporter 1	CHMD; FLOT1; FOLT; IFC-1; IFC1; Intestinal folate carrier 1; Placental folate transporter; REFC; RFC; RFC1; Reduced folate carrier protein; SLC19A1; Solute carrier family 19 member 1	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0126	SLC19A1	Folate transporter 1	CHMD; FLOT1; FOLT; IFC-1; IFC1; Intestinal folate carrier 1; Placental folate transporter; REFC; RFC; RFC1; Reduced folate carrier protein; SLC19A1; Solute carrier family 19 member 1	DR00318	Pemetrexed	(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN]
DTD0127	SLC19A2	Thiamine transporter 1	SLC19A2; Solute carrier family 19 member 2; TC1; THMD1; THT1; TRMA; ThTr-1; ThTr1; Thiamine carrier 1	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0128	SLC19A3	Thiamine transporter 2	BBGD; SLC19A3; Solute carrier family 19 member 3; THMD2; ThTr-2; ThTr2	DR00117	Vitamin B1	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol; 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium chloride, monohydrochloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride; 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; Aneurin; Aneurine; Antiberiberi factor; Apatate drape; B-Amin; Beivon; Bequin; Betabion; Betalin S; Betaxin; Bethiamin; Bewon; Biamine; Chloride-hydrochloride salt of thiamine; LT00233141; Oryzanin; Oryzanine; THD; THIAMIN, VITAMIN B1; Thiadoxine; Thiamin; Thiamin dichloride; Thiamine; Thiamine (INN); Thiamine HCL; Thiamine [INN:BAN]; Thiamine chloride; Thiamine chloride hydrochloride; Thiamine dichloride; Thiamine hydrochloride [JAN]; Thiamine monochloride; Thiamine monohydrochloride; Thiamine(1+) ion; Thiamine, chloride; Thiamine, chloride, hydrochloride; Thiamine, monohydrochloride; Thiaminium; Thiaminium chloride hydrochloride; Thiaminum; Thiaminum [INN-Latin]; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride (1:1); Tiamina; Tiamina [INN-Spanish]; VIB; Vitamin B1 (TN); Vitamin B1 hydrochloride (VAN); Vitamin b1(thiamine); Vitaneurin; Vitaneuron; [5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride
DTD0128	SLC19A3	Thiamine transporter 2	BBGD; SLC19A3; Solute carrier family 19 member 3; THMD2; ThTr-2; ThTr2	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0129	SLC1A1	Excitatory amino acid transporter 3	DCBXA; EAAC1; EAAT3; Excitatory amino-acid carrier 1; Neuronal and epithelial glutamate transporter; SCZD18; SLC1A1; Sodium-dependent glutamate/aspartate transporter 3; Solute carrier family 1 member 1	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0130	SLC1A2	Excitatory amino acid transporter 2	EAAT2; EIEE41; GLT-1; GLT1; Glutamate/aspartate transporter II; HBGT; SLC1A2; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0131	SLC1A3	Excitatory amino acid transporter 1	EA6; EAAT1; GLAST; GLAST-1; GLAST1; SLC1A3; Sodium-dependent glutamate/aspartate transporter 1; Solute carrier family 1 member 3	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0132	SLC1A4	Alanine/serine/cysteine/threonine transporter 1	ASCT-1; ASCT1; Neutral amino acid transporter A; SATT; SLC1A4; SPATCCM; Solute carrier family 1 member 4	DR00047	D-serine	(2R)-2-amino-3-hydroxy-propanoic acid; (2R)-2-amino-3-hydroxypropanoic acid; (2R)-serine; (R)-2-Amino-3-hydroxypropionic acid; (R)-2-amino-3-hydroxypropanoic acid; (R)-Serine; 1K77H2Z9B1; AI3-18476; CHEBI:16523; CHEMBL285123; D-2-Amino-3-hydroxypropanoic acid; D-2-Amino-3-hydroxypropionic Acid; D-Ser; D-Serin; D-Serine, 98%; DSN; EINECS 206-229-4; MFCD00004269; MTCFGRXMJLQNBG-UWTATZPHSA-N; NCGC00094363-03; NSC 77689; NSC77689; Serine D-form; Serine, D-; UNII-1K77H2Z9B1; [3h]-d-serine; d-(+)-serine; serine d-
DTD0132	SLC1A4	Alanine/serine/cysteine/threonine transporter 1	ASCT-1; ASCT1; Neutral amino acid transporter A; SATT; SLC1A4; SPATCCM; Solute carrier family 1 member 4	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00027	Ganciclovir	2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00047	D-serine	(2R)-2-amino-3-hydroxy-propanoic acid; (2R)-2-amino-3-hydroxypropanoic acid; (2R)-serine; (R)-2-Amino-3-hydroxypropionic acid; (R)-2-amino-3-hydroxypropanoic acid; (R)-Serine; 1K77H2Z9B1; AI3-18476; CHEBI:16523; CHEMBL285123; D-2-Amino-3-hydroxypropanoic acid; D-2-Amino-3-hydroxypropionic Acid; D-Ser; D-Serin; D-Serine, 98%; DSN; EINECS 206-229-4; MFCD00004269; MTCFGRXMJLQNBG-UWTATZPHSA-N; NCGC00094363-03; NSC 77689; NSC77689; Serine D-form; Serine, D-; UNII-1K77H2Z9B1; [3h]-d-serine; d-(+)-serine; serine d-
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00078	Valacyclovir	2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN)
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00242	Glycine	(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00244	L-threonine	Threonine
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00255	L-carnitine	(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00325	Acyclovir	2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one; 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; 2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one; 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl); 9-((2-Hydroxyethoxy)methyl)guanine; 9-(2-Hydroxyethoxy)methylguanine; 9-HYROXYETHOXYMETHYLGUANINE; 9-[(2-Hydroxyethoxy)-methyl]guanine; 9-[(2-Hydroxyethoxy)methyl]guanine; A 4669; ACV; ACV & Pluronic F-68; Aciclovier; Aciclovir (JAN/INN); Aciclovir, Acycloguanosine, Zovirax, Acyclovir; Aciclovirum; Aciclovirum [INN-Latin]; Aciclovirum [Latin]; Acivir (TN); Acivirax (TN); Activir; AcycloFoam; Acycloguanosine; Acyclovir; Acyclovir & Pluronic F-68; Acyclovir (USP); Acyclovir Lauriad; Acyclovir [USAN]; Acyclovir-side chain-2-3H; Alti-Acyclovir; Avirax; B-LF& ACV; BW-248-U; BW-248U; BW-248U74; Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one; Cyclovir (TN); DRG-0008; Genvir; Hascovir; Herpex (TN); Maynar; Vipral; Virolex; Viropump; Virorax; W-248-U; Wellcome-248U; Zovir; Zovir (TN); Zovirax; Zovirax (TN); Zovirax Oral Acyclovir (ACV) Suspension
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR00404	Valganciclovir	5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one; Cymeval; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester; L-Valine, ester with ganciclovir; RO1079070/194; RS 79070; Valcyte (TN); Valganciclovir (INN); Valganciclovir (Oral); Valganciclovir [INN:BAN]; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate
DTD0133	SLC1A5	Alanine/serine/cysteine/threonine transporter 2	AAAT; ASCT2; ATB(0); ATBO; Baboon M7 virus receptor; M7V1; M7VS1; Neutral amino acid transporter B(0); R16; RD114/simian type D retrovirus receptor; RDR; RDRC; SLC1A5; Sodium-dependent neutral amino acid transporter type 2; Solute carrier family 1 member 5	DR01184	Nitric oxide	HNO; ()NO; 10102-43-9; AC1L3QHF; Bioxyde d'azote; Bioxyde d'azote [French]; CHEBI:16480; CHEMBL1200689; CTK0H7679; DTXSID1020938; EDRF; Endogenous Nitrate Vasodilator; Endothelium-Derived Nitric Oxide; Endothelium-derived relaxing factor (EDRF); INOmax; INOmax (TN); Mononitrogen monoxide; Monoxide, Mononitrogen; Monoxide, Nitrogen; Monoxido de nitrogeno; Monoxyde d'azote; NITRIC-OXIDE; NO(); Nitrate Vasodilator, Endogenous; Nitric Oxide, Endothelium Derived; Nitric Oxide, Endothelium-Derived; Nitric oxide; Nitric oxide (JAN); Nitric oxide 10% by volume or more; Nitric oxide trimer; Nitric oxide, 985%; Nitric oxide, compressed [UN1660] [Poison gas]; Nitrogen monoxide; Nitrogen oxide (NO); Nitrogen(II) oxide; Nitrosoradical; Nitrosyl; Nitrosyl hydride; Nitrosyl hydride ((NO)H); Nitrosyl radical; Nitroxide radical; Nitroxyl; OHM 11771; Oxide, Nitric; Oxido de nitrogeno(II); Oxido nitrico; Oxidonitrogen; Oxoazanyl; Oxyde azotique; Oxyde nitrique [French]; Stickmonoxyd; Stickmonoxyd [German]; Stickstoff(II)-oxid; Stickstoffmonoxid; Vasodilator, Endogenous Nitrate; [NO]; endothelium-derived relaxing factor; monoxido de nitrogeno; monoxyde d'azote; nitric oxide; nitrogen monoxide; nitrogen protoxide; nitrosyl; oxido de nitrogeno(II); oxido nitrico; oxidonitrogen; oxoazanyl; oxyde azotique
DTD0134	SLC1A6	Excitatory amino acid transporter 4	EAAT4; SLC1A6; Sodium-dependent glutamate/aspartate transporter; Solute carrier family 1 member 6	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0135	SLC1A7	Excitatory amino acid transporter 5	EAAT5; Retinal glutamate transporter; SLC1A7; Solute carrier family 1 member 7	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0136	SLC20A1	Sodium-dependent phosphate transporter 1	GLVR-1; GLVR1; Gibbon ape leukemia virus receptor 1; Leukemia virus receptor 1 homolog; PIT1; Phosphate transporter 1; PiT-1; SLC20A1; Solute carrier family 20 member 1	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0137	SLC20A2	Sodium-dependent phosphate transporter 2	GLVR-2; GLVR2; Gibbon ape leukemia virus receptor 2; IBGC1; IBGC3; MLVAR; Phosphate transporter 2; PiT-2; Pit2; RAM1; Ram-1; SLC20A2; Solute carrier family 20 member 2; hPit2	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0139	SLC22A13	Organic cation transporter-like 3	OAT10; OCTL1; OCTL3; ORCTL-3; ORCTL3; SLC22A13; Solute carrier family 22 member 13	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0139	SLC22A13	Organic cation transporter-like 3	OAT10; OCTL1; OCTL3; ORCTL-3; ORCTL3; SLC22A13; Solute carrier family 22 member 13	DR00352	Aspartic acid	(2S)-2-aminobutanedioic acid; (2S)-Aspartic acid; (S)-2-Aminosuccinic acid; (S)-Aminobutanedioic acid; (S)-Aspartic acid; Acidum asparticum; Aminosuccinic acid; Asparagic acid; Asparaginic acid; Asparaginsaeure [German]; Aspartate, L-; Aspartic acid, L-; Aspatofort; Butanedioic acid, amino-, (S); H-Asp-OH; L-(+)-Aspartic acid; L-2-Aminobutanedioic acid; L-Aminosuccinic acid; L-Asp; L-Asparagic acid; L-Asparaginic acid; L-Asparaginsaeure; L-Asparaginsyra; L-Aspartinsaeure; L-aspartate; L-aspartic acid; aspartate; aspartic acid
DTD0142	SLC22A16	Fly-like putative transporter 2	OCT6; CT2; Carnitine transporter 2; FLIPT2; Flipt 2; HEL-S-18; OKB1; Organic cation transporter OKB1; SLC22A16; Solute carrier family 22 member 16; dJ261K5.1; Organic cation/carnitine transporter 6	DR00255	L-carnitine	(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT
DTD0142	SLC22A16	Fly-like putative transporter 2	OCT6; CT2; Carnitine transporter 2; FLIPT2; Flipt 2; HEL-S-18; OKB1; Organic cation transporter OKB1; SLC22A16; Solute carrier family 22 member 16; dJ261K5.1; Organic cation/carnitine transporter 6	DR00301	Doxorubicin	14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; ADM; ADR; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastin; Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin; Adriamycin PFS; Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriamycin semiquinone; Adriblas tina; Adriblastin; Adriblastina; Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Aerosolized Doxorubicin; Caelyx (TN); Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DM2; DOX-SL; Doxil; Doxorubicin (USAN/INN); Doxorubicin Hydrochloride; Doxorubicin [USAN:INN:BAN]; Doxorubicin citrate; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Doxorubicina; Doxorubicina [INN-Spanish]; Doxorubicine; Doxorubicine [INN-French]; Doxorubicinum; Doxorubicinum [INN-Latin]; FI 106; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); JT9100000; Myocet; Myocet (TN); NDC 38242-874; RDF Rubex; Resmycin; Rubex; Rubex (TN); Rubex (hydrochloride salt); TLC D-99; ThermoDox
DTD0145	SLC22A20	Organic anion transporter 6	SLC22A20; SLC22A20P; OAT6; Solute carrier family 22 member 20; Solute carrier family 22 member 20 pseudogene	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0146	SLC22A23	Solute carrier family 22 member 23	C6orf85; SLC22A23; Solute carrier 22 member 23	DR00855	Quetiapine	111974-69-7; 2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol; 2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol; BGL0JSY5SI; C21H25N3O2S; CHEBI:8707; CHEMBL716; Co-Quetiapine; Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-; Ketipinor (TN); NCGC00095911-03; Norsic; Norsic (TN); PD-172760; Quetiapina; Quetiapine (INN); Quetiapine [INN:BAN]; Quetiapine hemifumarate; Quetiapinum; Seroquel (Fumarate); Seroquel (TN); UNII-BGL0JSY5SI; URKOMYMAXPYINW-UHFFFAOYSA-N; quetiapine
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00054	Quinine	(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00106	Tetraethylammonium	4-04-00-00331 (Beilstein Handbook Reference); 56-34-8 (chloride); 5AV7G7EIEE; 66-40-0; 68-05-3 (iodide); 71-91-0 (bromide); 77-98-5 (hydroxide); AC1L1KAW; AMMONIUM, TETRAETHYL-; BRN 1738225; C8H20N; CHEBI:44296; CHEMBL9324; Ethanaminium; GTPL2343; GTPL4575; Lopac-T-2265; N,N,N-Triethylethanaminium; NEt4(+); SCHEMBL16267; TETRAETHYLAMMONIUM ION; Tetraethylammonium; Tetraetilammonio; Tetraetilammonio [Italian]; Tetramon; Tetrylammonium; UNII-5AV7G7EIEE; [14C]-TEA; [14C]TEA; tetraethyl ammonium; tetraethylamine; tetraethylazanium
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00217	Gabapentin	1-(Aminomethyl)-cyclohexaneacetic acid; 1-(Aminomethyl)cyclohexaneacetic acid; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Aclonium; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; DDS-2003; DM-1796; DM-5689; G-154; GBN; GOE 2450; Gabapen; Gabapentin (JAN/USAN/INN); Gabapentin (Neurontin); Gabapentin GR; Gabapentin Hexal; Gabapentin Stada; Gabapentin [USAN:INN:BAN]; Gabapentin-ratiopharm; Gabapentina; Gabapentine; Gabapentine [INN-French]; Gabapentinium; Gabapentino; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum; Gabapentinum [INN-Latin]; Gabapetin; Go 3450; Goe-3450; Hexal brand of gabapentin; Neurontin; Neurontin (TN); Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Ratiopharm brand of gabapentin; Serada; Stadapharm brand of gabapentin; Vultin; Warner-Lambert brand of gabapentin; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00255	L-carnitine	(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00264	Verapamil	(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00277	Ipratropium	(+-)-Ipratropine; (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane; (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane; (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; 3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-(propan-2-yl)-8-azoniabicyclo[3.2.1]octane; Aerodose; Aerovent; Apo-Ipravent; Apovent; Apovent (TN); Atronase; Atrovent; Atrovent (TN); Atrovent Aerosol; Atrovent Hfa; Atrovent Nasal; Bitrop; Disne-Asmol; Ipatropium Bromide; Ipratropium bromide; Ipravent; Ipvent; Kendral-Ipratropium; N-Isopropylatropine; Narilet; Rhinotrop; Rhinovent; Rinatec; Rinoberen; Rinovagos; Vagos; X8M; [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
DTD0151	SLC22A4	Organic cation/carnitine transporter 1	DFNB60; ET transporter; ETT; Ergothioneine transporter; OCTN1; SLC22A4; Solute carrier family 22 member 4; UT2H	DR00416	Cytarabine	(beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil
DTD0152	SLC22A9	Organic anion transporter 7	OAT7; SLC22A9; Solute carrier family 22 member 9; UST3; UST3H	DR00045	Pravastatin	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid; Eptastatin; KS-5015; Oliprevin; Pravachol (TN); Pravastatin (INN); Pravastatin Sodium Salt; Pravastatin [INN:BAN]; Pravastatin tert-Octylamine Salt; Pravastatina; Pravastatina [Spanish]; Pravastatine; Pravastatine [French]; Pravastatinum; Pravastatinum [Latin]; Pravator; Pravator (TN); RMS-431; SQ-31,000; Selektine (TN); Vasten
DTD0155	SLC22B3	Synaptic vesicle glycoprotein 2C	KIAA1054; SV2C; Synaptic vesicle glycoprotein SV2C	DR00283	Dopamine	(3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine
DTD0158	SLC23A1	Sodium-dependent vitamin C transporter 1	Na(+)/L-ascorbic acid transporter 1; SLC23A1; SVCT1; Solute carrier family 23 member 1; YSPL3; Yolk sac permease-like molecule 3; hSVCT1	DR00289	Vitamin C	(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one; (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one; 3-Keto-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone (enol form); Acid Ascorbic; Acide ascorbique; Acide ascorbique [INN-French]; Acido ascorbico; Acido ascorbico [INN-Spanish]; Acidum ascorbicum; Acidum ascorbicum [INN-Latin]; Acidum ascorbinicum; Adenex; Allercorb; Antiscorbic vita min; Antiscorbic vitamin; Antiscorbutic factor; Antiscorbutic vitamin; Arco-cee; Ascoltin; Ascoltin (TN); Ascor-B.I.D.; Ascor-b.i.d; Ascorb; Ascorbajen; Ascorbate; Ascorbic Acid, Monosodium Salt; Ascorbic acid; Ascorbic acid (JP15/USP/INN); Ascorbic acid [BAN:INN:JAN]; Ascorbic acid [INN:BAN:JAN]; Ascorbicab; Ascorbicap; Ascorbicap (TN); Ascorbicin; Ascorbinsaeure; Ascorbutina; Ascorbyl radical; Ascorin; Ascorteal; Ascorvit; C-Level; C-Long; C-Quin; C-Span; C-Vimin; CE-VI-Sol; Cantan; Cantaxin; Catavin C; Ce lent; Ce-Mi-Lin; Cebicure; Cebid; Cebion; Cebione; Cecon; Cee-Vite; Cee-caps td; Cegiolan; Ceglion; Celaskon; Celin; Cemagyl; Cemill; Cenetone; Cenolate; Cereon; Cergona; Cescorbat; Cetamid; Cetane-Caps TC; Cetane-Caps TD; Cetebe; Cetemican; Cevalin; Cevatine; Cevex; Cevi-Bid; Cevibid; Cevimin; Cevital; Cevitamic acid; Cevitamin; Cevitan; Cevitex; Cewin; Ciamin; Cipca; Citriscorb; Colascor; Component of Cortalex; Component of E and C-Level; Component of Endoglobin Forte; Component of Ferancee; Concemin; Cortalex; Davitamon C; Dora-C-500; Duoscorb; Ferancee; Ferrous ascorbate; Hicee; Hybrin; IDO-C; Iron(II) ascorbate; Iron-ascorbic acid complexes;L-Ascorbic acid; Kyselina askorbova; Kyselina askorbova [Czech]; L(+)-Ascorbic acid; L-(+)-Ascorbic Acid; L-3-Ketothreohexuronic acid lactone; L-3-ketothreohexuronic acid; L-Ascorbic acid, free radical form; L-Lyxoascorbic acid; L-Threoascorbic acid; L-Xyloascorbic acid; L-ascorbate; L-ascorbic acid; L-threo-Hex-2-enonic acid, gamma-lactone; L-threo-ascorbic acid; L-threo-hex-1-eofuranos-3-ulose; L-threo-hex-2-enono-1,4-lactone; Laroscorbine; Lemascorb; Liqui-Cee; Magnesium Ascorbicum; Magnorbin; Meri-C; Monodehydroascorbic acid; Natrascorb; Natrascorb injectable; Oral Vitamin C; Planavit C; Proscorbin; Redoxon; Ribena; Roscorbi c; Roscorbic; Scorbacid; Scorbu-C; Secorbate; Semidehydroascorbate; Sodascorbate; Sodium Ascorbate (Ascorbic Acid); Stuartinic; Sunkist; Testascorbic; Tolfrinic; Vicelat; Vicin; Vicomin C; Viforcit; Viscorin; Vitace; Vitacee; Vitacimin; Vitacin; Vitamin-C; Vitamisin; Vitascorbol; Xitix
DTD0159	SLC23A2	Sodium-dependent vitamin C transporter 2	KIAA0238; NBTL1; Na(+)/L-ascorbic acid transporter 2; Nucleobase transporter-like 1 protein; SLC23A2; SVCT2; Solute carrier family 23 member 2; YSPL2; Yolk sac permease-like molecule 2; hSVCT2	DR00289	Vitamin C	(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one; (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one; 3-Keto-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone (enol form); Acid Ascorbic; Acide ascorbique; Acide ascorbique [INN-French]; Acido ascorbico; Acido ascorbico [INN-Spanish]; Acidum ascorbicum; Acidum ascorbicum [INN-Latin]; Acidum ascorbinicum; Adenex; Allercorb; Antiscorbic vita min; Antiscorbic vitamin; Antiscorbutic factor; Antiscorbutic vitamin; Arco-cee; Ascoltin; Ascoltin (TN); Ascor-B.I.D.; Ascor-b.i.d; Ascorb; Ascorbajen; Ascorbate; Ascorbic Acid, Monosodium Salt; Ascorbic acid; Ascorbic acid (JP15/USP/INN); Ascorbic acid [BAN:INN:JAN]; Ascorbic acid [INN:BAN:JAN]; Ascorbicab; Ascorbicap; Ascorbicap (TN); Ascorbicin; Ascorbinsaeure; Ascorbutina; Ascorbyl radical; Ascorin; Ascorteal; Ascorvit; C-Level; C-Long; C-Quin; C-Span; C-Vimin; CE-VI-Sol; Cantan; Cantaxin; Catavin C; Ce lent; Ce-Mi-Lin; Cebicure; Cebid; Cebion; Cebione; Cecon; Cee-Vite; Cee-caps td; Cegiolan; Ceglion; Celaskon; Celin; Cemagyl; Cemill; Cenetone; Cenolate; Cereon; Cergona; Cescorbat; Cetamid; Cetane-Caps TC; Cetane-Caps TD; Cetebe; Cetemican; Cevalin; Cevatine; Cevex; Cevi-Bid; Cevibid; Cevimin; Cevital; Cevitamic acid; Cevitamin; Cevitan; Cevitex; Cewin; Ciamin; Cipca; Citriscorb; Colascor; Component of Cortalex; Component of E and C-Level; Component of Endoglobin Forte; Component of Ferancee; Concemin; Cortalex; Davitamon C; Dora-C-500; Duoscorb; Ferancee; Ferrous ascorbate; Hicee; Hybrin; IDO-C; Iron(II) ascorbate; Iron-ascorbic acid complexes;L-Ascorbic acid; Kyselina askorbova; Kyselina askorbova [Czech]; L(+)-Ascorbic acid; L-(+)-Ascorbic Acid; L-3-Ketothreohexuronic acid lactone; L-3-ketothreohexuronic acid; L-Ascorbic acid, free radical form; L-Lyxoascorbic acid; L-Threoascorbic acid; L-Xyloascorbic acid; L-ascorbate; L-ascorbic acid; L-threo-Hex-2-enonic acid, gamma-lactone; L-threo-ascorbic acid; L-threo-hex-1-eofuranos-3-ulose; L-threo-hex-2-enono-1,4-lactone; Laroscorbine; Lemascorb; Liqui-Cee; Magnesium Ascorbicum; Magnorbin; Meri-C; Monodehydroascorbic acid; Natrascorb; Natrascorb injectable; Oral Vitamin C; Planavit C; Proscorbin; Redoxon; Ribena; Roscorbi c; Roscorbic; Scorbacid; Scorbu-C; Secorbate; Semidehydroascorbate; Sodascorbate; Sodium Ascorbate (Ascorbic Acid); Stuartinic; Sunkist; Testascorbic; Tolfrinic; Vicelat; Vicin; Vicomin C; Viforcit; Viscorin; Vitace; Vitacee; Vitacimin; Vitacin; Vitamin-C; Vitamisin; Vitascorbol; Xitix
DTD0168	SLC25A10	Mitochondrial dicarboxylate carrier	DIC; SLC25A10; Solute carrier family 25 member 10	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0168	SLC25A10	Mitochondrial dicarboxylate carrier	DIC; SLC25A10; Solute carrier family 25 member 10	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0169	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier	OGC; OGCP; SLC20A4; SLC25A11; Solute carrier family 25 member 11	DR00139	Alpha-ketoglutaric acid	2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate
DTD0170	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	AGC1; ARALAR; ARALAR1; EIEE39; Mitochondrial aspartate glutamate carrier 1; SLC25A12; Solute carrier family 25 member 12	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0171	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	ARALAR2; CTLN2; Citrin; Mitochondrial aspartate glutamate carrier 2; SLC25A13; Solute carrier family 25 member 13	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0175	SLC25A16	Graves disease carrier protein	D10S105E; GDA; GDC; Graves disease autoantigen; HGT.1; ML7; SLC25A16; Solute carrier family 25 member 16; hML7; Mitochondrial solute carrier protein homolog	DR00302	Coenzyme A	3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A
DTD0176	SLC25A17	Peroxisomal membrane protein PMP34	34 kDa peroxisomal membrane protein; PMP34; SLC25A17; Solute carrier family 25 member 17	DR00100	Adenosine monophosphate	(S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(dihydrogen phosphate); 1H-Pyrazolo(4,3-d)pyrimidine, 7-amino-3-beta-D-ribofuranosyl-, 5'-(dihydrogen phosphate)-, hydrate; 5'-AMP; 5'-Adenylic acid, homopolymer; 5'-Deoxy-5'-thioadenosine 5'-monophosphate; 5'-O-phosphonatoadenosine; 5'-O-phosphonoadenosine; 5'-Thio-5'-adenylic acid; 5'-adenosine monophosphate; 5'-adenylic acid; 7-Amino-3-beta-D-ribofuranosyl-1H-pyrazolo(4,3-d)pyrimidine 5'-(dihydrogen phosphate) hydrate; 7A8E6D15-9136-44C1-88C9-E1A224638E56; 7gpb; 8-Aminoadenosine 5'-monophosphate; 8gpb; A-5mp; ADENOSINE-5'-PHOSPHATE; AMP; AMP (VAN); AMP (nucleotide); AMP dianion; ASMP; Adenine polynucleotides; Adenosine 5'-(dihydrogen phosphate); Adenosine 5'-monophosphate; Adenosine 5'-monophosphoric acid; Adenosine 5'-phosphate; Adenosine 5'-phosphoric acid; Adenosine Monophosphate (Amp); Adenosine phosphate; Adenosine phosphate (USAN/INN); Adenosine phosphate [USAN:BAN:INN]; Adenosine phosphate [USAN:INN:BAN]; Adenosine, mono(dihydrogen phosphate) (ester); Adenosine-5'-monophosphate; Adenosine-5'-monophosphoric acid; Adenosine-5'P; Adenosine-5-monophosphate dianion; Adenosine-5-monophosphate(2-); Adenosine-5-monophosphoric acid; Adenosine-5-phosphate; Adenosine-monophosphate; Adenosine-phosphate; Adenosini phosphas; Adenosini phosphas [INN-Latin]; Adenovite; Adenyl; Adenyl (TN);Adenylic acid (VAN); Adenylate; Adenylic acid; Ado5'P; Cardiomone; Ergadenylic acid; Formycin 5'-monophosphate hydrate; Formycin 5'-phosphate; Formycin 5'-phosphate hydrate; Formycin A 5'-monophosphate hydrate; Fosfato de adenosina; Fosfato de adenosina [INN-Spanish]; GAMMA-ARSONO-BETA, GAMMA-METHYLENEADENOSINE-5'-DIPHOSPHATE; Lycedan; Monophosphadenine; Muscle adenylic acid; Muskeladenosin-phosphorsaeure; Muskeladenylsaeure; My-B-Den; Myoston; PAdo; POLY A; Phosaden; Phosphaden; Phosphate d'adenosine; Phosphate d'adenosine [INN-French]; Phosphentaside; Polyadenylic acids; Vitamin B8; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
DTD0176	SLC25A17	Peroxisomal membrane protein PMP34	34 kDa peroxisomal membrane protein; PMP34; SLC25A17; Solute carrier family 25 member 17	DR00302	Coenzyme A	3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A
DTD0177	SLC25A18	Mitochondrial glutamate carrier 2	GC-2; GC2; Glutamate/H(+) symporter 2; SLC25A18; Solute carrier family 25 member 18	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0178	SLC25A19	Mitochondrial thiamine pyrophosphate carrier	DNC; MCPHA; MUP1; Mitochondrial uncoupling protein 1; SLC25A19; Solute carrier family 25 member 19; THMD3; THMD4; TPC	DR00335	Thiamine pyrophosphate	B-Neurox; Berolase; Biosyth; Bioxylasi; Bivitasi; Co-Bi; Co-carboxylase; Cocarbina; Cocarboxil; Cocarboxilasa; Cocarboxylasum; Cocarboxylasum [INN-Latin]; Coenbione; Coxylase; Diphosphothiamin; Diphosphothiamine; Farmaneurina; Metabolase; Nutrase; Pyrolase; Pyruvodehydrase; TDP (thiamin ester); TPP (coenzyme); Thiamine pyrophosphate; Thiamine pyrophosphate chloride; Thiamine pyrophosphoric ester; Thiamine-PP; Thiaminediphosphate; Thiaminepyrophosphate; Thiaminpyrophosphate; UNII-XMK8K8EVIU; cocarboxylase
DTD0179	SLC25A2	Mitochondrial ornithine transporter 2	ORC2; ORNT2; SLC25A2; Solute carrier family 25 member 2	DR00188	Arginine	1-Hydrochloride arginine; 2-Amino-5-guanidinopentanoic acid hydrochloride; 2-Amino-5-guanidinovaleric acid monohydrochloride; 220144-84-3; 32042-43-6; ARGININE, (L); Arginine monochloride; Arginine monohydrochloride, L-(+)-; D-Arginine, hydrochloride (1:1); DL-(+/-)-Arginine Hydrochloride; DL-Arginine HCl; DL-Arginine hydrochloride; DL-Arginine hydrochloride, 98%, anhydrous; EINECS 239-674-8; EINECS 250-903-0; H-DL-Arg-OH.xHCl; L(+)-Arginine hydrochloride; NSC7914; WLN: MUYZM3YZVQ &amp; argininhydrochlorid
DTD0180	SLC25A20	Carnitine/acylcarnitine translocase	CAC; CACT; Mitochondrial carnitine/acylcarnitine carrier protein; SLC25A20; Solute carrier family 25 member 20	DR00255	L-carnitine	(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate; (-)-Carnitine; (-)-L-Carnitin; (-)-L-Carnitine; (3-Carboxy-2-hydroxypropyl)trimethyl-ammonium hydroxide, inner salt; (3R)-3-hydroxy-4-(trimethylammonio)butanoate; (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide; (R)-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; (R)-3-Hydroxy-4-(trimethylammonio)butyrate; (R)-3-Hydroxy-4-trimethylammoniobutyrate; (R)-Carnitine; 1-CARNITINE; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt; 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-(9CI); 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, innersalt; 3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-(8CI); Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide,inner salt; Bicarnesine; C-1985; Carnicor; Carniking; Carniking 50; Carnilean; Carnitene; Carnitine; Carnitine (L-form); Carnitolo; Carnitor; Carnitor (TN); Carnovis; Carrier; DRG-0211; Gamma-Trimethyl-ammonium-beta-hydroxybutirate; Gamma-Trimethyl-beta-hydroxybutyrobetaine; Karnitin; L-(-)-Carnitine; L-Carnitine inner salt; L-carnitine Base; L-gamma-trimethyl-beta-hydroxybutyrobetaine; Lefcar; Levocarnitina; Levocarnitina [Spanish]; Levocarnitine; Levocarnitine (JAN/USP/INN); Levocarnitine [USAN:INN]; Levocarnitinum; Levocarnitinum [Latin]; Metina; R-(-)-3-hydroxy-4-trimethylaminobutyrate; ST 198; Vitamin B T; Vitamin BT
DTD0182	SLC25A21	Mitochondrial 2-oxodicarboxylate carrier	ODC; ODC1; SLC25A21; Solute carrier family 25 member 21	DR00139	Alpha-ketoglutaric acid	2-Oxoglutarate; 2-ketoglutarate; 2-ketoglutaric acid; alpha-ketoglutarate; oxoglutarate
DTD0182	SLC25A21	Mitochondrial 2-oxodicarboxylate carrier	ODC; ODC1; SLC25A21; Solute carrier family 25 member 21	DR00218	Alpha-oxoadipic acid	2-Oxoadipate; 2-ketoadipate; Alpha-ketoadipic acid
DTD0183	SLC25A22	Mitochondrial glutamate carrier 1	EIEE3; GC-1; GC1; Glutamate/H(+) symporter 1; NET44; SLC25A22; Solute carrier family 25 member 22	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0184	SLC25A23	Calcium-binding mitochondrial carrier protein SCaMC-3	APC2; MCSC2; Mitochondrial ATP-Mg/Pi carrier protein 2; Mitochondrial Ca(2+)-dependent solute carrier protein 2; SCAMC3; SCaMC-3; SLC25A23; Small calcium-binding mitochondrial carrier protein 3; Solute carrier family 25 member 23	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0185	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	APC1; MCSC1; Mitochondrial ATP-Mg/Pi carrier protein 1; Mitochondrial Ca(2+)-dependent solute carrier protein 1; SCAMC-1; SCAMC1; SLC25A24; Small calcium-binding mitochondrial carrier protein 1; Solute carrier family 25 member 24	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0186	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	APC3; KIAA1896; MCSC; MCSC3; Mitochondrial ATP-Mg/Pi carrier protein 3; Mitochondrial Ca(2+)-dependent solute carrier protein 3; PCSCL; SCAMC-2; SCAMC2; SLC25A25; Small calcium-binding mitochondrial carrier protein 2; Solute carrier family 25 member 25	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0187	SLC25A26	S-adenosylmethionine mitochondrial carrier protein	COXPD28; Mitochondrial S-adenosylmethionine transporter; SAMC; SLC25A26; Solute carrier family 25 member 26	DR00105	S-adenosylmethionine	29908-03-0; 6EZ5466ZUX; Active methionine; Adenosine, 5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, inner salt, (3S)-; AdoMet; CCRIS 7130; CHEBI:67040; EINECS 249-946-8; K093C397UL; L-Methionine, S-adenosyl-; L-S-Adenosylmethionine; Methionine, S-adenosyl-; Methioninyladenylate; S Amet; S-adenosyl-L-methioninate; S-adenosyl-L-methionine; SAM; UNII-6EZ5466ZUX; UNII-7LP2MPO46S; UNII-K093C397UL; adenosylmethionine; s-(5-adenosyl)l-methionine
DTD0190	SLC25A29	Mitochondrial ornithine transporter 3	C14orf69; CACL; CACT-like; Carnitine/acylcarnitine translocase-like; Mitochondrial basic amino acids transporter; Mitochondrial carnitine/acylcarnitine carrier protein CACL; ORNT3; SLC25A29; Solute carrier family 25 member 29	DR00115	Lysine	Enisyl
DTD0190	SLC25A29	Mitochondrial ornithine transporter 3	C14orf69; CACL; CACT-like; Carnitine/acylcarnitine translocase-like; Mitochondrial basic amino acids transporter; Mitochondrial carnitine/acylcarnitine carrier protein CACL; ORNT3; SLC25A29; Solute carrier family 25 member 29	DR00188	Arginine	1-Hydrochloride arginine; 2-Amino-5-guanidinopentanoic acid hydrochloride; 2-Amino-5-guanidinovaleric acid monohydrochloride; 220144-84-3; 32042-43-6; ARGININE, (L); Arginine monochloride; Arginine monohydrochloride, L-(+)-; D-Arginine, hydrochloride (1:1); DL-(+/-)-Arginine Hydrochloride; DL-Arginine HCl; DL-Arginine hydrochloride; DL-Arginine hydrochloride, 98%, anhydrous; EINECS 239-674-8; EINECS 250-903-0; H-DL-Arg-OH.xHCl; L(+)-Arginine hydrochloride; NSC7914; WLN: MUYZM3YZVQ &amp; argininhydrochlorid
DTD0190	SLC25A29	Mitochondrial ornithine transporter 3	C14orf69; CACL; CACT-like; Carnitine/acylcarnitine translocase-like; Mitochondrial basic amino acids transporter; Mitochondrial carnitine/acylcarnitine carrier protein CACL; ORNT3; SLC25A29; Solute carrier family 25 member 29	DR00192	L-homoarginine	Homoarginine
DTD0191	SLC25A3	Phosphate carrier protein	OK/SW-cl.48; PHC; PTP; Phosphate transport protein; SLC25A3; Solute carrier family 25 member 3	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0194	SLC25A32	Mitochondrial folate transporter/carrier	MFT; MFTC; RREI; SLC25A32; Solute carrier family 25 member 32	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0205	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	SLC25A42; Solute carrier family 25 member 42	DR00302	Coenzyme A	3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] dihydrogen diphosphate}; 3'-phosphoadenosine-(5')diphospho(4')pantatheine; 85-61-0; CHEBI:15346; Co-A-SH; CoA; CoA-SH; CoASH; Coenzym A; Coenzyme A hydrate; Coenzyme ASH; Depot-Zeel; HS-CoA; HSCoA; Reduced CoA; SAA04E81UX; UNII-SAA04E81UX; Zeel; co-A; co-enzyme-A
DTD0222	SLC25A6	Adenine nucleotide translocator 3	AAC3; ADP/ATP translocase 3; ANT 3; ANT3; ANT3Y; ADP,ATP carrier protein 3; SLC25A6; Solute carrier family 25 member 6; ADP,ATP carrier protein, isoform T2	DR00126	Adenine	1,6-Dihydro-6-Imnopurine; 1,6-Dihydro-6-iminopurine; 1H-Purin-6-amine; 1H-Purin-6-amine (9CI); 1H-Purine, 6-amino; 2'-DEOXY-ADENOSINE-3'-5'-DIPHOSPHATE; 3,6-Dihydro-6-iminopurine; 4, Vitamin B; 6-Amino-1H-purine; 6-Amino-3H-purine; 6-Amino-7H-purine; 6-Amino-9H-purine; 6-Aminopurine; 7H-Purin-6-amine; 9H-Purin-6-amine; AD2; ADE; ALBB-005925; ANE; Adenin; Adenine (8CI); Adenine (JAN/USP); Adenine [JAN]; Adenine-8-14C; Adenine-ring; Adeninimine; B 4, Vitamin; Leuco-4; Leucon (TN); Pedatisectine B; Purine, 6; USAF CB-18; Vitamin B 4; Vitamin B4; Vitamin-B4
DTD0227	SLC26A1	Sulfate anion transporter 1	CAON; SAT-1; SAT1; SLC26A1; Solute carrier family 26 member 1	DR00022	Oxalate	oxalate2-
DTD0227	SLC26A1	Sulfate anion transporter 1	CAON; SAT-1; SAT1; SLC26A1; Solute carrier family 26 member 1	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0227	SLC26A1	Sulfate anion transporter 1	CAON; SAT-1; SAT1; SLC26A1; Solute carrier family 26 member 1	DR00138	Bicarbonate	71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
DTD0230	SLC26A2	Sulfate transporter	D5S1708; DTD; DTDST; Diastrophic dysplasia protein; EDM4; MST153; MSTP157; SLC26A2; Solute carrier family 26 member 2	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0234	SLC26A6	Anion exchange transporter	Pendrin-L1; Pendrin-like protein 1; SLC26A6; Solute carrier family 26 member 6	DR00022	Oxalate	oxalate2-
DTD0234	SLC26A6	Anion exchange transporter	Pendrin-L1; Pendrin-like protein 1; SLC26A6; Solute carrier family 26 member 6	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0234	SLC26A6	Anion exchange transporter	Pendrin-L1; Pendrin-like protein 1; SLC26A6; Solute carrier family 26 member 6	DR00138	Bicarbonate	71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
DTD0235	SLC26A7	Anion exchange transporter	SLC26A7; SUT2; Solute carrier family 26 member 7	DR00009	Nitrate	14797-55-8; 84145-82-4 (Parent); AC1L1ADK; AKOS015904030; BDBM26988; CHEBI:17632; CHEMBL186200; CTK0H4660; I14-18318; MCULE-5142506228; NHNBFGGVMKEFGY-UHFFFAOYSA-N; NITRATE ION; NO3; NO3(-); NO3-; Nitrate(1-); Nitrate(6CI,7CI,8CI,9CI); Nitrates; Nitrates, in; Nitrates, inorganic, aqueous solution, n.o.s.; Nitrates, inorganic, n.o.s.; Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer]; T93E9Y2844; UN3218; UNII-T93E9Y2844; [NO3](-); nitrooxidane; trioxidonitrate; trioxidonitrate(1-); trioxonitrate; trioxonitrate(1-); trioxonitrate(V)
DTD0235	SLC26A7	Anion exchange transporter	SLC26A7; SUT2; Solute carrier family 26 member 7	DR00022	Oxalate	oxalate2-
DTD0235	SLC26A7	Anion exchange transporter	SLC26A7; SUT2; Solute carrier family 26 member 7	DR00060	Sulfate	14808-79-8; 7IS9N8KPMG; AC1L1ARH; BDBM26992; CHEBI:16189; CHEMBL183495; CTK0H6976; Colistin Sulfate (mixture); QAOWNCQODCNURD-UHFFFAOYSA-L; SO4(2-); SO4--; SO4-2; SO42-; SULFATE STANDARD; Sulfate (7CI,8CI,9CI); Sulfate (S-35); Sulfate (ion); Sulfate anion; Sulfate anion(2-); Sulfate dianion; Sulfate ion; Sulfate ions; Sulfate radical anion; Sulfate(2-); Sulfate-35S; Sulphate; Sulphate Ion; UNII-7IS9N8KPMG; Zirconium Basic sulfate; sulfuric acid, ion(2-); tetraoxidosulfate(2-); tetraoxosulfate(2-); tetraoxosulfate(VI)
DTD0235	SLC26A7	Anion exchange transporter	SLC26A7; SUT2; Solute carrier family 26 member 7	DR00138	Bicarbonate	71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
DTD0237	SLC26A9	Anion transporter/exchanger protein 9	Solute carrier family 26 member 9; SLC26A9	DR00138	Bicarbonate	71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
DTD0238	SLC27A1	Fatty acid transport protein 1	ACSVL5; FATP; FATP-1; FATP1; Long-chain fatty acid transport protein 1; SLC27A1; Solute carrier family 27 member 1	DR00152	Oleic acid	(Z)-Octadec-9-enoic acid; 9-Octadecenoic acid (Z)-; Century cd fatty acid; Cis-9-Octadecenoic acid; Elaidoic acid; Emersol 205; Emersol 210; Emersol 211; Emersol 213; Emersol 233LL; Emersol 6321; Extraolein 90; Glycon RO; Glycon wo; Groco 2; Groco 4; Groco 5l; Groco 6; Industrene 105; Industrene 205; Industrene 206; L'Acide oleique; Metaupon; Oelsauere; Oleine 7503; Oleinic acid; Pamolyn; Pamolyn 100; Tego-oleic 130; Vopcolene 27; Wecoline OO; Z-9-Octadecenoic acid; cis-Octadec-9-enoic acid; cis-Oleic acid; oleate
DTD0244	SLC28A1	Concentrative nucleoside transporter 1	CNT 1; CNT1; Na(+)/nucleoside cotransporter 1; SLC28A1; Sodium-coupled nucleoside transporter 1; Sodium/nucleoside cotransporter 1; Solute carrier family 28 member 1; hCNT1	DR00063	Gemcitabine	2',2'-DiF-dC; 2',2'-Difluoro-2'-deoxycytidine; 2',2'-Difluorodeoxycytidine; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; 2'-Deoxy-2',2'-difluorocytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; DDFC; DFdC; DFdCyd; Folfugem; GEO; Gamcitabine; GemLip; Gemcel; Gemcin; Gemcitabina; Gemcitabina [INN-Spanish]; Gemcitabine (USAN/INN); Gemcitabine HCl; Gemcitabine stereoisomer; Gemcitabinum; Gemcitabinum [INN-Latin]; Gemtro; Gemzar; Gemzar (TN); Gemzar (hydrochloride); Inno-D07001; LY 188011; LY-188011; LY188011; Zefei
DTD0244	SLC28A1	Concentrative nucleoside transporter 1	CNT 1; CNT1; Na(+)/nucleoside cotransporter 1; SLC28A1; Sodium-coupled nucleoside transporter 1; Sodium/nucleoside cotransporter 1; Solute carrier family 28 member 1; hCNT1	DR00096	Trifluridine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN)
DTD0244	SLC28A1	Concentrative nucleoside transporter 1	CNT 1; CNT1; Na(+)/nucleoside cotransporter 1; SLC28A1; Sodium-coupled nucleoside transporter 1; Sodium/nucleoside cotransporter 1; Solute carrier family 28 member 1; hCNT1	DR00321	Uridine	1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; AI3-52690; C9H12N2O6; CHEBI:16704; DRTQHJPVMGBUCF-XVFCMESISA-N; EINECS 200-407-5; MLS000069625; SMR000058222; UNII-WHI7HQ7H85; Uracil riboside; Uracil-1-beta-d-ribofuranoside; Urd; Uridin; WHI7HQ7H85; b-Uridine; beta-Uridine; d-uridine
DTD0244	SLC28A1	Concentrative nucleoside transporter 1	CNT 1; CNT1; Na(+)/nucleoside cotransporter 1; SLC28A1; Sodium-coupled nucleoside transporter 1; Sodium/nucleoside cotransporter 1; Solute carrier family 28 member 1; hCNT1	DR00416	Cytarabine	(beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil
DTD0245	SLC28A2	Concentrative nucleoside transporter 2	CNT 2; CNT2; HsT17153; Na(+)/nucleoside cotransporter 2; SLC28A2; SPNT; SPNT1; Sodium-coupled nucleoside transporter 2; Sodium/nucleoside cotransporter 2; Sodium/purine nucleoside co-transporter; Solute carrier family 28 member 2; hCNT2	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0245	SLC28A2	Concentrative nucleoside transporter 2	CNT 2; CNT2; HsT17153; Na(+)/nucleoside cotransporter 2; SLC28A2; SPNT; SPNT1; Sodium-coupled nucleoside transporter 2; Sodium/nucleoside cotransporter 2; Sodium/purine nucleoside co-transporter; Solute carrier family 28 member 2; hCNT2	DR00176	Ribavirin	1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN)
DTD0245	SLC28A2	Concentrative nucleoside transporter 2	CNT 2; CNT2; HsT17153; Na(+)/nucleoside cotransporter 2; SLC28A2; SPNT; SPNT1; Sodium-coupled nucleoside transporter 2; Sodium/nucleoside cotransporter 2; Sodium/purine nucleoside co-transporter; Solute carrier family 28 member 2; hCNT2	DR00321	Uridine	1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; AI3-52690; C9H12N2O6; CHEBI:16704; DRTQHJPVMGBUCF-XVFCMESISA-N; EINECS 200-407-5; MLS000069625; SMR000058222; UNII-WHI7HQ7H85; Uracil riboside; Uracil-1-beta-d-ribofuranoside; Urd; Uridin; WHI7HQ7H85; b-Uridine; beta-Uridine; d-uridine
DTD0245	SLC28A2	Concentrative nucleoside transporter 2	CNT 2; CNT2; HsT17153; Na(+)/nucleoside cotransporter 2; SLC28A2; SPNT; SPNT1; Sodium-coupled nucleoside transporter 2; Sodium/nucleoside cotransporter 2; Sodium/purine nucleoside co-transporter; Solute carrier family 28 member 2; hCNT2	DR01175	Didanosine	69655-05-6; 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine; 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE; 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one; BMY 40900; BMY-40900; CHEBI:490877; DDI; DIDEOXYINOSINE; DRG-0016; DSSTox_CID_2927; Didanosina; Didanosina [INN-Spanish]; Didanosinum; Didanosinum [INN-Latin]; Inosine, 2',3'-dideoxy-; K3GDH6OH08; NCGC00090691-03; NCGC00159514-02; NSC 612049; UNII-K3GDH6OH08; Videx; Videx EC; ddIno; didanosine
DTD0245	SLC28A2	Concentrative nucleoside transporter 2	CNT 2; CNT2; HsT17153; Na(+)/nucleoside cotransporter 2; SLC28A2; SPNT; SPNT1; Sodium-coupled nucleoside transporter 2; Sodium/nucleoside cotransporter 2; Sodium/purine nucleoside co-transporter; Solute carrier family 28 member 2; hCNT2	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0246	SLC28A3	Concentrative Na(+)-nucleoside cotransporter 3	CNT 3; CNT3; SLC28A3; Solute carrier family 28 member 3; hCNT3	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0246	SLC28A3	Concentrative Na(+)-nucleoside cotransporter 3	CNT 3; CNT3; SLC28A3; Solute carrier family 28 member 3; hCNT3	DR00176	Ribavirin	1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN)
DTD0246	SLC28A3	Concentrative Na(+)-nucleoside cotransporter 3	CNT 3; CNT3; SLC28A3; Solute carrier family 28 member 3; hCNT3	DR00510	Thioguanine	2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; BW 5071; DX4; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Guanine, thio-(VAN); LT00455187; Lanvis; Lanvis (TN); Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; THG; Tabloid; Thioguanin GSK; Thioguanin-GSK; ThioguaninGSK; Thioguanine (Guanine analog); Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Thioguanine [USAN:BAN]; Tioguanin; Tioguanina; Tioguanina Wellcome; Tioguanina[INN-Spanish]; Tioguanine; Tioguanine (INN); Tioguanine GlaxoSmithKline Brand; Tioguaninum; Tioguaninum [INN-Latin]; Wellcome Brand of Thioguanine; Wellcome U3B
DTD0246	SLC28A3	Concentrative Na(+)-nucleoside cotransporter 3	CNT 3; CNT3; SLC28A3; Solute carrier family 28 member 3; hCNT3	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0246	SLC28A3	Concentrative Na(+)-nucleoside cotransporter 3	CNT 3; CNT3; SLC28A3; Solute carrier family 28 member 3; hCNT3	DR01330	Clofarabine	(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN)
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00096	Trifluridine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN)
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00153	Fluorouracil	1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5-fluoro-1H-pyrimidine-2,4-dione; 5-fluoropyrimidine-2,4(1H,3H)-dione; 5FU; Adrucil; Adrucil (TN); Allergan Brand of Fluorouracil; Arumel; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Carac; Carac (TN); Carzonal; Cinco FU; Dakota Brand of Fluorouracil; Dakota, Fluorouracile; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Effluderm; Effluderm (free base); Efudex; Efudex (TN); Efudix; Efurix; F 6627; F0151; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroblastin; Fluoroplex; Fluoroplex (TN); Fluorouracil (JP15/USP/INN); Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracil [USAN:INN:BAN:JAN]; Fluorouracil-GRY; Fluorouracile; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo; Fluorouracilo Ferrer Far; Fluorouracilo [INN-Spanish]; Fluorouracilum; Fluorouracilum [INN-Latin]; Fluoruracil; Fluracedyl; Fluracil; Fluracilum; Fluri; Fluril; Fluro Uracil; Fluroblastin; Flurodex; Ftoruracil; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Haemato-fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; IN1335; Inhibits thymilidate synthetase; Kecimeton; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Neofluor; Onkofluor; Onkoworks Brand of Fluorouracil; Phthoruracil; Phtoruracil; Queroplex; Ribofluor; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Ro 2-9757; Ro-2-9757; Roche Brand of Fluorouracil; Tetratogen; Teva Brand of Fluorouracil; Timazin; U 8953; U-8953; URF; Ulup
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00176	Ribavirin	1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; AA-504/07617051; C-Virin; Copegus; Copegus (TN); Cotronak; DRG-0028; Drug: Ribavirin; ICN-1229; KS-1104; R 9644; R-964; RBV; RG-964; RTC; RTCA; Ravanex; Rebetol; Rebetol (TN); Rebetron; Rebretron; Ribacine; Ribamide; Ribamidil; Ribamidyl; Ribasphere; Ribasphere (TN); Ribav; Ribavirin (JAN/USP/INN); Ribavirin Capsules; Ribavirin [USAN:INN]; Ribavirina; Ribavirina [INN-Spanish]; Ribavirine; Ribavirine [INN-French]; Ribavirinum; Ribavirinum [INN-Latin]; Ribovirin; Ro 20-9963/000; Ro-20-9963; SCH 18908; Tribavirin; Varazid; Vilona; Vilona (TN); Viramid; Viramide; Virazid; Virazide; Virazole; Virazole (Ribavirin) Inhalation Solution; Virazole (TN)
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00416	Cytarabine	(beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00904	Adenosine	(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; 6-Amino-9beta-D-ribofuranosyl-9H-purine; 9-(beta-D-Arabinofuranosyl)adenine; 9-beta-D-Ribofuranosidoadenine; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; 9-beta-D-Ribofuranosyladenine; 9beta-D-Ribofuranosyladenine; Adenine 9-beta-D-arabinofuranoside; Adenine-9-beta-D-ribofuranoside; Adenosine, homopolymer; Beta-D-Ribofuranoside, adenine-9; EA6C60C2-6AFB-4264-A2F0-541373DB950E
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR00923	Tecadenoson	CVT-510; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol; 204512-90-3; AC1L4KMO; Adenosine, N-(3R)-tetrahydro-3-furanyl)-; Adenosine, N-(3R)-tetrahydro-3-furanyl-; BDBM50138530; BDBM50224766; CHEMBL356254; CHEMBL392149; CS-0016174; CVT-510; D06019; DB04954; DTXSID80174415; GTPL5592; GZ1X96601Z; HY-19661; LS-190860; N-(3-Tetrahydrofuranyl)-6-aminopurine riboside; N6-[3-(R)-tetrahydrofuranyl]adenosine; SCHEMBL246787; Selenocompounds; Tecadenoson (USAN/INN); Tecadenoson [USAN:INN]; UNII-GZ1X96601Z
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0247	SLC29A1	Equilibrative nucleoside transporter 1	ENT1; Equilibrative NBMPR-sensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Nucleoside transporter, es-type; SLC29A1; Solute carrier family 29 member 1	DR01330	Clofarabine	(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN)
DTD0248	SLC29A2	Equilibrative nucleoside transporter 2	36 kDa nucleolar protein HNP36; DER12; Delayed-early response protein 12; ENT2; Equilibrative NBMPR-insensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter; HNP36; Hydrophobic nucleolar protein; Nucleoside transporter, ei-type; SLC29A2; Solute carrier family 29 member 2	DR00096	Trifluridine	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione; 2'-Deoxy-5-(trifluoromethyl)uridine; 2'-Deoxy-5-trifluoromethyluridine; 5-(Trifluoromethyl)-2'-deoxyuridine; 5-(Trifluoromethyl)deoxyuridine; 5-Trifluoro-2'-deoxythymidine; 5-Trifluoromethyl-2'-deoxyuridine; 5-Trifluoromethyl-2-deoxyuridine; 5-Trifluorothymidine; Alpha,alpha,alpha-Trifluorothymidine; CF3dUrd; F3DThd; F3T; F3TDR; Fluridine; HS-0007; TFDU; TRIFLUOROTHYMIDINE; Trifluoridine; Trifluoromethyldeoxyuridine; Trifluorothymine deoxyriboside; Trifluridina; Trifluridina [INN-Spanish]; Trifluridine (USP/INN);Viroptic, Trifluorothymidine, Trifluridine; Trifluridine [USAN:INN]; Trifluridinum; Trifluridinum [INN-Latin]; Virophta; Viroptic; Viroptic (TN)
DTD0248	SLC29A2	Equilibrative nucleoside transporter 2	36 kDa nucleolar protein HNP36; DER12; Delayed-early response protein 12; ENT2; Equilibrative NBMPR-insensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter; HNP36; Hydrophobic nucleolar protein; Nucleoside transporter, ei-type; SLC29A2; Solute carrier family 29 member 2	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0248	SLC29A2	Equilibrative nucleoside transporter 2	36 kDa nucleolar protein HNP36; DER12; Delayed-early response protein 12; ENT2; Equilibrative NBMPR-insensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter; HNP36; Hydrophobic nucleolar protein; Nucleoside transporter, ei-type; SLC29A2; Solute carrier family 29 member 2	DR00416	Cytarabine	(beta-D-Arabinofuranosyl)cytosine; 1-.beta.-D-arabinofuranosyl-cytosine; 1-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 1-beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; 1-beta-D-Arabinosylcytosine; 1beta-Arabinofuranasylcytosine; 1beta-D-Arabinofuranosylcytosine; 1beta-D-Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; AR3; Alexan; Ara-C; Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine; Ara-Cytidine; AraC; Arabinocytidine; Arabinofuranosylcytosine; Arabinosyl Cytosine; Arabinosylcytosine; Arabitin; Aracytidine; Aracytin; Aracytine; Arafcyt; BTB15125; Beta-Ara C; Beta-Arabinosylcytosine; Beta-D-Arabinosylcytosine; Beta-cytosine arabinoside; CHX 3311; CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9); Citarabina; Citarabina [INN-Spanish]; Cytarabin; Cytarabina; Cytarabine (JP15/USP/INN); Cytarabine [USAN:INN:BAN:JAN]; Cytarabine liposome injection; Cytarabinoside; Cytarabinum; Cytarabinum [INN-Latin]; Cytarbel; Cytonal; Cytosar; Cytosar-U; Cytosar-U (TN); Cytosine 1-beta-D-arabinofuranoside; Cytosine arabinofuranoside; Cytosine arabinose; Cytosine arabinoside; Cytosine arabinoside (VAN); Cytosine beta-D-arabinofuranoside; Cytosine beta-D-arabinofuranoside hydrochloride; Cytosine beta-D-arabinoside; Cytosine, beta-D-arabinoside; Cytosine-1-beta-D-arabinofuranoside; Cytosine-beta-D-arabinofuranoside; Cytosine-beta-arabinoside; Cytosinearabinoside; DepoCyte; Depocyt; Depocyt (TN); Depocyt (liposomal); Erpalfa; Intrathecal (injected into the spinal fluid) DepoCyt; Intrathecal cytarabine (also known as ara-C); Iretin; Spongocytidine; Tarabine; U 19920A; U-19,920; U-19920; Udicil
DTD0248	SLC29A2	Equilibrative nucleoside transporter 2	36 kDa nucleolar protein HNP36; DER12; Delayed-early response protein 12; ENT2; Equilibrative NBMPR-insensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter; HNP36; Hydrophobic nucleolar protein; Nucleoside transporter, ei-type; SLC29A2; Solute carrier family 29 member 2	DR01277	Entecavir	2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate; BMS-200475; Baraclude; Baraclude (TN); ETV; Entecavir (INN); Entecavir (USAN); Entecavir hydrate; Entecavir hydrate (JAN); Entecavir monohydrate; SQ-34676
DTD0248	SLC29A2	Equilibrative nucleoside transporter 2	36 kDa nucleolar protein HNP36; DER12; Delayed-early response protein 12; ENT2; Equilibrative NBMPR-insensitive nucleoside transporter; Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter; HNP36; Hydrophobic nucleolar protein; Nucleoside transporter, ei-type; SLC29A2; Solute carrier family 29 member 2	DR01330	Clofarabine	(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 2-Cl-2'-F-araA; 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine; 3S211048; CAFdA; CFB; Cl-F-Ara-A; Clofarabina; Clofarabine (USAN/INN); Clofarabine [USAN]; Clofarabinum; Clofarex; Clolar; Clolar (TN); Clolar, Evoltra, Clofarabine; Evoltra; Evoltra (TN)
DTD0249	SLC29A3	Equilibrative nucleoside transporter 3	Solute carrier family 29 member 3; hENT3; SLC29A3; ENT3; HJCD; PHID; HCLAP	DR00087	Cladribine	(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2 Chlorodeoxyadenosine; 2'-Deoxy-2-chloroadenosine; 2-CdA; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-2'-deoxyadenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine; 2-Chlorodeoxyadenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; Adenosine, 2-chloro-2'-deoxy; CL9; Chlorodeoxyadenosine; Cladarabine; Cladaribine; Cladribina; Cladribine (JAN/USAN/INN); Cladribine [USAN:INN:BAN]; Cladribinum; CldAdo; Leustat; Leustatin; Leustatin (TN); Leustatin, 2-chlorodeoxyadenosine, Cladribine; Litak; Movectro;Mylinax; RWJ 26251; RWJ-26251; RWJ-26251-000
DTD0249	SLC29A3	Equilibrative nucleoside transporter 3	Solute carrier family 29 member 3; hENT3; SLC29A3; ENT3; HJCD; PHID; HCLAP	DR00717	Cordycepin	3'-deoxyadenosine
DTD0249	SLC29A3	Equilibrative nucleoside transporter 3	Solute carrier family 29 member 3; hENT3; SLC29A3; ENT3; HJCD; PHID; HCLAP	DR00718	Tubercidin	Sparsamycin A
DTD0250	SLC29A4	Equilibrative nucleoside transporter 4	ENT4; PMAT; Plasma membrane monoamine transporter; SLC29A4; Solute carrier family 29 member 4; hENT4	DR00081	Ergotidine	1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine
DTD0250	SLC29A4	Equilibrative nucleoside transporter 4	ENT4; PMAT; Plasma membrane monoamine transporter; SLC29A4; Solute carrier family 29 member 4; hENT4	DR00133	Metformin	1,1-Dimethyl biguanide; 1,1-Dimethylbiguanide; 3-(diaminomethylidene)-1,1-dimethylguanidine; DMGG; Diabetosan; Diabex; Diabex (TN); Diaformin (TN); Dianben (TN); Dimethylbiguanide; Dimethylbiguanidine; Dimethyldiguanide; Dimethylguanylguanidine; Fluamine; Flumamine; Fortamet (TN); Gen-Metformin; Glifage; Gliguanid; Glucophage (TN); Glumetza; Glumetza (TN); Glycon; Haurymelin; Islotin; LA-6023; Melbin; Metformin (USAN/INN); Metformin [USAN:INN:BAN]; Metformina; Metformina [DCIT]; Metformina [Spanish]; Metformine; Metformine [INN-French]; Metforminum; Metforminum [INN-Latin]; Metiguanide; N,N-Dimethylbiguanide; N,N-Dimethyldiguanide; N,N-dimethylimidodicarbonimidic diamide; N1,N1-Dimethylbiguanide; NNDG; Nu-Metformin; Obimet (TN); Riomet (TN); Siofor
DTD0250	SLC29A4	Equilibrative nucleoside transporter 4	ENT4; PMAT; Plasma membrane monoamine transporter; SLC29A4; Solute carrier family 29 member 4; hENT4	DR00189	Serotonin	1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY
DTD0251	SLC2A1	Glucose transporter type 1	CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0251	SLC2A1	Glucose transporter type 1	CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1	DR00165	D-glucose	(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; 2280-44-6; CPC hydrate; Cartose Cerelose; Clearsweet 95; Clintose L; D-Glc; D-Glcp; D-Glucopyranose; D-Glucopyranose, anhydrous; D-Glucopyranoside; D-glucose-ring; DSSTox_CID_2910; EINECS 218-914-5; Glc; Glc-OH; Glucodin; Glucopyranose; Glucopyranose, D-; Glucopyranoside; Glucose 40; Glucose solution; Meritose; Meritose 200; Roferose ST; Staleydex 130; Staleydex 95M; glc-ring
DTD0251	SLC2A1	Glucose transporter type 1	CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0251	SLC2A1	Glucose transporter type 1	CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1	DR00260	Dehydroascorbic acid	dehydroascorbate
DTD0251	SLC2A1	Glucose transporter type 1	CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1	DR00312	Arsenite	13768-07-5; AC1L2NJ5; Arsenenous acid; Arsenite (ion)
DTD0252	SLC2A10	Glucose transporter type 10	ATORS; ATS; GLUT-10; GLUT10; SLC2A10; Solute carrier family 2, facilitated glucose transporter member 10	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0254	SLC2A12	Glucose transporter type 12	GLUT-12; GLUT12; SLC2A12; Solute carrier family 2, facilitated glucose transporter member 12	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0256	SLC2A14	Glucose transporter type 14	GLUT-14; GLUT14; SLC2A14; SLC2A3P3; Solute carrier family 2, facilitated glucose transporter member 14	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0256	SLC2A14	Glucose transporter type 14	GLUT-14; GLUT14; SLC2A14; SLC2A3P3; Solute carrier family 2, facilitated glucose transporter member 14	DR00260	Dehydroascorbic acid	dehydroascorbate
DTD0257	SLC2A2	Glucose transporter type 2	Solute carrier family 2, facilitated glucose transporter member 2; GLUT-2; SLC2A2; GLUT2	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0258	SLC2A3	Glucose transporter type 3	GLUT-3; GLUT3; SLC2A3; Solute carrier family 2, facilitated glucose transporter member 3	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0262	SLC2A4	Glucose transporter type 4	GLUT-4; GLUT4; SLC2A4; Solute carrier family 2, facilitated glucose transporter member 4	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0263	SLC2A5	Glucose transporter type 5	Fructose transporter; GLUT-5; GLUT5; SLC2A5; Solute carrier family 2, facilitated glucose transporter member 5	DR00043	Fructose	(3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, &gt; D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose
DTD0264	SLC2A6	Glucose transporter type 6	GLUT-6; GLUT6; HSA011372; SLC2A6; Solute carrier family 2, facilitated glucose transporter member 6	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0265	SLC2A7	Glucose transporter type 7	GLUT-7; GLUT7; SLC2A7; Solute carrier family 2, facilitated glucose transporter member 7	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0265	SLC2A7	Glucose transporter type 7	GLUT-7; GLUT7; SLC2A7; Solute carrier family 2, facilitated glucose transporter member 7	DR00043	Fructose	(3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, &gt; D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose
DTD0266	SLC2A8	Glucose transporter type 8	GLUT-8; GLUT8; GLUTX1; Glucose transporter type X1; SLC2A8; Solute carrier family 2, facilitated glucose transporter member 8	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0269	SLC30A1	Zinc transporter 1	SLC30A1; Solute carrier family 30 member 1; ZNT1; ZRC1; ZnT-1	DR00068	Zinc salts	.
DTD0270	SLC30A10	Zinc transporter 10	HMDPC; HMNDYT1; Manganese transporter SLC30A10; SLC30A10; Solute carrier family 30 member 10; ZNT10; ZnT-10	DR00068	Zinc salts	.
DTD0271	SLC30A2	Zinc transporter 2	PP12488; SLC30A2; Solute carrier family 30 member 2; TNZD; ZNT2; ZnT-2	DR00068	Zinc salts	.
DTD0272	SLC30A3	Zinc transporter 3	SLC30A3; Solute carrier family 30 member 3; ZNT3; ZnT-3	DR00068	Zinc salts	.
DTD0273	SLC30A4	Zinc transporter 4	SLC30A4; Solute carrier family 30 member 4; ZNT4; ZnT-4	DR00068	Zinc salts	.
DTD0274	SLC30A5	Zinc transporter 5	SLC30A5; Solute carrier family 30 member 5; ZNT5; ZNTL1; ZTL1; ZnT-5; ZnT-like transporter 1; hZTL1	DR00068	Zinc salts	.
DTD0275	SLC30A6	Zinc transporter 6	MST103; MSTP103; SLC30A6; Solute carrier family 30 member 6; ZNT6; ZnT-6	DR00068	Zinc salts	.
DTD0276	SLC30A7	Zinc transporter 7	SLC30A7; Solute carrier family 30 member 7; ZNT7; ZNTL2; ZnT-7; Znt-like transporter 2	DR00068	Zinc salts	.
DTD0277	SLC30A9	Zinc transporter 9	BILAPES; C4orf1; GAC63; HuEL; Human embryonic lung protein; SLC30A9; Solute carrier family 30 member 9; ZNT9; ZnT-9	DR00068	Zinc salts	.
DTD0278	SLC31A1	High affinity copper uptake protein 1	COPT1; CTR1; Copper transporter 1; SLC31A1; Solute carrier family 31 member 1; hCTR1	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0278	SLC31A1	High affinity copper uptake protein 1	COPT1; CTR1; Copper transporter 1; SLC31A1; Solute carrier family 31 member 1; hCTR1	DR00316	Oxaliplatin	ACT 078; Oxaloplatine; Oxaloplatino; Oxalitin; NSC 271670; Oxalato(1,2-diaminocyclohexane)platinum(II); Platinum (II), (cyclohexane-1,2-diammine)oxalato-; CCRIS 9143; Platinum, (1,2-cyclohexanediamine-N,N')(ethanedioato(2-)-O,O')-, (SP-4-2-(trans))-; Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')(ethanedioato(2-)-kappaO1,kappaO2)-, (SP-4-2-(trans))-; Oxaliplatin [USAN:USP:INN:BAN]; CS-0992; HY-17371; NCI60_002138
DTD0278	SLC31A1	High affinity copper uptake protein 1	COPT1; CTR1; Copper transporter 1; SLC31A1; Solute carrier family 31 member 1; hCTR1	DR00469	Carboplatin	(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum; 1,1-Cyclobutanedicarboxylate diammine platinum (II); 1,1-Cyclobutanedicarboxylate diammine platinum(II); Azanide; C 2538; Carbopaltin; Carboplatin (JAN/USP/INN); Carboplatin (USAN); Carboplatin [USAN:INN:BAN:JAN]; Carboplatine; Carboplatine [French]; Carboplatino; Carboplatino [Spanish]; Carboplatinum; Carboplatinum [Latin]; Cbdca; Cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II); Cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II); Cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II); Cis-Diammine(1,1-cyclobutanedicarboxylato) platinum; Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum; Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II); Cis-Diammine(cyclobutanedicarboxylato)platinumII; Cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum; Cyclobutane-1,1-dicarboxylate; Cyclobutane-1,1-dicarboxylic acid; Diammine(1,1-cyclobutanedicarboxylato)platinum (II); Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum; Diammine-1,1-cyclobutane dicarboxylate platinum II; Diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum; Ercar; IUPAC: Azane; JM 8; JM-8; Paraplatin; Paraplatin (TN); Paraplatin, Carboplatin; Paraplatin-AQ; Platinum(+2) Cation; Platinum(2+); Platinum(II), (1, 1-cyclobutanedicar; Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2); Platinum, {diammine[1,1-cyclobut
DTD0278	SLC31A1	High affinity copper uptake protein 1	COPT1; CTR1; Copper transporter 1; SLC31A1; Solute carrier family 31 member 1; hCTR1	DR01187	Cupric sulfate	7758-98-7; All Clear Root Destroyer; BCS copper fungicide; Blue copper (VAN); Blue stone; Bonide Root Destroyer; CUPRIC SULFATE; Copper II sulfate; Copper Sulfate Powder; Copper monosulfate; Copper sulfate; Copper sulfate (1:1); Copper sulfate (CuSO; Copper sulphate; Copper(2+) sulfate; Copper(II) sulfate; Copper(ii) sulfate, anhydrous; CuSO4; Cupric sulfate anhydrous; Cupric sulphate; Cupricsulfate; Delcup; Hylinec; Incracide 10A; Incracide E 51; Kupfersulfat [German]; Monocopper sulfate; Sulfuric acid copper(2+) salt (1:1); Trinagle
DTD0280	SLC31A2	Probable low affinity copper uptake protein 2	Copper transporter 2; hCTR2; COPT2; CTR2; SLC31A2; Solute carrier family 31 member 2	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0281	SLC32A1	Vesicular inhibitory amino acid transporter	GABA and glycine transporter; SLC32A1; Solute carrier family 32 member 1; VGAT; VIAAT; Vesicular GABA transporter; hVIAAT	DR00831	Gamma-aminobutyric acid	1956/12/2; 3-Carboxypropylamine; 4-Aminobutanoic acid; 4-amino-butanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminalon; Butyric acid, 4-amino-; GABA; GAMMA-AMINO-BUTANOIC ACID; Gaballon; Gamarex; Gamastan; Gammagee; Gammalon; Gammalone; Gammar; Gammasol; Gamulin; Immu-G; Mielogen; Mielomade; Piperidic acid; Piperidinic acid; Reanal; butanoic acid, 4-amino-; gamma-Amino butyric acid; gamma-Aminobutanoic acid; gamma-Aminobuttersaeure; gamma-Aminobutyric acid; gamma-amino-n-butyric acid; gamma-aminobutyric acid; omega-Aminobutyric acid
DTD0284	SLC34A1	Sodium-dependent phosphate transport protein 2A	FRTS2; HCINF2; NPHLOP1; NPT2; NPTIIa; Na(+)-dependent phosphate cotransporter 2A; Na(+)/Pi cotransporter 2A; NaPi-2a; NaPi-3; SLC11; SLC34A1; Sodium-phosphate transport protein 2A; Sodium/phosphate cotransporter 2A; Solute carrier family 34 member 1	DR00339	Calcium phosphate	Bonarka; Calcigenol simple; Calcium orthophosphate; Calcium phosphate; Calcium phosphate (3:2); Calcium phosphate (Ca3(PO4)2); Calcium phosphate tribasic; Calcium tertiary phosphate; Natural whitlockite; Phosphoric acid, calcium salt; Phosphoric acid, calcium salt (2:3); Synthos; TRICALCIUM PHOSPHATE; Tertiary calcium phosphate; Tribasic calcium phosphate; Tricalcium diphosphate; Tricalcium orthophosphate; beta-TCP; beta-Tricalcium phosphate
DTD0285	SLC34A2	Sodium-dependent phosphate transport protein 2B	NAPI-3B; NAPI-IIb; NPTIIb; Na(+)-dependent phosphate cotransporter 2B; Na(+)/Pi cotransporter 2B; NaPi-2b; NaPi3b; SLC34A2; Sodium-phosphate transport protein 2B; Sodium/phosphate cotransporter 2B; Solute carrier family 34 member 2	DR00376	Sodium phosphate dibasic/Sodium phosphate monobasic	Anhydrous sodium acid phosphate; Dibasic sodium phosphate; Dipotassium phosphate anhydrous; Monobasic potassium acid phosphate; Monobasic sodium phosphate; Phosphate; Potassium phosphate; Sodium phosphate
DTD0286	SLC34A3	Sodium-dependent phosphate transport protein 2C	HHRH; NPT2C; NPTIIC; Na(+)-dependent phosphate cotransporter 2C; Na(+)/Pi cotransporter 2C; NaPi-2c; SLC34A3; Sodium-phosphate transport protein 2C; Sodium/inorganic phosphate cotransporter IIC; Sodium/phosphate cotransporter 2C; Solute carrier family 34 member 3	DR00355	Calcium phosphate dihydrate	Calcium phosphate dihydrate
DTD0287	SLC35A1	CMP-sialic acid transporter	CDG2F; CMP-SA-Tr; CMP-Sia-Tr; CMPST; CST; SLC35A1; Solute carrier family 35 member A1; hCST	DR00114	CMP-sialic acid	(2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid; 3063-71-6; CHEBI:16556; CMP acetylneuraminic acid; CMP-N-acetyl-beta-neuraminate; CMP-N-acetylneuraminate; CMP-NeuNAc; CMP-Sialic acid; CYTIDINE-5'-MONOPHOSPHATE-5-N-ACETYLNEURAMINIC ACID; Cmp-D-N-acetylneuraminic acid; Cmp-nana; NCC; cytidine monophosphate N-acetylneuraminic acid
DTD0295	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	SLC35B4; Solute carrier family 35 member B4; YEA; YEA4; YEA4 homolog	DR00090	UDP-xylose	AC1L2DQI; CHEBI:16082; DB01713; GTPL4730; J-700264; Mono-a-D-xylopyranosyl ester; P1-a-D-xylopyranosyl ester; UDP-ALPHA-D-XYLOPYRANOSE; UDP-D-xylose; UDP-a-D-xylose; UDP-alpha-D-xylose; UDP-xylose; UDPxylose; UDX; URIDINE DIPHOSPHATE XYLOSE; URIDINE-5'-DIPHOSPHATE-XYLOPYRANOSE; Udp xylose; Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-xylopyranosyl ester; Uridine 5'-diphosphoric acid beta-a; Uridine 51-pyrophosphate, a-D-xylopyranosyl ester; ZINC8551129; uridine 5'-[3-(alpha-D-xylopyranosyl) dihydrogen diphosphate]
DTD0296	SLC35C1	GDP-fucose transporter 1	CDG2C; FUCT1; SLC35C1; Solute carrier family 35 member C1	DR00160	GDP-fucose	GDP-L-fucose; guanosine diphosphate fucose
DTD0299	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	HFRC; HFRC1; Homolog of Fringe connection protein 1; SLC35D2; SQV7-like protein; SQV7L; Solute carrier family 35 member D2; UDP-galactose transporter-related protein 8; UGTrel8	DR00178	UDP-glucose	uridine diphosphate glucose
DTD0305	SLC35E4	Solute carrier family 35 member E4	SLC35E4; Solute carrier 35 member E4	DR00335	Thiamine pyrophosphate	B-Neurox; Berolase; Biosyth; Bioxylasi; Bivitasi; Co-Bi; Co-carboxylase; Cocarbina; Cocarboxil; Cocarboxilasa; Cocarboxylasum; Cocarboxylasum [INN-Latin]; Coenbione; Coxylase; Diphosphothiamin; Diphosphothiamine; Farmaneurina; Metabolase; Nutrase; Pyrolase; Pyruvodehydrase; TDP (thiamin ester); TPP (coenzyme); Thiamine pyrophosphate; Thiamine pyrophosphate chloride; Thiamine pyrophosphoric ester; Thiamine-PP; Thiaminediphosphate; Thiaminepyrophosphate; Thiaminpyrophosphate; UNII-XMK8K8EVIU; cocarboxylase
DTD0308	SLC35F3	Putative thiamine transporter SLC35F3	SLC35F3; Solute carrier family 35 member F3	DR00117	Vitamin B1	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol; 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium chloride, monohydrochloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride; 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; Aneurin; Aneurine; Antiberiberi factor; Apatate drape; B-Amin; Beivon; Bequin; Betabion; Betalin S; Betaxin; Bethiamin; Bewon; Biamine; Chloride-hydrochloride salt of thiamine; LT00233141; Oryzanin; Oryzanine; THD; THIAMIN, VITAMIN B1; Thiadoxine; Thiamin; Thiamin dichloride; Thiamine; Thiamine (INN); Thiamine HCL; Thiamine [INN:BAN]; Thiamine chloride; Thiamine chloride hydrochloride; Thiamine dichloride; Thiamine hydrochloride [JAN]; Thiamine monochloride; Thiamine monohydrochloride; Thiamine(1+) ion; Thiamine, chloride; Thiamine, chloride, hydrochloride; Thiamine, monohydrochloride; Thiaminium; Thiaminium chloride hydrochloride; Thiaminum; Thiaminum [INN-Latin]; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride (1:1); Tiamina; Tiamina [INN-Spanish]; VIB; Vitamin B1 (TN); Vitamin B1 hydrochloride (VAN); Vitamin b1(thiamine); Vitaneurin; Vitaneuron; [5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00004	Gaboxadol	4,5,6,7-Tetrahydroisoxazole(5,4-c)pyridin-3-ol; 4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-ol; 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one; Gaboxadol (USAN/INN); Gaboxadol [USAN:INN]; Gaboxadolum; Gaboxadolum [Latin]; Isoxazolo(5,4-c)pyridin-3(2H)-one, 4,5,6,7-tetrahydro-, hydrate; LU 2030; LU-2-030; Lu 02-030; Lu-02-030; MK-0928; THIP
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00057	Aminolevulinic acid	5-ALA; 5-Amino-4-oxopentanoate; 5-Amino-4-oxopentanoic acid; 5-Amino-4-oxovaleric acid; 5-Aminolevulinate; 5-Aminolevulinic acid; 5-amino-levulinate; Aladerm; Aminolevulinate; Aminolevulinic; Delta-ALA; Delta-aminolevulinic acid; Kerastick; Levulinic acid, 5-amino-(8CI); Pentanoic acid, 5-amino-4-oxo-(9CI)
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00179	L-proline	(-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin]
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00197	Cycloserine	(+)-4-Amino-3-isoxazolidinone; (+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; (4R)-4-amino-1,2-oxazolidin-3-one; (4R)-4-aminoisoxazolidin-3-one; (R)-(+)-4-Amino-3-isoxazolidinone; (R)-(+)-Cycloserine; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; (R)-4-Amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; (R)-Cycloserine; 3-Isoxazolidinone, 4-amino-, (+)-(8CI); 3-Isoxazolidinone, 4-amino-, (4R)-(9CI); 3-Isoxazolidinone, 4-amino-, (R); 3-Isoxazolidinone, 4-amino-, D; Alpha-Cycloserine; C 3909; C-9390; C-9400; Cicloserina; Cicloserina [INN-Spanish]; Cicloserina [Italian]; Closerin; Closina; Cyclo-D-serine; Cyclorin; Cycloserine (JP15/USP/INN); Cycloserine [INN:BAN:JAN]; Cycloserinum; Cycloserinum [INN-Latin]; D-(+)-Cycloserine; D-4-Amino-3-isossazolidone; D-4-Amino-3-isossazolidone [Italian]; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; D-CS; D-amino-3-isoxazolidinone; D-cycloserine; DRG-0195; E-733-A; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; Farmiserina; I-1431; K-300; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamicina [Italian]; Oxamycin; PA 94; PA-94; R(+)-4-Amino-3-isoxazolidinone; R-(+)-Cycloserine; R-4-Amino-3-isoxazolidinone; RO-1-9213; SC-49088; Seromycin; Seromycin (TN); Tebemicina; Tisomycin; Wasserina
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00242	Glycine	(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00270	Vigabatrin	(R,S)-4-Amino-5-hexenoic acid; (inverted question mark)-gamma-Vinyl GABA; 4-Amino-5-hexenoic acid; 4-Aminohexenoic acid; 4-aminohex-5-enoic acid; Acid, gamma-Vinyl-gamma-Aminobutyric; Aventis Brand of Vigabatrin; CPP-109; GVG; Gamma Vinyl GABA; Gamma Vinyl gamma Aminobutyric Acid; Gamma-Vinyl GABA; Gamma-Vinyl-GABA; Gamma-Vinyl-gamma-Aminobutyric Acid; Hexenoic acid, 4-amino; Hoechst Brand of Vigabatrin; M071754; MDL 71,754; MDL 71754; MDL-71754; RMI 71754; RMI-71754; RMI-71890; Sabril; Sabril (TN); Sabrilex; Sabrilex (TN); V 8261; V8261_SIGMA; Vigabatrin (JAN/USAN/INN); Vigabatrin Aventis Brand; Vigabatrin Hoechst Brand; Vigabatrin Yamanouchi Brand; Vigabatrin [USAN:BAN:INN]; Vigabatrin [USAN:INN:BAN]; Vigabatrina; Vigabatrina [Spanish]; Vigabatrine; Vigabatrine [French]; Vigabatrinum; Vigabatrinum [Latin]; Yamanouchi Brand of Vigabatrin
DTD0318	SLC36A1	Proton-coupled amino acid transporter 1	LYAAT1; PAT1; Proton/amino acid transporter 1; SLC36A1; Solute carrier family 36 member 1; TRAMD3; hPAT1	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0319	SLC36A2	Proton-coupled amino acid transporter 2	PAT2; Proton/amino acid transporter 2; SLC36A2; Solute carrier family 36 member 2; TRAMD1; Tramdorin-1	DR00197	Cycloserine	(+)-4-Amino-3-isoxazolidinone; (+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; (4R)-4-amino-1,2-oxazolidin-3-one; (4R)-4-aminoisoxazolidin-3-one; (R)-(+)-4-Amino-3-isoxazolidinone; (R)-(+)-Cycloserine; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; (R)-4-Amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; (R)-Cycloserine; 3-Isoxazolidinone, 4-amino-, (+)-(8CI); 3-Isoxazolidinone, 4-amino-, (4R)-(9CI); 3-Isoxazolidinone, 4-amino-, (R); 3-Isoxazolidinone, 4-amino-, D; Alpha-Cycloserine; C 3909; C-9390; C-9400; Cicloserina; Cicloserina [INN-Spanish]; Cicloserina [Italian]; Closerin; Closina; Cyclo-D-serine; Cyclorin; Cycloserine (JP15/USP/INN); Cycloserine [INN:BAN:JAN]; Cycloserinum; Cycloserinum [INN-Latin]; D-(+)-Cycloserine; D-4-Amino-3-isossazolidone; D-4-Amino-3-isossazolidone [Italian]; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; D-CS; D-amino-3-isoxazolidinone; D-cycloserine; DRG-0195; E-733-A; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; Farmiserina; I-1431; K-300; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamicina [Italian]; Oxamycin; PA 94; PA-94; R(+)-4-Amino-3-isoxazolidinone; R-(+)-Cycloserine; R-4-Amino-3-isoxazolidinone; RO-1-9213; SC-49088; Seromycin; Seromycin (TN); Tebemicina; Tisomycin; Wasserina
DTD0320	SLC36A3	Proton-coupled amino acid transporter 3	PAT3; Proton/amino acid transporter 3; SLC36A3; Solute carrier family 36 member 3; TRAMD2; Tramdorin-2; tramdorin2	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0321	SLC36A4	Proton-coupled amino acid transporter 4	PAT4; Proton/amino acid transporter 4; SLC36A4; Solute carrier family 36 member 4	DR00086	L-tryptophan	(-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin]
DTD0321	SLC36A4	Proton-coupled amino acid transporter 4	PAT4; Proton/amino acid transporter 4; SLC36A4; Solute carrier family 36 member 4	DR00179	L-proline	(-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin]
DTD0322	SLC37A1	Glycerol-3-phosphate permease	G-3-P permease; G3PP; Glucose-6-phosphate exchanger SLC37A1; SLC37A1; Solute carrier family 37 member 1	DR00098	Glucose-6-phosphate	299-31-0; 6-O-phosphono-D-glucopyranose; AC1L1LI0; AC1Q28E3; CHEBI:4170; D-Glucopyranose 6-phosphoric acid; D-glucopyranose 6-phosphate; D-glucopyranose, 6-(dihydrogen phosphate); D-glucose-6-P; D-glucose-6P; GTPL4647; Glc6P; Glucose 6-(dihydrogen phosphate); Glucose 6-phosphate; Robison ester; SCHEMBL48379; a-D-glucose 6- phosphate; {[(2R,3S,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}phosphonic acid
DTD0322	SLC37A1	Glycerol-3-phosphate permease	G-3-P permease; G3PP; Glucose-6-phosphate exchanger SLC37A1; SLC37A1; Solute carrier family 37 member 1	DR00132	Phosphate	14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
DTD0325	SLC37A4	Glucose-6-phosphate translocase	G6PT; G6PT1; G6PT2; G6PT3; GSD1b; GSD1c; GSD1d; Glucose-5-phosphate transporter; Glucose-6-phosphate exchanger SLC37A4; PRO0685; SLC37A4; Solute carrier family 37 member 4; TRG-19; TRG19; Transformation-related gene 19 protein	DR00098	Glucose-6-phosphate	299-31-0; 6-O-phosphono-D-glucopyranose; AC1L1LI0; AC1Q28E3; CHEBI:4170; D-Glucopyranose 6-phosphoric acid; D-glucopyranose 6-phosphate; D-glucopyranose, 6-(dihydrogen phosphate); D-glucose-6-P; D-glucose-6P; GTPL4647; Glc6P; Glucose 6-(dihydrogen phosphate); Glucose 6-phosphate; Robison ester; SCHEMBL48379; a-D-glucose 6- phosphate; {[(2R,3S,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}phosphonic acid
DTD0326	SLC38A1	Sodium-coupled neutral amino acid transporter 1	ATA1; Amino acid transporter A1; N-system amino acid transporter 2; NAT2; SLC38A1; SNAT1; Solute carrier family 38 member 1; System A amino acid transporter 1; System N amino acid transporter 1	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0326	SLC38A1	Sodium-coupled neutral amino acid transporter 1	ATA1; Amino acid transporter A1; N-system amino acid transporter 2; NAT2; SLC38A1; SNAT1; Solute carrier family 38 member 1; System A amino acid transporter 1; System N amino acid transporter 1	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0327	SLC38A10	Putative sodium-coupled neutral amino acid transporter 10	PP1744; SLC38A10; Solute carrier family 38 member 10	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0327	SLC38A10	Putative sodium-coupled neutral amino acid transporter 10	PP1744; SLC38A10; Solute carrier family 38 member 10	DR00352	Aspartic acid	(2S)-2-aminobutanedioic acid; (2S)-Aspartic acid; (S)-2-Aminosuccinic acid; (S)-Aminobutanedioic acid; (S)-Aspartic acid; Acidum asparticum; Aminosuccinic acid; Asparagic acid; Asparaginic acid; Asparaginsaeure [German]; Aspartate, L-; Aspartic acid, L-; Aspatofort; Butanedioic acid, amino-, (S); H-Asp-OH; L-(+)-Aspartic acid; L-2-Aminobutanedioic acid; L-Aminosuccinic acid; L-Asp; L-Asparagic acid; L-Asparaginic acid; L-Asparaginsaeure; L-Asparaginsyra; L-Aspartinsaeure; L-aspartate; L-aspartic acid; aspartate; aspartic acid
DTD0328	SLC38A11	Putative sodium-coupled neutral amino acid transporter 11	AVT2; SLC38A11; Solute carrier family 38 member 11	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0329	SLC38A2	Sodium-coupled neutral amino acid transporter 2	ATA2; Amino acid transporter A2; KIAA1382; PRO1068; Protein 40-9-1; SAT2; SLC38A2; SNAT2; Solute carrier family 38 member 2; System A amino acid transporter 2; System A transporter 1; System N amino acid transporter 2	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0329	SLC38A2	Sodium-coupled neutral amino acid transporter 2	ATA2; Amino acid transporter A2; KIAA1382; PRO1068; Protein 40-9-1; SAT2; SLC38A2; SNAT2; Solute carrier family 38 member 2; System A amino acid transporter 2; System A transporter 1; System N amino acid transporter 2	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0330	SLC38A3	Sodium-coupled neutral amino acid transporter 3	G17; Na(+)-coupled neutral amino acid transporter 3; SLC38A3; SN1; SNAT3; Solute carrier family 38 member 3	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0330	SLC38A3	Sodium-coupled neutral amino acid transporter 3	G17; Na(+)-coupled neutral amino acid transporter 3; SLC38A3; SN1; SNAT3; Solute carrier family 38 member 3	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0330	SLC38A3	Sodium-coupled neutral amino acid transporter 3	G17; Na(+)-coupled neutral amino acid transporter 3; SLC38A3; SN1; SNAT3; Solute carrier family 38 member 3	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0330	SLC38A3	Sodium-coupled neutral amino acid transporter 3	G17; Na(+)-coupled neutral amino acid transporter 3; SLC38A3; SN1; SNAT3; Solute carrier family 38 member 3	DR01160	Aminosalicylic acid	2-Hydroxy-4-aminobenzoic acid; 4-Aminosalicylic acid; 65-49-6; APAS; Aminopar; Aminosalicylate Sodium; Aminosalicylic Acid Resin Complex; Aminosalicylic acid; Aminox; Apacil; Benzoic acid, 4-amino-2-hydroxy-; Deapasil; Entepas; Ferrosan; Gabbropas; Hellipidyl; Osacyl; P-AMINOSALICYLIC ACID; PAS (acid); PAS-C; PASK; Pamacyl; Pamisyl; Para-Pas; Paramycin; Parasal; Parasalicil; Parasalindon; Pasa; Pasalon; Pasara; Pascorbic; Pasdium; Pasem; Paser; Pasmed; Pasnodia; Pasolac; Propasa; Rezipas; Sanipirol-4
DTD0331	SLC38A4	Sodium-coupled neutral amino acid transporter 4	ATA3; Amino acid transporter A3; NAT3; Na(+)-coupled neutral amino acid transporter 4; PAAT; SLC38A4; SNAT4; Solute carrier family 38 member 4; System A amino acid transporter 3; System N amino acid transporter 3	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0331	SLC38A4	Sodium-coupled neutral amino acid transporter 4	ATA3; Amino acid transporter A3; NAT3; Na(+)-coupled neutral amino acid transporter 4; PAAT; SLC38A4; SNAT4; Solute carrier family 38 member 4; System A amino acid transporter 3; System N amino acid transporter 3	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0332	SLC38A5	Sodium-coupled neutral amino acid transporter 5	JM24; SLC38A5; SN2; SNAT5; Solute carrier family 38 member 5; System N transporter 2; pp7194	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0332	SLC38A5	Sodium-coupled neutral amino acid transporter 5	JM24; SLC38A5; SN2; SNAT5; Solute carrier family 38 member 5; System N transporter 2; pp7194	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0333	SLC38A6	Probable sodium-coupled neutral amino acid transporter 6	N-system amino acid transporter 1; NAT-1; NAT1; Na(+)-coupled neutral amino acid transporter 6; SLC38A6; SNAT6; Solute carrier family 38 member 6	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0334	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	SLC38A7; SNAT7; Solute carrier family 38 member 7	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0334	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	SLC38A7; SNAT7; Solute carrier family 38 member 7	DR00464	Anastrozole	1,3-benzenediacetonitrile, a, a,a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl); 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile); 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile); 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile); 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile; Alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; Alpha,alpha,alpha',alpha'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; Anastrazole; Anastrole; Anastrozol; Anastrozole (JAN/USAN/INN); Anastrozole [USAN:INN:BAN]; Arimidex; Arimidex (TN); Arimidex (Zeneca); Arimidex, Anastrozole; Asiolex; Astra brand of anastrozole; AstraZeneca brand of anastrozole; ZD 1033; ZD-1033; ZD1033; Zeneca ZD 1033; Zeneca brand of anastrozole
DTD0335	SLC38A8	Putative sodium-coupled neutral amino acid transporter 8	FVH2; SLC38A8; Solute carrier family 38 member 8	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0336	SLC38A9	Sodium-coupled neutral amino acid transporter 9	SLC38A9; Solute carrier family 38 member 9; URLC11; Up-regulated in lung cancer 11	DR00188	Arginine	1-Hydrochloride arginine; 2-Amino-5-guanidinopentanoic acid hydrochloride; 2-Amino-5-guanidinovaleric acid monohydrochloride; 220144-84-3; 32042-43-6; ARGININE, (L); Arginine monochloride; Arginine monohydrochloride, L-(+)-; D-Arginine, hydrochloride (1:1); DL-(+/-)-Arginine Hydrochloride; DL-Arginine HCl; DL-Arginine hydrochloride; DL-Arginine hydrochloride, 98%, anhydrous; EINECS 239-674-8; EINECS 250-903-0; H-DL-Arg-OH.xHCl; L(+)-Arginine hydrochloride; NSC7914; WLN: MUYZM3YZVQ &amp; argininhydrochlorid
DTD0337	SLC39A1	Zrt- and Irt-like protein 1	IRT1; SLC39A1; Solute carrier family 39 member 1; ZIP-1; ZIP1; ZIRTL; Zinc transporter ZIP1; Zinc-iron-regulated transporter-like; hZIP1	DR00068	Zinc salts	.
DTD0338	SLC39A10	Zrt- and Irt-like protein 10	KIAA1265; LZT-Hs2; SLC39A10; Solute carrier family 39 member 10; ZIP-10; ZIP10; Zinc transporter ZIP10	DR00068	Zinc salts	.
DTD0339	SLC39A11	Zrt- and Irt-like protein 11	C17orf26; SLC39A11; Solute carrier family 39 member 11; ZIP-11; ZIP11; Zinc transporter ZIP11	DR00068	Zinc salts	.
DTD0340	SLC39A12	Zrt- and Irt-like protein 12	LIV-1 subfamily of ZIP zinc transporter 8; LZT-Hs8; SLC39A12; Solute carrier family 39 member 12; ZIP-12; ZIP12; Zinc transporter ZIP12; bA570F3.1	DR00068	Zinc salts	.
DTD0341	SLC39A13	Zrt- and Irt-like protein 13	EDSSPD3; LIV-1 subfamily of ZIP zinc transporter 9; LZT-Hs9; SCDEDS; SLC39A13; Solute carrier family 39 member 13; ZIP-13; ZIP13; Zinc transporter ZIP13	DR00068	Zinc salts	.
DTD0342	SLC39A14	Zrt- and Irt-like protein 14	HCIN; HMNDYT2; KIAA0062; LIV-1 subfamily of ZIP zinc transporter 4; LZT-Hs4; NET34; SLC39A14; Solute carrier family 39 member 14; ZIP-14; ZIP14; Zinc transporter ZIP14; cig19	DR00068	Zinc salts	.
DTD0343	SLC39A2	Zrt- and Irt-like protein 2	6A1; Eti-1; SLC39A2; Solute carrier family 39 member 2; ZIP-2; ZIP2; Zinc transporter ZIP2; hZIP2	DR00068	Zinc salts	.
DTD0344	SLC39A3	Zrt- and Irt-like protein 3	SLC39A3; Solute carrier family 39 member 3; ZIP-3; ZIP3; Zinc transporter ZIP3	DR00068	Zinc salts	.
DTD0345	SLC39A4	Zrt- and Irt-like protein 4	AEZ; AWMS2; SLC39A4; Solute carrier family 39 member 4; ZIP-4; ZIP4; Zinc transporter ZIP4	DR00068	Zinc salts	.
DTD0346	SLC39A5	Zrt- and Irt-like protein 5	LZT-Hs7; MYP24; SLC39A5; Solute carrier family 39 member 5; ZIP-5; ZIP5; Zinc transporter ZIP5	DR00068	Zinc salts	.
DTD0347	SLC39A6	Zrt- and Irt-like protein 6	Estrogen-regulated protein LIV-1; LIV-1; LIV1; SLC39A6; Solute carrier family 39 member 6; ZIP-6; ZIP6; Zinc transporter ZIP6	DR00068	Zinc salts	.
DTD0348	SLC39A7	Zrt- Irt-like protein 7	D6S115E; D6S2244E; H2-KE4; HKE4; Histidine-rich membrane protein Ke4; KE4; RING5; Really interesting new gene 5 protein; SLC39A7; Solute carrier family 39 member 7; ZIP7; Zinc transporter SLC39A7	DR00068	Zinc salts	.
DTD0349	SLC39A8	Zrt- and Irt-like protein 8	BCG-induced integral membrane protein in monocyte clone 103 protein; BIGM103; CDG2N; LIV-1 subfamily of ZIP zinc transporter 6; LZT-Hs6; PP3105; SLC39A8; Solute carrier family 39 member 8; ZIP-8; ZIP8; Zinc transporter ZIP8	DR00068	Zinc salts	.
DTD0350	SLC39A9	Zrt- and Irt-like protein 9	SLC39A9; Solute carrier family 39 member 9; ZIP-9; ZIP9; Zinc transporter ZIP9	DR00068	Zinc salts	.
DTD0351	SLC3A1	Neutral and basic amino acid transport protein rBAT	ATR1; CSNU1; D2h; NBAT; RBAT; SLC3A1; Solute carrier family 3 member 1; b(0),+-type amino acid transport protein	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0352	SLC3A2	Lymphocyte activation antigen 4F2	Solute carrier family 3 member 2; 4F2 cell-surface antigen heavy chain; 4F2hc; 4F2 heavy chain antigen; Lymphocyte activation antigen 4F2 large subunit; 4F2; 4T2HC; CD98HC; MDU1; NACAE; SLC3A2	DR01251	Polyamine	.
DTD0353	SLC40A1	Iron-regulated transporter 1	FPN1; Ferroportin-1; HFE4; IREG1; MST079; MSTP079; MTP1; SLC11A3; SLC40A1; Solute carrier family 40 member 1	DR00068	Zinc salts	.
DTD0358	SLC42A2	Ammonium transporter Rh type B	RHBG; Rh family type B glycoprotein; Rh type B glycoprotein; Rhesus blood group family type B glycoprotein; SLC42A2	DR00194	Ammonia	Ammonia N13
DTD0359	SLC42A3	Ammonium transporter Rh type C	C15orf6; CDRC2; PDRC2; RHCG; RHGK; Rh family type C glycoprotein; Rh glycoprotein kidney; Rh type C glycoprotein; Rhesus blood group family type C glycoprotein; SLC42A3; Tumor-related protein DRC2	DR00194	Ammonia	Ammonia N13
DTD0360	SLC43A1	L-type amino acid transporter 3	LAT3; Large neutral amino acids transporter small subunit 3; PB39; POV1; Prostate cancer overexpressed gene 1 protein; R00504; SLC43A1; Solute carrier family 43 member 1	DR00214	L-isoleucine	(2S,3S)-2-Amino-3-methylpentanoic acid; (S)-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; 2S,3S-Isoleucine; 443-79-8; 73-32-5; Acetic acid, amino-sec-butyl-; CCRIS 5229; H-Ile-OH; ISOLEUCINE, L-; Isoleucina [Spanish]; Isoleucine; Isoleucine (VAN); Isoleucinum [Latin]; L-(+)-Isoleucine; L-Ile; L-Norvaline, 3-methyl-, erythro-; Norvaline, 3-methyl-; Pentanoic acid, 2-amino-3-methyl-; Valeric acid, 2-amino-3-methyl-; alpha-Amino-beta-methylvaleric acid; erythro-L-Isoleucine; iso-leucine; l-isoleucine
DTD0360	SLC43A1	L-type amino acid transporter 3	LAT3; Large neutral amino acids transporter small subunit 3; PB39; POV1; Prostate cancer overexpressed gene 1 protein; R00504; SLC43A1; Solute carrier family 43 member 1	DR00236	L-valine	(2S)-2-amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutyric acid; (S)-Valine; (S)-alpha-Amino-beta-methylbutyric acid; 2-Amino-3-methylbutanoic acid, (S)-; 2-Amino-3-methylbutyric acid; 2-Amino-3-methylbutyric acid, (S)-; 72-18-4; Butanoic acid, 2-amino-3-methyl-; Butanoic acid, 2-amino-3-methyl-, (S)-; H-Val-OH; L(+)-alpha-Aminoisovaleric acid; L-alpha-Amino-beta-methylbutyric acid; L-valin; VALINE, L-; Valina [Spanish]; Valine; Valine (VAN); Valine [USAN:INN]; Valinum [Latin]
DTD0360	SLC43A1	L-type amino acid transporter 3	LAT3; Large neutral amino acids transporter small subunit 3; PB39; POV1; Prostate cancer overexpressed gene 1 protein; R00504; SLC43A1; Solute carrier family 43 member 1	DR00266	L-phenylalanine	(2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin]
DTD0360	SLC43A1	L-type amino acid transporter 3	LAT3; Large neutral amino acids transporter small subunit 3; PB39; POV1; Prostate cancer overexpressed gene 1 protein; R00504; SLC43A1; Solute carrier family 43 member 1	DR00303	L-leucine	(2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine
DTD0361	SLC43A2	L-type amino acid transporter 4	LAT4; Large neutral amino acids transporter small subunit 4; SLC43A2; Solute carrier family 43 member 2	DR00214	L-isoleucine	(2S,3S)-2-Amino-3-methylpentanoic acid; (S)-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; 2S,3S-Isoleucine; 443-79-8; 73-32-5; Acetic acid, amino-sec-butyl-; CCRIS 5229; H-Ile-OH; ISOLEUCINE, L-; Isoleucina [Spanish]; Isoleucine; Isoleucine (VAN); Isoleucinum [Latin]; L-(+)-Isoleucine; L-Ile; L-Norvaline, 3-methyl-, erythro-; Norvaline, 3-methyl-; Pentanoic acid, 2-amino-3-methyl-; Valeric acid, 2-amino-3-methyl-; alpha-Amino-beta-methylvaleric acid; erythro-L-Isoleucine; iso-leucine; l-isoleucine
DTD0361	SLC43A2	L-type amino acid transporter 4	LAT4; Large neutral amino acids transporter small subunit 4; SLC43A2; Solute carrier family 43 member 2	DR00236	L-valine	(2S)-2-amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutyric acid; (S)-Valine; (S)-alpha-Amino-beta-methylbutyric acid; 2-Amino-3-methylbutanoic acid, (S)-; 2-Amino-3-methylbutyric acid; 2-Amino-3-methylbutyric acid, (S)-; 72-18-4; Butanoic acid, 2-amino-3-methyl-; Butanoic acid, 2-amino-3-methyl-, (S)-; H-Val-OH; L(+)-alpha-Aminoisovaleric acid; L-alpha-Amino-beta-methylbutyric acid; L-valin; VALINE, L-; Valina [Spanish]; Valine; Valine (VAN); Valine [USAN:INN]; Valinum [Latin]
DTD0361	SLC43A2	L-type amino acid transporter 4	LAT4; Large neutral amino acids transporter small subunit 4; SLC43A2; Solute carrier family 43 member 2	DR00266	L-phenylalanine	(2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin]
DTD0361	SLC43A2	L-type amino acid transporter 4	LAT4; Large neutral amino acids transporter small subunit 4; SLC43A2; Solute carrier family 43 member 2	DR00303	L-leucine	(2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine
DTD0362	SLC43A3	Equilibrative nucleobase transporter 1	EEG1; ENBT1; FOAP-13; PRO1659; PSEC0252; Protein FOAP-13; SEEEG-1; SLC43A3; Solute carrier family 43 member 3	DR00145	Mercaptopurine	1,7-Dihydro-6H-purine-6-thione; 1,9-dihydro-6H-purine-6-thione; 3,7-dihydropurine-6-thione; 3H-Purine-6-thiol; 6 MP; 6 Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Mercaptopurine; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; 7-Mercapto-1,3,4,6-tetrazaindene; 7H-purine-6-thiol; 9H-Purin-6-yl hydrosulfide; 9H-Purine-6(1H)-thione; AG-670/31547064; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Ismipur; Leukerin; Leukerin, 99%-Carc; Leupu rin; Leupurin; M0063; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurin [German]; Mercaptopurina; Mercaptopurina Wellcome; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (Purine analog); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurine anhydrous; Mercaptopurinum; Mercaptopurinum [INN-Latin]; Mercapurin; Merkaptopuryna; Merkaptopuryna [Polish]; Mern; NCIMech_000025; PM6; Puri Nethol; Puri-Nethol; Purimethol; Purine-6(1H)-thione; Purine-6-thiol; Purineantimetabolite: inhibits nucleic acid replication; Purinethiol; Purinethol; Purinethol (TN); Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; Thiopurine; U-4748; Wellcome Brand of 6 Mercaptopurine; Wellcome Brand of 6-Mercaptopurine
DTD0363	SLC44A1	Choline transporter-like protein 1	CD92; CDw92; CHTL1; CTL1; SLC44A1; Solute carrier family 44 member 1	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0364	SLC44A2	Choline transporter-like protein 2	CTL2; PP1292; SLC44A2; Solute carrier family 44 member 2	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0366	SLC44A4	Choline transporter-like protein 4	C6orf29; CTL4; DFNA72; NG22; SLC44A4; Solute carrier family 44 member 4; TPPT; TPPT1; Thiamine pyrophosphate transporter 1; hTPPT1	DR00070	Acetylcholine	Miochol; Miochol-e
DTD0366	SLC44A4	Choline transporter-like protein 4	C6orf29; CTL4; DFNA72; NG22; SLC44A4; Solute carrier family 44 member 4; TPPT; TPPT1; Thiamine pyrophosphate transporter 1; hTPPT1	DR00117	Vitamin B1	2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol; 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydrox yethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium chloride, monohydrochloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride monohydrochloride; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride; 3[(4-Amino-2-methyl-5-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride; Aneurin; Aneurine; Antiberiberi factor; Apatate drape; B-Amin; Beivon; Bequin; Betabion; Betalin S; Betaxin; Bethiamin; Bewon; Biamine; Chloride-hydrochloride salt of thiamine; LT00233141; Oryzanin; Oryzanine; THD; THIAMIN, VITAMIN B1; Thiadoxine; Thiamin; Thiamin dichloride; Thiamine; Thiamine (INN); Thiamine HCL; Thiamine [INN:BAN]; Thiamine chloride; Thiamine chloride hydrochloride; Thiamine dichloride; Thiamine hydrochloride [JAN]; Thiamine monochloride; Thiamine monohydrochloride; Thiamine(1+) ion; Thiamine, chloride; Thiamine, chloride, hydrochloride; Thiamine, monohydrochloride; Thiaminium; Thiaminium chloride hydrochloride; Thiaminum; Thiaminum [INN-Latin]; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, chloride, monohydrochloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride; Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-chloride (1:1); Tiamina; Tiamina [INN-Spanish]; VIB; Vitamin B1 (TN); Vitamin B1 hydrochloride (VAN); Vitamin b1(thiamine); Vitaneurin; Vitaneuron; [5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methylpyrimidin-4-yl]azanium dichloride
DTD0366	SLC44A4	Choline transporter-like protein 4	C6orf29; CTL4; DFNA72; NG22; SLC44A4; Solute carrier family 44 member 4; TPPT; TPPT1; Thiamine pyrophosphate transporter 1; hTPPT1	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0367	SLC44A5	Choline transporter-like protein 5	CTL5; SLC44A5; Solute carrier family 44 member 5	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0368	SLC45A1	Proton-associated sugar transporter A	DNB5; DNb-5; Deleted in neuroblastoma 5 protein; IDDNPF; PAST-A; SLC45A1; Solute carrier family 45 member 1	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0369	SLC45A2	Membrane-associated transporter protein	1A1; AIM1; MATP; Melanoma antigen AIM1; OCA4; Protein AIM-1; SHEP5; SLC45A2; Solute carrier family 45 member 2	DR00131	Sucrose	57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar
DTD0370	SLC45A3	Solute carrier family 45 member 3	IPCA-2; IPCA-6; IPCA-8; IPCA6; PCANAP2; PCANAP6; PCANAP8; PRST; Prostate cancer-associated protein 6; Prostein; SLC45A3	DR00131	Sucrose	57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar
DTD0371	SLC45A4	Solute carrier family 45 member 4	KIAA1126; SLC45A4; Solute carrier 45 member 4	DR00131	Sucrose	57-50-1; Amerfand; Amerfond; Beet sugar; CCRIS 2120; CHEBI:17992; Cane sugar; Confectioner's sugar; D(+)-Saccharose; D(+)-Sucrose; D-(+)-Saccharose; D-Saccharose; D-Sucrose; Granulated sugar; HSDB 500; Microse; Rock candy; Rohrzucker; Saccharose; Saccharum; Sacharose; Sucraloxum [INN-Latin]; Sucrose [USAN:JAN]; Sucrose, dust; Sucrose, pure; Table sugar; White sugar; alpha-D-Glucopyranosyl beta-D-fructofuranoside; beta-D-Fructofuranosyl alpha-D-glucopyranoside; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; sacarosa; sugar
DTD0372	SLC46A1	Proton-coupled folate transporter	G21; HCP1; Heme carrier protein 1; PCFT; PCFT/HCP1; SLC46A1; Solute carrier family 46 member 1	DR00041	Pralatrexate	Folotyn (TN)
DTD0372	SLC46A1	Proton-coupled folate transporter	G21; HCP1; Heme carrier protein 1; PCFT; PCFT/HCP1; SLC46A1; Solute carrier family 46 member 1	DR00082	Methotrexate	(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid; A-Methopterin; A-Methpterin; Abitrexate; Amethopterin; Amethopterin L-; Amethopterine; Antifolan; Folex-Pfs; Hdmtx; L-Amethopterin; MTX; Maxtrex; Metatrexan; Methotextrate; Methotrexat; Methotrexat-Ebewe; Methotrexate, L-; Methotrexatum; Methylaminopterin; Methylaminopterinum; Metotressato [DCIT]; Metotrexato; Mexate; Mexate-Aq; N-Bismethylpteroylglutamic acid; Rasuvo; Rheumatrex; [3H]methotrexate; methotrexate
DTD0372	SLC46A1	Proton-coupled folate transporter	G21; HCP1; Heme carrier protein 1; PCFT; PCFT/HCP1; SLC46A1; Solute carrier family 46 member 1	DR00134	Folic acid	(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Acfol (Spain); Acide folique [INN-French]; Acidefolique; Acido folico; Acido folico [INN-Spanish]; Acidum folicum; Acidum folicum [INN-Latin]; Acifolic; Antianemia factor; Apo-Folic; BIF0608; Cytofol; Dosfolat B activ; F0043; FOL; Facid; Factor U; Folacid; Folacin; Folaemin; Folaemin [Netherlands]; Folan; Folasic (Australia); Folate; Folbal; Folcidin; Folcidin (VAN); Folcysteine; Foldine; Foldine [France]; Folettes; Foliamin; Folic; Folic acid (JP15/USP/INN); Folic acid (TN); Folic acid [BAN:INN:JAN]; Folic acid [INN:BAN:JAN]; Folic acid dihydrate; Folicet; Folicet (TN); Folico; Folico (Italy); Folina; Folina (Italy); Folipac; Folsaeure; Folsan; Folsaure; Folsav; Folvite; Folvron; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Incafolic; Kyselina listova; Kyselina listova [Czech]; LiverLactobacillus casei factor; Millafol; Mission prenatal; Mittafol; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo-yl)-L-glutamic acid; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Nifolin; Nifolin [Denmark]; Novofolacid; Novofolacid [Canada]; PGA (VAN); PteGlu; Pteroyl-L-glutamic acid; Pteroyl-L-monoglutamic acid; Pteroylglutamic acid; Pteroylmonoglutamate; Pteroylmonoglutamic acid; Serum Folate Level; Usaf cb-13; Vitamin B11; Vitamin B9; Vitamin Bc; Vitamin Be; Vitamin M
DTD0372	SLC46A1	Proton-coupled folate transporter	G21; HCP1; Heme carrier protein 1; PCFT; PCFT/HCP1; SLC46A1; Solute carrier family 46 member 1	DR00318	Pemetrexed	(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; Alimta; Alimta (TN); LY 231,514; LY 231514; LY-231,514; LY-2315; LY-231514; LY231514; LYA; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid; Pemetrexed (INN); Pemetrexed [INN:BAN]
DTD0376	SLC49A1	Feline leukemia virus subgroup C receptor-related protein 1	AXPC1; FLVCR; FLVCR1; Feline leukemia virus subgroup C receptor; MFSD7B; PCA; PCARP; SLC49A1; hFLVCR	DR00225	Quercetin	2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3',4',5,7-Tetrahydroxyflavan-3-ol; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,3',4',5,7-Pentahydroxyflavone; 3,3',4',5,7-Pentahydroxyflavone dihydrate; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; C.I . natural yellow 10; C.I. 75670; C.I. Natural Yellow 10; C.I. Natural red 1; C.I. Natural yellow 10 & 13; CI Natural Yellow 10; CU-01000012502-3; Cyanidelonon 1522; Flavin meletin; KSC-10-126; KSC-23-76; KUC104418N; KUC107684N; Kvercetin; Kvercetin [Czech]; LIM-5662; LNS-5662; Meletin; MixCom3_000183; Natural Yellow 10; P0042; Q 0125; QUE; Quercetin content; Quercetin dihydrate; Quercetine; Quercetol; Quercitin; Quertin; Quertine; Sophoretin; T-Gelb bzw. grun 1; TNP00070; TNP00089; Xanthaurine
DTD0376	SLC49A1	Feline leukemia virus subgroup C receptor-related protein 1	AXPC1; FLVCR; FLVCR1; Feline leukemia virus subgroup C receptor; MFSD7B; PCA; PCARP; SLC49A1; hFLVCR	DR00312	Arsenite	13768-07-5; AC1L2NJ5; Arsenenous acid; Arsenite (ion)
DTD0381	SLC4A10	Sodium-driven chloride bicarbonate exchanger	NBCn2; NCBE; SLC4A10; Solute carrier family 4 member 10	DR00038	Sodium bicarbonate	800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal
DTD0383	SLC4A2	Anion exchange protein 2	AE 2; AE2; Anion exchanger 2; BND3L; EPB3L1; HKB3; MPB3L; NBND3; Non-erythroid band 3-like protein; SLC4A2; Solute carrier family 4 member 2	DR00138	Bicarbonate	71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
DTD0384	SLC4A3	Anion exchange protein 3	AE 3; AE3; Anion exchanger 3; CAE3/BAE3; Cardiac/brain band 3-like protein; Neuronal band 3-like protein; SLC2C; SLC4A3; Solute carrier family 4 member 3	DR00138	Bicarbonate	71-52-3; AC1L19ZH; Acid carbonate; Bicarbonate anion; Bicarbonate ion; Bicarbonate ions; Bicarbonates; Carbonate (HCO31-); Carbonate ion (HCO31-); Carbonate, hydrogen; Carbonic acid, ion(1-); Carboxyolate; HCO3; HCO3-; HN1ZRA3Q20; HYDROXYFORMATE; Hydrocarbonate(1-); Hydrogen carbonate; Hydrogen carbonate anion; Hydrogen carbonate ion; Hydrogencarbonate; Monohydrogen carbonate; UNII-HN1ZRA3Q20; hydrogen-carbonate; hydrogencarbonate(1-); hydrogentrioxocarbonate(1-); hydrogentrioxocarbonate(IV)
DTD0385	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	HNBC1; KNBC; NBC1; NBCE1; NBCe1-A; Na(+)/HCO3(-) cotransporter; SLC4A4; Sodium bicarbonate cotransporter; Solute carrier family 4 member 4; hhNMC; kNBC1; pNBC	DR00038	Sodium bicarbonate	800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal
DTD0386	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	NBC4; NBCe2; SLC4A5; Solute carrier family 4 member 5	DR00038	Sodium bicarbonate	800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal
DTD0387	SLC4A7	Sodium bicarbonate cotransporter 3	BT; Bicarbonate transporter; Electroneutral Na/HCO(3) cotransporter; NBC2; NBC2B; NBC3; NBCn1; SBC2; SLC4A6; SLC4A7; Sodium bicarbonate cotransporter 2; Sodium bicarbonate cotransporter 2b; Solute carrier family 4 member 7	DR00038	Sodium bicarbonate	800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal
DTD0388	SLC4A8	Electroneutral sodium bicarbonate exchanger 1	Electroneutral Na(+)-driven Cl-HCO3 exchanger; KIAA0739; NDCBE; NDCBE1; SLC4A8; Solute carrier family 4 member 8; k-NBC3	DR00038	Sodium bicarbonate	800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal
DTD0389	SLC4A9	Anion exchange protein 4	AE 4; AE4; Anion exchanger 4; SBC5; SLC4A9; Sodium bicarbonate cotransporter 5; Solute carrier family 4 member 9	DR00038	Sodium bicarbonate	800 Sodium Bicarbonate Powder; Acidosan; BSS plus; Baking soda; Bicarbonate of soda; Bicarbonate, Sodium; Carbonic acid monosodium salt; Carbonic acid sodium salt (1:1); Carbonic acid, monosodium salt; Co-lav; Col-evac; Colovage; E-Z-EM Prep Lyte; Glycoprep; Go-evac; Golytely; Gripe water; Hema BP-38; Hydrogen Carbonate, Sodium; Jusonin; Lithium bicarbonate; Meylon; Meylon (TN); Monosodium carbonate; Monosodium hydrogen carbonate; NaHCO3; Natrii hydrogencarbonas; Natrium bicarbonicum; Natrium hydrogencarbonicum; Natriumhydrogenkarbonat; Natron; Natrum bicarbonicum; Neut; Neut (TN); Nulytely; Peg-lyte; Sandoz sodium bicarbonate; Sel De vichy; Soda (van); Soda Mint; Soda, Baking; Sodium acid carbonate; Sodium bicarbonate (1:1); Sodium bicarbonate (JP15/USP); Sodium bicarbonate [USAN:JAN]; Sodium bicarbonate in plastic container; Sodium bicarbonate liquid concentrate; Sodium bicarbonate solution; Sodium carbonate (Na(HCO3)); Sodium hydrocarbonate; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Soludal
DTD0391	SLC51A	Organic solute transporter subunit alpha	OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0391	SLC51A	Organic solute transporter subunit alpha	OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0391	SLC51A	Organic solute transporter subunit alpha	OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0391	SLC51A	Organic solute transporter subunit alpha	OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0391	SLC51A	Organic solute transporter subunit alpha	OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00053	Sodium taurocholate	Sodium taurocholate (rectal gel, diabetes/ obesity)
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0392	SLC51B	Organic solute transporter subunit beta	OST-beta; OSTB; OSTBETA; SLC51B; Solute carrier family 51 subunit beta	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0393	SLC52A1	Riboflavin transporter 1	GPCR42; GPR172B; PAR2; PERV-A receptor 2; Porcine endogenous retrovirus A receptor 2; Protein GPR172B; RBFVD; RFT1; RFVT1; SLC52A1; Solute carrier family 52, riboflavin transporter, member 1; hRFT1	DR00079	Riboflavin	(-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2
DTD0394	SLC52A2	Riboflavin transporter 3	BVVLS2; D15Ertd747e; GPCR41; GPR172A; PAR1; PERV-A receptor 1; Porcine endogenous retrovirus A receptor 1; Protein GPR172A; RFT3; RFVT2; SLC52A2; Solute carrier family 52, riboflavin transporter, member 2; hRFT3	DR00079	Riboflavin	(-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2
DTD0395	SLC52A3	Riboflavin transporter 2	BVVLS; BVVLS1; C20orf54; RFT2; RFVT3; SLC52A3; Solute carrier family 52, riboflavin transporter, member 3; bA371L19.1; hRFT2	DR00079	Riboflavin	(-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2
DTD0416	SLC59A1	Major facilitator superfamily domain-containing protein 2A	3-PGDH; 3PGDH; HEL-S-113; MFSD2; MFSD2A; NLS; NLS1; PDG; PGAD; PGD; PGDH; PHGDHD; SERA; Sodium-dependent LPC symporter 1; Sodium-dependent lysophosphatidylcholine symporter 1	DR00231	Lysophosphatidylcholine	1-acetyl-sn-glycero-3-phosphocholine; 3,5,9-Trioxa-4-phosphaundecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-; AC1NSKBT; CHEBI:138424; GTPL2508; LMGP01050043; SCHEMBL19821626; [(2R)-3-acetyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; [(2R)-3-acetyloxy-2-hydroxypropyl] 2-trimethylazaniumylethyl phosphate
DTD0416	SLC59A1	Major facilitator superfamily domain-containing protein 2A	3-PGDH; 3PGDH; HEL-S-113; MFSD2; MFSD2A; NLS; NLS1; PDG; PGAD; PGD; PGDH; PHGDHD; SERA; Sodium-dependent LPC symporter 1; Sodium-dependent lysophosphatidylcholine symporter 1	DR00274	Docosahexaenoic acid	(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid; 6217-54-5; AquaGrow Advantage; CCRIS 7670; CHEMBL367149; Cervonic acid; Doconexent; Doconexento; Doconexentum; Docosahexaenoate; Docosahexaenoic acid; Docosahexaenoic acid (all-Z); Doxonexent; Eicosapentaenoic acid/docosa-hexaenoic acid; Martek DHA HM; Ropufa 60; UNII-ZAD9OKH9JC; ZAD9OKH9JC; all-Z-Docosahexaenoic acid; all-cis-4,7,10,13,16,19-Docosahexaenoic acid; all-cis-DHA; all-cis-docosa-4,7,10,13,16,19-hexaenoic acid; cis-4,7,10,13,16,19-Docosahexaenoic acid
DTD0418	SLC5A1	Sodium/glucose cotransporter 1	D22S675; High affinity sodium-glucose cotransporter; NAGT; Na(+)/glucose cotransporter 1; SGLT1; SLC5A1; Solute carrier family 5 member 1	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0418	SLC5A1	Sodium/glucose cotransporter 1	D22S675; High affinity sodium-glucose cotransporter; NAGT; Na(+)/glucose cotransporter 1; SGLT1; SLC5A1; Solute carrier family 5 member 1	DR00198	Fucose	6-Desoxygalactose; AKOS030212707; L-galactomethylose; SCHEMBL13092958
DTD0419	SLC5A10	Sodium/glucose cotransporter 5	Na(+)/glucose cotransporter 5; SGLT-5; SGLT5; SLC5A10; Solute carrier family 5 member 10	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0420	SLC5A11	Sodium/myo-inositol cotransporter 2	KST1; Na(+)/myo-inositol cotransporter 2; RKST1; SGLT6; SLC5A11; SLGTX; SMIT2; Sodium-dependent glucose cotransporter; Sodium/glucose cotransporter KST1; Sodium/myo-inositol transporter 2; Solute carrier family 5 member 11	DR00122	MYO-inositol	1D-Chiro-inositol; 1L-Chiro-inositol; 488-59-5; 643-12-9; 6917-35-7; 87-89-8; Allo-inositol; Cocositol; Cyclohexane-1,2,3,4,5,6-hexaol; Cyclohexitol; D-(+)-chiro-Inositol; D-chiro-Inositol; Dambose; Inosital; Inosite; Inositene; Inositina; Iso-inositol; Meat sugar; Mesoinosit; Mesoinosite; Muco-Inositol; Myoinosite; Neo-inositol; Phaseomannite; Phaseomannitol; Quercinitol; Scyllite; Scyllitol; Scyllo-inositol; cis-Inositol; cyclohexane-1,2,3,4,5,6-hexol; epi-Inositol; i-Inositol; inositol; meso-Inositol; mesoinositol
DTD0421	SLC5A12	Sodium-coupled monocarboxylate transporter 2	Electroneutral sodium monocarboxylate cotransporter; Low-affinity sodium-lactate cotransporter; SLC5A12; SMCT2; Solute carrier family 5 member 12	DR00556	Salicylic acid	2 Hydroxybenzoic Acid; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic acid; 2-Hydroxybenzoic acid; 2-hydroxy(1-14c)benzoic acid; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); ATA fraction 10, ammonium salt; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; Acido o-idrossibenzoico; Acido o-idrossibenzoico [Italian]; Acido salicilico; Acido salicilico [Italian]; Acidum salicylicum; Advanced pain relief callus removers; Advanced pain relief corn removers; Akurza Cream; Akurza Lotion; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Benzoic acid, 2-hydroxy-(9CI); CMC_13852; Clear away wart remover; DHS Sal Shampoo; Domerine; Dr. Scholl's callus removers; Dr. Scholl's corn removers; Dr. Scholl's wart remover kit; DuoPlant Gel; Duofil wart remover; Duofilm; Duoplant; E9A559BE-383B-4F83-BC02-3031D03D558A; Freezone; Hydrisalic Gel; Ionil; Ionil plus; Ionil-Plus; K 537; Keralyt; Kyselina 2-hydroxybenzoova; Kyselina 2-hydroxybenzoova [Czech]; Kyselina salicylova; Kyselina salicylova [Czech]; Mediplast pads; O Hydroxybenzoic Acid; O-Carboxyphenol; O-hydroxybenzoic acid; Occlusal; Ortho Hydroxybenzoic Acid; Ortho-Hydroxybenzoic Acid; Orthohydroxybenzoic acid; P&S Shampoo; Phenol derivative, 7; Phenol-2-carboxylic acid; Propa pH Peel-Off Acne Mask; Psoriacid-S-stift; Retarder SAX; Retarder W; Rutranex; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SALICYLIC ACID, ACS; SAX; Salex Cream; Salex Lotion; Salicylate; Salicylic acid; Salicylic acid & Sulfur Soap; Salicylic acid (6CI,8CI); Salicylic acid (JP15/USP); Salicylic acid (TN); Salicylic acid [USAN:JAN]; Salicylic acid collodion; Salicylic acid soap; Salicylic acid, tech; Salicylic acid, tech.; Salicylic acid-ring-UL-14C; Saligel; Salonil; Sebucare; Sebulex; Stri-Dex; Trans-Ver-Sal; Verrugon
DTD0421	SLC5A12	Sodium-coupled monocarboxylate transporter 2	Electroneutral sodium monocarboxylate cotransporter; Low-affinity sodium-lactate cotransporter; SLC5A12; SMCT2; Solute carrier family 5 member 12	DR00703	Benzoic acid	3230-EP2316457A1; 3230-EP2316825A1; 3230-EP2372017A1; 3230-EP2374454A1; 4-Carboxybenzenide; 766-76-7; AC1L18SS; AC1Q1HDY; AC1Q22CA; BDBM36181; Benzene formic acid; Benzenecarboxylate; Benzeneformate; Benzenemethanoate; Benzoic acid, ion(1-); CHEBI:16150; CJ-00025; CTK2H9612; DTXSID4043771; GTPL4565; LS-190261; NCGC00247905-01; Oracyclic acid; Phenyl carboxylic acid; Phenylcarboxylate; Phenylformate; Retarded BA; STL483236; Tennplas; WPYMKLBDIGXBTP-UHFFFAOYSA-M; ZB000218; ZINC328578076; benzoate anion; benzoic acid anion
DTD0421	SLC5A12	Sodium-coupled monocarboxylate transporter 2	Electroneutral sodium monocarboxylate cotransporter; Low-affinity sodium-lactate cotransporter; SLC5A12; SMCT2; Solute carrier family 5 member 12	DR00987	Gamma-hydroxybutyric acid	3-carboxypropoxy acid; 4 HB; 4-Hydroxy; 4-Hydroxyacid; 4-Hydroxyalkanoic acid; 4-Hydroxybutanoic acid; 4-Hydroxybuttersaeure; 4-Hydroxybutyrate sodium; 4-Hydroxybutyric acid; 4-Hydroxybutyric acid monosodium salt; 4-Hydroxycarboxylic acid; 4-OHB; 4-hydroxy-butyric acid; AA3E2AF0-AB7A-4A1E-A391-199C049D7162; Anetamin; Butanoic acid, 4-hydroxy-, monosodium salt; Butanoic acid, 4-hydroxy-, sodium salt; Butyric acid, 4-hydroxy-, monosodium salt; Butyric acid, 4-hydroxy-, sodium salt; EB 27; GHB; Gam-OH; Gamma OH; Gamma-Hydroxy butyrate; Gamma-Hydroxy sodium butyrate; Gamma-Hydroxybutanoic acid; Gamma-Hydroxybutyrate sodium; Gamma-Hydroxybutyric acid; Gamma-Hydroxybutyric acid decomposition product; Gamma-Hydroxybutyric acid monosodium salt; Gamma-Hydroxybutyric acid, sodium salt; Gamma-OH; Hydroxyb; Oxy-n-butyric acid; Oxybate; Oxybate sodium; SHB; Sodium .gamma.-hydroxybutyrate; Sodium .gamma.-oxybutyrate; Sodium Oxybate (4-hydroxybutanoic acid); Somsanit; Utyric acid monosodium salt; WY 3478; Xyrem; Xyrem (TN)
DTD0422	SLC5A2	Sodium/glucose cotransporter 2	Low affinity sodium-glucose cotransporter; Na(+)/glucose cotransporter 2; SGLT2; SLC5A2; Solute carrier family 5 member 2	DR00165	D-glucose	(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; 2280-44-6; CPC hydrate; Cartose Cerelose; Clearsweet 95; Clintose L; D-Glc; D-Glcp; D-Glucopyranose; D-Glucopyranose, anhydrous; D-Glucopyranoside; D-glucose-ring; DSSTox_CID_2910; EINECS 218-914-5; Glc; Glc-OH; Glucodin; Glucopyranose; Glucopyranose, D-; Glucopyranoside; Glucose 40; Glucose solution; Meritose; Meritose 200; Roferose ST; Staleydex 130; Staleydex 95M; glc-ring
DTD0423	SLC5A3	Sodium/myo-inositol cotransporter	BCW2; Na(+)/myo-inositol cotransporter; SLC5A3; SMIT; SMIT1; Sodium/myo-inositol transporter 1; Solute carrier family 5 member 3	DR00122	MYO-inositol	1D-Chiro-inositol; 1L-Chiro-inositol; 488-59-5; 643-12-9; 6917-35-7; 87-89-8; Allo-inositol; Cocositol; Cyclohexane-1,2,3,4,5,6-hexaol; Cyclohexitol; D-(+)-chiro-Inositol; D-chiro-Inositol; Dambose; Inosital; Inosite; Inositene; Inositina; Iso-inositol; Meat sugar; Mesoinosit; Mesoinosite; Muco-Inositol; Myoinosite; Neo-inositol; Phaseomannite; Phaseomannitol; Quercinitol; Scyllite; Scyllitol; Scyllo-inositol; cis-Inositol; cyclohexane-1,2,3,4,5,6-hexol; epi-Inositol; i-Inositol; inositol; meso-Inositol; mesoinositol
DTD0424	SLC5A4	Sodium/glucose cotransporter 3	DJ90G24.4; SAAT1; SGLT3; SLC5A4; Solute carrier family 5 member 4	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0425	SLC5A5	Sodium/iodide cotransporter	NIS; Na(+)/I(-) cotransporter; Na(+)/I(-) symporter; SLC5A5; Sodium-iodide symporter; Solute carrier family 5 member 5; TDH1	DR00009	Nitrate	14797-55-8; 84145-82-4 (Parent); AC1L1ADK; AKOS015904030; BDBM26988; CHEBI:17632; CHEMBL186200; CTK0H4660; I14-18318; MCULE-5142506228; NHNBFGGVMKEFGY-UHFFFAOYSA-N; NITRATE ION; NO3; NO3(-); NO3-; Nitrate(1-); Nitrate(6CI,7CI,8CI,9CI); Nitrates; Nitrates, in; Nitrates, inorganic, aqueous solution, n.o.s.; Nitrates, inorganic, n.o.s.; Nitrates, inorganic, n.o.s. [UN1447] [Oxidizer]; T93E9Y2844; UN3218; UNII-T93E9Y2844; [NO3](-); nitrooxidane; trioxidonitrate; trioxidonitrate(1-); trioxonitrate; trioxonitrate(1-); trioxonitrate(V)
DTD0426	SLC5A6	Sodium-dependent multivitamin transporter	Na(+)-dependent multivitamin transporter; SLC5A6; SMVT; Solute carrier family 5 member 6	DR00089	Gabapentin enacarbil	ASP8825; GSK 1838262; Gabapentin-XP; Horizant; Regnite; Solzira; XP13512
DTD0427	SLC5A7	High affinity choline transporter 1	CHT; CHT1; CMS20; HMN7A; Hemicholinium-3-sensitive choline transporter; SLC5A7; Solute carrier family 5 member 7	DR00025	Triethylcholine	152-22-7 (chloride); 302-61-4; 5957-17-5 (iodide); 9B2PFY5LLZ; AC1L2YNS; BDBM50366913; CHEMBL318993; CHEMBL555023; Ethanaminium, N,N,N-triethyl-2-hydroxy-; GTPL4760; MCULE-9715160196; SCHEMBL476985; Triethyl (2-hydroxyethyl)ammonium chloride; Triethylaminoethanol; UNII-9B2PFY5LLZ; ZINC394634; triethyl(2-hydroxyethyl)azanium
DTD0428	SLC5A8	Sodium-coupled monocarboxylate transporter 1	AIT; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; SLC5A8; SMCT; SMCT1; Sodium iodide-related cotransporter; Solute carrier family 5 member 8	DR00089	Gabapentin enacarbil	ASP8825; GSK 1838262; Gabapentin-XP; Horizant; Regnite; Solzira; XP13512
DTD0428	SLC5A8	Sodium-coupled monocarboxylate transporter 1	AIT; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; SLC5A8; SMCT; SMCT1; Sodium iodide-related cotransporter; Solute carrier family 5 member 8	DR00156	Propionate	28488-34-8; 3002-EP2374454A1; AC1L2XEZ; AC1Q2RL9; AKOS015901051; AKW5EM890C; BDBM50257201; Bugle; CH3-CH2-COO(-); CHEBI:17272; CHEMBL500826; CJ-04452; CTK4G1579; DTXSID90222279; EtCO2 anion; LS-190254; NCGC00159468-02; NCGC00159468-03; NCGC00159468-04; Propanoic acid, ion(1-); Propanoic acid,neodymium(3+) salt (9CI); Propionate ion; STL483862; Sentry Grain Preservative; UNII-AKW5EM890C; XBDQKXXYIPTUBI-UHFFFAOYSA-M; ZB014971; carboxylatoethane; ethanecarboxylate; metacetonate; propanate; pseudoacetate
DTD0429	SLC5A9	Sodium/glucose cotransporter 4	Na(+)/glucose cotransporter 4; SGLT4; SLC5A9; Solute carrier family 5 member 9; hSGLT4	DR00011	2-Deoxyglucose	2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
DTD0429	SLC5A9	Sodium/glucose cotransporter 4	Na(+)/glucose cotransporter 4; SGLT4; SLC5A9; Solute carrier family 5 member 9; hSGLT4	DR00043	Fructose	(3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, &gt; D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose
DTD0429	SLC5A9	Sodium/glucose cotransporter 4	Na(+)/glucose cotransporter 4; SGLT4; SLC5A9; Solute carrier family 5 member 9; hSGLT4	DR00202	D-mannose	Mannose
DTD0435	SLC63A2	Protein spinster homolog 2	SPNS2; Spinster homolog 2	DR00118	Sphingosine-1-phosphate	(2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate
DTD0439	SLC65A2	Niemann-Pick C1-like protein 1	LDLCQ7; NPC1-like intracellular cholesterol transporter 1; NPC11L1; NPC1L1; SLC65A2	DR00036	Cholesterol	(-)-Cholesterol; (3beta)-cholest-5-en-3-ol; 3-beta-Hydroxycholest-5-ene; 3beta-Hydroxycholest-5-ene; 5-Cholesten-3beta-ol; 5:6-Cholesten-3beta-ol; CCRIS 2834; Cholest-5-en-3-beta-ol; Cholest-5-en-3-ol (3beta)-; Cholest-5-en-3beta-ol; Cholesterin; Cholesterine; Cholesterol base H; Cholesteryl alcohol; Cholestrin; Cholestrol; Cordulan; Dastar; Dusoline; Dusoran; Dythol; HSDB 7; Hydrocerin; Kathro; Lanol; Lidinit; Lidinite; Nimco cholesterol base H; Provitamin D; Super hartolan; Tegolan; Tegolan (VAN); Wool alcohols B. P.
DTD0440	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	Solute carrier family 6 member 1; GAT-1; SLC6A1; GABATR; GABT1; GAT1	DR00831	Gamma-aminobutyric acid	1956/12/2; 3-Carboxypropylamine; 4-Aminobutanoic acid; 4-amino-butanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminalon; Butyric acid, 4-amino-; GABA; GAMMA-AMINO-BUTANOIC ACID; Gaballon; Gamarex; Gamastan; Gammagee; Gammalon; Gammalone; Gammar; Gammasol; Gamulin; Immu-G; Mielogen; Mielomade; Piperidic acid; Piperidinic acid; Reanal; butanoic acid, 4-amino-; gamma-Amino butyric acid; gamma-Aminobutanoic acid; gamma-Aminobuttersaeure; gamma-Aminobutyric acid; gamma-amino-n-butyric acid; gamma-aminobutyric acid; omega-Aminobutyric acid
DTD0443	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GABT3; GAT-3; GAT3; GAT4; SLC6A11; Solute carrier family 6 member 11	DR00306	Beta-alanine	.beta.-Alanine; .beta.-Aminopropionic acid; 11P2JDE17B; 2-Carboxyethylamine; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionic acid; 3-Aminopropionsaeure; 3-amino-propionic acid; AI3-18470; Abufene; Alanine, beta-; B-ALANINE; Beta Alanine; CHEBI:16958; CHEMBL297569; EINECS 203-536-5; FEMA No. 3252; H-beta-Ala-OH; MFCD00008200; NSC 7603; NSC7603; Propanoic acid, 3-amino-; UNII-11P2JDE17B; beta-Ala; beta-Alaine; beta-Alanine, 99%; beta-Aminopropionic acid; beta-Aminopropionsaeure; omega-Aminopropionic acid
DTD0444	SLC6A12	Na(+)/Cl(-) betaine/GABA transporter	BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12	DR00054	Quinine	(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
DTD0444	SLC6A12	Na(+)/Cl(-) betaine/GABA transporter	BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12	DR00121	Choline	(2-Hydroxyethyl)trimethylammonium; (beta-hydroxyethyl)trimethylammonium; 2-Hydroxy-N,N,N-trimethylethanaminium; 2-hydroxyethyl(trimethyl)ammonium; 62-49-7; AI3-24208; BRN 1736748; Bilineurine; CCRIS 5847; CHEBI:15354; CHEMBL920; Choline cation; Choline ion; Cholinum; EINECS 200-535-1; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; N,N,N-trimethylethanol-ammonium; N-trimethylethanolamine; N91BDP6H0X; UNII-N91BDP6H0X; trimethylethanolamine
DTD0444	SLC6A12	Na(+)/Cl(-) betaine/GABA transporter	BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12	DR00179	L-proline	(-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin]
DTD0444	SLC6A12	Na(+)/Cl(-) betaine/GABA transporter	BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12	DR00242	Glycine	(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
DTD0444	SLC6A12	Na(+)/Cl(-) betaine/GABA transporter	BGT-1; BGT1; SLC6A12; Sodium- and chloride-dependent betaine transporter; Solute carrier family 6 member 12	DR00314	Betaine	Cystadane
DTD0445	SLC6A13	Sodium- and chloride-dependent GABA transporter 2	GAT-2; GAT2; SLC6A13; Solute carrier family 6 member 13	DR00306	Beta-alanine	.beta.-Alanine; .beta.-Aminopropionic acid; 11P2JDE17B; 2-Carboxyethylamine; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionic acid; 3-Aminopropionsaeure; 3-amino-propionic acid; AI3-18470; Abufene; Alanine, beta-; B-ALANINE; Beta Alanine; CHEBI:16958; CHEMBL297569; EINECS 203-536-5; FEMA No. 3252; H-beta-Ala-OH; MFCD00008200; NSC 7603; NSC7603; Propanoic acid, 3-amino-; UNII-11P2JDE17B; beta-Ala; beta-Alaine; beta-Alanine, 99%; beta-Aminopropionic acid; beta-Aminopropionsaeure; omega-Aminopropionic acid
DTD0446	SLC6A14	Amino acid transporter ATB0+	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+); BMIQ11; SLC6A14; Solute carrier family 6 member 14	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0449	SLC6A17	Sodium-dependent neurotransmitter transporter	NTT4; SLC6A17; Sodium-dependent neutral amino acid transporter SLC6A17; Solute carrier family 6 member 17	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0450	SLC6A18	Sodium-dependent neutral amino acid transporter B(0)AT3	SLC6A18; Sodium- and chloride-dependent transporter XTRP2; Solute carrier family 6 member 18; Inactive sodium-dependent neutral amino acid transporter B(0)AT3; XTRP2; B(0)AT3; System B(0) neutral amino acid transporter AT3	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0451	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	B0AT1; HND; SLC6A19; Solute carrier family 6 member 19; System B(0) neutral amino acid transporter AT1	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0452	SLC6A2	Sodium-dependent noradrenaline transporter	NET; NET1; Norepinephrine transporter; SLC6A2; Solute carrier family 6 member 2	DR00084	Amphetamine	Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
DTD0452	SLC6A2	Sodium-dependent noradrenaline transporter	NET; NET1; Norepinephrine transporter; SLC6A2; Solute carrier family 6 member 2	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0453	SLC6A20	Sodium/imino-acid transporter 1	SIT1; SLC6A20; Sodium- and chloride-dependent transporter XTRP3; Solute carrier family 6 member 20; Transporter rB21A homolog; XT3; XTRP3	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0455	SLC6A3	Sodium-dependent dopamine transporter	DA transporter; DAT; DAT1; PKDYS; PKDYS1; SLC6A3; Solute carrier family 6 member 3	DR00084	Amphetamine	Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
DTD0455	SLC6A3	Sodium-dependent dopamine transporter	DA transporter; DAT; DAT1; PKDYS; PKDYS1; SLC6A3; Solute carrier family 6 member 3	DR00283	Dopamine	(3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol; A-(3,4-Dihydroxyphenyl)-b-aminoethane; ASL 279; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamin; Dopamina; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine (USAN)(*hydrochloride*); Dopamine [INN:BAN]; Dopaminum; Dopaminum [INN-Latin]; Dophamine; Hydroxytyramin; Hydroxytyramine; IP 498; Intropin; Intropin [*hydrochloride*]; KW-3-060; L-DOPAMINE; LDP; M-Hydroxytyramine hydrochloride; Medopa (TN); Oxytyramine; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; Revimine
DTD0455	SLC6A3	Sodium-dependent dopamine transporter	DA transporter; DAT; DAT1; PKDYS; PKDYS1; SLC6A3; Solute carrier family 6 member 3	DR01325	Bretylium	(2-bromobenzyl)ethyldimethylaminium; (2-bromophenyl)methyl-ethyl-dimethylazanium; (o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate; 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium; Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1); Bretylium tolsylate; Bretylium tosylate(USAN); Bretylum; N-(2-bromobenzyl)-N,N-dimethylethanaminium; N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium
DTD0455	SLC6A3	Sodium-dependent dopamine transporter	DA transporter; DAT; DAT1; PKDYS; PKDYS1; SLC6A3; Solute carrier family 6 member 3	DR01328	Benztropine	benztropine; Benzatropine; Tropine benzohydryl ether; Benzatropinum; Benzatropina; Cogentin; Cogentinol; 3endo-benzhydryloxytropane; UNII-1NHL2J4X8K; Benztropinum; Cogentine; Cobrentin; Akitan; 3alpha-(diphenylmethoxy)tropane; HSDB 3014; NK 02; 1NHL2J4X8K; Benzatropinum [INN-Latin]; Benzatropina [INN-Spanish]; 3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane; 3alpha-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; NCGC00159471-02; (3-endo)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane
DTD0455	SLC6A3	Sodium-dependent dopamine transporter	DA transporter; DAT; DAT1; PKDYS; PKDYS1; SLC6A3; Solute carrier family 6 member 3	DR01335	Brexpiprazole	OPC-34712
DTD0456	SLC6A4	Sodium-dependent serotonin transporter	5-HTT; 5-HTTLPR; 5HT transporter; 5HTT; HTT; OCD1; SERT; SERT1; SLC6A4; Solute carrier family 6 member 4; hSERT; hSERT	DR00189	Serotonin	1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY
DTD0456	SLC6A4	Sodium-dependent serotonin transporter	5-HTT; 5-HTTLPR; 5HT transporter; 5HTT; HTT; OCD1; SERT; SERT1; SLC6A4; Solute carrier family 6 member 4; hSERT; hSERT	DR01227	Oxypertine	1H-Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-; 5,6-Dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indole; 5,6-Dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]-1H-indole; 5JGL4G25R7; BRN 0899339; DO 180; EINECS 205-818-3; Equipertine; Forit; Opertil; Oxipertina [INN-Spanish]; Oxipertine; Oxipertinum; Oxypertine [USAN:INN:BAN:JAN]; Oxypertinum [INN-Latin]; UNII-5JGL4G25R7; WIN 18501-2; XCWPUUGSGHNIDZ-UHFFFAOYSA-N; oxypertine
DTD0457	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GlyT-2; GlyT2; HKPX3; SLC6A5; Solute carrier family 6 member 5	DR00242	Glycine	(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
DTD0457	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GlyT-2; GlyT2; HKPX3; SLC6A5; Solute carrier family 6 member 5	DR00268	Norepinephrine	(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
DTD0457	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GlyT-2; GlyT2; HKPX3; SLC6A5; Solute carrier family 6 member 5	DR00389	Methylphenidate	2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester; Alpha-Phenyl-2-piperidineacetic acid methyl ester; Alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester; Attenta (TN); Biphentin (TN); C 4311; Calocain; Centedein; Centedrin; Centredin; Concerta; Concerta (TN); D-methylphenidate HCl; Daytrana; Daytrana (TN); Equasym (TN); METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R); Meridil; Metadate; Metadate CD; Metadate ER; Metadate ER (TN); MethyPatch; Methyl (2-phenyl-2-(2-piperidyl)acetate); Methyl 2-phenyl-2-piperidin-2-ylacetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; Methyl alpha-phenyl-alpha-2-piperidinylacetate; Methyl phenidate; Methyl phenidyl acetate; Methyl phenidylacetate; Methyl phenyl(piperidin-2-yl)acetate; Methylfenidan; Methylin; Methylin (TN); Methylin ER; Methylofenidan; Methylphen; Methylphenidan; Methylphenidate (USAN/INN); Methylphenidate [INN:BAN]; Methylphenidatum; Methylphenidatum [INN-Latin]; Metilfenidato; Metilfenidato [INN-Spanish]; Metilfenidato [Italian]; Motiron (TN); PMS-Methylphenidate; Phenidylate; Plimasine; Riphenidate; Ritalin; Ritalin (TN); Ritalin LA; Ritalin LA (TN); Ritalin SR; Ritalin-SR; Ritaline; Ritcher works; Rubifen (TN); Tsentedrin
DTD0458	SLC6A6	Sodium- and chloride-dependent taurine transporter	SLC6A6; Solute carrier family 6 member 6; TAUT	DR00167	Taurine	.beta.-Aminoethylsulfonic acid; 1-Aminoethane-2-sulfonic acid; 107-35-7; 1EQV5MLY3D; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine; 2-aminoethane-1-sulfonic acid; 2-aminoethanesulfonic acid; AI3-18307; Aminoethanesulfonic acid; CCRIS 4721; CHEBI:15891; EINECS 203-483-8; Ethanesulfonic acid, 2-amino-; FEMA No. 3813; L-Taurine; NCI-C60606; NSC 32428; NSC32428; O-Due; Taurina [Spanish]; Taurine [INN]; Taurinum [Latin]; UNII-1EQV5MLY3D; aminoethylsulfonic acid; beta-Aminoethylsulfonic acid; taufon; tauphon
DTD0458	SLC6A6	Sodium- and chloride-dependent taurine transporter	SLC6A6; Solute carrier family 6 member 6; TAUT	DR00306	Beta-alanine	.beta.-Alanine; .beta.-Aminopropionic acid; 11P2JDE17B; 2-Carboxyethylamine; 3-Aminopropanoate; 3-Aminopropanoic acid; 3-Aminopropionic acid; 3-Aminopropionsaeure; 3-amino-propionic acid; AI3-18470; Abufene; Alanine, beta-; B-ALANINE; Beta Alanine; CHEBI:16958; CHEMBL297569; EINECS 203-536-5; FEMA No. 3252; H-beta-Ala-OH; MFCD00008200; NSC 7603; NSC7603; Propanoic acid, 3-amino-; UNII-11P2JDE17B; beta-Ala; beta-Alaine; beta-Alanine, 99%; beta-Aminopropionic acid; beta-Aminopropionsaeure; omega-Aminopropionic acid
DTD0459	SLC6A7	Sodium-dependent proline transporter	PROT; SLC6A7; Solute carrier family 6 member 7	DR00179	L-proline	(-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin]
DTD0460	SLC6A8	Creatine transporter 1	CCDS1; CRT; CRTR; CT1; CTR5; SLC6A8; Sodium- and chloride-dependent creatine transporter 1; Solute carrier family 6 member 8	DR00034	Creatine ALS-08	AL-02 (ALS), Avicena; AL-08 (ALS), Avicena; ALS-02; ALS-05; ALS-08; Creatine; Creatine (ALS), Avicena; Creatine (Huntington's disease), Avicena; Creatine (Parkinson's disease), Avicena; Creatine (amyotrophic lateral sclerosis), Avicena; HD-02; PD-01, Avicena; PD-02; PD-04; PD-06
DTD0461	SLC6A9	Sodium- and chloride-dependent glycine transporter 1	GCENSG; GlyT-1; GlyT1; SLC6A9; Solute carrier family 6 member 9	DR00242	Glycine	(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
DTD0461	SLC6A9	Sodium- and chloride-dependent glycine transporter 1	GCENSG; GlyT-1; GlyT1; SLC6A9; Solute carrier family 6 member 9	DR00326	Sarcosine	(Methylamino)acetic acid; (Methylamino)ethanoic acid; 2-(methylamino)acetic acid; AI3-15410; Acetic acid, (methylamino)-; BRN 1699442; CHEBI:15611; CHEMBL304383; Cocoylsarcosine; EINECS 203-538-6; FSYKKLYZXJSNPZ-UHFFFAOYSA-N; Glycine, N-methyl-; H-Sar-OH; Methylamino-Acetic Acid; Methylaminoacetic acid; Methylglycine; N-Methyl glycine; N-Methylaminoacetic acid; N-methyl-Glycine; N-methylglycine; Polysarcosine; SAR; Sarcosin; Sarcosine, 98%; Sarcosinic acid; Sargosine hydrochloride; UNII-Z711V88R5F; Z711V88R5F
DTD0462	SLC7A1	High affinity cationic amino acid transporter 1	ATRC1; CAT-1; CAT1; ERR; Ecotropic retroviral leukemia receptor homolog; Ecotropic retrovirus receptor homolog; HCAT1; REC1L; SLC7A1; Solute carrier family 7 member 1; System Y+ basic amino acid transporter	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0463	SLC7A10	Asc-type amino acid transporter 1	ASC1; Asc-1; HASC-1; SLC7A10; Solute carrier family 7 member 10	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0464	SLC7A11	Cystine/glutamate transporter	Amino acid transport system xc-; CCBR1; Calcium channel blocker resistance protein CCBR1; SLC7A11; Solute carrier family 7 member 11; xCT	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0465	SLC7A13	Sodium-independent aspartate/glutamate transporter 1	AGT-1; AGT1; SLC7A13; Solute carrier family 7 member 13; X-amino acid transporter 2; XAT2	DR00005	L-glutamic acid	(2S)-2-Aminopentanedioic acid; (S)-(+)-Glutamic acid; (S)-2-Aminopentanedioic acid; (S)-Glutamic acid; 1-Aminopropane-1,3-dicarboxylic acid; 2-Aminoglutaric acid; 2-aminopentanedioic acid; A-Aminoglutaric acid; A-Glutamic acid; Acide glutamique; Acide glutamique [INN-French]; Acido glutamico; Acido glutamico [INN-Spanish]; Acidum glutamicum; Acidum glutamicum [INN-Latin]; Acidum glutaminicum; Aciglut; Alpha-Aminoglutaric acid (VAN); Alpha-Glutamic acid; Alpha-L-Glutamic acid polymer; Alpha-aminoglutaric acid; D-Glutamiensuur; E 620; GLUTAMIC ACID; Glu; Glusate; Glut; Glutacid; Glutamate; Glutamic Acid (L-glutamic acid); Glutamic Acid [USAN:INN]; Glutamic acid (H-3); Glutamic acid (VAN); Glutamic acid polymer; Glutamic acid, L-(7CI,8CI); Glutamic acid, L-, peptides; Glutamicol; Glutamidex; Glutaminic acid; Glutaminic acid (VAN); Glutaminol; Glutaton; Gulutamine; Gulutamine (USP); H-Glu-OH; L-(+)-glutamic acid; L-2-Aminoglutaric acid; L-Glutamic acid (9CI); L-Glutamic acid (JAN); L-Glutamic acid hydrochloride; L-Glutamic acid, homopolymer; L-Glutamic acid, homopolymer (9CI); L-Glutaminic acid; L-Glutaminsaeure; L-a-Aminoglutaric acid; L-alpha-Aminoglutaric acid; L-glu; L-glutamate; POLYGLUTAMIC ACID; Poly(alpha-L-glutamic acid); Poly-L-glutamate; Sodium Glutamate (L-glutamic Acid)
DTD0468	SLC7A2	Cationic amino acid transporter 2	ATRC2; CAT-2; CAT2; HCAT2; Low affinity cationic amino acid transporter 2; SLC7A2; Solute carrier family 7 member 2	DR00065	L-ornithine	OKG; Ornithine
DTD0469	SLC7A3	Cationic amino acid transporter 3	ATRC3; CAT-3; CAT3; Cationic amino acid transporter y+; SLC7A3; Solute carrier family 7 member 3	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0471	SLC7A5	L-type amino acid transporter 1	4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter	DR00024	L-glutamine	AES-14; Aesgen-14; E-6014; Glutamine (INN); L-glutamine (oral, short bowel syndrome), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus; L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles; L-glutamine (topical, chemotherapy-induced mucositis), Aesgen; NutreStore; Saforis
DTD0471	SLC7A5	L-type amino acid transporter 1	4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter	DR00125	Levodopa	Levodopa (optimized formulation, Parkinson's disease); Levodopa (optimized formulation, Parkinson's disease), Orion; More effective levodopa (Parkinson's disease), Orion
DTD0471	SLC7A5	L-type amino acid transporter 1	4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter	DR00217	Gabapentin	1-(Aminomethyl)-cyclohexaneacetic acid; 1-(Aminomethyl)cyclohexaneacetic acid; 2-[1-(aminomethyl)cyclohexyl]acetic acid; Aclonium; Apo-Gabapentin; Apotex brand of gabapentin; Aventis brand of gabapentin; DDS-2003; DM-1796; DM-5689; G-154; GBN; GOE 2450; Gabapen; Gabapentin (JAN/USAN/INN); Gabapentin (Neurontin); Gabapentin GR; Gabapentin Hexal; Gabapentin Stada; Gabapentin [USAN:INN:BAN]; Gabapentin-ratiopharm; Gabapentina; Gabapentine; Gabapentine [INN-French]; Gabapentinium; Gabapentino; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum; Gabapentinum [INN-Latin]; Gabapetin; Go 3450; Goe-3450; Hexal brand of gabapentin; Neurontin; Neurontin (TN); Novo-Gabapentin; Novopharm brand of gabapentin; PMS-Gabapentin; Parke Davis brand of gabapentin; Pfizer brand of gabapentin; Pharmascience brand of gabapentin; Ratiopharm brand of gabapentin; Serada; Stadapharm brand of gabapentin; Vultin; Warner-Lambert brand of gabapentin; [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
DTD0471	SLC7A5	L-type amino acid transporter 1	4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter	DR00282	L-histidine	Histidine
DTD0471	SLC7A5	L-type amino acid transporter 1	4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter	DR00303	L-leucine	(2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine
DTD0471	SLC7A5	L-type amino acid transporter 1	4F2 LC; 4F2 light chain; 4F2LC; CD98; CD98 light chain; CD98LC; D16S469E; E16; Integral membrane protein E16; LAT1; Large neutral amino acids transporter small subunit 1; MPE16; SLC7A5; Solute carrier family 7 member 5; hLAT1; y+ system cationic amino acid transporter	DR01255	Pregabalin	Pregabalin (controlled-release, oral); Pregabalin (controlled-release, oral), Pfizer; Pregabalin CR
DTD0473	SLC7A6	Y+L amino acid transporter 2	Cationic amino acid transporter, y+ system; KIAA0245; LAT-2; SLC7A6; Solute carrier family 7 member 6; Y+LAT2; y(+)L-type amino acid transporter 2; y+LAT-2	DR00374	Amino acids	Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
DTD0475	SLC7A8	L-type amino acid transporter 2	LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2	DR00020	L-tyrosine	(-)-alpha-Amino-p-hydroxyhydrocinnamic acid; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; (S)-3-(p-Hydroxyphenyl)alanine; (S)-Tyrosine; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; 2-Amino-3-(p-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; 3-(p-Hydroxyphenyl)alanine; 4-Hydroxy-L-phenylalanine; 4ts1; Alpha-Amino-beta-(4-hydroxyphenyl)propionic acid; Beta-(p-Hydroxyphenyl)alanine; DD69927C-C6A8-4BC6-8E9A-0AB423B176E7; DTY; Free-Form L-Tyrosine; H-Tyr-OH; L-(-)-Tyrosine; L-2-Amino-3-p-hydroxyphenylpropanoic acid; L-Tyrosin; L-Tyrosine (9CI); L-Tyrosine (JAN); L-Tyrosine hydrochloride; L-Tyrosine, homopolymer; L-Tyrosine, monomer; L-p-Tyrosine; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours; P-Tyrosine; Rxosine; TYR NH3+ COOH; Tirosina; Tirosina [Spanish]; Tyr; Tyrosine; Tyrosine (USP/INN); Tyrosine (VAN); Tyrosine Power; Tyrosine [USAN:INN]; Tyrosine, L-(8CI); Tyrosinum; Tyrosinum [Latin]
DTD0475	SLC7A8	L-type amino acid transporter 2	LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2	DR00086	L-tryptophan	(-)-Tryptophan; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; (L)-TRYPTOPHAN; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; (S)-(-)-Tryptopha n; (S)-(-)-Tryptophan; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; (S)-Tryptophan; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-a-Amino-b-indolepropionic acid; (S)-a-Aminoindole-3-propionic acid; (S)-alpha-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; (S)-alpha-Aminoindole-3-propionic acid; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; 1-beta-3-Indolylalanine; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; 1H-Indole-3-alanine; 1H-Indole-3-alanine (VAN); 1beta-3-Indolylalanine; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; 2-Amino-3-indolylpropanoic acid; 2-amino-3-indol-3-ylpropionic acid; 3-Indol-3-ylalanine; Alanine, 3-indol-3-yl; Alpha'-Amino-3-indolepropionic acid; Alpha-Amino-beta-(3-indolyl)-propionic acid; Alpha-amino-beta-(3-indolyl)-pr opionic acid; Alti-Tryptophan; Ardeytropin; EH 121; H-Trp-oh; Indole-3-alanine; Kalma; L-(-)-Tryptophan; L-(-)-Tryptophane; L-TRYPTOPHAN SIGMA GRADE; L-Trp; L-Tryptofan; L-Tryptophan (9CI); L-Tryptophan (JP15); L-Tryptophane; L-Ttp; L-a-Aminoindole-3-propionic acid; L-alpha-Aminoindole-3-propionic acid; L-alpha-amino-3-indolepropionic acid; L-b-3-Indolylalanine; L-beta-3-Indolylalanine; LTR; Lyphan; MT1; Optimax; Pacitron; Propionic acid, 2-amino-3-indol-3-yl; S(-)-1-alpha-Aminoindole-3-propionic acid; Sedanoct; T 0254; TRP NH3+ COOH; TRP-01; Triptofano; Triptofano [Spanish]; Trofan; Trp; Tryptacin; Tryptan; Tryptophan; Tryptophan (H-3); Tryptophan (USP/INN); Tryptophan (VAN); Tryptophan [USAN:INN]; Tryptophan, L-(8CI); Tryptophane; Tryptophane [French]; Tryptophanum; Tryptophanum [Latin]
DTD0475	SLC7A8	L-type amino acid transporter 2	LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2	DR00142	L-alanine	(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
DTD0475	SLC7A8	L-type amino acid transporter 2	LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2	DR00179	L-proline	(-)-(S)-Proline; (-)-2-Pyrrolidinecarboxylic acid; (-)-Proline; (-)-Proline (S)-2-Carboxypyrrolidine; (2S)-pyrrolidine-2-carboxylic acid; (L)-PROLINE; (S)-2-Carboxypyrrolidine; (S)-2-Pyrrolidinecarboxylic acid; (S)-Proline; (S)-Pyrrolidine-2-carboxylic acid; 2-pyrrolidinecarboxylic acid; CB 1707; Carboxypyrrolidine; H-Pro-OH; L-(-)-Proline; L-(2,3-3H)Proline; L-Prolin; L-Proline (JAN); L-Proline, labeled with carbon-14; L-Proline-15N; L-Pyrrolidine-2-carboxylic acid; L-alpha-Pyrrolidinecarboxylic acid; PRO (IUPACabbreviation); Pro; Prolina; Prolina [Spanish]; Proline; Proline (USP); Proline (VAN); Proline [USAN:INN]; Prolinum; Prolinum [Latin]
DTD0475	SLC7A8	L-type amino acid transporter 2	LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2	DR00242	Glycine	(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
DTD0475	SLC7A8	L-type amino acid transporter 2	LAT2; LPI-PC1; Large neutral amino acids transporter small subunit 2; SLC7A8; Solute carrier family 7 member 8; hLAT2	DR00266	L-phenylalanine	(2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin]
DTD0476	SLC7A9	Glycoprotein-associated amino acid transporter b0, +AT1	BAT1; CSNU3; SLC7A9; Solute carrier family 7 member 9; b(0,+)-type amino acid transporter 1; b(0,+)AT1	DR00725	L-citrulline	(2S)-2-amino-5-(carbamoylamino)pentanoic acid; (S)-2-Amino-5-ureidopentanoic acid; 2-Amino-5-ureidovaleric acid; 372-75-8; Citrulline; Citrulline, L-; H-cit-oh; L(+)-citrulline; L-(+)-Citrulline; L-2-Amino-5-ureidovaleric acid; L-Cytrulline; L-Ornithine, N5-(aminocarbonyl)-; L-citrullin; N(delta)-Carbamylornithine; N5-(Aminocarbonyl)ornithine; N5-Carbamoyl-L-ornithine; N5-carbamoylornithine; Ornithine, N5-(aminocarbonyl)-; Sitrulline; alpha-Amino-delta-ureidovaleric acid; d-ureidonorvaline; delta-Ureidonorvaline
DTD0499	SLCO1C1	Organic anion transporting polypeptide 1C1	OAT-RP-5; OATP-14; OATP-F; OATP14; OATP1C1; OATPF; OATPRP5; Organic anion transporter F; Organic anion transporter polypeptide-related protein 5; Organic anion-transporting polypeptide 14; SLC21A14; SLCO1C1; Solute carrier family 21 member 14; Solute carrier organic anion transporter family member 1C1; Thyroxine transporter	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0499	SLCO1C1	Organic anion transporting polypeptide 1C1	OAT-RP-5; OATP-14; OATP-F; OATP14; OATP1C1; OATPF; OATPRP5; Organic anion transporter F; Organic anion transporter polypeptide-related protein 5; Organic anion-transporting polypeptide 14; SLC21A14; SLCO1C1; Solute carrier family 21 member 14; Solute carrier organic anion transporter family member 1C1; Thyroxine transporter	DR00107	Levothyroxine	(-)-Thyroxine; (125I)T4; (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid; 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid; 3,3',5,5"-Tetraiodo-L-thyronine; 3,3',5,5''-Tetraiodo-L-thyronine; 3,3',5,5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodo-L-thyronine; 3,5,3',5'-Tetraiodothyronine; 3,5,3'5'-Tetraiodo-L-thyronine; 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine; 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine; 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine; Beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine;O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; DL-Thyroxin; Eltroxin; Eltroxin (TN); Euthyrox; Euthyrox (TN); Eutirox (TN); Forthyron; Forthyron (TN); L-3,5,3',5'-Tetraiodothyronine; L-T4; L-Thryoxin; L-Thyroxin; L-thyroxine; L-thyroxine (TN); LT00440967; Laevothyroxinum; Laevothyroxinum (acid); Laevoxin; Levaxin (TN); Levo-T; Levolet; Levothroid; Levothroid (*Sodiumsalt*); Levothyrox; Levothyroxin; Levothyroxine (BAN); Levothyroxine Sodium (L-thyroxine); Levothyroxine sodium; Levothyroxinum (acid); Levoxyl; Levoxyl (TN); O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine; O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine; Oroxine; Synthroid; Synthroid (*Sodium salt*); Synthroid (TN); Synthroid sodium; T-3850; T4 (Hormone); T4 levothyroxine; THX; Tetraiodothyronine; Thyratabs; Thyrax; Thyrax (TN); Thyreoideum; Thyrox (TN); Thyroxevan; Thyroxin; Thyroxinal; Thyroxine (VAN); Thyroxine (l); Thyroxine [BAN]; Thyroxine iodine; Thyroxine, L-(8CI)
DTD0499	SLCO1C1	Organic anion transporting polypeptide 1C1	OAT-RP-5; OATP-14; OATP-F; OATP14; OATP1C1; OATPF; OATPRP5; Organic anion transporter F; Organic anion transporter polypeptide-related protein 5; Organic anion-transporting polypeptide 14; SLC21A14; SLCO1C1; Solute carrier family 21 member 14; Solute carrier organic anion transporter family member 1C1; Thyroxine transporter	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0499	SLCO1C1	Organic anion transporting polypeptide 1C1	OAT-RP-5; OATP-14; OATP-F; OATP14; OATP1C1; OATPF; OATPRP5; Organic anion transporter F; Organic anion transporter polypeptide-related protein 5; Organic anion-transporting polypeptide 14; SLC21A14; SLCO1C1; Solute carrier family 21 member 14; Solute carrier organic anion transporter family member 1C1; Thyroxine transporter	DR00208	Estradiol-17beta-glucuronide	[3H]-estradiol-17beta-glucuronide
DTD0500	SLCO2A1	Organic anion transporting polypeptide 2A1	MATR1; OATP2A1; PGT; PHOAR2; Prostaglandin transporter; SLC21A2; SLCO2A1; Solute carrier family 21 member 2; Solute carrier organic anion transporter family member 2A1	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0500	SLCO2A1	Organic anion transporting polypeptide 2A1	MATR1; OATP2A1; PGT; PHOAR2; Prostaglandin transporter; SLC21A2; SLCO2A1; Solute carrier family 21 member 2; Solute carrier organic anion transporter family member 2A1	DR00099	Iloprost	ILOPROST; Ciloprost; Ventavis; Iloprostum; Endoprost; Ilomedin; ZK 36374; 78919-13-8; CHEMBL494; Iloprostum [Latin]; [3H]-Iloprost; Ventavis (TN); ZK-36374; (16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I2; (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid; SR-05000001498; Iloprost [USAN:INN:BAN]; Ilomedine; BAY Q6256; (16R,S)-Methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I(sub 2)
DTD0500	SLCO2A1	Organic anion transporting polypeptide 2A1	MATR1; OATP2A1; PGT; PHOAR2; Prostaglandin transporter; SLC21A2; SLCO2A1; Solute carrier family 21 member 2; Solute carrier organic anion transporter family member 2A1	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0500	SLCO2A1	Organic anion transporting polypeptide 2A1	MATR1; OATP2A1; PGT; PHOAR2; Prostaglandin transporter; SLC21A2; SLCO2A1; Solute carrier family 21 member 2; Solute carrier organic anion transporter family member 2A1	DR00168	Latanoprost	AR-202; Catioprost; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; L1167_SIGMA; Latanoprost (JAN/USAN/INN); Latanoprost free acid; Nova-21027; PHXA-41; PhXA34 [as 15(R,S)-isomer]; PhXA41; Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate; Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; XA-41; XA41; Xalatan; Xalatan (TN)
DTD0500	SLCO2A1	Organic anion transporting polypeptide 2A1	MATR1; OATP2A1; PGT; PHOAR2; Prostaglandin transporter; SLC21A2; SLCO2A1; Solute carrier family 21 member 2; Solute carrier organic anion transporter family member 2A1	DR00210	Alprostadil	(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros
DTD0501	SLCO3A1	Organic anion transporting polypeptide 3A1	OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1	DR00007	Prostaglandin f2Alpha	Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
DTD0501	SLCO3A1	Organic anion transporting polypeptide 3A1	OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0501	SLCO3A1	Organic anion transporting polypeptide 3A1	OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1	DR00099	Iloprost	ILOPROST; Ciloprost; Ventavis; Iloprostum; Endoprost; Ilomedin; ZK 36374; 78919-13-8; CHEMBL494; Iloprostum [Latin]; [3H]-Iloprost; Ventavis (TN); ZK-36374; (16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I2; (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid; SR-05000001498; Iloprost [USAN:INN:BAN]; Ilomedine; BAY Q6256; (16R,S)-Methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I(sub 2)
DTD0501	SLCO3A1	Organic anion transporting polypeptide 3A1	OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0501	SLCO3A1	Organic anion transporting polypeptide 3A1	OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1	DR00210	Alprostadil	(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid; (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid; (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid; 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid; Alista; Alprostadil (JP15/USP/INN); Alprostadil Prostoglandin E1; Alprostadilum; Alprox-TD; BML1-F06; Befar; Befar (TN); Caverject; Caverject (TN); Edex; Edex (TN); FemLife; Femprox; HEI-507; L-Prostaglandin E1; MR 256; MR-256; Muse; Muse (TN); PGE1; PGE1 Oligomer; Prink; Prink (TN); Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer; Prostaglandin E1; Prostavasin; Prostin VR; Prostin VR Pediatric; Prostin VR pediatric (TN); RayVa; Sugiran; Topiglan; U-10136; Viridal; Vitaros
DTD0501	SLCO3A1	Organic anion transporting polypeptide 3A1	OATP-D; OATP-RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide-related protein 3; Organic anion-transporting polypeptide D; PGE1 transporter; SLC21A11; SLCO3A1; Sodium-independent organic anion transporter D; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0502	SLCO4A1	Organic anion transporting polypeptide 4A1	Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0502	SLCO4A1	Organic anion transporting polypeptide 4A1	Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0502	SLCO4A1	Organic anion transporting polypeptide 4A1	Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0502	SLCO4A1	Organic anion transporting polypeptide 4A1	Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1	DR00488	Benzylpenicillin	6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
DTD0502	SLCO4A1	Organic anion transporting polypeptide 4A1	Colon organic anion transporter; OATP-E; OATP-RP1; OATP4A1; OATPE; OATPRP1; Organic anion transporter polypeptide-related protein 1; Organic anion-transporting polypeptide E; POAT; SLC21A12; SLCO4A1; Sodium-independent organic anion transporter E; Solute carrier family 21 member 12; Solute carrier organic anion transporter family member 4A1	DR01121	Taurocholic acid	2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
DTD0503	SLCO4C1	Organic anion transporting polypeptide 4C1	OATP-H; OATP-M1; OATP4C1; OATPX; Organic anion transporter M1; PRO2176; SLC21A20; SLCO4C1; Solute carrier family 21 member 20	DR00019	Estrone sulfate	Estrone 3-sulfate; Estrone hydrogen sulfate; Estrone sulphate; [3H]-estrone hydrogen sulfate; [3H]-estrone-3-sulphate; [3H]estrone-3-sulfate; [3H]estrone-3-sulphate
DTD0503	SLCO4C1	Organic anion transporting polypeptide 4C1	OATP-H; OATP-M1; OATP4C1; OATPX; Organic anion transporter M1; PRO2176; SLC21A20; SLCO4C1; Solute carrier family 21 member 20	DR00148	Digoxin	(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; 12beta-Hydroxydigitoxin; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}; Digitek (TN); Digoxin (JP15/USP); Lanoxicaps (TN); Lanoxin (TN)
DTD0503	SLCO4C1	Organic anion transporting polypeptide 4C1	OATP-H; OATP-M1; OATP4C1; OATPX; Organic anion transporter M1; PRO2176; SLC21A20; SLCO4C1; Solute carrier family 21 member 20	DR00155	Ouabain	3-((6-deoxyhexopyranosyl)oxy)-1,5,11,14,19-pentahydroxycard-20(22)-enolide; 3-[(6-Deoxyhexopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide; Acocantherin; Acocantherine; Acolongifloroside K; Astrobain; G-Strophanthin; G-Strophanthin (JAN); G-Strophicor; Gratibain; Gratus strophanthin; Kombetin; O 3125; OBN; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabagenin-L-rhamnosid [German]; Ouabain (anhydrous); Ouabain anhydrous; Ouabain octahydrate; Ouabain, Octahydrate; Ouabaine; Oubain; Purostrophan; Quabain; Rectobaina; Solufantina; Strodival; Strophalen; Strophanthin G; Strophanthin-G; Strophoperm; Strophosan; Uabaina; Uabanin
DTD0503	SLCO4C1	Organic anion transporting polypeptide 4C1	OATP-H; OATP-M1; OATP4C1; OATPX; Organic anion transporter M1; PRO2176; SLC21A20; SLCO4C1; Solute carrier family 21 member 20	DR00173	Liothyronine	(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid; 3,3',5-Triiodo-L-thyronine; 3,3',5-Triiodothyronine; 3,3'5-Triiodo-L-thyronine; 3,5,3'-Tri-iodo-L-thyronine; 3,5,3'-Triiodo-L-thyronine; 3,5,3'-triiodothyronine; 3,5,3'TRIIODOTHYRONINE; 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine; 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine; Cytomel (TN); Euthroid-0.5; Euthroid-1; Euthroid-2; Euthroid-3; L-3,3',5-TriioDOThyronine; L-3,5,3'-Triiodothyronine; L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine; L-Liothyronine; L-T3; L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI); Liothyronin; Liothyronine (INN); Liothyronine I 131; Liothyronine I 131 [USAN]; Liothyronine [INN:BAN]; Liothyroninum; Liothyroninum[INN-Latin]; Liotironina; Liotironina [INN-Spanish]; Lyothyronine; O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine; Rathyronine; T3 (Hormone); T3 (Triiodothyronine); T3 (VAN); T3 (amino acid); T3 liothyronine; THYROID HORMONE; TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%); Tertroxin (TN); Thyrolar-0.25; Thyrolar-0.5; Thyrolar-1; Thyrolar-2; Thyrolar-3; Thyronine, 3,3',5-triiodo-, L-(6CI); Tresitope; Tri-Thyrotope; Triiodo-L-thyronine; Triiodothyronine; Triiodothyronine (T3); Triomet-131; Triothyrone
DTD0503	SLCO4C1	Organic anion transporting polypeptide 4C1	OATP-H; OATP-M1; OATP4C1; OATPX; Organic anion transporter M1; PRO2176; SLC21A20; SLCO4C1; Solute carrier family 21 member 20	DR00226	Saxagliptin	(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3; BMS 477118-11; BMS-477118; BMS-477118-11; Kombiglyze XR (TN); OPC-262; Onglyza; Onglyza (TN)
DTD0504	SLCO5A1	Organic anion transporting polypeptide 5A1	OATP-J; OATP-RP4; OATP5A1; OATPJ; OATPRP4; Solute carrier organic anion transporter family member 5A1; SLC21A15; SLCO5A1; Solute carrier family 21 member 15; Organic anion transporter polypeptide-related protein 4	DR00102	Dinoprostone	(15S)-Prostaglandin E2; (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI); 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; Alpha, PGE2; Alpha, Prostaglandin E2; BML1-F07; BMS-279654 & PGE2; Cervidil; Cervidil (TN); Dinoproston; Dinoprostona; Dinoprostona [INN-Spanish]; Dinoprostone (JAN/USP/INN); Dinoprostone Prostaglandin E2; Dinoprostone [USAN:INN:BAN:JAN]; Dinoprostone beta-Cyclodextrin Clathrate; Dinoprostonum; Dinoprostonum [INN-Latin]; E2 alpha, Prostaglandin; E2, Prostaglandin; E2alpha, Prostaglandin; Gel, Prepidil; L-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid; L-PGE2; L-Prostaglandin E2; Minprositin E2; Minprostin E2; PGE2; PGE2 alpha; PGE2alpha; Prepidil; Prepidil (TN); Prepidil Gel; Propess; Propess (TN); Prostaglandin E2; Prostaglandin E2 alpha; Prostaglandin E2alpha; Prostarmon E2; Prostarmon E;Prostin E; Prostenon; Prostin; Prostin E2; Prostin E2 (TN); U 12062; U-12062; [3H]PGE2
DTD0515	ATP10A	Probable phospholipid-transporting ATPase VA	ATP10A; ATP10C; ATPVA; ATPVC; ATPase class V type 10A; Aminophospholipid translocase VA; KIAA0566; P4-ATPase flippase complex alpha subunit ATP10A	DR00294	Phosphatidylethanolamine	Cephalin
DTD0533	ATP7B	Copper-transporting ATPase 2	ATP7B; Copper pump 2; PWD; WC1; WND; Wilson disease-associated protein	DR00291	Cisplatin	(SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Abiplatin; Biocisplatinum; Briplatin; Cis-DDP; Cis-Diamminedichloroplatinum; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Cismaplat; Cisplatin (Chemotherapy); Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Peyrone's chloride; Peyrone's salt; Plastin; Platamine; Platidiam; Platinoxan; Randa; Trans-diamminedichloridoplatinum(II)
DTD0537	RALBP1	RalBP1-associated Eps domain-containing protein 2	POB1; Partner of RalBP1; REPS2; RIP1; RLIP1; RLIP76; RalBP1-interacting protein 2	DR00304	Sorafenib	4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate; 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide; 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE; N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nexavar; Nexavar (TN); Sorafenib (INN); Sorafenib (Pan-TK inhibitor); Sorafenib [INN]; Sorafenibum
DTD0537	RALBP1	RalBP1-associated Eps domain-containing protein 2	POB1; Partner of RalBP1; REPS2; RIP1; RLIP1; RLIP76; RalBP1-interacting protein 2	DR00454	Sunitinib	5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE; KS-5022; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; PDGF TK antagonist; SU-11248J; SU-12662; SU11248; Su-011248; Sunitanib; Sunitinib (INN); Sunitinib (Pan-TK inhibitor); Sunitinib (free base); Sunitinibum; Sutent (TN)